PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Meckler, AN; Clarkson, MO; Cobb, KM; Sodemann, H; Adkins, JF				Meckler, A. N.; Clarkson, M. O.; Cobb, K. M.; Sodemann, H.; Adkins, J. F.			Interglacial Hydroclimate in the Tropical West Pacific Through the Late Pleistocene	SCIENCE			English	Article							WARM POOL; CLIMATE; VARIABILITY; ICE; TEMPERATURES; INSOLATION; MARINE; TRENDS; KA	Records of atmospheric carbon dioxide concentration (P-CO2) and Antarctic temperature have revealed an intriguing change in the magnitude of interglacial warmth and P-CO2 at around 430,000 years ago (430 ka), but the global climate repercussions of this change remain elusive. Here, we present a stalagmite-based reconstruction of tropical West Pacific hydroclimate from 570 to 210 ka. The results suggest similar regional precipitation amounts across the four interglacials contained in the record, implying that tropical hydroclimate was insensitive to interglacial differences in P-CO2 and high-latitude temperature. In contrast, during glacial terminations, drying in the tropical West Pacific accompanied cooling events in northern high latitudes. Therefore, the tropical convective heat engine can either stabilize or amplify global climate change, depending on the nature of the climate forcing.	[Meckler, A. N.; Adkins, J. F.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Meckler, A. N.] Swiss Fed Inst Technol, Inst Geol, Zurich, Switzerland; [Clarkson, M. O.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Cobb, K. M.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Sodemann, H.] Swiss Fed Inst Technol, Inst Atmosphere & Climate, Zurich, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; University System of Georgia; Georgia Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Meckler, AN (corresponding author), CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA.	nele.meckler@erdw.ethz.ch	Adkins, Jess/GYI-8778-2022; Meckler, Anna Nele/AAC-2490-2020; Sodemann, Harald/ABG-5304-2021	Meckler, Anna Nele/0000-0002-7225-8276; Sodemann, Harald/0000-0002-8167-0860; Clarkson, Matthew/0000-0002-2527-4556; Cobb, Kim/0000-0002-2125-9164	Swiss National Science Foundation (SNF); German Research Foundation (DFG); US NSF [ATM-0318445, ATM-0903099, ATM-0645291]; Edinburgh University	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); German Research Foundation (DFG)(German Research Foundation (DFG)); US NSF(National Science Foundation (NSF)); Edinburgh University	We thank B. Clark, S. Lejau, and J. Malang of Mulu National Park, as well as J. Partin for assistance in the field. A. Tuen (Universiti Malaysia Sarawak) greatly facilitated fieldwork in Sarawak. N. Sharma and K. Stewart are acknowledged for assistance with stable isotope measurements. D. Lund, A. Subhas, and D. Fernandez are thanked for assistance and advice with U-Th dating. J. Eiler provided access to his facilities at the California Institute of Technology. Support for this work was provided by the Swiss National Science Foundation (SNF) and the German Research Foundation (DFG) through postdoctoral fellowships to A.N.M.; by the US NSF through grants ATM-0318445 and ATM-0903099 to J.F.A, as well as ATM-0645291 to K.M.C.; and by an Edinburgh University Principal's Career Development Ph.D. Scholarship to M.O.C.	Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Candy I, 2010, EARTH-SCI REV, V103, P183, DOI 10.1016/j.earscirev.2010.09.007; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; de Garidel-Thoron T, 2005, NATURE, V433, P294, DOI 10.1038/nature03189; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Fairchild IJ, 2006, EARTH-SCI REV, V75, P105, DOI 10.1016/j.earscirev.2005.08.003; Fawcett PJ, 2011, NATURE, V470, P518, DOI 10.1038/nature09839; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Knippertz P, 2010, J CLIMATE, V23, P987, DOI 10.1175/2009JCLI3333.1; Kurita N, 2009, J GEOCHEM EXPLOR, V102, P113, DOI 10.1016/j.gexplo.2009.03.002; Lang N, 2011, CLIM PAST, V7, P361, DOI 10.5194/cp-7-361-2011; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Lewis SC, 2010, CLIM PAST, V6, P325, DOI 10.5194/cp-6-325-2010; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MANABE S, 1980, J GEOPHYS RES-OCEANS, V85, P5529, DOI 10.1029/JC085iC10p05529; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Tachikawa K, 2011, QUATERNARY SCI REV, V30, P3716, DOI 10.1016/j.quascirev.2011.09.016; Tzedakis PC, 2006, QUATERNARY SCI REV, V25, P3416, DOI 10.1016/j.quascirev.2006.09.002; Tzedakis PC, 2009, NAT GEOSCI, V2, P751, DOI 10.1038/NGEO660; Yin QZ, 2008, CLIM PAST, V4, P29, DOI 10.5194/cp-4-29-2008; Yin QZ, 2010, NAT GEOSCI, V3, P243, DOI 10.1038/NGEO771	29	63	67	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1301	1304		10.1126/science.1218340	http://dx.doi.org/10.1126/science.1218340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22555435				2022-12-28	WOS:000304905300045
J	Blumenthal, D				Blumenthal, David			Performance Improvement in Health Care - Seizing the Moment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA; [Blumenthal, David] Commiss High Performance Hlth Syst, Commonwealth Fund, New York, NY USA	Harvard University; Harvard Medical School; Commonwealth Fund	Blumenthal, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Anderson G, 2010, CHRONIC CARE MAKING; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Commission on a High Performance Health System, 2012, PERF IMPR IMP UT COO; Guterman S, 2009, REFORMING PROVI3ER P; Holahan J, 2011, POTENTIAL SAVINGS EN	5	42	42	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1953	1955		10.1056/NEJMp1203427	http://dx.doi.org/10.1056/NEJMp1203427			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946LL	22533534				2022-12-28	WOS:000304353000004
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC Allocation of NHS resources: are some patients more equal than others?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Jaques H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3391	2	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e3362	10.1136/bmj.e3362	http://dx.doi.org/10.1136/bmj.e3362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589525				2022-12-28	WOS:000304086900014
J	Petersen, LA; Simpson, K; SoRelle, R; Urech, T; Chitwood, SS				Petersen, Laura A.; Simpson, Kate; SoRelle, Richard; Urech, Tracy; Chitwood, Supicha Sookanan			How Variability in the Institutional Review Board Review Process Affects Minimal-Risk Multisite Health Services Research	ANNALS OF INTERNAL MEDICINE			English	Review							MULTICENTER; QUALITY; PERFORMANCE; DESIGN; IMPACT; TRIAL; COSTS; PAY	Background: The Department of Health and Human Services recently called for public comment on human subjects research protections. Objective: To assess variability in reviews across institutional review boards (IRBs) for a multisite, minimal-risk trial of financial incentives for evidence-based hypertension care and to quantify the effect of review determinations on site participation, budget, and timeline. Design: A natural experiment occurring from multiple IRBs reviewing the same protocol for a multicenter trial (May 2005 to October 2007). Participants: 25 Veterans Affairs (VA) medical centers. Measurements: Number of submissions, time to approval, and costs were evaluated; patient complexity, academic affiliation, size, and location (urban or rural) between participating and nonparticipating VA medical centers were compared. Results: Of 25 eligible VA medical centers, 6 did not meet requirements for IRB review and 2 declined to participate. Of 17 applications, 14 were approved. The process required 115 submissions, lasted 27 months, and cost close to $170 000 in staff salaries. One IRB's concern about incentivizing a particular medication recommended by national guidelines prompted a change in our design to broaden our inclusion criteria beyond uncomplicated hypertension. The change required amending the protocol at 14 sites to preserve internal validity. The IRBs that approved the protocol classified it as minimal risk. The 12 sites that ultimately participated in the trial were more likely to be urban and academically affiliated and to care for more complex patients, which limits the external validity of the trial's findings. Limitation: Because data came from a single multisite trial in the VA system that uses a 2-stage review process, generalizability is limited. Conclusion: Complying with IRB requirements for a minimal-risk study required substantial resources and threatened the study's internal and external validity. The current review of regulatory requirements may address some of these problems.	[Petersen, Laura A.] Michael E DeBakey VA Med Ctr, Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Petersen, LA (corresponding author), Michael E DeBakey VA Med Ctr, Houston Vet Affairs Hlth Serv Res & Dev Ctr Excel, Hlth Serv Res & Dev 152,2002 Holcombe Blvd, Houston, TX 77030 USA.	laurap@bcm.edu			Veterans Affairs Health Services Research and Development [04-349]; National Heart, Lung, and Blood Institute; National Institutes of Health [R01 HL079173-01]; Houston Veterans Affairs Health Services Research and Development Center of Excellence [HFP90-020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079173] Funding Source: NIH RePORTER	Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Veterans Affairs Health Services Research and Development Center of Excellence; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Veterans Affairs Health Services Research and Development and the National Heart, Lung, and Blood Institute.; The Veterans Affairs Health Services Research and Development Investigator-Initiated Research 04-349, National Institutes of Health R01 HL079173-01, and Houston Veterans Affairs Health Services Research and Development Center of Excellence HFP90-020 funded the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation of this manuscript.	Angell EL, 2008, QUAL SAF HEALTH CARE, V17, P131, DOI 10.1136/qshc.2007.022756; Baily MA, 2008, NEW ENGL J MED, V358, P768, DOI 10.1056/NEJMp0800372; Blustein J, 2007, HEALTH SERV RES, V42, P1773, DOI 10.1111/j.1475-6773.2006.00687.x; Byrne MM, 2009, HEALTH SERV RES, V44, P577, DOI 10.1111/j.1475-6773.2008.00916.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dziak K, 2005, HEALTH SERV RES, V40, P279, DOI 10.1111/j.1475-6773.2005.00353.x; Emanuel EJ, 2011, NEW ENGL J MED, V365, P1145, DOI 10.1056/NEJMsb1106942; Gittner LS, 2011, J MED ETHICS, V37, P118, DOI 10.1136/jme.2010.037226; Green LA, 2006, HEALTH SERV RES, V41, P214, DOI 10.1111/j.1475-6773.2005.00458.x; Greene SM, 2006, J CLIN EPIDEMIOL, V59, P784, DOI 10.1016/j.jclinepi.2005.11.018; Greene SM, 2006, ANN EPIDEMIOL, V16, P275, DOI 10.1016/j.annepidem.2005.02.016; Helfand BT, 2009, J UROLOGY, V181, P2674, DOI 10.1016/j.juro.2009.02.032; Hirshon JM, 2002, ACAD EMERG MED, V9, P1417, DOI 10.1197/aemj.9.12.1417; Humphreys K, 2003, ANN INTERN MED, V139, P77, DOI 10.7326/0003-4819-139-1-200307010-00021; Larson E, 2004, J NURS SCHOLARSHIP, V36, P260, DOI 10.1111/j.1547-5069.2004.04047.x; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; Naik AD, 2009, NEW ENGL J MED, V360, P1929, DOI 10.1056/NEJMp0902195; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Petersen LA, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-114; Pogorzelska M, 2010, NURS OUTLOOK, V58, P181, DOI 10.1016/j.outlook.2010.04.003; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Ravina B, 2010, ANN NEUROL, V67, P258, DOI 10.1002/ana.21831; Silberman G, 2011, MILBANK Q, V89, P599, DOI 10.1111/j.1468-0009.2011.00644.x; Silverman H, 2001, CRIT CARE MED, V29, P235, DOI 10.1097/00003246-200102000-00002; Stair TO, 2001, ACAD EMERG MED, V8, P636, DOI 10.1111/j.1553-2712.2001.tb00177.x; Stark AR, 2010, J PERINATOL, V30, P163, DOI 10.1038/jp.2009.157; Thompson DA, 2011, J HEALTHC QUAL; Vick CC, 2005, AM J SURG, V190, P805, DOI 10.1016/j.amjsurg.2005.07.024; Wagner TH, 2010, J CLIN ONCOL, V28, P662, DOI 10.1200/JCO.2009.23.2470	29	35	35	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					728	U120		10.7326/0003-4819-156-10-201205150-00011	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	944IQ	22586010	Green Accepted			2022-12-28	WOS:000304193400019
J	Barbot, S; Lapusta, N; Avouac, JP				Barbot, Sylvain; Lapusta, Nadia; Avouac, Jean-Philippe			Under the Hood of the Earthquake Machine: Toward Predictive Modeling of the Seismic Cycle	SCIENCE			English	Article							SAN-ANDREAS FAULT; ROCK FRICTION; PARKFIELD; RUPTURE; SLIP; RECURRENCE; SIMULATION; CALIFORNIA; STRENGTH; BEHAVIOR	Advances in observational, laboratory, and modeling techniques open the way to the development of physical models of the seismic cycle with potentially predictive power. To explore that possibility, we developed an integrative and fully dynamic model of the Parkfield segment of the San Andreas Fault. The model succeeds in reproducing a realistic earthquake sequence of irregular moment magnitude (M-w) 6.0 main shocks-including events similar to the ones in 1966 and 2004-and provides an excellent match for the detailed interseismic, coseismic, and postseismic observations collected along this fault during the most recent earthquake cycle. Such calibrated physical models provide new ways to assess seismic hazards and forecast seismicity response to perturbations of natural or anthropogenic origins.	[Barbot, Sylvain; Lapusta, Nadia; Avouac, Jean-Philippe] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lapusta, Nadia] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Barbot, S (corresponding author), CALTECH, Div Geol & Planetary Sci, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sbarbot@caltech.edu	Avouac, Jean-Philippe/B-5699-2015; Barbot, Sylvain/H-2959-2012	Avouac, Jean-Philippe/0000-0002-3060-8442; Barbot, Sylvain/0000-0003-4257-7409	National Science Foundation [EAR 0548277]; Gordon and Betty Moore Foundation; Southern California Earthquake Center (SCEC); Humboldt Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Southern California Earthquake Center (SCEC); Humboldt Foundation(Alexander von Humboldt Foundation)	This study was supported partly by the National Science Foundation (grant EAR 0548277 to N.L.), the Gordon and Betty Moore Foundation, and the Southern California Earthquake Center (SCEC). This is Tectonics Observatory contribution #194 and SCEC #1600. Numerical simulations for this study were carried out on the CITerra Dell cluster at the Division of Geological and Planetary Sciences of the California Institute of Technology. J.P.A. worked on this study while on sabbatical at GFZ (German Research Centre for Geosciences) (Potsdam, Germany) with support from the Humboldt Foundation. GPS data used in this study are available from the Scripps Orbit and Permanent Array Center. Numerical data are available upon request to the authors.	Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; BAKUN WH, 1985, SCIENCE, V229, P619, DOI 10.1126/science.229.4714.619; Barbot S, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005748; Beeler NM, 1996, J GEOPHYS RES-SOL EA, V101, P8697, DOI 10.1029/96JB00411; BEN-ZION Y, 1993, J GEOPHYS RES-SOL EA, V98, P2135, DOI 10.1029/92JB02154; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Bruhat L, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008073; Dieterich JH, 2010, PURE APPL GEOPHYS, V167, P1087, DOI 10.1007/s00024-010-0094-0; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Ferri F, 2010, TERRA NOVA, V22, P347, DOI 10.1111/j.1365-3121.2010.00955.x; Fletcher JB, 1998, J GEOPHYS RES-SOL EA, V103, P835, DOI 10.1029/97JB01797; Hori T, 2004, EARTH PLANET SC LETT, V228, P215, DOI 10.1016/j.epsl.2004.09.033; Johanson IA, 2006, B SEISMOL SOC AM, V96, pS269, DOI 10.1785/0120050818; Kaneko Y, 2010, NAT GEOSCI, V3, P363, DOI 10.1038/NGEO843; Konca AO, 2008, NATURE, V456, P631, DOI 10.1038/nature07572; Lapusta N, 2000, J GEOPHYS RES-SOL EA, V105, P23765, DOI 10.1029/2000JB900250; Lapusta N, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005934; Lockner DA, 2011, NATURE, V472, P82, DOI 10.1038/nature09927; Ma S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005216; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Noda H, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007780; Olsen KB, 1997, SCIENCE, V278, P834, DOI 10.1126/science.278.5339.834; OPPENHEIMER DH, 1990, J GEOPHYS RES-SOLID, V95, P8483, DOI 10.1029/JB095iB06p08483; Peng ZG, 2009, NAT GEOSCI, V2, P877, DOI 10.1038/ngeo697; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; SEGALL P, 1993, J GEOPHYS RES-SOL EA, V98, P4527, DOI 10.1029/92JB02408; Shelly DR, 2010, NATURE, V463, P648, DOI 10.1038/nature08755; Thurber C, 2006, B SEISMOL SOC AM, V96, pS38, DOI 10.1785/0120050825; Tullis TE, 1996, P NATL ACAD SCI USA, V93, P3803, DOI 10.1073/pnas.93.9.3803; Uchide T, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036824; Waldhauser F, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020649; WYSS M, 1990, NATURE, V345, P426, DOI 10.1038/345426a0; Yamashita F, 2004, SCIENCE, V306, P261, DOI 10.1126/science.1101771	35	169	175	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					707	710		10.1126/science.1218796	http://dx.doi.org/10.1126/science.1218796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582259				2022-12-28	WOS:000303872300046
J	Ding, DQ; Okamasa, K; Yamane, M; Tsutsumi, C; Haraguchi, T; Yamamoto, M; Hiraoka, Y				Ding, Da-Qiao; Okamasa, Kasumi; Yamane, Miho; Tsutsumi, Chihiro; Haraguchi, Tokuko; Yamamoto, Masayuki; Hiraoka, Yasushi			Meiosis-Specific Noncoding RNA Mediates Robust Pairing of Homologous Chromosomes in Meiosis	SCIENCE			English	Article							MEIOTIC REGULATOR MEI2P; FISSION YEAST; RECOMBINATION; DYNAMICS; RECOGNITION; MOVEMENT; PROPHASE	Pairing and recombination of homologous chromosomes are essential for ensuring reductional segregation in meiosis. However, the mechanisms by which chromosomes recognize their homologous partners are poorly understood. Here, we report that the sme2 gene encodes a meiosis-specific noncoding RNA that mediates homologous recognition in the fission yeast Schizosaccharomyces pombe. The sme2 locus shows robust pairing from early in meiotic prophase. The sme2 RNA transcripts accumulate at their respective gene loci and greatly enhance pairing of homologous loci: Deletion of the sme2 sequence eliminates this robust pairing, whereas transposition to other chromosomal sites confers robust pairing at those ectopic sites. Thus, we propose that RNA transcripts retained on the chromosome play an active role in recognition of homologous chromosomes for pairing.	[Ding, Da-Qiao; Okamasa, Kasumi; Yamane, Miho; Tsutsumi, Chihiro; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan; [Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamamoto, Masayuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; University of Tokyo	Hiraoka, Y (corresponding author), Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan.	hiraoka@fbs.osaka-u.ac.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228; Ding, Da-Qiao/0000-0003-4403-2760	KAKENHI from MEXT of Japan; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	KAKENHI from MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Andoh and T. Tani for providing the RNA visualizing system; J. Nakayama for S. pombe strains; A. Yamashita for discussions; C. Mori and N. Sakurai for technical support. This work was supported by KAKENHI grants from MEXT of Japan to D.-Q.D., T.H., M. Yamamoto, and Y.H.	Andoh T, 2006, BIOCHEM BIOPH RES CO, V351, P999, DOI 10.1016/j.bbrc.2006.10.139; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Ding DQ, 2010, FEBS J, V277, P565, DOI 10.1111/j.1742-4658.2009.07501.x; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ellermeier C, 2005, P NATL ACAD SCI USA, V102, P10952, DOI 10.1073/pnas.0504805102; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; McKim KS, 2005, CELL, V123, P989, DOI 10.1016/j.cell.2005.11.031; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Shimada T, 2003, MOL BIOL CELL, V14, P2461, DOI 10.1091/mbc.E02-11-0738; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	23	89	91	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					732	736		10.1126/science.1219518	http://dx.doi.org/10.1126/science.1219518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582262				2022-12-28	WOS:000303872300053
J	Gagne, JP; Rouleau, M; Poirier, GG				Gagne, Jean-Philippe; Rouleau, Michele; Poirier, Guy G.			PARP-1 Activation- Bringing the Pieces Together	SCIENCE			English	Editorial Material							POLY(ADP-RIBOSE) POLYMERASE-1; BINDING DOMAIN; ZINC-FINGER; DNA		[Gagne, Jean-Philippe; Rouleau, Michele; Poirier, Guy G.] Univ Laval, CHUL, Canc Res Unit, CHUQ Res Ctr, Quebec City, PQ, Canada	Laval University	Gagne, JP (corresponding author), Univ Laval, CHUL, Canc Res Unit, CHUQ Res Ctr, Quebec City, PQ, Canada.	guy.poirier@crchul.ulaval.ca		Poirier, Guy/0000-0002-4869-1424				Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Jorgensen TJ, 2009, J MOL RECOGNIT, V22, P446, DOI 10.1002/jmr.962; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Loeffler PA, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-37; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Petrucco S, 2008, FEBS J, V275, P883, DOI 10.1111/j.1742-4658.2008.06259.x; Pic E, 2011, EXPERT REV PROTEOMIC, V8, P759, DOI [10.1586/EPR.11.63, 10.1586/epr.11.63]; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Spagnolo L, 2012, NUCLEIC ACIDS RES, V40, P4168, DOI 10.1093/nar/gkr1231	16	18	19	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					678	679		10.1126/science.1221870	http://dx.doi.org/10.1126/science.1221870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582250				2022-12-28	WOS:000303872300035
J	Goldfine, AB				Goldfine, Allison B.			Statins: Is It Really Time to Reassess Benefits and Risks?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; THERAPY		[Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goldfine, Allison B.] Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Goldfine, AB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Goldfine, Allison/0000-0002-0345-1048				Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6	5	65	66	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1752	1755		10.1056/NEJMp1203020	http://dx.doi.org/10.1056/NEJMp1203020			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22533536				2022-12-28	WOS:000303817000002
J	Liu, LQ; Pai, CF; Li, Y; Tseng, HW; Ralph, DC; Buhrman, RA				Liu, Luqiao; Pai, Chi-Feng; Li, Y.; Tseng, H. W.; Ralph, D. C.; Buhrman, R. A.			Spin-Torque Switching with the Giant Spin Hall Effect of Tantalum	SCIENCE			English	Article							DRIVEN; FILMS; TA	Spin currents can apply useful torques in spintronic devices. The spin Hall effect has been proposed as a source of spin current, but its modest strength has limited its usefulness. We report a giant spin Hall effect (SHE) in beta-tantalum that generates spin currents intense enough to induce efficient spin-torque switching of ferromagnets at room temperature. We quantify this SHE by three independent methods and demonstrate spin-torque switching of both out-of-plane and in-plane magnetized layers. We furthermore implement a three-terminal device that uses current passing through a tantalum-ferromagnet bilayer to switch a nanomagnet, with a magnetic tunnel junction for read-out. This simple, reliable, and efficient design may eliminate the main obstacles to the development of magnetic memory and nonvolatile spin logic technologies.	[Liu, Luqiao; Pai, Chi-Feng; Li, Y.; Tseng, H. W.; Ralph, D. C.; Buhrman, R. A.] Cornell Univ, Ithaca, NY 14853 USA; [Ralph, D. C.] Kavli Inst Cornell, Ithaca, NY 14853 USA	Cornell University	Buhrman, RA (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	rab8@cornell.edu	Liu, Luqiao/A-5215-2014	Pai, Chi-Feng/0000-0001-6723-8302	Army Research Office; Defense Advanced Research Projects Agency; Office of Naval Research; NSF/Materials Research Science and Engineering Center through the Cornell Center for Materials Research (CCMR) [DMR-1120296]; NSF/Nanoscale Science and Engineering Center through the Cornell Center for Nanoscale Systems; NSF; Div Of Electrical, Commun & Cyber Sys [0922836] Funding Source: National Science Foundation	Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); NSF/Materials Research Science and Engineering Center through the Cornell Center for Materials Research (CCMR); NSF/Nanoscale Science and Engineering Center through the Cornell Center for Nanoscale Systems; NSF(National Science Foundation (NSF)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We acknowledge support from the Army Research Office, Defense Advanced Research Projects Agency, Office of Naval Research, and NSF/Materials Research Science and Engineering Center (DMR-1120296) through the Cornell Center for Materials Research (CCMR), as well as the NSF/Nanoscale Science and Engineering Center Program through the Cornell Center for Nanoscale Systems. We also acknowledge NSF support through use of the Cornell Nanofabrication Facility/National Nanofabrication Infrastructure Network and the CCMR facilities. Patent disclosures have been filed on behalf of the authors regarding the use of the spin Hall effect in Ta for magnetic memory and logic applications.	Ando K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036601; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Braganca PM, 2009, IEEE T NANOTECHNOL, V8, P190, DOI 10.1109/TNANO.2008.2005187; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Gu B, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216401; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Hoogeveen R, 1996, THIN SOLID FILMS, V275, P203, DOI 10.1016/0040-6090(95)07043-5; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/NMAT2804, 10.1038/nmat2804]; Kajiwara Y, 2010, NATURE, V464, P262, DOI 10.1038/nature08876; Katine JA, 2000, PHYS REV LETT, V84, P3149, DOI 10.1103/PhysRevLett.84.3149; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Kimura T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.037201; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; KISHI T, 2008, P IEDM SAN FRANC CA, DOI DOI 10.1109/IEDM.2008.4796680; Lee H, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/21/215001; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Liu LQ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3107262; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; Mizukami S, 2001, J MAGN MAGN MATER, V226, P1640, DOI 10.1016/S0304-8853(00)01097-0; Moriyama T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3481798; Morota M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174405; Mosendz O, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214403; Mosendz O, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046601; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Myers EB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196801; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; READ MH, 1965, APPL PHYS LETT, V7, P51, DOI 10.1063/1.1754294; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Sun JZ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3237025; Sun JZ, 2000, PHYS REV B, V62, P570, DOI 10.1103/PhysRevB.62.570; Suzuki T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579155; Tanaka T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165117; Tserkovnyak Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117601; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Yang T, 2008, NAT PHYS, V4, P851, DOI 10.1038/nphys1095; Zhang SF, 2000, PHYS REV LETT, V85, P393, DOI 10.1103/PhysRevLett.85.393	39	2546	2668	68	866	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					555	558		10.1126/science.1218197	http://dx.doi.org/10.1126/science.1218197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556245	Green Submitted			2022-12-28	WOS:000303498800037
J	Reich, PB; Tilman, D; Isbell, F; Mueller, K; Hobbie, SE; Flynn, DFB; Eisenhauer, N				Reich, Peter B.; Tilman, David; Isbell, Forest; Mueller, Kevin; Hobbie, Sarah E.; Flynn, Dan F. B.; Eisenhauer, Nico			Impacts of Biodiversity Loss Escalate Through Time as Redundancy Fades	SCIENCE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIP; PLANT DIVERSITY; GRASSLAND EXPERIMENT; COMPLEMENTARITY; MECHANISMS; NITROGEN; COMMUNITIES; STABILITY; SELECTION; SERVICES	Plant diversity generally promotes biomass production, but how the shape of the response curve changes with time remains unclear. This is a critical knowledge gap because the shape of this relationship indicates the extent to which loss of the first few species will influence biomass production. Using two long-term (>= 13 years) biodiversity experiments, we show that the effects of diversity on biomass productivity increased and became less saturating over time. Our analyses suggest that effects of diversity-dependent ecosystem feedbacks and interspecific complementarity accumulate over time, causing high-diversity species combinations that appeared functionally redundant during early years to become more functionally unique through time. Consequently, simplification of diverse ecosystems will likely have greater negative impacts on ecosystem functioning than has been suggested by short-term experiments.	[Reich, Peter B.; Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Tilman, David; Isbell, Forest; Mueller, Kevin; Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm, Santa Barbara, CA 93106 USA; [Flynn, Dan F. B.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Eisenhauer, Nico] Tech Univ Munich, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany	University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara; University of Zurich; Technical University of Munich	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.		Flynn, Dan/AAT-7028-2020; Isbell, Forest/C-6915-2012; Eisenhauer, Nico/I-3191-2019; Tilman, David/ABD-5309-2021; Eisenhauer, Nico/I-5932-2012; Mueller, Kevin E/I-3633-2019; Flynn, Dan/A-4200-2008	Flynn, Dan/0000-0002-2978-5257; Isbell, Forest/0000-0001-9689-769X; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Mueller, Kevin E/0000-0002-0739-7472; Flynn, Dan/0000-0002-2978-5257; Hobbie, Sarah/0000-0001-5159-031X; Reich, Peter/0000-0003-4424-662X	U.S. Department of Energy [DE-FG02-96ER62291]; National Institute for Climatic Change Research [DE-FC02-06ER64158]; National Science Foundation [DEB-9411972, DEB-0080382, DEB-0620652, DEB-0322057, DEB-0716587]; University of Minnesota	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute for Climatic Change Research; National Science Foundation(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	We thank the U.S. Department of Energy Program for Ecosystem Research (DE-FG02-96ER62291) and the National Institute for Climatic Change Research (DE-FC02-06ER64158); the National Science Foundation Long-Term Ecological Research (DEB-9411972, DEB-0080382, and DEB-0620652), Biocomplexity Coupled Biogeochemical Cycles (DEB-0322057) and Long-Term Research in Environmental Biology Programs (DEB-0716587), and the University of Minnesota for supporting this research. The data sets used in this study are available at the Cedar Creek Ecosystem Science Reserve Web site. The authors declare no conflicts of interest.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2009, ECOLOGY, V90, P1821, DOI 10.1890/08-0514.1; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Tilman D, 1997, SCIENCE, V278, P1866; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	27	529	546	26	642	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					589	592		10.1126/science.1217909	http://dx.doi.org/10.1126/science.1217909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556253				2022-12-28	WOS:000303498800046
J	Chen, CY; Chi, YH; Mutalif, RA; Starost, MF; Myers, TG; Anderson, SA; Stewart, CL; Jeang, KT				Chen, Chia-Yen; Chi, Ya-Hui; Mutalif, Rafidah Abdul; Starost, Matthew F.; Myers, Timothy G.; Anderson, Stasia A.; Stewart, Colin L.; Jeang, Kuan-Teh			Accumulation of the Inner Nuclear Envelope Protein Sun1 Is Pathogenic in Progeric and Dystrophic Laminopathies	CELL			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CHARCOT-MARIE-TOOTH; LAMIN-A/C GENE; MISSENSE MUTATION; MIGRATION; DEFECTS; LMNA; ORGANIZATION; ARCHITECTURE; EXPRESSION	Human LMNA gene mutations result in laminopathies that include Emery-Dreifuss muscular dystrophy (AD-EDMD) and Hutchinson-Gilford progeria, the premature aging syndrome (HGPS). The Lmna null (Lmna(-/-)) and progeroid Lmna Delta 9 mutant mice are models for AD-EDMD and HGPS, respectively. Both animals develop severe tissue pathologies with abbreviated life spans. Like HGPS cells, Lmna(-/-) and Lmna Delta 9 fibroblasts have typically misshapen nuclei. Unexpectedly, Lmna(-/-) or Lmna Delta 9 mice that are also deficient for the inner nuclear membrane protein Sun1 show markedly reduced tissue pathologies and enhanced longevity. Concordantly, reduction of SUN1 overaccumulation in LMNA mutant fibroblasts and in cells derived from HGPS patients corrected nuclear defects and cellular senescence. Collectively, these findings implicate Sun1 protein accumulation as a common pathogenic event in Lmna(-/-), Lmna Delta 9, and HGPS disorders.	[Chi, Ya-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan; [Chen, Chia-Yen; Jeang, Kuan-Teh] NIAID, Natl Inst Hlth, Bethesda, MD 20892 USA; [Starost, Matthew F.] Natl Inst Hlth, Div Vet Resources, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Natl Inst Hlth, Bethesda, MD 20892 USA; [Anderson, Stasia A.] Natl Heart Lung & Blood Inst Anim MRI Core, Natl Inst Hlth, Bethesda, MD 20892 USA; [Mutalif, Rafidah Abdul; Stewart, Colin L.] Inst Med Biol, Singapore 138648, Singapore; [Stewart, Colin L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Chi, YH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan.	ychi@nhri.org.tw; kjeang@nih.gov	Chi, Ya-Hui/ABE-8550-2020; Chi, Ya-Hui/B-1080-2010; Jeang, Kuan-Teh/A-2424-2008	Chi, Ya-Hui/0000-0002-9216-0938; Anderson, Stasia/0000-0002-2566-6947; Myers, Timothy Gene/0000-0002-7059-5906	NIAID; IATAP, NIAID; NHRI, Taiwan [NHRI 99A1-CSPP11-014]; NSC, Taiwan [NSC 98-2320-B-400-009-MY3]; Singapore Biomedical Research Council; Agency for Science, Technology and Research (AstarSTAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001023] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IATAP, NIAID; NHRI, Taiwan(National Health Research Institutes - Taiwan); NSC, Taiwan(Ministry of Science and Technology, Taiwan); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (AstarSTAR)(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by NIAID intramural funds, the IATAP, NIAID contract to SoBran, Inc., the NHRI, Taiwan (NHRI 99A1-CSPP11-014), and NSC, Taiwan (NSC 98-2320-B-400-009-MY3), and the Singapore Biomedical Research Council and Agency for Science, Technology and Research (A<SUP>star</SUP>STAR). We thank S.-Y. Chuang, E. Miyagi, J.M. Ward, L. I. Cheng, Z.J. Chen, J. Kabat, S. Becker, S. Bradford, Q. Su, and D. Donahue for assistance; and W. Leonard, J. Hanover, A. Dayton, Y.B. Shi, and D. Camerini-Otero for reading the manuscript.	Alsheimer M, 2004, J CELL SCI, V117, P1173, DOI 10.1242/jcs.00975; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2001, TRAFFIC, V2, P675, DOI 10.1034/j.1600-0854.2001.21001.x; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Chaouch M, 2003, NEUROMUSCULAR DISORD, V13, P60, DOI 10.1016/S0960-8966(02)00196-7; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chi YH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-96; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Kitaguchi T, 2001, NEUROMUSCULAR DISORD, V11, P542, DOI 10.1016/S0960-8966(01)00207-3; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; Mattioli E, 2011, CELL DEATH DIFFER, V18, P1305, DOI 10.1038/cdd.2010.183; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Metz TF, 2011, CLIN CHEM, V57, P1286, DOI 10.1373/clinchem.2011.164640; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	57	143	148	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					565	577		10.1016/j.cell.2012.01.059	http://dx.doi.org/10.1016/j.cell.2012.01.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541428	Green Accepted, Bronze			2022-12-28	WOS:000303443100009
J	Riding, R				Riding, Robert			A Hard Life for Cyanobacteria	SCIENCE			English	Editorial Material							CALCIFICATION		Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Riding, R (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	rriding@utk.edu						Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Ehrlich HL., 2015, GEOMICROBIOL J; Golubic S., 1973, BIOL BLUE GREEN ALGA, P434; Kah LC, 2007, GEOLOGY, V35, P799, DOI 10.1130/G23680A.1; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KLEIN C, 1987, PRECAMBRIAN RES, V36, P81, DOI 10.1016/0301-9268(87)90018-0; Mann S., 2001, BIOMINERALIZATION PR; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; PENTECOST A, 1981, Field Studies, V5, P365; RIDING R, 2006, GEOBIOLOGY, V4, P299, DOI DOI 10.1111/J.1472-4669.2006.00087.X; THOMPSON JB, 1990, GEOLOGY, V18, P995, DOI 10.1130/0091-7613(1990)018<0995:CPOGCA>2.3.CO;2	13	26	35	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					427	428		10.1126/science.1221055	http://dx.doi.org/10.1126/science.1221055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539710				2022-12-28	WOS:000303233400034
J	Eisenstein, M				Eisenstein, Michael			DRUG DEVELOPMENT Holding out for reinforcements	NATURE			English	Editorial Material							MALARIA											Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225	6	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S16	S18		10.1038/484S16a	http://dx.doi.org/10.1038/484S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534526				2022-12-28	WOS:000303200400001
J	Palm, NW; Rosenstein, RK; Medzhitov, R				Palm, Noah W.; Rosenstein, Rachel K.; Medzhitov, Ruslan			Allergic host defences	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; MAST-CELLS; IMMUNOLOGICAL INDUCTION; MOLECULAR-MECHANISMS; STRUCTURAL BIOLOGY; FLAVOR AVERSION; DENDRITIC CELLS; MURINE MODEL; INNATE; TISSUE	Allergies are generally thought to be a detrimental outcome of a mistargeted immune response that evolved to provide immunity to macroparasites. Here we present arguments to suggest that allergic immunity has an important role in host defence against noxious environmental substances, including venoms, haematophagous fluids, environmental xenobiotics and irritants. We argue that appropriately targeted allergic reactions are beneficial, although they can become detrimental when excessive. Furthermore, we suggest that allergic hypersensitivity evolved to elicit anticipatory responses and to promote avoidance of suboptimal environments.	[Palm, Noah W.; Rosenstein, Rachel K.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu		Palm, Noah/0000-0001-7262-9455	Howard Hughes Medical Institute; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in R.M.'s laboratory is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Cara DC, 1997, SCAND J IMMUNOL, V45, P16, DOI 10.1046/j.1365-3083.1997.d01-363.x; CARA DC, 1994, BRAZ J MED BIOL RES, V27, P1331; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costa-Pinto FA, 2005, BRAIN BEHAV IMMUN, V19, P52, DOI 10.1016/j.bbi.2004.02.005; Costa-Pinto FA, 2007, BRAIN BEHAV IMMUN, V21, P783, DOI 10.1016/j.bbi.2007.01.002; DUDLER T, 1995, J IMMUNOL, V155, P2605; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; HIGGINBOTHAM RD, 1971, J IMMUNOL, V106, P233; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; JUSTESEN DR, 1970, SCIENCE, V170, P864, DOI 10.1126/science.170.3960.864; Kalish RS, 1999, J ALLERGY CLIN IMMUN, V103, P192, DOI 10.1016/S0091-6749(99)70489-6; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Lang PM, 2006, J NEUROPHYSIOL, V96, P2963, DOI 10.1152/jn.00716.2006; Li Jinze, 2010, Handb Exp Pharmacol, P493, DOI 10.1007/978-3-642-00663-0_18; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; MACKENZIE M, 1961, ANN ALLERGY, V19, P298; MACQUEEN G, 1989, SCIENCE, V243, P83, DOI 10.1126/science.2911721; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matthews KR, 2011, SCIENCE, V331, P1149, DOI 10.1126/science.1198077; McKenzie, 1896, AM J MED SCI, V91, P45, DOI DOI 10.1097/00000441-188601000-00004; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mirotti L, 2010, J ALLERGY CAIRO, V2010; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muller UR, 2010, CHEM IMMUNOL ALLERGY, V95, P141, DOI 10.1159/000315948; Muller-Doblies UU, 2007, PARASITE IMMUNOL, V29, P485, DOI 10.1111/j.1365-3024.2007.00966.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Navarro-Zorraquino M, 2001, WORLD J SURG, V25, P585, DOI 10.1007/s002680020089; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Siegel S, 1997, ENVIRON HEALTH PERSP, V105, P521, DOI 10.2307/3433363; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; THORPE SC, 1989, IMMUNOLOGY, V68, P307; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Zacharia B, 2003, MED HYPOTHESES, V60, P1, DOI 10.1016/S0306-9877(02)00217-7; Zarzana EC, 2009, NEUROIMMUNOMODULAT, V16, P19, DOI 10.1159/000179663; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	86	259	275	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					465	472		10.1038/nature11047	http://dx.doi.org/10.1038/nature11047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538607	Green Accepted			2022-12-28	WOS:000303200400041
J	Roehr, B				Roehr, Bob			What will a doctor bring to the World Bank? A popular public health doctor has been appointed to the hotly contested position of president of the World Bank. Bob Roehr looks at his credentials and what is expected of him	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 26	2012	344								e2921	10.1136/bmj.e2921	http://dx.doi.org/10.1136/bmj.e2921			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539178				2022-12-28	WOS:000303433900010
J	Cappa, C; Wardlaw, T; Langevin-Falcon, C; Diers, J				Cappa, Claudia; Wardlaw, Tessa; Langevin-Falcon, Catherine; Diers, Judith			Progress for children: a report card on adolescents	LANCET			English	Editorial Material									[Cappa, Claudia; Wardlaw, Tessa; Langevin-Falcon, Catherine; Diers, Judith] UNICEF, New York, NY 10017 USA	UNICEF	Cappa, C (corresponding author), UNICEF, New York, NY 10017 USA.	ccappa@unicef.org	Patton, George C/B-5246-2013; Shek, Daniel T.L./N-9576-2014	Patton, George C/0000-0001-5039-8326; Shek, Daniel T.L./0000-0003-3359-6229				[Anonymous], 2011, WORLD POP PROSP 2010; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; UNICEF, 2011, STAT WORLDS CHILDR 2; UNICEF, 2012, PROGR CHILDR REP CAR	4	16	16	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 23	2012	379	9834					2324	2325		10.1016/S0140-6736(12)60531-5	http://dx.doi.org/10.1016/S0140-6736(12)60531-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22538182				2022-12-28	WOS:000305509600009
J	Sharp, D				Sharp, David			Thomas Wakley (1795-1862): a biographical sketch	LANCET			English	Biographical-Item									2 Iron Mills, Minchinhampton GL6 9AL, Glos, England		Sharp, D (corresponding author), 2 Iron Mills, Minchinhampton GL6 9AL, Glos, England.	davidwsharp@sky.com						WAKLEY T, PUBLICATION LIST	1	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1914	1921		10.1016/S0140-6736(12)60526-1	http://dx.doi.org/10.1016/S0140-6736(12)60526-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22595800				2022-12-28	WOS:000304194200033
J	O'Connell, M; Goulden, V				O'Connell, Michael; Goulden, Victoria			"Half-Half" Blisters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Connell, Michael; Goulden, Victoria] Leeds Gen Infirm, Leeds, W Yorkshire, England	Leeds General Infirmary; University of Leeds	O'Connell, M (corresponding author), Leeds Gen Infirm, Leeds, W Yorkshire, England.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					E31	E31		10.1056/NEJMicm1013242	http://dx.doi.org/10.1056/NEJMicm1013242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591309				2022-12-28	WOS:000304083000001
J	Patten, IS; Rana, S; Shahul, S; Rowe, GC; Jang, C; Liu, L; Hacker, MR; Rhee, JS; Mitchell, J; Mahmood, F; Hess, P; Farrell, C; Koulisis, N; Khankin, EV; Burke, SD; Tudorache, I; Bauersachs, J; del Monte, F; Hilfiker-Kleiner, D; Karumanchi, SA; Arany, Z				Patten, Ian S.; Rana, Sarosh; Shahul, Sajid; Rowe, Glenn C.; Jang, Cholsoon; Liu, Laura; Hacker, Michele R.; Rhee, Julie S.; Mitchell, John; Mahmood, Feroze; Hess, Philip; Farrell, Caitlin; Koulisis, Nicole; Khankin, Eliyahu V.; Burke, Suzanne D.; Tudorache, Igor; Bauersachs, Johann; del Monte, Federica; Hilfiker-Kleiner, Denise; Karumanchi, S. Ananth; Arany, Zoltan			Cardiac angiogenic imbalance leads to peripartum cardiomyopathy	NATURE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; TYROSINE KINASE 1; HEART-FAILURE; MITOCHONDRIAL BIOGENESIS; EJECTION FRACTION; SKELETAL-MUSCLE; ANGIOTENSIN-II; UNITED-STATES; MICE LACKING; PREECLAMPSIA	Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1 alpha, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-1a. Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.	[Patten, Ian S.; Rowe, Glenn C.; Jang, Cholsoon; Liu, Laura; Farrell, Caitlin; Koulisis, Nicole; del Monte, Federica; Arany, Zoltan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02115 USA; [Patten, Ian S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Rana, Sarosh; Hacker, Michele R.; Rhee, Julie S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med,Dept Obstet & Gynecol, Boston, MA 02115 USA; [Shahul, Sajid; Mitchell, John; Mahmood, Feroze; Hess, Philip] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Anesthesia & Crit Care, Boston, MA 02115 USA; [Khankin, Eliyahu V.; Burke, Suzanne D.; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Tudorache, Igor] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany; [Bauersachs, Johann; Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Burke, Suzanne D.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Hannover Medical School; Hannover Medical School; Howard Hughes Medical Institute	Arany, Z (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, 330 Brookline Ave, Boston, MA 02115 USA.	hilfiker.denise@mh-hannover.de; zarany@bidmc.harvard.edu	Mahmood, Feroze/B-1383-2008; Hess, Philip/A-8577-2013; del Monte, Federica/AAF-3961-2020; Farrell, Caitlin/AAR-2799-2021; Rowe, Glenn/N-5314-2019; Karumanchi, Subbian Ananth/AAI-1694-2021; Khankin, Eli/M-7648-2013; del Monte, Federica/AAB-3982-2019; Hacker, Michele/ABC-5031-2021	Mahmood, Feroze/0000-0002-7071-0476; Hess, Philip/0000-0002-1206-0102; Mitchell, John/0000-0001-6087-5210; Burke, Suzanne/0000-0003-4594-4163; Patten, Ian/0000-0003-1888-656X; Rowe, Glenn/0000-0002-8195-9605; Hacker, Michele/0000-0003-0217-9991; del Monte, Federica/0000-0001-9506-9665; Farrell, Caitlin/0000-0001-8547-4659; Khankin, Eliyahu/0000-0002-1695-7267; Jang, Cholsoon/0000-0001-6651-4213	Harvard Faculty; John Hedley White grant; Merck; Harvard Catalyst; Clinical and Translational Science Center; Harvard University; NHLBI; Smith Family Foundation; Ellison Medical Foundation; March of Dimes Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094499] Funding Source: NIH RePORTER	Harvard Faculty; John Hedley White grant; Merck(Merck & Company); Harvard Catalyst; Clinical and Translational Science Center; Harvard University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Smith Family Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); March of Dimes Foundation(March of Dimes); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.R. is supported by a Harvard Faculty Development and Diversity Award. S. S is supported by a John Hedley White grant. G. C. R. is supported by a Merck Fellowship. M. R. H. is supported by Harvard Catalyst, the Clinical and Translational Science Center, and Harvard University and affiliated academic health care centers. S. A. K. is an investigator of the Howard Hughes Medical Institute. Z.A. is supported by the NHLBI, the Smith Family Foundation, the Ellison Medical Foundation, the March of Dimes Foundation, and the Harvard Stem Cell Institute.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Amos AM, 2006, AM HEART J, V152, P509, DOI 10.1016/j.ahj.2006.02.008; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Bdolah Y, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.783; Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cruz MO, 2010, OBSTET GYN CLIN N AM, V37, P283, DOI 10.1016/j.ogc.2010.02.003; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Elkayam U, 2011, J AM COLL CARDIOL, V58, P659, DOI 10.1016/j.jacc.2011.03.047; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fett JD, 2005, MAYO CLIN PROC, V80, P1602, DOI 10.4065/80.12.1602; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goland S, 2011, J CARD FAIL, V17, P426, DOI 10.1016/j.cardfail.2011.01.007; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Horne B.D., 2004, CIRC-CARDIOVASC GENE, V4, P359; Hubel CA, 2007, HYPERTENSION, V49, P612, DOI 10.1161/01.HYP.0000256565.20983.d4; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; Poulsen SH, 2000, AM J CARDIOL, V85, P19, DOI 10.1016/S0002-9149(99)00599-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Saxena AR, 2010, HYPERTENSION, V55, P1239, DOI 10.1161/HYPERTENSIONAHA.109.147595; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Uraizee I, 2011, NEW ENGL J MED, V365, P1649, DOI 10.1056/NEJMc1108849; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinkestijn AS, 2004, J CARDIOL, V23, P19; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	53	341	353	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					333	U76		10.1038/nature11040	http://dx.doi.org/10.1038/nature11040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596155	Green Accepted, Green Submitted			2022-12-28	WOS:000304099100034
J	Schattner, A				Schattner, Ami			Review: Biologic agents increase short-term risk for some adverse events in conditions other than HIV or AIDS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Furst DE, 2012, ANN RHEUM DIS, V71, P2, DOI 10.1136/annrheumdis-2011-201036	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-9	10.7326/0003-4819-156-10-201205150-02009	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586027				2022-12-28	WOS:000304193400008
J	Colledge, J; Quigley, S; Liyanage, S				Colledge, Jonathan; Quigley, Shaun; Liyanage, Shilpa			PICTURE QUIZ A weak leg	BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICALLY ISOLATED SYNDROMES; PROTON MR SPECTROSCOPY; NECROTIC BRAIN-TUMOR; MULTIPLE-SCLEROSIS; FOLLOW-UP; DIFFUSION; DIAGNOSIS; ABSCESS; ABNORMALITIES; DISABILITY		[Colledge, Jonathan; Quigley, Shaun; Liyanage, Shilpa] Barts & Royal London NHS Trust, London E1 1BB, England	Barts Health NHS Trust; University of London; Queen Mary University London	Colledge, J (corresponding author), Barts & Royal London NHS Trust, London E1 1BB, England.	jonathancolledge@googlemail.com						Bosca I, 2010, J NEUROIMMUNOL, V226, P143, DOI 10.1016/j.jneuroim.2010.05.032; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brodsky M, 2008, ARCH NEUROL-CHICAGO, V65, P727, DOI 10.1001/archneur.65.6.727; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chiang IC, 2009, BRIT J RADIOL, V82, P813, DOI 10.1259/bjr/90100265; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Dalton CM, 2002, J NEUROL NEUROSUR PS, V73, P141, DOI 10.1136/jnnp.73.2.141; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Grand S, 1999, RADIOLOGY, V213, P785, DOI 10.1148/radiology.213.3.r99dc10785; He J, 2001, AM J NEURORADIOL, V22, P664; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Lai PH, 2002, AM J NEURORADIOL, V23, P1369; Masdeu JC, 2000, NEUROLOGY, V54, P1427, DOI 10.1212/WNL.54.7.1427; McQuaid S, 2005, INT CONGR SER, V1277, P235, DOI 10.1016/j.ics.2005.02.026; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Pakos EE, 2005, CLIN NEUROL NEUROSUR, V107, P152, DOI 10.1016/j.clineuro.2004.06.003; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RICHARDS TL, 1991, AM J ROENTGENOL, V157, P1073, DOI 10.2214/ajr.157.5.1927795; Rosso C, 2006, AM J NEURORADIOL, V27, P1006; Sahraian MA, 2010, CLIN NEUROL NEUROSUR, V112, P609, DOI 10.1016/j.clineuro.2010.03.022; Wakerley B, 2008, MEDICINE, V36, P625	25	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 14	2012	344								e2712	10.1136/bmj.e2712	http://dx.doi.org/10.1136/bmj.e2712			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XW	22586230				2022-12-28	WOS:000304085900001
J	Vannier, JB; Pavicic-Kaltenbrunner, V; Petalcorin, MIR; Ding, H; Boulton, SJ				Vannier, Jean-Baptiste; Pavicic-Kaltenbrunner, Visnja; Petalcorin, Mark I. R.; Ding, Hao; Boulton, Simon J.			RTEL1 Dismantles T Loops and Counteracts Telomeric G4-DNA to Maintain Telomere Integrity	CELL			English	Article							HOLLIDAY JUNCTION RESOLUTION; STRUCTURE-SPECIFIC NUCLEASES; HOMOLOGOUS RECOMBINATION; FRAGILE SITES; FANCONI-ANEMIA; DNA-REPAIR; LENGTH; SLX4; PROTEIN; CELLS	T loops and telomeric G-quadruplex (G4) DNA structures pose a potential threat to genome stability and must be dismantled to permit efficient telomere replication. Here we implicate the helicase RTEL1 in the removal of telomeric DNA secondary structures, which is essential for preventing telomere fragility and loss. In the absence of RTEL1, T loops are inappropriately resolved by the SLX4 nuclease complex, resulting in loss of the telomere as a circle. Depleting SLX4 or blocking DNA replication abolished telomere circles (TCs) and rescued telomere loss in RTEL1(-/-) cells but failed to suppress telomere fragility. Conversely, stabilization of telomeric G4-DNA or loss of BLM dramatically enhanced telomere fragility in RTEL1-deficient cells but had no impact on TC formation or telomere loss. We propose that RTEL1 performs two distinct functions at telomeres: it disassembles T loops and also counteracts telomeric G4-DNA structures, which together ensure the dynamics and stability of the telomere.	[Vannier, Jean-Baptiste; Pavicic-Kaltenbrunner, Visnja; Petalcorin, Mark I. R.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada	Cancer Research UK; University of Manitoba	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk		Petalcorin, Mark/0000-0001-8211-9440	Cancer Research UK; ERC; Royal Society; EMBO; CIHR (Canada Institute of Health Research); Terry Fox foundation; Cancer Research UK [11581] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); EMBO(European Molecular Biology Organization (EMBO)); CIHR (Canada Institute of Health Research)(Canadian Institutes of Health Research (CIHR)); Terry Fox foundation; Cancer Research UK(Cancer Research UK)	We wish to thank the Biological Research Unit at Clare Hall for mouse breeding, Clare McGowan and Alan Bradley for providing mouse strains, Titia de Lange for providing conditional TRF1-deficient cells and plasmids, and John Rouse for antibodies. The lab of S.J.B. is funded by Cancer Research UK and by an ERC Advanced Investigator Grant (RecMitMei). S.J.B. is a recipient of a Royal Society Wolfson Research Merit Award. J.-B.V. is funded by a long-term fellowship from EMBO. H. D. is a holder of Canada Research Chair and is funded by CIHR (Canada Institute of Health Research) and the Terry Fox foundation.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bayani J., 2005, CURR PROTOC CELL BIO; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Izbicka E, 1999, CANCER RES, V59, P639; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Silvestre DC, 2011, STEM CELLS, V29, P440, DOI 10.1002/stem.600; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu XL, 2007, GENESIS, V45, P788, DOI 10.1002/dvg.20359; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	45	322	327	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					795	806		10.1016/j.cell.2012.03.030	http://dx.doi.org/10.1016/j.cell.2012.03.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579284	Bronze			2022-12-28	WOS:000303934700013
J	Tsadok, MA; Jackevicius, CA; Rahme, E; Humphries, KH; Behlouli, H; Pilote, L				Tsadok, Meytal Avgil; Jackevicius, Cynthia A.; Rahme, Elham; Humphries, Karin H.; Behlouli, Hassan; Pilote, Louise			Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EURO HEART SURVEY; PREDICTING STROKE; GENDER-DIFFERENCES; ISCHEMIC-STROKE; ANTICOAGULATION; POPULATION; PREVENTION; THERAPY; STRATIFICATION; GUIDELINE	Context Stroke is a serious complication associated with atrial fibrillation (AF). Women with AF are at higher risk of stroke compared with men. Reasons for this higher stroke risk in women remain unclear, although some studies suggest that undertreatment with warfarin may be a cause. Objective To compare utilization patterns of warfarin and the risk of subsequent stroke between older men and women with AF at the population level. Design, Setting, and Patients Population-based cohort study of patients 65 years or older admitted to the hospital with recently diagnosed AF in the province of Quebec, Canada, 1998-2007, using administrative data with linkage between hospital discharge, physicians, and prescription drug claims databases. Main Outcome Measures Risk of stroke. Results The cohort comprised 39 398 men (47.2%) and 44 115 women (52.8%). At admission, women were older and had a higher CHADS(2) (congestive heart failure, hypertension, age >= 75 years, diabetes mellitus, prior stroke or transient ischemic attack) score than men (1.99 [SD, 1.10] vs 1.74 [SD, 1.13], P<.001). At 30 days postdischarge, 58.2% of men and 60.6% of women had filled a warfarin prescription. In adjusted analysis, women appeared to fill more warfarin prescriptions compared with men (odds ratio, 1.07 [95% CI, 1.04-1.11]; P<.001). Adherence to warfarin treatment was good in both sexes. Crude stroke incidence was 2.02 per 100 person-years (95% CI, 1.95-2.10) in women vs 1.61 per 100 person-years (95% CI, 1.54-1.69) in men (P<.001). The sex difference was mainly driven by the population of patients 75 years or older. In multivariable Cox regression analysis, women had a higher risk of stroke than men (adjusted hazard ratio, 1.14 [95% CI, 1.07-1.22]; P<.001), even after adjusting for baseline comorbid conditions, individual components of the CHADS2 score, and warfarin treatment. Conclusion Among older patients admitted with recently diagnosed AF, the risk of stroke was greater in women than in men, regardless of warfarin use. JAMA. 2012;307(18):1952-1958 www.jama.com	[Tsadok, Meytal Avgil; Rahme, Elham; Behlouli, Hassan; Pilote, Louise] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Pilote, Louise] McGill Univ, Ctr Hlth, Div Gen Internal Med, Montreal, PQ H3A 1A1, Canada; [Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA USA; [Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Humphries, Karin H.] Univ British Columbia, Div Cardiol, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; Western University of Health Sciences; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia	Pilote, L (corresponding author), McGill Univ, Ctr Hlth, Div Clin Epidemiol, 687 Pine Ave W,5 Bldg, Montreal, PQ H3A 1A1, Canada.	louise.pilote@McGill.ca		Pilote, Louise/0000-0002-6159-0628	Canadian Institutes of Health Research (CIHR) [MOP-84304]; Fonds de recherche en sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Avgil Tsadok reported receiving a fellowship award from the Canadian Institutes of Health Research (CIHR) and receiving a travel award from the CIHR to present the study results at a conference (American Heart Association 2011 Scientific Sessions). Dr Humphries reported receiving a new investigator award from the CIHR. Dr Pilote reported serving as a James McGill Chair at McGill University and receiving a national investigator award from the Fonds de recherche en sante du Quebec.; This study was supported by operating grant MOP-84304 from the CIHR.	Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gomberg-Maitland M, 2006, EUR HEART J, V27, P1947, DOI 10.1093/eurheartj/ehl103; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Humphries KH, 2001, CIRCULATION, V103, P2365; Inoue H, 2010, CIRC J, V74, P650, DOI 10.1253/circj.CJ-09-0802; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Niska R, 2009, J AM BOARD FAM MED, V22, P299, DOI 10.3122/jabfm.2009.03.080218; Pamboukian SV, 2008, CLIN CARDIOL, V31, P30, DOI 10.1002/clc.20175; Poli D, 2009, THROMB HAEMOSTASIS, V101, P938, DOI 10.1160/TH08-10-0635; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	23	175	180	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1952	1958		10.1001/jama.2012.3490	http://dx.doi.org/10.1001/jama.2012.3490			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570463	Bronze			2022-12-28	WOS:000303741900029
J	Teeling, H; Fuchs, BM; Becher, D; Klockow, C; Gardebrecht, A; Bennke, CM; Kassabgy, M; Huang, SX; Mann, AJ; Waldmann, J; Weber, M; Klindworth, A; Otto, A; Lange, J; Bernhardt, J; Reinsch, C; Hecker, M; Peplies, J; Bockelmann, FD; Callies, U; Gerdts, G; Wichels, A; Wiltshire, KH; Glockner, FO; Schweder, T; Amann, R				Teeling, Hanno; Fuchs, Bernhard M.; Becher, Doerte; Klockow, Christine; Gardebrecht, Antje; Bennke, Christin M.; Kassabgy, Mariette; Huang, Sixing; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Otto, Andreas; Lange, Jana; Bernhardt, Joerg; Reinsch, Christine; Hecker, Michael; Peplies, Joerg; Bockelmann, Frank D.; Callies, Ulrich; Gerdts, Gunnar; Wichels, Antje; Wiltshire, Karen H.; Gloeckner, Frank Oliver; Schweder, Thomas; Amann, Rudolf			Substrate-Controlled Succession of Marine Bacterioplankton Populations Induced by a Phytoplankton Bloom	SCIENCE			English	Article							BACTERIAL COMMUNITY; SP NOV.; ORGANIC-MATTER; OCEAN; CARBON; GAMMAPROTEOBACTERIUM; DEGRADATION; DIVERSITY; TRANSPORT; DYNAMICS	Phytoplankton blooms characterize temperate ocean margin zones in spring. We investigated the bacterioplankton response to a diatom bloom in the North Sea and observed a dynamic succession of populations at genus-level resolution. Taxonomically distinct expressions of carbohydrate-active enzymes (transporters; in particular, TonB-dependent transporters) and phosphate acquisition strategies were found, indicating that distinct populations of Bacteroidetes, Gammaproteobacteria, and Alphaproteobacteria are specialized for successive decomposition of algal-derived organic matter. Our results suggest that algal substrate availability provided a series of ecological niches in which specialized populations could bloom. This reveals how planktonic species, despite their seemingly homogeneous habitat, can evade extinction by direct competition.	[Becher, Doerte; Waldmann, Jost; Lange, Jana; Reinsch, Christine; Hecker, Michael; Wiltshire, Karen H.] Inst Marine Biotechnol, D-17489 Greifswald, Germany; [Teeling, Hanno; Fuchs, Bernhard M.; Klockow, Christine; Bennke, Christin M.; Kassabgy, Mariette; Huang, Sixing; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Gloeckner, Frank Oliver; Amann, Rudolf] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Klockow, Christine; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Gloeckner, Frank Oliver] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Gerdts, Gunnar; Wichels, Antje; Wiltshire, Karen H.] Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, D-27483 Helgoland, Germany; [Becher, Doerte; Otto, Andreas; Bernhardt, Joerg; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany; [Bernhardt, Joerg] DECODON, D-17489 Greifswald, Germany; [Peplies, Joerg] Ribocon, D-28359 Bremen, Germany; [Bockelmann, Frank D.; Callies, Ulrich] HZG Res Ctr, D-21502 Geesthacht, Germany	Max Planck Society; Jacobs University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Schweder, T (corresponding author), Inst Marine Biotechnol, Walther Rathenau Str 49A, D-17489 Greifswald, Germany.	schweder@uni-greifswald.de; ramann@mpi-bremen.de	Becher, Doerte/B-4454-2015; Gerdts, Gunnar/R-7000-2016; Amann, Rudolf I/C-6534-2014; Wichels, Antje/R-6992-2016; Wiltshire, Karen H./N-9494-2017	Becher, Doerte/0000-0002-9630-5735; Gerdts, Gunnar/0000-0003-0872-3927; Amann, Rudolf I/0000-0002-0846-7372; Wichels, Antje/0000-0002-2060-1845; Wiltshire, Karen/0000-0002-7148-0529; Fuchs, Bernhard/0000-0001-9828-1290; Schweder, Thomas/0000-0002-7213-3596; Bockelmann, Frank-Detlef/0000-0003-4900-6780	European Bioinformatics Institute [ERP001227]; German Federal Ministry of Education and Research (BMBF) [03F0480A]	European Bioinformatics Institute; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank T. Hammer and T. Ferdelman for critical reading of the manuscript; M. Meiners, E. Karamehmedovic, B. Voigt, and V. Damare for sample processing; F. Ruhnau and L. Sayavedra for work on transporters; M. Zeder for automated counting; and R. Hahnke and J. Harder for help with probe testing. We are also grateful to our colleagues from the Bundesamt fur Seeschifffahrt und Hydrographie for provision of operational model output. Analyses and visualizations used in fig. S1, D to F, were produced with the Giovanni online data system, developed and maintained by the NASA Goddard Earth Sciences Data and Information Service Center. We acknowledge the Moderate Resolution Imaging Spectroradiometer mission scientists and associated NASA personnel for these data. The sequence data reported in this study can be obtained from the European Bioinformatics Institute (study number ERP001227; www.ebi.ac.uk/ena/data/view/ERP001227). The German Federal Ministry of Education and Research (BMBF) supported this study by funding the Microbial Interactions in Marine Systems project (MIMAS, project 03F0480A, http://mimas-project.de).	Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi A, 2010, INT J SYST EVOL MICR, V60, P2813, DOI 10.1099/ijs.0.018739-0; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; Fandino LB, 2001, AQUAT MICROB ECOL, V23, P119, DOI 10.3354/ame023119; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Giebel HA, 2011, ISME J, V5, P8, DOI 10.1038/ismej.2010.87; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Khodse VB, 2010, BIOFOULING, V26, P527, DOI 10.1080/08927014.2010.492468; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Pinhassi J, 1999, AQUAT MICROB ECOL, V17, P13, DOI 10.3354/ame017013; Pinhassi J, 2007, INT J SYST EVOL MICR, V57, P2370, DOI 10.1099/ijs.0.65091-0; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Romanenko LA, 2004, INT J SYST EVOL MICR, V54, P669, DOI 10.1099/ijs.0.02846-0; Rostovtseva TK, 2002, BIOPHYS J, V82, P160, DOI 10.1016/S0006-3495(02)75383-6; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Sun J., 2011, PLOS ONE, V6; Tada Y, 2011, APPL ENVIRON MICROB, V77, P4055, DOI 10.1128/AEM.02952-10; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tittel J, 2012, J PLANKTON RES, V34, P102, DOI 10.1093/plankt/fbr094; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wustman BA, 1997, PLANT PHYSIOL, V113, P1059, DOI 10.1104/pp.113.4.1059	41	854	883	33	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					608	611		10.1126/science.1218344	http://dx.doi.org/10.1126/science.1218344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556258				2022-12-28	WOS:000303498800051
J	Oxtoby, K				Oxtoby, Kathy			Technological approaches to improving care	BRITISH MEDICAL JOURNAL			English	Editorial Material												kathyoxtoby@blueyonder.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e2936	10.1136/bmj.e2936	http://dx.doi.org/10.1136/bmj.e2936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NC	22551714				2022-12-28	WOS:000303817200010
J	Smith, GL; Xu, Y; Buchholz, TA; Giordano, SH; Jiang, J; Shih, YCT; Smith, BD				Smith, Grace L.; Xu, Ying; Buchholz, Thomas A.; Giordano, Sharon H.; Jiang, Jing; Shih, Ya-Chen Tina; Smith, Benjamin D.			Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSENSUS STATEMENT; RADIATION-THERAPY; AMERICAN SOCIETY; LOCAL RECURRENCE; CLAIMS DATA; RADIOTHERAPY; GUIDELINES; PATTERNS; TRIALS; CARE	Context Brachytherapy is a radiation treatment that uses an implanted radioactive source. In recent years, use of breast brachytherapy after lumpectomy for early breast cancer has increased substantially despite a lack of randomized trial data comparing its effectiveness with standard whole-breast irradiation (WBI). Because results of long-term randomized trials will not be reported for years, detailed analysis of clinical outcomes in a nonrandomized setting is warranted. Objective To compare the likelihood of breast preservation, complications, and survival for brachytherapy vs WBI among a nationwide cohort of older women with breast cancer with fee-for-service Medicare. Design Retrospective population-based cohort study of 92 735 women aged 67 years or older with incident invasive breast cancer, diagnosed between 2003 and 2007 and followed up through 2008. After lumpectomy 6952 patients were treated with brachytherapy vs 85 783 with WBI. Main Outcome Measures Cumulative incidence and adjusted risk of subsequent mastectomy (an indicator of failure to preserve the breast) and death were compared using the log-rank test and proportional hazards models. Odds of postoperative infectious and noninfectious complications within 1 year were compared using the chi(2) test and logistic models. Cumulative incidences of long-term complications were compared using the log-rank test. Results Five-year incidence of subsequent mastectomy was higher in women treated with brachytherapy (3.95%; 95% CI, 3.19%-4.88%) vs WBI (2.18%; 95% CI, 2.04%-2.33%; P<.001) and persisted after multivariate adjustment (hazard ratio [HR], 2.19; 95% CI, 1.84-2.61, P<.001). Brachytherapy was associated with more frequent infectious(16.20%; 95% CI, 15.34%-17.08% vs 10.33%; 95% CI, 10.13%-10.53%; P<.001; adjusted odds ratio [OR], 1.76; 1.64-1.88) and noninfectious (16.25%; 95% CI, 15.39%-17.14% vs 9.00%; 95% CI, 8.81%-9.19%; P<.001; adjusted OR, 2.03; 95% CI, 1.89-2.17) postoperative complications; and higher 5-year incidence of breast pain (14.55%, 95% CI, 13.39%-15.80% vs 11.92%; 95% CI, 11.63%-12.21%), fat necrosis (8.26%; 95% CI, 7.27-9.38 vs 4.05%; 95% CI, 3.87%-4.24%), and rib fracture (4.53%; 95% CI, 3.63%-5.64% vs 3.62%; 95% CI, 3.44%-3.82%; P <=.01 for all). Five-year overall survival was 87.66% (95% CI, 85.94%-89.18%) in patients treated with brachytherapy vs 87.04% (95% CI, 86.69%-87.39%) in patients treated with WBI (adjusted HR, 0.94; 95% CI, 0.84-1.05; P=.26). Conclusion In a cohort of older women with breast cancer, treatment with brachytherapy compared with WBI was associated worse with long-term breast preservation and increased complications but no difference in survival. JAMA. 2012;307(17):1827-1837 www.jama.com	[Smith, Grace L.; Buchholz, Thomas A.; Smith, Benjamin D.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Xu, Ying; Jiang, Jing] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA; [Giordano, Sharon H.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Shih, Ya-Chen Tina] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Chicago	Smith, BD (corresponding author), 1515 Holcombe Blvd,Unit 1202, Houston, TX 77030 USA.	bsmith3@mdanderson.org		Giordano, Sharon H./0000-0002-8700-2767; Shih, Ya-Chen Tina/0000-0001-7290-3864; Smith, Benjamin/0000-0001-7866-1093; Buchholz, Thomas/0000-0002-7859-5572; Smith, Grace/0000-0002-3171-2911	Varian Medical Systems; Cancer Prevention & Research Institute of Texas [RP101207]; Department of Defense; Agency for Healthcare Research and Quality [R01 HS018535]; National Cancer Institute [RC1CA145799, R21CA165092]; University of Chicago Cancer Research Foundation Women's Board; Department of Health and Human Services National Cancer Institute [CA16672, T32CA77050]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018535] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA077050, R21CA165092, P30CA016672, RC1CA145799] Funding Source: NIH RePORTER	Varian Medical Systems; Cancer Prevention & Research Institute of Texas; Department of Defense(United States Department of Defense); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Cancer Research Foundation Women's Board; Department of Health and Human Services National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Smith receives research support from Varian Medical Systems, but this support was not used for any portion of the current manuscript. None of the other coauthors have conflicts to report.; Dr B. Smith and Dr Giordano are supported by grant RP101207 from the Cancer Prevention & Research Institute of Texas. Dr G. Smith was supported by a Multidisciplinary Postdoctoral Award from the Department of Defense. Dr Shih is supported by grant R01 HS018535 from the Agency for Healthcare Research and Quality and by grants RC1CA145799 and R21CA165092 from the National Cancer Institute, and from the University of Chicago Cancer Research Foundation Women's Board. This study was also supported in part by grants CA16672 and T32CA77050 from the Department of Health and Human Services National Cancer Institute. This study was also supported by a philanthropic gift from Ann Cazalot and Clarence Cazalot.	Abbott AM, 2011, CANCER-AM CANCER SOC, V117, P3305, DOI 10.1002/cncr.25927; Abe O, 2005, LANCET, V366, P2087; [Anonymous], MED UT ENR; [Anonymous], AR RES FIL ARF 2009; [Anonymous], MAMMOSITE TARG RAD T; [Anonymous], AR RES FIL ARF 2007; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Buchholz TA, 2003, INT J RADIAT ONCOL, V57, P1214, DOI 10.1016/S0360-3016(03)00813-7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Gold HT, 2007, HEALTH SERV RES, V42, P2056, DOI 10.1111/j.1475-6773.2007.00705.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hattangadi JA, 2012, JNCI-J NATL CANCER I, V104, P29, DOI 10.1093/jnci/djr495; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Husain ZA, 2011, BRACHYTHERAPY, V10, P479, DOI 10.1016/j.brachy.2011.05.001; Klabunde CN, 2002, MED CARE, V40, P26; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Mandelblatt JS, 2008, MED CARE, V46, P759, DOI 10.1097/MLR.0b013e3181844867; Nattinger AB, 2004, HEALTH SERV RES, V39, P1733, DOI 10.1111/j.1475-6773.2004.00315.x; Norris D, 2008, ONCOLOGY ISSUES  JAN, P20; Parsons LS, 2001, SAS SUGI, P214; Polgar C, 2007, INT J RADIAT ONCOL, V69, P694, DOI 10.1016/j.ijrobp.2007.04.022; Punglia RS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c845; Shaitelman SF, 2010, CANCER-AM CANCER SOC, V116, P4677, DOI 10.1002/cncr.25383; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P1302, DOI 10.1093/jnci/djj359; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P681, DOI 10.1093/jnci/djj186; Smith BD, 2009, J AM COLL SURGEONS, V209, P269, DOI 10.1016/j.jamcollsurg.2009.02.066; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Smith GL, 2011, J CLIN ONCOL, V29, P157, DOI 10.1200/JCO.2009.27.0942; Srokowski TR, 2008, CANCER-AM CANCER SOC, V113, P22, DOI 10.1002/cncr.23513; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Vaidya JS, 1996, BRIT J CANCER, V74, P820, DOI 10.1038/bjc.1996.442; Vicini F, 2011, INT J RADIAT ONCOL, V79, P977, DOI 10.1016/j.ijrobp.2009.12.047; Warren JL, 2002, MED CARE, V40, P3	37	152	155	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1827	1837		10.1001/jama.2012.3481	http://dx.doi.org/10.1001/jama.2012.3481			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550197	Bronze, Green Accepted			2022-12-28	WOS:000303386800022
J	Prasad, SM; Drazer, MW; Huo, DZ; Hu, JC; Eggener, SE				Prasad, Sandip M.; Drazer, Michael W.; Huo, Dezheng; Hu, Jim C.; Eggener, Scott E.			2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MEN		[Prasad, Sandip M.; Drazer, Michael W.; Eggener, Scott E.] Univ Chicago, Med Ctr, Urol Sect, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Med Ctr, Dept Hlth Studies, Chicago, IL 60637 USA; [Hu, Jim C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of California System; University of California Los Angeles	Prasad, SM (corresponding author), Univ Chicago, Med Ctr, Urol Sect, Chicago, IL 60637 USA.	seggener@surgery.bsd.uchicago.edu						Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	6	45	49	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1692	1694		10.1001/jama.2012.534	http://dx.doi.org/10.1001/jama.2012.534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535850				2022-12-28	WOS:000303147500015
J	Salvarani, C; Brown, RD; Hunder, GG				Salvarani, Carlo; Brown, Robert D., Jr.; Hunder, Gene G.			Adult primary central nervous system vasculitis	LANCET			English	Article							CEREBRAL AMYLOID ANGIOPATHY; DEFINED PRIMARY ANGIITIS; CHURG-STRAUSS-SYNDROME; GIANT-CELL ARTERITIS; OF-THE-LITERATURE; TERM-FOLLOW-UP; GRANULOMATOUS-ANGIITIS; NEUROLOGIC MANIFESTATIONS; WEGENERS-GRANULOMATOSIS; LUPUS-ERYTHEMATOSUS	Primary CNS vasculitis is an uncommon disorder of unknown cause that is restricted to brain and spinal cord. The median age of onset is 50 years. The neurological manifestations are diverse, but generally consist of headache, altered cognition, focal weakness, or stroke. Serological markers of inflammation are usually normal. Cerebrospinal fluid is abnormal in about 80-90% of patients. Diagnosis is unlikely in the presence of a normal MRI of the brain. Biopsy of CNS tissue showing vasculitis is the only definitive test; however, angiography has often been used for diagnosis even though it has only moderate sensitivity and specificity. The size of the affected vessels varies and determines outcome and response to treatment. Early recognition is important because treatment with corticosteroids with or without cytotoxic drugs can often prevent serious outcomes. The differential diagnosis includes reversible cerebral vasoconstriction syndromes and secondary cerebral vasculitis.	[Salvarani, Carlo] Ist Ricovero & Cura Carattere Sci, Azienda Osped ASMN, Dept Internal Med, Rheumatol Unit, I-42123 Reggio Emilia, Italy; [Brown, Robert D., Jr.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Hunder, Gene G.] Mayo Clin, Coll Med, Rochester, MN USA	IRCCS Arcispedale S. Maria Nuova; Mayo Clinic; Mayo Clinic	Salvarani, C (corresponding author), Ist Ricovero & Cura Carattere Sci, Azienda Osped ASMN, Dept Internal Med, Rheumatol Unit, I-42123 Reggio Emilia, Italy.	salvarani.carlo@asmn.re.it	Salvarani, Carlo/K-2431-2018	Salvarani, Carlo/0000-0001-5426-5133				Al-Araji A, 2009, LANCET NEUROL, V8, P192, DOI 10.1016/S1474-4422(09)70015-8; ALHALABI M, 1994, NEUROLOGY, V44, P1221, DOI 10.1212/WNL.44.7.1221; Alrawi A, 1999, NEUROLOGY, V53, P858, DOI 10.1212/WNL.53.4.858; ARTHUR G, 1977, ARCH PATHOL LAB MED, V101, P382; Barinagarrementeria F, 1998, STROKE, V29, P123, DOI 10.1161/01.STR.29.1.123; Bekiesinska-Figatowska Monika, 2004, Med Sci Monit, V10 Suppl 3, P80; Benseler SM, 2006, ARTHRITIS RHEUM-US, V54, P1291, DOI 10.1002/art.21766; Berlit P, 2009, J NEUROL, V256, P792, DOI 10.1007/s00415-009-5018-5; Bilge I, 2005, PEDIATR NEPHROL, V20, P529, DOI 10.1007/s00467-004-1736-1; Birnbaum J, 2009, ARCH NEUROL-CHICAGO, V66, P704, DOI 10.1001/archneurol.2009.76; Bleck TP, 1999, NEUROL CLIN, V17, P801, DOI 10.1016/S0733-8619(05)70167-5; BORENSTEIN D, 1988, CANCER, V62, P375, DOI 10.1002/1097-0142(19880715)62:2<375::AID-CNCR2820620224>3.0.CO;2-3; Pons NC, 2010, JOINT BONE SPINE, V77, P361, DOI 10.1016/j.jbspin.2010.02.030; Cacoub P, 2005, AIDS, V19, pS128, DOI 10.1097/01.aids.0000192081.33938.2f; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Calabrese Leonard H., 1996, Current Opinion in Rheumatology, V8, P34, DOI 10.1097/00002281-199601000-00006; CALABRESE LH, 1993, J RHEUMATOL, V20, P2046; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/1529-0131(199707)40:7<1189::AID-ART2>3.0.CO;2-4; CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; Cloft HJ, 1999, ACTA RADIOL, V40, P83; CRAVIOTO H, 1959, NEUROLOGY, V9, P599, DOI 10.1212/WNL.9.9.599; CUPPS TR, 1983, AM J MED, V74, P97, DOI 10.1016/0002-9343(83)91125-7; Ducros Anne, 2009, Pract Neurol, V9, P256, DOI 10.1136/jnnp.2009.187856; DUNA GF, 1995, J RHEUMATOL, V22, P662; Eleftheriou D, 2010, DEV MED CHILD NEUROL, V52, P863, DOI 10.1111/j.1469-8749.2009.03591.x; ELLIS SG, 1979, SEMIN ARTHRITIS RHEU, V8, P212, DOI 10.1016/S0049-0172(79)80009-8; Eng JA, 2004, ANN NEUROL, V55, P250, DOI 10.1002/ana.10810; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; FERRIS EJ, 1973, RADIOLOGY, V109, P327, DOI 10.1148/109.2.327; Gaa J, 2004, EUR RADIOL, V14, P746, DOI 10.1007/s00330-003-2015-4; Ghinoi A, 2010, CLIN EXP RHEUMATOL, V28, P759; GOLDEN MP, 1994, MEDICINE, V73, P246, DOI 10.1097/00005792-199409000-00003; Goncalves C, 2004, An Pediatr (Barc), V60, P188; GRAF WD, 1993, J CHILD NEUROL, V8, P256, DOI 10.1177/088307389300800309; GREENAN TJ, 1992, RADIOLOGY, V182, P65, DOI 10.1148/radiology.182.1.1727311; Griffin J, 1973, Trans Am Neurol Assoc, V98, P145; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Hajj-Ali RA, 2002, ARTHRIT RHEUM-ARTHR, V47, P662, DOI 10.1002/art.10797; HANLY JG, 1992, J RHEUMATOL, V19, P732; Harbitz F, 1922, AM J MED SCI, V163, P250, DOI 10.1097/00000441-192202000-00010; HARRIS KG, 1994, AM J NEURORADIOL, V15, P317; HARRISON PE, 1976, J NEUROL SCI, V29, P335, DOI 10.1016/0022-510X(76)90182-9; Heinrich A, 2003, EUR NEUROL, V50, P109, DOI 10.1159/000072510; Hirohata S, 2008, J NEUROL SCI, V267, P41, DOI 10.1016/j.jns.2007.09.041; Holle JU, 2011, CURR OPIN RHEUMATOL, V23, P7, DOI 10.1097/BOR.0b013e32834115f9; Hou WH, 2009, CEREBROVASC DIS, V27, P479, DOI 10.1159/000210095; Iwase T, 2001, EUR NEUROL, V45, P184, DOI 10.1159/000052120; Kadkhodayan Y, 2004, RADIOLOGY, V233, P878, DOI 10.1148/radiol.2333031621; Kakumani PL, 2009, J RHEUMATOL, V36, P655, DOI 10.3899/jrheum.080605; Katchanov J, 2010, NEUROCRIT CARE, V12, P369, DOI 10.1007/s12028-010-9335-4; Kuker W, 2007, NEURORADIOLOGY, V49, P471, DOI 10.1007/s00234-007-0223-3; Kuker W, 2008, CEREBROVASC DIS, V26, P23, DOI 10.1159/000135649; LAWRENCE WP, 1974, CLIN RADIOL, V25, P343, DOI 10.1016/S0009-9260(74)80165-0; LIE JT, 1992, HUM PATHOL, V23, P164, DOI 10.1016/0046-8177(92)90238-X; Ma M, 2002, NEUROLOGY, V59, P1994, DOI 10.1212/01.WNL.0000038948.09158.A7; MARRA CM, 1995, CURR OPIN NEUROL, V8, P164; MCCORMICK HM, 1958, J NEUROPATH EXP NEUR, V17, P471, DOI 10.1097/00005072-195807000-00007; Melica G, 2009, J MED VIROL, V81, P578, DOI 10.1002/jmv.21462; Miller DV, 2009, AM J SURG PATHOL, V33, P35, DOI 10.1097/PAS.0b013e318181e097; Molloy ES, 2008, ANN RHEUM DIS, V67, P1732, DOI 10.1136/ard.2008.096800; Molloy ES, 2006, RHEUM DIS CLIN N AM, V32, P157, DOI 10.1016/j.rdc.2005.12.002; MOORE PM, 1989, NEUROLOGY, V39, P167, DOI 10.1212/WNL.39.2.167; Nagashima T, 2000, NEUROPATHOLOGY, V20, P309, DOI 10.1046/j.1440-1789.2000.00352.x; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e8; NEWMAN W, 1952, T AM NEUROL ASSOC, P114; Niemala RK, 1999, SEMIN ARTHRITIS RHEU, V29, P4, DOI 10.1016/S0049-0172(99)80033-X; NISHINO H, 1993, ANN NEUROL, V33, P4, DOI 10.1002/ana.410330103; Oran I, 1999, NEURORADIOLOGY, V41, P436, DOI 10.1007/s002340050779; Ovetchkine P, 2002, SCAND J INFECT DIS, V34, P307, DOI 10.1080/00365540110077452; PARISI JE, 1994, SEMIN NEUROL, V14, P341, DOI 10.1055/s-2008-1041093; Pomper MG, 1999, AM J NEURORADIOL, V20, P75; Provenzale JM, 1998, AM J NEURORADIOL, V19, P611; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; Regan M, 2001, J RHEUMATOL, V28, P207; Ringleb PA, 2005, RHEUMATOLOGY, V44, P1012, DOI 10.1093/rheumatology/keh664; Rosen CL, 2000, NEUROSURGERY, V46, P1504, DOI 10.1097/00006123-200006000-00037; Saliou G, 2008, RHEUMATOLOGY, V47, P107, DOI 10.1093/rheumatology/kem264; Salvarani C, 2008, RHEUMATOLOGY, V47, P1671, DOI 10.1093/rheumatology/ken328; Salvarani C, 2008, CLIN EXP RHEUMATOL, V26, pS111; Salvarani C, 2008, NEUROLOGY, V70, P2394, DOI 10.1212/01.wnl.0000314687.69681.24; Salvarani C, 2001, RHEUMATOLOGY, V50, P349; Salvarani C, 2008, MEDICINE, V87, P264, DOI 10.1097/MD.0b013e31818896e1; Salvarani C, 2008, ARTHRITIS RHEUM, V58, P595, DOI 10.1002/art.23300; Salvarani C, 2008, ARTHRIT RHEUM-ARTHR, V59, P291, DOI 10.1002/art.23337; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.21226; Salvarani C, 2006, ARTHRIT RHEUM-ARTHR, V55, P985, DOI 10.1002/art.22359; Salvarani C, 2011, ARTHRITIS RHEUM-US, V63, P3598, DOI 10.1002/art.30594; SANDHU R, 1979, ARCH NEUROL-CHICAGO, V36, P433, DOI 10.1001/archneur.1979.00500430063009; Scheid R, 2007, EUR J NEUROL, V14, P483, DOI 10.1111/j.1468-1331.2007.01718.x; SEHGAL M, 1995, MAYO CLIN PROC, V70, P337, DOI 10.4065/70.4.337; Sen ES, 2010, RHEUMATOLOGY, V49, P806, DOI 10.1093/rheumatology/kep453; SHOEMAKER EI, 1994, AM J NEURORADIOL, V15, P331; Starke J R, 1999, Semin Pediatr Neurol, V6, P318, DOI 10.1016/S1071-9091(99)80029-1; Swartz RH, 2009, NEUROLOGY, V72, P627, DOI 10.1212/01.wnl.0000342470.69739.b3; Tabarki B, 2001, PEDIATR NEUROL, V25, P239, DOI 10.1016/S0887-8994(01)00290-9; THOMAS L, 1966, J EXP MED, V123, P897, DOI 10.1084/jem.123.5.897; VOLLMER TL, 1993, ARCH NEUROL-CHICAGO, V50, P925, DOI 10.1001/archneur.1993.00540090032007; Wasserman BA, 2001, AM J ROENTGENOL, V177, P455, DOI 10.2214/ajr.177.2.1770455; White ML, 2007, AM J NEURORADIOL, V28, P933; Williams PJ, 2002, NATION, V274, P9; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Woolfenden AR, 1998, NEUROLOGY, V51, P183, DOI 10.1212/WNL.51.1.183; Zeller V, 2004, PRESSE MED, V33, P1385, DOI 10.1016/S0755-4982(04)98937-3; Zuckerman D, 2006, ONCOLOGIST, V11, P496, DOI 10.1634/theoncologist.11-5-496	104	151	159	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					767	777		10.1016/S0140-6736(12)60069-5	http://dx.doi.org/10.1016/S0140-6736(12)60069-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	995IK	22575778				2022-12-28	WOS:000308001300034
J	Jamieson, DJ; Chasela, CS; Hudgens, MG; King, CC; Kourtis, AP; Kayira, D; Hosseinipour, MC; Kamwendo, DD; Ellington, SR; Wiener, JB; Fiscus, SA; Tegha, G; Mofolo, IA; Sichali, DS; Adair, LS; Knight, RJ; Martinson, F; Kacheche, Z; Soko, A; Hoffman, I; van der Horst, C				Jamieson, Denise J.; Chasela, Charles S.; Hudgens, Michael G.; King, Caroline C.; Kourtis, Athena P.; Kayira, Dumbani; Hosseinipour, Mina C.; Kamwendo, Deborah D.; Ellington, Sascha R.; Wiener, Jeffrey B.; Fiscus, Susan A.; Tegha, Gerald; Mofolo, Innocent A.; Sichali, Dorothy S.; Adair, Linda S.; Knight, Rodney J.; Martinson, Francis; Kacheche, Zebrone; Soko, Alice; Hoffman, Irving; van der Horst, Charles		BAN Study Team	Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial	LANCET			English	Article							TO-CHILD TRANSMISSION; UNINFECTED CHILDREN; INFECTED WOMEN; MOTHERS; BORN; MORTALITY; THERAPY; PROPHYLAXIS; GASTROENTERITIS; ZIDOVUDINE	Background In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We assessed the effect of 28 weeks of maternal or infant antiretroviral prophylaxis on postnatal HIV infection at 48 weeks. Methods The Breastfeeding, Antiretrovirals, and Nutrition (BAN) Study was undertaken in Lilongwe, Malawi, between April 21, 2004, and Jan 28, 2010. 2369 HIV-infected breastfeeding mothers with a CD4 count of 250 cells per mu L or more and their newborn babies were randomly assigned with a variable-block design to one of three, 28-week regimens: maternal triple antiretroviral (n=849); daily infant nevirapine (n=852); or control (n=668). Patients and local clinical staff were not masked to treatment allocation, but other study investigators were. All mothers and infants received one dose of nevirapine (mother 200 mg; infant 2 mg/kg) and 7 days of zidovudine (mother 300 mg; infants 2 mg/kg) and lamivudine (mothers 150 mg; infants 4 mg/kg) twice a day. Mothers were advised to wean between 24 weeks and 28 weeks after birth. The primary endpoint was HIV infection by 48 weeks in infants who were not infected at 2 weeks and in all infants randomly assigned with censoring at loss to follow-up. This trial is registered with ClinicalTrials.gov, number NCT00164736. Findings 676 mother-infant pairs completed follow-up to 48 weeks or reached an endpoint in the maternal-antiretroviral group, 680 in the infant-nevirapine group, and 542 in the control group. By 32 weeks post partum, 96% of women in the intervention groups and 88% of those in the control group reported no breastfeeding since their 28-week visit. 30 infants in the maternal-antiretroviral group, 25 in the infant-nevirapine group, and 38 in the control group became HIV infected between 2 weeks and 48 weeks of life; 28 (30%) infections occurred after 28 weeks (nine in maternal-antiretroviral, 13 in infant-nevirapine, and six in control groups). The cumulative risk of HIV-1 transmission by 48 weeks was significantly higher in the control group (7%, 95% CI 5-9) than in the maternal-antiretroviral (4%, 3-6; p=0.0273) or the infant-nevirapine (4%, 2-5; p=0.0027) groups. The rate of serious adverse events in infants was significantly higher during 29-48 weeks than during the intervention phase (1.1 [95% CI 1.0-1.2] vs 0.7 [0.7-0.8] per 100 person-weeks; p<0.0001), with increased risk of diarrhoea, malaria, growth faltering, tuberculosis, and death. Nine women died between 2 weeks and 48 weeks post partum (one in maternal-antiretroviral group, two in infant-nevirapine group, six in control group). Interpretation In resource-limited settings where no suitable alternative to breastfeeding is available, antiretroviral prophylaxis given to mothers or infants might decrease HIV transmission. Weaning at 6 months might increase infant morbidity.	[Jamieson, Denise J.; King, Caroline C.; Kourtis, Athena P.; Ellington, Sascha R.; Wiener, Jeffrey B.] US Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; [Chasela, Charles S.; Kayira, Dumbani; Hosseinipour, Mina C.; Kamwendo, Deborah D.; Tegha, Gerald; Mofolo, Innocent A.; Sichali, Dorothy S.; Martinson, Francis; Kacheche, Zebrone; Soko, Alice] UNC Project, Lilongwe, Malawi; [Hudgens, Michael G.; Hosseinipour, Mina C.; Fiscus, Susan A.; Adair, Linda S.; Martinson, Francis; Hoffman, Irving; van der Horst, Charles] Univ N Carolina, Chapel Hill, NC USA; [Knight, Rodney J.] Principia Int, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Jamieson, DJ (corresponding author), US Ctr Dis Control & Prevent, 4770 Buford Highway,Mailstop K-34, Atlanta, GA 30341 USA.	djj0@cdc.gov	Kayira, Dumbani Lyspin/I-4449-2019	Kayira, Dumbani Lyspin/0000-0002-7772-8070; Jamieson, Denise/0000-0003-2597-1201; Kourtis, Athena/0000-0003-1585-1310; Sellers, Christopher/0000-0003-4672-8198	US Centers for Disease Control and Prevention; Abbott Laboratories; GlaxoSmithKline; Abbott; Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention [SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, SIP 22-09 U48-DP001944-01]; National Institute of Allergy and Infectious Diseases; University of North Carolina Center for AIDS Research [P30-AI50410]; NIH Fogarty AIDS International Training and Research Program [DHHS/NIH/FIC 2-D43 TW01039-06, R24 TW007988]; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson and Johnson; US Agency for International Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039, R24TW007988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Abbott Laboratories(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; NIH Fogarty AIDS International Training and Research Program; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); US Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US Centers for Disease Control and Prevention.; The University of North Carolina received grant support from Abbott Laboratories and GlaxoSmithKline. SAF received free diagnostic kits from Abbott, Roche, Gen-Probe, IQuum, and Perkin-Elmer; and has been a consultant for Alderon and on a scientific advisory board for Abbott, Roche, and Gen-Probe. SAF and MCH have received lecture fees from Abbott. All other authors declare that they have no conflicts of interest.; The BAN study was supported by grants from the Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention (SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, and SIP 22-09 U48-DP001944-01); the National Institute of Allergy and Infectious Diseases; the University of North Carolina Center for AIDS Research (P30-AI50410); and the NIH Fogarty AIDS International Training and Research Program (DHHS/NIH/FIC 2-D43 TW01039-06 and R24 TW007988; the American Recovery and Reinvestment Act). The antiretrovirals used were donated by Abbott Laboratories, GlaxoSmithKline, Boehringer Ingelheim, Roche Pharmaceuticals, and Bristol-Myers Squibb. The Call to Action for the Preventing Mother-to-Child Transmission programme was supported by the Elizabeth Glaser Pediatric AIDS Foundation, the United Nations Children's Fund, the World Food Program, the Malawi Ministry of Health and Population, Johnson and Johnson, and the US Agency for International Development. We thank all the women and their infants who agreed to participate in the study.	Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Arpadi S, 2009, AM J CLIN NUTR, V90, P344, DOI 10.3945/ajcn.2009.27745; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chavula C, 2012, CONTEMP CLIN TRIALS, V33, P55, DOI 10.1016/j.cct.2011.10.006; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Division of AIDS, 2004, TABL GRAD SEV AD PED; Emergency Nutrition Network, 2011, MEAS MALN IND ASS; Fawzy A, 2011, J INFECT DIS, V203, P1222, DOI 10.1093/infdis/jir019; Fowler MG, 2002, J ACQ IMMUN DEF SYND, V30, P230, DOI [10.1097/00042560-200206010-00012, 10.1097/01.QAI.0000018364.28828.14]; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Kafulafula G, 2010, JAIDS-J ACQ IMM DEF, V53, P6, DOI 10.1097/QAI.0b013e3181bd5a47; Kayira D, 2012, AM J CLIN NUTR, V95, P759, DOI 10.3945/ajcn.111.018812; Kerac M, 2011, ARCH DIS CHILD, V96, P1008, DOI 10.1136/adc.2010.191882; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Omer SB, 2011, AIDS, V25, P767, DOI 10.1097/QAD.0b013e328344c12a; Onyango-Makumbi C, 2010, JAIDS-J ACQ IMM DEF, V53, P20, DOI 10.1097/QAI.0b013e3181bdf68e; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Parker ME, 2011, AIDS EDUC PREV, V23, P281, DOI 10.1521/aeap.2011.23.3.281; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Phuka JC, 2012, MATERN CHILD NUTR, V8, P239, DOI 10.1111/j.1740-8709.2011.00294.x; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; *US FDA, FDA PUBL HLTH ADV NE; van der Horst C, 2009, CONTEMP CLIN TRIALS, V30, P24, DOI 10.1016/j.cct.2008.09.001; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization, 2001, NEW DAT PREV MOTH TO; World Health Organization, 2010, GUID HIV INF FEED PR; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	41	68	70	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2449	2458		10.1016/S0140-6736(12)60321-3	http://dx.doi.org/10.1016/S0140-6736(12)60321-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22541418	Green Accepted, Green Submitted			2022-12-28	WOS:000305915900029
J	Kemper, AR; Martin, GR				Kemper, Alex R.; Martin, Gerard R.			Screening of newborn babies: from blood spot to bedside	LANCET			English	Editorial Material							CONGENITAL HEART-DISEASE; PULSE OXIMETRY		[Kemper, Alex R.] Duke Univ, Dept Pediat, Durham, NC 27705 USA; [Martin, Gerard R.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Martin, Gerard R.] George Washington Univ, Sch Med, Washington, DC USA	Duke University; Children's National Health System; George Washington University	Kemper, AR (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27705 USA.	alex.kemper@duke.edu		Kemper, Alex/0000-0001-5491-3997				Centers for Disease Control and Prevention, 2011, EP INT SERV AT NCEH; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Kemper AR, 2008, GENET MED, V10, P259, DOI 10.1097/GIM.0b013e31816b64f9; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; Mitka M, 2011, JAMA-J AM MED ASSOC, V306, P1748, DOI 10.1001/jama.2011.1552; Secretary's Advisory Committee on Heritable Disorders in Newborns and Children, 2012, REC RESP HHS SECR; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Walsh W, 2011, J PERINATOL, V31, P125, DOI 10.1038/jp.2010.70	9	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2407	2408		10.1016/S0140-6736(12)60242-6	http://dx.doi.org/10.1016/S0140-6736(12)60242-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22554861				2022-12-28	WOS:000305915900006
J	Bramwell, VHC				Bramwell, Vivien H. C.			Pazopanib and the treatment palette for soft-tissue sarcoma	LANCET			English	Editorial Material							COST		Alberta Hlth Serv Canc Care, Tom Baker Canc Ctr, Calgary, AB T2N 4N2, Canada	Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary	Bramwell, VHC (corresponding author), Alberta Hlth Serv Canc Care, Tom Baker Canc Ctr, Calgary, AB T2N 4N2, Canada.	vivien.bramwell@albertahealthservices.ca						Amir E, 2011, J CLIN ONCOL, V29, P2543, DOI 10.1200/JCO.2011.35.2393; Booth CM, 2012, J CLIN ONCOL, V30, P1030, DOI 10.1200/JCO.2011.38.7571; Hillner BE, 2009, J CLIN ONCOL, V27, P2111, DOI 10.1200/JCO.2008.21.0534; Korn EL, 2011, J CLIN ONCOL, V29, P2439, DOI 10.1200/JCO.2011.34.6056; Meropol NJ, 2009, J CLIN ONCOL, V27, P3868, DOI 10.1200/JCO.2009.23.1183; Mileshkin L, 2009, J CLIN ONCOL, V27, P5830, DOI 10.1200/JCO.2009.22.7793; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Van Glabbeke M, 2010, J CLIN ONCOL, V28, P1247, DOI 10.1200/JCO.2009.24.2099; VANGLABBEKE M, 2002, EUR J CANCER, V38, P543, DOI DOI 10.1016/S0959-8049(01)00398-7; Verweij J, 2010, EUR J CANCER, V46, P863, DOI 10.1016/j.ejca.2010.01.016	12	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1854	1856		10.1016/S0140-6736(12)60739-9	http://dx.doi.org/10.1016/S0140-6736(12)60739-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22595798				2022-12-28	WOS:000304194200005
J	Bridges, NT; Ayoub, F; Avouac, JP; Leprince, S; Lucas, A; Mattson, S				Bridges, N. T.; Ayoub, F.; Avouac, J-P.; Leprince, S.; Lucas, A.; Mattson, S.			Earth-like sand fluxes on Mars	NATURE			English	Article							DUNE MOVEMENT; MODEL; CALIFORNIA; ABRASION; RIPPLES; EROSION; VALLEY	Strong and sustained winds on Mars have been considered rare, on the basis of surface meteorology measurements and global circulation models(1,2), raising the question of whether the abundant dunes and evidence for wind erosion seen on the planet are a current process. Recent studies(3-6) showed sand activity, but could not determine whether entire dunes were moving-implying large sand fluxes-or whether more localized and surficial changes had occurred. Here we present measurements of the migration rate of sand ripples and dune lee fronts at the Nili Patera dune field. We show that the dunes are near steady state, with their entire volumes composed of mobile sand. The dunes have unexpectedly high sand fluxes, similar, for example, to those in Victoria Valley, Antarctica, implying that rates of landscape modification on Mars and Earth are similar.	[Bridges, N. T.] Johns Hopkins Univ, Appl Phys Lab, Dept Space, Laurel, MD 20723 USA; [Ayoub, F.; Avouac, J-P.; Leprince, S.; Lucas, A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Mattson, S.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; University of Arizona	Bridges, NT (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Dept Space, Johns Hopkins Rd, Laurel, MD 20723 USA.	nathan.bridges@jhuapl.edu	Bridges, Nathan T/D-6341-2016; Avouac, Jean-Philippe/B-5699-2015; Lucas, Antoine/A-9752-2009	Avouac, Jean-Philippe/0000-0002-3060-8442; Lucas, Antoine/0000-0003-2192-4416	NASA; Keck Institute for Space Studies; Jet Propulsion Laboratory	NASA(National Aeronautics & Space Administration (NASA)); Keck Institute for Space Studies; Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA))	Discussions with R. Ewing, C. Narteau, and S. Silvestro on bedforms and R. Kirk on stereo data significantly improved this research. This research was supported by grants from NASA's Mars Data Analysis Program, the Keck Institute for Space Studies, and seed funding from the Jet Propulsion Laboratory's Director's Research and Development Fund.	Ahmedou DO, 2007, J GEOPHYS RES-EARTH, V112; ANDERSON RS, 1987, SEDIMENTOLOGY, V34, P943, DOI 10.1111/j.1365-3091.1987.tb00814.x; Andreotti B, 2004, J FLUID MECH, V510, P47, DOI 10.1017/S0022112004009073; Andreotti B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028001; Armstrong JC, 2005, ICARUS, V176, P57, DOI 10.1016/j.icarus.2005.01.005; ARVIDSON RE, 1983, SCIENCE, V222, P463, DOI 10.1126/science.222.4623.463; Bagnold R.A., 1954, PHYS BLOWN SAND DESE; Bourke MC, 2009, GEOMORPHOLOGY, V109, P148, DOI 10.1016/j.geomorph.2009.02.028; Bridges NT, 2012, GEOLOGY, V40, P31, DOI 10.1130/G32373.1; Chojnacki M, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003675; Claudin P, 2006, EARTH PLANET SC LETT, V252, P30, DOI 10.1016/j.epsl.2006.09.004; Fenton L.K., 2010, MARS, V5, P159, DOI DOI 10.1555/MARS.2010.0007; Fenton LK, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002309; FRYBERGER SG, 1984, SEDIMENTOLOGY, V31, P413, DOI 10.1111/j.1365-3091.1984.tb00869.x; Golombek MP, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002754; GREELEY R, 1982, J GEOPHYS RES, V87, P9, DOI 10.1029/JB087iB12p10009; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hansen CJ, 2011, SCIENCE, V331, P575, DOI 10.1126/science.1197636; Kok JF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.074502; Laity JE, 2009, GEOMORPHOLOGY, V105, P202, DOI 10.1016/j.geomorph.2008.09.014; LANCASTER N, 1994, J ARID ENVIRON, V27, P113, DOI 10.1006/jare.1994.1052; Leprince S, 2007, IEEE T GEOSCI REMOTE, V45, P1529, DOI 10.1109/TGRS.2006.888937; LONG JT, 1964, GEOL SOC AM BULL, V75, P149, DOI 10.1130/0016-7606(1964)75[149:BMIIVC]2.0.CO;2; Malin M. C., 1986, ANTARCT J US, V20, P18; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; McEwen AS, 2010, ICARUS, V205, P2, DOI 10.1016/j.icarus.2009.04.023; Silvestro S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044743; Spiga A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003242; Sullivan R, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003101; Vermeesch P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035921	30	193	193	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					339	342		10.1038/nature11022	http://dx.doi.org/10.1038/nature11022			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596156				2022-12-28	WOS:000304099100035
J	Landeta, F; Hoffmeier, A; Fuchs, M; Scheld, H; Maintz, D; Stypmann, J; Schober, O; Kirchhof, P; Spieker, T; Waltenberger, J				Landeta, Federico; Hoffmeier, Andreas; Fuchs, Martin; Scheld, Hans; Maintz, David; Stypmann, Joerg; Schober, Otmar; Kirchhof, Paulus; Spieker, Tilmann; Waltenberger, Johannes			Ectopic thyroid mass in the heart	LANCET			English	Editorial Material							SUBSTERNAL GOITERS; MANAGEMENT		[Landeta, Federico; Stypmann, Joerg; Kirchhof, Paulus; Waltenberger, Johannes] Univ Hosp Muenster, Dept Cardiol & Angiol, D-48149 Munster, Germany; [Hoffmeier, Andreas; Scheld, Hans] Univ Hosp Muenster, Dept Thorac & Cardiovasc Surg, D-48149 Munster, Germany; [Maintz, David] Univ Hosp Muenster, Inst Clin Radiol, D-48149 Munster, Germany; [Schober, Otmar] Univ Hosp Muenster, Dept Nucl Med, D-48149 Munster, Germany; [Spieker, Tilmann] Univ Hosp Muenster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Fuchs, Martin] St Franziskus Hosp, Dept Nucl Med, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; St. Franziskus-Hospital	Landeta, F (corresponding author), Univ Hosp Muenster, Dept Cardiol & Angiol, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	federicojose.landeta@ukmuenster.de	Kirchhof, Paulus/AAT-7074-2021; Maintz, David/ABG-3220-2020; Waltenberger, Johannes/I-1813-2013	Kirchhof, Paulus/0000-0002-1881-0197; Waltenberger, Johannes/0000-0002-2417-9880				ALLO MD, 1983, SURGERY, V94, P969; KATLIC MR, 1985, ANN THORAC SURG, V39, P391, DOI 10.1016/S0003-4975(10)62645-8; MACK E, 1995, SURG CLIN N AM, V75, P377, DOI 10.1016/S0039-6109(16)46628-4; Wakeley CPG, 1940, SURG GYNECOL OBSTET, V70, P702; Wakely CPG, 1940, SURG GYNECOL OBSTET, V70, P2500; ZAPATERO J, 1988, JPN J SURG, V18, P105, DOI 10.1007/BF02470855	6	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					1762	1762		10.1016/S0140-6736(12)60111-1	http://dx.doi.org/10.1016/S0140-6736(12)60111-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22559902				2022-12-28	WOS:000303658500036
J	Wessely, S				Wessely, Simon			Anders Breivik, the public, and psychiatry	LANCET			English	Editorial Material									Kings Coll London, Inst Psychiat, Weston Educ Ctr, Dept Psychol Med, London SE5 9RS, England	University of London; King's College London	Wessely, S (corresponding author), Kings Coll London, Inst Psychiat, Weston Educ Ctr, Dept Psychol Med, London SE5 9RS, England.	simon.wessely@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929				Anda LG, 2011, BBC NEWS WORLD  1129; Bondevik Kjell Magne, 2010, J Ment Health, V19, P369, DOI 10.3109/09638231003728182; GAUPP R, 1914, MUNCHEN MED WOCHEN, V61, P633; Grondahl P, 2005, NORD J PSYCHIAT, V59, P92, DOI 10.1080/08039480510022927; GROUNDS A, 1991, BRIT J CRIMINOL, V31, P54, DOI 10.1093/oxfordjournals.bjc.a048085; JENKINS P, 1988, J CRIM JUST, V16, P1, DOI 10.1016/0047-2352(88)90031-1; Korsvold K, 2012, AFTENPOSTEN     0413; Norwegian Ministry of Health and Care Services, 2009, MENT HLTH SERV NORW; Orange R, 2012, OBSERVER        0415; Rokeach M., 1964, 3 CHRISTS YPSILANTI	10	17	17	2	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1563	1564		10.1016/S0140-6736(12)60655-2	http://dx.doi.org/10.1016/S0140-6736(12)60655-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22541565				2022-12-28	WOS:000303452600004
J	Gervais, WM; Norenzayan, A				Gervais, Will M.; Norenzayan, Ara			Analytic Thinking Promotes Religious Disbelief	SCIENCE			English	Article							FOUNDATIONS; EVOLUTION; QUALITY	Scientific interest in the cognitive underpinnings of religious belief has grown in recent years. However, to date, little experimental research has focused on the cognitive processes that may promote religious disbelief. The present studies apply a dual-process model of cognitive processing to this problem, testing the hypothesis that analytic processing promotes religious disbelief. Individual differences in the tendency to analytically override initially flawed intuitions in reasoning were associated with increased religious disbelief. Four additional experiments provided evidence of causation, as subtle manipulations known to trigger analytic processing also encouraged religious disbelief. Combined, these studies indicate that analytic processing is one factor (presumably among several) that promotes religious disbelief. Although these findings do not speak directly to conversations about the inherent rationality, value, or truth of religious beliefs, they illuminate one cognitive factor that may influence such discussions.	[Gervais, Will M.; Norenzayan, Ara] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Gervais, WM (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z4, Canada.	will@psych.ubc.ca; ara@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada [410-2010-0297]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Supported by a Social Sciences and Humanities Research Council of Canada grant (410-2010-0297) to A.N. The authors acknowledge no potential conflicts of interest. M. Schaller and R. Reber provided valuable advice. All data are available from the authors upon request. Additional references (35-37) are provided in the online supplementary materials.	Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; [Anonymous], 1843, FEAR TREMBLING; Aquinas T, 1272, SUMMA THEOLOGICA; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Bering JM, 2006, BEHAV BRAIN SCI, V29, P453, DOI 10.1017/S0140525X06009101; Bloom P, 2007, DEVELOPMENTAL SCI, V10, P147, DOI 10.1111/j.1467-7687.2007.00577.x; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Dennett DC, 2006, BREAKING THE SPELL; Epley N, 2009, P NATL ACAD SCI USA, V106, P21533, DOI 10.1073/pnas.0908374106; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Harris PL, 2006, CHILD DEV, V77, P505, DOI 10.1111/j.1467-8624.2006.00886.x; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; HOGE DR, 1972, J SCI STUD RELIG, V11, P369; Hood Bruce M., 2009, SUPERSENSE WHY WE BE; Kahneman D., 2011, THINKING FAST SLOW; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kelemen D, 2004, PSYCHOL SCI, V15, P295, DOI 10.1111/j.0956-7976.2004.00672.x; Kelemen D, 2009, COGNITION, V111, P138, DOI 10.1016/j.cognition.2009.01.001; McCullough ME, 2005, J PERS SOC PSYCHOL, V89, P78, DOI 10.1037/0022-3514.89.1.78; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Norenzayan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036880; Norris Pippa, 2004, SACRED SECULAR RELIG; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Song HJ, 2008, SOC COGNITION, V26, P791, DOI 10.1521/soco.2008.26.6.791; SRULL TK, 1980, J PERS SOC PSYCHOL, V38, P841, DOI 10.1037/0022-3514.38.6.841; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Uhlmann EL, 2011, J EXP SOC PSYCHOL, V47, P312, DOI 10.1016/j.jesp.2010.10.013; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; Zuckerman P., 2008, SOC GOD	33	309	312	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					493	496		10.1126/science.1215647	http://dx.doi.org/10.1126/science.1215647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	931QC	22539725				2022-12-28	WOS:000303233400052
J	Rajasethupathy, P; Antonov, I; Sheridan, R; Frey, S; Sander, C; Tuschl, T; Kandel, ER				Rajasethupathy, Priyamvada; Antonov, Igor; Sheridan, Robert; Frey, Sebastian; Sander, Chris; Tuschl, Thomas; Kandel, Eric R.			A Role for Neuronal piRNAs in the Epigenetic Control of Memory-Related Synaptic Plasticity	CELL			English	Article							LONG-TERM FACILITATION; SMALL RNAS; DNA DEMETHYLATION; MOLECULAR TURNOVER; FEEDBACK LOOP; APLYSIA CPEB; TRANSCRIPTION; METHYLATION; PROTEIN; TESTES	Small RNA-mediated gene regulation during development causes long-lasting changes in cellular phenotypes. To determine whether small RNAs of the adult brain can regulate memory storage, a process that requires stable and long-lasting changes in the functional state of neurons, we generated small RNA libraries from the Aplysia CNS. In these libraries, we discovered an unexpectedly abundant expression of a 28 nucleotide sized class of piRNAs in brain, which had been thought to be germline specific. These piRNAs have unique biogenesis patterns, predominant nuclear localization, and robust sensitivity to serotonin, a modulatory transmitter that is important for memory. We find that the Piwi/piRNA complex facilitates serotonin-dependent methylation of a conserved CpG island in the promoter of CREB2, the major inhibitory constraint of memory in Aplysia, leading to enhanced long-term synaptic facilitation. These findings provide a small RNA-mediated gene regulatory mechanism for establishing stable long-term changes in neurons for the persistence of memory.	[Frey, Sebastian; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Rajasethupathy, Priyamvada; Antonov, Igor; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10065 USA.	ttuschl@rockefeller.edu; erk5@columbia.edu			HHMI [P50 HG002806]; NIH [P01 GM073047]; NRSA [5F30MH086267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH086267] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Tom Maniatis and Praveen Sethupathy for comments on the manuscript and for helpful discussions throughout. We also thank Ferdinando Fiumara, Doron Betel, Pavankumar Puvulla, and Pierre Trifilieff for experimental advice and discussions and Frank Grasso for gifting invertebrate CNS samples. We thank Vivian Zhu and Edward Konstantinov for technical assistance with cell cultures. This work is supported by an HHMI grant P50 HG002806, NIH grant P01 GM073047, and NRSA training grant 5F30MH086267.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Liu RY, 2008, J NEUROSCI, V28, P1970, DOI 10.1523/JNEUROSCI.3848-07.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Song H, 2007, BIOPHYS J, V92, P3407, DOI 10.1529/biophysj.106.096891; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017	46	380	400	0	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					693	707		10.1016/j.cell.2012.02.057	http://dx.doi.org/10.1016/j.cell.2012.02.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541438	Bronze, Green Accepted			2022-12-28	WOS:000303443100019
J	DeWeerdt, S				DeWeerdt, Sarah			VACCINES The take-home lesson	NATURE			English	Editorial Material							MALARIA VACCINE; TRIAL											Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	5	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S24	S25		10.1038/484S24a	http://dx.doi.org/10.1038/484S24a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534529	Bronze			2022-12-28	WOS:000303200400004
J	Kim, K; Kim, YH; Kim, SY; Kim, S; Lee, YJ; Kim, KP; Lee, HS; Ahn, S; Kim, T; Hwang, SS; Song, KJ; Kang, SB; Kim, DW; Park, SH; Lee, KH				Kim, Kyuseok; Kim, Young Hoon; Kim, So Yeon; Kim, Suyoung; Lee, Yoon Jin; Kim, Kwang Pyo; Lee, Hye Seung; Ahn, Soyeon; Kim, Taeyun; Hwang, Seung-sik; Song, Ki Jun; Kang, Sung-Bum; Kim, Duck-Woo; Park, Seong Ho; Lee, Kyoung Ho			Low-Dose Abdominal CT for Evaluating Suspected Appendicitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; NEGATIVE APPENDECTOMY; DIAGNOSTIC PERFORMANCE; UNENHANCED CT; ADULTS; ULTRASONOGRAPHY; METAANALYSIS; PROTOCOLS; SINGLE; TIME	Background Computed tomography (CT) has become the predominant test for diagnosing acute appendicitis in adults. In children and young adults, exposure to CT radiation is of particular concern. We evaluated the rate of negative (unnecessary) appendectomy after low-dose versus standard-dose abdominal CT in young adults with suspected appendicitis. Methods In this single-institution, single-blind, noninferiority trial, we randomly assigned 891 patients with suspected appendicitis to either low-dose CT (444 patients) or standard-dose CT (447 patients). The median radiation dose in terms of dose-length product was 116 mGy.cm in the low-dose group and 521 mGy.cm in the standard-dose group. The primary end point was the percentage of negative appendectomies among all nonincidental appendectomies, with a noninferiority margin of 5.5 percentage points. Secondary end points included the appendiceal perforation rate and the proportion of patients with suspected appendicitis who required additional imaging. Results The negative appendectomy rate was 3.5% (6 of 172 patients) in the low-dose CT group and 3.2% (6 of 186 patients) in the standard-dose CT group (difference, 0.3 percentage points; 95% confidence interval, -3.8 to 4.6). The two groups did not differ significantly in terms of the appendiceal perforation rate (26.5% with low-dose CT and 23.3% with standard-dose CT, P=0.46) or the proportion of patients who needed additional imaging tests (3.2% and 1.6%, respectively; P=0.09). Conclusions Low-dose CT was noninferior to standard-dose CT with respect to negative appendectomy rates in young adults with suspected appendicitis. (Funded by GE Healthcare Medical Diagnostics and others; ClinicalTrials.gov number, NCT00913380.)	[Kim, Young Hoon; Kim, Suyoung; Lee, Yoon Jin; Lee, Kyoung Ho] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Radiol, Songnam 463707, Gyeonggi Do, South Korea; [Kim, Kyuseok; Kim, Taeyun] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Emergency Med, Songnam 463707, Gyeonggi Do, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Pathol, Songnam 463707, Gyeonggi Do, South Korea; [Kang, Sung-Bum; Kim, Duck-Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Songnam 463707, Gyeonggi Do, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam 463707, Gyeonggi Do, South Korea; [Kim, Kwang Pyo] Kyung Hee Univ, Dept Nucl Engn, Gyeonggi Do, South Korea; [Kim, So Yeon; Park, Seong Ho] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, So Yeon; Park, Seong Ho] Univ Ulsan, Asan Med Ctr, Coll Med, Res Inst Radiol, Seoul, South Korea; [Song, Ki Jun] Yonsei Univ, Coll Med, Yonsei Univ Hosp, Dept Biostat, Seoul, South Korea; [Hwang, Seung-sik] Inha Univ, Sch Med, Dept Social & Prevent Med, Inchon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Inha University	Lee, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Radiol, 300 Gumi Dong, Songnam 463707, Gyeonggi Do, South Korea.	kholeemail@gmail.com	Kim, Young Hoon/J-5416-2012; Lee, Kyoung Ho/J-5570-2012; Kang, Sung-Bum/J-5361-2012; Lee, Hye Seung/G-6419-2011; Park, Seong Ho/E-2271-2014	Lee, Hye Seung/0000-0002-1667-7986; Park, Seong Ho/0000-0002-1257-8315; Kim, Taeyun/0000-0002-9390-0870; Lee, Kyoung Ho/0000-0001-6045-765X; Kim, Kyuseok/0000-0002-7991-9428; Song, Ki Jun/0000-0003-2505-4112	GE Healthcare Medical Diagnostics, Korea [OM-09-01]; National Research Foundation of Korea [2011-0012117]; Seoul National University Bundang Hospital [04-2011-004]	GE Healthcare Medical Diagnostics, Korea; National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Bundang Hospital	Supported by a grant (OM-09-01) from GE Healthcare Medical Diagnostics, Korea; a Mid-Career Researcher Program grant (2011-0012117) from the National Research Foundation of Korea; and a grant (04-2011-004) from the Seoul National University Bundang Hospital Research Fund. No potential conflict of interest relevant to this article was reported.	ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; [Anonymous], 2006, HLTH RISKS EXPOSURE; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brix G, 2003, EUR RADIOL, V13, P1979, DOI 10.1007/s00330-003-1883-y; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Cuschieri J, 2008, ANN SURG, V248, P557, DOI 10.1097/SLA.0b013e318187aeca; Daly CP, 2005, AM J ROENTGENOL, V184, P1813, DOI 10.2214/ajr.184.6.01841813; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; Hart D, 2010, HLTH PROTECTION AGEN; Huda W, 2011, RADIOLOGY, V258, P236, DOI 10.1148/radiol.10100297; Jang KM, 2010, EUR J RADIOL, V74, P71, DOI 10.1016/j.ejrad.2008.11.017; Johnson PT, 2006, J COMPUT ASSIST TOMO, V30, P758, DOI 10.1097/01.rct.0000228156.65904.b4; Joo SM, 2009, RADIOLOGY, V251, P780, DOI 10.1148/radiol.2513081617; Kambadakone AR, 2010, RADIOGRAPHICS, V30, P603, DOI 10.1148/rg.303095146; Keyzer C, 2004, RADIOLOGY, V232, P164, DOI 10.1148/radiol.2321031115; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Kim SY, 2011, RADIOLOGY, V260, P437, DOI 10.1148/radiol.11102247; Lameris W, 2009, ACAD EMERG MED, V16, P835, DOI 10.1111/j.1553-2712.2009.00486.x; Leeuwenburgh MMN, 2011, BMJ; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; Paulson EK, 2003, NEW ENGL J MED, V348, P236, DOI 10.1056/NEJMcp013351; Paulson EK, 2009, AM J ROENTGENOL, V193, P1268, DOI 10.2214/AJR.09.3313; Pickhardt PJ, 2011, ANN INTERN MED, V154, P789, DOI 10.7326/0003-4819-154-12-201106210-00006; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rhea JT, 2005, AM J ROENTGENOL, V184, P1802, DOI 10.2214/ajr.184.6.01841802; Seo H, 2009, AM J ROENTGENOL, V193, P96, DOI 10.2214/AJR.08.1237; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Soni NK, 2009, MDCT PHYS BASICS TEC, P125; Tack D, 2005, RADIOLOGY, V237, P189, DOI 10.1148/radiol.2371041432; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; Tsapaki V, 2010, SEMIN ULTRASOUND CT, V31, P29, DOI 10.1053/j.sult.2009.09.004; van Randen A, 2008, RADIOLOGY, V249, P97, DOI 10.1148/radiol.2483071652; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Weston AR, 2005, INT J TECHNOL ASSESS, V21, P368, DOI 10.1017/S0266462305050488	40	206	210	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1596	1605		10.1056/NEJMoa1110734	http://dx.doi.org/10.1056/NEJMoa1110734			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533576	Bronze			2022-12-28	WOS:000303200100008
J	Tullius, SG; Rudolf, JA; Malek, SK				Tullius, Stefan G.; Rudolf, Julia A.; Malek, Sayeed K.			Moving Boundaries - The Nightingale Twins and Transplantation Science	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KIDNEY		[Tullius, Stefan G.; Rudolf, Julia A.; Malek, Sayeed K.] Brigham & Womens Hosp, Div Transplant Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Tullius, SG (corresponding author), Brigham & Womens Hosp, Div Transplant Surg, 75 Francis St, Boston, MA 02115 USA.							[Anonymous], 2012, AM J TRANSPLANT S1, V12, P7; MERRILL JP, 1963, JAMA-J AM MED ASSOC, V185, P347, DOI 10.1001/jama.1963.03060050025015; MURRAY JE, 1963, AM J SURG, V105, P205, DOI 10.1016/0002-9610(63)90292-7; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659	4	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1564	1565		10.1056/NEJMp1114193	http://dx.doi.org/10.1056/NEJMp1114193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533575				2022-12-28	WOS:000303200100004
J	McGuire, JJ; Beroza, GC				McGuire, Jeffrey J.; Beroza, Gregory C.			A Rogue Earthquake Off Sumatra	SCIENCE			English	Editorial Material							STRESS; SLIP		[McGuire, Jeffrey J.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Beroza, Gregory C.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Woods Hole Oceanographic Institution; Stanford University	McGuire, JJ (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	jmcguire@whoi.edu; beroza@stanford.edu						Abercrombie RE, 2001, NATURE, V410, P74, DOI 10.1038/35065064; Boettcher MS, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004301; Choy GL, 2002, GEOPHYS J INT, V150, P506, DOI 10.1046/j.1365-246X.2002.01720.x; CHRISTENSEN DH, 1988, J GEOPHYS RES-SOLID, V93, P13421, DOI 10.1029/JB093iB11p13421; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; Kato A, 2011, EARTH PLANETS SPACE, V63, P745, DOI 10.5047/eps.2011.06.014; Kelemen PB, 2007, NATURE, V446, P787, DOI 10.1038/nature05717; Meng L., 2012, SEISMOL RES LETT, V83, P409; Robinson DP, 2011, GEOPHYS J INT, V186, P1121, DOI 10.1111/j.1365-246X.2011.05092.x; Rodgers DW, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004065; Royer JY, 1997, SCIENCE, V277, P1268, DOI 10.1126/science.277.5330.1268; Schlupp A, 2007, GEOPHYS J INT, V169, P1115, DOI [10.1111/j.1365-246X.2007.03323.x, 10.1111/J.1365-246X.2007.03323.x]	12	50	51	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1118	1119		10.1126/science.1223983	http://dx.doi.org/10.1126/science.1223983			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22582017				2022-12-28	WOS:000304647900035
J	van der Graaf, WTA; Blay, JY; Chawla, SP; Kim, DW; Binh, BN; Casali, PG; Schoffski, P; Aglietta, M; Staddon, AP; Beppu, Y; Le Cesne, A; Gelderblom, H; Judson, IR; Araki, N; Ouali, M; Marreaud, S; Hodge, R; Dewji, MR; Coens, C; Demetri, GD; Fletcher, CD; Tos, APD; Hohenberger, P				van der Graaf, Winette T. A.; Blay, Jean-Yves; Chawla, Sant P.; Kim, Dong-Wan; Binh Bui-Nguyen; Casali, Paolo G.; Schoffski, Patrick; Aglietta, Massimo; Staddon, Arthur P.; Beppu, Yasuo; Le Cesne, Axel; Gelderblom, Hans; Judson, Ian R.; Araki, Nobuhito; Ouali, Monia; Marreaud, Sandrine; Hodge, Rachel; Dewji, Mohammed R.; Coens, Corneel; Demetri, George D.; Fletcher, Christopher D.; Tos, Angelo Paolo Dei; Hohenberger, Peter		EORTC Soft Tissue & Bone Sarcoma G	Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial	LANCET			English	Article							EUROPEAN-ORGANIZATION; II TRIAL; ANGIOGENESIS; GEMCITABINE; CARDIOTOXICITY; INHIBITOR; DOCETAXEL; SUNITINIB; IMATINIB; EORTC	Background Pazopanib, a multitargeted tyrosine kinase inhibitor, has single-agent activity in patients with advanced non-adipocytic soft-tissue sarcoma. We investigated the effect of pazopanib on progression-free survival in patients with metastatic non-adipocytic soft-tissue sarcoma after failure of standard chemotherapy. Methods This phase 3 study was done in 72 institutions, across 13 countries. Patients with angiogenesis inhibitor-naive, metastatic soft-tissue sarcoma, progressing despite previous standard chemotherapy, were randomly assigned by an interactive voice randomisation system in a 2:1 ratio in permuted blocks (with block sizes of six) to receive either pazopanib 800 mg once daily or placebo, with no subsequent cross-over. Patients, investigators who gave the treatment, those assessing outcomes, and those who did the analysis were masked to the allocation. The primary endpoint was progression-free survival. Efficacy analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00753688. Findings 372 patients were registered and 369 were randomly assigned to receive pazopanib (n = 246) or placebo (n = 123). Median progression-free survival was 4.6 months (95% CI 3.7-4.8) for pazopanib compared with 1.6 months (0.9-1.8) for placebo (hazard ratio [HR] 0.31, 95% CI 0.24-0.40; p < 0.0001). Overall survival was 12.5 months (10.6-14.8) with pazopanib versus 10.7 months (8.7-12.8) with placebo (HR 0.86, 0.67-1.11; p = 0.25). The most common adverse events were fatigue (60 in the placebo group [49%] vs 155 in the pazopanib group [65%]), diarrhoea (20 [16%] vs 138 [58%]), nausea (34 [28%] vs 129 [54%]), weight loss (25 [20%] vs 115 [48%]), and hypertension (8 [7%] vs 99 [41%]). The median relative dose intensity was 100% for placebo and 96% for pazopanib. Interpretation Pazopanib is a new treatment option for patients with metastatic non-adipocytic soft-tissue sarcoma after previous chemotherapy.	[van der Graaf, Winette T. A.] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 GA Nijmegen, Netherlands; [Blay, Jean-Yves] Ctr Leon Berard, F-69373 Lyon, France; [Chawla, Sant P.] Sarcoma Oncol Ctr, Santa Monica Oncol Ctr, Santa Monica, CA USA; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Binh Bui-Nguyen] Inst Bergonie, Bordeaux, France; [Casali, Paolo G.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Schoffski, Patrick] Katholieke Univ Leuven, Dept Gen Med Oncol, Louvain, Belgium; [Schoffski, Patrick] Katholieke Univ Leuven, Expt Oncol Lab, Univ Hosp Leuven, Leuven Canc Inst, Louvain, Belgium; [Aglietta, Massimo] Univ Torino, Inst Canc Res & Treatment, Candiolo, Italy; [Staddon, Arthur P.] Univ Penn, Philadelphia, PA 19104 USA; [Beppu, Yasuo] Natl Canc Ctr, Tokyo, Japan; [Le Cesne, Axel] Inst Gustave Roussy, Villejuif, France; [Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Judson, Ian R.] Royal Marsden NHS Fdn Trust, London, England; [Araki, Nobuhito] Osaka Med Ctr, Osaka, Japan; [Ouali, Monia; Marreaud, Sandrine] European Org Res & Treatment Canc Headquarters, Brussels, Belgium; [Hodge, Rachel; Dewji, Mohammed R.] GlaxoSmithKline Oncol, Uxbridge, Middx, England; [Demetri, George D.] Dana Farber Canc Inst, Ludwig Ctr, Boston, MA 02115 USA; [Demetri, George D.] Harvard Univ, Sch Med, Boston, MA USA; [Fletcher, Christopher D.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Tos, Angelo Paolo Dei] Gen Hosp Treviso, Dept Oncol Anat Pathol, Treviso, Italy; [Hohenberger, Peter] Univ Klinikum Mannheim, Mannheim, Germany	Radboud University Nijmegen; UNICANCER; Centre Leon Berard; Seoul National University (SNU); Seoul National University Hospital; UNICANCER; Institut Bergonie; Fondazione IRCCS Istituto Nazionale Tumori Milan; KU Leuven; KU Leuven; University Hospital Leuven; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Pennsylvania; National Cancer Center - Japan; UNICANCER; Gustave Roussy; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Marsden NHS Foundation Trust; Osaka Medical Center for Cancer & Cardiovascular Diseases; European Organisation for Research & Treatment of Cancer; GlaxoSmithKline; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Ruprecht Karls University Heidelberg	van der Graaf, WTA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol 452, Geert Grooteplein Zuid 8, NL-6525 GA Nijmegen, Netherlands.	w.vandergraaf@onco.umcn.nl	IBIS, BIOMARCADORES/P-3515-2015; Kim, Dong-Wan/J-5391-2012; Dei Tos, Angelo/AAN-3244-2020; van der Graaf, Winette T/A-5006-2014; Martín-Broto, Javier/AAI-2313-2019; Blay, Jean-Yves/N-3966-2016; casali, Paolo Giovanni/D-1524-2017	Dei Tos, Angelo/0000-0002-1228-8940; van der Graaf, Winette T/0000-0001-7549-3338; Blay, Jean-Yves/0000-0001-7190-120X; casali, Paolo Giovanni/0000-0003-4056-8023; AGLIETTA, Massimo/0000-0002-2255-7972; Martin-Broto, Javier/0000-0001-7350-6916; PENEL, Nicolas/0000-0001-5243-1548; Gelderblom, Hans/0000-0001-9270-8636	GlaxoSmithKline; Novartis; Roche; PharmaMar; Merck; Sharp; Dohme; Pfizer; Sanofi; Ariad; Johnson and Johnson; Daiichi-Sankyo; Amgen; Bayer	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Roche(Roche Holding); PharmaMar; Merck(Merck & Company); Sharp; Dohme; Pfizer(Pfizer); Sanofi; Ariad; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Amgen(Amgen); Bayer(Bayer AG)	Funding GlaxoSmithKline.; J-YB has received research support and honoraria from GlaxoSmithKline, Novartis, Roche, PharmaMar, and Merck, Sharp, and Dohme. IRJ has received research support and honoraria from GlaxoSmithKline and has been on an advisory board for GlaxoSmithKline. GDD has received consultant and research support from GlaxoSmithKline, Pfizer, Novartis, Sanofi, Ariad, Merck, Johnson and Johnson, PharmaMar, Daiichi-Sankyo, and Amgen; and has been a consultant for ZioPharm. D-WK has been a consultant for GlaxoSmithKline. PS has received research funding from GlaxoSmithKline, and has been a consultant for and received honoraria from GlaxoSmithKline. ALC has received honoraria from Novartis, Pfizer, and PharmaMar. RH and MRD are employees of GlaxoSmithKline and hold shares in GlaxoSmithKline. HG has received research grants from GlaxoSmithKline, Novartis, and Pfizer. APS has received research support from GlaxoSmithKline. SPC has been a consultant for GlaxoSmithKline. PGC has received honoraria and travel grants from and is on advisory boards for Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and PharmaMar. MA, WTAvdG, SM, NA, APDT, CDF, PH, BB-N, MO, CC, and YB declare that they have no conflicts of interest.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bamias A, 2011, EUR J CANCER, V47, P1660, DOI 10.1016/j.ejca.2011.03.033; Casali PG, 2010, ANN ONCOL, V21, pv198, DOI 10.1093/annonc/mdq209; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Damron TA, 2011, J SURG ONCOL, V103, P643, DOI 10.1002/jso.21884; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2009, J CLIN ONCOL, V27, P4188, DOI 10.1200/JCO.2008.21.0088; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; George S, 2009, J CLIN ONCOL, V27, P3154, DOI 10.1200/JCO.2008.20.9890; Hoag JB, 2010, CHEST, V138, P510, DOI 10.1378/chest.09-2292; Le Cesne A, 2005, J CLIN ONCOL, V23, P576, DOI 10.1200/JCO.2005.01.180; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; Maki RG, 2007, ONCOLOGIST, V12, P999, DOI 10.1634/theoncologist.12-8-999; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Penel N, 2008, J CLIN ONCOL, V26, P5269, DOI 10.1200/JCO.2008.17.3146; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rutkowski P, 2010, J CLIN ONCOL, V28, P1772, DOI 10.1200/JCO.2009.25.7899; Schutz FAB, 2011, CRIT REV ONCOL HEMAT, V77, P163, DOI 10.1016/j.critrevonc.2010.02.012; Scurr M, 2011, CURR TREAT OPTION ON, V12, P32, DOI 10.1007/s11864-011-0140-x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sleijfer S, 2010, EUR J CANCER, V46, P72, DOI 10.1016/j.ejca.2009.09.022; Sleijfer S, 2008, ONCOLOGIST, V13, P1193, DOI 10.1634/theoncologist.2008-0188; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van Glabbeke M, 2002, EUR J CANCER, V38, P543, DOI 10.1016/S0959-8049(01)00398-7; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0	31	1355	1378	4	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1879	1886		10.1016/S0140-6736(12)60651-5	http://dx.doi.org/10.1016/S0140-6736(12)60651-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22595799	Green Submitted			2022-12-28	WOS:000304194200029
J	Booth, MJ; Branco, MR; Ficz, G; Oxley, D; Krueger, F; Reik, W; Balasubramanian, S				Booth, Michael J.; Branco, Miguel R.; Ficz, Gabriella; Oxley, David; Krueger, Felix; Reik, Wolf; Balasubramanian, Shankar			Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; MOUSE; BRAIN; TET1; HYDROXYMETHYLCYTOSINE; TRANSCRIPTION; CONVERSION; 5HMC; 5MC	5-Methylcytosine can be converted to 5-hydroxymethylcytosine (5hmC) in mammalian DNA by the ten-eleven translocation (TET) enzymes. We introduce oxidative bisulfite sequencing (oxBS-Seq), the first method for quantitative mapping of 5hmC in genomic DNA at single-nucleotide resolution. Selective chemical oxidation of 5hmC to 5-formylcytosine (5fC) enables bisulfite conversion of 5fC to uracil. We demonstrate the utility of oxBS-Seq to map and quantify 5hmC at CpG islands (CGIs) in mouse embryonic stem (ES) cells and identify 800 5hmC-containing CGIs that have on average 3.3% hydroxymethylation. High levels of 5hmC were found in CGIs associated with transcriptional regulators and in long interspersed nuclear elements, suggesting that these regions might undergo epigenetic reprogramming in ES cells. Our results open new questions on 5hmC dynamics and sequence-specific targeting by TETs.	[Branco, Miguel R.; Ficz, Gabriella; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Booth, Michael J.; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Branco, Miguel R.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Oxley, David] Babraham Inst, Prote Res Grp, Cambridge CB22 3AT, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SP, England; [Balasubramanian, Shankar] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	wolf.reik@babraham.ac.uk; sb10031@cam.ac.uk	Reik, Wolf/I-6794-2012; Ficz, Gabriella/HCH-3771-2022; Balasubramanian, Shankar/C-1671-2009; Krueger, Felix/J-3340-2019; Branco, Miguel/H-9509-2019	Branco, Miguel/0000-0001-9447-1548; Reik, Wolf/0000-0003-0216-9881; Booth, Michael/0000-0002-4224-798X; Balasubramanian, Shankar/0000-0002-0281-5815; Krueger, Felix/0000-0002-5513-3324; Ficz, Gabriella/0000-0001-9313-9578	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council; Wellcome Trust; European Union EpiGeneSys; BLUEPRINT; Cancer Research UK; Medical Research Council [G0801156] Funding Source: researchfish; MRC [G0801156] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union EpiGeneSys; BLUEPRINT; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Green and R. Rodriguez for helpful discussions and J. Webster for help with mass spectrometry. We thank the Biotechnology and Biological Sciences Research Council (BBSRC) for a studentship (M.J.B.). The W.R. lab is supported by BBSRC, Medical Research Council, the Wellcome Trust, European Union EpiGeneSys, and BLUEPRINT. The S.B. lab is supported by core funding from Cancer Research UK. M.J.B. and S.B. are inventors on provisional applications filed for U.S. patents on oxBS-Seq (patent applications US61/605702; US61/641134; US61/623461; and US61/513356). OxRRBS data are deposited in the European Molecular Biology Laboratory-European Bioinformatics Institute ArrayExpress Archive (http://www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-1042. S.B. is an advisor to Illumina.	Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; GREEN G, 1984, J CHEM SOC PERK T 1, P681, DOI 10.1039/p19840000681; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005	25	626	679	13	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					934	937		10.1126/science.1220671	http://dx.doi.org/10.1126/science.1220671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22539555				2022-12-28	WOS:000304145600070
J	McHugh, PR; Slavney, PR				McHugh, Paul R.; Slavney, Phillip R.			Mental Illness - Comprehensive Evaluation or Checklist?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEPRESSION		[McHugh, Paul R.; Slavney, Phillip R.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Johns Hopkins University	McHugh, PR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.							ANTHONY JC, 1985, ARCH GEN PSYCHIAT, V42, P667; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Kupfer DJ, 2010, CEREBRUM 2010 EMERGI, P81; McHugh PR, 1998, PERSPECTIVES PSYCHIA; Parker G, 2005, PSYCHOL MED, V35, P467, DOI 10.1017/S0033291704004210	5	33	33	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1853	1855		10.1056/NEJMp1202555	http://dx.doi.org/10.1056/NEJMp1202555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WU	22591291				2022-12-28	WOS:000304083000003
J	Farrell, M; Wodak, A; Gowing, L				Farrell, Michael; Wodak, Alex; Gowing, Linda			THERAPEUTICS Maintenance drugs to treat opioid dependence	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METHADONE-MAINTENANCE; HEROIN-ADDICTS; DOUBLE-BLIND; BUPRENORPHINE; RETENTION; MORTALITY; RISK		[Farrell, Michael] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia; [Wodak, Alex] St Vincents Hosp, Alcohol & Drug Serv, Darlinghurst, NSW 2010, Australia; [Gowing, Linda] Univ Adelaide, Discipline Pharmacol, Adelaide, SA 5005, Australia	University of New South Wales Sydney; St Vincents Hospital Sydney; University of Adelaide	Farrell, M (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2031, Australia.	michael.farrell@unsw.edu.au	Farrell, Michael P/A-4769-2012; Gowing, Linda/G-1402-2012	Farrell, Michael P/0000-0001-7008-8130; Gowing, Linda/0000-0002-9124-4056	Reckitt Benckiser	Reckitt Benckiser	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work. The National Drug and Alcohol Research Centre, of which MF is the director, has received unrestricted grant income from Reckitt Benckiser for post-marketing surveillance and for other evaluation of buprenorphine and naloxone combined. MF has participated in workshops in the Asia Pacific region on the development of treatment services and of research with opioid users; these workshops were supported by an unrestricted educational grant from Reckitt Benckiser, paid to the University of Adelaide. The authors declare no other relationships or activities that could appear to have influenced the submitted work.	Amato L, 2008, COCHRANE DB SYST REV, V4; Anchersen K, 2009, ADDICTION, V104, P993, DOI 10.1111/j.1360-0443.2009.02549.x; Bell J, 2009, ADDICTION, V104, P1193, DOI 10.1111/j.1360-0443.2009.02627.x; Burns L, 2007, ADDICTION, V102, P264, DOI 10.1111/j.1360-0443.2006.01651.x; Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; [Department of Health (England) Scottish Government Welsh Assembly Government Northern Ireland Executive], 2007, DRUG MIS DEP UK GUID; European Monitoring Centre on Drugs and Drug Addiction, 2011, STAND GUID; Farrell M, 1998, BMJ-BRIT MED J, V316, P69; FERRI M, 2010, COCHRANE DB SYST REV, V8; Fischer G, 2006, ADDICTION, V101, P275, DOI 10.1111/j.1360-0443.2006.01321.x; Jaffe JH, 1980, GOODMAN GILMANS PHAR, P535; Jegu J, 2011, BRIT J CLIN PHARMACO, V71, P832, DOI 10.1111/j.1365-2125.2011.03923.x; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2003, ADDICTION, V98, P441, DOI 10.1046/j.1360-0443.2003.00335.x; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Minozzi S, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006318.PUB2; National Health and Medical Research Council, 2011, NALTR IMPL TRATM OP; National Institute for Health and Clinical Excellence, 2007, NALTR MAN OP DEP; National Institute for Health and Clinical Excellence, 2007, METH BUPR MAN OP DEP; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Oviedo-Joekes E, 2010, J SUBST ABUSE TREAT, V38, P408, DOI 10.1016/j.jsat.2010.03.003; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; Strang J, 2010, LANCET, V375, P1885, DOI 10.1016/S0140-6736(10)60349-2; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; World Health Organization, 2009, GUID PSYCH ASS PHARM; Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0	28	18	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e2823	10.1136/bmj.e2823	http://dx.doi.org/10.1136/bmj.e2823			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942YF	22589497	Green Submitted			2022-12-28	WOS:000304086900004
J	Duffy, SK; Friesen, H; Baryshnikova, A; Lambert, JP; Chong, YT; Figeys, D; Andrews, B				Duffy, Supipi Kaluarachchi; Friesen, Helena; Baryshnikova, Anastasia; Lambert, Jean-Philippe; Chong, Yolanda T.; Figeys, Daniel; Andrews, Brenda			Exploring the Yeast Acetylome Using Functional Genomics	CELL			English	Article							SYNTHETIC DOSAGE LETHALITY; CYCLE-DEPENDENT TRANSCRIPTION; GENETIC INTERACTION NETWORK; HISTONE DEACETYLASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; NONHISTONE PROTEINS; LYSINE ACETYLATION; G1-SPECIFIC TRANSCRIPTION; ORDERED RECRUITMENT	Lysine acetylation is a dynamic posttranslational modification with a well-defined role in regulating histones. The impact of acetylation on other cellular functions remains relatively uncharacterized. We explored the budding yeast acetylome with a functional genomics approach, assessing the effects of gene overexpression in the absence of lysine deacetylases (KDACs). We generated a network of 463 synthetic dosage lethal (SDL) interactions involving class I and II KDACs, revealing many cellular pathways regulated by different KDACs. A biochemical survey of genes interacting with the KDAC RPD3 identified 72 proteins acetylated in vivo. In-depth analysis of one of these proteins, Swi4, revealed a role for acetylation in G1-specific gene expression. Acetylation of Swi4 regulates interaction with its partner Swi6, both components of the SBF transcription factor. This study expands our view of the yeast acetylome, demonstrates the utility of functional genomic screens for exploring enzymatic pathways, and provides functional information that can be mined for future studies.	[Duffy, Supipi Kaluarachchi; Friesen, Helena; Baryshnikova, Anastasia; Chong, Yolanda T.; Andrews, Brenda] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON M3S 3E1, Canada; [Duffy, Supipi Kaluarachchi; Baryshnikova, Anastasia; Andrews, Brenda] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Lambert, Jean-Philippe; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Toronto; University of Ottawa	Andrews, B (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, 160 Coll St, Toronto, ON M3S 3E1, Canada.	brenda.andrews@utoronto.ca		Baryshnikova, Anastasia/0000-0002-0123-2052; Figeys, Daniel/0000-0002-5373-7546; Lambert, Jean-Philippe/0000-0002-0833-1221	Canadian Institutes of Health Research (CIHR) [MOP-11206, MOP97939, MOP-102629]; National Institutes of Health [US-R01HG005853-01]; Ontario Graduate Scholarship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Andrews group for helpful discussions. This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to B. A. and Tim Hughes (MOP-11206). The automated cell biology screens were supported by CIHR grant MOP97939 to B. A. and Charles Boone. Operation of our automated yeast genetics platform is supported by grants from the CIHR (MOP-102629) and the National Institutes of Health (US-R01HG005853-01). S. K. D. was the recipient of an Ontario Graduate Scholarship.	ANDREWS BJ, 1992, P NATL ACAD SCI USA, V89, P11852, DOI 10.1073/pnas.89.24.11852; ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; Archer SY, 1999, CURR OPIN GENET DEV, V9, P171, DOI 10.1016/S0959-437X(99)80026-4; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carmen AA, 1999, P NATL ACAD SCI USA, V96, P12356, DOI 10.1073/pnas.96.22.12356; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CROSS FR, 1994, MOL CELL BIOL, V14, P4779, DOI 10.1128/MCB.14.7.4779; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Huang DQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000188; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kavanaugh SA, 2010, AM J HEALTH-SYST PH, V67, P793, DOI 10.2146/ajhp090247; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JH, 2010, GENE DEV, V24, P2766, DOI 10.1101/gad.1979710; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kroll ES, 1996, GENETICS, V143, P95; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lambert Jean-Philippe, 2009, Mol Cell Proteomics, V8, P870, DOI 10.1074/mcp.M800447-MCP200; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sardiu ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007310; Schaefer JB, 2004, CELL, V117, P849, DOI 10.1016/j.cell.2004.06.008; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sharifpoor S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r39; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Sopko R, 2006, CELL CYCLE, V5, P1397, DOI 10.4161/cc.5.13.2922; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang CG, 2001, FRONT BIOSCI-LANDMRK, V6, pD610, DOI 10.2741/1wang1; Wang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000189; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Wu JS, 2001, P NATL ACAD SCI USA, V98, P4391, DOI 10.1073/pnas.081560698; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou Q, 2010, PROTEOMICS, V10, P1029, DOI 10.1002/pmic.200900602; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	101	50	50	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					936	948		10.1016/j.cell.2012.02.064	http://dx.doi.org/10.1016/j.cell.2012.02.064			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579291	Bronze, Green Accepted			2022-12-28	WOS:000303934700024
J	Page, MJ; Symeonidis, M; Vieira, JD; Altieri, B; Amblard, A; Arumugam, V; Aussel, H; Babbedge, T; Blain, A; Bock, J; Boselli, A; Buat, V; Castro-Rodriguez, N; Cava, A; Chanial, P; Clements, DL; Conley, A; Conversi, L; Cooray, A; Dowell, CD; Dubois, EN; Dunlop, JS; Dwek, E; Dye, S; Eales, S; Elbaz, D; Farrah, D; Fox, M; Franceschini, A; Gear, W; Glenn, J; Griffin, M; Halpern, M; Hatziminaoglou, E; Ibar, E; Isaak, K; Ivison, RJ; Lagache, G; Levenson, L; Lu, N; Madden, S; Maffei, B; Mainetti, G; Marchetti, L; Nguyen, HT; O'Halloran, B; Oliver, SJ; Omont, A; Panuzzo, P; Papageorgiou, A; Pearson, CP; Perez-Fournon, I; Pohlen, M; Rawlings, JI; Rigopoulou, D; Riguccini, L; Rizzo, D; Rodighiero, G; Roseboom, IG; Rowan-Robinson, M; Portal, MS; Schulz, B; Scott, D; Seymour, N; Shupe, DL; Smith, AJ; Stevens, JA; Trichas, M; Tugwell, KE; Vaccari, M; Valtchanov, I; Viero, M; Vigroux, L; Wang, L; Ward, R; Wright, G; Xu, CK; Zemcov, M				Page, M. J.; Symeonidis, M.; Vieira, J. D.; Altieri, B.; Amblard, A.; Arumugam, V.; Aussel, H.; Babbedge, T.; Blain, A.; Bock, J.; Boselli, A.; Buat, V.; Castro-Rodriguez, N.; Cava, A.; Chanial, P.; Clements, D. L.; Conley, A.; Conversi, L.; Cooray, A.; Dowell, C. D.; Dubois, E. N.; Dunlop, J. S.; Dwek, E.; Dye, S.; Eales, S.; Elbaz, D.; Farrah, D.; Fox, M.; Franceschini, A.; Gear, W.; Glenn, J.; Griffin, M.; Halpern, M.; Hatziminaoglou, E.; Ibar, E.; Isaak, K.; Ivison, R. J.; Lagache, G.; Levenson, L.; Lu, N.; Madden, S.; Maffei, B.; Mainetti, G.; Marchetti, L.; Nguyen, H. T.; O'Halloran, B.; Oliver, S. J.; Omont, A.; Panuzzo, P.; Papageorgiou, A.; Pearson, C. P.; Perez-Fournon, I.; Pohlen, M.; Rawlings, J. I.; Rigopoulou, D.; Riguccini, L.; Rizzo, D.; Rodighiero, G.; Roseboom, I. G.; Rowan-Robinson, M.; Sanchez Portal, M.; Schulz, B.; Scott, D.; Seymour, N.; Shupe, D. L.; Smith, A. J.; Stevens, J. A.; Trichas, M.; Tugwell, K. E.; Vaccari, M.; Valtchanov, I.; Viero, M.; Vigroux, L.; Wang, L.; Ward, R.; Wright, G.; Xu, C. K.; Zemcov, M.			The suppression of star formation by powerful active galactic nuclei	NATURE			English	Article							BLACK-HOLES; GALAXY FORMATION; AGN; OUTFLOWS; FEEDBACK; CATALOGS; QUASARS; FIELDS; GROWTH; MODEL	The old, red stars that constitute the bulges of galaxies, and the massive black holes at their centres, are the relics of a period in cosmic history when galaxies formed stars at remarkable rates and active galactic nuclei (AGN) shone brightly as a result of accretion onto black holes. It is widely suspected, but unproved, that the tight correlation between the mass of the black hole and the mass of the stellar bulge(1) results from the AGN quenching the surrounding star formation as it approaches its peak luminosity(2-4). X-rays trace emission from AGN unambiguously(5), whereas powerful star-forming galaxies are usually dust-obscured and are brightest at infrared and submillimetre wavelengths(6). Here we report submillimetre and X-ray observations that show that rapid star formation was common in the host galaxies of AGN when the Universe was 2-6 billion years old, but that the most vigorous star formation is not observed around black holes above an X-ray luminosity of 10(44) ergs per second. This suppression of star formation in the host galaxy of a powerful AGN is a key prediction of models in which the AGN drives an outflow(7-9), expelling the interstellar medium of its host and transforming the galaxy's properties in a brief period of cosmic time.	[Page, M. J.; Symeonidis, M.; Rawlings, J. I.; Seymour, N.; Tugwell, K. E.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Altieri, B.; Conversi, L.; Sanchez Portal, M.; Valtchanov, I.] European Space Astron Ctr, Herschel Sci Ctr, Madrid 28691, Spain; [Amblard, A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Arumugam, V.; Dunlop, J. S.; Ivison, R. J.; Roseboom, I. G.] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Aussel, H.; Chanial, P.; Elbaz, D.; Madden, S.; Panuzzo, P.; Riguccini, L.] Univ Paris Diderot, CE Saclay, CEA DSM IRFU, CNRS,Lab AIM Paris Saclay, F-91191 Gif Sur Yvette, France; [Babbedge, T.; Clements, D. L.; Fox, M.; O'Halloran, B.; Rizzo, D.; Rowan-Robinson, M.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Blain, A.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Bock, J.; Dowell, C. D.; Levenson, L.; Nguyen, H. T.; Zemcov, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Boselli, A.; Buat, V.] Univ Aix Marseille, CNRS, OAMP, Lab Astrophys Marseille, F-13388 Marseille 13, France; [Castro-Rodriguez, N.; Perez-Fournon, I.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; [Castro-Rodriguez, N.; Perez-Fournon, I.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Cava, A.] Univ Complutense Madrid, Fac CC Fis, Dept Astrofis, E-28040 Madrid, Spain; [Conley, A.; Glenn, J.] Univ Colorado, Ctr Astrophys & Space Astron UCB 389, Boulder, CO 80309 USA; [Cooray, A.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Dubois, E. N.; Farrah, D.; Oliver, S. J.; Roseboom, I. G.; Smith, A. J.; Wang, L.; Ward, R.] Univ Sussex, Dept Phys & Astron, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Dwek, E.] NASA, Goddard Space Flight Ctr, Observat Cosmol Lab, Greenbelt, MD 20771 USA; [Dye, S.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Eales, S.; Gear, W.; Griffin, M.; Papageorgiou, A.; Pohlen, M.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales; [Franceschini, A.; Mainetti, G.; Marchetti, L.; Rodighiero, G.; Vaccari, M.] Univ Padua, Dipartimento Astron, I-35122 Padua, Italy; [Glenn, J.] Univ Colorado, Dept Astrophys & Planetary Sci, CASA UCB 389, Boulder, CO 80309 USA; [Halpern, M.; Scott, D.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Hatziminaoglou, E.] ESO, D-85748 Garching, Germany; [Ibar, E.; Ivison, R. J.; Wright, G.] Royal Observ, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Isaak, K.] European Space Res & Technol Ctr ESTEC, NL-2201 AZ Noordwijk, Netherlands; [Lagache, G.] Univ Paris 11, IAS, F-91405 Orsay, France; [Lagache, G.] CNRS, UMR 8617, F-91405 Orsay, France; [Lu, N.; Schulz, B.; Shupe, D. L.; Xu, C. K.] CALTECH, JPL, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA; [Maffei, B.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Omont, A.; Vigroux, L.] Univ Paris 06, CNRS, UMR 7095, Inst Astrophys Paris, F-75014 Paris, France; [Pearson, C. P.; Rigopoulou, D.] Rutherford Appleton Lab, RAL Space, Didcot OX11 0QX, Oxon, England; [Pearson, C. P.] Univ Lethbridge, Inst Space Imaging Sci, Lethbridge, AB T1K 3M4, Canada; [Rigopoulou, D.] Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; [Seymour, N.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Stevens, J. A.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Trichas, M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of London; University College London; European Space Agency; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Edinburgh; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Imperial College London; University of Leicester; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Complutense University of Madrid; University of Colorado System; University of Colorado Boulder; University of California System; University of California Irvine; University of Sussex; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Nottingham; Cardiff University; University of Padua; University of Colorado System; University of Colorado Boulder; University of British Columbia; University of Edinburgh; European Space Agency; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Manchester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Lethbridge; University of Oxford; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Hertfordshire; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Page, MJ (corresponding author), Univ Coll London, Mullard Space Sci Lab, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	mjp@mssl.ucl.ac.uk	Elbaz, David/AAB-4141-2020; Seymour, Nicholas/M-4698-2017; Ivison, R. J./G-4450-2011; Perez-Fournon, Ismael/AAG-9049-2019; Symeonidis, Myrto/GNM-5974-2022; Vaccari, Mattia/R-3431-2016; Ibar, Edo/AAI-5516-2020; Castro-Rodríguez, Nieves/HHC-0597-2022; amblard, alexandre/L-7694-2014; Marchetti, Lucia/AAC-7835-2021; Cava, Antonio/C-5274-2017; Rodighiero, Giulia/U-7935-2017	Elbaz, David/0000-0002-7631-647X; Seymour, Nicholas/0000-0003-3506-5536; Ivison, R. J./0000-0001-5118-1313; Perez-Fournon, Ismael/0000-0002-2807-6459; Vaccari, Mattia/0000-0002-6748-0577; amblard, alexandre/0000-0002-2212-5395; Marchetti, Lucia/0000-0003-3948-7621; Cava, Antonio/0000-0002-4821-1275; Stevens, Jason/0000-0002-4010-8310; Altieri, Bruno/0000-0003-3936-0284; Rodighiero, Giulia/0000-0002-9415-2296; Shupe, David/0000-0003-4401-0430; Maffei, Bruno/0000-0002-2214-5329; Dye, Simon/0000-0002-1318-8343; Scott, Douglas/0000-0002-6878-9840; Panuzzo, Pasquale/0000-0002-0016-8271; Farrah, Duncan/0000-0003-1748-2010; Aussel, Herve/0000-0002-1371-5705; Conversi, Luca/0000-0002-6710-8476; Madden, Suzanne/0000-0003-3229-2899	CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN(Spain); SNSB(Sweden); STFC (UK); UKSA (UK); NASA (USA); STFC [ST/J001562/1, ST/I000976/1, ST/H00260X/1, ST/G001979/1, ST/H001530/1, ST/F007019/1, ST/H002456/1, ST/J001449/1, ST/I001212/1, ST/I005765/1, ST/G002630/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F007019/1, ST/J001562/1, ST/I005765/1, ST/G001979/1, ST/H002456/1, ST/H00260X/1, ST/I001212/1, ST/G002630/1, ST/I000976/1] Funding Source: researchfish; UK Space Agency [ST/G003874/1, ST/F012373/1, ST/J004812/1] Funding Source: researchfish	CSA (Canada); NAOC (China); CEA (France)(French Atomic Energy Commission); CNES (France)(Centre National D'etudes Spatiales); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); MCINN(Spain); SNSB(Sweden); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UKSA (UK); NASA (USA)(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and which includes: University of Lethbridge (Canada); NAOC (China); CEA, LAM (France); IFSI, University of Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC, University of Sussex (UK); and Caltech, JPL, NHSC, University of Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES, CNRS (France); ASI (Italy); MCINN(Spain); SNSB(Sweden); STFC, UKSA (UK); and NASA (USA).	Alexander DM, 2003, ASTRON J, V126, P539, DOI 10.1086/376473; Barger AJ, 2008, ASTROPHYS J, V689, P687, DOI 10.1086/592735; Blain AW, 2003, MON NOT R ASTRON SOC, V338, P733, DOI 10.1046/j.1365-8711.2003.06086.x; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Brandt WN, 2005, ANNU REV ASTRON ASTR, V43, P827, DOI 10.1146/annurev.astro.43.051804.102213; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Ebrero J, 2009, ASTRON ASTROPHYS, V493, P55, DOI 10.1051/0004-6361:200810919; Fabian AC, 1999, MON NOT R ASTRON SOC, V308, pL39, DOI 10.1046/j.1365-8711.1999.03017.x; Farrah D, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/178; Granato GL, 2004, ASTROPHYS J, V600, P580, DOI 10.1086/379875; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Hatziminaoglou E, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014679; Kennicutt RC, 1998, ASTROPHYS J, V498, P541, DOI 10.1086/305588; King AR, 2010, MON NOT R ASTRON SOC, V402, P1516, DOI 10.1111/j.1365-2966.2009.16013.x; Mateos S, 2005, ASTRON ASTROPHYS, V444, P79, DOI 10.1051/0004-6361:20052881; Oliver SJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014697; Roseboom IG, 2010, MON NOT R ASTRON SOC, V409, P48, DOI 10.1111/j.1365-2966.2010.17634.x; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Seymour N, 2011, MON NOT R ASTRON SOC, V413, P1777, DOI 10.1111/j.1365-2966.2011.18253.x; Siebenmorgen R, 2007, ASTRON ASTROPHYS, V461, P445, DOI 10.1051/0004-6361:20065700; Sijacki D, 2007, MON NOT R ASTRON SOC, V380, P877, DOI 10.1111/j.1365-2966.2007.12153.x; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Smith AJ, 2012, MON NOT R ASTRON SOC, V419, P377, DOI 10.1111/j.1365-2966.2011.19709.x; Springel V, 2005, MON NOT R ASTRON SOC, V361, P776, DOI 10.1111/j.1365-2966.2005.09238.x; Symeonidis M, 2009, MON NOT R ASTRON SOC, V397, P1728, DOI 10.1111/j.1365-2966.2009.15040.x; Trouille L, 2008, ASTROPHYS J SUPPL S, V179, P1, DOI 10.1086/591648	29	155	155	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					213	216		10.1038/nature11096	http://dx.doi.org/10.1038/nature11096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575961	Green Submitted, Green Accepted			2022-12-28	WOS:000303799800035
J	Matsushita, K; Mahmoodi, BK; Woodward, M; Emberson, JR; Jafar, TH; Jee, SH; Polkinghorne, KR; Shankar, A; Smith, DH; Tonelli, M; Warnock, DG; Wen, CP; Coresh, J; Gansevoort, RT; Hemmelgarn, BR; Levey, AS				Matsushita, Kunihiro; Mahmoodi, Bakhtawar K.; Woodward, Mark; Emberson, Jonathan R.; Jafar, Tazeen H.; Jee, Sun Ha; Polkinghorne, Kevan R.; Shankar, Anoop; Smith, David H.; Tonelli, Marcello; Warnock, David G.; Wen, Chi-Pang; Coresh, Josef; Gansevoort, Ron T.; Hemmelgarn, Brenda R.; Levey, Andrew S.		Chronic Kidney Dis Prognosis Conso	Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; EPIDEMIOLOGY COLLABORATION EQUATION; STAGE RENAL-DISEASE; CARDIOVASCULAR RISK; HIGHER ALBUMINURIA; CYSTATIN-C; COCKCROFT-GAULT; POPULATION; GFR	Context The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation more accurately estimates glomerular filtration rate (GFR) than the Modification of Diet in Renal Disease (MDRD) Study equation using the same variables, especially at higher GFR, but definitive evidence of its risk implications in diverse settings is lacking. Objective To evaluate risk implications of estimated GFR using the CKD-EPI equation compared with the MDRD Study equation in populations with a broad range of demographic and clinical characteristics. Design, Setting, and Participants A meta-analysis of data from 1.1 million adults (aged >= 18 years) from 25 general population cohorts, 7 high-risk cohorts (of vascular disease), and 13 CKD cohorts. Data transfer and analyses were conducted between March 2011 and March 2012. Main Outcome Measures All-cause mortality (84 482 deaths from 40 cohorts), cardiovascular mortality (22 176 events from 28 cohorts), and end-stage renal disease (ESRD) (7644 events from 21 cohorts) during 9.4 million person-years of follow-up; the median of mean follow-up time across cohorts was 7.4 years (interquartile range, 4.2-10.5 years). Results Estimated GFR was classified into 6 categories (>= 90, 60-89, 45-59, 30-44, 15-29, and <15 mL/min/1.73m(2)) by both equations. Compared with the MDRD Study equation, 24.4% and 0.6% of participants from general population cohorts were reclassified to a higher and lower estimated GFR category, respectively, by the CKD-EPI equation, and the prevalence of CKD stages 3 to 5 (estimated GFR <60 mL/min/1.73 m(2)) was reduced from 8.7% to 6.3%. In estimated GFR of 45 to 59 mL/min/1.73m(2) by the MDRD Study equation, 34.7% of participants were reclassified to estimated GFR of 60 to 89 mL/min/1.73m2 by the CKD-EPI equation and had lower incidence rates (per 1000 person-years) for the outcomes of interest (9.9 vs 34.5 for all-cause mortality, 2.7 vs 13.0 for cardiovascular mortality, and 0.5 vs 0.8 for ESRD) compared with those not reclassified. The corresponding adjusted hazard ratios were 0.80 (95% CI, 0.74-0.86) for all-cause mortality, 0.73 (95% CI, 0.65-0.82) for cardiovascular mortality, and 0.49 (95% CI, 0.27-0.88) for ESRD. Similar findings were observed in other estimated GFR categories by the MDRD Study equation. Net reclassification improvement based on estimated GFR categories was significantly positive for all outcomes (range, 0.06-0.13; all P<.001). Net reclassification improvement was similarly positive in most subgroups defined by age (<65 years and >= 65 years), sex, race/ethnicity (white, Asian, and black), and presence or absence of diabetes and hypertension. The results in the high-risk and CKD cohorts were largely consistent with the general population cohorts. Conclusion The CKD-EPI equation classified fewer individuals as having CKD and more accurately categorized the risk for mortality and ESRD than did the MDRD Study equation across a broad range of populations. JAMA. 2012;307(18):1941-1951 www.jama.com	[Matsushita, Kunihiro; Mahmoodi, Bakhtawar K.; Woodward, Mark; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Woodward, Mark] Univ Sydney, George Inst, Sydney, NSW 2006, Australia; [Emberson, Jonathan R.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Emberson, Jonathan R.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Jafar, Tazeen H.] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Inst Hlth Promot, Seoul 120749, South Korea; [Polkinghorne, Kevan R.] Monash Med Ctr, Dept Nephrol, Melbourne, Vic, Australia; [Polkinghorne, Kevan R.] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Shankar, Anoop] W Virginia Univ, Sch Med, Dept Community Med, Morgantown, WV 26506 USA; [Smith, David H.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA; [Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Warnock, David G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA; [Wen, Chi-Pang] China Med Univ Hosp, Taichung, Taiwan; [Wen, Chi-Pang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Mahmoodi, Bakhtawar K.; Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands; [Hemmelgarn, Brenda R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Sydney; University of Oxford; University of Oxford; Aga Khan University; Yonsei University; Yonsei University Health System; Monash University; Monash University; West Virginia University; Kaiser Permanente; University of Alberta; University of Alabama System; University of Alabama Birmingham; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; University of Groningen; University of Calgary; Tufts Medical Center	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium Data Coordi, 615 N Wolfe St, Baltimore, MD 21205 USA.	ckdpc@jhmi.edu	Marks, Angharad/H-5657-2019; de Zeeuw, Dick/E-9080-2014; Matsushita, Kunihiro/AAJ-5817-2020; Hemmelgarn, Brenda R./I-6894-2012; Woodward, Mark/L-6817-2017; Matsushita, Kunihiro/B-1021-2018; Stengel, Benedicte/G-5730-2015; Kikuya, Masahiro/X-5662-2018; Mahmoodi, Bakhtawar/ABA-7050-2020; Wetzels, Jack F.M./A-1720-2014; Brenner, Hermann/ABE-6383-2020; Woodward, Mark/D-8492-2015; Tonelli, Marcello/B-3028-2009; Heerspink, Hiddo J Lambers/K-3358-2014; Schöttker, Ben/F-8183-2014; Kronenberg, Florian/B-1736-2008; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Marks, Angharad/0000-0003-1910-462X; de Zeeuw, Dick/0000-0003-3434-7777; Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Stengel, Benedicte/0000-0001-9469-0804; Kikuya, Masahiro/0000-0002-3080-6107; Wetzels, Jack F.M./0000-0002-0650-6921; Brenner, Hermann/0000-0002-6129-1572; Tonelli, Marcello/0000-0002-0846-3187; Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Schöttker, Ben/0000-0002-1217-4521; Kronenberg, Florian/0000-0003-2229-1120; Sairenchi, Toshimi/0000-0001-8896-6501; Woodward, Mark/0000-0001-9800-5296; Polkinghorne, Kevan/0000-0002-9851-002X; Yatsuya, Hiroshi/0000-0002-6220-9251; Prescott, Gordon/0000-0002-9156-2361; Froissart, Marc/0000-0002-4010-3173; Townend, Jonathan/0000-0002-5881-5806; Kleefstra, Nanne/0000-0003-1473-8519; Klein, Ronald/0000-0002-4428-6237; rossing, peter/0000-0002-1531-4294; Metzger, Marie/0000-0003-3597-5409; Emberson, Jonathan/0000-0001-7792-9422; Jee, Sun Ha/0000-0001-9519-3068	Netherlands Organization for Scientific Research; Dutch Kidney Foundation; National Institutes of Health; Genzyme; National Kidney Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; US National Kidney Foundation (National Kidney Foundation include Abbott and Amgen); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC085079, N01HC015103, N01HC025195, N01HC095159, N01HC035129, N01HC045133, N01HC075150, N01HC085086] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043232, R01HL080295, R01HL068140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK035073, R01DK073217, K23DK067303, ZIADK069062, R01DK031801, K23DK002904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007181, R01AG023629, R01AG015928, R01AG027058, R01AG028507, R01AG020098] Funding Source: NIH RePORTER; Chief Scientist Office [CZH/4/656] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme(Sanofi-AventisGenzyme Corporation); National Kidney Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Kidney Foundation (National Kidney Foundation include Abbott and Amgen); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chief Scientist Office	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Mahmoodi reported receiving grant support from the Netherlands Organization for Scientific Research and the Dutch Kidney Foundation. Dr Shankar reported receiving grant support from the National Institutes of Health. Dr Warnock reported serving as a consultant to Genzyme, Reata, Allocure, and Prion; receiving grant support from Genzyme; serving on speakers bureaus for Abbott; and owning stock options in Reata, Relypsa, Allocure, and Prion. Dr Coresh reported serving as a consultant to Amgen and Merck; and having grants pending with the National Institutes of Health and the National Kidney Foundation. Dr Levey reported being the editor in chief of the American Journal of Kidney Diseases; and having grants pending with the National Institute of Diabetes and Digestive and Kidney Diseases and the National Kidney Foundation.; The Chronic Kidney Disease Prognosis Consortium (CKD-PC) Data Coordinating Center is underpinned by a program grant from the US National Kidney Foundation (National Kidney Foundation funding sources include Abbott and Amgen). A variety of sources have supported enrollment and data collection including laboratory measurements and follow-up in the collaborating cohorts of the CKDPC. These funding sources of the collaborating cohorts are listed in eAppendix 3 at http://www.jama.com.	Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Bilo HJG, 2009, DIABETIC MED, V26, P478, DOI 10.1111/j.1464-5491.2009.02709.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Bui AL, 2009, AM J KIDNEY DIS, V53, P389, DOI 10.1053/j.ajkd.2008.06.025; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Cirillo M, 2010, AM J KIDNEY DIS, V56, P802, DOI 10.1053/j.ajkd.2010.07.002; College of American Pathologists, CURR STAT REP EST GL; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eriksen BO, 2010, KIDNEY INT, V78, P1305, DOI 10.1038/ki.2010.321; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2007, HYPERTENS RES, V30, P55, DOI 10.1291/hypres.30.55; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jafar TH, 2009, NEPHROL DIAL TRANSPL, V24, P2111, DOI 10.1093/ndt/gfp042; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Jones GRD, 2010, PATHOLOGY, V42, P487, DOI 10.3109/00313025.2010.494291; Jorsal A, 2008, KIDNEY INT, V74, P649, DOI 10.1038/ki.2008.201; Jurkovitz CT, 2008, AM J KIDNEY DIS, V51, pS3, DOI 10.1053/j.ajkd.2007.12.022; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Kukla A, 2010, NEPHROL DIAL TRANSPL, V25, P1653, DOI 10.1093/ndt/gfp668; Landray MJ, 2001, AM J KIDNEY DIS, V38, P537, DOI 10.1053/ajkd.2001.26850; Lane BR, 2010, J UROLOGY, V183, P896, DOI 10.1016/j.juro.2009.11.023; Lee BJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2395; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Marks A, 2011, J EPIDEMIOL COMMUN H, V65, pA269, DOI 10.1136/jech.2011.142976j.8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Miller WG, 2009, CLIN CHEM LAB MED, V47, P1017, DOI 10.1515/CCLM.2009.264; Mitsuhashi H, 2009, CIRC J, V73, P667, DOI 10.1253/circj.CJ-08-0626; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Murata K, 2011, CLIN J AM SOC NEPHRO, V6, P1963, DOI 10.2215/CJN.02300311; Nakayama M, 2007, NEPHROL DIAL TRANSPL, V22, P1910, DOI 10.1093/ndt/gfm051; Noda H, 2009, CIRCULATION, V119, P2136, DOI 10.1161/CIRCULATIONAHA.108.795666; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pavkov ME, 2008, AM J KIDNEY DIS, V51, P759, DOI 10.1053/j.ajkd.2008.01.011; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Rognant N, 2011, DIABETES CARE, V34, P1320, DOI 10.2337/dc11-0203; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Shimizu Y, 2011, STROKE, V42, P2531, DOI 10.1161/STROKEAHA.110.600759; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tent H, 2010, CLIN J AM SOC NEPHRO, V5, P1960, DOI 10.2215/CJN.08761209; Teo BW, 2011, AM J KIDNEY DIS, V58, P56, DOI 10.1053/j.ajkd.2011.02.393; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; van den Brand JAJG, 2011, NEPHROL DIAL TRANSPL, V26, P3176, DOI 10.1093/ndt/gfr003; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; van Zuilen AD, 2008, J NEPHROL, V21, P261; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	79	689	729	2	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1941	1951		10.1001/jama.2012.3954	http://dx.doi.org/10.1001/jama.2012.3954			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570462	Green Accepted, Bronze			2022-12-28	WOS:000303741900028
J	Coombes, R				Coombes, Rebecca			MANAGEMENT CONSULTANTS Mark Britnell: "I've got every intention of returning to the NHS"	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com						Boffey Daniel, 2011, GUARDIAN 0514; Britnell M, 2011, HLTH SERVICE J  0517	2	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3239	10.1136/bmj.e3239	http://dx.doi.org/10.1136/bmj.e3239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569868				2022-12-28	WOS:000304083400019
J	Brown, D				Brown, David			Mutant flu - the view from the newsroom	NATURE			English	Editorial Material												browndm@washpost.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					7	7		10.1038/485007a	http://dx.doi.org/10.1038/485007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	934NV	22552053	Bronze			2022-12-28	WOS:000303451900004
J	Viner, RM; Ozer, EM; Denny, S; Marmot, M; Resnick, M; Fatusi, A; Currie, C				Viner, Russell M.; Ozer, Elizabeth M.; Denny, Simon; Marmot, Michael; Resnick, Michael; Fatusi, Adesegun; Currie, Candace			Adolescent Health 2 Adolescence and the social determinants of health	LANCET			English	Article							POSITIVE YOUTH DEVELOPMENT; PROTECTIVE FACTORS; INCOME INEQUALITY; RISK BEHAVIORS; EDUCATIONAL-ATTAINMENT; AMERICAN ADOLESCENTS; SOCIOECONOMIC-STATUS; PEER INFLUENCES; URBAN CHILDREN; MENTAL-HEALTH	The health of adolescents is strongly affected by social factors at personal, family, community, and national levels. Nations present young people with structures of opportunity as they grow up. Since health and health behaviours correspond strongly from adolescence into adult life, the way that these social determinants affect adolescent health are crucial to the health of the whole population and the economic development of nations. During adolescence, developmental effects related to puberty and brain development lead to new sets of behaviours and capacities that enable transitions in family, peer, and educational domains, and in health behaviours. These transitions modify childhood trajectories towards health and wellbeing and are modified by economic and social factors within countries, leading to inequalities. We review existing data on the effects of social determinants on health in adolescence, and present findings from country-level ecological analyses on the health of young people aged 10-24 years. The strongest determinants of adolescent health world wide are structural factors such as national wealth, income inequality, and access to education. Furthermore, safe and supportive families, safe and supportive schools, together with positive and supportive peers are crucial to helping young people develop to their full potential and attain the best health in the transition to adulthood. Improving adolescent health worldwide requires improving young people's daily life with families and peers and in schools, addressing risk and protective factors in the social environment at a population level, and focusing on factors that are protective across various health outcomes. The most effective interventions are probably structural changes to improve access to education and employment for young people and to reduce the risk of transport-related injury.	[Viner, Russell M.] UCL, UCL Inst Child Hlth, London WC1N 1EH, England; [Ozer, Elizabeth M.] Univ Calif San Francisco, Off Divers & Outreach, San Francisco, CA 94143 USA; [Denny, Simon] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Marmot, Michael] UCL, UCL Res Dept Epidemiol & Publ Hlth, London WC1N 1EH, England; [Resnick, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Fatusi, Adesegun] Obafemi Awolowo Univ, Coll Hlth Sci, Dept Commu Hlth, Ife, Nigeria; [Currie, Candace] Univ St Andrews, Child & Adolescent Hlth Res Unit, St Andrews KY16 9AJ, Fife, Scotland	University of London; University College London; University of California System; University of California San Francisco; University of Auckland; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; Obafemi Awolowo University; University of St Andrews	Viner, RM (corresponding author), UCL, UCL Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	rviner@ich.ucl.ac.uk	Viner, Russell M/A-1441-2009; Marmot, M G/Y-3920-2019	Viner, Russell M/0000-0003-3047-2247; Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0902037, G8802774, G0100222, G19/35] Funding Source: Medline; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ajdacic-Gross V, 2006, AM J PUBLIC HEALTH, V96, P1752, DOI 10.2105/AJPH.2005.075812; Anderson DR, 2001, MONOGR SOC RES CHILD, V66, P1, DOI 10.1111/1540-5834.00121; Aneshensel CS, 1996, J HEALTH SOC BEHAV, V37, P293, DOI 10.2307/2137258; [Anonymous], 2009, POPUL BULL, V64, P2; Anteghini M, 2001, J ADOLESCENT HEALTH, V28, P295, DOI 10.1016/S1054-139X(00)00197-X; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barber BK, 2005, MONOGR SOC RES CHILD, V70, pVII; Barnekow V., 2008, INEQUALITIES YOUNG P; Bartlett S, 2008, ENVIRON URBAN, V20, P501, DOI 10.1177/0956247808096125; Bauman KE, 2001, ADDICT BEHAV, V26, P349, DOI 10.1016/S0306-4603(00)00110-6; Baumrind D., 1991, FAMILY TRANSITIONS; Beal AC, 2001, J ADOLESCENT HEALTH, V28, P474, DOI 10.1016/S1054-139X(01)00194-X; Bhui K, 2005, SOC PSYCH PSYCH EPID, V40, P259, DOI 10.1007/s00127-005-0890-5; Bhui K, 2005, J EPIDEMIOL COMMUN H, V59, P296, DOI 10.1136/jech.2003.014456; Blum RW, 2003, AM J PUBLIC HEALTH, V93, P456, DOI 10.2105/AJPH.93.3.456; Blum RW, 2000, AM J PUBLIC HEALTH, V90, P1879, DOI 10.2105/AJPH.90.12.1879; Bond L, 2004, J EPIDEMIOL COMMUN H, V58, P997, DOI 10.1136/jech.2003.009449; Bonnie R.J., 2004, REDUCING UNDERAGE DR; Borges Carolina M, 2010, BMC Res Notes, V3, P338, DOI 10.1186/1756-0500-3-338; Borowsky IW, 2002, AMBUL PEDIATR, V2, P475, DOI 10.1367/1539-4409(2002)002<0475:VRAPFA>2.0.CO;2; Boyle MH, 2007, CHILD DEV, V78, P168, DOI 10.1111/j.1467-8624.2007.00991.x; Branche C., 2008, WORLD REPORT CHILD I; Bruneforth Michael., 2010, OUT OF SCH ADOLESCEN; Catalano R. F., 1996, DELINQUENCY CRIME CU, P149; Catalano RF, 2002, J ADOLESCENT HEALTH, V31, P230, DOI 10.1016/S1054-139X(02)00496-2; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; CATANIA JA, 1989, J SEX RES, V26, P514, DOI 10.1080/00224498909551532; Chao RK, 2001, CHILD DEV, V72, P1832, DOI 10.1111/1467-8624.00381; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; Collins WA, 2006, HDB CHILD PSYCHOL; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Crosby RA, 2003, ARCH PEDIAT ADOL MED, V157, P169, DOI 10.1001/archpedi.157.2.169; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Donovan JE, 2004, J ADOLESCENT HEALTH, V35, pe7, DOI [10.1016/j, DOI 10.1016/J.JADOHEALTH.2004.02.003]; Dorling D, 2007, BMJ-BRIT MED J, V335, P873, DOI 10.1136/bmj.39349.507315.DE; Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128; Erbaydar T, 2005, EUR J PUBLIC HEALTH, V15, P404, DOI 10.1093/eurpub/cki040; Flay BR, 2004, ARCH PEDIAT ADOL MED, V158, P377, DOI 10.1001/archpedi.158.4.377; Fletcher AC, 2004, CHILD DEV, V75, P781, DOI 10.1111/j.1467-8624.2004.00706.x; Ford CA, 2005, ARCH PEDIAT ADOL MED, V159, P657, DOI 10.1001/archpedi.159.7.657; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gavin LE, 2010, J ADOLESCENT HEALTH, V46, pS75, DOI 10.1016/j.jadohealth.2009.11.215; Gold R, 2001, Matern Child Health J, V5, P161; Gold R, 2002, HEALTH PLACE, V8, P77, DOI 10.1016/S1353-8292(01)00027-2; Gordon-Larsen P, 2003, SOC SCI MED, V57, P2023, DOI 10.1016/S0277-9536(03)00072-8; Gunnell D, 1999, BRIT J PSYCHIAT, V175, P263, DOI 10.1192/bjp.175.3.263; Gutman LM, 2002, AM J COMMUN PSYCHOL, V30, P367, DOI 10.1023/A:1015389103911; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Harding DJ, 2003, AM J SOCIOL, V109, P676, DOI 10.1086/379217; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Hawkins JD, 2002, ADDICT BEHAV, V27, P951, DOI 10.1016/S0306-4603(02)00298-8; Hawkins JD, 2005, ARCH PEDIAT ADOL MED, V159, P25, DOI 10.1001/archpedi.159.1.25; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Holland T, 2011, INT J EDUC DEV, V31, P149, DOI 10.1016/j.ijedudev.2010.07.002; Irwin L, 2007, EARLY CHILD DEV POWE; Jaccard J, 2005, DEV PSYCHOL, V41, P135, DOI 10.1037/0012-1649.41.1.135; Jayakody A, 2011, J ADOLESCENT HEALTH, V48, P499, DOI 10.1016/j.jadohealth.2010.08.010; Jessor R, 1998, J PERS SOC PSYCHOL, V75, P788, DOI 10.1037/0022-3514.75.3.788; Kaplan CP, 2001, ADDICT BEHAV, V26, P531, DOI 10.1016/S0306-4603(00)00143-X; Khawaja M, 2006, SOC SCI MED, V63, P1304, DOI 10.1016/j.socscimed.2006.03.047; Klasen F, 2010, CHILD DEV, V81, P1096, DOI 10.1111/j.1467-8624.2010.01456.x; Knoester C, 2005, J MARRIAGE FAM, V67, P767, DOI 10.1111/j.1741-3737.2005.00168.x; Kohrt BA, 2010, TRANSCULT PSYCHIATRY, V47, P727, DOI 10.1177/1363461510381290; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; Kretman SE., 2009, ADOLESCENT HLTH UNDE, P213; Laursen B., 2009, HDB ADOLESCENT PSYCH, DOI DOI 10.1002/9780470479193.ADLPSY002002; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Leventhal T., 2009, HDB ADOLESCENT PSYCH, P451; Li JH, 2009, HEALTH SOCIOL REV, V18, P3, DOI 10.5172/hesr.18.1.3; Little AW, 2009, INT J EDUC DEV, V29, P166, DOI 10.1016/j.ijedudev.2008.09.011; Lohaus A, 2009, J EARLY ADOLESCENCE, V29, P449, DOI 10.1177/0272431608322954; Machel G., 2001, IMPACT WAR CHILDREN; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 1999, ANN NY ACAD SCI, V896, P16, DOI 10.1111/j.1749-6632.1999.tb08102.x; Morgan A, 2009, HEALTH PROMOT INT, V24, P363, DOI 10.1093/heapro/dap028; Morrell SL, 1998, MED J AUSTRALIA, V168, P236, DOI 10.5694/j.1326-5377.1998.tb140139.x; OZER EM, 1990, J PERS SOC PSYCHOL, V58, P472, DOI 10.1037/0022-3514.58.3.472; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Pettit GS, 2001, CHILD DEV, V72, P583, DOI 10.1111/1467-8624.00298; Pitel L, 2010, PUBLIC HEALTH, V124, P512, DOI 10.1016/j.puhe.2010.05.005; Raphael D, 1996, J ADOLESCENT HEALTH, V19, P6, DOI 10.1016/1054-139X(95)00233-I; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Richter M, 2007, EUR J PUBLIC HEALTH, V17, P565, DOI 10.1093/eurpub/ckm010; Salazar L.F., 2009, ADOLESCENT HLTH UNDE, P274; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Sethi D, 2010, EUROPEAN REPORT PREV; Sinha S, 2007, ETHNIC HEALTH, V12, P423, DOI 10.1080/13557850701616839; Spencer N, 2004, CHILD CARE HLTH DEV, V30, P699, DOI 10.1111/j.1365-2214.2004.00485.x; Ssewamala FM, 2010, J ADOLESCENT HEALTH, V46, P372, DOI 10.1016/j.jadohealth.2009.08.010; Stahl T., 2006, HLTH ALL POLICIES PR; Steinberg L, 2001, J RES ADOLESCENCE, V11, P1, DOI 10.1111/1532-7795.00001; Strasburger VC, 2010, PEDIATRICS, V125, P756, DOI 10.1542/peds.2009-2563; Swift R, 2011, HEALTH ECON, V20, P306, DOI 10.1002/hec.1590; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; Taffa N, 2002, INT J STD AIDS, V13, P714, DOI 10.1258/095646202760326480; Torsheim T, 2004, SOC SCI MED, V59, P1, DOI 10.1016/j.socscimed.2003.09.032; United Nat ions Populat ion Division, 2008, WORLD URB PROSP 2007; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; Vesely SK, 2004, J ADOLESCENT HEALTH, V34, P356, DOI [10.1016/j.jadohealth.2003.08.008, 10.1016/S1054-139X(03)00333-1]; Viner Russell M, 2006, J Adolesc Health, V38, P55, DOI 10.1016/j.jadohealth.2004.09.017; WANG MQ, 1995, J ADOLESCENT HEALTH, V16, P200, DOI 10.1016/1054-139X(94)00097-X; World Bank, 2007, WORLD DEV REP DEV NE	108	1104	1122	15	321	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1641	1652		10.1016/S0140-6736(12)60149-4	http://dx.doi.org/10.1016/S0140-6736(12)60149-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538179				2022-12-28	WOS:000303452600038
J	Bates, FS; Hillmyer, MA; Lodge, TP; Bates, CM; Delaney, KT; Fredrickson, GH				Bates, Frank S.; Hillmyer, Marc A.; Lodge, Timothy P.; Bates, Christopher M.; Delaney, Kris T.; Fredrickson, Glenn H.			Multiblock Polymers: Panacea or Pandora's Box?	SCIENCE			English	Review							ABC TRIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; DIBLOCK COPOLYMERS; PHASE-BEHAVIOR; POLYMERIZATION; POLYDISPERSITY; MORPHOLOGIES; TERPOLYMERS; POLYSTYRENE; SEGREGATION	Advances in synthetic polymer chemistry have unleashed seemingly unlimited strategies for producing block polymers with arbitrary numbers (n) and types (k) of unique sequences of repeating units. Increasing (k, n) leads to a geometric expansion of possible molecular architectures, beyond conventional ABA-type triblock copolymers (k = 2, n = 3), offering alluring opportunities to generate exquisitely tailored materials with unparalleled control over nanoscale-domain geometry, packing symmetry, and chemical composition. Transforming this potential into targeted structures endowed with useful properties hinges on imaginative molecular designs guided by predictive theory and computer simulation. Here, we review recent developments in the field of block polymers.	[Bates, Frank S.; Lodge, Timothy P.] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Hillmyer, Marc A.; Lodge, Timothy P.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Bates, Christopher M.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Delaney, Kris T.; Fredrickson, Glenn H.] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Fredrickson, Glenn H.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	bates001@umn.edu	Delaney, Kris T/D-4324-2011	Delaney, Kris T/0000-0003-0356-1391; Hillmyer, Marc/0000-0001-8255-3853; Lodge, Timothy/0000-0001-5916-8834; Bates, Frank/0000-0003-3977-1278	NSF [DMR-0819885, DMR-1121053]	NSF(National Science Foundation (NSF))	This work was supported by the Materials Research Science and Engineering Centers Program of the NSF under award numbers DMR-0819885 (F. S. B., M. A. H., T. P. L.) and DMR-1121053 (G. H. F., K. T. D.). C. M. B. thanks C. G. Willson for his support.	[Anonymous], 2007, PRINCIPLES CONDENSED; Arriola DJ, 2006, SCIENCE, V312, P714, DOI 10.1126/science.1125268; AUSCHRA C, 1993, MACROMOLECULES, V26, P2171, DOI 10.1021/ma00061a005; Bates FS, 2001, AICHE J, V47, P762, DOI 10.1002/aic.690470402; BATES FS, 1986, PHYS REV LETT, V57, P1429, DOI 10.1103/PhysRevLett.57.1429; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Bellas V, 2000, MACROMOLECULES, V33, P6993, DOI 10.1021/ma000635i; Bluemle MJ, 2010, MACROMOLECULES, V43, P4449, DOI 10.1021/ma100510p; Chatterjee J, 2007, MACROMOLECULES, V40, P2882, DOI 10.1021/ma062249s; Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Christodoulou S, 2008, MACROMOLECULES, V41, P2607, DOI 10.1021/ma702605w; Cochran EW, 2006, MACROMOLECULES, V39, P2449, DOI 10.1021/ma0527707; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; EDWARDS SF, 1966, P PHYS SOC LOND, V88, P265, DOI 10.1088/0370-1328/88/2/301; Fredrickson G.H., 2006, EQUILIBRIUM THEORY I; Fredrickson GH, 2002, MACROMOLECULES, V35, P16, DOI 10.1021/ma011515t; Goldacker T, 1999, NATURE, V398, P137, DOI 10.1038/18191; Guo SW, 2006, CHEM MATER, V18, P1719, DOI 10.1021/cm052694m; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; HELFAND E, 1978, MACROMOLECULES, V11, P682, DOI 10.1021/ma60064a013; Hermel TJ, 2003, MACROMOLECULES, V36, P2190, DOI 10.1021/ma021754w; Hirao A, 2006, MACROMOLECULES, V39, P6081, DOI 10.1021/ma061075b; Jackson EA, 2010, ACS NANO, V4, P3548, DOI 10.1021/nn1014006; Kiesewetter MK, 2010, MACROMOLECULES, V43, P2093, DOI 10.1021/ma9025948; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee S, 2010, SCIENCE, V330, P349, DOI 10.1126/science.1195552; LEIBLER L, 1980, MACROMOLECULES, V13, P1602, DOI 10.1021/ma60078a047; Lennon EM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.138302; Lucas E, 1891, THEORIE DES NOMBRES; Lynd NA, 2005, MACROMOLECULES, V38, P8803, DOI 10.1021/ma051025r; MATSEN MW, 1994, PHYS REV LETT, V72, P2660, DOI 10.1103/PhysRevLett.72.2660; Matsen MW, 2002, J PHYS-CONDENS MAT, V14, pR21, DOI 10.1088/0953-8984/14/2/201; Matyjaszewski K, 2011, SCIENCE, V333, P1104, DOI 10.1126/science.1209660; Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d; Meuler AJ, 2007, MACROMOLECULES, V40, P760, DOI 10.1021/ma0623338; MOGI Y, 1994, MACROMOLECULES, V27, P6755, DOI 10.1021/ma00101a013; Moughton AO, 2012, MACROMOLECULES, V45, P2, DOI 10.1021/ma201865s; Okamoto K, 2011, POLYM CHEM-UK, V2, P2424, DOI 10.1039/c1py00171j; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Qin J, 2010, MACROMOLECULES, V43, P5128, DOI 10.1021/ma100400q; Riordan J., 1978, INTRO COMBINATORIAL; Ruiz R, 2008, SCIENCE, V321, P936, DOI 10.1126/science.1157626; RUSSELL TP, 1990, MACROMOLECULES, V23, P890, DOI 10.1021/ma00205a033; Stasiak P, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11110-0; Stefik M, 2009, CHEM MATER, V21, P5466, DOI 10.1021/cm902626z; SZWARC M, 1956, J AM CHEM SOC, V78, P2656, DOI 10.1021/ja01592a101; Tzeremes G, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041806; Widin JM, 2012, J AM CHEM SOC, V134, P3834, DOI 10.1021/ja210548e; Zalusky AS, 2002, J AM CHEM SOC, V124, P12761, DOI 10.1021/ja0278584; Zhang JW, 2012, MACROMOLECULES, V45, P256, DOI 10.1021/ma202196c; ZHENG W, 1995, MACROMOLECULES, V28, P7215, DOI 10.1021/ma00125a026	52	770	790	24	890	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					434	440		10.1126/science.1215368	http://dx.doi.org/10.1126/science.1215368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539713				2022-12-28	WOS:000303233400037
J	Moazed, D				Moazed, Danesh			A piRNA to Remember	CELL			English	Editorial Material							SMALL RNAS; PIWI	In this issue of Cell, Rajasethupathy et al. report a surprising role for piRNAs, previously thought to act mainly in the animal germline to silence transposons, in transcriptional regulation of plasticity-related genes in the central nervous system of the sea slug Aplysia californica. The findings expand the functions of small RNAs and have important implications for our understanding of how transient signals can give rise to long-term memories.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu						Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367	10	4	4	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					512	514		10.1016/j.cell.2012.04.008	http://dx.doi.org/10.1016/j.cell.2012.04.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541425	Bronze			2022-12-28	WOS:000303443100004
J	Thangaratinam, S; Brown, K; Zamora, J; Khan, KS; Ewer, AK				Thangaratinam, Shakila; Brown, Kiritrea; Zamora, Javier; Khan, Khalid S.; Ewer, Andrew K.			Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis	LANCET			English	Article							TEST ACCURACY; PRENATAL-DIAGNOSIS; COST-EFFECTIVENESS; FETAL DIAGNOSIS; DISEASE; MALFORMATIONS; SURVIVAL; INFANTS; IMPACT; TESTS	Background Screening for critical congenital heart defects in newborn babies can aid in early recognition, with the prospect of improved outcome. We assessed the performance of pulse oximetry as a screening method for the detection of critical congenital heart defects in asymptomatic newborn babies. Methods In this systematic review, we searched Medline (1951-2011), Embase (1974-2011), Cochrane Library (2011), and Scisearch (1974-2011) for relevant citations with no language restriction. We selected studies that assessed the accuracy of pulse oximetry for the detection of critical congenital heart defects in asymptomatic newborn babies. Two reviewers selected studies that met the predefined criteria for population, tests, and outcomes. We calculated sensitivity, specificity, and corresponding 95% CIs for individual studies. A hierarchical receiver operating characteristic curve was fitted to generate summary estimates of sensitivity and specificity with a random effects model. Findings We screened 552 studies and identified 13 eligible studies with data for 229 421 newborn babies. The overall sensitivity of pulse oximetry for detection of critical congenital heart defects was 76.5% (95% CI 67.7-83.5). The specificity was 99.9% (99.7-99.9), with a false-positive rate of 0.14% (0.06-0.33). The false-positive rate for detection of critical congenital heart defects was particularly low when newborn pulse oximetry was done after 24 h from birth than when it was done before 24 h (0.05% [0.02-0.12] vs 0.50 [0.29-0.86]; p=0.0017). Interpretation Pulse oximetry is highly specific for detection of critical congenital heart defects with moderate sensitivity, that meets criteria for universal screening.	[Thangaratinam, Shakila; Khan, Khalid S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London E1 4NS, England; [Brown, Kiritrea; Ewer, Andrew K.] Birmingham Womens NHS Fdn Trust, Birmingham, W Midlands, England; [Zamora, Javier] Hosp Ramon y Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain; [Zamora, Javier] CIBERESP, Madrid, Spain; [Ewer, Andrew K.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England	University of London; Queen Mary University London; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Birmingham	Thangaratinam, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London E1 4NS, England.	s.thangaratinam@qmul.ac.uk	Khan, Khalid S/AAT-8824-2020; Thangaratinam, Shakila/AAP-3724-2021; Zamora, Javier/B-1722-2009; Zamora, Javier/AEO-0608-2022; Ewer, Andrew K/B-1050-2013	Khan, Khalid S/0000-0001-5084-7312; Thangaratinam, Shakila/0000-0002-4254-460X; Zamora, Javier/0000-0003-4901-588X; Zamora, Javier/0000-0003-4901-588X; Brown, Katherine/0000-0002-0729-4959; Ewer, Andrew/0000-0002-3825-4781				ABUHARB M, 1994, ARCH DIS CHILD-FETAL, V71, pF179, DOI 10.1136/fn.71.3.F179; Arlettaz R, 2006, EUR J PEDIATR, V165, P94, DOI 10.1007/s00431-005-0006-y; Bakr AF, 2005, PEDIATR CARDIOL, V26, P832, DOI 10.1007/s00246-005-0981-9; Brown JW, 2001, ANN THORAC SURG, V71, P1978, DOI 10.1016/S0003-4975(01)02529-2; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Ewer AK, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16020; Ewer AK, 2011, LANCET, V378, P785, DOI 10.1016/S0140-6736(11)60753-8; Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67; Garne E, 2001, ULTRASOUND OBST GYN, V17, P386, DOI 10.1046/j.1469-0705.2001.00385.x; Granelli AD, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3037; Hoke TR, 2002, PEDIATR CARDIOL, V23, P403, DOI 10.1007/s00246-002-1482-8; Kawalec W, 2006, CARDIOL YOUNG, V16, P25; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Khan KS, 2001, EUR J OBSTET GYN R B, V95, P6, DOI 10.1016/S0301-2115(00)00463-2; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; LLOYD J, 2003, COCHRANE DB SYST REV, V2; Mahle W, 2011, LANCET, V378, P749, DOI 10.1016/S0140-6736(11)61032-5; Mahle WT, 2009, PEDIATRICS, V124, P823, DOI 10.1542/peds.2009-1397; Meberg A, 2008, J PEDIATR-US, V152, P761, DOI 10.1016/j.jpeds.2007.12.043; Meberg A, 2009, ACTA PAEDIATR, V98, P682, DOI 10.1111/j.1651-2227.2008.01199.x; Reich JD, 2003, J PEDIATR-US, V142, P268, DOI 10.1067/mpd.2003.87; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Rosati E, 2005, J PERINAT MED, V33, P455, DOI 10.1515/JPM.2005.080; Sendelbach DM, 2008, PEDIATRICS, V122, pE815, DOI 10.1542/peds.2008-0781; Tegnander E, 2006, ULTRASOUND OBST GYN, V27, P252, DOI 10.1002/uog.2710; Thangaratinam S, 2007, ARCH DIS CHILD-FETAL, V92, pF176, DOI 10.1136/adc.2006.107656; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wren C, 2008, ARCH DIS CHILD-FETAL, V93, pF33, DOI 10.1136/adc.2007.119032; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49	36	212	225	0	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2459	2464		10.1016/S0140-6736(12)60107-X	http://dx.doi.org/10.1016/S0140-6736(12)60107-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22554860				2022-12-28	WOS:000305915900030
J	Kellum, JA; Bellomo, R; Ronco, C				Kellum, John A.; Bellomo, Rinaldo; Ronco, Claudio			Kidney Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE-RENAL-FAILURE; INJURY; MORTALITY; PNEUMONIA; OUTCOMES		[Kellum, John A.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care & Med, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Ronco, Claudio] Osped San Bortolo, Int Renal Res Inst, Dept Nephrol, Vicenza, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Kellum, JA (corresponding author), Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Room 604,Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kellumja@ccm.upmc.edu	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Ronco, Claudio/0000-0002-6697-4065				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT S, V2, P89; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Singbartl K, 2011, KIDNEY INT, V80, P633, DOI 10.1038/ki.2011.201; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813	9	72	73	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2265	2266		10.1001/jama.2012.4315	http://dx.doi.org/10.1001/jama.2012.4315			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22572776				2022-12-28	WOS:000304801700019
J	Bloche, MG				Bloche, M. Gregg			Beyond the "R Word"? Medicine's New Frugality	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		Georgetown Univ, Ctr Law, Washington, DC 20007 USA	Georgetown University	Bloche, MG (corresponding author), Georgetown Univ, Ctr Law, Washington, DC 20007 USA.							Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; House Committee on the Budget, PATH PROSP BLUEPR AM; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	4	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1951	1953		10.1056/NEJMp1203521	http://dx.doi.org/10.1056/NEJMp1203521			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946LL	22551108				2022-12-28	WOS:000304353000003
J	Lok, ASF; Ward, JW; Perrillo, RP; McMahon, BJ; Liang, TJ				Lok, Anna S. F.; Ward, John W.; Perrillo, Robert P.; McMahon, Brian J.; Liang, T. Jake			Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS INFECTION; CYTOTOXIC CHEMOTHERAPY; LAMIVUDINE; RECOMMENDATIONS; IDENTIFICATION; MANAGEMENT; RITUXIMAB; DISEASES		Univ Michigan, Ann Arbor, MI 48109 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Baylor Med Ctr, Dallas, TX USA; Ctr Dis Control & Prevent, Liver Dis & Hepatitis Program, Alaska Native Med Ctr, Anchorage, AK USA; Ctr Dis Control & Prevent, Arctic Invest Programs, Anchorage, AK USA; Amer Assoc Study Liver Dis, Alexandria, VA USA	University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; Alaska Native Medical Center; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lok, ASF (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, 3110G Taubman Ctr,SPC 5368,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	aslok@umich.edu		Yang, Shuman/0000-0002-9638-0890	Intramural NIH HHS [ZIA DK054500-16] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Carroll MB, 2010, CLIN RHEUMATOL, V29, P1021, DOI 10.1007/s10067-010-1523-2; Chan TM, 2002, HEPATOLOGY, V36, P1246, DOI 10.1053/jhep.2002.36156; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Grob P, 2000, J MED VIROL, V62, P450, DOI 10.1002/1096-9071(200012)62:4&lt;450::AID-JMV9&gt;3.0.CO;2-Y; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Leung C, 2011, ONCOLOGIST, V16, P579, DOI 10.1634/theoncologist.2010-0182; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; MCQUILLAN GM, 1987, AM J EPIDEMIOL, V126, P484, DOI 10.1093/oxfordjournals.aje.a114680; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Sorrell MF, 2009, ANN INTERN MED, V150, P104, DOI 10.7326/0003-4819-150-2-200901200-00100; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Tran TT, 2010, ALIMENT PHARM THER, V31, P240, DOI 10.1111/j.1365-2036.2009.04158.x; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0	20	61	68	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					743	745		10.7326/0003-4819-156-10-201205150-00013	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586011	Green Accepted			2022-12-28	WOS:000304193400020
J	Meeuwsen, EJ; Melis, RJF; Van der Aa, GCHM; Goluke-Willemse, GAM; De Leest, BJM; Van Raak, FHJM; Scholzel-Dorenbos, CJM; Verheijen, DCM; Verhey, FRJ; Visser, MC; Wolfs, CA; Adang, EMM; Rikkert, MGMO				Meeuwsen, Els J.; Melis, Rene J. F.; Van der Aa, Geert C. H. M.; Goluke-Willemse, Gertie A. M.; De Leest, Benoit J. M.; Van Raak, Frank H. J. M.; Scholzel-Dorenbos, Carla J. M.; Verheijen, Desiree C. M.; Verhey, Frans R. J.; Visser, Marieke C.; Wolfs, Claire A.; Adang, Eddy M. M.; Rikkert, Marcel G. M. Olde			Effectiveness of dementia follow-up care by memory clinics or general practitioners: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; DIAGNOSTIC-APPROACH; PRAGMATIC TRIALS; STRATEGY; PEOPLE; VALIDATION; INTENTION; THERAPY; PROGRAM; ENGLAND	Objective To examine the effectiveness of post-diagnosis dementia treatment and coordination of care by memory clinics compared with general practitioners. Design Multicentre randomised controlled trial. Setting Nine memory clinics and 159 general practitioners in the Netherlands. Participants 175 patients with a new diagnosis of mild to moderate dementia living in the community and their informal caregivers. Interventions Usual care provided by memory clinic or general practitioner. Main outcome measures Caregiver rated quality of life of the patient measured with the quality of life in Alzheimer's disease instrument and self perceived burden of the informal caregiver measured with the sense of competence questionnaire (intention to treat analysis). Results The quality of life of the patients in the memory clinic group was 0.5 (95% confidence interval -0.7 to 1.6) points higher than in the general practitioner group. Caregivers' burden was 2.4 (-5.8 to 1.0) points lower in the memory clinic group than in the general practitioner group. Conclusion No evidence was found that memory clinics were more effective than general practitioners with regard to post-diagnosis treatment and coordination care for patients with dementia. Without further evidence on the effectiveness of these modalities, other arguments, such as cost minimisation, patients' preferences, or regional health service planning, can determine which type of dementia care is offered.	[Meeuwsen, Els J.; Melis, Rene J. F.; Scholzel-Dorenbos, Carla J. M.; Rikkert, Marcel G. M. Olde] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, Alzheimer Ctr Nijmegen, NL-6500 HB Nijmegen, Netherlands; [Van der Aa, Geert C. H. M.] Catharina Hosp, Dept Geriatr, NL-5602 ZA Eindhoven, Netherlands; [Goluke-Willemse, Gertie A. M.] Rijnstate Hosp, Dept Geriatr, NL-6800 TA Arnhem, Netherlands; [De Leest, Benoit J. M.] Elkerliek Hosp, Dept Geriatr, NL-5700 AB Helmond, Netherlands; [Van Raak, Frank H. J. M.] Ctr Land van Cuijk, GGZ Oost Brabant, NL-5830 AC Boxmeer, Netherlands; [Scholzel-Dorenbos, Carla J. M.] Slingeland Hosp, Memory Clin, NL-7000 AD Doetinchem, Netherlands; [Verheijen, Desiree C. M.] Gelderse Vallei Hosp, Dept Geriatr, NL-6710 HN Ede, Netherlands; [Verhey, Frans R. J.; Wolfs, Claire A.] Maastricht Univ, Med Ctr, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, NL-6202 AZ Maastricht, Netherlands; [Visser, Marieke C.] VU Med Ctr Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Catharina Hospital; Rijnstate Hospital; Gelderse Vallei Hospital; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Meeuwsen, EJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, Alzheimer Ctr Nijmegen, POB 9101, NL-6500 HB Nijmegen, Netherlands.	E.Meeuwsen@ger.umcn.nl	Adang, E.M.M./L-4169-2015; Rikkert, M.G.M. Olde/H-8078-2014; Rikkert, Marcel Olde/D-9773-2012; Melis, René/J-5943-2012	Rikkert, M.G.M. Olde/0000-0003-1397-1677; Melis, René/0000-0002-7863-4738	ZonMw (Netherlands Organization for Health Research and Development) [945-07-703]; Radboud University Nijmegen Medical Centre	ZonMw (Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and Development); Radboud University Nijmegen Medical Centre	This work was supported by ZonMw (Netherlands Organization for Health Research and Development; grant no 945-07-703) and by the Radboud University Nijmegen Medical Centre.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Banerjee S, 2010, INT J GERIATR PSYCH, V25, P917, DOI 10.1002/gps.2598; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; BOOMSMA LJ, 2005, HUISARTS WET, V48, P124; Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b931; Cahill S, 2010, INT J GERIATR PSYCH, V25, P912, DOI 10.1002/gps.2597; Connelly P, 2010, INT J GERIATR PSYCH, V25, P908, DOI 10.1002/gps.2596; Coombes R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b550; Craig D., 2004, PSYCHIAT B, V28, P375, DOI [10.1192/pb.28.10.375, DOI 10.1192/PB.28.10.375]; Dam van-Baggen CMJ, 1986, INVENTARISATIELIJST; Department of Health, 2009, LIVING WELL DEMENTIA; Doncaster E, 2011, AGING MENT HEALTH, V15, P23, DOI 10.1080/13607863.2010.519322; Dragkovic I, 2008, INT J GERIATR PSYCH, V23, P119, DOI 10.1002/gps.1848; Eriksson S, 2010, INT J GERIATR PSYCH, V25, P885, DOI 10.1002/gps.2592; EYSENCK SBG, 1972, PSYCHOL MED, V2, P50, DOI 10.1017/S0033291700045608; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geldmacher DS, 2002, SEMIN NEUROL, V22, P63, DOI 10.1055/s-2002-33049; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Greaves I, 2010, BRIT J GEN PRACT, V60, P193, DOI 10.3399/bjgp10X483553; Hean S, 2011, J PSYCHIATR MENT HLT, V18, P81, DOI 10.1111/j.1365-2850.2010.01665.x; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Jolley SD, 2006, POSTGRAD MED J, V82, P199, DOI 10.1136/pgmj.2005.040592; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; LoGiudice D, 1999, INT J GERIATR PSYCH, V14, P626, DOI 10.1002/(SICI)1099-1166(199908)14:8<626::AID-GPS990>3.0.CO;2-5; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Manthorpe J, 2010, BRIT J GEN PRACT, V60, P373, DOI 10.3399/bjgp10X501903; Meeuwsen EJ, 2009, J NUTR HEALTH AGING, V13, P242, DOI 10.1007/s12603-009-0066-1; Melis RJF, 2009, J ROY SOC MED, V102, P456, DOI 10.1258/jrsm.2009.090259; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nederlands Huisarts Genootschap, 2021, NHG STAND DEM M21 VE; Nederlandse Vereniging voor Klinische Geriatrie, 2005, DIAGN MED BEH DEM; Nourhashemi F, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2466; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Perry M, 2010, J AM GERIATR SOC, V58, P557, DOI 10.1111/j.1532-5415.2010.02726.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ramakers IHGB, 2011, AGING MENT HEALTH, V15, P34, DOI 10.1080/13607863.2010.519321; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Spector A, 2003, BRIT J PSYCHIAT, V183, P248, DOI 10.1192/bjp.183.3.248; Spielberger C., 1983, STAI MANUAL; Teunisse S, 1991, Tijdschr Gerontol Geriatr, V22, P53; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; van Crevel H, 1999, J NEUROL, V246, P73, DOI 10.1007/s004150050311; VernooijDassen MJFJ, 1996, SOC SCI MED, V43, P41, DOI 10.1016/0277-9536(95)00332-0; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Wolfs CAG, 2008, BRIT J PSYCHIAT, V192, P300, DOI 10.1192/bjp.bp.107.035204; Wolfs CAG, 2009, ARCH GEN PSYCHIAT, V66, P313, DOI 10.1001/archgenpsychiatry.2008.544	48	69	69	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e3086	10.1136/bmj.e3086	http://dx.doi.org/10.1136/bmj.e3086			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589500	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000304086900008
J	O'Keeffe, AB; Terris, J; Hormbrey, P				O'Keeffe, Andrew Brian; Terris, Jane; Hormbrey, Philip			PICTURE QUIZ A sinister cause of back pain in a young man	BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-THE-LITERATURE; PSOAS ABSCESS; ILIOPSOAS ABSCESS; ETIOLOGY; SERIES		[O'Keeffe, Andrew Brian] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Terris, Jane; Hormbrey, Philip] John Radcliffe Hosp, Emergency Dept, Oxford OX3 9DU, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Oxford	O'Keeffe, AB (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	andrewbokeeffe@yahoo.com						Alvi AR, 2010, TROP DOCT, V40, P56, DOI 10.1258/td.2009.090212; Baier PK, 2006, LANGENBECK ARCH SURG, V391, P411, DOI 10.1007/s00423-006-0052-6; Heaton DC, 2000, HAEMOPHILIA, V6, P41; Koo EH, 2010, KOREAN J PAIN, V23, P270, DOI 10.3344/kjp.2010.23.4.270; Kumar P, 2005, CLIN MED, P573; LEU SY, 1986, DIS COLON RECTUM, V29, P694, DOI 10.1007/BF02555310; Plaza R, 2006, HIP INT, V16, P234, DOI 10.5301/HIP.2008.4392; SAPICO FL, 1979, REV INFECT DIS, V1, P754; SHAMBERGER RC, 1989, J PEDIATR SURG, V24, P933, DOI 10.1016/S0022-3468(89)80599-8; Tabrizian P, 2009, ARCH SURG-CHICAGO, V144, P946, DOI 10.1001/archsurg.2009.144; Tang YW, 2004, J CLIN MICROBIOL, V42, P1849, DOI 10.1128/JCM.42.4.1849-1850.2004; van den Berge M, 2005, NETH J MED, V63, P413	12	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 11	2012	344								e3015	10.1136/bmj.e3015	http://dx.doi.org/10.1136/bmj.e3015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XU	22581571				2022-12-28	WOS:000304085700001
J	Speese, SD; Ashley, J; Jokhi, V; Nunnari, J; Barria, R; Li, YH; Ataman, B; Koon, A; Chang, YT; Li, Q; Moore, MJ; Budnik, V				Speese, Sean D.; Ashley, James; Jokhi, Vahbiz; Nunnari, John; Barria, Romina; Li, Yihang; Ataman, Bulent; Koon, Alex; Chang, Young-Tae; Li, Qian; Moore, Melissa J.; Budnik, Vivian			Nuclear Envelope Budding Enables Large Ribonucleoprotein Particle Export during Synaptic Wnt Signaling	CELL			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; VIRUS TYPE-1 EGRESS; PROTEIN-KINASE-C; NUCLEOPLASMIC RETICULUM; NEUROMUSCULAR-JUNCTION; GENETIC-ANALYSIS; MAMMALIAN-CELLS; DROSOPHILA; WINGLESS; ORGANIZATION	Localized protein synthesis requires assembly and transport of translationally silenced ribonucleoprotein particles (RNPs), some of which are exceptionally large. Where in the cell such large RNP granules first assemble was heretofore unknown. We previously reported that during synapse development, a fragment of the Wnt-1 receptor, DFrizzled2, enters postsynaptic nuclei where it forms prominent foci. Here we show that these foci constitute large RNP granules harboring synaptic protein transcripts. These granules exit the nucleus by budding through the inner and the outer nuclear membranes in a nuclear egress mechanism akin to that of herpes viruses. This budding involves phosphorylation of A-type lamin, a protein linked to muscular dystrophies. Thus nuclear envelope budding is an endogenous nuclear export pathway for large RNP granules.	[Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA & Neuro Therapeut Inst,Dept Biochem & Mol Ph, Worcester, MA 01605 USA; [Speese, Sean D.; Ashley, James; Jokhi, Vahbiz; Nunnari, John; Barria, Romina; Li, Yihang; Ataman, Bulent; Koon, Alex; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Chang, Young-Tae] A STAR Biopolis, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore 117543, Singapore; [Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Chang, Young-Tae] Natl Univ Singapore, Med Chem Program, Singapore 117543, Singapore; [Li, Qian] NYU, Dept Chem, New York, NY 10003 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; New York University	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA & Neuro Therapeut Inst,Dept Biochem & Mol Ph, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu; vivian.budnik@umassmed.edu	Chang, Young-Tae/B-2780-2010	Chang, Young-Tae/0000-0002-1927-3688; Speese, Sean/0000-0002-3965-9828; Koon, Alex/0000-0002-4274-7052; Ashley, James/0000-0002-6693-1014	NRSA; NIH [RO1NS063228]; DERC [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063228] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Thoru Pederson and Jeanne Lawrence for helpful advice and discussions. We also thank Dr. Kate Koles and Ms. Yuly Fuentes-Medel for support in some of the molecular studies, as well as Stefanie Kaech Petrie and Aurelie Snyder of the Jungers Center Advance Microscopy Core for help with structured illumination images. Finally, we are grateful to the UMassMed Electron Microscopy Facility for support on ultrastructural studies, and Aaron DiAntonio, Martine Simonelig, and Lori Wallrath for reagent sharing. This work was supported by an NRSA to S. D. S., NIH grant RO1NS063228 to V. B., and core resources from DERC grant DK32520. M.J.M. is a HHMI investigator. S. D. S. designed and conducted many of the experiments and contributed intellectually to the project and manuscript writing. J.A. conducted FISH, live imaging, and contributed intellectually to the project and manuscript editing. J.N. conducted EM. R. B. and Y.L. provided technical support. V.J. performed experiments related to aPKC, and contributed to experimental design. B. A. was the first to discover that nuclear DFz2C foci where localized at LamC foci, and that synaptic activity regulated the number of LamC foci in conjunction with DFz2C foci. A. K. contributed to live imaging. Y.-T.C. and Q. L. supplied the E36 dye. M.J.M. provided intellectual input, contributed to experimental design, and collaborated in writing the manuscript. V. B. directed the project and contributed to experimental design, discussions, and manuscript writing.	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; DARLINGTON RW, 1968, J VIROL, V2, P48, DOI 10.1128/JVI.2.1.48-55.1968; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DICKINSON H G, 1971, Grana, V11, P117; GAY H, 1956, COLD SPRING HARB SYM, V21, P257, DOI 10.1101/SQB.1956.021.01.021; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; HAAS M, 1993, EUR J CELL BIOL, V62, P237; HADEK R, 1962, J CELL BIOL, V13, P445, DOI 10.1083/jcb.13.3.445; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Li Q, 2006, CHEM BIOL, V13, P615, DOI 10.1016/j.chembiol.2006.04.007; Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Maric M, 2011, J VIROL, V85, P9667, DOI 10.1128/JVI.05314-11; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; MONNERON A, 1969, J ULTRA MOL STRUCT R, V27, P266, DOI 10.1016/S0022-5320(69)80017-1; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Ostlund C, 2001, J CELL SCI, V114, P4435; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Richard J. Roller, 2008, [Virologica Sinica, 中国病毒学], V23, P406, DOI 10.1007/s12250-008-3004-1; Robottom Bradley J, 2011, Handb Clin Neurol, V100, P465, DOI 10.1016/B978-0-444-52014-2.00036-7; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Schulze SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007564; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; SZOLLOSI D, 1965, J CELL BIOL, V25, P545, DOI 10.1083/jcb.25.3.545; SZOLLOSI MS, 1988, J CELL SCI, V91, P257; Tam R., 2002, FISH PRACTICAL APPRO, P93; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; Yamashita S, 2009, J ELECTRON MICROSC, V58, P267, DOI 10.1093/jmicro/dfp017; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	66	238	243	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					832	846		10.1016/j.cell.2012.03.032	http://dx.doi.org/10.1016/j.cell.2012.03.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579286	Bronze, Green Accepted			2022-12-28	WOS:000303934700016
J	Nam, KH; Park, IH; Ko, SH				Nam, Koo Hyun; Park, Il H.; Ko, Seung Hwan			Patterning by controlled cracking	NATURE			English	Article							QUENCHED GLASS PLATES; MATERIALS SCIENCE; FRACTURE; INSTABILITIES; TRIMATERIAL; INTERFACE; CERAMICS; BREAK	Crack formation drives material failure and is often regarded as a process to be avoided(1-3). However, closer examination of cracking phenomena has revealed exquisitely intricate patterns such as spirals(4), oscillating(5,6,7) and branched(7) fracture paths and fractal geometries(8). Here we demonstrate the controlled initiation, propagation and termination of a variety of channelled crack patterns in a film/substrate system(9-11) comprising a silicon nitride thin film deposited on a silicon substrate using low-pressure chemical vapour deposition. Micro-notches etched into the silicon substrate concentrated stress for crack initiation, which occurred spontaneously during deposition of the silicon nitride layer. We reproducibly created three distinct crack morphologies-straight, oscillatory and orderly bifurcated (stitchlike)-through careful selection of processing conditions and parameters. We induced direction changes by changing the system parameters, and we terminated propagation at preformed multi-step crack stops. We believe that our patterning technique presents new opportunities in nanofabrication and offers a starting point for atomic-scale pattern formation(12), which would be difficult even with current state-of-the-art nanofabrication methodologies.	[Nam, Koo Hyun; Park, Il H.] Ewha Womans Univ, Dept Phys, Res Ctr MEMS Space Telescope, Seoul 120750, South Korea; [Ko, Seung Hwan] Korea Adv Inst Sci & Technol, Dept Mech Engn, Appl Nano Technol & Sci Lab, Taejon 305701, South Korea	Ewha Womans University; Korea Advanced Institute of Science & Technology (KAIST)	Nam, KH (corresponding author), Ewha Womans Univ, Dept Phys, Res Ctr MEMS Space Telescope, Daehyun Dong 11-1, Seoul 120750, South Korea.	koonam@namk.org; maxko@kaist.ac.kr	Ko, Seung Hwan/B-5448-2008; Ko, Seung Hwan/B-5448-2008	Ko, Seung Hwan/0000-0002-7477-0820; Ko, Seung Hwan/0000-0001-5614-4773; Nam, Koo Hyun/0000-0001-8069-7968	Creative Research Initiatives (Research Center of MEMS Space Telescope) of MEST/NRF	Creative Research Initiatives (Research Center of MEMS Space Telescope) of MEST/NRF	This research was supported by Creative Research Initiatives (Research Center of MEMS Space Telescope) of MEST/NRF. We thank Y.Y. Earmme at KAIST for discussions and J. Yeo, Y. D. Suh, S. Hong, P. Lee, Y. Rho and J.-A. Jeon for technical assistance with fabrications and experiments.	Ball P., 2009, NATURES PATTERNS TAP; BEUTH JL, 1992, INT J SOLIDS STRUCT, V29, P1657, DOI 10.1016/0020-7683(92)90015-L; Bouchbinder E, 2010, ANNU REV CONDEN MA P, V1, P371, DOI 10.1146/annurev-conmatphys-070909-104019; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Choi ST, 2002, INT J SOLIDS STRUCT, V39, P943, DOI 10.1016/S0020-7683(01)00230-X; Choi ST, 2002, INT J SOLIDS STRUCT, V39, P1199, DOI 10.1016/S0020-7683(01)00231-1; Clegg WJ, 1999, SCIENCE, V286, P1097, DOI 10.1126/science.286.5442.1097; COTTERELL B, 1980, INT J FRACTURE, V16, P155, DOI 10.1007/BF00012619; Deegan RD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.014304; Deegan RD, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066209; EIE, 2020, ENG IS ELEMENTARY; FABER KT, 1983, ACTA METALL MATER, V31, P565, DOI 10.1016/0001-6160(83)90046-9; Green DJ, 1999, SCIENCE, V283, P1295, DOI 10.1126/science.283.5406.1295; He MY, 1989, J APPL MECH-T ASME, V56, P270, DOI 10.1115/1.3176078; Hellemans A, 1998, SCIENCE, V281, P943, DOI 10.1126/science.281.5379.943; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63, DOI 10.1016/s0065-2156(08)70164-9; KOBEDA E, 1987, J VAC SCI TECHNOL B, V5, P15, DOI 10.1116/1.583853; Leung KT, 2001, NATURE, V410, P166, DOI 10.1038/35065517; Livne A, 2010, SCIENCE, V327, P1359, DOI 10.1126/science.1180476; MARDER M, 1993, NATURE, V362, P295, DOI 10.1038/362295a0; Marder M, 1996, PHYS TODAY, V49, P24, DOI 10.1063/1.881515; Nam SW, 2010, NANO LETT, V10, P3324, DOI 10.1021/nl100999e; Rao MP, 1999, SCIENCE, V286, P102, DOI 10.1126/science.286.5437.102; SHARON E, 1995, PHYS REV LETT, V74, P5096, DOI 10.1103/PhysRevLett.74.5096; SKJELTORP AT, 1988, NATURE, V335, P424, DOI 10.1038/335424a0; Son Y, 2011, ADV MATER, V23, P3176, DOI 10.1002/adma.201100717; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; YE T, 1992, INT J SOLIDS STRUCT, V29, P2639, DOI 10.1016/0020-7683(92)90227-K; YUSE A, 1993, NATURE, V362, P329, DOI 10.1038/362329a0; Yuse A, 1997, PHYSICA D, V108, P365, DOI 10.1016/S0167-2789(97)00011-0	30	186	193	9	276	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					221	224		10.1038/nature11002	http://dx.doi.org/10.1038/nature11002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575963				2022-12-28	WOS:000303799800037
J	Sinha, IP; Stickland, A; Mathews, C				Sinha, Ian P.; Stickland, Anna; Mathews, Cheri			10-MINUTE CONSULTATION A child with neck swelling	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinha, Ian P.] Univ Liverpool, Alder Hey Childrens Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L12 2AP, Merseyside, England; [Stickland, Anna] Univ Liverpool, Community Studies Unit, Liverpool L69 3GE, Merseyside, England; [Mathews, Cheri] St Helens & Knowsley Teaching Hosp NHS Trust, Dept Paediat, Liverpool L35 5DR, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; University of Liverpool	Sinha, IP (corresponding author), Univ Liverpool, Alder Hey Childrens Hosp, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L12 2AP, Merseyside, England.	iansinha79@doctors.org.uk						Choby BA, 2009, AM FAM PHYSICIAN, V79, P383; Davenport M, 1996, BRIT MED J, V312, P368; NHS Clinical Knowledge Summaries, NECK LUMP MAN; Patient.co.uk, NECK LUMPS BUMPS	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3171	10.1136/bmj.e3171	http://dx.doi.org/10.1136/bmj.e3171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WY	22569864				2022-12-28	WOS:000304083400005
J	Prochaska, JJ; Hilton, JF				Prochaska, Judith J.; Hilton, Joan F.			Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; PLACEBO-CONTROLLED TRIAL; SMOKING-CESSATION; DOUBLE-BLIND; SMOKELESS TOBACCO; EFFICACY; SMOKERS; SAFETY; DEPENDENCE	Objective To examine the risk of treatment emergent, cardiovascular serious adverse events associated with varenicline use for tobacco cessation. Design Meta-analysis comparing study effects using four summary estimates. Data sources Medline, Cochrane Library, online clinical trials registries, and reference lists of identified articles. Review methods We included randomised controlled trials of current tobacco users of adult age comparing use of varenicline with an inactive control and reporting adverse events. We defined treatment emergent, cardiovascular serious adverse events as occurring during drug treatment or within 30 days of discontinuation, and included any ischaemic or arrhythmic adverse cardiovascular event (myocardial infarction, unstable angina, coronary revascularisation, coronary artery disease, arrhythmias, transient ischaemic attacks, stroke, sudden death or cardiovascular related death, or congestive heart failure). Results We identified 22 trials; all were double blinded and placebo controlled; two included participants with active cardiovascular disease and 11 enrolled participants with a history of cardiovascular disease. Rates of treatment emergent, cardiovascular serious adverse events were 0.63% (34/5431) in the varenicline groups and 0.47% (18/3801) in the placebo groups. The summary estimate for the risk difference, 0.27% (95% confidence interval -0.10 to 0.63; P=0.15), based on all 22 trials, was neither clinically nor statistically significant. For comparison, the relative risk (1.40, 0.82 to 2.39; P=0.22), Mantel-Haenszel odds ratio (1.41, 0.82 to 2.42; P=0.22), and Peto odds ratio (1.58, 0.90 to 2.76; P=0.11), all based on 14 trials with at least one event, also indicated a non-significant difference between varenicline and placebo groups. Conclusions This meta-analysis-which included all trials published to date, focused on events occurring during drug exposure, and analysed findings using four summary estimates-found no significant increase in cardiovascular serious adverse events associated with varenicline use. For rare outcomes, summary estimates based on absolute effects are recommended and estimates based on the Peto odds ratio should be avoided.	[Prochaska, Judith J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Prochaska, Judith J.] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prochaska, JJ (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	JProchaska@ucsf.edu	Prochaska, Judith J/I-4510-2013	Prochaska, Judith J/0000-0001-7925-326X	National Institute on Drug Abuse [P50 DA09253, R34 DA030538]; State of California Tobacco [17RT-0077]; National Institute of Mental Health [MH083684]; Pfizer [WS981308]; Flight Attendant Medical Research Institute; National Institutes of Health; Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R34DA030538, P50DA009253] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); State of California Tobacco; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pfizer(Pfizer); Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JJP is funded by the National Institute on Drug Abuse (P50 DA09253) and the State of California Tobacco-Related Disease Research Program (17RT-0077) for the submitted work. The funding agencies had no role in the conduct of the research or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this study received support from the National Institute on Drug Abuse and the State of California Tobacco-Related Disease Research Program; JJP is principal investigator on R01 MH083684 from the National Institute of Mental Health and an Investigator Initiated Research award from Pfizer (WS981308), and is a collaborator on R34 DA030538 from the National Institute on Drug Abuse and a Cahan Award from the Flight Attendant Medical Research Institute, all of which are tobacco control trials; JFH is coinvestigator on five randomised controlled trials funded by the National Institutes of Health and the Agency for Healthcare Research and Quality, none of which are relevant to the submitted work; JFH has had no relationship with any company that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Barth J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006886; Bolliger CT, 2011, CLIN THER, V33, P465, DOI 10.1016/j.clinthera.2011.04.013; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Cahill K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub5; Critchley J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003041.PUB2, 10.1002/14651858.CD003041.pub2]; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ebbert JO, 2011, NICOTINE TOB RES, V13, P820, DOI 10.1093/ntr/ntr078; European Medicines Agency, 2011, EUR MED AG CONF POS; Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Food and Drug Administration, 2011, FDA DRUG SAF COMM CH; Foulds J, 2006, INT J CLIN PRACT, V60, P571, DOI 10.1111/j.1368-5031.2006.00955.x; Garza D, 2011, BIOL PSYCHIAT, V69, P1075, DOI 10.1016/j.biopsych.2010.12.005; Gerber Y, 2009, J AM COLL CARDIOL, V54, P2382, DOI 10.1016/j.jacc.2009.09.020; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; GREENLAND S, 1990, STAT MED, V9, P247, DOI 10.1002/sim.4780090307; Hays JT, 2011, CAN MED ASSOC J, V183, P1346, DOI 10.1503/cmaj.110804; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hong LE, 2011, ARCH GEN PSYCHIAT, V68, P1195, DOI 10.1001/archgenpsychiatry.2011.83; Hughes JR, 2011, NICOTINE TOB RES, V13, P955, DOI 10.1093/ntr/ntr103; Hutton JL, 2009, BRIT J HAEMATOL, V146, P27, DOI 10.1111/j.1365-2141.2009.07707.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; Niaura R, 2008, CURR MED RES OPIN, V24, P1931, DOI [10.1185/03007990802177523, 10.1185/03007990802177523 ]; Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561; Oncken C, 2006, ARCH INTERN MED, V166, P1571, DOI 10.1001/archinte.166.15.1571; Orexigen Therapeutics, 2010, OREXIGEN THERAPEUTIC; Pfizer, 2011, SMOK CESS STUD PAT S; Poling J, 2010, AM J ADDICTION, V19, P401, DOI 10.1111/j.1521-0391.2010.00066.x; Rennard S, 2012, NICOTINE TOB RES, V14, P343, DOI 10.1093/ntr/ntr220; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Samuels L, 2011, CAN MED ASSOC J, V183, DOI 10.1503/cmaj.111-2073; Singh S, 2011, CAN MED ASSOC J, V183, P1359, DOI 10.1503/cmaj.110218; Squire EN, 2011, CAN MED ASSOC J, V183, P1404, DOI 10.1503/cmaj.111-2070; Steinberg MB, 2011, ADDICT BEHAV, V36, P1127, DOI 10.1016/j.addbeh.2011.07.002; Takagi H, 2011, CAN MED ASSOC J, V183, P1404, DOI 10.1503/cmaj.111-2063; Tashkin DP, 2011, CHEST, V139, P591, DOI 10.1378/chest.10-0865; Tobacco Use and Dependence Guideline Pane, 2008, TREAT TOB US DEP 200; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Tsai ST, 2007, CLIN THER, V29, P1027, DOI 10.1016/j.clinthera.2007.06.011; Vandermeer B, 2009, STAT METHODS MED RES, V18, P421, DOI 10.1177/0962280208092559; Wang C, 2009, RESPIROLOGY, V14, P384, DOI 10.1111/j.1440-1843.2008.01476.x; Williams KE, 2007, CURR MED RES OPIN, V23, P793, DOI 10.1185/030079907X182185; Wilson D, 2011, NY TIMES        0705; Woods DJ, 2011, CAN MED ASSOC J, V183, P1404, DOI 10.1503/cmaj.111-2064	53	134	139	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2012	344								e2856	10.1136/bmj.e2856	http://dx.doi.org/10.1136/bmj.e2856			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NN	22563098	hybrid, Green Published			2022-12-28	WOS:000303818500002
J	Azzopardi, L; Quirk, J				Azzopardi, Laura; Quirk, Jennifer			An acquired source of seizures	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEUROCYSTICERCOSIS; DIAGNOSIS		[Azzopardi, Laura; Quirk, Jennifer] S London Healthcare NHS Trust, Princess Royal Univ Hosp, Dept Med, Orpington BR6 8ND, England		Azzopardi, L (corresponding author), S London Healthcare NHS Trust, Princess Royal Univ Hosp, Dept Med, Orpington BR6 8ND, England.	laura.azzopardi@doctors.org.uk						Aicardi J., 2008, EPILEPSY COMPREHENSI; Carpio A, 1996, EPLIEPSIA, V37, P19; Coyle CM, 2009, INTERDISCIP PERSPECT; DELBRUTTO OH, 1992, NEUROLOGY, V42, P389, DOI 10.1212/WNL.42.2.389; Garcia HH, 2005, AM J TROP MED HYG, V72, P3, DOI 10.4269/ajtmh.2005.72.3; Garcia HH, 2004, NEW ENGL J MED, V350, P249, DOI 10.1056/NEJMoa031294; Proano-Narvaez JV, 2002, J CLIN MICROBIOL, V40, P2115, DOI 10.1128/JCM.40.6.2115-2118.2002	7	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e2991	10.1136/bmj.e2991	http://dx.doi.org/10.1136/bmj.e2991			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NG	22556049				2022-12-28	WOS:000303817700009
J	Libman, H; Trivedi, NS				Libman, Howard; Trivedi, Neha S.			Update: A 60-Year-Old Woman With Mild Memory Impairment Review of Mild Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Ellison JM, 2008, JAMA-J AM MED ASSOC, V300, P1566, DOI 10.1001/jama.300.9.jrr80008	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1858	1858		10.1001/jama.2012.3464	http://dx.doi.org/10.1001/jama.2012.3464			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550200				2022-12-28	WOS:000303386800025
J	de Boer, IH; Levin, G; Robinson-Cohen, C; Biggs, ML; Hoofnagle, AN; Siscovick, DS; Kestenbaum, B				de Boer, Ian H.; Levin, Gregory; Robinson-Cohen, Cassianne; Biggs, Mary L.; Hoofnagle, Andy N.; Siscovick, David S.; Kestenbaum, Bryan			Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							VITAMIN-D DEFICIENCY; SEASONAL-VARIATION; TIME; AGE	Background: Circulating concentrations of 25-hydroxyvitamin D [25-(OH)D] are used to define vitamin D deficiency. Current clinical 25-(OH)D targets based on associations with intermediate markers of bone metabolism may not reflect optimal levels for other chronic diseases and do not account for known seasonal variation in 25(OH)D concentration. Objective: To evaluate the relationship of 25-(OH)D concentration with the incidence of major clinical disease events that are pathophysiologically relevant to vitamin D. Design: Cohort study. Setting: The Cardiovascular Health Study conducted in 4 U. S. communities. Data from 1992 to 2006 were included in this analysis. Participants: 1621 white older adults. Measurements: Serum 25-(OH)D concentration (using a high-performance liquid chromatography-tandem mass spectrometry assay that conforms to National Institute of Standards and Technology reference standards)and associations with time to a composite outcome of incident hip fracture, myocardial infarction, cancer, or death. Results: Over a median 11-year follow-up, the composite outcome occurred in 1018 participants (63%). Defining events included 137hip fractures, 186 myocardial infarctions, 335 incidences of cancer, and 360 deaths. The association of low 25-(OH)D concentration with risk for the composite outcome varied by season (P = 0.057). A concentration lower than a season-specific Z score of -0.54 best discriminated risk for the composite outcome and was associated with a 24% higher risk in adjusted analyses (95% CI, 9% to 42%). Corresponding season-specific 25-(OH) D concentrations were 43, 50, 61, and 55 nmol/L (17, 20, 24, and 22 ng/mL) in winter, spring, summer, and autumn, respectively. Limitation: The observational study was restricted to white participants. Conclusion: Threshold concentrations of 25-(OH) D associated with increased risk for relevant clinical disease events center near 50 nmol/L (20 ng/mL). Season-specific targets for 25-(OH) D concentration may be more appropriate than static targets when evaluating health risk.	[de Boer, Ian H.; Levin, Gregory; Robinson-Cohen, Cassianne; Biggs, Mary L.; Hoofnagle, Andy N.; Siscovick, David S.; Kestenbaum, Bryan] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Box 359606,325 9th Ave, Seattle, WA 98104 USA.	deboer@u.washington.edu	de Boer, Ian/GYJ-3282-2022; Robinson-Cohen, Cassianne/ABB-4985-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046	National Heart, Lung, and Blood Institute [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295, R01HL084443, R01HL096875]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK088762]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085081, N01HC015103, N01HC075150, N01HC055222, N01HC085083, N01HC085082, N01HC045133, N01HC085084, N01HC085085, N01HC085080, N01HC085079, N01HC085086, N01HC035129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295, R01HL096875, R01HL084443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928, R56AG023629, R56AG020098, R01AG027058, R01AG023629, R01AG020098] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Heart, Lung, and Blood Institute (contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grant HL080295), with additional contribution from the National Institute of Neurologic Disorders and Stroke. Additional support was provided by the National Institute on Aging (AG-023629, AG-15928, AG-20098, and AG-027058); the National Heart, Lung, and Blood Institute (grants R01HL084443 and R01HL096875); and the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01DK088762). A full list of principal CHS investigators and institutions can be found at www.chs-nhlbi.org/pi.htm.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Chen C, 2005, CANCER, V103, P76, DOI 10.1002/cncr.20727; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Dawson-Hughes B, 2010, Osteoporos Int, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Efron B., 1994, INTRO BOOTSTRAP; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Therneau T, PACKAGE SURVIVAL ANA; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	34	79	82	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					627	U62		10.7326/0003-4819-156-9-201205010-00004	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547472				2022-12-28	WOS:000303403700003
J	Chin, JW				Chin, Jason W.			Reprogramming the Genetic Code	SCIENCE			English	Editorial Material							AMINO-ACIDS; DE-NOVO; RIBOSOME; MUTAGENESIS; GENOME		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	chin@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105181009] Funding Source: Medline; MRC [MC_U105181009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; FAHNESTOCK S, 1971, SCIENCE, V173, P340, DOI 10.1126/science.173.3994.340; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.bb.24.060195.002251; Morimoto J, 2011, ACCOUNTS CHEM RES, V44, P1359, DOI 10.1021/ar2000953; Neumann H, 2010, J AM CHEM SOC, V132, P2142, DOI 10.1021/ja9068722; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Wang KH, 2012, ANGEW CHEM INT EDIT, V51, P2288, DOI 10.1002/anie.201105016; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	18	36	38	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					428	429		10.1126/science.1221761	http://dx.doi.org/10.1126/science.1221761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539711				2022-12-28	WOS:000303233400035
J	Denef, VJ; Banfield, JF				Denef, Vincent J.; Banfield, Jillian F.			In Situ Evolutionary Rate Measurements Show Ecological Success of Recently Emerged Bacterial Hybrids	SCIENCE			English	Article							ESCHERICHIA-COLI; DYNAMICS; ENVIRONMENT; ADAPTATION; COMMUNITIES; BIOFILMS; GENOMES	Few data are available on how quickly free-living microorganisms evolve. We analyzed biofilms collected from a well-defined acid mine drainage system over 9 years to investigate the processes and determine rates of bacterial evolution directly in the environment. Population metagenomic analyses of the dominant primary producer yielded the nucleotide substitution rate, which we used to show that proliferation of a series of recombinant bacterial strains occurred over the past few decades. The ecological success of hybrid bacterial types highlights the role of evolutionary processes in rapid adaptation within natural microbial communities.	[Denef, Vincent J.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu		Banfield, Jill/0000-0001-8203-8771	Office of Biological and Environmental Research, U.S. Department of Energy [DE-FG02-05ER64134, DE-FG02-10ER64996]	Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE))	We thank T. W. Arman (president, Iron Mountain Mines Inc.) and R. Sugarek (U.S. Environmental Protection Agency) for site access; R. Carver and M. Jones for on-site assistance; R. Carver for Richmond Mine flow data; J. Sickles (U.S. EPA) for providing site history documentation; Banfield laboratory members for their contributions to sample collection; C. Miller, C. Sun, and B. Thomas (University of California, Berkeley) for assistance with next-generation sequencing data analysis; and C. Miller and K. Vogel (University of Arizona) and three anonymous reviewers for constructive criticism. Supported by the Office of Biological and Environmental Research, U.S. Department of Energy, through the Genomic Sciences (DE-FG02-05ER64134) and Carbon-Cycling (DE-FG02-10ER64996) programs. The authors declare no conflict of interest. All 454 and Illumina sequencing reads generated for this study have been deposited in the NCBI sequence reads archive (accession number SRA047370). The Leptospirillum group II C75 strain genome has been deposited at DDBJ/EMBL/GenBank under the Whole Genome Shotgun project accession number AIJM00000000. The version described in this paper, containing the assembled and annotated contigs, is the first version, AIJM01000000.	Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Buckley M., 2011, MICROBIAL EVOLUTION; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Denef VJ, 2009, ENVIRON MICROBIOL, V11, P313, DOI 10.1111/j.1462-2920.2008.01769.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	24	73	74	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					462	466		10.1126/science.1218389	http://dx.doi.org/10.1126/science.1218389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539719				2022-12-28	WOS:000303233400044
J	Kawamoto, S; Tran, TH; Maruya, M; Suzuki, K; Doi, Y; Tsutsui, Y; Kato, LM; Fagarasan, S				Kawamoto, Shimpei; Tran, Thinh H.; Maruya, Mikako; Suzuki, Keiichiro; Doi, Yasuko; Tsutsui, Yumi; Kato, Lucia M.; Fagarasan, Sidonia			The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut	SCIENCE			English	Article							HELPER T-CELLS; GERMINAL CENTER; GENERATION; AFFINITY; HYPERMUTATION; DYNAMICS; MUTATION; MICE	Immunoglobulin A (IgA) is essential to maintain the symbiotic balance between gut bacterial communities and the host immune system. Here we provide evidence that the inhibitory co-receptor programmed cell death-1 (PD-1) regulates the gut microbiota through appropriate selection of IgA plasma cell repertoires. PD-1 deficiency generates an excess number of T follicular helper (T-FH) cells with altered phenotypes, which results in dysregulated selection of IgA precursor cells in the germinal center of Peyer's patches. Consequently, the IgAs produced in PD-1-deficient mice have reduced bacteria-binding capacity, which causes alterations of microbial communities in the gut. Thus, PD-1 plays a critical role in regulation of antibody diversification required for the maintenance of intact mucosal barrier.	[Kawamoto, Shimpei; Tran, Thinh H.; Maruya, Mikako; Suzuki, Keiichiro; Doi, Yasuko; Tsutsui, Yumi; Kato, Lucia M.; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Tran, Thinh H.] Hanoi Med Univ, Dept Biochem, Hanoi, Vietnam; [Suzuki, Keiichiro] Kyoto Univ, AK Project, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Lucia M.] Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Hanoi Medical University; Kyoto University; Kyoto University	Fagarasan, S (corresponding author), RIKEN, Lab Mucosal Immun, Res Ctr Allergy & Immunol, 1-7-22 Tsurumi, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402	RIKEN; Special Postdoctoral Researchers Program	RIKEN; Special Postdoctoral Researchers Program	We thank T. Honjo, T. Okazaki, T. Okada, I. Taniuchi, O. Kanagawa, N. Minato, and S. Casola for inspiring discussions, suggestions, and critical comments; M. Miyajima and D. Sutherland for critically reading of the manuscript; and Y. Murahashi and T. Kaji for technical assistance. The data reported in this paper are tabulated in the main paper and the supplementary materials. Supported by Grants-in-Aid for Scientific Research in Priority Areas (S. F.) and by RIKEN President's Discretionary Fund (S. F.) and Special Postdoctoral Researchers Program (S.K.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mei HE, 2010, BLOOD, V116, P5181, DOI 10.1182/blood-2010-01-266536; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Yuvaraj S, 2009, J IMMUNOL, V183, P4871, DOI 10.4049/jimmunol.0901315	23	308	335	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					485	489		10.1126/science.1217718	http://dx.doi.org/10.1126/science.1217718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539724				2022-12-28	WOS:000303233400050
J	Pollock, AM; Macfarlane, A; Godden, S				Pollock, Allyson M.; Macfarlane, Alison; Godden, Sylvia			Dismantling the signposts to public health? NHS data under the Health and Social Care Act 2012	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FORMULA		[Pollock, Allyson M.; Godden, Sylvia] Univ London, Ctr Primary Care & Publ Hlth, London, England; [Macfarlane, Alison] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	University of London; City University London	Pollock, AM (corresponding author), Univ London, Ctr Primary Care & Publ Hlth, London, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				[Anonymous], 2010, DEP HLTH CONS PROP; Bevan G, 2009, FINANC ACCOUNT MANAG, V25, P391, DOI 10.1111/j.1468-0408.2009.00484.x; Department for Communities and Local Government, ENGL IND DEPR 2010; Department of Health, 2012, IMPR OUTC SUPP TRA 1; Department of Health, 2011, NHS OUTC FRAM 2012 1; Department of Health, 2010, TRANSP OUTC FRAM NHS; Department of Health, 2011, RISK ASS CONF DEV CL; Dixon J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6608; Edwards D, 2011, PROVIDING CANC INFOR; Farr W., 1839, 1 ANN REPORT REGISTR, ps; Finney N., 2009, CHALLENGING MYTHS RA; Galbraith J, 2011, J R STAT SOC A STAT, V174, P517, DOI 10.1111/j.1467-985X.2010.00700.x; Healthcare Commission, 2008, IND SECT TREATM CTR; Healthcare Commission, 2007, IND SECT TREATM CTR; House of Commons, 2011, HLTH SOC CAR BILL 20; Kerrison S, 2000, OFFICIAL HLTH STAT U; Lansley A, 2010, COMMUNICATION   1011; Mason A, 2010, J ROY SOC MED, V103, P322, DOI 10.1258/jrsm.2010.100044; NHS Connecting for Health, PERS DEM SERV; Office for National Statistics, 2011, MID YEAR NAT LOC AUT; Pollock A., 2012, HLTH SOCIAL CARE BIL; Pollock AM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1729; Pollock AM, 2012, LANCET, V379, P387, DOI 10.1016/S0140-6736(12)60119-6; Pollock AM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1695	24	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2012	344								e2364	10.1136/bmj.e2364	http://dx.doi.org/10.1136/bmj.e2364			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539174	Green Accepted			2022-12-28	WOS:000303433900003
J	Huang, YH; Tseng, SH				Huang, Yi-Hsun; Tseng, Sung-Huei			Corneal snowflakes	LANCET			English	Editorial Material									[Huang, Yi-Hsun; Tseng, Sung-Huei] Natl Cheng Kung Univ, Dept Ophthalmol, Coll Med & Hosp, Tainan, Taiwan	National Cheng Kung University	Tseng, SH (corresponding author), Natl Cheng Kung Univ, Dept Ophthalmol, Coll Med & Hosp, 138 Sheng Li Rd, Tainan, Taiwan.	shtseng1@gmail.com							0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2012	380	9840					506	506		10.1016/S0140-6736(12)60162-7	http://dx.doi.org/10.1016/S0140-6736(12)60162-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983GY	22569280				2022-12-28	WOS:000307109000032
J	Kamada, N; Kim, YG; Sham, HP; Vallance, BA; Puente, JL; Martens, EC; Nunez, G				Kamada, Nobuhiko; Kim, Yun-Gi; Sham, Ho Pan; Vallance, Bruce A.; Puente, Jose L.; Martens, Eric C.; Nunez, Gabriel			Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota	SCIENCE			English	Article							CITROBACTER-RODENTIUM; ENTEROCYTE EFFACEMENT; ESCHERICHIA-COLI; EFFACING PATHOGEN; INFECTION; LOCUS; CELLS; MODEL; MICE; LER	The virulence mechanisms that allow pathogens to colonize the intestine remain unclear. Here, we show that germ-free animals are unable to eradicate Citrobacter rodentium, a model for human infections with attaching and effacing bacteria. Early in infection, virulence genes were expressed and required for pathogen growth in conventionally raised mice but not germ-free mice. Virulence gene expression was down-regulated during the late phase of infection, which led to relocation of the pathogen to the intestinal lumen where it was outcompeted by commensals. The ability of commensals to outcompete C. rodentium was determined, at least in part, by the capacity of the pathogen and commensals to grow on structurally similar carbohydrates. Thus, pathogen colonization is controlled by bacterial virulence and through competition with metabolically related commensals.	[Kamada, Nobuhiko; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Kamada, Nobuhiko; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Sham, Ho Pan; Vallance, Bruce A.] Univ British Columbia, BC Childrens Hosp, Div Gastroenterol, Vancouver, BC V6H 3V4, Canada; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62210, Morelos, Mexico; [Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; BC Childrens Hospital; University of British Columbia; Universidad Nacional Autonoma de Mexico; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Kamada, Nobuhiko/AAW-3299-2020; Nuñez, Gabriel/A-7160-2014	Kamada, Nobuhiko/0000-0002-1980-4178; Vallance, Bruce/0000-0003-1345-6747; Puente, Jose/0000-0002-8411-4974	University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory; Center for Molecular Imaging; NIH [DK61707, DK091191]; Consejo Nacional de Ciencia y Tecnologia, CONACyT; Canadian Institutes of Health Research; Uehara Memorial Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK095782, R01DK061707] Funding Source: NIH RePORTER	University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory; Center for Molecular Imaging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory, and the Center for Molecular Imaging for support; S. Koonse for animal husbandry; A. Huerta-Saquero for constructing the pler-lux plasmid; N. Pudlo for anaerobic bacteria culture; T. Stappenbeck for mouse commensal strains; J. Rousseau for technical assistance; and M. H. Shaw and G. Chen for expert review of the manuscript. B. A. V. is the Canada Research Chair (Tier 2) in Pediatric Gastroenterology and the CH. I. L. D. Foundation Chair in Pediatric Inflammatory Bowel Disease Research. This work was supported by grants from the NIH, grants DK61707 and DK091191 (G.N.); Consejo Nacional de Ciencia y Tecnologia, CONACyT (J.L.P.); Canadian Institutes of Health Research (B. A. V.); and the Uehara Memorial Foundation and Crohn's and Colitis Foundation of America Fellowship Awards (N.K). N.K. and G.N. hold U. S. provisional patent application no. 61/616,707 regarding inhibition of LEE virulence as a potential therapeutic for infection with AE pathogens. The data reported in this paper are tabulated in the main paper and in the supplementary materials.	Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; COOPER HS, 1993, LAB INVEST, V69, P238; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Luperchio SA, 2000, J CLIN MICROBIOL, V38, P4343, DOI 10.1128/JCM.38.12.4343-4350.2000; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003	19	387	400	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1325	1329		10.1126/science.1222195	http://dx.doi.org/10.1126/science.1222195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582016	Green Accepted			2022-12-28	WOS:000304905300052
J	Breen, JO				Breen, James O.			Lost in Translation - Como se dice, "Patient Protection and Affordable Care Act"?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH REFORM		Univ N Carolina, Dept Family Med, Sch Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Breen, JO (corresponding author), Univ N Carolina, Dept Family Med, Sch Med, Chapel Hill, NC 27514 USA.							Association of American Medical Colleges, 2010, IMP HLTH CAR REF FUT; Cortez N, 2011, SOUTH CALIF LAW REV, V84, P859; Hulse C, 2009, NY TIMES        0909, pA26; Kirch DG, 2012, ANNU REV MED, V63, P435, DOI 10.1146/annurev-med-050310-134634; Zuckerman S, 2011, HEALTH AFFAIR, V30, P1997, DOI 10.1377/hlthaff.2011.0604	5	6	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2045	2047		10.1056/NEJMp1202039	http://dx.doi.org/10.1056/NEJMp1202039			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949YE	22591256				2022-12-28	WOS:000304613400001
J	Leung, CC; Yu, ITS; Chen, WH				Leung, Chi Chiu; Yu, Ignatius Tak Sun; Chen, Weihong			Silicosis	LANCET			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; CHRONIC INTERSTITIAL PNEUMONIA; IDIOPATHIC PULMONARY-FIBROSIS; LUNG-CANCER RISK; CRYSTALLINE SILICA; GOLD MINERS; OCCUPATIONAL-EXPOSURE; NALP3 INFLAMMASOME; UNITED-STATES; HONG-KONG	Silicosis is a fibrotic lung disease caused by inhalation of free crystalline silicon dioxide or silica. Occupational exposure to respirable crystalline silica dust particles occurs in many industries. Phagocytosis of crystalline silica in the lung causes lysosomal damage, activating the NALP3 inflammasome and triggering the inflammatory cascade with subsequent fibrosis. Impairment of lung function increases with disease progression, even after the patient is no longer exposed. Diagnosis of silicosis needs carefully documented records of occupational exposure and radiological features, with exclusion of other competing diagnoses. Mycobacterial diseases, airway obstruction, and lung cancer are associated with silica dust exposure. As yet, no curative treatment exists, but comprehensive management strategies help to improve quality of life and slow deterioration. Further efforts are needed for recognition and control of silica hazards, especially in developing countries.	[Leung, Chi Chiu] Dept Hlth, Ctr Hlth Protect, TB & Chest Serv, Hong Kong, Hong Kong, Peoples R China; [Yu, Ignatius Tak Sun] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Occupat & Environm Hlth, Hong Kong, Hong Kong, Peoples R China; [Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Hubei, Peoples R China; [Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm Hlth, Wuhan 430074, Hubei, Peoples R China	Chinese University of Hong Kong; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Leung, CC (corresponding author), Pneumoconiosis Clin, 4-F,8 Chai Wan Rd, Shaukeiwan, Hong Kong, Peoples R China.	cc_leung@dh.gov.hk	Chen, Weihong/D-2177-2011	Chen, Weihong/0000-0001-8689-7311				[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Akbar-Khanzadeh F, 2010, J OCCUP ENVIRON HYG, V7, P700, DOI 10.1080/15459624.2010.527552; ALDRICH TE, 1993, ANNU REV PUBL HEALTH, V14, P205; American Conference of Governmental Industrial Hygienists, 2009, 2009 TLVS BEIS; Arakawa H, 2008, AM J ROENTGENOL, V191, P1040, DOI 10.2214/AJR.07.3871; Arakawa H, 2007, CHEST, V131, P1870, DOI 10.1378/chest.06-2553; Arakawa H, 2009, EUR J RADIOL, V69, P80, DOI 10.1016/j.ejrad.2007.08.035; Bang KM, 2008, AM J IND MED, V51, P633, DOI 10.1002/ajim.20607; Basu S, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-11; Beamer CA, 2007, AM J RESP CELL MOL, V37, P729, DOI 10.1165/rcmb.2007-0099OC; Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Beckett W, 1997, AM J RESP CRIT CARE, V155, P761, DOI 10.1164/ajrccm.155.2.9032226; Bhagia Lakho J, 2008, Indian J Occup Environ Med, V12, P128, DOI 10.4103/0019-5278.44694; Brown T, 2009, OCCUP MED-OXFORD, V59, P89, DOI 10.1093/occmed/kqn171; BUECHNER HA, 1969, DIS CHEST, V55, P274, DOI 10.1378/chest.55.4.274; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Centers for Disease Control and Prevention, HIGH IMP SIL LUNG CA; Chen W, 2005, AM J IND MED, V48, P1, DOI 10.1002/ajim.20174; Chinese National Standard, 2007, OCC EXP LIM HAZ AG W; Chong S, 2006, RADIOGRAPHICS, V26, P59, DOI 10.1148/rg.261055070; Churchyard GJ, 2011, THORAX, V66, P134, DOI 10.1136/thx.2010.139048; Colinet JF, 2010, DHHS NIOSH PUBLICATI, V2010-110; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; Cowie RL, 1996, TUBERCLE LUNG DIS, V77, P239, DOI 10.1016/S0962-8479(96)90007-6; Crockett AJ, 2001, COCHRANE DB SYST REV, V3; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; DEE P, 1978, RADIOLOGY, V126, P359, DOI 10.1148/126.2.359; Denny JJ, 1937, CAN MED ASSOC J, V37, P1; Di Giuseppe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005689; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; Donroe JA, 2008, INT J OCCUP ENV HEAL, V14, P187, DOI 10.1179/oeh.2008.14.3.187; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ehrlich RI, 2011, OCCUP ENVIRON MED, V68, P96, DOI 10.1136/oem.2009.048827; Erren TC, 2009, INT ARCH OCC ENV HEA, V82, P997, DOI 10.1007/s00420-008-0387-0; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; Glazer CS, 2009, EUR RESPIR MONOGR, P265; GOODMAN GB, 1992, CHEST, V101, P366, DOI 10.1378/chest.101.2.366; Government of Hong Kong Department of Justice, 2008, PNEUM MES COMP ORD; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; GROSS BH, 1980, AM J ROENTGENOL, V135, P1265, DOI 10.2214/ajr.135.6.1265; Gulumian M, 2006, J TOXICOL ENV HEAL B, V9, P357, DOI 10.1080/15287390500196537; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hansell DM, 2010, IMAGING DIS CHEST, V5th, P463; Harris JS, 2003, PRACTICAL APPROACH O, P242; Harrison J, 2005, AM J IND MED, V48, P10, DOI 10.1002/ajim.20175; He Tao, 2007, CONSTRUCTION TECHNOL, V1, P1, DOI DOI 10.1002/9780471729259.MC0LC03S05; Hedlund U, 2008, ANN OCCUP HYG, V52, P3, DOI 10.1093/annhyg/mem057; Hessische Verwaltung fur Bodenmanagement und Geoinformation, 2004, HESS VERW BOD GEOINF; *HLTH SAF EX, PNEUM SIL; HNIZDO E, 1993, AM J IND MED, V24, P427, DOI 10.1002/ajim.4700240408; Holland A, 2008, COCHRANE DB SYST REV, V4; Honma K, 2004, HUM PATHOL, V35, P1515, DOI 10.1016/j.humpath.2004.09.008; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Idec-Sadkowska Iwona, 2006, Medycyna Pracy, V57, P271; *INT AG RES CANC, 1997, IARC MON EV CARC RIS, V68; International Labour Organization, 2000, GUID US ILO INT CLAS; Jalloul AS, 2007, ENV OCCUPATIONAL MED, V4th, P365; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KENNEDY M C, 1956, Br J Ind Med, V13, P85; Kromhout H, 2002, OCCUP ENVIRON MED, V59, P349, DOI 10.1136/oem.59.5.349; Kurihara N, 2004, IND HEALTH, V42, P303, DOI 10.2486/indhealth.42.303; Lacasse Y, 2005, SCAND J WORK ENV HEA, V31, P450, DOI 10.5271/sjweh.949; Lacasse Y, 2009, CANCER CAUSE CONTROL, V20, P925, DOI 10.1007/s10552-009-9296-0; Lahiri S, 2005, AM J IND MED, V48, P503, DOI 10.1002/ajim.20222; Lam B, 2009, LUNG CANCER, V64, P289, DOI 10.1016/j.lungcan.2008.09.016; Laney AS, 2011, CHEST, V140, P1574, DOI 10.1378/chest.11-0629; Law Y. W. S., 2001, Hong Kong Medical Journal, V7, P343; Leung CC, 2007, EUR RESPIR J, V29, P745, DOI 10.1183/09031936.00134706; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Leung CC, 2005, OCCUP MED-OXFORD, V55, P490, DOI 10.1093/occmed/kqi107; Leung CC, 2010, AM J RESP CRIT CARE, V182, P834, DOI 10.1164/rccm.200912-1875OC; Linch KD, 1998, AM J IND MED, V34, P547, DOI 10.1002/(SICI)1097-0274(199812)34:6<547::AID-AJIM2>3.0.CO;2-B; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Lopes Agnaldo José, 2008, J. bras. pneumol., V34, P264, DOI 10.1590/S1806-37132008000500004; Low SY, 2006, RESPIROLOGY, V11, P84, DOI 10.1111/j.1440-1843.2006.00789.x; Madl AK, 2008, J TOXICOL ENV HEAL B, V11, P548, DOI 10.1080/10937400801909135; Makol A, 2011, AM J IND MED, V54, P255, DOI 10.1002/ajim.20917; Marchiori E, 2007, AM J ROENTGENOL, V189, P1402, DOI 10.2214/AJR.07.2402; Mazurek JM, 2008, AM J IND MED, V51, P568, DOI 10.1002/ajim.20597; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; MONSO E, 1990, ARCH ENVIRON HEALTH, V45, P185, DOI 10.1080/00039896.1990.9936714; Mosiewicz J, 2004, ANN AGR ENV MED, V11, P279; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; NAGELSCHMIDT G, 1960, Br J Ind Med, V17, P247; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; *NAT TOX PROGR, 2005, REP CARC; National Institute for Occupational Safety and Health, 2003, NIOSH MAN AN METH NM; National Institute for Occupational Safety and Health, 2002, HLTH EFF OCC EXP RES; National Institute of Occupational Safety and Health, 2008, RESP PROT REC AIRB E; National Institute of Occupational Safety and Health, 1997, GUID WORK SAF SIL IT; Nelson G, 2010, ENVIRON HEALTH PERSP, V118, P421, DOI 10.1289/ehp.0900918; NG TP, 1987, J SOC OCCUP MED, V37, P62; Nonoyama ML, 2007, COCHRANE DB SYST REV, V2; NORBOO T, 1991, THORAX, V46, P341, DOI 10.1136/thx.46.5.341; Ooi GC, 2003, RADIOLOGY, V228, P816, DOI 10.1148/radiol.2283020557; OXMAN AD, 1993, AM REV RESPIR DIS, V148, P38, DOI 10.1164/ajrccm/148.1.38; Ozkan M, 2009, ANN NUCL MED, V23, P883, DOI 10.1007/s12149-009-0309-6; Ozmen CA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-17; Pacurari M, 2008, TOXICOLOGIST, V102, P61; Park HH, 2009, AM J IND MED, V52, P901, DOI 10.1002/ajim.20767; Pelucchi C, 2006, ANN ONCOL, V17, P1039, DOI 10.1093/annonc/mdj125; Raymond LW, 2006, J OCCUP ENVIRON MED, V48, P95, DOI 10.1097/01.jom.0000188277.15721.22; Rees D, 2007, INT J TUBERC LUNG D, V11, P474; Rosenman KD, 2003, AM J IND MED, V44, P141, DOI 10.1002/ajim.10243; Rosenman KD, 2010, J OCCUP ENVIRON MED, V52, P1173, DOI 10.1097/JOM.0b013e3181fc5e50; Rushton Lesley, 2007, Reviews on Environmental Health, V22, P255; Sa PM, 2010, IEEE ENG MED BIO, P398, DOI 10.1109/IEMBS.2010.5627284; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Carneiro APS, 2006, AM J IND MED, V49, P811, DOI 10.1002/ajim.20379; Schenker MB, 2009, ENVIRON HEALTH PERSP, V117, P988, DOI 10.1289/ehp.0800144; SEATON A, 1991, LANCET, V337, P341, DOI 10.1016/0140-6736(91)90956-P; SHARMA SK, 1991, AM REV RESPIR DIS, V143, P814, DOI 10.1164/ajrccm/143.4_Pt_1.814; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; Steenland K, 2001, CANCER CAUSE CONTROL, V12, P773, DOI 10.1023/A:1012214102061; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Sun JK, 2008, J OCCUP HEALTH, V50, P400, DOI 10.1539/joh.L8015; Sun Y, 2010, LIFE SCI, V87, P232, DOI 10.1016/j.lfs.2010.06.016; t Mannetje A, 2002, AM J IND MED, V42, P73, DOI 10.1002/ajim.10097; teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; Tse LA, 2007, AM J IND MED, V50, P876, DOI 10.1002/ajim.20510; Tsuda T, 1997, J OCCUP HEALTH, V39, P285, DOI 10.1539/joh.39.285; UK Government, PNEUM ETC WORK COMP; VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213; van Berlo D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-13; Verma DK, 2008, AM J IND MED, V51, P524, DOI 10.1002/ajim.20589; Wagner GR, 1996, SCREENING SURVEILLAN; WANG XR, 1995, IND HEALTH, V33, P163, DOI 10.2486/indhealth.33.163; WHO, 2000, SIL; WIESSNER JH, 1988, AM REV RESPIR DIS, V138, P445, DOI 10.1164/ajrccm/138.2.445; Wilt JL, 1996, J OCCUP ENVIRON MED, V38, P619, DOI 10.1097/00043764-199606000-00014; World Health Organization, 2007, GLOB OCC HLTH NETW N; Xiao GB, 2006, IND HEALTH, V44, P556, DOI 10.2486/indhealth.44.556; Zhang M, 2010, BIOMED ENVIRON SCI, V23, P121, DOI 10.1016/S0895-3988(10)60041-4	140	667	711	16	236	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					2008	2018		10.1016/S0140-6736(12)60235-9	http://dx.doi.org/10.1016/S0140-6736(12)60235-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22534002				2022-12-28	WOS:000304757700036
J	Bloomgren, G; Richman, S; Hotermans, C; Subramanyam, M; Goelz, S; Natarajan, A; Lee, S; Plavina, T; Scanlon, JV; Sandrock, A; Bozic, C				Bloomgren, Gary; Richman, Sandra; Hotermans, Christophe; Subramanyam, Meena; Goelz, Susan; Natarajan, Amy; Lee, Sophia; Plavina, Tatiana; Scanlon, James V.; Sandrock, Alfred; Bozic, Carmen			Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-SCLEROSIS; PREVALENCE	BACKGROUND Progressive multifocal leukoencephalopathy (PML) is associated with natalizumab treatment. We quantified the risk of PML in patients with multiple sclerosis, according to the presence or absence of three risk factors: positive status with respect to anti-JC virus antibodies, prior use of immunosuppressants, and increasing duration of natalizumab treatment. METHODS We used data from postmarketing sources, clinical studies, and an independent Swedish registry to estimate the incidence of PML among natalizumab-treated patients with multiple sclerosis, according to positive or negative status with respect to anti-JC virus antibodies, prior or no prior use of immunosuppressants, and duration of treatment (1 to 24 months vs. 25 to 48 months). Blood samples were available for anti-JC virus antibody testing from 5896 patients with multiple sclerosis and from 54 patients with multiple sclerosis who were treated with natalizumab and in whom PML later developed. RESULTS As of February 29, 2012, there were 212 confirmed cases of PML among 99,571 patients treated with natalizumab (2.1 cases per 1000 patients). All 54 patients with PML for whom samples were available before the diagnosis were positive for anti-JC virus antibodies. When the risk of PML was stratified according to three risk factors, the risk of PML was lowest among the patients who were negative for anti-JC virus antibodies, with the incidence estimated to be 0.09 cases or less per 1000 patients (95% confidence interval [CI], 0 to 0.48). Patients who were positive for anti-JC virus antibodies, had taken immunosuppressants before the initiation of natalizumab therapy, and had received 25 to 48 months of natalizumab treatment had the highest estimated risk (incidence, 11.1 cases per 1000 patients [95% CI, 8.3 to 14.5]). CONCLUSIONS Positive status with respect to anti-JC virus antibodies, prior use of immunosuppressants, and increased duration of natalizumab treatment, alone or in combination, were associated with distinct levels of PML risk in natalizumab-treated patients with multiple sclerosis.	[Bloomgren, Gary; Richman, Sandra; Hotermans, Christophe; Subramanyam, Meena; Goelz, Susan; Natarajan, Amy; Lee, Sophia; Plavina, Tatiana; Scanlon, James V.; Sandrock, Alfred; Bozic, Carmen] Biogen Idec Inc, Weston, MA USA	Biogen	Bloomgren, G (corresponding author), Biogen Idec Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	gary.bloomgren@biogenidec.com			Biogen Idec; Elan Pharmaceuticals	Biogen Idec(Biogen); Elan Pharmaceuticals	Funded by Biogen Idec and Elan Pharmaceuticals.	[Anonymous], 2012, TYS NAT; [Anonymous], 2011, SUMM PROD CHAR TYS N; Bozic C, 2011, MULT SCLER J, V17, pS355; Bozic C, 2011, ANN NEUROL, V70, P713, DOI 10.1002/ana.22606; Butzkueven H, 2011, MULT SCLER J, V17, pS519; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Gorelik L, 2010, MULT SCLER S10, V16, pS306; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Olsson T, 2011, MULT SCLER J, V17, pS134; Olsson T, 2010, MULT SCLER J S, V16, pS348; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Subramanyam M, 2010, MULT SCLER, V16, pS38; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Warnke C, 2011, NERVENARZT, V82, P1314, DOI 10.1007/s00115-011-3319-2; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	21	855	890	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1870	1880		10.1056/NEJMoa1107829	http://dx.doi.org/10.1056/NEJMoa1107829			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591293				2022-12-28	WOS:000304083000006
J	Friedman, RA				Friedman, Richard A.			Grief, Depression, and the DSM-5	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA	Cornell University	Friedman, RA (corresponding author), Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA.							Carey B., 2012, NEW YORK TIMES  0120, pA1; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Mojtabai R, 2011, ARCH GEN PSYCHIAT, V68, P920, DOI 10.1001/archgenpsychiatry.2011.95; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601	5	51	55	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1855	1857		10.1056/NEJMp1201794	http://dx.doi.org/10.1056/NEJMp1201794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WU	22591292	Bronze			2022-12-28	WOS:000304083000004
J	Golzio, C; Willer, J; Talkowski, ME; Oh, EC; Taniguchi, Y; Jacquemont, S; Reymond, A; Sun, M; Sawa, A; Gusella, JF; Kamiya, A; Beckmann, JS; Katsanis, N				Golzio, Christelle; Willer, Jason; Talkowski, Michael E.; Oh, Edwin C.; Taniguchi, Yu; Jacquemont, Sebastien; Reymond, Alexandre; Sun, Mei; Sawa, Akira; Gusella, James F.; Kamiya, Atsushi; Beckmann, Jacques S.; Katsanis, Nicholas			KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant	NATURE			English	Article							TOOTH DISEASE TYPE-1A; MICRODELETION SYNDROME; CHROMOSOME 16P11.2; SYNDROME REGION; AUTISM; GENE; SCHIZOPHRENIA; DUPLICATIONS; ASSOCIATION; DELETIONS	Copy number variants (CNVs) are major contributors to genetic disorders(1). We have dissected a region of the 16p11.2 chromosome-which encompasses 29 genes-that confers susceptibility to neurocognitive defects when deleted or duplicated(2,3). Overexpression of each human transcript in zebrafish embryos identified KCTD13 as the sole message capable of inducing the microcephaly phenotype associated with the 16p11.2 duplication(2-5), whereas suppression of the same locus yielded the macrocephalic phenotype associated with the 16p11.2 deletion(5,6), capturing the mirror phenotypes of humans. Analyses of zebrafish and mouse embryos suggest that microcephaly is caused by decreased proliferation of neuronal progenitors with concomitant increase in apoptosis in the developing brain, whereas macrocephaly arises by increased proliferation and no changes in apoptosis. A role for KCTD13 dosage changes is consistent with autism in both a recently reported family with a reduced 16p11.2 deletion and a subject reported here with a complex 16p11.2 rearrangement involving de novo structural alteration of KCTD13. Our data suggest that KCTD13 is a major driver for the neurodevelopmental phenotypes associated with the 16p11.2 CNV, reinforce the idea that one or a small number of transcripts within a CNV can underpin clinical phenotypes, and offer an efficient route to identifying dosage-sensitive loci.	[Golzio, Christelle; Willer, Jason; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Golzio, Christelle; Willer, Jason; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Talkowski, Michael E.; Sun, Mei; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Talkowski, Michael E.; Gusella, James F.] Harvard Univ, Sch Med, Dept Neurol & Genet, Boston, MA 02115 USA; [Taniguchi, Yu; Sawa, Akira; Kamiya, Atsushi] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Jacquemont, Sebastien; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA	Duke University; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Duke University	Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu	Jacquemont, Sebastien/AAS-5060-2021; Kutalik, Zoltan/HHZ-5697-2022; Katsanis, Nicholas/E-1837-2012; Beckmann, Jacques S/A-9772-2008; kamiya, atsushi/L-8550-2016	Jacquemont, Sebastien/0000-0001-6838-8767; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; kamiya, atsushi/0000-0002-4274-5567; Willer, Jason/0000-0002-5869-3992; Katsanis, Nicholas/0000-0002-2480-0171; Talkowski, Michael/0000-0003-2889-0992; Reymond, Alexandre/0000-0003-1030-8327; Golzio, Christelle/0000-0002-4420-3921	Silvo O. Conte center from the National Institute of Mental Health (NIMH), National Institutes of Health [MH-094268, MH-084018, MH-091230, HD06286]; Simon's Foundation; Autism Consortium of Boston; Leenaards Foundation; Swiss National Science Foundation; Swiss National Science Foundation Sinergia; NIMH National Research Service [F32MH087123]; bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, P50MH094268, R01MH091230, R01MH092443, F32MH087123] Funding Source: NIH RePORTER	Silvo O. Conte center from the National Institute of Mental Health (NIMH), National Institutes of Health; Simon's Foundation; Autism Consortium of Boston; Leenaards Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); NIMH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Hanscom for technical assistance. We also thank J. Black, J. Whetstine, K. Brown and C. Lee for assistance with the initial and confirmatory array CGH experiments, S. Santagelo for analysis of clinical phenotype data, and M. State, M. Daley and R. Gibbs for sharing unpublished exome sequencing data. This work was supported by a Silvo O. Conte center grant (MH-094268) from the National Institute of Mental Health (NIMH), National Institutes of Health grant MH-084018 (A. S., A. K. and N.K.), grant MH-091230 (A. K.), grant HD06286 (J. F. G.), the Simon's Foundation, the Autism Consortium of Boston (J. F. G.), the Leenaards Foundation Prize (S. J. and A. R.), the Swiss National Science Foundation (A. R. and J. S. B.), a Swiss National Science Foundation Sinergia grant (S. J., J. S. B. and A. R.). M. E. T. was supported by an NIMH National Research Service Award (F32MH087123). S. J. is a recipient of a bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne. N.K. is a Distinguished Brumley Professor.	Azizieh R, 2011, MOL NEUROBIOL, V44, P111, DOI 10.1007/s12035-011-8194-0; Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Crepel A, 2011, AM J MED GENET B, V156B, P243, DOI 10.1002/ajmg.b.31163; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; TAKEDA H, 1994, GENE DEV, V8, P45, DOI 10.1101/gad.8.1.45; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	31	266	274	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					363	U111		10.1038/nature11091	http://dx.doi.org/10.1038/nature11091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596160	Green Accepted, Green Submitted			2022-12-28	WOS:000304099100041
J	Ma, R				Ma, Richard			Discrimination against doctors with HIV must end	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ma, Richard] Village Practice, London, England; [Ma, Richard] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Ma, R (corresponding author), Village Practice, London, England.	richard.ma@btinternet.com	Ma, Richard/Z-6047-2019	Ma, Richard/0000-0001-6877-2785					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 16	2012	344								e3440	10.1136/bmj.e3440	http://dx.doi.org/10.1136/bmj.e3440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YO	22592852	Green Submitted			2022-12-28	WOS:000304087800011
J	Dentali, F				Dentali, Francesco			Enoxaparin plus idrabiotaparinux was noninferior to enoxaparin plus warfarin for recurrent VTE in acute PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VENOUS THROMBOEMBOLISM; IDRAPARINUX; THERAPY		Insubria Univ, Varese, Italy	University of Insubria	Dentali, F (corresponding author), Insubria Univ, Varese, Italy.							Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Harenberg J, 2009, THROMB HAEMOSTASIS, V102, P811, DOI 10.1160/TH09-08-0555; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-4	10.7326/0003-4819-156-10-201205150-02004	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586022				2022-12-28	WOS:000304193400003
J	Fan, VS; Gaziano, JM; Lew, R; Bourbeau, J; Adams, SG; Leatherman, S; Thwin, SS; Huang, GD; Robbins, R; Sriram, PS; Sharafkhaneh, A; Mador, MJ; Sarosi, G; Panos, RJ; Rastogi, P; Wagner, TH; Mazzuca, SA; Shannon, C; Colling, C; Liang, MH; Stoller, JK; Fiore, L; Niewoehner, DE				Fan, Vincent S.; Gaziano, J. Michael; Lew, Robert; Bourbeau, Jean; Adams, Sandra G.; Leatherman, Sarah; Thwin, Soe Soe; Huang, Grant D.; Robbins, Richard; Sriram, Peruvemba S.; Sharafkhaneh, Amir; Mador, M. Jeffery; Sarosi, George; Panos, Ralph J.; Rastogi, Padmashri; Wagner, Todd H.; Mazzuca, Steven A.; Shannon, Colleen; Colling, Cindy; Liang, Matthew H.; Stoller, James K.; Fiore, Louis; Niewoehner, Dennis E.			A Comprehensive Care Management Program to Prevent Chronic Obstructive Pulmonary Disease Hospitalizations A Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SELF-MANAGEMENT; ACUTE EXACERBATIONS; ACTION PLAN; COPD; HEALTH; METAANALYSIS; MORTALITY; DIAGNOSIS; EDUCATION; RECOVERY	Background: Improving a patient's ability to self-monitor and manage changes in chronic obstructive pulmonary disease (COPD) symptoms may improve outcomes. Objective: To determine the efficacy of a comprehensive care management program (CCMP) in reducing the risk for COPD hospitalization. Design: A randomized, controlled trial comparing CCMP with guideline-based usual care. (ClinicalTrials.gov registration number: NCT00395083) Setting: 20 Veterans Affairs hospital-based outpatient clinics. Participants: Patients hospitalized for COPD in the past year. Intervention: The CCMP included COPD education during 4 individual sessions and 1 group session, an action plan for identification and treatment of exacerbations, and scheduled proactive telephone calls for case management. Patients in both the intervention and usual care groups received a COPD informational booklet; their primary care providers received a copy of COPD guidelines and were advised to manage their patients according to these guidelines. Patients were randomly assigned, stratifying by site based on random, permuted blocks of variable size. Measurements: The primary outcome was time to first COPD hospitalization. Staff blinded to study group performed telephone-based assessment of COPD exacerbations and hospitalizations, and all hospitalizations were blindly adjudicated. Secondary outcomes included non-COPD health care use, all-cause mortality, health-related quality of life, patient satisfaction, disease knowledge, and self-efficacy. Results: Of the eligible patients, 209 were randomly assigned to the intervention group and 217 to the usual care group. Citing serious safety concerns, the data monitoring committee terminated the intervention before the trial's planned completion after 426 (44%) of the planned total of 960 patients were enrolled. Mean follow-up was 250 days. When the study was stopped, the 1-year cumulative incidence of COPD-related hospitalization was 27% in the intervention group and 24% in the usual care group (hazard ratio, 1.13 [95% CI, 0.70 to 1.80]; P = 0.62). There were 28 deaths from all causes in the intervention group versus 10 in the usual care group (hazard ratio, 3.00 [CI, 1.46 to 6.17]; P = 0.003). Cause could be assigned in 27 (71%) deaths. Deaths due to COPD accounted for the largest difference: 10 in the intervention group versus 3 in the usual care group (hazard ratio, 3.60 [CI, 0.99 to 13.08]; P = 0.053). Limitations: Available data could not fully explain the excess mortality in the intervention group. Ability to assess the quality of the educational sessions provided by the case managers was limited. Conclusion: A CCMP in patients with severe COPD had not decreased COPD-related hospitalizations when the trial was stopped prematurely. The CCMP was associated with unanticipated excess mortality, results that differ markedly from similar previous trials. A data monitoring committee should be considered in the design of clinical trials involving behavioral interventions.	[Fan, Vincent S.] Vet Affairs Puget Sound Hlth Care Syst, Hlth Serv Res & Dev Ctr Excellence, Seattle, WA 98108 USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Montreal Chest Inst, Montreal, PQ, Canada; S Texas Vet Hlth Care Syst, San Antonio, TX USA; Dept Vet Affairs Cooperat Studies Program, Washington, DC USA; Phoenix Vet Affairs Med Ctr, Phoenix, AZ USA; N Florida S Georgia Vet Hlth Syst, Gainesville, FL USA; Michael E DeBakey VA Med Ctr, Houston, TX USA; Vet Affairs Western New York Healthcare Syst, Buffalo, NY USA; Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; Dallas Vet Affairs Med Ctr, Dallas, TX USA; Vet Affairs Palo Alto Healthcare Syst, Menlo Pk, CA USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Indianapolis, IN USA; Vet Affairs Cooperat Studies Program Clin Res Pha, Albuquerque, NM USA; Minneapolis Vet Affairs Healthcare Syst, Minneapolis, MN USA; Cleveland Clin, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; McGill University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Cleveland Clinic Foundation	Fan, VS (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Hlth Serv Res & Dev Ctr Excellence, 1600 S Columbian Way, Seattle, WA 98108 USA.	vincent.fan@va.gov		Sriram, P.S/0000-0002-6103-3573; Wagner, Todd/0000-0001-7625-3504	Veterans Affairs Cooperative Study Program; Veterans Affairs Office of Research and Development [560]	Veterans Affairs Cooperative Study Program; Veterans Affairs Office of Research and Development	Veterans Affairs Cooperative Study Program.; By the Cooperative Studies Program (CSP #560), Veterans Affairs Office of Research and Development.	Adams SG, 2007, ARCH INTERN MED, V167, P551, DOI 10.1001/archinte.167.6.551; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bourbeau J, 2007, CLIN CHEST MED, V28, P617, DOI 10.1016/j.ccm.2007.06.002; Camargo CA, 2008, INTERN EMERG MED, V3, P355, DOI 10.1007/s11739-008-0197-0; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chandra D, 2009, COPD, V6, P95, DOI 10.1080/15412550902751746; Corson K, 2004, AM J MANAG CARE, V10, P839; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Gallefoss F, 2000, RESP MED, V94, P279, DOI 10.1053/rmed.1999.0749; Green L.W., 2005, HLTH PROGRAM PLANNIN, V4th; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hermiz O, 2002, BRIT MED J, V325, P938, DOI 10.1136/bmj.325.7370.938; Hilleman DE, 2000, CHEST, V118, P1278, DOI 10.1378/chest.118.5.1278; Jennison C, 2000, GROUP SEQUENTIAL MET; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; McGhan R, 2007, CHEST, V132, P1748, DOI 10.1378/chest.06-3018; Ofman JJ, 2004, AM J MED, V117, P182, DOI 10.1016/j.amjmed.2004.03.018; Peytremann-Bridevaux I, 2008, AM J MED, V121, P433, DOI 10.1016/j.amjmed.2008.02.009; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rea H, 2004, INTERN MED J, V34, P608, DOI 10.1111/j.1445-5994.2004.00672.x; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Sedeno MF, 2009, COPD, V6, P352, DOI 10.1080/15412550903150252; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Sullivan SD, 2000, CHEST, V117, P5; Taylor SJC, 2005, BMJ-BRIT MED J, V331, P485, DOI 10.1136/bmj.38512.664167.8F; The Management of COPD Working Group, 2007, VA DOD CLIN PRACT GU; TSIATIS AA, 1981, BIOMETRIKA, V68, P311, DOI 10.1093/biomet/68.1.311; Ware J., 2001, SF 36 PHYS MENTAL HL, P1994; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	43	256	262	1	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					673	U46		10.7326/0003-4819-156-10-201205150-00003	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586006				2022-12-28	WOS:000304193400013
J	Hawkes, C				Hawkes, Corinna			Food policies for healthy populations and healthy economies	BRITISH MEDICAL JOURNAL			English	Editorial Material							SOFT DRINKS; WORLDWIDE		City Univ London, Ctr Food Policy, London EC1V 0HB, England	City University London	Hawkes, C (corresponding author), City Univ London, Ctr Food Policy, London EC1V 0HB, England.	corinnahawkes@o2.co.uk						Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; FAO, 2002, BRAZ PROJ FOM ZER RE; FAO, 2011, STAT FOOD INS WORLD; Fulponi L, 2009, 14 OECD; Hawkes C, 2011, INT J PEDIATR OBES, V6, P83, DOI 10.3109/17477166.2010.486836; Hawkes C, 2010, WOODHEAD FOOD SERIES, V184; Hawkes C, 2012, FOOD POLICY, V37, P343, DOI 10.1016/j.foodpol.2012.02.011; Hawkes C, 2010, AM J PREV MED, V38, P457, DOI 10.1016/j.amepre.2010.01.011; International Food and Beverage Alliance, OUR COMM; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; NCD Alliance, 2011, PROP OUTC DOC UN HIG; Organization WH, 2016, GLOBAL STATUS REPORT; Rudd Center for Food Policy and Obesity, PLEDG FOOD MARK CHIL; Thow AM, 2011, HEALTH PROMOT INT, V26, P55, DOI 10.1093/heapro/daq057; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; WHO, DOC WHA65; World Bank, 2011, GROW DANG NONC DIS A; *WORLD BANK, WORLD DEV REP 2008 A; World Health Organization, 2011, 1 MIN C HLTH LIF NON	22	24	24	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e2801	10.1136/bmj.e2801	http://dx.doi.org/10.1136/bmj.e2801			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589521				2022-12-28	WOS:000304086900003
J	Lord, R; Flight, W; Sweeney, A; Chaudhry, N				Lord, Robert; Flight, William; Sweeney, Alan; Chaudhry, Nauman			PICTURE QUIZ A 64 year old woman with headache and breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENTILATION; KYPHOSCOLIOSIS; DISORDERS; SLEEP		[Lord, Robert; Flight, William; Sweeney, Alan; Chaudhry, Nauman] Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Lord, R (corresponding author), Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England.	roblord@doctors.net.uk	Lord, Robert/AAA-3618-2021	Lord, Robert/0000-0001-9008-2502				[Anonymous], 1999, CHEST, V116, P521; Baydur A, 2000, THORAX, V55, P4, DOI 10.1136/thorax.55.1.4; ELLIS ER, 1988, CHEST, V94, P811, DOI 10.1378/chest.94.4.811; Gonzalez C, 2003, CHEST, V124, P857, DOI 10.1378/chest.124.3.857; GUILLEMINAULT C, 1981, CHEST, V79, P626, DOI 10.1378/chest.79.6.626; Gustafson T, 2006, CHEST, V130, P1828, DOI 10.1378/chest.130.6.1828; KESTEN S, 1991, CHEST, V99, P663, DOI 10.1378/chest.99.3.663; Nauffal D, 2002, RESP MED, V96, P777, DOI 10.1053/rmed.2002.1347; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; SIMONDS AK, 1995, THORAX, V50, P604, DOI 10.1136/thx.50.6.604; Simonds AK, 2007, NONINVASIVE RESP SUP; Windisch W, 2008, EUR RESPIR MONOGR, P240	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e3158	10.1136/bmj.e3158	http://dx.doi.org/10.1136/bmj.e3158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942YF	22589502				2022-12-28	WOS:000304086900010
J	Stringer, C				Stringer, Chris			What makes a modern human	NATURE			English	Editorial Material							ADMIXTURE		Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Natural History Museum London	Stringer, C (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	c.stringer@nhm.ac.uk						Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; DAY MH, 1991, ANTHROPOLOGIE, V95, P573; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Jolly CJ, 2009, EVOL ANTHROPOL, V18, P275, DOI 10.1002/evan.20234; Kohn M., 1995, RACE GALLERY RETURN; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Stringer C., 2012, LONE SURVIVORS WE CA; Wolpoff MH, 1986, ANTHROPOS BRNO, V23, P41	9	41	43	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					33	35		10.1038/485033a	http://dx.doi.org/10.1038/485033a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	934NV	22552077	Bronze			2022-12-28	WOS:000303451900017
J	Yong, E				Yong, Ed			Trials at the ready: preparing for the next pandemic	BRITISH MEDICAL JOURNAL			English	Editorial Material												edyong209@gmail.com							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e2982	10.1136/bmj.e2982	http://dx.doi.org/10.1136/bmj.e2982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NG	22556048				2022-12-28	WOS:000303817700011
J	Holmes, D				Holmes, David			Profile Omar Ghannoum: an irresistible force for change	LANCET			English	Biographical-Item																		GHANNOUM O, PUBLICATION LIST	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1582	1582		10.1016/S0140-6736(12)60665-5	http://dx.doi.org/10.1016/S0140-6736(12)60665-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934OB	22541569				2022-12-28	WOS:000303452600018
J	Durack, PJ; Wijffels, SE; Matear, RJ				Durack, Paul J.; Wijffels, Susan E.; Matear, Richard J.			Ocean Salinities Reveal Strong Global Water Cycle Intensification During 1950 to 2000	SCIENCE			English	Article							HYDROLOGICAL CYCLE; PRECIPITATION; CLIMATE; ATMOSPHERE; TRENDS	Fundamental thermodynamics and climate models suggest that dry regions will become drier and wet regions will become wetter in response to warming. Efforts to detect this long-term response in sparse surface observations of rainfall and evaporation remain ambiguous. We show that ocean salinity patterns express an identifiable fingerprint of an intensifying water cycle. Our 50-year observed global surface salinity changes, combined with changes from global climate models, present robust evidence of an intensified global water cycle at a rate of 8 +/- 5% per degree of surface warming. This rate is double the response projected by current-generation climate models and suggests that a substantial (16 to 24%) intensification of the global water cycle will occur in a future 2 degrees to 3 degrees warmer world.	[Durack, Paul J.; Wijffels, Susan E.; Matear, Richard J.] CSIRO Marine & Atmospher Res, Ctr Australian Weather & Climate Res, Hobart, Tas 7001, Australia; [Durack, Paul J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Durack, Paul J.; Wijffels, Susan E.; Matear, Richard J.] CSIRO, Hobart, Tas 7001, Australia; [Durack, Paul J.] Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Durack, PJ (corresponding author), CSIRO Marine & Atmospher Res, Ctr Australian Weather & Climate Res, GPO Box 1538, Hobart, Tas 7001, Australia.	pauldurack@llnl.gov	matear, richard J/C-5133-2011; Durack, Paul James/A-8758-2010; Wijffels, Susan/I-8215-2012; Bindoff, Nathaniel L/C-8050-2011	matear, richard J/0000-0002-3225-0800; Durack, Paul James/0000-0003-2835-1438; Bindoff, Nathaniel L/0000-0001-5662-9519; Wijffels, Susan/0000-0002-4717-0811	Department of Climate Change and Energy Efficiency; Bureau of Meteorology; CSIRO; QMS-University of Tasmania; CSIRO's Wealth from Oceans Flagship; U.S. Department of Energy [DE-AC52-07NA27344]	Department of Climate Change and Energy Efficiency; Bureau of Meteorology(Bureau of Meteorology - Australia); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); QMS-University of Tasmania; CSIRO's Wealth from Oceans Flagship; U.S. Department of Energy(United States Department of Energy (DOE))	This work has been undertaken as part of the Australian Climate Change Science Program, funded jointly by the Department of Climate Change and Energy Efficiency, the Bureau of Meteorology, and CSIRO. P.J.D. was supported by a joint QMS-University of Tasmania Ph.D. scholarship in Quantitative Marine Science (QMS) with support from CSIRO's Wealth from Oceans Flagship. Work undertaken at Lawrence Livermore National Laboratory is supported by the U.S. Department of Energy under contract DE-AC52-07NA27344. We acknowledge the modeling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) and the WCRP's Working Group on Coupled Modelling (WGCM), for their roles in making available the WCRP CMIP3 multimodel data set. We thank numerous colleagues from CSIRO, the Centre for Australian Weather and Climate Research (CAWCR), and the University of Tasmania for valuable feedback and input into this project. CAWCR is a partnership between CSIRO and the Australian Bureau of Meteorology. We also thank J. Durack of the University of California at Berkeley, S. Griffies of the Geophysical Fluid Dynamics Laboratory (GFDL), and R. Colman of CAWCR for helpful comments with early drafts of this manuscript. We acknowledge J. Fasullo of the National Center for Atmospheric Research, R. Schmitt of Woods Hole Oceanographic Institution, and an anonymous third reviewer for their feedback, which strongly improved the manuscript. Observed salinity change data can be downloaded from the CSIRO Ocean Change Web site at www.cmar.csiro.au/oceanchange. P. J. D. conceived the study, completed the analysis, and shared responsibility for writing the manuscript. S. E. W. assisted in the analysis and shared responsibility for writing the manuscript. R. J. M. undertook the idealized model simulations. All authors contributed to the final version of the manuscript.	Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Arkin PA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/035201; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Boyer TP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021791; Chou C, 2009, J CLIMATE, V22, P1982, DOI 10.1175/2008JCLI2471.1; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; Dai A, 2009, J CLIMATE, V22, P2773, DOI 10.1175/2008JCLI2592.1; Durack P. J., 2011, B AM METEOROL SOC, V92, ps91; Durack PJ, 2010, J CLIMATE, V23, P4342, DOI 10.1175/2010JCLI3377.1; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Freeland H., 2010, EUROPEAN SPACE AGENC, V2; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Hosoda S, 2009, J OCEANOGR, V65, P579, DOI 10.1007/s10872-009-0049-1; Josey S. A., 1998, SOUTHAMPTON OCEANOGR; Lau KM, 2007, INT J CLIMATOL, V27, P979, DOI 10.1002/joc.1454; Lin JL, 2007, J CLIMATE, V20, P4497, DOI 10.1175/JCLI4272.1; Liu JP, 2011, J CLIMATE, V24, P1198, DOI 10.1175/2010JCLI3699.1; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Ming Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042895; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Schanze JJ, 2010, J MAR RES, V68, P569, DOI 10.1357/002224010794657164; Schmitt RW, 2008, OCEANOGRAPHY, V21, P12, DOI 10.5670/oceanog.2008.63; Stephens GL, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014532; Stephens GL, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025209; Tian YD, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011949; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Wust G, 1936, LANDERKUNDLICHE FORS, P347; Yin XG, 2004, J HYDROMETEOROL, V5, P1207, DOI 10.1175/JHM-392.1; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	32	618	636	29	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					455	458		10.1126/science.1212222	http://dx.doi.org/10.1126/science.1212222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539717	Green Submitted			2022-12-28	WOS:000303233400042
J	Hopf, TA; Colwell, LJ; Sheridan, R; Rost, B; Sander, C; Marks, DS				Hopf, Thomas A.; Colwell, Lucy J.; Sheridan, Robert; Rost, Burkhard; Sander, Chris; Marks, Debora S.			Three-Dimensional Structures of Membrane Proteins from Genomic Sequencing	CELL			English	Article							CRYSTAL-STRUCTURE; RESIDUE CONTACTS; ABC TRANSPORTER; GLYCEROL-3-PHOSPHATE TRANSPORTER; PREDICTION; MUTATION; IDENTIFICATION; COVARIANCE; CHANNEL; CRYSTALLOGRAPHY	We show that amino acid covariation in proteins, extracted from the evolutionary sequence record, can be used to fold transmembrane proteins. We use this technique to predict previously unknown 3D structures for 11 transmembrane proteins (with up to 14 helices) from their sequences alone. The prediction method (EVfold_membrane) applies a maximum entropy approach to infer evolutionary covariation in pairs of sequence positions within a protein family and then generates all-atom models with the derived pairwise distance constraints. We benchmark the approach with blinded de novo computation of known transmembrane protein structures from 23 families, demonstrating unprecedented accuracy of the method for large transmembrane proteins. We show how the method can predict oligomerization, functional sites, and conformational changes in transmembrane proteins. With the rapid rise in large-scale sequencing, more accurate and more comprehensive information on evolutionary constraints can be decoded from genetic variation, greatly expanding the repertoire of transmembrane proteins amenable to modeling by this method.	[Hopf, Thomas A.; Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Hopf, Thomas A.; Rost, Burkhard] Tech Univ Munich, Dept Informat, D-85748 Garching, Germany; [Colwell, Lucy J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Harvard University; Harvard Medical School; Technical University of Munich; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	evfold_membrane@cbio.mskcc.org	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424	Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center [NIH U54-CA143798]; Engineering and Physical Sciences Research Council [EP/H028064/1]; German National Academic Foundation; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; EPSRC [EP/H028064/1, EP/H028064/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H028064/2] Funding Source: researchfish	Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German National Academic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Guy Montelione, Rebecca Ward, Nicholas Stroustrup, Steven Long, Nikola Pavletich, Anil Korkut, Edda Kloppman, Marc Offman, Yitzak Pilpel, Andrea Pagnani, Riccardo Zecchina, David Baker, Richard Stein, James Thompson, and Michael Lappe for scientific discussions; Johannes Soeding and Michael Remmert for help with HHblits; Marco Punta and Jaina Mistry for help with PFAM numbers; and Nathan Marks-Forder for graphical abstract image. C. S. and R. S. have support from the Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center (NIH U54-CA143798). L.J.C. is supported by an Engineering and Physical Sciences Research Council fellowship (EP/H028064/1). T. A. H. has support from the German National Academic Foundation. D. S. M. thanks the Systems Biology Department at Harvard Medical School for their generous support.	Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CRONET P, 1993, PROTEIN ENG, V6, P59, DOI 10.1093/protein/6.1.59; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horn F, 1998, RECEPTOR CHANNEL, V5, P305; HOWELL N, 1991, AM J HUM GENET, V49, P939; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jaksch M, 1996, HUM MUTAT, V7, P358, DOI 10.1002/(SICI)1098-1004(1996)7:4<358::AID-HUMU11>3.3.CO;2-V; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Lapedes A.S., 1997, CORRELATED MUTATIONS; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Nemoto W, 2004, PROTEIN J, V23, P427, DOI 10.1023/B:JOPC.0000039556.95629.cf; Neumann S, 2012, PROTEINS, V80, P839, DOI 10.1002/prot.23242; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; VALIQUETTE M, 1995, EMBO J, V14, P5542, DOI 10.1002/j.1460-2075.1995.tb00241.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	75	358	368	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1607	1621		10.1016/j.cell.2012.04.012	http://dx.doi.org/10.1016/j.cell.2012.04.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22579045	Bronze, Green Accepted			2022-12-28	WOS:000305753800024
J	Dusheiko, G				Dusheiko, Geoffrey			Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?	LANCET			English	Editorial Material							PREVENT PERINATAL TRANSMISSION; VIRUS INFECTION; PREGNANCY; PHARMACOKINETICS; LAMIVUDINE; RISK		[Dusheiko, Geoffrey] Royal Free Hosp, Sheila Sherlock Ctr Hepatol, London NW3 2QG, England; [Dusheiko, Geoffrey] UCL, Sch Med, London W1N 8AA, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School	Dusheiko, G (corresponding author), Royal Free Hosp, Ctr Hepatol, Pond St, London NW3 2QG, England.	g.dusheiko@medsch.ucl.ac.uk						Benaboud S, 2011, ANTIMICROB AGENTS CH, V55, P1315, DOI 10.1128/AAC.00514-10; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Chen DS, 2009, J HEPATOL, V50, P805, DOI 10.1016/j.jhep.2009.01.002; Chotiyaputta W, 2009, J VIRAL HEPATITIS, V16, P91, DOI 10.1111/j.1365-2893.2008.01067.x; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Hill JB, 2002, OBSTET GYNECOL, V99, P1049, DOI 10.1016/S0029-7844(02)02000-8; Johnson MA, 1999, CLIN PHARMACOKINET, V36, P41, DOI 10.2165/00003088-199936010-00004; Jonas MM, 2009, LIVER INT, V29, P133, DOI 10.1111/j.1478-3231.2008.01933.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Nguyen G, 2009, ALIMENT PHARM THER, V29, P755, DOI 10.1111/j.1365-2036.2009.03932.x; Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission, REC US ANT DRUGS PRE; RAWAL BK, 1991, LANCET, V337, P364, DOI 10.1016/0140-6736(91)90993-Y; Read JS, 2010, CLIN PERINATOL, V37, P765, DOI 10.1016/j.clp.2010.08.007; Shao ZJ, 2011, J MED VIROL, V83, P791, DOI 10.1002/jmv.22043; ter Borg MJ, 2008, J VIRAL HEPATITIS, V15, P37, DOI 10.1111/j.1365-2893.2007.00894.x; Van Rompay KKA, 2005, ANTIMICROB AGENTS CH, V49, P2093, DOI 10.1128/AAC.49.5.2093-2094.2005; van Zonneveld M, 2003, J VIRAL HEPATITIS, V10, P294, DOI 10.1046/j.1365-2893.2003.00440.x; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x	20	20	20	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					2019	2021		10.1016/S0140-6736(11)61182-3	http://dx.doi.org/10.1016/S0140-6736(11)61182-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22549045				2022-12-28	WOS:000304757700037
J	Okie, S				Okie, Susan			The Evolving Primary Care Physician	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Sch Med, Washington, DC 20007 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20007 USA.							[Anonymous], C SUMM ATL 2011 ENS; Dower C, 2011, 22 RW JOHNS FDN; Margolius D, 2010, HEALTH AFFAIR, V29, P779, DOI 10.1377/hlthaff.2010.0045; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Sung SH, 2004, 10 ANN HMO RES NETW	5	28	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1849	1853		10.1056/NEJMp1201526	http://dx.doi.org/10.1056/NEJMp1201526			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WU	22591290	Bronze			2022-12-28	WOS:000304083000002
J	Bond-Smith, G; Banga, N; Hammond, TM; Imber, CJ				Bond-Smith, Giles; Banga, Neal; Hammond, Toby M.; Imber, Charles J.			Pancreatic adenocarcinoma	BRITISH MEDICAL JOURNAL			English	Review							PHASE HELICAL CT; ENDOSCOPIC ULTRASOUND; SURGICAL PALLIATION; CANCER; RESECTION; DIAGNOSIS; CHEMOTHERAPY; CARCINOMA; PANCREATICODUODENECTOMY; MORTALITY		[Bond-Smith, Giles; Banga, Neal; Imber, Charles J.] Royal Free Hosp, Hepatopancreat Biliary Surg & Liver Transplant Un, London NW3 2QG, England; [Hammond, Toby M.] St Marks Hosp, Dept Surg, Harrow, Middx, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London	Bond-Smith, G (corresponding author), Royal Free Hosp, Hepatopancreat Biliary Surg & Liver Transplant Un, Pond St, London NW3 2QG, England.	gelsmith@yahoo.co.uk		Banga, Neal/0000-0002-1767-8438				*AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; Anderson KE, 2006, CANC EPIDEMIOLOGY PR; Bernhardt SL, 2006, BRIT J CANCER, V95, P1474, DOI 10.1038/sj.bjc.6603437; Briggs CD, 2009, J GASTROINTEST SURG, V13, P1129, DOI 10.1007/s11605-008-0797-z; Cancer Research UK, 2011, PANCR CANC UK INC ST; Cancer Research UK, 2009, CANC MORT UK STAT; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Chua TC, 2010, J GASTROINTEST SURG, V14, P1442, DOI 10.1007/s11605-009-1129-7; Elliss-Brookes L, 2010, ROUTES DIAGNOSIS; Evans DB, 2009, ANN SURG ONCOL, V16, P1736, DOI 10.1245/s10434-009-0416-6; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Gullo L, 2001, PANCREAS, V22, P210, DOI 10.1097/00006676-200103000-00017; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Garcia JI, 2009, REV ESP ENFERM DIG, V101, P631; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Kahl S, 2004, DIGEST DIS, V22, P26, DOI 10.1159/000078732; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Kelly KJ, 2011, J GASTROINTEST SURG, V15, P250, DOI 10.1007/s11605-010-1390-9; KOPROWSKI H, 1981, SCIENCE, V212, P53, DOI 10.1126/science.6163212; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; McPhee JT, 2007, ANN SURG, V246, P246, DOI 10.1097/01.sla.0000259993.17350.3a; MULLER MF, 1994, RADIOLOGY, V190, P745; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ramacciato G, 2009, ANN SURG ONCOL, V16, P817, DOI 10.1245/s10434-008-0281-8; Reddy SK, 2007, ONCOLOGIST, V12, P654, DOI 10.1634/theoncologist.12-6-654; Shrikhande SV, 2008, SURG PANCREATIC TUMO; SINGH SM, 1989, SURG CLIN N AM, V69, P599; SINGH SM, 1990, ANN SURG, V212, P132, DOI 10.1097/00000658-199008000-00003; Tabuchi T, 1999, AM J ROENTGENOL, V173, P375, DOI 10.2214/ajr.173.2.10430140; Valls C, 2002, AM J ROENTGENOL, V178, P821, DOI 10.2214/ajr.178.4.1780821; Watanabe I, 2004, PANCREAS, V28, P160, DOI 10.1097/00006676-200403000-00007; Whipple AO, 1935, ANN SURG, V102, P763, DOI 10.1097/00000658-193510000-00023; Yang YM, 2005, WORLD J GASTROENTERO, V11, P2456, DOI 10.3748/wjg.v11.i16.2456; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004; Zhou W, 2010, AM J SURG, V200, P529, DOI 10.1016/j.amjsurg.2009.12.022	37	97	102	0	14	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 16	2012	344								e2476	10.1136/bmj.e2476	http://dx.doi.org/10.1136/bmj.e2476			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942YO	22592847				2022-12-28	WOS:000304087800001
J	Dernburg, AF				Dernburg, Abby F.			RNA Plays Meiotic Matchmaker	SCIENCE			English	Editorial Material							FISSION YEAST; CHROMOSOMES; MEIOSIS; ONSET		[Dernburg, Abby F.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Dernburg, Abby F.] Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; [Dernburg, Abby F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Dernburg, Abby F.] Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Dernburg, AF (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	afdernburg@lbl.gov		Dernburg, Abby/0000-0001-8037-1079	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; HIRAOKA Y, 1993, J CELL BIOL, V120, P591, DOI 10.1083/jcb.120.3.591; HOTTA Y, 1985, CELL, V40, P785, DOI 10.1016/0092-8674(85)90338-1; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; Stevens N. M., 1908, Journal of Experimental Zoology Philadelphia, V5, DOI 10.1002/jez.1400050304; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014	15	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					681	682		10.1126/science.1222647	http://dx.doi.org/10.1126/science.1222647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582252				2022-12-28	WOS:000303872300037
J	Moynihan, R				Moynihan, Ray			REALITY CHECK The dos and don'ts of collaborating with industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Association of the British Pharmaceutical Industry, COD PRACT PHARM IND; Cutting Edge Information, KEY OP LEAD PH 122 R; Ethical Standards in Health & Life Sciences Group, GUID COLL HEALTHC PR; FLETCHER SW, 2008, CONT ED HLTH PROF IM; Godlee F, 2009, BMJ-BRIT MED J, V338, pb463; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Moynihan R, 2010, ALLEN UNWIN, P95; Moynihan R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1648; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; YouTube, PROM POS COLL IMPR P	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2012	344								e3247	10.1136/bmj.e3247	http://dx.doi.org/10.1136/bmj.e3247			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569871				2022-12-28	WOS:000304083400022
J	Liao, J				Liao, Joshua			The art of medicine Sacred words	LANCET			English	Editorial Material									Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Liao, J (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	jmliao@bcm.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					1696	1697		10.1016/S0140-6736(12)60707-7	http://dx.doi.org/10.1016/S0140-6736(12)60707-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	937KX	22567673				2022-12-28	WOS:000303658500015
J	Azzopardi, P				Azzopardi, Peter			The art of medicine Adolescent health comes of age	LANCET			English	Editorial Material									[Azzopardi, Peter] Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic 3052, Australia; [Azzopardi, Peter] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Azzopardi, Peter] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Azzopardi, Peter] Victorian Aboriginal Hlth Serv, Melbourne, Vic, Australia; [Azzopardi, Peter] Baker IDI Heart & Diabet Inst, Alice Springs, NT, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Baker Heart and Diabetes Institute	Azzopardi, P (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic 3052, Australia.	Peter.azzopardi@rch.org.au	azzopardi, peter/J-7355-2012	azzopardi, peter/0000-0002-9280-6997					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1583	1584		10.1016/S0140-6736(12)60666-7	http://dx.doi.org/10.1016/S0140-6736(12)60666-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22553828				2022-12-28	WOS:000303452600019
J	Moretti, B; Pesce, V; Maccagnano, G; Vicenti, G; Lovreglio, P; Soleo, L; Apostoli, P				Moretti, Biagio; Pesce, Vito; Maccagnano, Giuseppe; Vicenti, Giovanni; Lovreglio, Piero; Soleo, Leonardo; Apostoli, Pietro			Peripheral neuropathy after hip replacement failure: is vanadium the culprit?	LANCET			English	Editorial Material									[Lovreglio, Piero; Soleo, Leonardo] Univ Bari, Interdisciplinary Dept Med, Sect Occupat Med EC Vigliani, I-70124 Bari, Italy; [Moretti, Biagio; Pesce, Vito; Maccagnano, Giuseppe; Vicenti, Giovanni] Univ Bari, Dept Neurosci & Sense Organ, Unit Orthopaed & Traumatol 2, I-70124 Bari, Italy; [Apostoli, Pietro] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Hlth & Ind Hyg, Brescia, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Brescia	Lovreglio, P (corresponding author), Univ Bari, Interdisciplinary Dept Med, Sect Occupat Med EC Vigliani, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	p.lovreglio@medlav.uniba.it	Vicenti, Giovanni/AAC-9719-2019; Maccagnano, Giuseppe/AAC-9739-2019	Maccagnano, Giuseppe/0000-0002-8596-2422; Soleo, Leonardo/0000-0001-6633-1089; vicenti, giovanni/0000-0002-7412-7990; Lovreglio, Piero/0000-0002-1609-9397; Moretti, Biagio/0000-0002-1234-8616				Jacobs JJ, 1999, CLIN ORTHOP RELAT R, P173; LEWIS C E, 1959, AMA Arch Ind Health, V19, P497; Nordberg GF, 2007, HDB TOXICOLOGY MET; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6	4	22	22	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1676	1676		10.1016/S0140-6736(12)60273-6	http://dx.doi.org/10.1016/S0140-6736(12)60273-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22541583				2022-12-28	WOS:000303452600041
J	Ebert, MS; Sharp, PA				Ebert, Margaret S.; Sharp, Phillip A.			Roles for MicroRNAs in Conferring Robustness to Biological Processes	CELL			English	Review							3' UNTRANSLATED REGIONS; NEGATIVE FEEDBACK LOOP; MESSENGER-RNAS; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; REGULATORY CIRCUITS; MAMMALIAN MICRORNAS; CANCER-CELLS; FAMILY; NOISE	Biological systems use a variety of mechanisms to maintain their functions in the face of environmental and genetic perturbations. Increasing evidence suggests that, among their roles as post-transcriptional repressors of gene expression, microRNAs (miRNAs) help to confer robustness to biological processes by reinforcing transcriptional programs and attenuating aberrant transcripts, and they may in some network contexts help suppress random fluctuations in transcript copy number. These activities have important consequences for normal development and physiology, disease, and evolution. Here, we will discuss examples and principles of miRNAs that contribute to robustness in animal systems.	[Ebert, Margaret S.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ebert, Margaret S.; Sharp, Phillip A.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu			United States Public Health Service from the National Institutes of Health [R01-CA133404]; Cancer Center from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P01CA042063, P30CA014051, R01CA133404] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health; Cancer Center from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank David Bartel, Shankar Mukherji, Anthony Leung, and anonymous reviewers for critical reading and helpful suggestions. We thank Mary Lindstrom for assistance making figures. This work was supported by United States Public Health Service grant R01-CA133404 from the National Institutes of Health and partially by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Dill H, 2012, GENE DEV, V26, P25, DOI 10.1101/gad.177774.111; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Smibert P, 2011, RNA, V17, P1997, DOI 10.1261/rna.2983511; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zheng GXY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002054	87	1159	1198	5	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					515	524		10.1016/j.cell.2012.04.005	http://dx.doi.org/10.1016/j.cell.2012.04.005			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541426	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000303443100005
J	Jiao, BW; Ma, H; Shokhirev, MN; Drung, A; Yang, Q; Shin, JD; Lu, SL; Byron, M; Kalantry, S; Mercurio, AM; Lawrence, JB; Hoffmann, A; Bach, I				Jiao, Baowei; Ma, Hong; Shokhirev, Maxim N.; Drung, Alexander; Yang, Qin; Shin, JongDae; Lu, Shaolei; Byron, Meg; Kalantry, Sundeep; Mercurio, Arthur M.; Lawrence, Jeanne B.; Hoffmann, Alexander; Bach, Ingolf			Paternal RLIM/Rnf12 Is a Survival Factor for Milk-Producing Alveolar Cells	CELL			English	Article							X-CHROMOSOME INACTIVATION; MAMMARY-GLAND; TRANSCRIPTION FACTORS; DOSAGE COMPENSATION; LIM COFACTORS; EXPRESSION; GROWTH; MORPHOGENESIS; DEPLETION; SELECTION	In female mouse embryos, somatic cells undergo a random form of X chromosome inactivation (XCI), whereas extraembryonic trophoblast cells in the placenta undergo imprinted XCI, silencing exclusively the paternal X chromosome. Initiation of imprinted XCI requires a functional maternal allele of the X-linked gene Rnf12, which encodes the ubiquitin ligase Rnf12/RLIM. We find that knockout (KO) of Rnf12 in female mammary glands inhibits alveolar differentiation and milk production upon pregnancy, with alveolar cells that lack RLIM undergoing apoptosis as they begin to differentiate. Genetic analyses demonstrate that these functions are mediated primarily by the paternal Rnf12 allele due to non-random maternal XCI in mammary epithelial cells. These results identify paternal Rnf12/RLIM as a critical survival factor for milk-producing alveolar cells and, together with population models, reveal implications of transgenerational epigenetic inheritance.	[Jiao, Baowei; Ma, Hong; Drung, Alexander; Yang, Qin; Shin, JongDae; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Lu, Shaolei; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Byron, Meg; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Bach, Ingolf] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shokhirev, Maxim N.; Hoffmann, Alexander] Univ Calif San Diego, BioCircuits Inst, San Diego Ctr Syst Biol Cellular Stress Responses, La Jolla, CA 92093 USA; [Shokhirev, Maxim N.; Hoffmann, Alexander] Univ Calif San Diego, Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Kalantry, Sundeep] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Bach, I (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	ingolf.bach@umassmed.edu		JIAO, BAOWEI/0000-0001-8559-9160; Lu, Shaolei/0000-0003-2870-5793; Lawrence, Jeanne/0000-0001-6572-3128	NIH [R01CA131158, R01GM053234, R01CA89209]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055333] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA131158, R01CA089209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Andersen, E. Baehrecke, T. Fazzio, D. Haig, O. Rando, W. Robinson, L. Shaw, and S. Sinha for advice, comments, and/or reagents and T. Fazzio for critically reading the manuscript. I. B. is a member of the UMass DERC (DK32520). This work was supported by NIH grants R01CA131158 to I. B., R01GM053234 to J.B.L., and R01CA89209 to A.M.M.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Breen G, 2000, BIOTECHNIQUES, V28, P464, DOI 10.2144/00283st03; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Flint D, 2008, J MAMMARY GLAND BIOL, V13, P443, DOI 10.1007/s10911-008-9095-3; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Langdon SP, 2004, METH MOLEC MED, V88, P133; Li W, 2009, P NATL ACAD SCI USA, V106, P4725, DOI 10.1073/pnas.0807640106; LIDICKER WZ, 1966, ECOL MONOGR, V36, P27, DOI 10.2307/1948487; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Mohanty AK, 2009, PROTEIN EXPRES PURIF, V64, P213, DOI 10.1016/j.pep.2008.11.001; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pereira F.A., 2001, CURR PROTOC MOL  MAY; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sutherland KD, 2007, CELL CYCLE, V6, P799, DOI 10.4161/cc.6.7.4037; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r79	45	23	23	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					630	641		10.1016/j.cell.2012.02.056	http://dx.doi.org/10.1016/j.cell.2012.02.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541433	Green Accepted, Bronze			2022-12-28	WOS:000303443100014
J	Seth, D; Hausladen, A; Wang, YJ; Stamler, JS				Seth, Divya; Hausladen, Alfred; Wang, Ya-Juan; Stamler, Jonathan S.			Endogenous Protein S-Nitrosylation in E. coli: Regulation by OxyR	SCIENCE			English	Article							ESCHERICHIA-COLI; NITRIC-OXIDE; NITROSATIVE STRESS; REDUCTASE; FNR; NITRATE; FLAVOHEMOGLOBIN; ACTIVATION; MECHANISM; CATALYSIS	Endogenous S-nitrosylation of proteins, a principal mechanism of cellular signaling in eukaryotes, has not been observed in microbes. We report that protein S-nitrosylation is an obligate concomitant of anaerobic respiration on nitrate in Escherichia coli. Endogenous S-nitrosylation during anaerobic respiration is controlled by the transcription factor OxyR, previously thought to operate only under aerobic conditions. Deletion of OxyR resulted in large increases in protein S-nitrosylation, and S-nitrosylation of OxyR induced transcription from a regulon that is distinct from the regulon induced by OxyR oxidation. Furthermore, products unique to the anaerobic regulon protected against S-nitrosothiols, and anaerobic growth of E. coli lacking OxyR was impaired on nitrate. Thus, OxyR serves as a master regulator of S-nitrosylation, and alternative posttranslational modifications of OxyR control distinct transcriptional responses.	[Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Stamler, JS (corresponding author), Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572; Wang, Yajuan (Megan)/0000-0002-3284-9012	NIH [R01-HL096673, R01-HL095463, R01-HL059130]; Defense Advanced Research Projects Agency [N66001-10-C-2015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096673, R01HL095463, R01HL059130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (R01-HL096673, R01-HL095463, R01-HL059130) and Defense Advanced Research Projects Agency (N66001-10-C-2015). We thank D. Hess for helpful discussions and suggestions; P. McLaughlin for excellent technical assistance; M. Chance, G. Gokulrangan, and L. Wang for valuable assistance and discussion. The microarray data reported in this paper have been submitted in MIAME-compliant format to the Gene Expression Omnibus database (accession number GSE24524).	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; CALMELS S, 1988, J GEN MICROBIOL, V134, P221; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; JI XB, 1988, APPL ENVIRON MICROB, V54, P1791, DOI 10.1128/AEM.54.7.1791-1794.1988; Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RALT D, 1988, J BACTERIOL, V170, P359, DOI 10.1128/jb.170.1.359-364.1988; STEWART V, 1988, MICROBIOL REV, V52, P190, DOI 10.1128/MMBR.52.2.190-232.1988; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	26	121	122	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					470	473		10.1126/science.1215643	http://dx.doi.org/10.1126/science.1215643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539721	Green Accepted			2022-12-28	WOS:000303233400046
J	Yi, C; Ma, MS; Ran, LL; Zheng, JX; Tong, JJ; Zhu, J; Ma, CY; Sun, YF; Zhang, SJ; Feng, WZ; Zhu, LY; Le, Y; Gong, XQ; Yan, XH; Hong, B; Jiang, FJ; Xie, ZP; Miao, D; Deng, H; Yu, L				Yi, Cong; Ma, Meisheng; Ran, Leili; Zheng, Jingxiang; Tong, Jingjing; Zhu, Jing; Ma, Chengying; Sun, Yufen; Zhang, Shaojin; Feng, Wenzhi; Zhu, Liyuan; Le, Yan; Gong, Xingqi; Yan, Xianghua; Hong, Bing; Jiang, Fen-Jun; Xie, Zhiping; Miao, Di; Deng, Haiteng; Yu, Li			Function and Molecular Mechanism of Acetylation in Autophagy Regulation	SCIENCE			English	Article							VACUOLE TARGETING PATHWAY; ACETYLTRANSFERASE; TRANSCRIPTION; CYTOPLASM	Protein acetylation emerged as a key regulatory mechanism for many cellular processes. We used genetic analysis of Saccharomyces cerevisiae to identify Esa1 as a histone acetyltransferase required for autophagy. We further identified the autophagy signaling component Atg3 as a substrate for Esa1. Specifically, acetylation of K19 and K48 of Atg3 regulated autophagy by controlling Atg3 and Atg8 interaction and lipidation of Atg8. Starvation induced transient K19-K48 acetylation through spatial and temporal regulation of the localization of acetylase Esa1 and the deacetylase Rpd3 on pre-autophagosomal structures (PASs) and their interaction with Atg3. Attenuation of K19-K48 acetylation was associated with attenuation of autophagy. Increased K19-K48 acetylation after deletion of the deacetylase Rpd3 caused increased autophagy. Thus, protein acetylation contributes to control of autophagy.	[Yi, Cong; Ma, Meisheng; Ran, Leili; Zheng, Jingxiang; Tong, Jingjing; Zhu, Jing; Sun, Yufen; Zhang, Shaojin; Feng, Wenzhi; Zhu, Liyuan; Le, Yan; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Ma, Chengying; Gong, Xingqi; Yu, Li] Tsinghua Univ, Ctr Struct Biol, Beijing 100084, Peoples R China; [Yan, Xianghua] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Hong, Bing; Jiang, Fen-Jun; Xie, Zhiping] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Miao, Di; Deng, Haiteng] Tsinghua Univ, Prote Facil, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Huazhong Agricultural University; Nankai University; Tsinghua University	Yu, L (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	liyulab@mail.tsinghua.edu.cn	Xie, Zhiping/A-1306-2015	Xie, Zhiping/0000-0001-5816-6159; Deng, Haiteng/0000-0001-9496-1280	973 Program [2011CB910101, 2010CB833704]; National Science Foundation [31030043, 31125018, 30971484, 30971441, 31172290, 31072036]; Tsinghua University [2010THZ0, 2009THZ03071]	973 Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Tsinghua University	We are grateful to Y. Ohsumi and H. Nakatogawa for antibodies and plasmids, N. Gao for assistance with protein purification, B. Zhou for providing the yeast deletion library, J. Cote for EPL1 and epl1-1, L. Pillus for ESA1 and esa1-1, and G. Yang for image processing. This research was supported by 973 Program 2011CB910101 and 2010CB833704; National Science Foundation grants 31030043, 31125018, and 30971484; and Tsinghua University grants 2010THZ0 and 2009THZ03071 to L. Y.; National Science Foundation grant 30971441 to Z.X.; and National Science Foundation grants 31172290 and 31072036 to X.Y.	Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Ohsumi Yoshinori, 2006, Tanpakushitsu Kakusan Koso, V51, P1453; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	15	177	199	5	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					474	477		10.1126/science.1216990	http://dx.doi.org/10.1126/science.1216990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539722				2022-12-28	WOS:000303233400047
J	Hatch, EM; Hetzer, MW				Hatch, Emily M.; Hetzer, Martin W.			RNP Export by Nuclear Envelope Budding	CELL			English	Editorial Material								Nuclear export of mRNAs is thought to occur exclusively through nuclear pore complexes. In this issue of Cell, Speese et al. identify an alternate pathway for mRNA export in muscle cells where ribonucleoprotein complexes involved in forming neuromuscular junctions transit the nuclear envelope by fusing with and budding through the nuclear membrane.	[Hatch, Emily M.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Hatch, Emily/0000-0002-3393-4075	National Cancer Institute; National Institute of Health [RO1 GM098749]; American Cancer Association; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098749] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were supported by Award Number P30CA014195 from the National Cancer Institute and a grant from the National Institute of Health (RO1 GM098749) and an award from the American Cancer Association.	Daneholt B, 2001, CHROMOSOMA, V110, P173, DOI 10.1007/s004120000127; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032	7	8	8	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					733	735		10.1016/j.cell.2012.04.018	http://dx.doi.org/10.1016/j.cell.2012.04.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579277	Bronze			2022-12-28	WOS:000303934700006
J	Catalano, RF; Fagan, AA; Gavin, LE; Greenberg, MT; Irwin, CE; Ross, DA; Shek, DTL				Catalano, Richard F.; Fagan, Abigail A.; Gavin, Loretta E.; Greenberg, Mark T.; Irwin, Charles E., Jr.; Ross, David A.; Shek, Daniel T. L.			Adolescent Health 3 Worldwide application of prevention science in adolescent health	LANCET			English	Article							SOCIAL-DEVELOPMENT INTERVENTION; EARLY-CHILDHOOD INTERVENTION; 15-YEAR FOLLOW-UP; SUBSTANCE USE; LOW-INCOME; PROTECTIVE FACTORS; RANDOMIZED-TRIAL; MENTAL-HEALTH; SEXUAL-BEHAVIOR; TRANSLATIONAL RESEARCH	The burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelerating in low-income and middle-income countries, whereas the burden from infectious diseases has declined. Since this transition, the prevention of non-communicable disease as well as communicable disease causes of adolescent mortality has risen in importance. Problem behaviours that increase the short-term or long-term likelihood of morbidity and mortality, including alcohol, tobacco, and other drug misuse, mental health problems, unsafe sex, risky and unsafe driving, and violence are largely preventable. In the past 30 years new discoveries have led to prevention science being established as a discipline designed to mitigate these problem behaviours. Longitudinal studies have provided an understanding of risk and protective factors across the life course for many of these problem behaviours. Risks cluster across development to produce early accumulation of risk in childhood and more pervasive risk in adolescence. This understanding has led to the construction of developmentally appropriate prevention policies and programmes that have shown short-term and long-term reductions in these adolescent problem behaviours. We describe the principles of prevention science, provide examples of efficacious preventive interventions, describe challenges and potential solutions to take efficacious prevention policies and programmes to scale, and conclude with recommendations to reduce the burden of adolescent mortality and morbidity worldwide through preventive intervention.	[Catalano, Richard F.] Univ Washington, Sch Social Work, Social Dev Res Grp, Seattle, WA 98195 USA; [Fagan, Abigail A.] Univ S Carolina, Dept Criminol & Criminal Justice, Columbia, SC 29208 USA; [Gavin, Loretta E.] US Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Greenberg, Mark T.] Penn State Univ, Prevent Res Ctr, University Pk, PA 16802 USA; [Irwin, Charles E., Jr.] Univ Calif San Francisco, Dept Pediat, Div Adolescent Med, San Francisco, CA USA; [Ross, David A.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Infect Dis Epidemiol Dept, London WC1, England; [Shek, Daniel T. L.] Hong Kong Polytech Univ, Dept Appl Social Sci, Hunghom, Hong Kong, Peoples R China	University of Washington; University of Washington Seattle; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; Hong Kong Polytechnic University	Catalano, RF (corresponding author), Univ Washington, Sch Social Work, Social Dev Res Grp, 9725 3rd Ave NE,Suite 401, Seattle, WA 98195 USA.	catalano@uw.edu	Shek, Daniel T.L./N-9576-2014	Shek, Daniel T.L./0000-0003-3359-6229				Allebeck P, 2008, EUR J PUBLIC HEALTH, V18, P215, DOI 10.1093/eurpub/ckn048; American Academy of Child and Adolescent Psychiatry, 2011, FACTS FAM; Arthur MW, 2002, EVALUATION REV, V26, P575, DOI 10.1177/019384102237850; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Beyers JM, 2004, J ADOLESCENT HEALTH, V35, P3, DOI 10.1016/j.jadohealth.2003.08.015; Bond L, 2005, PREV SCI, V6, P73, DOI 10.1007/s11121-005-3407-2; Bond L, 2004, J EPIDEMIOL COMMUN H, V58, P997, DOI 10.1136/jech.2003.009449; Botvin GJ, 2006, PREV SCI, V7, P403, DOI 10.1007/s11121-006-0057-y; Brown E, 2011, 19 ANN M SOC PREV RE; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Castro FG, 2004, PREV SCI, V5, P41, DOI 10.1023/B:PREV.0000013980.12412.cd; Catalano R. F., 2002, PREVENTION TREATMENT, V5, P15, DOI DOI 10.1037/1522-3736.5.1.515A; Catalano RF., 2011, CLIN MANUAL ADOLESCE, P25; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; DEMOS J, 1969, J MARRIAGE FAM, V31, P632, DOI 10.2307/349302; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dodge KA, 2008, CHILD DEV, V79, P1907, DOI 10.1111/j.1467-8624.2008.01233.x; Duflo E., 2006, 4024 WORLD BANK; Duncan GJ, 1999, EDUC PSYCHOL-US, V34, P29, DOI 10.1207/s15326985ep3401_3; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; ELLICKSON PL, 1990, SCIENCE, V247, P1299, DOI 10.1126/science.2180065; Elliott DS, 2004, PREV SCI, V5, P47, DOI 10.1023/B:PREV.0000013981.28071.52; ENNETT ST, 1994, AM J PUBLIC HEALTH, V84, P1394, DOI 10.2105/AJPH.84.9.1394; Faggiano F, 2010, DRUG ALCOHOL DEPEN, V108, P56, DOI 10.1016/j.drugalcdep.2009.11.018; Feinberg ME, 2008, AM J PREV MED, V34, P495, DOI 10.1016/j.amepre.2008.01.030; Fergusson D.M., 2003, RESILIENCE VULNERABI, P130, DOI DOI 10.1017/CBO9780511615788.008; FLAY BR, 1988, PREV MED, V17, P585, DOI 10.1016/0091-7435(88)90053-9; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Galbraith JS, 2011, HEALTH EDUC RES, V26, P872, DOI 10.1093/her/cyr030; Gilson L, 2008, HEALTH POLICY PLANN, V23, P294, DOI 10.1093/heapol/czn019; Glaser RR, 2005, J QUANT CRIMINOL, V21, P73, DOI 10.1007/s10940-004-1788-1; Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261; Gottfredson DC, 1999, PREVENTING CRIME WHA; Griffin KW, 2004, PREV SCI, V5, P207, DOI 10.1023/B:PREV.0000037643.78420.74; Guldi M, 2008, DEMOGRAPHY, V45, P817, DOI 10.1353/dem.0.0026; Hawkins JD, 2012, ARCH PEDIAT ADOL MED, V166, P141, DOI 10.1001/archpediatrics.2011.183; Hawkins JD, 2009, ARCH PEDIAT ADOL MED, V163, P789, DOI 10.1001/archpediatrics.2009.141; Hawkins JD, 2008, ARCH PEDIAT ADOL MED, V162, P1133, DOI 10.1001/archpedi.162.12.1133; Hawkins JD, 1999, ARCH PEDIAT ADOL MED, V153, P226, DOI 10.1001/archpedi.153.3.226; Hawkins JD, 2005, ARCH PEDIAT ADOL MED, V159, P25, DOI 10.1001/archpedi.159.1.25; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hibell B., 2009, 2007 ESPAD REPORT SU, P1; Hyder AA, 2011, HEALTH POLICY PLANN, V26, P73, DOI 10.1093/heapol/czq020; Janus M, 2007, EARLY CHILD DEVELOPMENT FROM MEASUREMENT TO ACTION: A PRIORITY FOR GROWTH AND EQUITY, P183; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Johnston LD, 2010, NIH PUBLICATION; Kearney MS, 2009, REV ECON STAT, V91, P137, DOI 10.1162/rest.91.1.137; Kellam SG, 1999, AM J COMMUN PSYCHOL, V27, P463, DOI 10.1023/A:1022129127298; Kirby D, 2006, WHO TECH REP SER, V938, P103; KLEIN NC, 1977, J CONSULT CLIN PSYCH, V45, P469, DOI 10.1037/0022-006X.45.3.469; Kreuter MW, 2009, AM J PUBLIC HEALTH, V99, P2123, DOI 10.2105/AJPH.2008.155218; Lee S., 2011, 11071201 WASH STAT I; Lloyd C., 2005, GROWING GLOBAL CHANG; Lonczak HS, 2002, ARCH PEDIAT ADOL MED, V156, P438, DOI 10.1001/archpedi.156.5.438; Masten A, 2003, RESILIENCE VULNERABI, P1; Mrazek PJ, 2008, COMMUNITY MONITORING; Nair V, 2008, AM J PUBLIC HEALTH, V98, P1354, DOI 10.2105/AJPH.2007.127563; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; OLDS DL, 1988, AM J PUBLIC HEALTH, V78, P1436, DOI 10.2105/AJPH.78.11.1436; ORINGANJE C, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005215.PUB2; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patton GC, 2006, AM J PUBLIC HEALTH, V96, P1582, DOI 10.2105/AJPH.2004.047399; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pittman K. J., 1993, YOUTH DEV RESILIENCY; Pober JS, 2001, FASEB J, V15, P2303, DOI 10.1096/fj.01-0540lsf; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Quinby RK, 2008, J COMMUNITY PSYCHOL, V36, P313, DOI 10.1002/jcop.20194; Renati S, 2011, 19 ANN M SOC PREV RE; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Ringwalt C, 2009, PREV SCI, V10, P33, DOI 10.1007/s11121-008-0112-y; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Rotheram-Borus MJ, 2009, AIDS BEHAV, V13, P387, DOI 10.1007/s10461-009-9531-4; Russell KF, 2011, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD003300.PUB3; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saul J, 2008, AM J COMMUN PSYCHOL, V41, P197, DOI 10.1007/s10464-008-9171-2; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Schinke SP, 2004, J STUD ALCOHOL, V65, P443, DOI 10.15288/jsa.2004.65.443; Schweinhart LJ, 1993, SIGNIFICANT BENEFITS; Schwinn TM, 2010, J STUD ALCOHOL DRUGS, V71, P535, DOI 10.15288/jsad.2010.71.535; Sexton TL, 2000, FUNCTIONAL FAMILY TH; Shapiro CJ, 2008, J CHILD FAM STUD, V17, P457, DOI 10.1007/s10826-007-9167-9; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P546, DOI 10.1100/tsw.2011.33; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P253, DOI 10.1100/tsw.2011.6; Shek DTL, 2004, INT PERSPECTIVES EVI, P213; Shope JT, 2007, J SAFETY RES, V38, P165, DOI 10.1016/j.jsr.2007.02.004; SNOW WH, 1985, CHILD YOUTH SERV REV, V7, P1, DOI 10.1016/0190-7409(85)90036-2; Spoth R, 2004, PREV SCI, V5, P31, DOI 10.1023/B:PREV.0000013979.52796.8b; Spoth R, 2004, J CONSULT CLIN PSYCH, V72, P535, DOI 10.1037/0022-006X.72.3.535; Spoth R, 1998, J CONSULT CLIN PSYCH, V66, P385, DOI 10.1037/0022-006X.66.2.385; Spoth R, 2011, AM J PREV MED, V40, P440, DOI 10.1016/j.amepre.2010.12.012; Spoth R, 2009, J CONSULT CLIN PSYCH, V77, P620, DOI 10.1037/a0016029; Spoth RL, 2000, ARCH PEDIAT ADOL MED, V154, P1248, DOI 10.1001/archpedi.154.12.1248; Spoth RL, 2001, J CONSULT CLIN PSYCH, V69, P627, DOI 10.1037//0022-006X.69.4.627; Thomas BH, 1992, PREVENTING ADOLESCEN, P28; Tobler N.S., 2000, J PRIM PREV, V20, P275, DOI [DOI 10.1023/A:1021314704811, 10.1023/A:1021314704811]; Toumbourou JW, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P53, DOI 10.1002/9780470713624.ch5; Valentine JC, 2011, PREV SCI, V12, P103, DOI 10.1007/s11121-011-0217-6; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wagenaar AC, 2002, J STUD ALCOHOL, P206, DOI 10.15288/jsas.2002.s14.206; Wagenaar AC, 2009, ADDICTION, V104, P179, DOI 10.1111/j.1360-0443.2008.02438.x; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; Weisz JR, 2005, AM PSYCHOL, V60, P628, DOI 10.1037/0003-066X.60.6.628; Wolchik SA, 2002, JAMA-J AM MED ASSOC, V288, P1874, DOI 10.1001/jama.288.15.1874; World Health Organization, GLOB SCH BAS STUD HL; Yang Z, 2010, J ADOLESCENT HEALTH, V46, P517, DOI 10.1016/j.jadohealth.2010.03.021; ZABIN LS, 1986, FAM PLANN PERSPECT, V18, P119, DOI 10.2307/2135344; Zavodny M, 2004, AM J PUBLIC HEALTH, V94, P1347, DOI 10.2105/AJPH.94.8.1347; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	115	364	368	7	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1653	1664		10.1016/S0140-6736(12)60238-4	http://dx.doi.org/10.1016/S0140-6736(12)60238-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538180	Green Accepted			2022-12-28	WOS:000303452600039
J	Predehl, K; Grosche, G; Raupach, SMF; Droste, S; Terra, O; Alnis, J; Legero, T; Hansch, TW; Udem, T; Holzwarth, R; Schnatz, H				Predehl, K.; Grosche, G.; Raupach, S. M. F.; Droste, S.; Terra, O.; Alnis, J.; Legero, Th.; Haensch, T. W.; Udem, Th.; Holzwarth, R.; Schnatz, H.			A 920-Kilometer Optical Fiber Link for Frequency Metrology at the 19th Decimal Place	SCIENCE			English	Article							COHERENT TRANSFER; RESOLUTION; NETWORK; CLOCKS	Optical clocks show unprecedented accuracy, surpassing that of previously available clock systems by more than one order of magnitude. Precise intercomparisons will enable a variety of experiments, including tests of fundamental quantum physics and cosmology and applications in geodesy and navigation. Well-established, satellite-based techniques for microwave dissemination are not adequate to compare optical clocks. Here, we present phase-stabilized distribution of an optical frequency over 920 kilometers of telecommunication fiber. We used two antiparallel fiber links to determine their fractional frequency instability (modified Allan deviation) to 5 x 10(-15) in a 1-second integration time, reaching 10(-18) in less than 1000 seconds. For long integration times tau, the deviation from the expected frequency value has been constrained to within 4 x 10(-19). The link may serve as part of a Europe-wide optical frequency dissemination network.	[Predehl, K.; Droste, S.; Alnis, J.; Haensch, T. W.; Udem, Th.; Holzwarth, R.] MaxPlanck Inst Quantenopt, D-85748 Garching, Germany; [Grosche, G.; Raupach, S. M. F.; Terra, O.; Legero, Th.; Schnatz, H.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Grosche, G.; Schnatz, H.] Leibniz Univ Hannover, QUEST, D-30167 Hannover, Germany; [Haensch, T. W.] Univ Munich, Dept Phys, D-80799 Munich, Germany; [Holzwarth, R.] Menlo Syst GmbH, D-82152 Martinsried, Germany	Physikalisch-Technische Bundesanstalt (PTB); Leibniz University Hannover; University of Munich; Menlo Systems GmbH	Predehl, K (corresponding author), MaxPlanck Inst Quantenopt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	kdp@mpq.mpg.de	Terra, Osama/F-1250-2014	Terra, Osama/0000-0001-9376-914X; Legero, Thomas/0000-0003-0277-3907; Alnis, Janis/0000-0003-3824-9699	European Space Agency; excellence cluster QUEST; Max Planck Foundation	European Space Agency(European Space AgencyEuropean Commission); excellence cluster QUEST; Max Planck Foundation(Foundation CELLEX)	We thank the members of Deutsches Forschungsnetz in Berlin, Leipzig, and Erlangen, Germany, as well as Gasline GmbH for a fruitful collaboration. We also thank the European Space Agency and the excellence cluster QUEST for financial support; A. Koczwara, N. Kolachevsky, U. Sterr, A. Thaller, and T. Wilken for experimental support and helpful discussions; F. Riehle for long-term encouragement; and B. Lipphardt for technical support. T. W. H. acknowledges support by the Max Planck Foundation.	Bauch A, 2006, METROLOGIA, V43, P109, DOI 10.1088/0026-1394/43/1/016; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Dawkins ST, 2007, IEEE T ULTRASON FERR, V54, P918, DOI 10.1109/TUFFC.2007.337; Gill P., 2006, P 20 EUR FREQ TIM FO; Grosche G, 2009, OPT LETT, V34, P2270, DOI 10.1364/OL.34.002270; HOCKER GB, 1979, APPL OPTICS, V18, P1445, DOI 10.1364/AO.18.001445; Jiang H, 2008, J OPT SOC AM B, V25, P2029, DOI 10.1364/JOSAB.25.002029; Lopez O, 2008, EUR PHYS J D, V48, P35, DOI 10.1140/epjd/e2008-00059-5; Lopez O, 2010, OPT EXPRESS, V18, P16849, DOI 10.1364/OE.18.016849; MA LS, 1994, OPT LETT, V19, P1777, DOI 10.1364/OL.19.001777; Marra G, 2011, OPT LETT, V36, P511, DOI 10.1364/OL.36.000511; Musha M, 2008, OPT EXPRESS, V16, P16459, DOI 10.1364/OE.16.016459; Newbury NR, 2007, OPT LETT, V32, P3056, DOI 10.1364/OL.32.003056; Parthey CG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.203001; Riley W. J., 2008, HDB FREQUENCY STABIL; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Schiller S, 2009, EXP ASTRON, V23, P573, DOI 10.1007/s10686-008-9126-5; Shelkovnikov A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150801; Terra O, 2010, OPT EXPRESS, V18, P16102, DOI 10.1364/OE.18.016102; Terra O, 2009, APPL PHYS B-LASERS O, V97, P541, DOI 10.1007/s00340-009-3653-2; Udem T, 1998, OPT LETT, V23, P1387, DOI 10.1364/OL.23.001387; Weyers S, 2001, METROLOGIA, V38, P343, DOI 10.1088/0026-1394/38/4/7; Yamaguchi A, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.082203	24	392	407	12	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					441	444		10.1126/science.1218442	http://dx.doi.org/10.1126/science.1218442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539714				2022-12-28	WOS:000303233400038
J	Yang, H; Shi, LY; Wang, BA; Liang, D; Zhong, CQ; Liu, W; Nie, YZ; Liu, J; Zhao, J; Gao, X; Li, DS; Xu, GL; Li, JS				Yang, Hui; Shi, Linyu; Wang, Bang-An; Liang, Dan; Zhong, Cuiqing; Liu, Wei; Nie, Yongzhan; Liu, Jie; Zhao, Jing; Gao, Xiang; Li, Dangsheng; Xu, Guo-Liang; Li, Jinsong			Generation of Genetically Modified Mice by Oocyte Injection of Androgenetic Haploid Embryonic Stem Cells	CELL			English	Article							MOUSE EMBRYOS; NUCLEAR TRANSFER; CLONED MICE; GENE-EXPRESSION; GENOME; METAPHASE; LINES; BLASTOCYSTS; METHYLATION; DERIVATION	Haploid cells are amenable for genetic analysis. Recent success in the derivation of mouse haploid embryonic stem cells (haESCs) via parthenogenesis has enabled genetic screening in mammalian cells. However, successful generation of live animals from these haESCs, which is needed to extend the genetic analysis to the organism level, has not been achieved. Here, we report the derivation of haESCs from androgenetic blastocysts. These cells, designated as AG-haESCs, partially maintain paternal imprints, express classical ESC pluripotency markers, and contribute to various tissues, including the germline, upon injection into diploid blastocysts. Strikingly, live mice can be obtained upon injection of AG-haESCs into MII oocytes, and these mice bear haESC-carried genetic traits and develop into fertile adults. Furthermore, gene targeting via homologous recombination is feasible in the AG-haESCs. Our results demonstrate that AG-haESCs can be used as a genetically tractable fertilization agent for the production of live animals via injection into oocytes.	[Wang, Bang-An; Liu, Wei; Xu, Guo-Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Grp DNA Metab, Shanghai 200031, Peoples R China; [Yang, Hui; Shi, Linyu; Liang, Dan; Zhong, Cuiqing; Li, Jinsong] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Grp Epigenet Reprogramming, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Nie, Yongzhan; Liu, Jie] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Nie, Yongzhan; Liu, Jie] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Peoples R China; [Zhao, Jing; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Air Force Military Medical University; Air Force Military Medical University; Nanjing University	Xu, GL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Grp DNA Metab, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn; jsli@sibs.ac.cn	Liu, Dominic/AAH-5057-2021; zhao, jing/B-3868-2019	Liang, Dan/0000-0003-2404-3075; li, jin song/0000-0003-3456-662X; Wang, Bang-An/0000-0003-4488-1738; yang, hui/0000-0003-3590-722X	Ministry of Science and Technology of China [2009CB941101, 2011CB811304]; National Natural Science Foundation of China [30730059]; Chinese Academy of Sciences [XDA01010403, XDA01010301]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank M. Dym, X. Sun, and C. Walsh for critical reading of the manuscript. This study was supported by grants from the Ministry of Science and Technology of China (2009CB941101 to J.L. and G.-L. X., 2011CB811304), the National Natural Science Foundation of China (30730059 to G.-L. X.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010403 to J.L.; XDA01010301 to G.-L.X.).	Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Dean W, 1998, DEVELOPMENT, V125, P2273; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jiang J, 2011, J MOL CELL BIOL, V3, P197, DOI 10.1093/jmcb/mjr012; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1978, J EMBRYOL EXP MORPH, V45, P85; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kuretake S, 1996, BIOL REPROD, V55, P789, DOI 10.1095/biolreprod55.4.789; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li JS, 2008, BIOL REPROD, V79, P588, DOI 10.1095/biolreprod.108.069583; Lin JW, 2011, CELL STEM CELL, V8, P371, DOI 10.1016/j.stem.2011.02.007; Liu H, 2001, BIOL REPROD, V65, P1794, DOI 10.1095/biolreprod65.6.1794; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MODLINSKI JA, 1975, J EMBRYOL EXP MORPH, V33, P897; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Ono Y, 2001, REPRODUCTION, V122, P731, DOI 10.1530/reprod/122.5.731; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schimenti J, 2011, CELL STEM CELL, V9, P488, DOI 10.1016/j.stem.2011.11.006; Sukov WR, 2010, CANCER GENET CYTOGEN, V202, P123, DOI 10.1016/j.cancergencyto.2010.07.120; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1976, NATURE, V259, P663, DOI 10.1038/259663a0; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9; Yang H, 2011, CELL RES, V21, P854, DOI 10.1038/cr.2011.45; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	48	136	169	10	128	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					605	617		10.1016/j.cell.2012.04.002	http://dx.doi.org/10.1016/j.cell.2012.04.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541431	Bronze			2022-12-28	WOS:000303443100012
J	Ying, HQ; Kimmelman, AC; Lyssiotis, CA; Hua, SJ; Chu, GC; Fletcher-Sananikone, E; Locasale, JW; Son, J; Zhang, HL; Coloff, JL; Yan, HY; Wang, W; Chen, SJ; Viale, A; Zheng, HW; Paik, JH; Lim, C; Guimaraes, AR; Martin, ES; Chang, J; Hezel, AF; Perry, SR; Hu, J; Gan, BY; Xiao, YH; Asara, JM; Weissleder, R; Wang, YA; Chin, L; Cantley, LC; DePinho, RA				Ying, Haoqiang; Kimmelman, Alec C.; Lyssiotis, Costas A.; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Locasale, Jason W.; Son, Jaekyoung; Zhang, Hailei; Coloff, Jonathan L.; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Guimaraes, Alexander R.; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Asara, John M.; Weissleder, Ralph; Wang, Y. Alan; Chin, Lynda; Cantley, Lewis C.; DePinho, Ronald A.			Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism	CELL			English	Article							N-LINKED CARBOHYDRATE; K-RAS ADDICTION; CANCER; INDUCTION; MYC; EXPRESSION; BIOLOGY; PATHWAY; CELLS; MICE	Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent. Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a critical role in tumor initiation. Here, an inducible Kras(G12D)-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on Kras(G12D) expression. Transcriptome and metabolomic analyses indicate that Kras(G12D) serves a vital role in controlling tumor metabolism through stimulation of glucose uptake and channeling of glucose intermediates into the hexosamine biosynthesis and pentose phosphate pathways (PPP). These studies also reveal that oncogenic Kras promotes ribose biogenesis. Unlike canonical models, we demonstrate that Kras(G12D) drives glycolysis intermediates into the nonoxidative PPP, thereby decoupling ribose biogenesis from NADP/NADPH-mediated redox control. Together, this work provides in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming in native tumors and illuminates potential metabolic targets that can be exploited for therapeutic benefit in PDAC.	[Kimmelman, Alec C.; Son, Jaekyoung] Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Zhang, Hailei; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Yan, Haiyan; Wang, Wei; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Locasale, Jason W.; Weissleder, Ralph; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Coloff, Jonathan L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Locasale, Jason W.; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wang, Wei] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Guimaraes, Alexander R.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Med Genet, Houston, TX 77030 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kimmelman, AC (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA.	alec_kimmelman@dfci.harvard.edu; rdepinho@mdanderson.org	Ying, Haoqiang/AAK-4325-2020; Lyssiotis, Costas A/AAI-1923-2019; Locasale, Jason W/ABE-6505-2020; Gan, Boyi/HDM-4206-2022; Cantley, Lewis C/D-1800-2014	Lyssiotis, Costas A/0000-0001-9309-6141; Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; DePinho, Ronald/0000-0002-5625-577X; /0000-0003-0828-4143; Zheng, Hongwu/0000-0002-5823-4913	NIH [T32 CA009382-26, P01 CA117969]; BIDMC; National Cancer Institute [R01 CA157490]; Kimmel Scholar Award; AACR; Damon Runyon Fellowship; NATIONAL CANCER INSTITUTE [P01CA117969, T32CA009382, P50CA086355, U24CA092782, P30CA006516, P01CA120964, R01CA157490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIDMC; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR; Damon Runyon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Wright for the p48-Cre mice; Shan Zhou and Shan Jiang for expert monitoring of the mouse colony; Yingchun Liu, Yuxiang Zheng, Ning Wu, Alexandra Grassian, Joan Brugge, Min Yuan, and Susanne Breitkopf for helpful suggestions and technical support. Grant support derives from NIH grants T32 CA009382-26 (H.Y.) and P01 CA117969 (R. W., L. C., L. C. C., R. A. D.). Imaging was supported by U24 CA092782 and P50 CA86355 (R. W.). Mass spectrometry was supported by 5P01CA120964-05 (L. C. C. and J.A.), 5P30CA006516-46 (J.A.), and the BIDMC Research Capital Fund. A. C. K. is supported by the National Cancer Institute Grant R01 CA157490, Kimmel Scholar Award and AACR-PanCAN Career Development Award. C. A. L. is the Amgen Fellow of the Damon Runyon Cancer Research Foundation (DRG-2056-10). S. H. is supported by a Damon Runyon Fellowship. A. C. K. is a Consultant for Forma Therapeutics. L. C. C. is a founder of Agios Pharmaceuticals, a company developing drugs to target metabolic enzymes for cancer therapy.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; BOLSCHER JGM, 1988, EMBO J, V7, P3361, DOI 10.1002/j.1460-2075.1988.tb03208.x; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DENNIS JW, 1989, ONCOGENE, V4, P853; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Marino S, 2000, GENE DEV, V14, P994; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; RACKER E, 1985, P NATL ACAD SCI USA, V82, P3535, DOI 10.1073/pnas.82.11.3535; RAK JW, 1991, CANCER LETT, V57, P27, DOI 10.1016/0304-3835(91)90059-Q; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WOJCIECHOWICZ DC, 1995, BIOCHEM BIOPH RES CO, V212, P758, DOI 10.1006/bbrc.1995.2034; Yuan M., 2012, NAT PROTOC IN PRESS; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhou WD, 2011, J PROTEOME RES, V10, P1944, DOI 10.1021/pr101179t	52	1198	1229	9	233	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					656	670		10.1016/j.cell.2012.01.058	http://dx.doi.org/10.1016/j.cell.2012.01.058			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541435	Green Accepted, Bronze			2022-12-28	WOS:000303443100016
J	Chiang, N; Fredman, G; Backhed, F; Oh, SF; Vickery, T; Schmidt, BA; Serhan, CN				Chiang, Nan; Fredman, Gabrielle; Backhed, Fredrik; Oh, Sungwhan F.; Vickery, Thad; Schmidt, Birgitta A.; Serhan, Charles N.			Infection regulates pro-resolving mediators that lower antibiotic requirements	NATURE			English	Article							ACUTE LUNG INJURY; INFLAMMATION; RESOLUTION; ASPIRIN; INNATE; MICE; PHAGOCYTOSIS; MACROPHAGES; INHIBITION; RESPONSES	Underlying mechanisms for how bacterial infections contribute to active resolution of acute inflammation are unknown(1-4). Here, we performed exudate leukocyte trafficking and mediator-metabololipidomics of murine peritoneal Escherichia coli infections with temporal identification of pro-inflammatory (prostaglandins and leukotrienes) and specialized pro-resolving mediators (SPMs). In self-resolving E. coli exudates (10(5) colony forming units, c.f.u.), the dominant SPMs identified were resolvin (Rv) D5 and protectin D1 (PD1), which at 12 h were at significantly greater levels than in exudates from higher titre E. coli (10(7) c.f.u.)-challenged mice. Germfree mice had endogenous RvD1 and PD1 levels higher than in conventional mice. RvD1 and RvD5 (nanograms per mouse) each reduced bacterial titres in blood and exudates, E. coli-induced hypothermia and increased survival, demonstrating the first actions of RvD5. With human polymorphonuclear neutrophils and macrophages, RvD1, RvD5 and PD1 each directly enhanced phagocytosis of E. coli, and RvD5 counter-regulated a panel of pro-inflammatory genes, including NF-kappa B and TNF-alpha. RvD5 activated the RvD1 receptor, GPR32, to enhance phagocytosis. With self-limited E. coli infections, RvD1 and the antibiotic ciprofloxacin accelerated resolution, each shortening resolution intervals (R-i). Host-directed RvD1 actions enhanced ciprofloxacin's therapeutic actions. In 10(7) c.f.u. E. coli infections, SPMs (RvD1, RvD5, PD1) together with ciprofloxacin also heightened host antimicrobial responses. In skin infections, SPMs enhanced vancomycin clearance of Staphylococcus aureus. These results demonstrate that specific SPMs are temporally and differentially regulated during infections and that they are anti-phlogistic, enhance containment and lower antibiotic requirements for bacterial clearance.	[Chiang, Nan; Fredman, Gabrielle; Oh, Sungwhan F.; Vickery, Thad; Schmidt, Birgitta A.; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Boston, MA 02115 USA; [Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Gothenburg	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Backhed, Fredrik/ABE-6613-2020; Chiang, Nan/ABA-4924-2021	Backhed, Fredrik/0000-0002-4871-8818; Chiang, Nan/0000-0003-1963-1585	NIH [P01GM095467, R01GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Small for assistance with manuscript preparation, J. Lederer for cytokine measurements, J. Dalli for discussions, and N. Petasis for preparation of deuterium-labelled RvD1. This work was supported in part by NIH grants P01GM095467 and R01GM38765 (C.N.S.).	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256; Houck J. C., 1979, CHEM MESSENGERS INFL; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Klingensmith M. E., 1998, PHYSL BASIS MODERN S, P478; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Link A, 2008, CRIT CARE, V12, DOI 10.1186/cc7158; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Prescott D, 2011, AM J PHYSIOL-GASTR L, V301, pG487, DOI 10.1152/ajpgi.00042.2011; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Winyard P. G., 2003, INFLAMMATION PROTOCO; World Health Organization (WHO), 2020, ANTIMICROBIAL RESIST; Xu YN, 2011, ANESTH ANALG, V112, P1403, DOI 10.1213/ANE.0b013e318213fbd3; Yang R., 2011, CURR PROTOC IMMUNOL, V95	30	456	467	6	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					524	U152		10.1038/nature11042	http://dx.doi.org/10.1038/nature11042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538616	Green Submitted, Green Accepted			2022-12-28	WOS:000303200400053
J	Athan, E; Chu, VH; Tattevin, P; Selton-Suty, C; Jones, P; Naber, C; Miro, JM; Ninot, S; Fernandez-Hidalgo, N; Durante-Mangoni, E; Spelman, D; Hoen, B; Lejko-Zupanc, T; Cecchi, E; Thuny, F; Hannan, MM; Pappas, P; Henry, M; Fowler, VG; Crowley, AL; Wang, A				Athan, Eugene; Chu, Vivian H.; Tattevin, Pierre; Selton-Suty, Christine; Jones, Phillip; Naber, Christoph; Miro, Jose M.; Ninot, Salvador; Fernandez-Hidalgo, Nuria; Durante-Mangoni, Emanuele; Spelman, Denis; Hoen, Bruno; Lejko-Zupanc, Tatjana; Cecchi, Enrico; Thuny, Franck; Hannan, Margaret M.; Pappas, Paul; Henry, Margaret; Fowler, Vance G., Jr.; Crowley, Anna Lisa; Wang, Andrew		ICE-PCS Investigators	Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVERTER-DEFIBRILLATOR INFECTION; PERMANENT PACEMAKER; VALVE ENDOCARDITIS; RISK-FACTORS; MANAGEMENT; DIAGNOSIS; MORTALITY; PROGRESS	Context Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. Objectives To describe the clinical characteristics and outcome of cardiac device infective endocarditis (CDIE) with attention to its health care association and to evaluate the association between device removal during index hospitalization and outcome. Design, Setting, and Patients Prospective cohort study using data from the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS), conducted June 2000 through August 2006 in 61 centers in 28 countries. Patients were hospitalized adults with definite endocarditis as defined by modified Duke endocarditis criteria. Main Outcome Measures In-hospital and 1-year mortality. Results CDIE was diagnosed in 177 (6.4% [95% CI, 5.5%-7.4%]) of a total cohort of 2760 patients with definite infective endocarditis. The clinical profile of CDIE included advanced patient age (median, 71.2 years [interquartile range, 59.8-77.6]); causation by staphylococci (62 [35.0% {95% CI, 28.0%-42.5%}] Staphylococcus aureus and 56 [31.6% {95% CI, 24.9%-39.0%}] coagulase-negative staphylococci); and a high prevalence of health care-associated infection (81 [45.8% {95% CI, 38.3%-53.4%}]). There was coexisting valve involvement in 66 (37.3% [95% CI, 30.2%-44.9%]) patients, predominantly tricuspid valve infection (43/177 [24.3%]), with associated higher mortality. In-hospital and 1-year mortality rates were 14.7% (26/177 [95% CI, 9.8%-20.8%]) and 23.2% (41/177 [95% CI, 17.2%-30.1%]), respectively. Proportional hazards regression analysis showed a survival benefit at 1 year for device removal during the initial hospitalization (28/141 patients [19.9%] who underwent device removal during the index hospitalization had died at 1 year, vs 13/34 [38.2%] who did not undergo device removal; hazard ratio, 0.42 [95% CI, 0.22-0.82]). Conclusions Among patients with CDIE, the rate of concomitant valve infection is high, as is mortality, particularly if there is valve involvement. Early device removal is associated with improved survival at 1 year. JAMA. 2012;307(16):1727-1735	[Athan, Eugene; Henry, Margaret] Barwon Hlth, Dept Infect Dis, Geelong, Vic, Australia; [Chu, Vivian H.; Pappas, Paul; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Crowley, Anna Lisa; Wang, Andrew] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Tattevin, Pierre] Pontchaillou Univ, ICU, Rennes, France; [Selton-Suty, Christine] CHU Nancy Brabois, Nancy, France; [Jones, Phillip] Univ New S Wales, Sydney, NSW, Australia; [Naber, Christoph] W German Heart Ctr, Dept Cardiol, Essen, Germany; [Miro, Jose M.; Ninot, Salvador] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Fernandez-Hidalgo, Nuria] Hosp Univ Vall Hebron, Barcelona, Spain; [Durante-Mangoni, Emanuele] Univ Naples 2, Monaldi Hosp, Naples, Italy; [Spelman, Denis] Alfred Hosp, Melbourne, Vic, Australia; [Hoen, Bruno] Univ Med Ctr Besancon, Besancon, France; [Lejko-Zupanc, Tatjana] Med Ctr Ljubljana, Ljubljana, Slovenia; [Cecchi, Enrico] Maria Vittoria Hosp, Turin, Italy; [Thuny, Franck] Fac Med Marseille, F-13385 Marseille, France; [Hannan, Margaret M.] Mater Univ Hosp, Dept Microbiol, Dublin, Ireland	Duke University; Duke University; CHU Rennes; CHU de Nancy; University of New South Wales Sydney; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitari Vall d'Hebron; Universita della Campania Vanvitelli; Florey Institute of Neuroscience & Mental Health; Universite de Franche-Comte; CHU Besancon; University Medical Centre Ljubljana; Maria Vittoria Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Mater Misericordiae University Hospital	Wang, A (corresponding author), Duke Hosp, DUMC 3428,Room 7401,Erwin Rd, Durham, NC 27710 USA.	a.wang@duke.edu	Muñoz, Patricia/E-9431-2017; Fournier, Pierre-Edouard/AAC-6155-2021; yasmin, Mohamad/M-5472-2018; Pericàs, Juan M/N-5674-2019; Thuny, Franck/ABB-2408-2021; Fowler, Vance/AAW-2017-2021; Gonzalez Ramallo, Victor José/Y-6248-2018; Durante, Marco/K-1315-2014; Revest, Matthieu/L-9533-2015; De Rosa, Francesco Giuseppe/J-3049-2013; Cervera, Carlos/U-4538-2018; Toniolo, Antonio Q./B-4103-2015; RAOULT, Didier/A-8434-2008; Bouza, Emilio/D-8661-2014; Rudez, Igor/O-3950-2019; Marco, Francesc D/K-2900-2017; Thuny, Franck/ABC-7157-2020; Thuny, Franck/GSD-2668-2022; Rogers, Margaret/ABI-1852-2020; solis, jorge/E-2709-2018	Muñoz, Patricia/0000-0001-5706-5583; Fournier, Pierre-Edouard/0000-0001-8463-8885; yasmin, Mohamad/0000-0002-5859-1769; Pericàs, Juan M/0000-0002-3645-3293; Thuny, Franck/0000-0002-8727-7154; Gonzalez Ramallo, Victor José/0000-0002-9867-1472; Durante, Marco/0000-0002-4615-553X; Cervera, Carlos/0000-0002-0161-1749; Toniolo, Antonio Q./0000-0003-3008-2126; RAOULT, Didier/0000-0002-0633-5974; Bouza, Emilio/0000-0001-6967-9267; Rudez, Igor/0000-0002-7735-6721; Marco, Francesc D/0000-0002-1863-6379; Thuny, Franck/0000-0002-8727-7154; Selton-Suty, Christine/0000-0003-4129-5784; Wang, Andrew/0000-0001-8729-0933; Stryjewski, Martin/0000-0002-4986-6564; Rizk, Hussien/0000-0001-5791-2359; Henry, Assoc Prof Margaret J/0000-0002-1233-6754; Israel, Sarah/0000-0001-5646-0071; Falces, Carlos/0000-0002-3483-3786; solis, jorge/0000-0002-4227-7062; Fernandez-Hidalgo, Nuria/0000-0002-2115-344X; Gordon, David/0000-0003-3276-9685; Athan, Eugene/0000-0001-9838-6471; Samad, Zainab/0000-0003-2422-3199; Kanj, Souha/0000-0001-6413-3396; ALAUZET, Corentine/0000-0001-7953-4870; Moreno Camacho, Asuncion/0000-0002-5850-5007; alla, francois/0000-0002-5793-7190; Durante-Mangoni, Emanuele/0000-0002-5381-3537	American Heart Association; Cubist; Novartis; Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health); National Institutes of Health; RIS-III (Spanish Network for AIDS Research); Pfizer; MSD; Astellas; Merck; Theravance; Cerexa; Advanced Liquid Logic; MedImmune; Gilead Sciences; Edwards Lifesciences; Abbott Vascular; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain; Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Instituto de Salud Carlos III, Madrid, Spain [INT10/219]; Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain	American Heart Association(American Heart Association); Cubist; Novartis(Novartis); Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIS-III (Spanish Network for AIDS Research); Pfizer(Pfizer); MSD; Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Theravance; Cerexa; Advanced Liquid Logic; MedImmune(AstraZenecaMedimmune); Gilead Sciences(Gilead Sciences); Edwards Lifesciences; Abbott Vascular(Abbott Laboratories); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases; Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain(Generalitat de Catalunya)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chu reported receiving a career development award from the American Heart Association. Dr Tattevin reported receiving travel support to attend a meeting from Novartis. Dr Miro reported serving on the advisory boards of Cubist and Novartis; serving as a consultant for Abbott, Bristol-Myers Squibb, Cubist, Gilead Sciences, Merck, Novartis, Pfizer, and Theravance; receiving grants or grants pending from Cubist, Novartis, Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health), the National Institutes of Health, and RIS-III (Spanish Network for AIDS Research); and receiving payment for lectures from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Cubist, GlaxoSmithKline, Gilead Sciences, Janssen-Cilag, MSD, Novartis, Pfizer, Roche, Schering-Plough, Theravance, and ViiV. Dr Durante-Mangoni reported receiving payment for lectures from Novartis. Dr Hannan reported receiving an educational travel grant from Pfizer and receiving travel grants to attend international meetings from Pfizer and MSD. Dr Fowler reported serving as a consultant for Astellas, Cubist, Merck, Johnson & Johnson, Galderma, NovaDigm, The Medicines Company, Biosynexus, MedImmune, Novartis, and Pfizer; receiving grants or grants pending from the National Institutes of Health, Astellas, Cubist, Merck, Theravance, Cerexa, Pfizer, Novartis, Advanced Liquid Logic, and MedImmune; holding a patent (planned, pending, or issued) for a diagnostic approach; receiving royalties from UpToDate; and receiving honoraria for development of educational presentations from Arpida, Astellas, Cubist, Inhibitex, Merck, Pfizer, Targanta, Theravance, Wyeth, Ortho-McNeil, Novartis, Vertex Pharmaceuticals, and MedImmune. Dr Wang reported providing expert testimony for trial defense; receiving grants or grants pending from Gilead Sciences, Edwards Lifesciences, and Abbott Vascular; receiving payment for lectures from American Physician; receiving royalties for serving as an editor from Springer; and receiving payment for development of educational presentations from the American College of Cardiology Foundation. No other authors reported disclosures. None of the investigators received compensation for participation in ICE-PCS.; This work was supported in part by grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain, and the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008). Dr Miro holds an INT10/219 Intensification Research Grant (I3SNS & PRICS programs) from the Instituto de Salud Carlos III, Madrid, Spain, and the Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain.	ARBER N, 1994, MEDICINE, V73, P299, DOI 10.1097/00005792-199411000-00003; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Baman TS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P129, DOI 10.1161/CIRCEP.108.816868; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Cacoub P, 1998, AM J CARDIOL, V82, P480, DOI 10.1016/S0002-9149(98)00365-8; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011; Da Costa A, 1998, CIRCULATION, V97, P1791, DOI 10.1161/01.CIR.97.18.1791; Da Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Duval X, 2004, CLIN INFECT DIS, V39, P68, DOI 10.1086/421493; Ferguson TB, 1996, J THORAC CARDIOV SUR, V111, P742, DOI 10.1016/S0022-5223(96)70334-3; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Greenspon AJ, 2012, J AM COLL CARDIOL, V59, P681, DOI 10.1016/j.jacc.2011.11.011; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Jarcho JA, 2006, NEW ENGL J MED, V355, P288, DOI 10.1056/NEJMct055185; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Le KY, 2011, PACE, V34, P450, DOI 10.1111/j.1540-8159.2010.02991.x; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Massoure PL, 2007, PACE, V30, P12; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Sohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354	31	185	187	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1727	1735		10.1001/jama.2012.497	http://dx.doi.org/10.1001/jama.2012.497			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535857	Green Published			2022-12-28	WOS:000303147500026
J	Migliore, M; Signorelli, M				Migliore, Marcello; Signorelli, Maria			Episodic Abdominal and Chest Pain in a Young Adult	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Migliore, Marcello] Univ Catania, Dept Surg, I-95124 Catania, Italy; [Signorelli, Maria] Univ Catania, Policlin Hosp, Unit Psychiat, I-95124 Catania, Italy	University of Catania; University of Catania	Migliore, M (corresponding author), Univ Catania, Dept Surg, Via S Sofia, I-95124 Catania, Italy.	mmiglior@unict.it	Migliore, Marcello/O-7545-2017; Signorelli, Maria S/A-7422-2016; Signorelli, Maria/E-6155-2010; Signorelli, Maria Salvina/E-6155-2010	Migliore, Marcello/0000-0002-6272-8983; Signorelli, Maria S/0000-0002-6941-9454; Signorelli, Maria/0000-0002-6941-9454; Signorelli, Maria Salvina/0000-0001-5835-4176				Ergin M, 2011, J CLIN ANAL MED, V2, P119, DOI 10.4328/JCAM.308; HOWELL J M, 1992, Journal of Emergency Medicine, V10, P435, DOI 10.1016/0736-4679(92)90272-U; LIPKIN M, 1955, NEW ENGL J MED, V253, P591, DOI 10.1056/NEJM195510062531403; Maigne JY, 2010, JOINT BONE SPINE, V77, P474, DOI 10.1016/j.jbspin.2010.04.009; Simpson J Keith, 2007, Chiropr Osteopat, V15, P13, DOI 10.1186/1746-1340-15-13	5	13	13	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1746	1747		10.1001/jama.2012.506	http://dx.doi.org/10.1001/jama.2012.506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535859				2022-12-28	WOS:000303147500028
J	Stockwell, MS; Kharbanda, EO; Martinez, RA; Vargas, CY; Vawdrey, DK; Camargo, S				Stockwell, Melissa S.; Kharbanda, Elyse Olshen; Martinez, Raquel Andres; Vargas, Celibell Y.; Vawdrey, David K.; Camargo, Stewin			Effect of a Text Messaging Intervention on Influenza Vaccination in an Urban, Low-Income Pediatric and Adolescent Population A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION PRACTICES ACIP; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; YOUNG-CHILDREN; UNITED-STATES; OTITIS-MEDIA; PREVENTION; COVERAGE; RECALL	Context Influenza infection results in substantial costs, morbidity, and mortality. Vaccination against influenza is particularly important in children and adolescents who are a significant source of transmission to other high-risk populations, yet pediatric and adolescent vaccine coverage remains low. Traditional vaccine reminders have had a limited effect on low-income populations; however, text messaging is a novel, scalable approach to promote influenza vaccination. Objective To evaluate targeted text message reminders for low-income, urban parents to promote reciept of influenza vaccination among children and adolescents. Design, Setting, and Participants Randomized controlled trial of 9213 children and adolescents aged 6 months to 18 years receiving care at 4 community-based clinics in the United States during the 2010-2011 influenza season. Of the 9213 children and adolescents, 7574 had not received influenza vaccine prior to the intervention start date and were included in the primary analysis. Intervention Parents of children assigned to the intervention received up to 5 weekly immunization registry-linked text messages providing educational information and instructions regarding Saturday clinics. Both the intervention and usual care groups received the usual care, an automated telephone reminder, and access to informational flyers posted at the study sites. Main Outcome Measures Receipt of an influenza vaccine dose recorded in the immunization registry via an electronic health record by March 31, 2011. Receipt was secondarily assessed at an earlier fall review date prior to typical widespread influenza activity. Results Study children and adolescents were primarily minority, 88% were publicly insured, and 58% were from Spanish-speaking families. As of March 31, 2011, a higher proportion of children and adolescents in the intervention group (43.6%; n=1653) compared with the usual care group (39.9%; n=1509) had received influenza vaccine (difference, 3.7% [95% CI, 1.5%-5.9%]; relative rate ratio [RRR], 1.09 [95% CI, 1.04-1.15]; P=.001). At the fall review date, 27.1% (n=1026) of the intervention group compared with 22.8% (n=864) of the usual care group had received influenza vaccine (difference, 4.3% [95% CI, 2.3%-6.3%]; RRR, 1.19 [95% CI, 1.10-1.28]; P<.001). Conclusions Among children and adolescents in a low-income, urban population, a text messaging intervention compared with usual care was associated with an increased rate of influenza vaccination. However, the overall influenza vaccination rate remained low.	[Stockwell, Melissa S.; Martinez, Raquel Andres; Vargas, Celibell Y.; Camargo, Stewin] Columbia Univ, Dept Pediat, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Stockwell, Melissa S.; Martinez, Raquel Andres] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Stockwell, Melissa S.; Vawdrey, David K.] New York Presbyterian Hosp, New York, NY USA; [Kharbanda, Elyse Olshen] HealthPartners Res Fdn, Minneapolis, MN USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; HealthPartners Institute for Education & Research	Stockwell, MS (corresponding author), Columbia Univ, Dept Pediat, Mailman Sch Publ Hlth, 622 W 168th St,VC 402, New York, NY 10032 USA.	mstockwell@columbia.edu	Stockwell, Melissa/AAS-5914-2021		Maternal and Child Health Bureau [R40 MC17169]; Health Resources and Services Administration, Department of Health and Human Services	Maternal and Child Health Bureau; Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	This study was supported by grant R40 MC17169 from the Maternal and Child Health Bureau (Title V, Social Security Act), Health Resources and Services Administration, Department of Health and Human Services.	Ahlers-Schmidt CR, 2010, PREV MED, V50, P306, DOI 10.1016/j.ypmed.2010.02.008; Belshe RB, 2000, PEDIATR INFECT DIS J, V19, pS66, DOI 10.1097/00006454-200005001-00010; Bhatt P, 2011, PEDIATR INFECT DIS J, V30, P100, DOI 10.1097/INF.0b013e3181efff54; Centers for Disease Control and Prevention (US), FIN STAT LEV INFL VA; Clark SJ, 2011, PEDIATRICS, V128, pE1100, DOI 10.1542/peds.2011-0270; Dombkowski KJ, 2012, AM J PREV MED, V42, P71, DOI 10.1016/j.amepre.2011.09.028; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; Furlow Carolyn, 2011, Morbidity and Mortality Weekly Report, V60, P737; Grant VJ, 2003, CAN MED ASSOC J, V168, P39; Grohskopf Lisa, 2011, Morbidity and Mortality Weekly Report, V60, P1128; Hambidge SJ, 2004, ARCH PEDIAT ADOL MED, V158, P162, DOI 10.1001/archpedi.158.2.162; Hoberman A, 2003, JAMA-J AM MED ASSOC, V290, P1608, DOI 10.1001/jama.290.12.1608; Irigoyen MM, 2006, AMBUL PEDIATR, V6, P100, DOI 10.1016/j.ambp.2005.10.006; Kempe A, 2005, PEDIATRICS, V115, P146, DOI 10.1542/peds.2004-1804; Kempe A, 2001, J PEDIATR-US, V139, P630, DOI 10.1067/mpd.2001.117069; Kharbanda EO, 2011, VACCINE, V29, P2537, DOI 10.1016/j.vaccine.2011.01.065; LANNON C, 1995, ARCH PEDIAT ADOL MED, V149, P1070, DOI 10.1001/archpedi.1995.02170230024003; LeBaron CW, 2004, ARCH PEDIAT ADOL MED, V158, P255, DOI 10.1001/archpedi.158.3.255; Lee BY, 2011, HEALTH AFFAIR, V30, P1141, DOI 10.1377/hlthaff.2010.0778; Metroka Amy E, 2009, J Public Health Manag Pract, V15, pE13, DOI 10.1097/PHH.0b013e3181a8c31f; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nowalk MP, 2005, AM J PREV MED, V29, P210, DOI 10.1016/j.amepre.2005.05.010; Papadouka V, 2007, 41 NAT IMM C MARCH 7; Rosenthal J, 2004, PEDIATRICS, V113, pE296, DOI 10.1542/peds.113.4.e296; Stockwell MS, 2012, AM J PUBLIC HEALTH, V102, pE15, DOI 10.2105/AJPH.2011.300331; Williams W, 2011, J PUBLIC HEALTH MAN, V17, P449, DOI 10.1097/PHH.0b013e31821138fe	27	248	248	4	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1702	1708		10.1001/jama.2012.502	http://dx.doi.org/10.1001/jama.2012.502			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535855	Bronze			2022-12-28	WOS:000303147500023
J	Kuhn, L; Coovadia, HM				Kuhn, Louise; Coovadia, Hoosen M.			Protecting infants of HIV-positive mothers in Malawi	LANCET			English	Editorial Material							CHILDREN; TRANSMISSION; INFECTION		[Kuhn, Louise] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Kuhn, Louise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Coovadia, Hoosen M.] Univ Witwatersrand, Maternal Adolescent & Child Hlth MATCH, Johannesburg, South Africa; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Durban, South Africa	Columbia University; Columbia University; University of Witwatersrand; University of Kwazulu Natal	Kuhn, L (corresponding author), Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10032 USA.	lk24@columbia.edu						Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kafulafula G, 2010, JAIDS-J ACQ IMM DEF, V53, P6, DOI 10.1097/QAI.0b013e3181bd5a47; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuhn L, 2010, CLIN INFECT DIS, V50, P437, DOI 10.1086/649886; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; World Health Organization, 2010, GUID HIV INF FEED PR; World Health Organization, 2021, ANT DRUGS TREAT PREG	14	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2405	2406		10.1016/S0140-6736(12)60483-8	http://dx.doi.org/10.1016/S0140-6736(12)60483-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22541419				2022-12-28	WOS:000305915900005
J	Murray, NW				Murray, Norman W.			Evidence of Things Not Seen	SCIENCE			English	Editorial Material							TIMING VARIATIONS; PLANETS; SYSTEM; MASS		Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada	University of Toronto	Murray, NW (corresponding author), Univ Toronto, Canadian Inst Theoret Astrophys, 60 St George St, Toronto, ON M5S 3H8, Canada.	murray@cita.utoronto.ca		Murray, Norman/0000-0002-8659-3729				Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Ballard S, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/200; Batalha N.M., 2012, ARXIV12025852V1; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Johnson JA, 2009, ASTROPHYS J LETT, V692, pL100, DOI 10.1088/0004-637X/692/2/L100; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Nesvorny D, 2012, SCIENCE, V336, P1133, DOI 10.1126/science.1221141	9	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1121	1122		10.1126/science.1222590	http://dx.doi.org/10.1126/science.1222590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22582014				2022-12-28	WOS:000304647900037
J	Brody, H				Brody, Howard			From an Ethics of Rationing to an Ethics of Waste Avoidance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		Univ Texas Galveston, Med Branch, Inst Med Humanities, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Brody, H (corresponding author), Univ Texas Galveston, Med Branch, Inst Med Humanities, Galveston, TX 77555 USA.		Brody, Howard/GQA-6310-2022					Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Fleck LM, 2006, JUST CARING HLTH CAR; TRUOG RD, 1992, NEW ENGL J MED, V326, P1560, DOI 10.1056/NEJM199206043262310; Welch WG, 2011, OVERDIAGNOSED MAKING	5	114	118	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1949	1951		10.1056/NEJMp1203365	http://dx.doi.org/10.1056/NEJMp1203365			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22551106				2022-12-28	WOS:000304353000002
J	Davis, SM; Donnan, GA				Davis, Stephen M.; Donnan, Geoffrey A.			Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYMPTOMATIC CAROTID STENOSIS; HEALTH-CARE PROFESSIONALS; VASCULAR EVENTS; CARDIOVASCULAR EVENTS; AGGRESSIVE REDUCTION; HEMORRHAGIC STROKE; MEDICAL THERAPY; BLOOD-PRESSURE; ASPIRIN; ENDARTERECTOMY	A 62-year-old woman is seen 1 week after an ischemic stroke. She had presented to another hospital with dysphasia and right-sided weakness; magnetic resonance imaging (MRI) showed a recent infarction in the left parietal cortex, and computed tomographic angiography (CTA) showed a high-grade stenosis in the left proximal internal carotid artery with normal intracranial vessels (Fig. 1). She was treated with intravenous recombinant tissue plasminogen activator and discharged home, taking aspirin and a statin. She stopped smoking 12 years ago. On examination, the blood pressure is 145/90 mm Hg. She reports some mild residual clumsiness of her right hand. What would you advise to reduce the risk of stroke recurrence?	[Davis, Stephen M.] Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3050, Australia; [Davis, Stephen M.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Davis, Stephen M.; Donnan, Geoffrey A.] Univ Melbourne, Dept Neurol, Melbourne, Vic, Australia; [Donnan, Geoffrey A.] Florey Neurosci Inst, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Davis, SM (corresponding author), Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3050, Australia.	stephen.davis@mh.org.au	Davis, Stephen M/L-5260-2013	Davis, Stephen M/0000-0003-0962-2300; Donnan, Geoffrey/0000-0001-6324-3403	Boehringer Ingelheim; Sanofi-Aventis; Bayer HealthCare	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	Dr. Davis reports receiving consulting fees from Boehringer Ingelheim and lecture fees from Sanofi-Aventis, and Dr. Donnan receiving consulting fees from Bayer HealthCare. No other potential conflict of interest relevant to this article was reported.	Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; Amarenco P, 2007, STROKE, V38, P3198, DOI 10.1161/STROKEAHA.107.493106; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Brott TG, 2010, NEW ENGL J MED, V363, P498; Brott TG, 2010, NEW ENGL J MED, V363, P198; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Collins R, 2004, LANCET, V363, P757; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Georgiadis D, 2009, NEUROLOGY, V72, P1810, DOI 10.1212/WNL.0b013e3181a2a50a; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Goldstein LB, 2008, NEUROLOGY, V70, P2364, DOI 10.1212/01.wnl.0000296277.63350.77; Goldstein LB, 2001, STROKE, V32, P1091, DOI 10.1161/01.STR.32.5.1091; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Macleod MR, 2004, LANCET NEUROL, V3, P408, DOI 10.1016/S1474-4422(04)00806-3; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; PROGRESS Collaborative Grp, 2002, LANCET, V359, P2120; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Towfighi A, 2012, J NEUROL NEUROSUR PS, V83, P146, DOI 10.1136/jnnp-2011-300743; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	60	65	74	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1914	1922		10.1056/NEJMcp1107281	http://dx.doi.org/10.1056/NEJMcp1107281			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591297				2022-12-28	WOS:000304083000010
J	Pasachoff, JM				Pasachoff, Jay M.			Last chance to see	NATURE			English	Editorial Material							2004 TRANSIT; VENUS		[Pasachoff, Jay M.] Williams Coll, Williamstown, MA 01267 USA; [Pasachoff, Jay M.] Amer Astron Soc Hist Astron Div, Washington, DC USA	Williams College	Pasachoff, JM (corresponding author), Williams Coll, Williamstown, MA 01267 USA.	eclipse@williams.edu						Pasachoff JM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/4/112; Pasachoff JM, 2005, TRANSITS VENUS NEW V, P242; Schaefer B. E., 2000, B AM ASTRONOMICAL SO, V32, P1383; Schneider G, 2006, ASTROPHYS J, V641, P565, DOI 10.1086/500427; Schneider G, 2004, ICARUS, V168, P249, DOI 10.1016/j.icarus.2003.11.020; Tanga P, 2012, ICARUS, V218, P207, DOI 10.1016/j.icarus.2011.12.004	6	1	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					303	304		10.1038/485303a	http://dx.doi.org/10.1038/485303a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596138	Bronze			2022-12-28	WOS:000304099100015
J	Davies, J				Davies, Justine			Profile Elmi Muller: bending rules, changing guidelines, making history	LANCET			English	Biographical-Item														Davies, Justine/0000-0001-6834-1838					0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1781	1781		10.1016/S0140-6736(12)60749-1	http://dx.doi.org/10.1016/S0140-6736(12)60749-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22579311				2022-12-28	WOS:000303937700017
J	Robinson, A				Robinson, Andrew			The art of medicine Jean-Francois Champollion and ancient Egyptian embalming	LANCET			English	Editorial Material												andrew.robinson33@virgin.net							0	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1782	1783		10.1016/S0140-6736(12)60750-8	http://dx.doi.org/10.1016/S0140-6736(12)60750-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	941BR	22586721				2022-12-28	WOS:000303937700018
J	Twelvetrees, A; Hendricks, AG; Holzbaur, ELF				Twelvetrees, Alison; Hendricks, Adam G.; Holzbaur, Erika L. F.			SnapShot: Axonal Transport	CELL			English	Editorial Material							TUG-OF-WAR; NEURONS; MOTORS; DYNEIN; DISEASE		[Twelvetrees, Alison; Hendricks, Adam G.; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Twelvetrees, Alison] Canc Res UK London Res Inst, London WC2A 3LY, England	University of Pennsylvania; Pennsylvania Medicine; Cancer Research UK	Twelvetrees, A (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.		Twelvetrees, Alison/K-8712-2019; Hendricks, Adam/B-3692-2009	Twelvetrees, Alison/0000-0002-1796-1508; Hendricks, Adam/0000-0003-3635-1577				Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008	12	14	14	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					950	U251		10.1016/j.cell.2012.05.001	http://dx.doi.org/10.1016/j.cell.2012.05.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579292	Bronze			2022-12-28	WOS:000303934700025
J	Kelly, S				Kelly, Sean			Ulcerative colitis	BRITISH MEDICAL JOURNAL			English	Editorial Material									York Teaching Hosp NHS Fdn Trust, York Hosp, York YO31 8HE, N Yorkshire, England		Kelly, S (corresponding author), York Teaching Hosp NHS Fdn Trust, York Hosp, York YO31 8HE, N Yorkshire, England.	Sean.M.Kelly@York.NHS.UK							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 10	2012	344								e2947	10.1136/bmj.e2947	http://dx.doi.org/10.1136/bmj.e2947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XR	22577187	Bronze			2022-12-28	WOS:000304085400003
J	Seufert, V; Ramankutty, N; Foley, JA				Seufert, Verena; Ramankutty, Navin; Foley, Jonathan A.			Comparing the yields of organic and conventional agriculture	NATURE			English	Article							PRODUCTIVITY; METAANALYSES; AVAILABILITY; CHALLENGE; QUALITY; LEGUME; FEED	Numerous reports have emphasized the need for major changes in the global food system: agriculture must meet the twin challenge of feeding a growing population, with rising demand for meat and high-calorie diets, while simultaneously minimizing its global environmental impacts(1,2). Organic farming-a system aimed at producing food with minimal harm to ecosystems, animals or humans-is often proposed as a solution(3,4). However, critics argue that organic agriculture may have lower yields and would therefore need more land to produce the same amount of food as conventional farms, resulting in more widespread deforestation and bio-diversity loss, and thus undermining the environmental benefits of organic practices(5). Here we use a comprehensive meta-analysis to examine the relative yield performance of organic and conventional farming systems globally. Our analysis of available data shows that, overall, organic yields are typically lower than conventional yields. But these yield differences are highly contextual, depending on system and site characteristics, and range from 5% lower organic yields (rain-fed legumes and perennials on weak-acidic to weak-alkaline soils), 13% lower yields (when best organic practices are used), to 34% lower yields (when the conventional and organic systems are most comparable). Under certain conditions-that is, with good management practices, particular crop types and growing conditions-organic systems can thus nearly match conventional yields, whereas under others it at present cannot. To establish organic agriculture as an important tool in sustainable food production, the factors limiting organic yields need to be more fully understood, alongside assessments of the many social, environmental and economic benefits of organic farming systems.	[Seufert, Verena; Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H2T 3A3, Canada; [Seufert, Verena; Ramankutty, Navin] McGill Univ, Global Environm & Climate Change Ctr, Montreal, PQ H2T 3A3, Canada; [Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA	McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities	Seufert, V (corresponding author), McGill Univ, Dept Geog, Montreal, PQ H2T 3A3, Canada.	verena.seufert@mail.mcgill.ca	Ramankutty, Navin/AAM-6074-2020; Seufert, Verena/H-8262-2019; Foley, Jonathan A/GRS-5522-2022	Ramankutty, Navin/0000-0002-3737-5717; Seufert, Verena/0000-0003-2975-5856; 	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to the authors of the 66 studies whose extensive field work provided the data for this meta-analysis. Owing to space limitations our citations can be found in Supplementary Material. We would like to thank J. Reganold for useful comments on our manuscript. We are grateful to I. Perfecto, T. Moore, C. Halpenny, G. Seufert and S. Lehringer for valuable discussion and/or feedback on the manuscript and L. Gunst for sharing publications on the FiBL trials. D. Plouffe helped with the figures and M. Henry with compiling data. This research was supported by a Discovery Grant awarded to N.R. from the Natural Science and Engineering Research Council of Canada.	Badgley C, 2007, RENEW AGR FOOD SYST, V22, P86, DOI 10.1017/S1742170507001640; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Berry PM, 2002, SOIL USE MANAGE, V18, P248, DOI 10.1079/SUM2002129; Cassman K, 2007, RENEW AGR FOOD SYST, V22, P83; Colla G, 2000, AGRON J, V92, P924, DOI 10.2134/agronj2000.925924x; Connor DJ, 2008, FIELD CROP RES, V106, P187, DOI 10.1016/j.fcr.2007.11.010; Crews TE, 2005, NUTR CYCL AGROECOSYS, V72, P101, DOI 10.1007/s10705-004-6480-1; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; De Schutter O, 2010, REPORT SPECIAL UNPUB; Deryng D, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2009GB003765; Drinkwater LE, 2000, PLANT SOIL, V227, P99, DOI 10.1023/A:1026569715168; Englund G, 1999, ECOLOGY, V80, P1132, DOI 10.1890/0012-9658(1999)080[1132:TIODSC]2.0.CO;2; FAOSTAT, 2011, FAOSTAT; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hedges LV, 2014, STAT METHODS META AN; Hillebrand H, 2010, ECOLOGY, V91, P2545, DOI 10.1890/09-0070.1; IGBP-DIS, 1998, SOILD V 0 PROGR CREA; Johnston M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014004; Kirchmann H, 2001, COMMUN SOIL SCI PLAN, V32, P997, DOI 10.1081/CSS-100104101; Leifeld J, 2010, AMBIO, V39, P585, DOI 10.1007/s13280-010-0082-8; LIEBHARDT WC, 1989, AGRON J, V81, P150, DOI 10.2134/agronj1989.00021962008100020003x; Lotter DW, 2003, AM J ALTERNATIVE AGR, V18, P146, DOI 10.1079/AJAA200345; Martini EA, 2004, FIELD CROP RES, V86, P255, DOI 10.1016/j.fcr.2003.09.002; McIntyre B.D., 2009, AGR CROSSROADS INT A; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; National Research Council, 2010, SUST AGR SYST 21 CEN, DOI 10.17226/12832; Oehl F, 2002, NUTR CYCL AGROECOSYS, V62, P25, DOI 10.1023/A:1015195023724; Pang XP, 2000, SOIL SCI SOC AM J, V64, P247, DOI 10.2136/sssaj2000.641247x; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Raynolds LT, 2004, WORLD DEV, V32, P725, DOI 10.1016/j.worlddev.2003.11.008; Research Institute of Organic Agriculture (FiBL), 2011, FARM SYST COMP TROP; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Scialabba N. E. H., 2002, Organic agriculture, environment and food security; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; Valkila J, 2009, ECOL ECON, V68, P3018, DOI 10.1016/j.ecolecon.2009.07.002; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1	40	1008	1079	59	1543	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					229	U113		10.1038/nature11069	http://dx.doi.org/10.1038/nature11069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22535250				2022-12-28	WOS:000303799800039
J	Tsai, PY; Tzeng, WS				Tsai, Pei-Yu; Tzeng, Wen-Sheng			Vertebra Plana with Spontaneous Healing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsai, Pei-Yu; Tzeng, Wen-Sheng] Chi Mei Med Ctr, Tainan, Taiwan	Chi Mei Hospital	Tsai, PY (corresponding author), Chi Mei Med Ctr, Tainan, Taiwan.								0	6	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					E30	E30		10.1056/NEJMicm1101582	http://dx.doi.org/10.1056/NEJMicm1101582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571218				2022-12-28	WOS:000303817000012
J	Davies, P				Davies, Peter			Behind closed doors: how much power does McKinsey wield?	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Dudman J, 2012, GUARDIAN        0306; Griffiths K, 2005, INDEPENDENT     0627; Iacobucci G, 2011, PULSE           0309; Iacobucci G, 2010, PULSE           0607; McKinsey, 2009, ACHIEVING WORLD CLAS; Rose D, 2009, MAIL SUNDAY     0212; World Health Care Congress Latin America, 2011, WORLD HLTH CARE C	7	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e2905	10.1136/bmj.e2905	http://dx.doi.org/10.1136/bmj.e2905			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XB	22573649				2022-12-28	WOS:000304083800004
J	Khila, A; Abouheif, E; Rowe, L				Khila, Abderrahman; Abouheif, Ehab; Rowe, Locke			Function, Developmental Genetics, and Fitness Consequences of a Sexually Antagonistic Trait	SCIENCE			English	Article							SEX DETERMINATION; BEETLE HORNS; EVOLUTION; DROSOPHILA; CONFLICT; DIVERSIFICATION; HETEROPTERA; COEVOLUTION; APPENDAGES; PHYLOGENY	Sexual conflict is thought to be a potent force driving the evolution of sexually dimorphic traits. In the water strider Rheumatobates rileyi, we show that elaborated traits on male antennae function to grasp resistant females during premating struggles. Using RNA interference, we uncovered novel roles of the gene distal-less (dll) in generating these male-specific traits. Furthermore, graded reduction of the grasping traits resulted in a graded reduction of mating success in males, thus demonstrating both selection for elaboration of the traits and the role of dll in their evolution. By establishing developmental genetic tools in model systems where sexual selection and conflict are understood, we can begin to reveal how selection can exploit ancient developmental genes to enable the evolution of sexually dimorphic traits.	[Khila, Abderrahman; Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Khila, Abderrahman; Abouheif, Ehab] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Khila, Abderrahman] Ecole Normale Super Lyon, CNRS, UMR 5242, Inst Genom Fonct Lyon, F-69364 Lyon 07, France	University of Toronto; McGill University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Rowe, L (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	locke.rowe@utoronto.ca		Abouheif, Ehab/0000-0001-7651-1737; Khila, Abderrahman/0000-0003-0908-483X	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada; ATIP-Avenir CNRS France	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ATIP-Avenir CNRS France	Supported by the Canada Research Chairs program and the Natural Sciences and Engineering Research Council of Canada (L.R. and E.A.) and by ATIP-Avenir program CNRS France (A.K.). We thank G. Arnqvist, A. Bruce, and M. Sokolowski for comments; H. Rodd and A. Agrawal for sharing their high-speed camera; and S. B. Carroll for the Dll antibody. DNA sequences were deposited in GenBank (accession nos. JQ639098, JQ639093, JQ639097, JQ639094, JN936863, JQ639092, JQ639096, and JQ639095).	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Beermann A, 2001, DEVELOPMENT, V128, P287; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Clifford R, 2000, DEVELOPMENT, V127, P5265; Damgaard J, 2005, SYST ENTOMOL, V30, P289, DOI 10.1111/j.1365-3113.2004.00275.x; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Hosken D, 2005, AM NAT, V165, pS1, DOI 10.1086/429355; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Khila A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000583; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Rowe L, 2002, EVOLUTION, V56, P754; Rowe L, 2006, CAN ENTOMOL, V138, P568; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Westlake KP, 2000, SYST ENTOMOL, V25, P125, DOI 10.1046/j.1365-3113.2000.00098.x; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687	25	66	66	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					585	589		10.1126/science.1217258	http://dx.doi.org/10.1126/science.1217258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556252				2022-12-28	WOS:000303498800045
J	Sfeir, A; de Lange, T				Sfeir, Agnel; de lange, Titia			Removal of Shelterin Reveals the Telomere End-Protection Problem	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; JOINING PATHWAY; POT1 PROTEINS; YEAST KU; DNA; SGS1; NHEJ	The telomere end-protection problem is defined by the aggregate of DNA damage signaling and repair pathways that require repression at telomeres. To define the end-protection problem, we removed the whole shelterin complex from mouse telomeres through conditional deletion of TRF1 and TRF2 in nonhomologous end-joining (NHEJ) deficient cells. The data reveal two DNA damage response pathways not previously observed upon deletion of individual shelterin proteins. The shelterin-free telomeres are processed by microhomology-mediated alternative-NHEJ when Ku70/80 is absent and are attacked by nucleolytic degradation in the absence of 53BP1. The data establish that the end-protection problem is specified by six pathways [ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related) signaling, classical-NHEJ, alt-NHEJ, homologous recombination, and resection] and show how shelterin acts with general DNA damage response factors to solve this problem.	[Sfeir, Agnel; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [GM49046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. White for exceptional dedication to the mouse husbandry involved in this project and members of the de Lange laboratory for comments on this manuscript. This work was supported by grants from the NIH to T.dL. (GM49046 and AG016642). T.dL. is an American Cancer Society Research Professor.	Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	394	405	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					593	597		10.1126/science.1218498	http://dx.doi.org/10.1126/science.1218498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556254	Green Accepted			2022-12-28	WOS:000303498800047
J	Johnson, BC; Melosh, HJ				Johnson, B. C.; Melosh, H. J.			Impact spherules as a record of an ancient heavy bombardment of Earth	NATURE			English	Article							MAJOR ASTEROID IMPACT; WESTERN-AUSTRALIA; HAMERSLEY BASIN; IRIDIUM ANOMALIES; SOUTH-AFRICA; EJECTA; LAYER; BOUNDARY; CRUSTAL; ORIGIN	Impact craters are the most obvious indication of asteroid impacts, but craters on Earth are quickly obscured or destroyed by surface weathering and tectonic processes(1). Earth's impact history is inferred therefore either from estimates of the present-day impactor flux as determined by observations of near-Earth asteroids, or from the Moon's incomplete impact chronology(2-4). Asteroids hitting Earth typically vaporize a mass of target rock comparable to the projectile's mass. As this vapour expands in a large plume or fireball, it cools and condenses into molten droplets called spherules(5). For asteroids larger than about ten kilometres in diameter, these spherules are deposited in a global layer. Spherule layers preserved in the geologic record accordingly provide information about an impact even when the source crater cannot be found(1). Here we report estimates of the sizes and impact velocities of the asteroids that created global spherule layers. The impact chronology from these spherule layers reveals that the impactor flux was significantly higher 3.5 billion years ago than it is now. This conclusion is consistent with a gradual decline of the impactor flux after the Late Heavy Bombardment.	[Johnson, B. C.; Melosh, H. J.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Melosh, H. J.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Johnson, BC (corresponding author), Purdue Univ, Dept Phys, 525 Northwestern Ave, W Lafayette, IN 47907 USA.	johns477@purdue.edu		Johnson, Brandon/0000-0002-4267-093X	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank B. Simonson and C. Chapman, whose comments improved this work. We acknowledge support from NASA.	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Chadwick B, 2001, J GEOL SOC LONDON, V158, P331, DOI 10.1144/jgs.158.2.331; Collins GS, 2002, ICARUS, V157, P24, DOI 10.1006/icar.2002.6822; Glass BP, 1998, METEORIT PLANET SCI, V33, P229, DOI 10.1111/j.1945-5100.1998.tb01628.x; Glikson A, 2004, EARTH PLANET SC LETT, V220, P247, DOI 10.1016/S0012-821X(04)00062-7; Goderis S, 2011, 43 LUN PLAN SCI C, P1882; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hassler SW, 2011, GEOLOGY, V39, P307, DOI 10.1130/G31526.1; Ivanov B. A., 2007, TREATISE GEOPHYS, V10, P202, DOI DOI 10.1016/B978-044452748-6.00158-9; Johnson BC, 2012, ICARUS, V217, P416, DOI 10.1016/j.icarus.2011.11.020; KOHL I, 2006, GEOLOGICAL SOC AM SP, V405, P57; Kyte FT, 2011, EARTH PLANET SC LETT, V302, P279, DOI 10.1016/j.epsl.2010.12.006; Kyte FT, 2003, GEOLOGY, V31, P283, DOI 10.1130/0091-7613(2003)031<0283:EASBCI>2.0.CO;2; Le Feuvre M, 2011, ICARUS, V214, P1, DOI 10.1016/j.icarus.2011.03.010; Lowe DR, 2003, ASTROBIOLOGY, V3, P7, DOI 10.1089/153110703321632408; LOWE DR, 2010, LUNAR PLANET SCI, V41, P2563; MELOSH HJ, 1991, NATURE, V350, P494, DOI 10.1038/350494a0; Minton DA, 2010, ICARUS, V207, P744, DOI 10.1016/j.icarus.2009.12.008; Raizer Y. P, 1960, SOV PHYS JETP, V37, P1229; Rasmussen B, 2004, GEOLOGY, V32, P1029, DOI 10.1130/G20825.1; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; Simonson BM, 2004, ANNU REV EARTH PL SC, V32, P329, DOI 10.1146/annurev.earth.32.101802.120458; SIMONSON BM, 1992, GEOL SOC AM BULL, V104, P829, DOI 10.1130/0016-7606(1992)104<0829:GEFASF>2.3.CO;2; Simonson BM, 2009, PRECAMBRIAN RES, V175, P51, DOI 10.1016/j.precamres.2009.08.004; Simonson BM, 2009, PRECAMBRIAN RES, V169, P100, DOI 10.1016/j.precamres.2008.10.016; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; Stuart JS, 2004, ICARUS, V170, P295, DOI 10.1016/j.icarus.2004.03.018; Yancey TE, 2008, GEOL SOC AM BULL, V120, P1105, DOI 10.1130/B26146.1; [No title captured], DOI DOI 10.1130/SPE190-P103	29	75	77	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					75	77		10.1038/nature10982	http://dx.doi.org/10.1038/nature10982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22535246				2022-12-28	WOS:000303451900036
J	Sokol, DK				Sokol, Daniel K.			The hardest thing: admitting error	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Sokol, Daniel K.] Inner Temple, London, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Kroll L, 2008, MED EDUC, V42, P982, DOI 10.1111/j.1365-2923.2008.03151.x; Wright J, 2008, AVMA MED LEGAL J, V15, P193	2	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e3085	10.1136/bmj.e3085	http://dx.doi.org/10.1136/bmj.e3085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NC	22551716				2022-12-28	WOS:000303817200003
J	Brugues, J; Nuzzo, V; Mazur, E; Needleman, DJ				Brugues, Jan; Nuzzo, Valeria; Mazur, Eric; Needleman, Daniel J.			Nucleation and Transport Organize Microtubules in Metaphase Spindles	CELL			English	Article							ULTRAVIOLET MICROBEAM IRRADIATION; CHROMOSOMAL PASSENGER COMPLEX; EGG EXTRACT SPINDLES; MITOTIC-SPINDLE; MEIOTIC SPINDLE; IN-VITRO; SELF-ORGANIZATION; HUMAN-CELLS; DYNAMICS; REVEALS	Spindles are arrays of microtubules that segregate chromosomes during cell division. It has been difficult to validate models of spindle assembly due to a lack of information on the organization of microtubules in these structures. Here we present a method, based on femtosecond laser ablation, capable of measuring the detailed architecture of spindles. We used this method to study the metaphase spindle in Xenopus laevis egg extracts and found that microtubules are shortest near poles and become progressively longer toward the center of the spindle. These data, in combination with mathematical modeling, imaging, and biochemical perturbations, are sufficient to reject previously proposed mechanisms of spindle assembly. Our results support a model of spindle assembly in which microtubule polymerization dynamics are not spatially regulated, and the proper organization of microtubules in the spindle is determined by nonuniform microtubule nucleation and the local sorting of microtubules by transport.	[Brugues, Jan; Needleman, Daniel J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Brugues, Jan; Needleman, Daniel J.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Brugues, Jan; Nuzzo, Valeria; Mazur, Eric; Needleman, Daniel J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Brugues, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	jbrugues@fas.harvard.edu	Brugues, Jan/C-7727-2017	Brugues, Jan/0000-0002-6731-4130	Nation Science Foundation [PHY-0847188, DMR-0820484, CBET-0854288, PHY-0555583]; Human Frontiers Science Program	Nation Science Foundation(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program)	We thank Tim Mitchison for advice; Martin Wuehr, Ryoma Ohi, and Marija Zanic for providing us with P150-CC1, MCAK antibodies, and GFP-EB1, respectively; Ramon Xulvi-Brunet for useful discussions on error estimation and numerical fits; and Simone Reber, Tim Mitchison, Philippe Cluzel, Reza Farhadifar, Pierre Sens, and Bodo Stern for valuable comments on the manuscript. This work was supported by Nation Science Foundation grants PHY-0847188, DMR-0820484, CBET-0854288 and PHY-0555583 and a fellowship (to J.B.) from the Human Frontiers Science Program.	Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; COLOMBELLI J, 2005, MED LASER APPL, V20, P217; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; EUTENEUER U, 1982, J CELL BIOL, V94, P644, DOI 10.1083/jcb.94.3.644; EUTENEUER U, 1980, J CELL BIOL, V87, P509, DOI 10.1083/jcb.87.2.509; FORER A, 1965, J CELL BIOL, V25, P95, DOI 10.1083/jcb.25.1.95; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heisterkamp A, 2005, OPT EXPRESS, V13, P3690, DOI 10.1364/OPEX.13.003690; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Inoue S., 1964, PRIMITIVE MOTILE SYS, P549; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; LESLIE RJ, 1984, CELL, V36, P717, DOI 10.1016/0092-8674(84)90352-0; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MCINTOSH JR, 1971, J CELL BIOL, V49, P468, DOI 10.1083/jcb.49.2.468; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Murray A. W., 1993, METHOD CELL BIOL, P581; Needleman DJ, 2010, MOL BIOL CELL, V21, P323, DOI 10.1091/mbc.E09-09-0816; NICKLAS RB, 1989, J CELL SCI, V94, P415; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; SPURCK TP, 1990, J CELL BIOL, V111, P1505, DOI 10.1083/jcb.111.4.1505; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643	53	110	111	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					554	564		10.1016/j.cell.2012.03.027	http://dx.doi.org/10.1016/j.cell.2012.03.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541427	Bronze			2022-12-28	WOS:000303443100008
J	Feinmann, J				Feinmann, Jane			BMJ WINTER APPEAL Winter appeal latest: BMJ readers raise almost 34 pound 000 for Lifebox	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 27	2012	344								e807	10.1136/bmj.e807	http://dx.doi.org/10.1136/bmj.e807			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HE	22544836				2022-12-28	WOS:000303434000005
J	Kumar, MS; Hancock, DC; Molina-Arcas, M; Steckel, M; East, P; Diefenbacher, M; Armenteros-Monterroso, E; Lassailly, F; Matthews, N; Nye, E; Stamp, G; Behrens, A; Downward, J				Kumar, Madhu S.; Hancock, David C.; Molina-Arcas, Miriam; Steckel, Michael; East, Phillip; Diefenbacher, Markus; Armenteros-Monterroso, Elena; Lassailly, Francois; Matthews, Nik; Nye, Emma; Stamp, Gordon; Behrens, Axel; Downward, Julian			The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer	CELL			English	Article							KAPPA-B; ACTIVATION; MOUSE; INHIBITION; EXPRESSION; BINDING; ROCK; RHO	Non-small cell lung cancer (NSCLC) is the most frequent cause of cancer deaths worldwide; nearly half contain mutations in the receptor tyrosine kinase/RAS pathway. Here we show that RAS-pathway mutant NSCLC cells depend on the transcription factor GATA2. Loss of GATA2 reduced the viability of NSCLC cells with RAS-pathway mutations, whereas wild-type cells were unaffected. Integrated gene expression and genome occupancy analyses revealed GATA2 regulation of the proteasome, and IL-1-signaling, and Rho-signaling pathways. These pathways were functionally significant, as reactivation rescued viability after GATA2 depletion. In a Kras-driven NSCLC mouse model, Gata2 loss dramatically reduced tumor development. Furthermore, Gata2 deletion in established Kras mutant tumors induced striking regression. Although GATA2 itself is likely undruggable, combined suppression of GATA2-regulated pathways with clinically approved inhibitors caused marked tumor clearance. Discovery of the nononcogene addiction of KRAS mutant lung cancers to GATA2 presents a network of druggable pathways for therapeutic exploitation.	[Kumar, Madhu S.; Hancock, David C.; Molina-Arcas, Miriam; Steckel, Michael; Armenteros-Monterroso, Elena; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [East, Phillip] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Diefenbacher, Markus; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Nye, Emma; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk	Molina-Arcas, Miriam/R-4908-2019; Diefenbacher, Markus Elmar/AAY-8650-2021	Molina-Arcas, Miriam/0000-0002-8176-8948; Diefenbacher, Markus Elmar/0000-0002-7402-7949; Behrens, Axel/0000-0002-1557-1143; Downward, Julian/0000-0002-2331-4729	Cancer Research UK; European Commission [HEALTH-F2-2010-259770]; Cancer Research UK [15680, 15679] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK)	We thank S. M. Henshall for the GATA2 expression vector; D. Finley for the USP14 expression vector; R. Deshaies for the Nrf1 expression vector; D. Goubau for the NF-kappa B and control reporter plasmids; E. Meylan and W. Xue for the RelA expression vector; E. Sahai for the RhoA and ROCK: ER expression vectors; and F. Gouilleux for the STAT5<SUP>CA</SUP> expression vector. We thank the LRI FACS facility for cell-cycle assays and the Bart's Genome Centre for gene expression analysis. We thank C. Sheridan for micro-CT assistance. M. S. K. is a Long-Term Fellow of the Human Frontier Science Program and European Molecular Biology Organization. M. M. is a Marie Curie Postdoctoral Fellow. This work was supported by Cancer Research UK and by funding from the European Commission's Seventh Framework Programme (FP7/2007-2013) under the Lungtarget Grant agreement (HEALTH-F2-2010-259770).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	36	210	218	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					642	655		10.1016/j.cell.2012.02.059	http://dx.doi.org/10.1016/j.cell.2012.02.059			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541434	Bronze			2022-12-28	WOS:000303443100015
J	Roth, S; Lynch, J				Roth, Siegfried; Lynch, Jeremy			Does the Bicoid Gradient Matter?	CELL			English	Editorial Material							POSITIONAL INFORMATION; DETERMINES; LIMITS	The generation and interpretation of positional information are key processes in developmental systems. In this issue, Chen et al. report discoveries made in the Drosophila embryo that give new insights into how positional information can be produced by patterning gradients.	[Roth, Siegfried; Lynch, Jeremy] Univ Cologne, Bioctr, Inst Dev Biol, D-50674 Cologne, Germany	University of Cologne	Roth, S (corresponding author), Univ Cologne, Bioctr, Inst Dev Biol, Zulpicher Str 47b, D-50674 Cologne, Germany.	siegfried.roth@uni-koeln.de; jlynch@uni-koeln.de	Roth, Siegfried/E-8241-2010	Roth, Siegfried/0000-0001-5772-3558				Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Chen HT, 2012, CELL, V149, P618, DOI 10.1016/j.cell.2012.03.018; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Lohr U, 2009, P NATL ACAD SCI USA, V106, P21695, DOI 10.1073/pnas.0910225106; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Porcher A, 2010, CURR BIOL, V20, pR249, DOI 10.1016/j.cub.2010.01.026; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	10	9	9	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					511	512		10.1016/j.cell.2012.04.007	http://dx.doi.org/10.1016/j.cell.2012.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541424	Bronze			2022-12-28	WOS:000303443100003
J	Sayburn, A				Sayburn, Anna			BMJ GROUP IMPROVING HEALTH AWARDS 2012: HEALTHCARE COMMUNICATION CAMPAIGN Health campaigns that have changed public understanding	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Evidence Ctr, London WC1H 9JR, England		Sayburn, A (corresponding author), BMJ Evidence Ctr, London WC1H 9JR, England.	asayburn@bmj.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 25	2012	344								e2866	10.1136/bmj.e2866	http://dx.doi.org/10.1136/bmj.e2866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HC	22535738				2022-12-28	WOS:000303433800003
J	Moissiard, G; Cokus, SJ; Cary, J; Feng, SH; Billi, AC; Stroud, H; Husmann, D; Zhan, Y; Lajoie, BR; McCord, RP; Hale, CJ; Feng, W; Michaels, SD; Frand, AR; Pellegrini, M; Dekker, J; Kim, JK; Jacobsen, SE				Moissiard, Guillaume; Cokus, Shawn J.; Cary, Joshua; Feng, Suhua; Billi, Allison C.; Stroud, Hume; Husmann, Dylan; Zhan, Ye; Lajoie, Bryan R.; McCord, Rachel Patton; Hale, Christopher J.; Feng, Wei; Michaels, Scott D.; Frand, Alison R.; Pellegrini, Matteo; Dekker, Job; Kim, John K.; Jacobsen, Steven E.			MORC Family ATPases Required for Heterochromatin Condensation and Gene Silencing	SCIENCE			English	Article							DNA METHYLATION; RNA INTERFERENCE; C-ELEGANS; ARABIDOPSIS; GENOME; METHYLTRANSFERASE; SPERMATOGENESIS; REACTIVATION; MOUSE	Transposable elements (TEs) and DNA repeats are commonly targeted by DNA and histone methylation to achieve epigenetic gene silencing. We isolated mutations in two Arabidopsis genes, AtMORC1 and AtMORC6, which cause derepression of DNA-methylated genes and TEs but no losses of DNA or histone methylation. AtMORC1 and AtMORC6 are members of the conserved Microrchidia (MORC) adenosine triphosphatase (ATPase) family, which are predicted to catalyze alterations in chromosome superstructure. The atmorc1 and atmorc6 mutants show decondensation of pericentromeric heterochromatin, increased interaction of pericentromeric regions with the rest of the genome, and transcriptional defects that are largely restricted to loci residing in pericentromeric regions. Knockdown of the single MORC homolog in Caenorhabditis elegans also impairs transgene silencing. We propose that the MORC ATPases are conserved regulators of gene silencing in eukaryotes.	[Moissiard, Guillaume; Cokus, Shawn J.; Cary, Joshua; Feng, Suhua; Stroud, Hume; Husmann, Dylan; Hale, Christopher J.; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zhan, Ye; Lajoie, Bryan R.; McCord, Rachel Patton; Dekker, Job] Univ Massachusetts, Sch Med, Syst Biol & Gene Funct & Express, Worcester, MA 01605 USA; [Feng, Wei; Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Frand, Alison R.; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Terasaki Life Sci Bldg,610 Charles Young Dr E, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Michaels, Scott/D-5458-2009; Billi, Allison/AAP-1684-2021; Stroud, Hume/ABF-1325-2021	McCord, Rachel/0000-0003-0010-5323; Frand, Alison/0000-0001-5972-989X; Michaels, Scott/0000-0001-5248-3487; Pellegrini, Matteo/0000-0001-9355-9564	Ruth L. Kirschstein National Research Service Award [GM007185]; National Institute of General Medical Sciences [F32GM100617]; W. M. Keck Foundation; NIH [GM60398, GM088565, GM075060, HG003143]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565, R01GM075060, R01GM060398, F32GM100617, R37GM060398, T32GM007544, T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Akhavan for sequencing, L. Goddard and L. Iruela-Arispe for assistance with confocal microscopy, and P. Fransz and I. Schubert for helpful discussions. S.F. is a Special Fellow of the Leukemia and Lymphoma Society. J.C. is supported by the Ruth L. Kirschstein National Research Service Award GM007185. R.P.M. is supported by the National Institute of General Medical Sciences (grant F32GM100617), and J.D. is supported by a W. M. Keck Foundation Distinguished Young Scholar in Medical Research Award. Research in the Jacobsen, Kim, Michaels, and Dekker laboratories was supported by NIH grants GM60398, GM088565, GM075060, and HG003143, respectively. Sequencing files have been deposited at Gene Expression Omnibus (GEO) (accession code GSE37644). The authors declare no competing financial interests. S.E.J. is an investigator of the Howard Hughes Medical Institute. Correspondence and requests for materials should be addressed to S.E.J.	Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kang HG, 2008, CELL HOST MICROBE, V3, P48, DOI 10.1016/j.chom.2007.11.006; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kankel MW, 2003, GENETICS, V163, P1109; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	23	215	226	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1448	1451		10.1126/science.1221472	http://dx.doi.org/10.1126/science.1221472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22555433	Green Accepted			2022-12-28	WOS:000305211700048
J	Tagliabracci, VS; Engel, JL; Wen, JZ; Wiley, SE; Worby, CA; Kinch, LN; Xiao, JY; Grishin, NV; Dixon, JE				Tagliabracci, Vincent S.; Engel, James L.; Wen, Jianzhong; Wiley, Sandra E.; Worby, Carolyn A.; Kinch, Lisa N.; Xiao, Junyu; Grishin, Nick V.; Dixon, Jack E.			Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization	SCIENCE			English	Article							APPARATUS CASEIN KINASE; LACTATING MAMMARY-GLAND; GOLGI-APPARATUS; SPECIFICITY DETERMINANTS; MASS-SPECTROMETRY; PHOSPHOPROTEOME; PURIFICATION; OSTEOPONTIN; INHIBITION; SEQUENCE	Protein phosphorylation is a fundamental mechanism regulating nearly every aspect of cellular life. Several secreted proteins are phosphorylated, but the kinases responsible are unknown. We identified a family of atypical protein kinases that localize within the Golgi apparatus and are secreted. Fam20C appears to be the Golgi casein kinase that phosphorylates secretory pathway proteins within S-x-E motifs. Fam20C phosphorylates the caseins and several secreted proteins implicated in biomineralization, including the small integrin-binding ligand, N-linked glycoproteins (SIBLINGs). Consequently, mutations in Fam20C cause an osteosclerotic bone dysplasia in humans known as Raine syndrome. Fam20C is thus a protein kinase dedicated to the phosphorylation of extracellular proteins.	[Tagliabracci, Vincent S.; Engel, James L.; Wen, Jianzhong; Wiley, Sandra E.; Worby, Carolyn A.; Xiao, Junyu; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Grishin, Nick V.; Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@ucsd.edu	Xiao, Junyu/ABE-2192-2020; Wen, Jianzhong/AAI-4976-2020	Kinch, Lisa/0000-0003-3041-2615; Xiao, Junyu/0000-0003-1822-1701; Wiley, Sandra/0000-0003-3979-2474	NIH [DK018849-36, DK018024-37, GM094575]; NIH/National Cancer Institute [T32 CA009523]; Welch Foundation [I-1505]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R37DK018024, R01DK018024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants DK018849-36 and DK018024-37 (to J.E.D.), GM094575 (to N.V.G), NIH/National Cancer Institute Training Grant T32 CA009523 (to V. S. T.), and the Welch Foundation I-1505 (to N.V.G). We thank J. Jewell, G. Taylor, X. Guo, S. Mattoo, A. Newton, S. Taylor, A. DePaoli-Roach, P. Roach, and members of the Dixon lab for insightful discussions and comments regarding the manuscript.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; BENNETT HPJ, 1981, P NATL ACAD SCI-BIOL, V78, P4713, DOI 10.1073/pnas.78.8.4713; BINGHAM EW, 1972, J BIOL CHEM, V247, P8193; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; Blombaeck B., 1962, NATURE, V193, P833; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; BURNETT G, 1954, J BIOL CHEM, V211, P969; Carrascal M, 2010, J PROTEOME RES, V9, P876, DOI 10.1021/pr900780s; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; DOCKRAY GJ, 1987, J BIOL CHEM, V262, P8643; Duncan JS, 2000, BIOCHEM J, V350, P463, DOI 10.1042/0264-6021:3500463; Fradin M, 2011, CLIN GENET, V80, P177, DOI 10.1111/j.1399-0004.2010.01516.x; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; MOORE A, 1985, EUR J BIOCHEM, V152, P729, DOI 10.1111/j.1432-1033.1985.tb09254.x; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; TANG J, 1973, P NATL ACAD SCI USA, V70, P3437, DOI 10.1073/pnas.70.12.3437; Tibaldi E, 2010, FEBS LETT, V584, P801, DOI 10.1016/j.febslet.2009.12.052; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	29	320	328	12	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1150	1153		10.1126/science.1217817	http://dx.doi.org/10.1126/science.1217817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22582013	Green Accepted			2022-12-28	WOS:000304647900047
J	Mytton, OT; Clarke, D; Rayner, M				Mytton, Oliver T.; Clarke, Dushy; Rayner, Mike			Taxing unhealthy food and drinks to improve health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUGAR-SWEETENED BEVERAGES; REDUCE CONSUMPTION; PUBLIC-HEALTH; OBESITY; POLICY; TAXES; DIET; PRICE; INTERVENTION; STRATEGIES		[Mytton, Oliver T.; Clarke, Dushy; Rayner, Mike] Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford OX3 7LF, England	University of Oxford	Mytton, OT (corresponding author), Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford OX3 7LF, England.	oliver.mytton@dph.ox.ac.uk		Mytton, Oliver/0000-0003-3218-9912	National Institute for Health Research [ACF-2010-13-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2011, ADD DISCR FOOD TAX H; Bahl R, 2003, PUBLIC FINANC REV, V31, P510, DOI [10.1177/1091142103253753, 10.1177.1091142103253753, DOI 10.1177/1091142103253753]; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Buck D., 2011, OBESITY PUBLIC HLTH; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chouinard HH, 2007, FORUM HLTH EC POLICY, V10, P1, DOI DOI 10.2202/1558-9544.1071; Clark R, 2011, DAILY MAIL      1005; Colombini D, 2011, FOOD MANUFACTUR 1125; Crawford I, 2004, FAT TAX; Dharmasena S, 2011, HEALTH ECON, DOI [DOI 10.1002/HEC.1738, 10.1002/hec.1738]; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Holt E, 2010, LANCET, V375, P1070, DOI 10.1016/S0140-6736(10)60462-X; Jensen JD, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-10; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Kuchler F, 2005, REV AGR ECON, V27, P4, DOI 10.1111/j.1467-9353.2004.00204.x; Kuchler F, 2004, AGR INFO B, V747, P1; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Lock K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2403; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Marshall T, 2000, BRIT MED J, V320, P301, DOI 10.1136/bmj.320.7230.301; Medical Research Council, 2011, US NAT EXP EV POP HL; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Ng SW, 2011, BR J NUTR, V108, P1; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Powell LM, 2009, J ADOLESCENT HEALTH, V45, pS57, DOI 10.1016/j.jadohealth.2009.03.003; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Rose G., 1992, STRATEGY PREVENTIVE; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Scarborough P, 2010, CORONARY HEART DIS S; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Schroeter C, 2008, J HEALTH ECON, V27, P45, DOI 10.1016/j.jhealeco.2007.04.001; Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002; Street-Porter J, 2011, DAILY MAIL      1010; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Tiffin R, 2011, EUR J CLIN NUTR, V65, P427, DOI 10.1038/ejcn.2010.281; Tiffin R, 2010, EUR REV AGRIC ECON, V37, P501, DOI 10.1093/erae/jbq038; United Nations, 2011, REPORT SECRETARY GEN; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; World Health Organization, 2004, GLOB STRAT DIET PHYS; [No title captured]	48	207	210	0	110	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e2931	10.1136/bmj.e2931	http://dx.doi.org/10.1136/bmj.e2931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589522				2022-12-28	WOS:000304086900005
J	Kwan, KY; Lam, MMS; Johnson, MB; Dube, U; Shim, S; Rasin, MR; Sousa, AMM; Fertuzinhos, S; Chen, JG; Arellano, JI; Chan, DW; Pletikos, M; Vasung, L; Rowitch, DH; Huang, EJ; Schwartz, ML; Willemsen, R; Oostra, BA; Rakic, P; Heffer, M; Kostovic, I; Judas, M; Sestan, N				Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Vasung, Lana; Rowitch, David H.; Huang, Eric J.; Schwartz, Michael L.; Willemsen, Rob; Oostra, Ben A.; Rakic, Pasko; Heffer, Marija; Kostovic, Ivica; Judas, Milos; Sestan, Nenad			Species-Dependent Posttranscriptional Regulation of NOS1 by FMRP in the Developing Cerebral Cortex	CELL			English	Article							FRAGILE-X-SYNDROME; NITRIC-OXIDE SYNTHASE; MENTAL-RETARDATION PROTEIN; ANTERIOR CINGULATE CORTEX; AUTISM SPECTRUM DISORDERS; NEURONAL NADPH DIAPHORASE; MESSENGER-RNAS; HUMAN BRAIN; S-NITROSYLATION; PSD-95	Fragile X syndrome (FXS), the leading monogenic cause of intellectual disability and autism, results from loss of function of the RNA-binding protein FMRP. Here, we show that FMRP regulates translation of neuronal nitric oxide synthase 1 (NOS1) in the developing human neocortex. Whereas NOS1 mRNA is widely expressed, NOS1 protein is transiently coexpressed with FMRP during early synaptogenesis in layer-and region-specific pyramidal neurons. These include midfetal layer 5 subcortically projecting neurons arranged into alternating columns in the prospective Broca's area and orofacial motor cortex. Human NOS1 translation is activated by FMRP via interactions with coding region binding motifs absent from mouse Nos1 mRNA, which is expressed in mouse pyramidal neurons, but not efficiently translated. Correspondingly, neocortical NOS1 protein levels are severely reduced in developing human FXS cases, but not FMRP-deficient mice. Thus, alterations in FMRP posttranscriptional regulation of NOS1 in developing neocortical circuits may contribute to cognitive dysfunction in FXS.	[Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Schwartz, Michael L.; Rakic, Pasko; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Schwartz, Michael L.; Rakic, Pasko; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Rasin, Mladen-Roko] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Sousa, Andre M. M.] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099022 Oporto, Portugal; [Chen, Jie-Guang] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China; [Pletikos, Mihovil; Vasung, Lana; Kostovic, Ivica; Judas, Milos] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 10000, Croatia; [Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Neurosurg, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Willemsen, Rob; Oostra, Ben A.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Heffer, Marija] Josip Juraj Strossmayer Univ Osijek, Dept Med Biol, Osijek 31000, Croatia	Yale University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade do Porto; Wenzhou Medical University; University of Zagreb; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; University of JJ Strossmayer Osijek	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Kwan, Kenneth/AAI-2841-2021; Fertuzinhos, Sofia MS/G-8316-2011; Kwan, Kenneth Y/F-8489-2011; Vasung, Lana/AAE-8791-2019; Heffer, Marija/ABA-4694-2020; Huang, Eric J./AAH-7997-2019; Sousa, André M. M. M. M./C-1203-2015	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Vasung, Lana/0000-0003-0172-3174; Huang, Eric J./0000-0002-5381-3801; Sousa, André M. M. M. M./0000-0003-1740-5066; Dube, Umber/0000-0001-9324-1927; Lam, Mandy/0000-0001-7984-9709; Rowitch, David/0000-0002-0079-0060; Chan, Daniel/0000-0002-8082-2316; Heffer, Marija/0000-0001-6770-7359	Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP) [142675]; Portuguese Foundation for Science and Technology; National Institutes of Health [K99NS064303, DA023999, MH081896, MH089929, NS054273]; ZonMw [912-07-022]; Kavli Foundation; NARSAD; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089929, U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273, R01NS014841, U24NS051869, K99NS064303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP)(University of California System); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMw(Netherlands Organization for Health Research and Development); Kavli Foundation; NARSAD(NARSAD); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Budinscak, Z. Cmuk, Z. Krsnik, S. Liu-Chen, B. Popovic, B. Poulos, and B. Sajin for help with tissue acquisition; M. Nakane, W. Sessa, and I. Grkovic for antibodies and reagents; F. Cheng and M. Li for analyzing transcriptome data; E. Gulcicek for help with mass spectrometry; and M. Brown, L. Kaczmarek, A. Louvi, M. Gunel, M. State, and members of the N.S. laboratory for discussions and comments. E.J.H. and D. H. R. received technical support from the Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP Award #142675). D. H. R. is a HHMI Investigator. A. M. M. S. is supported by a fellowship from the Portuguese Foundation for Science and Technology. This work was supported by grants from National Institutes of Health (to M-R. R., K99NS064303; to P. R., DA023999; to N.S., MH081896, MH089929, and NS054273), ZonMw 912-07-022 (to R. W.), Kavli Foundation, NARSAD, and James S. McDonnell Foundation Scholar Award (to N.S.).	Abbeduto L, 2007, MENT RETARD DEV D R, V13, P36, DOI 10.1002/mrdd.20142; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Buxhoeveden D, 1996, ANAT EMBRYOL, V194, P23; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cui HX, 2010, SCHIZOPHR RES, V121, P172, DOI 10.1016/j.schres.2010.05.003; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Judas M, 1999, MICROSC RES TECHNIQ, V45, P401, DOI 10.1002/(SICI)1097-0029(19990615)45:6<401::AID-JEMT7>3.0.CO;2-Q; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keller SS, 2009, BRAIN LANG, V109, P29, DOI 10.1016/j.bandl.2008.11.005; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; MOLLIVER ME, 1973, BRAIN RES, V50, P403, DOI 10.1016/0006-8993(73)90741-5; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; ODonnell P, 1997, NEUROSCIENCE, V76, P1; Peters A, 2010, NEUROCHEMICAL BASIS OF AUTISM: FROM MOLECULES TO MINICOLUMNS, P45, DOI 10.1007/978-1-4419-1272-5_4; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Reif A, 2009, ARCH GEN PSYCHIAT, V66, P41, DOI 10.1001/archgenpsychiatry.2008.510; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SESTAN N, 1994, TRENDS NEUROSCI, V17, P105, DOI 10.1016/0166-2236(94)90115-5; Shinkai T, 2002, MOL PSYCHIATR, V7, P560, DOI 10.1038/sj.mp.4001041; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	67	94	95	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					899	911		10.1016/j.cell.2012.02.060	http://dx.doi.org/10.1016/j.cell.2012.02.060			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579290	Bronze, Green Accepted			2022-12-28	WOS:000303934700021
J	Tarallo, V; Hirano, Y; Gelfand, BD; Dridi, S; Kerur, N; Kim, Y; Cho, WG; Kaneko, H; Fowler, BJ; Bogdanovich, S; Albuquerque, RJC; Hauswirth, WW; Chiodo, VA; Kugel, JF; Goodrich, JA; Ponicsan, SL; Chaudhuri, G; Murphy, MP; Dunaief, JL; Ambati, BK; Ogura, Y; Yoo, JW; Lee, DK; Provost, P; Hinton, DR; Nunez, G; Baffi, JZ; Kleinman, ME; Ambati, J				Tarallo, Valeria; Hirano, Yoshio; Gelfand, Bradley D.; Dridi, Sami; Kerur, Nagaraj; Kim, Younghee; Cho, Won Gil; Kaneko, Hiroki; Fowler, Benjamin J.; Bogdanovich, Sasha; Albuquerque, Romulo J. C.; Hauswirth, William W.; Chiodo, Vince A.; Kugel, Jennifer F.; Goodrich, James A.; Ponicsan, Steven L.; Chaudhuri, Gautam; Murphy, Michael P.; Dunaief, Joshua L.; Ambati, Balamurali K.; Ogura, Yuichiro; Yoo, Jae Wook; Lee, Dong-ki; Provost, Patrick; Hinton, David R.; Nunez, Gabriel; Baffi, Judit Z.; Kleinman, Mark E.; Ambati, Jayakrishna			DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88	CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; CELL-DEATH; ACTIVATION; RECOGNITION; CASPASE-1; PROTEIN; IL-1	Alu RNA accumulation due to DICER1 deficiency in the retinal pigmented epithelium (RPE) is implicated in geographic atrophy (GA), an advanced form of age-related macular degeneration that causes blindness in millions of individuals. The mechanism of Alu RNA-induced cytotoxicity is unknown. Here we show that DICER1 deficit or Alu RNA exposure activates the NLRP3 inflammasome and triggers TLR-independent MyD88 signaling via IL18 in the RPE. Genetic or pharmacological inhibition of inflammasome components (NLRP3, Pycard, Caspase-1), MyD88, or IL18 prevents RPE degeneration induced by DICER1 loss or Alu RNA exposure. These findings, coupled with our observation that human GA RPE contains elevated amounts of NLRP3, PYCARD, and IL18 and evidence of increased Caspase-1 and MyD88 activation, provide a rationale for targeting this pathway in GA. Our findings also reveal a function of the inflammasome outside the immune system and an immunomodulatory action of mobile elements.	[Tarallo, Valeria; Hirano, Yoshio; Gelfand, Bradley D.; Dridi, Sami; Kerur, Nagaraj; Kim, Younghee; Cho, Won Gil; Kaneko, Hiroki; Fowler, Benjamin J.; Bogdanovich, Sasha; Albuquerque, Romulo J. C.; Baffi, Judit Z.; Kleinman, Mark E.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Fowler, Benjamin J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Cho, Won Gil] Yonsei Univ, Wonju Coll Med, Dept Anat, Wonju 220701, South Korea; [Hauswirth, William W.; Chiodo, Vince A.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Kugel, Jennifer F.; Goodrich, James A.; Ponicsan, Steven L.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Global Res Lab RNAi Med, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Sch Chem Mat Sci BK21, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea; [Provost, Patrick] Univ Laval, CHUL Res Ctr, CHUQ, Quebec City, PQ G1K 7P4, Canada; [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Hinton, David R.] Univ So Calif, Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Kentucky; University of Kentucky; Yonsei University; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder; Meharry Medical College; University of Pennsylvania; Pennsylvania Medicine; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Nagoya City University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Laval University; Laval University; Doheny Eye Institute; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Kaneko, Hiroki/AHA-2461-2022; Gelfand, Brad/L-3926-2019; Nuñez, Gabriel/A-7160-2014; Dridi, Sami/Q-8207-2019; Kaneko, Hiroki/O-7695-2015; Murphy, Michael P/C-2120-2009; Fowler, Benjamin/F-4987-2012; Provost, Patrick/G-2786-2010	Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; Murphy, Michael P/0000-0003-1115-9618; Provost, Patrick/0000-0002-6099-6562; Hirano, Yoshio/0000-0002-9173-0839; hauswirth, william/0000-0002-3244-4947; Kleinman, Mark/0000-0001-8557-7949; Tarallo, Valeria/0000-0002-6920-4402	NEI/NIH [R01EY018350, R01EY018836, R01EY020672, R01EY022238, R21EY019778, RC1EY020442]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Research to Prevent Blindness, RPB; NIH [K08EY021521, K08EY021757, T32HL091812, UL1RR033173, R01AI063331, R01AR052756, P30EY021721, R01EY017182, R01EY017950, P30EY003040, R01EY001545, R01GM068414]; International Retinal Research Foundation; American Health Assistance Foundation; Alcon Japan Research award; VA Merit Award; Department of Defense; MEST, Korea; RPB; University of Kentucky; Fonds de la Recherche en Sante du Quebec (FRSQ); MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, TL1TR000115, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173, TL1RR033172] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K08EY021521, R01EY017950, R21EY019778, R01EY022238, R01EY018350, R01EY017182, P30EY021721, R01EY020672, R01EY001545, K08EY021757, RC1EY020442, P30EY003040, R01EY018836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068414] Funding Source: NIH RePORTER	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Research to Prevent Blindness, RPB(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; American Health Assistance Foundation; Alcon Japan Research award; VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); RPB; University of Kentucky; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Akira, Z. Chen, M. Chrenek, J. Garcia-Perez, T. Heidmann, and J. V. Moran for providing mice, reagents, or tissues; R. King, L. Xu, M. McConnell, C. Payne, D. Robertson, G. Botzet, G. R. Pattison, and C. Spee for technical assistance; and S. Bondada, M. E. Boulton, R. A. Brekken, R. Kannan, K. Kariko, T. S. Khurana, R. Mohan, M. L. Peterson, V. Rangnekar, A. Sinai, A. M. Rao, G. S. Rao, and K. Ambati for discussions. J. A. was supported by NEI/NIH grants R01EY018350, R01EY018836, R01EY020672, R01EY022238, R21EY019778, and RC1EY020442, Doris Duke Distinguished Clinical Scientist Award, Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, and Senior Scientist Investigator Award (Research to Prevent Blindness, RPB); J.Z.B. by NIH K08EY021521, International Retinal Research Foundation, and American Health Assistance Foundation; M. E. K. by NIH K08EY021757; B. J. F., S. B., and M. E. K. by NIH T32HL091812 and UL1RR033173; G.N. by NIH R01AI063331 and R01AR052756; Y.H. by Alcon Japan Research award; W. W. H. by NIH P30EY021721; B. K. A. by NIH R01EY017182 and R01EY017950, VA Merit Award, and Department of Defense; D. R. H. by NIH P30EY003040 and R01EY001545; J. F. K. and J. A. G. by NIH R01GM068414; J.W.Y. and D.-k.L. by Global Research Laboratory grant from MEST, Korea. Departmental unrestricted grants from RPB supported J. A. and W. W. H. University of Kentucky Physician Scientist Awards supported J.Z.B. and M. E. K. P. P. is a Senior Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). Several authors are named as inventors on patent applications filed by their universities relating to described technologies. V. T., Y.H., B. D. G., S. D., Y.K., W. G. C., J.Z.B., H. K., N.K., B. J. F., S. B., and M. E. K. performed experiments. W. W. H., V. A. C, S. L. P., J. F. K., J. A. G., M. P. M., J.W.Y., D.-k.L, D. R. H., P. P., and G.N. provided reagents. J. A. conceived and directed the project and wrote the paper with assistance from B. K. A., B. J. F., and B. D. G. All authors had the opportunity to discuss the results and comment on the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allensworth JJ, 2011, J LEUKOCYTE BIOL, V90, P1159, DOI 10.1189/jlb.0511249; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; QURESHI N, 1991, INFECT IMMUN, V59, P441, DOI 10.1128/IAI.59.1.441-444.1991; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; SINNETT D, 1991, J BIOL CHEM, V266, P8675; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Suzuki N, 2003, J IMMUNOL, V170, P4031, DOI 10.4049/jimmunol.170.8.4031; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	82	424	456	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					847	859		10.1016/j.cell.2012.03.036	http://dx.doi.org/10.1016/j.cell.2012.03.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22541070	Green Accepted, Bronze			2022-12-28	WOS:000303934700017
J	Attal, M; Lauwers-Cances, V; Marit, G; Caillot, D; Moreau, P; Facon, T; Stoppa, AM; Hulin, C; Benboubker, L; Garderet, L; Decaux, O; Leyvraz, S; Vekemans, MC; Voillat, L; Michallet, M; Pegourie, B; Dumontet, C; Roussel, M; Leleu, X; Mathiot, C; Payen, C; Avet-Loiseau, H; Harousseau, JL				Attal, Michel; Lauwers-Cances, Valerie; Marit, Gerald; Caillot, Denis; Moreau, Philippe; Facon, Thierry; Stoppa, Anne Marie; Hulin, Cyrille; Benboubker, Lofti; Garderet, Laurent; Decaux, Olivier; Leyvraz, Serge; Vekemans, Marie-Christiane; Voillat, Laurent; Michallet, Mauricette; Pegourie, Brigitte; Dumontet, Charles; Roussel, Murielle; Leleu, Xavier; Mathiot, Claire; Payen, Catherine; Avet-Loiseau, Herve; Harousseau, Jean-Luc		IFM Investigators	Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DOSE CHEMOTHERAPY; PLUS DEXAMETHASONE; RANDOMIZED-TRIAL; FOLLOW-UP; THALIDOMIDE; THERAPY; SURVIVAL; SINGLE	Background High-dose chemotherapy with autologous stem-cell transplantation is a standard treatment for young patients with multiple myeloma. Residual disease is almost always present after transplantation and is responsible for relapse. This phase 3, placebo-controlled trial investigated the efficacy of lenalidomide maintenance therapy after transplantation. Methods We randomly assigned 614 patients younger than 65 years of age who had nonprogressive disease after first-line transplantation to maintenance treatment with either lenalidomide (10 mg per day for the first 3 months, increased to 15 mg if tolerated) or placebo until relapse. The primary end point was progression-free survival. Results Lenalidomide maintenance therapy improved median progression-free survival (41 months, vs. 23 months with placebo; hazard ratio, 0.50; P<0.001). This benefit was observed across all patient subgroups, including those based on the beta(2)-microglobulin level, cytogenetic profile, and response after transplantation. With a median follow-up period of 45 months, more than 70% of patients in both groups were alive at 4 years. The rates of grade 3 or 4 peripheral neuropathy were similar in the two groups. The incidence of second primary cancers was 3.1 per 100 patient-years in the lenalidomide group versus 1.2 per 100 patient-years in the placebo group (P=0.002). Median event-free survival (with events that included second primary cancers) was significantly improved with lenalidomide (40 months, vs. 23 months with placebo; P<0.001). Conclusions Lenalidomide maintenance after transplantation significantly prolonged progression-free and event-free survival among patients with multiple myeloma. Four years after randomization, overall survival was similar in the two study groups.	[Attal, Michel] Hop Purpan, Serv Hematol, Dept Hematol, F-31059 Toulouse, France; [Attal, Michel; Lauwers-Cances, Valerie; Roussel, Murielle; Payen, Catherine] Hop Purpan, Dept Biostat, F-31059 Toulouse, France; [Marit, Gerald] Hop Haut Leveque, Bordeaux, France; [Caillot, Denis] Ctr Hosp Bocage, Dijon, France; [Moreau, Philippe; Avet-Loiseau, Herve; Harousseau, Jean-Luc] Hop Hotel Dieu, Nantes, France; [Facon, Thierry; Leleu, Xavier] Hop C Huriez, Lille, France; [Stoppa, Anne Marie] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Hulin, Cyrille] Ctr Hosp Brabois, Nancy, France; [Benboubker, Lofti] Hop Bretonneau, Tours, France; [Garderet, Laurent] Hop St Antoine, F-75571 Paris, France; [Mathiot, Claire] Inst Curie, Paris, France; [Decaux, Olivier] Hop Pontchaillou, Rennes, France; [Voillat, Laurent] Hop Jean Minjoz, F-25030 Besancon, France; [Michallet, Mauricette; Dumontet, Charles] Hop Edouard Herriot, Lyon, France; [Pegourie, Brigitte] Hop Albert Michallon, Grenoble, France; [Leyvraz, Serge] Ctr Hosp Univ, Lausanne, Switzerland; [Vekemans, Marie-Christiane] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium	CHU de Toulouse; CHU de Toulouse; CHU Bordeaux; CHU Dijon Bourgogne; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; UNICANCER; Institut Paoli-Calmette (IPC); CHU de Nancy; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; CHU Rennes; Universite de Franche-Comte; CHU Besancon; CHU Lyon; CHU Grenoble Alpes; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Attal, M (corresponding author), Hop Purpan, Serv Hematol, Dept Hematol, Pl Docteur Baylac, F-31059 Toulouse, France.	attal.m@chu-toulouse.fr	Avet-Loiseau, Herve/P-8872-2014; ROUSSEL, MURIELLE/O-1412-2018; Zachee, Pierre/B-5391-2018	Avet-Loiseau, Herve/0000-0002-3050-0140; ROUSSEL, MURIELLE/0000-0002-4045-9428; Zachee, Pierre/0000-0002-2275-5143; OLIVIER, Pascale/0000-0002-1801-9581; chevret, sylvie/0000-0001-6449-4730; Dumontet, Charles/0000-0003-1875-134X; Bouscary, Didier/0000-0003-3654-5064; moreau, philippe/0000-0003-1780-8746	Programme Hospitalier de Recherche Clinique; Swiss Group for Clinical Cancer Research (SAKK); Celgene	Programme Hospitalier de Recherche Clinique; Swiss Group for Clinical Cancer Research (SAKK); Celgene(Bristol-Myers SquibbCelgene Corporation)	Funded by the Programme Hospitalier de Recherche Clinique and others; ClinicalTrials. gov number, NCT00430365.; Supported by the Programme Hospitalier de Recherche Clinique, the Swiss Group for Clinical Cancer Research (SAKK), and a grant from Celgene. Celgene provided the lenalidomide and placebo used in this trial.	Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Attal M, 2004, NEW ENGL J MED, V350, P2628; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Barlogie B, 2006, J CLIN ONCOL, V24, P929, DOI 10.1200/JCO.2005.04.5807; Barlogie B, 2006, BRIT J HAEMATOL, V135, P158, DOI 10.1111/j.1365-2141.2006.06271.x; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Cunningham D, 1998, BRIT J HAEMATOL, V102, P495, DOI 10.1046/j.1365-2141.1998.00795.x; Dimopoulos M, 2009, NEW ENGL J MED, V361, P544; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dong C, 2001, BRIT J CANCER, V85, P997, DOI 10.1054/bjoc.2001.1998; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2006, LEUKEMIA, V20, P2220, DOI 10.1038/sj.leu.2404428; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lokhorst HM, 2010, BLOOD, V115, P1113, DOI 10.1182/blood-2009-05-222539; Marriott JB, 2002, CLIN EXP IMMUNOL, V130, P75, DOI 10.1046/j.1365-2249.2002.01954.x; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596	25	816	840	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1782	1791		10.1056/NEJMoa1114138	http://dx.doi.org/10.1056/NEJMoa1114138			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571202				2022-12-28	WOS:000303817000007
J	Hattori, M; Gouaux, E				Hattori, Motoyuki; Gouaux, Eric			Molecular mechanism of ATP binding and ion channel activation in P2X receptors	NATURE			English	Article							PHARMACOLOGICAL CHARACTERIZATION; RECOMBINANT HUMAN; STRUCTURAL MOTIF; PORE; RESIDUES; IDENTIFICATION; SELECTIVITY; ACCESS; SITE; PERMEABILITY	P2X receptors are trimeric ATP-activated ion channels permeable to Na+, K+ and Ca2+. The seven P2X receptor subtypes are implicated in physiological processes that include modulation of synaptic transmission, contraction of smooth muscle, secretion of chemical transmitters and regulation of immune responses. Despite the importance of P2X receptors in cellular physiology, the three-dimensional composition of the ATP-binding site, the structural mechanism of ATP-dependent ion channel gating and the architecture of the open ion channel pore are unknown. Here we report the crystal structure of the zebrafish P2X(4) receptor in complex with ATP and a new structure of the apo receptor. The agonist-bound structure reveals a previously unseen ATP-binding motif and an open ion channel pore. ATP binding induces cleft closure of the nucleotide-binding pocket, flexing of the lower body beta-sheet and a radial expansion of the extracellular vestibule. The structural widening of the extracellular vestibule is directly coupled to the opening of the ion channel pore by way of an iris-like expansion of the transmembrane helices. The structural delineation of the ATP-binding site and the ion channel pore, together with the conformational changes associated with ion channel gating, will stimulate development of new pharmacological agents.	[Hattori, Motoyuki; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Hattori, Motoyuki/B-6069-2014; Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Hattori, Motoyuki/0000-0002-5327-5337	Japan Society for the Promotion of Science; American Asthma Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Alexander and D. C. Dawson for providing Xenopus oocytes, K. L. Durr and T. Friedrich for providing the pCNA3.1x vector, L. Vaskalis for assistance with figure illustrations, K. J. Swartz and M. P. Kavanaugh for advice related to the oocyte experiments, and Gouaux laboratory members for discussions. We are also grateful to the staff at the Advanced Photon Source beamline 24-ID-C for help with X-ray data collection. This work was supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (M. H.), by the American Asthma Foundation (E. G.) and the NIH (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Egan TM, 1998, J NEUROSCI, V18, P2350; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fujiwara Y, 2009, J GEN PHYSIOL, V133, P93, DOI 10.1085/jgp.200810002; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; Virginio C, 1998, MOL PHARMACOL, V53, P969; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Wildman SS, 1999, EUR J PHARMACOL, V367, P119, DOI 10.1016/S0014-2999(98)00976-5; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658	59	384	392	6	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					207	U91		10.1038/nature11010	http://dx.doi.org/10.1038/nature11010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22535247	Green Accepted			2022-12-28	WOS:000303799800034
J	Jaques, H				Jaques, Helen			Putting patients at the heart of quality	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Careers, London WC1H 9JR, England		Jaques, H (corresponding author), BMJ Careers, London WC1H 9JR, England.	hjaques@bmj.com						Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; Coulter A, 2006, PATIENT FOCUSED INTE; Coulter A., 2011, MAKING SHARED DECISI; Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21, DOI 10.1097/00004479-200701000-00005; Van der Schrieck-de Loos E, 2009, ROLE CLIENT PATIENT	5	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 10	2012	344								e3164	10.1136/bmj.e3164	http://dx.doi.org/10.1136/bmj.e3164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XR	22577188				2022-12-28	WOS:000304085400006
J	Rosansky, SJ				Rosansky, Steven J.			The Sad Truth About Early Initiation of Dialysis in Elderly Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KIDNEY-DISEASE; CARE		William Jennings Bryan Dorn VA Med Ctr, Dorn Res Inst, Columbia, SC 29206 USA		Rosansky, SJ (corresponding author), William Jennings Bryan Dorn VA Med Ctr, Dorn Res Inst, 526 N Trenholm Rd, Columbia, SC 29206 USA.	sjrcra@yahoo.com						Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Demoulin N, 2011, NEPHROL DIAL TRANSPL, V26, P220, DOI 10.1093/ndt/gfq372; Fassett RG, 2011, NEPHROLOGY, V16, P4, DOI 10.1111/j.1440-1797.2010.01409.x; GHAVAMIAN M, 1972, J AMER MED ASSOC, V222, P1386, DOI 10.1001/jama.222.11.1386; National Institutes of Heath National Institute of Diabetes and Digestive and Kidney Diseases, 2010, US REN DAT SYST USRD; O'Hare AM, 2010, JAMA-J AM MED ASSOC, V304, P180, DOI 10.1001/jama.2010.924; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Wong CF, 2007, RENAL FAILURE, V29, P653, DOI 10.1080/08860220701459634	8	23	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1919	1920		10.1001/jama.2012.3522	http://dx.doi.org/10.1001/jama.2012.3522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570459				2022-12-28	WOS:000303741900023
J	Cardinale, B				Cardinale, Bradley			Impacts of Biodiversity Loss	SCIENCE			English	Editorial Material							PLANT DIVERSITY; ECOSYSTEMS; PRODUCTIVITY; TIME		Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Cardinale, B (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 440 Church St, Ann Arbor, MI 48109 USA.	bradcard@umich.edu	Cardinale, Bradley J/I-7076-2013					Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Ehrlich P.R., 1981, EXTINCTION; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0	14	35	36	6	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					552	553		10.1126/science.1222102	http://dx.doi.org/10.1126/science.1222102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22556243				2022-12-28	WOS:000303498800035
J	Lederer, WJ; Hagen, BM; Zhao, GL				Lederer, W. Jonathan; Hagen, Brian M.; Zhao, Guiling			Superresolution Subspace Signaling	SCIENCE			English	Editorial Material							ARTERIAL SMOOTH-MUSCLE; CALCIUM SPARKS; CELLS; HEART; MICROSCOPY		[Lederer, W. Jonathan] Univ Maryland, Sch Med, Ctr BioMed Engn & Technol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Lederer, WJ (corresponding author), Univ Maryland, Sch Med, Ctr BioMed Engn & Technol, 725 W Lombard St, Baltimore, MD 21201 USA.	jlederer@umaryland.edu		Zhao, Guiling/0000-0001-5084-7152	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036974, R01HL105239, P01HL067849, R01HL106059] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL67849, R01 HL106059, P01 HL067849, R01 HL105239, R01 HL36974, R01 HL036974] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiello VD, 2003, MODERN PATHOL, V16, P411, DOI 10.1097/01.MP.0000067685.57858.D7; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Lederer W. J., 1996, MOL UNDERSTANDING EX, V95, P497; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Williams GSB, 2011, BIOPHYS J, V101, P1287, DOI 10.1016/j.bpj.2011.07.021	15	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					546	547		10.1126/science.1222540	http://dx.doi.org/10.1126/science.1222540			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22556238	Green Accepted			2022-12-28	WOS:000303498800030
J	Sonkusare, SK; Bonev, AD; Ledoux, J; Liedtke, W; Kotlikoff, MI; Heppner, TJ; Hill-Eubanks, DC; Nelson, MT				Sonkusare, Swapnil K.; Bonev, Adrian D.; Ledoux, Jonathan; Liedtke, Wolfgang; Kotlikoff, Michael I.; Heppner, Thomas J.; Hill-Eubanks, David C.; Nelson, Mark T.			Elementary Ca2+ Signals Through Endothelial TRPV4 Channels Regulate Vascular Function	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; SHEAR-STRESS; IN-VIVO; CELLS; MICE; RELAXATION; RECEPTORS; DILATION; TONE	Major features of the transcellular signaling mechanism responsible for endothelium-dependent regulation of vascular smooth muscle tone are unresolved. We identified local calcium (Ca2+) signals ("sparklets") in the vascular endothelium of resistance arteries that represent Ca2+ influx through single TRPV4 cation channels. Gating of individual TRPV4 channels within a four-channel cluster was cooperative, with activation of as few as three channels per cell causing maximal dilation through activation of endothelial cell intermediate (IK)- and small (SK)-conductance, Ca2+-sensitive potassium (K+) channels. Endothelial-dependent muscarinic receptor signaling also acted largely through TRPV4 sparklet-mediated stimulation of IK and SK channels to promote vasodilation. These results support the concept that Ca2+ influx through single TRPV4 channels is leveraged by the amplifier effect of cooperative channel gating and the high Ca2+ sensitivity of IK and SK channels to cause vasodilation.	[Sonkusare, Swapnil K.; Bonev, Adrian D.; Ledoux, Jonathan; Heppner, Thomas J.; Hill-Eubanks, David C.; Nelson, Mark T.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Ledoux, Jonathan] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ H1T 1C8, Canada; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Med & Neurobiol, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Ctr Translat Neurosci, Durham, NC 27710 USA; [Kotlikoff, Michael I.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Nelson, Mark T.] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England	University of Vermont; Universite de Montreal; Universite de Montreal; Duke University; Duke University; Cornell University; University of Manchester	Nelson, MT (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.	mark.nelson@uvm.edu	Liedtke, Wolfgang/GNH-1878-2022; Ledoux, Jonathan/D-2945-2012	Ledoux, Jonathan/0000-0001-8540-7763; Nelson, Mark/0000-0002-6608-8784	COBRE of the National Center for Research Resources; NIH [2-P20-RR-016435-06, HL044455, 1P01HL095488, R37DK053832, R01HL098243]; American Heart Association Founders Affiliate; Pulmonary Hypertension Association [10POST3690006]; FRSQ (Junior 1)/NIA (HSFC); Totman Medical Research Trust;  [NIH GM086736]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044455, P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	COBRE of the National Center for Research Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Founders Affiliate(American Heart Association); Pulmonary Hypertension Association; FRSQ (Junior 1)/NIA (HSFC); Totman Medical Research Trust; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank HydraBiosciences for HC-067047, Neurosearch A/S for NS309, and J. E. Brayden, K. Freeman, M. Koide, L. W. Nausch, and G. C. Wellman for comments on the manuscript. This work was supported by a grant from the COBRE Program of the National Center for Research Resources funded by the NIH (2-P20-RR-016435-06), an award from the American Heart Association Founders Affiliate and the Pulmonary Hypertension Association (10POST3690006) to S.K.S, and by grants NIH GM086736 to M.I.K.; FRSQ (Junior 1)/NIA (HSFC) to J.L.; and NIH HL044455, 1P01HL095488, R37DK053832, R01HL098243, and the Totman Medical Research Trust to M.T.N. The authors have no conflicts of interest.	Bogatcheva NV, 2005, MICROVASC RES, V69, P107, DOI 10.1016/j.mvr.2005.01.007; Coleman HA, 2004, CLIN EXP PHARMACOL P, V31, P641, DOI 10.1111/j.1440-1681.2004.04053.x; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fleming I, 1999, J MOL CELL CARDIOL, V31, P5, DOI 10.1006/jmcc.1998.0839; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100	20	368	372	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					597	601		10.1126/science.1216283	http://dx.doi.org/10.1126/science.1216283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556255	Green Accepted, Green Published			2022-12-28	WOS:000303498800048
J	Tsitsikas, DA; Emery, M; Pomfret, S; Mehta, JK; Mufti, S; Rezaeinia, A; Amos, RJ				Tsitsikas, Dimitris A.; Emery, Michelle; Pomfret, Suzanne; Mehta, Jasmeen Kaur; Mufti, Shaista; Rezaeinia, Alireza; Amos, Roger J.			Anaemia and unexplained abdominal pain: looking for a lead	BRITISH MEDICAL JOURNAL			English	Editorial Material							RECOMMENDATIONS; MANAGEMENT; MEDICINES; DIAGNOSIS; EXPOSURE; HUMANS		[Tsitsikas, Dimitris A.; Emery, Michelle; Pomfret, Suzanne; Mehta, Jasmeen Kaur; Mufti, Shaista; Rezaeinia, Alireza; Amos, Roger J.] Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England		Tsitsikas, DA (corresponding author), Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England.	dimitristsitsikas@hotmail.com	Tsitsikas, Dimitris A./AGL-2303-2022	Tsitsikas, Dimitris A./0000-0003-3468-049X				Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Buettner C, 2009, J GEN INTERN MED, V24, P1175, DOI 10.1007/s11606-009-1050-5; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Gawarammana IB, 2006, HUM EXP TOXICOL, V25, P645, DOI 10.1177/0960327106074594; Gelberg KH, 2010, PUBLIC HEALTH REP, V125, P103, DOI 10.1177/003335491012500114; Gogtay NJ, 2002, DRUG SAFETY, V25, P1005, DOI 10.2165/00002018-200225140-00003; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; LABBE RF, 1990, CLIN CHEM, V36, P1870; MCMICHAEL AJ, 1988, NEW ENGL J MED, V319, P468, DOI 10.1056/NEJM198808253190803; PAGLIA DE, 1977, J CLIN INVEST, V60, P1362, DOI 10.1172/JCI108896; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; RABINOWITZ MB, 1976, J CLIN INVEST, V58, P260, DOI 10.1172/JCI108467; RABINOWITZ MB, 1980, AM J CLIN NUTR, V33, P1784, DOI 10.1093/ajcn/33.8.1784; Saper RB, 2008, JAMA-J AM MED ASSOC, V300, P915, DOI 10.1001/jama.300.8.915; Thadani H, 2000, BMJ-BRIT MED J, V320, P1647, DOI 10.1136/bmj.320.7250.1647	18	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e2996	10.1136/bmj.e2996	http://dx.doi.org/10.1136/bmj.e2996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NC	22551804				2022-12-28	WOS:000303817200007
J	van Ravesteyn, NT; Miglioretti, DL; Stout, NK; Lee, SJ; Schechter, CB; Buist, DSM; Huang, H; Heijnsdijk, EAM; Trentham-Dietz, A; Alagoz, O; Near, AM; Kerlikowske, K; Nelson, HD; Mandelblatt, JS; de Koning, HJ				van Ravesteyn, Nicolien T.; Miglioretti, Diana L.; Stout, Natasha K.; Lee, Sandra J.; Schechter, Clyde B.; Buist, Diana S. M.; Huang, Hui; Heijnsdijk, Eveline A. M.; Trentham-Dietz, Amy; Alagoz, Oguzhan; Near, Aimee M.; Kerlikowske, Karla; Nelson, Heidi D.; Mandelblatt, Jeanne S.; de Koning, Harry J.			Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years A Comparative Modeling Study of Risk	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER MORTALITY; FALSE-POSITIVE RECALL; AMERICAN-COLLEGE; FOLLOW-UP; WOMEN; DENSITY; IMPACT; TRIAL; PERFORMANCE; THERAPY	Background: Timing of initiation of screening for breast cancer is controversial in the United States. Objective: To determine the threshold relative risk (RR) at which the harm-benefit ratio of screening women aged 40 to 49 years equals that of biennial screening for women aged 50 to 74 years. Design: Comparative modeling study. Data Sources: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and medical literature. Target Population: A contemporary cohort of women eligible for routine screening. Time Horizon: Lifetime. Perspective: Societal. Intervention: Mammography screening starting at age 40 versus 50 years with different screening methods (film, digital) and screening intervals (annual, biennial). Outcome Measures: Benefits: life-years gained, breast cancer deaths averted; harms: false-positive mammography findings; harm-benefit ratios: false-positive findings/life-years gained, false-positive findings/deaths averted. Results of Base-Case Analysis: Screening average-risk women aged 50 to 74 years biennially yields the same false-positive findings/life-years gained as biennial screening with digital mammography starting at age 40 years for women with a 2-fold increased risk above average (median threshold RR, 1.9 [range across models, 1.5 to 4.4]). The threshold RRs are higher for annual screening with digital mammography (median, 4.3 [range, 3.3 to 10]) and when false-positive findings/deaths averted is used as an outcome measure instead of false-positive findings/life-years gained. The harm-benefit ratio for film mammography is more favorable than for digital mammography because film has a lower false-positive rate. Results of Sensitivity Analysis: The threshold RRs changed slightly when a more comprehensive measure of harm was used and were relatively insensitive to lower adherence assumptions. Limitation: Risk was assumed to influence onset of disease without influencing screening performance. Conclusion: Women aged 40 to 49 years with a 2-fold increased risk have similar harm-benefit ratios for biennial screening mammography as average-risk women aged 50 to 74 years. Threshold RRs required for favorable harm-benefit ratios vary by screening method, interval, and outcome measure.	[van Ravesteyn, Nicolien T.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Univ Washington, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Univ Wisconsin, Madison, WI USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Lombardi Comprehens Canc Ctr, Canc Prevent & Control Program, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA	Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; Georgetown University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Oregon Health & Science University	van Ravesteyn, NT (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.vanravesteyn@erasmusmc.nl	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382	National Cancer Institute [U01CA086076-10S1, U01CA88283, U01CA152958, KO5CA96940, U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; BCSC; NATIONAL CANCER INSTITUTE [K05CA096940, P01CA154292, U01CA086082, U01CA063736, U01CA069976, U01CA088283, U01CA070040, U01CA152958, U01CA086076, U01CA070013, U01CA063740, U01CA063731] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The collection of BCSC cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see www.breastscreening.cancer.gov/work/acknowledgement.html. This research was supported by a National Cancer Institute Activities to Promote Research Collaboration supplement (U01CA086076-10S1), and, in part, by National Cancer Institute grants U01CA88283, U01CA152958, and KO5CA96940. Data collection was supported by the BCSC funded by the National Cancer Institute cooperative agreements U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040.	Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bluekens AMJ, 2010, EUR RADIOL, V20, P2067, DOI 10.1007/s00330-010-1786-7; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P26, DOI 10.1093/jncimonographs/lgj005; de Gelder R, 2011, BRIT J CANCER, V104, P1214, DOI 10.1038/bjc.2011.67; de Gelder R, 2008, INT J CANCER, V123, P680, DOI 10.1002/ijc.23540; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Kerlikowske K, 2009, ANN INTERN MED, V151, P750, DOI 10.7326/0003-4819-151-10-200911170-00012; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Lee SJ, 2003, ANN ONCOL, V14, P1199, DOI 10.1093/annonc/mdg323; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Nelson HD, 2009, 1005142EF1 AHRQ; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Rosenberg Marjorie A, 2006, J Natl Cancer Inst Monogr, P15, DOI 10.1093/jncimonographs/lgj004; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Taylor P, 2010, J MED SCREEN, V17, P31, DOI 10.1258/jms.2009.009048; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; U.S. Food and Drug Administration, 2011, MAMM QUAL STAND ACT; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; van Ravesteyn NT, 2011, BRIT J CANCER, V105, P1082, DOI 10.1038/bjc.2011.300; Wai ES, 2005, BRIT J CANCER, V92, P961, DOI 10.1038/sj.bjc.6602393; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655	48	93	93	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					609	U39		10.7326/0003-4819-156-9-201205010-00002	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547470	Green Accepted			2022-12-28	WOS:000303403700001
J	Britton, JW; Sawyer, BC; Keith, AC; Wang, CCJ; Freericks, JK; Uys, H; Biercuk, MJ; Bollinger, JJ				Britton, Joseph W.; Sawyer, Brian C.; Keith, Adam C.; Wang, C. -C. Joseph; Freericks, James K.; Uys, Hermann; Biercuk, Michael J.; Bollinger, John J.			Engineered two-dimensional Ising interactions in a trapped-ion quantum simulator with hundreds of spins	NATURE			English	Article							OPTICAL LATTICES; ULTRACOLD ATOMS; PHYSICS; GASES	The presence of long-range quantum spin correlations underlies a variety of physical phenomena in condensed-matter systems, potentially including high-temperature superconductivity(1,2). However, many properties of exotic, strongly correlated spin systems, such as spin liquids, have proved difficult to study, in part because calculations involving N-body entanglement become intractable for as few as N approximate to 30 particles(3). Feynman predicted that a quantum simulator-a special-purpose 'analogue' processor built using quantum bits (qubits)-would be inherently suited to solving such problems(4,5). In the context of quantum magnetism, a number of experiments have demonstrated the feasibility of this approach(6-14), but simulations allowing controlled, tunable interactions between spins localized on two- or three-dimensional lattices of more than a few tens of qubits have yet to be demonstrated, in part because of the technical challenge of realizing large-scale qubit arrays. Here we demonstrate a variable-range Ising-type spin-spin interaction, J(i,j), on a naturally occurring, two-dimensional triangular crystal lattice of hundreds of spin-half particles (beryllium ions stored in a Penning trap). This is a computationally relevant scale more than an order of magnitude larger than previous experiments. We show that a spin-dependent optical dipole force can produce an antiferromagnetic interaction J(i,j) proportional to d(i,j)(-a), where 0 <= a <= 3 and d(i,j) is the distance between spin pairs. These power laws correspond physically to infinite-range (a = 0), Coulomb-like (a = 1), monopole-dipole (a = 2) and dipole-dipole (a = 3) couplings. Experimentally, we demonstrate excellent agreement with a theory for 0.05 less than or similar to a less than or similar to 1.4. This demonstration, coupled with the high spin count, excellent quantum control and low technical complexity of the Penning trap, brings within reach the simulation of otherwise computationally intractable problems in quantum magnetism.	[Britton, Joseph W.; Sawyer, Brian C.; Bollinger, John J.] US Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA; [Keith, Adam C.; Wang, C. -C. Joseph; Freericks, James K.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA; [Keith, Adam C.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Uys, Hermann] CSIR, Natl Laser Ctr, ZA-0001 Pretoria, South Africa; [Biercuk, Michael J.] Univ Sydney, Sch Phys, Ctr Engn Quantum Syst, Sydney, NSW 2006, Australia	National Institute of Standards & Technology (NIST) - USA; Georgetown University; University of North Carolina; North Carolina State University; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Sydney	Britton, JW (corresponding author), US Natl Inst Stand & Technol, Div Time & Frequency, Boulder, CO 80305 USA.	joe.britton@gmail.com	Biercuk, Michael J/B-4768-2010; Freericks, James K/D-7502-2011; Uys, Hermann/Q-2002-2019	Biercuk, Michael J/0000-0002-4371-2580; Freericks, James K/0000-0002-6232-9165; Britton, Joe/0000-0001-8103-7347	DARPA OLE; NIST; NSF [DMR-1004268]; NRC; Australian Research Council Center of Excellence for Engineered Quantum Systems [CE110001013]; Direct For Mathematical & Physical Scien [1004268] Funding Source: National Science Foundation	DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIST(National Institute of Standards & Technology (NIST) - USA); NSF(National Science Foundation (NSF)); NRC(National Research Centre (NRC)); Australian Research Council Center of Excellence for Engineered Quantum Systems(Australian Research Council); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the DARPA OLE programme and NIST. A. C. K. was supported by the NSF under grant number DMR-1004268. B. C. S. is supported by an NRC fellowship funded by NIST. J.K.F. was supported by the McDevitt endowment bequest at Georgetown University. M.J.B. and J.J.B. acknowledge partial support from the Australian Research Council Center of Excellence for Engineered Quantum Systems CE110001013. We thank F. Da Silva, R. Jordens, D. Leibfried, A. O'Brien, R. Scalettar and A. M. Rey for discussions.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Biercuk MJ, 2009, QUANTUM INF COMPUT, V9, P920; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Islam R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1374; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Kohno M, 2007, NAT PHYS, V3, P790, DOI 10.1038/nphys749; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Levi BG, 2007, PHYS TODAY, V60, P16, DOI 10.1063/1.2711623; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Ma XS, 2011, NAT PHYS, V7, P399, DOI 10.1038/NPHYS1919; Mitchell TB, 1998, SCIENCE, V282, P1290, DOI 10.1126/science.282.5392.1290; Moessner R, 2000, PHYS REV LETT, V84, P4457, DOI 10.1103/PhysRevLett.84.4457; Porras D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250501; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Sachdev S., 2001, QUANTUM PHASE TRANSI; Sandvik AW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137204; Sawyer B. C., 2012, PHYS REV LE IN PRESS; Schmied R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.233002; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Varney CN, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.077201	30	608	610	8	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					489	492		10.1038/nature10981	http://dx.doi.org/10.1038/nature10981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538611	Green Submitted			2022-12-28	WOS:000303200400045
J	Gupta, V; Poss, KD				Gupta, Vikas; Poss, Kenneth D.			Clonally dominant cardiomyocytes direct heart morphogenesis	NATURE			English	Article							ZEBRAFISH HEART; MOUSE HEART; STEM-CELLS; REGENERATION; PROGENITORS; FIELD; DIFFERENTIATION; POPULATION; MYOCARDIUM; PHASES	As vertebrate embryos develop to adulthood, their organs undergo marked changes in size and tissue architecture. The heart acquires muscle mass and matures structurally to fulfil increasing circulatory needs, a process that is incompletely understood. Here we used multicolour clonal analysis to define the contributions of individual cardiomyocytes as the zebrafish heart undergoes morphogenesis from a primitive embryonic structure into its complex adult form. We find that the single-cardiomyocyte-thick wall of the juvenile ventricle forms by lateral expansion of several dozen cardiomyocytes into muscle patches of variable sizes and shapes. As juvenile zebrafish mature into adults, this structure becomes fully enveloped by a new lineage of cortical muscle. Adult cortical muscle originates from a small number of cardiomyocytes-an average of approximately eight per animal-that display clonal dominance reminiscent of stem cell populations. Cortical cardiomyocytes initially emerge from internal myofibres that in rare events breach the juvenile ventricular wall, and then expand over the surface. Our results illuminate the dynamic proliferative behaviours that generate adult cardiac structure, revealing clonal dominance as a key mechanism that shapes a vertebrate organ.	[Gupta, Vikas; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Gupta, Vikas; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Gupta, Vikas/0000-0002-3383-9828; Poss, Kenneth/0000-0002-6743-5709	National Heart, Lung, and Blood Institute (NHLBI) [HL081674]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Kikuchi for generating cmlc2:CreER animals and for advice; J. Burris, A. Eastes, P. Williams and N. Blake for zebrafish care; A. Dickson for artwork; B. Hogan and Poss laboratory members for comments on the manuscript; and S. Johnson and Y. Gao for imaging advice. V. G. was supported by a National Heart, Lung, and Blood Institute (NHLBI) Medical Scientist Training Program supplement. K. D. P. is an Early Career Scientist of the Howard Hughes Medical Institute. This work was supported by grants from NHLBI (HL081674) and American Heart Association to K.D.P.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	27	177	179	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					479	U102		10.1038/nature11045	http://dx.doi.org/10.1038/nature11045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538609	Green Accepted			2022-12-28	WOS:000303200400043
J	Sommers, BD; Bindman, AB				Sommers, Benjamin D.; Bindman, Andrew B.			New Physicians, the Affordable Care Act, and the Changing Practice of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sommers, Benjamin D.; Bindman, Andrew B.] US Dept Hlth & Human Serv, Off Hlth Policy, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med Hlth Policy Epidemiol & Biostat, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	Sommers, BD (corresponding author), US Dept Hlth & Human Serv, Off Hlth Policy, Off Assistant Secretary Planning & Evaluat, 200 Independence Ave SW,Room 447D, Washington, DC 20201 USA.	bsommers@hsph.harvard.edu						Association of American Medical Colleges, 2000, APPL 1 TIM APPL ACC; Deloitte Center for Health Solutions, PHYS PERSP HLTH CAR; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P367, DOI 10.1001/jama.2012.19; Huntoon KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023557; National Resident Matching Program, RES MATCH DAT 2011; Thomson-Reuters, 2011 NAT PHYS SURV F	6	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1697	1698		10.1001/jama.2012.523	http://dx.doi.org/10.1001/jama.2012.523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535852				2022-12-28	WOS:000303147500020
J	van Os, J; Howes, OD				van Os, Jim; Howes, Oliver D.			Antipsychotic drugs for prevention of relapse	LANCET			English	Editorial Material							ENVIRONMENT; MEDICATION		[van Os, Jim] Maastricht Univ, Dept Psychiat & Psychol, Med Ctr,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim; Howes, Oliver D.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, Kings Hlth Partners, London WC2R 2LS, England	Maastricht University; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Med Ctr,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/C-2113-2014; Howes, Oliver/E-7156-2010; van Os, Jim/I-9496-2012; van Os, Jim/V-8884-2019	Howes, Oliver/0000-0002-2928-1972; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586	Medical Research Council [1116129] Funding Source: researchfish; MRC [G0700995] Funding Source: UKRI; Medical Research Council [MC_U120097115, G0700995] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; de Haan L, 2000, AM J PSYCHIAT, V157, P1019, DOI 10.1176/appi.ajp.157.6.1019; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Moncrieff J., 2004, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD003012.PUB2; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Varese F, 2012, SCHIZOPHR B, DOI [10.1093/schbul/sb5050, DOI 10.1093/SCHBUL/SB5050]; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101	15	1	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2030	2031		10.1016/S0140-6736(12)60406-1	http://dx.doi.org/10.1016/S0140-6736(12)60406-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22560608				2022-12-28	WOS:000304759100010
J	Shan, YB; Eastwood, MP; Zhang, XW; Kim, ET; Arkhipov, A; Dror, RO; Jumper, J; Kuriyan, J; Shaw, DE				Shan, Yibing; Eastwood, Michael P.; Zhang, Xuewu; Kim, Eric T.; Arkhipov, Anton; Dror, Ron O.; Jumper, John; Kuriyan, John; Shaw, David E.			Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; LUNG-CANCER; MOLECULAR-DYNAMICS; SIGNAL PROPAGATION; TYROSINE KINASES; PROTEIN DYNAMICS; BINDING-SITE; DRUG-BINDING; ACTIVATION; DOMAIN	The mutation and overexpression of the epidermal growth factor receptor (EGFR) are associated with the development of a variety of cancers, making this prototypical dimerization-activated receptor tyrosine kinase a prominent target of cancer drugs. Using long-timescale molecular dynamics simulations, we find that the N lobe dimerization interface of the wild-type EGFR kinase domain is intrinsically disordered and that it becomes ordered only upon dimerization. Our simulations suggest, moreover, that some cancer-linked mutations distal to the dimerization interface, particularly the widespread L834R mutation (also referred to as L858R), facilitate EGFR dimerization by suppressing this local disorder. Corroborating these findings, our biophysical experiments and kinase enzymatic assays indicate that the L834R mutation causes abnormally high activity primarily by promoting EGFR dimerization rather than by allowing activation without dimerization. We also find that phosphorylation of EGFR kinase domain at Tyr845 may suppress the intrinsic disorder, suggesting a molecular mechanism for autonomous EGFR signaling.	[Shan, Yibing; Eastwood, Michael P.; Kim, Eric T.; Arkhipov, Anton; Dror, Ron O.; Jumper, John; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University	Shan, YB (corresponding author), DE Shaw Res, New York, NY 10036 USA.	yibing.shan@deshawresearch.com; david.shaw@deshawresearch.com	Arkhipov, Anton/AAE-7801-2020	Arkhipov, Anton/0000-0003-1106-8310; Dror, Ron/0000-0002-6418-2793	National Cancer Institute [R01 CA96504]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Natalia Jura, Kate Engel, and Markus Seeliger for generously providing samples of EGFR and Src kinases, Stevan R. Hubbard and Kresten Lindorff-Larsen for helpful discussions, and Rebecca Kastleman and Mollie Kirk for editorial assistance. Author contributions: Y.S., M. P. E, and D. E. S. designed research; Y.S., E. T. K., A. A., and J.J. performed simulations; X.Z. and J.K. designed, and X.Z. performed, native gel and light scattering experiments; Y.S. analyzed data; Y.S., M. P. E., R.O.D., and D. E. S. wrote the article. J.K. and X.Z. were supported by the National Cancer Institute (R01 CA96504).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Banavali NK, 2009, PROTEINS, V74, P378, DOI 10.1002/prot.22153; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Huang PH, 2010, MOL BIOSYST, V6, P1227, DOI 10.1039/c001196g; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu B, 2006, PROTEINS, V65, P331, DOI 10.1002/prot.21111; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Tompa P., 2010, STRUCTURE FUNCTION I; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	54	236	242	3	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					860	870		10.1016/j.cell.2012.02.063	http://dx.doi.org/10.1016/j.cell.2012.02.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579287	Bronze			2022-12-28	WOS:000303934700018
J	Chan, PS; Nallamothu, BK				Chan, Paul S.; Nallamothu, Brahmajee K.			Improving Outcomes Following In-Hospital Cardiac Arrest Life After Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFIBRILLATION; SURVIVAL; TIME		[Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO USA; [Nallamothu, Brahmajee K.] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd,5th Floor, Kansas City, MO 64111 USA.	pchan@saint-lukes.org			NHLBI NIH HHS [K23HL102224, K23 HL102224] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Chan PS, 2009, ARCH INTERN MED, V169, P1265, DOI 10.1001/archinternmed.2009.196; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Girotra S, 2011, CIRCULATION, V124; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	9	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1917	1918		10.1001/jama.2012.3504	http://dx.doi.org/10.1001/jama.2012.3504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570458	Green Accepted			2022-12-28	WOS:000303741900022
J	Sachs, AN; Avant, D; Lee, CS; Rodriguez, W; Murphy, MD				Sachs, Aaron N.; Avant, Debbie; Lee, Catherine S.; Rodriguez, William; Murphy, M. Dianne			Pediatric Information in Drug Product Labeling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sachs, Aaron N.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Avant, Debbie; Lee, Catherine S.; Rodriguez, William; Murphy, M. Dianne] US FDA, Off Pediat Therapeut, Silver Spring, MD USA	University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Sachs, AN (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	debbie.avant@fda.hhs.gov		Sachs, Aaron/0000-0002-8715-4445				[Anonymous], FDA PED LAB CHANG TA; PDR Network, EL PHYS DESK REF WEB; U.S. Food and Drug Administration, GUID IND COMPL PED R; [US Department of Health and Human Services Food and Drug Administration], NEW MOL ENT DRUG NEW; Wilson JT, 1999, PEDIATRICS, V104, P585; Wilson JT, 1975, BASIC THERAPEUTIC AS, P411	6	85	87	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1914	1915		10.1001/jama.2012.3435	http://dx.doi.org/10.1001/jama.2012.3435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570457	Bronze			2022-12-28	WOS:000303741900019
J	Spence, D				Spence, Des			The 15 minute consultation	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e3283	10.1136/bmj.e3283	http://dx.doi.org/10.1136/bmj.e3283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XB	22573658				2022-12-28	WOS:000304083800014
J	Tan, DTH; Dart, JKG; Holland, EJ; Kinoshita, S				Tan, Donald T. H.; Dart, John K. G.; Holland, Edward J.; Kinoshita, Shigeru			Ophthalmology 3 Corneal transplantation	LANCET			English	Article							ANTERIOR LAMELLAR KERATOPLASTY; BOSTON TYPE-1 KERATOPROSTHESIS; OSTEO-ODONTO-KERATOPROSTHESIS; TOPICAL CYCLOSPORINE-A; HIGH-RISK KERATOPLASTY; PENETRATING KERATOPLASTY; ENDOTHELIAL KERATOPLASTY; SURFACE RECONSTRUCTION; CELL TRANSPLANTATION; AMNIOTIC MEMBRANE	Corneal transplantation or keratoplasty has developed rapidly in the past 10 years. Penetrating keratoplasty, a procedure consisting of full-thickness replacement of the cornea, has been the dominant procedure for more than half a century, and successfully caters to most causes of corneal blindness. The adoption by specialist surgeons of newer forms of lamellar transplantation surgery, which selectively replace only diseased layers of the cornea, has been a fundamental change in recent years. Deep anterior lamellar keratoplasty is replacing penetrating keratoplasty for disorders affecting the corneal stromal layers, while eliminating the risk of endothelial rejection. Endothelial keratoplasty, which selectively replaces the corneal endothelium in patients with endothelial disease, has resulted in more rapid and predictable visual outcomes. Other emerging therapies are ocular surface reconstruction and artificial cornea (keratoprosthesis) surgery, which have become more widely available because of rapid advances in these techniques. Collectively, these advances have resulted in improved outcomes, and have expanded the number of cases of corneal blindness, which can now be treated successfully. Femtosecond-laser-assisted surgery, bioengineered corneas, and medical treatment for endothelial disease are also likely to play a part in the future.	[Tan, Donald T. H.] Singapore Natl Eye Ctr, Singapore 168751, Singapore; [Tan, Donald T. H.] Singapore Eye Res Inst, Singapore, Singapore; [Tan, Donald T. H.] Natl Univ Hlth Syst, Dept Ophthalmol, Singapore, Singapore; [Dart, John K. G.] Moorfields Eye Hosp NHS Fdn Trust, Ctr Ophthalmol, Natl Inst Hlth Res Biomed Res, London, England; [Dart, John K. G.] UCL, Inst Ophthalmol, London, England; [Holland, Edward J.] Cincinnati Eye Inst, Cincinnati, OH USA; [Holland, Edward J.] Univ Cincinnati, Cincinnati, OH USA; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University System of Ohio; University of Cincinnati; Kyoto Prefectural University of Medicine	Tan, DTH (corresponding author), Singapore Natl Eye Ctr, 3rd Hosp Ave, Singapore 168751, Singapore.	snecdt@pacific.net.sg	Dart, John Kenneth/GZM-7807-2022; Nosé, Walton/I-1431-2017; Binder, Perry S/M-2263-2018	Nosé, Walton/0000-0003-4510-1289; Binder, Perry S/0000-0002-2588-8080				Abou Shousha M, 2011, OPHTHALMOLOGY, V118, P315, DOI 10.1016/j.ophtha.2010.06.037; Aldave AJ, 2009, OPHTHALMOLOGY, V116, P640, DOI 10.1016/j.ophtha.2008.12.058; Ament JD, 2011, EYE, V25, P342, DOI 10.1038/eye.2010.197; [Anonymous], 2009 OPTN SRTR ANN R; [Anonymous], NAT HLTH SERV BLOOD; Anshu A, 2011, AM J OPHTHALMOL, V151, P442, DOI 10.1016/j.ajo.2010.09.002; Anshu A, 2009, OPHTHALMOLOGY, V116, P615, DOI 10.1016/j.ophtha.2008.12.043; Anwar M, 2002, CORNEA, V21, P374, DOI 10.1097/00003226-200205000-00009; Armitage WJ, 2003, INVEST OPHTH VIS SCI, V44, P3326, DOI 10.1167/iovs.02-1255; Beauchemin C, 2010, CAN J OPHTHALMOL, V45, P243, DOI 10.3129/i10-026; Birnbaum F, 2009, EYE, V23, P2063, DOI 10.1038/eye.2008.402; Cauchi PA, 2008, AM J OPHTHALMOL, V146, P251, DOI 10.1016/j.ajo.2008.03.018; Chan CC, 2012, CORNEA, V31, P346, DOI 10.1097/ICO.0b013e31821eea2f; Chan CC, 2011, CORNEA, V30, P1105, DOI 10.1097/ICO.0b013e318207f3bb; Chatel MA, 2010, AM J OPHTHALMOL, V150, P179, DOI 10.1016/j.ajo.2010.03.010; Chew HF, 2009, CORNEA, V28, P989, DOI 10.1097/ICO.0b013e3181a186dc; Ciralsky J, 2010, OCUL IMMUNOL INFLAMM, V18, P275, DOI 10.3109/09273941003682300; Claerhout Ilse, 2008, International Ophthalmology, V28, P165, DOI 10.1007/s10792-007-9087-0; Claesson M, 2009, CORNEA, V28, P1124, DOI 10.1097/ICO.0b013e3181a2a7a6; Colby KA, 2011, CURR OPIN OPHTHALMOL, V22, P267, DOI 10.1097/ICU.0b013e3283477d0d; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Daya SM, 2011, CORNEA, V30, P1115, DOI 10.1097/ICO.0b013e318207f135; Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023; Dohlman CH, 2007, DIGITAL J OPHTHALMOL, V13; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Durand ML, 2009, CORNEA, V28, P896, DOI 10.1097/ICO.0b013e3181983982; Espana EM, 2010, BRIT J OPHTHALMOL, V94, P903, DOI 10.1136/bjo.2009.165712; Fagerholm P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001022; Falcinelli G, 2005, ARCH OPHTHALMOL-CHIC, V123, P1319, DOI 10.1001/archopht.123.10.1319; Farid M, 2009, OPHTHALMOLOGY, V116, P1638, DOI 10.1016/j.ophtha.2009.05.003; Fuchsluger TA, 2011, GENE THER, V18, P778, DOI 10.1038/gt.2011.20; Greiner MA, 2011, OPHTHALMOLOGY, V118, P1543, DOI 10.1016/j.ophtha.2010.12.032; Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169; Hicks CR, 2006, CORNEA, V25, P1034, DOI 10.1097/01.ico.0000229982.23334.6b; Holland EJ, 2012, CORNEA, V31, P655, DOI 10.1097/ICO.0b013e31823f8b0c; Inatomi T, 2006, AM J OPHTHALMOL, V141, P267, DOI 10.1016/j.ajo.2005.09.003; Joseph A, 2007, BRIT J OPHTHALMOL, V91, P51, DOI 10.1136/bjo.2006.097428; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kampik D, 2012, EXP EYE RES, V95, P54, DOI 10.1016/j.exer.2011.07.001; Keenan TDL, 2011, BRIT J OPHTHALMOL, V95, P468, DOI 10.1136/bjo.2010.182329; Kelly TL, 2011, OPHTHALMOLOGY, V118, P1538, DOI 10.1016/j.ophtha.2011.01.002; Kelly TL, 2011, ARCH OPHTHALMOL-CHIC, V129, P691, DOI 10.1001/archophthalmol.2011.7; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Khor WB, 2011, AM J OPHTHALMOL, V151, P223, DOI 10.1016/j.ajo.2010.08.027; KIM JC, 1995, CORNEA, V14, P473; KINOSHITA S, 1982, INVEST OPHTH VIS SCI, V23, P73; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Klebe S, 2009, CURR OPIN ORGAN TRAN, V14, P4, DOI 10.1097/MOT.0b013e32831af1d7; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Lee JG, 2012, EXP EYE RES, V95, P35, DOI 10.1016/j.exer.2011.08.003; Lee WB, 2009, OPHTHALMOLOGY, V116, P1818, DOI 10.1016/j.ophtha.2009.06.021; Liu C, 2008, BRIT J OPHTHALMOL, V92, P1211, DOI 10.1136/bjo.2007.130567; Luengo-Gimeno F, 2011, OCUL SURF, V9, P98, DOI 10.1016/S1542-0124(11)70017-9; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; McCauley MB, 2011, CORNEA, V30, P315, DOI 10.1097/ICO.0b013e3181eeb71b; McCauley MB, 2009, J CATARACT REFR SURG, V35, P1659, DOI 10.1016/j.jcrs.2009.05.034; Mehta JS, 2008, CORNEA, V27, P706, DOI 10.1097/QAI.0b013e31815ee267; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mimura T, 2005, EXP EYE RES, V80, P149, DOI 10.1016/j.exer.2004.08.021; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Neff KD, 2011, CORNEA, V30, P388, DOI 10.1097/ICO.0b013e3181f236c6; Nguyen NX, 2007, AM J OPHTHALMOL, V144, P318, DOI 10.1016/j.ajo.2007.03.028; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Panda A, 2007, SURV OPHTHALMOL, V52, P375, DOI 10.1016/j.survophthal.2007.04.008; Patel SV, 2005, AM J OPHTHALMOL, V139, P311, DOI 10.1016/j.ajo.2004.09.045; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Poon A, 2008, CLIN EXP OPHTHALMOL, V36, P415, DOI 10.1111/j.1442-9071.2008.01784.x; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2011, OPHTHALMOLOGY, V118, P725, DOI 10.1016/j.ophtha.2010.08.012; Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reinhart WJ, 2011, OPHTHALMOLOGY, V118, P209, DOI 10.1016/j.ophtha.2010.11.002; Ross AH, 2009, OPHTHALMOLOGY, V116, P2369, DOI 10.1016/j.ophtha.2009.06.006; Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; Scorcia V, 2009, OPHTHALMOLOGY, V116, P1651, DOI 10.1016/j.ophtha.2009.04.035; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P2930; Shimazaki J, 2011, AM J OPHTHALMOL, V152, P33, DOI 10.1016/j.ajo.2011.01.019; Sinha R, 2010, GRAEF ARCH CLIN EXP, V248, P1167, DOI 10.1007/s00417-010-1388-8; Steinert RF, 2007, AM J OPHTHALMOL, V143, P689, DOI 10.1016/j.ajo.2006.11.043; Stewart RM, 2011, AM J OPHTHALMOL, V151, p[257, e251]; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Terry MA, 2006, CORNEA, V25, P873, DOI 10.1097/01.ico.0000244869.54761.50; THOFT RA, 1984, AM J OPHTHALMOL, V97, P1; Ti SE, 2007, AM J OPHTHALMOL, V143, P755, DOI 10.1016/j.ajo.2007.01.015; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201; Wagoner MD, 2009, CORNEA, V28, P385, DOI 10.1097/ICO.0b013e31818d3aef; Williams KA, 2008, TRANSPLANTATION, V86, P1720, DOI 10.1097/TP.0b013e3181903b0a; Yaghouti F, 2001, CORNEA, V20, P19, DOI 10.1097/00003226-200101000-00003; Zerbe BL, 2006, OPHTHALMOLOGY, V113, P1779, DOI 10.1016/j.ophtha.2006.05.015	97	477	496	7	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1749	1761		10.1016/S0140-6736(12)60437-1	http://dx.doi.org/10.1016/S0140-6736(12)60437-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22559901				2022-12-28	WOS:000303658500035
J	Kenny, EE; Timpson, NJ; Sikora, M; Yee, MC; Moreno-Estrada, A; Eng, C; Huntsman, S; Burchard, EG; Stoneking, M; Bustamante, CD; Myles, S				Kenny, Eimear E.; Timpson, Nicholas J.; Sikora, Martin; Yee, Muh-Ching; Moreno-Estrada, Andres; Eng, Celeste; Huntsman, Scott; Burchard, Esteban Gonzalez; Stoneking, Mark; Bustamante, Carlos D.; Myles, Sean			Melanesian Blond Hair Is Caused by an Amino Acid Change in TYRP1	SCIENCE			English	Article							OCULOCUTANEOUS ALBINISM; PIGMENTATION; TYROSINASE; MUTATION; SKIN		[Kenny, Eimear E.; Sikora, Martin; Yee, Muh-Ching; Moreno-Estrada, Andres; Bustamante, Carlos D.; Myles, Sean] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, Ctr Causal Analyses Translat Epidemiol, MRC, Bristol BS8 2BN, Avon, England; [Eng, Celeste; Huntsman, Scott; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci & Med, San Francisco, CA 94143 USA; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Bustamante, Carlos D.; Myles, Sean] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Myles, Sean] Nova Scotia Agr Coll, Dept Plant & Anim Sci, Truro, NS B2N 5E3, Canada	Stanford University; University of Bristol; University of California System; University of California San Francisco; Max Planck Society; Cornell University; Dalhousie University	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu; smyles@nsac.ca	Sikora, Martin/C-8609-2015; Attrill, Lauren/V-1688-2018; Moreno-Estrada, Andres/R-3950-2017; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Moreno-Estrada, Andres/AAP-4657-2021	Sikora, Martin/0000-0003-2818-8319; Moreno-Estrada, Andres/0000-0001-8329-8292; Timpson, Nicholas John/0000-0002-7141-9189; Moreno-Estrada, Andres/0000-0001-8329-8292; Myles, Sean/0000-0001-9754-5987	Wenner-Gren Foundation for Anthropological Research; MRC Centre for Causal Analyses in Translational Epidemiology [RD1634]; National Heart, Lung, and Blood Institute; National Human Genome Research Institute; Max Planck Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Wenner-Gren Foundation for Anthropological Research; MRC Centre for Causal Analyses in Translational Epidemiology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the people of the Solomon Islands for their participation in this study. We thank the Kosrae consortium for access to genetic data, G. Coop and G. Barsh for helpful comments, and C. Wegener for technical assistance. Funded by a Wenner-Gren Foundation for Anthropological Research grant to S.M., MRC Centre for Causal Analyses in Translational Epidemiology grant RD1634 to N.J.T., National Heart, Lung, and Blood Institute and National Human Genome Research Institute funding to C.D.B., and the Max Planck Society. Allele frequency data for this study are available from dbGAP (study accession phs000493.v1.p1). De-identified genotype data are available through a data access agreement for transfer of genetic data by contacting C.D.B.	Boissy RE, 1996, AM J HUM GENET, V58, P1145; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Norton HL, 2006, AM J PHYS ANTHROPOL, V130, P254, DOI 10.1002/ajpa.20343	7	66	72	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					554	554		10.1126/science.1217849	http://dx.doi.org/10.1126/science.1217849			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556244	Green Accepted			2022-12-28	WOS:000303498800036
J	Stanley, SA; Gagner, JE; Damanpour, S; Yoshida, M; Dordick, JS; Friedman, JM				Stanley, Sarah A.; Gagner, Jennifer E.; Damanpour, Shadi; Yoshida, Mitsukuni; Dordick, Jonathan S.; Friedman, Jeffrey M.			Radio-Wave Heating of Iron Oxide Nanoparticles Can Regulate Plasma Glucose in Mice	SCIENCE			English	Article							GENE-EXPRESSION; FERRITIN; HYPERTHERMIA; STIMULATION; FREQUENCY; CALCIUM; NEURONS; PROTEIN	Medical applications of nanotechnology typically focus on drug delivery and biosensors. Here, we combine nanotechnology and bioengineering to demonstrate that nanoparticles can be used to remotely regulate protein production in vivo. We decorated a modified temperature-sensitive channel, TRPV1, with antibody-coated iron oxide nanoparticles that are heated in a low-frequency magnetic field. When local temperature rises, TRPV1 gates calcium to stimulate synthesis and release of bioengineered insulin driven by a Ca2+-sensitive promoter. Studying tumor xenografts expressing the bioengineered insulin gene, we show that exposure to radio waves stimulates insulin release from the tumors and lowers blood glucose in mice. We further show that cells can be engineered to synthesize genetically encoded ferritin nanoparticles and inducibly release insulin. These approaches provide a platform for using nanotechnology to activate cells.	[Stanley, Sarah A.; Damanpour, Shadi; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Gagner, Jennifer E.] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Rensselaer Nanotechnol Ctr, Troy, NY 12180 USA; [Yoshida, Mitsukuni] Rockefeller Univ, Elizabeth & Vincent Meyer Lab Syst Canc Biol, New York, NY 10065 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Friedman, Jeffrey M.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rensselaer Polytechnic Institute; Rockefeller University; Rensselaer Polytechnic Institute; Howard Hughes Medical Institute	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA.	friedj@mail.rockefeller.edu		Yoshida, Mitsukuni/0000-0002-2752-1231	JPB Foundation; NIH [R01 GM095654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Friedman laboratory members for helpful discussions, S. Korres for assistance with manuscript preparation, S. Tavazoie for helpful discussions, R. Toledo-Crow and S. Abeytunge for assistance with RF technology, and the staff of the Rockefeller University Electron Microscopy Resource center for their technical support in imaging. This project was supported by funding from the JPB Foundation and grant no. R01 GM095654 from the NIH. The authors have filed a patent related to this work.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; FARRANT JL, 1954, BIOCHIM BIOPHYS ACTA, V13, P569, DOI 10.1016/0006-3002(54)90376-5; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gellhorn E, 1940, Science, V92, P288, DOI 10.1126/science.92.2387.288; Halperin D, 2008, P IEEE S SECUR PRIV, P129, DOI 10.1109/SP.2008.31; Hamad-Schifferli K, 2002, NATURE, V415, P152, DOI 10.1038/415152a; Hanna S, 2009, 3 INT S MED INF COMM; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Iordanova B, 2010, J BIOL INORG CHEM, V15, P957, DOI 10.1007/s00775-010-0657-7; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; Richardson HH, 2006, NANO LETT, V6, P783, DOI 10.1021/nl060105l; Samanta B, 2008, J MATER CHEM, V18, P1204, DOI 10.1039/b718745a; Sana B, 2010, BIOINTERPHASES, V5, pFA48, DOI 10.1116/1.3483216; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; STOCK G, 1979, ACTA NEUROCHIR, V47, P123, DOI 10.1007/BF01404668; Strauffer P. R., 1984, IEEE T BIOMED ENG, V31, P235; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Wang AZ, 2008, EXPERT OPIN BIOL TH, V8, P1063, DOI 10.1517/14712598.8.8.1063 ; YOUNG JH, 1980, ELECTRON LETT, V16, P358, DOI 10.1049/el:19800255; Ziv K, 2010, NMR BIOMED, V23, P523, DOI 10.1002/nbm.1491	27	353	374	8	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					604	608		10.1126/science.1216753	http://dx.doi.org/10.1126/science.1216753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556257	Green Accepted			2022-12-28	WOS:000303498800050
J	Prober, CG; Heath, C				Prober, Charles G.; Heath, Chip			BECOMING A PHYSICIAN Lecture Halls without Lectures - A Proposal for Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Prober, Charles G.] Stanford Univ, Stanford Sch Med, Stanford, CA 94305 USA; [Heath, Chip] Stanford Univ, Stanford Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University	Prober, CG (corresponding author), Stanford Univ, Stanford Sch Med, Stanford, CA 94305 USA.							[Anonymous], 2012, N ENGL J MED, V366, P553; Department of Education, 2010, EV EV BAS PRACT ONL; Deslauriers L, 2011, SCIENCE, V332, P862, DOI 10.1126/science.1201783; Heath Ch., 2007, MADE STICK WHY SOME	4	314	322	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1657	1659		10.1056/NEJMp1202451	http://dx.doi.org/10.1056/NEJMp1202451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HH	22551125				2022-12-28	WOS:000303434300003
J	Quill, TE; Holloway, RG				Quill, Timothy E.; Holloway, Robert G.			Evidence, Preferences, Recommendations - Finding the Right Balance in Patient Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Palliat Care Div, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.							Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Zikmund-Fisher BJ, 2010, MED DECIS MAKING, V30, p20S, DOI 10.1177/0272989X09353792	5	63	63	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1653	1655		10.1056/NEJMp1201535	http://dx.doi.org/10.1056/NEJMp1201535			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HH	22551123				2022-12-28	WOS:000303434300001
J	Boyce, N				Boyce, Niall			The Lancet Technology: April, 2012	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1580	1580		10.1016/S0140-6736(12)60663-1	http://dx.doi.org/10.1016/S0140-6736(12)60663-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22553821				2022-12-28	WOS:000303452600016
J	Patton, GC; Coffey, C; Cappa, C; Currie, D; Riley, L; Gore, F; Degenhardt, L; Richardson, D; Astone, N; Sangowawa, AO; Mokdad, A; Ferguson, J				Patton, George C.; Coffey, Carolyn; Cappa, Claudia; Currie, Dorothy; Riley, Leanne; Gore, Fiona; Degenhardt, Louisa; Richardson, Dominic; Astone, Nan; Sangowawa, Adesola O.; Mokdad, Ali; Ferguson, Jane			Adolescent Health 4 Health of the world's adolescents: a synthesis of internationally comparable data	LANCET			English	Article							DETECTING MAJOR DEPRESSION; GLOBAL PUBLIC-HEALTH; YOUNG-PEOPLE; SYSTEMATIC ANALYSIS; REGIONAL BURDEN; RISK-FACTORS; STATISTICS; MORTALITY; POLICY; PREVENTION	Adolescence and young adulthood off er opportunities for health gains both through prevention and early clinical intervention. Yet development of health information systems to support this work has been weak and so far lagged behind those for early childhood and adulthood. With falls in the number of deaths in earlier childhood in many countries and a shifting emphasis to non-communicable disease risks, injuries, and mental health, there are good reasons to assess the present sources of health information for young people. We derive indicators from the conceptual framework for the Series on adolescent health and assess the available data to describe them. We selected indicators for their public health importance and their coverage of major health outcomes in young people, health risk behaviours and states, risk and protective factors, social role transitions relevant to health, and health service inputs. We then specify definitions that maximise international comparability. Even with this optimisation of data usage, only seven of the 25 indicators, covered at least 50% of the world's adolescents. The worst adolescent health profiles are in sub-Saharan Africa, with persisting high mortality from maternal and infectious causes. Risks for non-communicable diseases are spreading rapidly, with the highest rates of tobacco use and overweight, and lowest rates of physical activity, predominantly in adolescents living in low-income and middle-income countries. Even for present global health agendas, such as HIV infection and maternal mortality, data sources are incomplete for adolescents. We propose a series of steps that include better coordination and use of data collected across countries, greater harmonisation of school-based surveys, further development of strategies for socially marginalised youth, targeted research into the validity and use of these health indicators, advocating for adolescent-health information within new global health initiatives, and a recommendation that every country produce a regular report on the health of its adolescents.	[Patton, George C.] Royal Childrens Hosp, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Patton, George C.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Parkville, Vic 3052, Australia; [Cappa, Claudia] UNICEF, Stat & Monitoring Sect, New York, NY USA; [Currie, Dorothy] Univ St Andrews, Child & Adolescent Hlth Res Unit, St Andrews KY16 9AJ, Fife, Scotland; [Riley, Leanne] WHO, Noncommunicable Dis Prevent & Hlth Promot Dept, CH-1211 Geneva, Switzerland; [Gore, Fiona] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Ferguson, Jane] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Richardson, Dominic] Org Econ Cooperat & Dev, Social Policy Div, Paris, France; [Astone, Nan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MA USA; [Sangowawa, Adesola O.] Univ Coll Hosp, Inst Child Hlth, Ibadan, Oyo State, Nigeria; [Mokdad, Ali] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; UNICEF; University of St Andrews; World Health Organization; World Health Organization; World Health Organization; University of New South Wales Sydney; Organisation for Economic Co-operation & Development (OECD); Johns Hopkins University; University of Ibadan; University College Hospital, Ibadan; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Patton, GC (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Currie, Dorothy/AAM-3210-2020; Mokdad, Ali H./AAD-1232-2022; Degenhardt, Louisa J/D-4515-2012; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022	Mokdad, Ali H./0000-0002-4994-3339; Degenhardt, Louisa J/0000-0002-8513-2218; Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Currie, Dorothy/0000-0001-7321-9394	National Health and Medical Research Council; Government of Victoria, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Government of Victoria, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	GP is supported by a National Health and Medical Research Council Senior Principal Research Fellowship and the Operational Infrastructure Support Programme, Government of Victoria, Australia. LD is supported by a National Health and Medical Research Council Senior Research Fellowship. Nicole Petrowski, Holly Newby, Priscilla Idele, and Danielle Burke from the UNICEF team provided assistance in gaining the data from the Multiple Indicator Cluster Surveys, Demographic and Health Surveys, AIDS Indicator Survey, and Reproductive Health Survey. Regina Guthold, Paul Bloem, and Krishna Bose from WHO provided comment on the indicator selection and definition. Steve Kapsos from the International Labour Organization provided invaluable advice on the unemployment indicator. Ron Kessler and Nancy Sampson from Harvard Medical School provided advice and data on the mental health indicators. We acknowledge the graphical assistance of Bill Reid and Chiara Bucello. We appreciate the comments from John Santelli at Columbia Medical School on an earlier draft of our report.	AbouZahr C, 2007, LANCET, V369, P1039, DOI 10.1016/S0140-6736(07)60463-2; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 2011, SURV YOUNG PEOPL EG; [Anonymous], 2011, WORLD POP PROSP 2010; [Anonymous], WHAA5314 WHO; Australian Institute for Health and Welfare, 2007, YOUNG AUSTR THEIR HL; Australian Institute of Health and Welfare, 2003, AUSTR YOUNG PEOPL TH; Bchir A, 2006, LANCET, V367, P190, DOI 10.1016/S0140-6736(06)68011-2; Beaglehole R, 2008, LANCET, V372, P1988, DOI 10.1016/S0140-6736(08)61558-5; Biglan A, 2003, AM PSYCHOL, V58, P433, DOI 10.1037/0003-066X.58.6-7.433; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Boerma JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000373; Boerma T, 2005, BRIT MED J, V330, P195, DOI 10.1136/bmj.330.7484.195-b; Bovet P, 2006, J SCHOOL HEALTH, V76, P133, DOI 10.1111/j.1746-1561.2006.00081.x; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Byass P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001006; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064; Davis KE, 2011, INDICATORS TECHNOLOG; Department for Children Schools and Families, 2010, EV CHILD MATT OUTC F; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fischoff B., 2001, ADOLESCENT RISK VULN; Gans JE, 1995, J ADOLESCENT HEALTH, V17, P306, DOI 10.1016/1054-139X(95)00182-R; Goldie SJ, 2008, REPROD HEALTH MATTER, V16, P86, DOI 10.1016/S0968-8080(08)32409-4; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Green JG, 2010, INT J METH PSYCH RES, V19, P23, DOI 10.1002/mpr.314; Greenberg MT, 2003, AM PSYCHOL, V58, P466, DOI 10.1037/0003-066X.58.6-7.466; Hawkins JD, 2009, ARCH PEDIAT ADOL MED, V163, P789, DOI 10.1001/archpediatrics.2009.141; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; International Labour Organization, KEY IND LAB MARK; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Kolbe L, 1997, Promot Educ, V4, P32, DOI 10.1177/102538239700400417; Kypri K, 2009, ALCOHOL CLIN EXP RES, V33, P307, DOI 10.1111/j.1530-0277.2008.00834.x; Lang TD, 2011, SCIENCE, V331, P714, DOI 10.1126/science.1199349; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McNeely CA, 2010, J ADOLESCENT RES, V25, P601, DOI 10.1177/0743558409357235; Ministry of Health, 2010, NAT GUID COMPR HEALT; Ministry of Social Development, 2008, CHILDR YOUNG PEOPL I; Ministry of Social Development, 2011, CHILDR YOUNG PEOPL I; Mokdad AH, 2010, PREV CHRONIC DIS, V7; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001004; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Nutbeam D, 1997, Promot Educ, V4, P10, DOI 10.1177/102538239700400405; Office of the Minister for Children and Youth Affairs, 2008, STAT NAT CHILDR IR 2; Olson AL, 2005, J DEV BEHAV PEDIATR, V26, P169, DOI 10.1097/00004703-200506000-00002; Organisation for Economic Cooperation and Development, OECD FAM DAT; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patton GC, 2006, AM J PUBLIC HEALTH, V96, P1582, DOI 10.2105/AJPH.2004.047399; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Pirkis JE, 2003, J ADOLESCENT HEALTH, V33, P279, DOI 10.1016/S1054-139X(03)00209-X; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Richardson LP, 2010, PEDIATRICS, V125, pE1097, DOI 10.1542/peds.2009-2712; Rosen JE, 2010, MAINSTREAMING ADOLES; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shope JT, 2001, JAMA-J AM MED ASSOC, V286, P1593, DOI 10.1001/jama.286.13.1593; Simmons R, 2007, SCALING HLTH SERVICE; STARFIELD B, 1993, PEDIATRICS, V91, P430; Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161; Strong K, 2008, EUR J CANCER PREV, V17, P153, DOI 10.1097/CEJ.0b013e3282b6fda8; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; U.S. Census Bureau, 2010, CURR POP SURV 2010 A; UN, HIV AIDS SURV IND DA; UNESCO, 2011, TABL 5 ENR RAT ISCED; Unicef, 2010, CHILDR LEFT LEAG TAB; UNICEF, 2007, 7 UNICEF INN RES CTR; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wagenaar AC, 2002, J STUD ALCOHOL, P206, DOI 10.15288/jsas.2002.s14.206; WAGENAAR AC, 1993, ADDICTION, V88, pS75, DOI 10.1111/j.1360-0443.1993.tb02165.x; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; WHO, 2011, YOUTH HLTH RISKS REP; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, WHO MORT DAT	80	280	289	5	86	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1665	1675		10.1016/S0140-6736(12)60203-7	http://dx.doi.org/10.1016/S0140-6736(12)60203-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538181				2022-12-28	WOS:000303452600040
J	Fisher, HL; Moffitt, TE; Houts, RM; Belsky, DW; Arseneault, L; Caspi, A				Fisher, Helen L.; Moffitt, Terrie E.; Houts, Renate M.; Belsky, Daniel W.; Arseneault, Louise; Caspi, Avshalom			Bullying victimisation and risk of self harm in early adolescence: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							REPRESENTATIVE COHORT; PSYCHOTIC SYMPTOMS; SUICIDAL-BEHAVIOR; FAMILY-HISTORY; YOUNG-CHILDREN; BIRTH-COHORT; CHILDHOOD; VIOLENCE; INJURY; SCHOOL	Objectives To test whether frequent bullying victimisation in childhood increases the likelihood of self harming in early adolescence, and to identify which bullied children are at highest risk of self harm. Design The Environmental Risk (E-Risk) longitudinal study of a nationally representative UK cohort of 1116 twin pairs born in 1994-95 (2232 children). Setting England and Wales, United Kingdom. Participants Children assessed at 5, 7, 10, and 12 years of age. Main outcome measures Relative risks of children's self harming behaviour in the six months before their 12th birthday. Results Self harm data were available for 2141 children. Among children aged 12 who had self harmed (2.9%; n=62), more than half were victims of frequent bullying (56%; n=35). Exposure to frequent bullying predicted higher rates of self harm even after children's pre-morbid emotional and behavioural problems, low IQ, and family environmental risks were taken into account (bullying victimisation reported by mother: adjusted relative risk 1.92, 95% confidence interval 1.18 to 3.12; bullying victimisation reported by child: 2.44, 1.36 to 4.40). Victimised twins were more likely to self harm than were their non-victimised twin sibling (bullying victimisation reported by mother: 13/162 v 3/162, ratio=4.3, 95% confidence interval 1.3 to 14.0; bullying victimisation reported by child: 12/144 v 7/144, ratio=1.7, 0.71 to 4.1). Compared with bullied children who did not self harm, bullied children who self harmed were distinguished by a family history of attempted/completed suicide, concurrent mental health problems, and a history of physical maltreatment by an adult. Conclusions Prevention of non-suicidal self injury in young adolescents should focus on helping bullied children to cope more appropriately with their distress. Programmes should target children who have additional mental health problems, have a family history of attempted/completed suicide, or have been maltreated by an adult.	[Fisher, Helen L.; Moffitt, Terrie E.; Arseneault, Louise; Caspi, Avshalom] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England; [Moffitt, Terrie E.; Houts, Renate M.; Caspi, Avshalom] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Moffitt, Terrie E.; Houts, Renate M.; Belsky, Daniel W.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27706 USA; [Moffitt, Terrie E.; Houts, Renate M.; Belsky, Daniel W.; Caspi, Avshalom] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Belsky, Daniel W.] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Publ Hlth, Chapel Hill, NC USA	University of London; King's College London; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Fisher, HL (corresponding author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England.	helen.2.fisher@kcl.ac.uk	Houts, Renate/AAC-5304-2019; caspi, avshalom/AAJ-5874-2020; Belsky, Daniel/HDN-5118-2022; caspi, avshalom/D-5294-2011; Moffitt, Terrie E/D-5295-2011; Belsky, Daniel W/I-7035-2013; Belsky, Daniel/AAB-4785-2021; Arseneault, Louise/ABE-7205-2020; Fisher, Helen L/A-7178-2010	Houts, Renate/0000-0002-1518-2631; caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Moffitt, Terrie E/0000-0002-8589-6760; Belsky, Daniel W/0000-0001-5463-2212; Belsky, Daniel/0000-0001-5463-2212; Fisher, Helen L/0000-0003-4174-2126; Arseneault, Louise/0000-0002-2938-2191	Medical Research Council (MRC) [G9806489, G1002190, G1002366]; Economic and Social Research Council [RES-177-25-0013]; US National Institute of Child Health and Human Development [HD061298]; US National Institute of Mental Health [MH077874]; British Academy; Nuffield Foundation; Jacobs Foundation; ESRC [ES/H034897/1] Funding Source: UKRI; MRC [G1002366, G1002190, G9806489] Funding Source: UKRI; Economic and Social Research Council [ES/H034897/1] Funding Source: researchfish; Medical Research Council [G9806489, G1002366, G1002190] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065563, R01HD061298, P2CHD065563, T32HD007376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077874] Funding Source: NIH RePORTER	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); US National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); British Academy; Nuffield Foundation; Jacobs Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The E-Risk Study is funded by the Medical Research Council (MRC; G9806489 and G1002190). Additional support was provided by the Economic and Social Research Council (RES-177-25-0013), the US National Institute of Child Health and Human Development (HD061298), the US National Institute of Mental Health (MH077874), the British Academy, the Nuffield Foundation, and the Jacobs Foundation. HLF is funded by an MRC population health scientist fellowship (G1002366). The sponsors played no part in the design or conduct of the study, the analysis or interpretation of data, or the writing of the article and the decision to submit it for publication.	Achenbach T.M., 1991, MANUAL TEACHERS REPO; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1991, MANUAL CHILD BEHAV C; Arseneault L, 2006, PEDIATRICS, V118, P130, DOI 10.1542/peds.2005-2388; Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Arseneault L, 2008, ARCH PEDIAT ADOL MED, V162, P145, DOI 10.1001/archpediatrics.2007.53; Belsky DW, 2012, DEV PSYCHOPATHOL, V24, P251, DOI 10.1017/S0954579411000812; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; Brent DA, 2006, NEW ENGL J MED, V355, P2719, DOI 10.1056/NEJMp068195; Cappadocia MC, 2009, CLIN PSYCHOL REV, V29, P506, DOI 10.1016/j.cpr.2009.06.001; Department for Children Schools and Families, 2009, SAF BULL GUID LOC AU; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Fergusson DM, 2005, PSYCHOL MED, V35, P983, DOI 10.1017/S0033291704004167; Fisher HL, 2011, CHILD ABUSE NEGLECT, V35, P117, DOI 10.1016/j.chiabu.2010.10.003; Garisch JA, 2010, BRIT J CLIN PSYCHOL, V49, P151, DOI 10.1348/014466509X441709; GJONE H, 1995, J CHILD PSYCHOL PSYC, V36, P1213, DOI 10.1111/j.1469-7610.1995.tb01366.x; Glassman LH, 2007, BEHAV RES THER, V45, P2483, DOI 10.1016/j.brat.2007.04.002; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Harrington R, 2006, J AM ACAD CHILD PSY, V45, P337, DOI 10.1097/01.chi.0000194564.78536.f2; Hawton K, 2005, BRIT MED J, V330, P891, DOI 10.1136/bmj.330.7496.891; Herba CM, 2008, J CHILD PSYCHOL PSYC, V49, P867, DOI 10.1111/j.1469-7610.2008.01900.x; Hu W, 2011, NY TIMES        0830; Jaffee SR, 2007, CHILD ABUSE NEGLECT, V31, P231, DOI 10.1016/j.chiabu.2006.03.011; Jutengren G, 2011, J SCHOOL PSYCHOL, V49, P249, DOI 10.1016/j.jsp.2010.11.001; Kim YS, 2006, ARCH GEN PSYCHIAT, V63, P1035, DOI 10.1001/archpsyc.63.9.1035; Kovacs M., 1992, CHILDRENS DEPRESSION; Landstedt E, 2011, SCAND J PUBLIC HEALT, V39, P17, DOI 10.1177/1403494810382941; Lansford JE, 2002, ARCH PEDIAT ADOL MED, V156, P824, DOI 10.1001/archpedi.156.8.824; March JS, 1997, MANUAL MULTIDIMENSIO; MARTLEW M, 1991, BRIT J EDUC PSYCHOL, V61, P355, DOI 10.1111/j.2044-8279.1991.tb00992.x; McGue M, 2010, PERSPECT PSYCHOL SCI, V5, P546, DOI 10.1177/1745691610383511; McMahon EM, 2010, PSYCHOL MED, V40, P1811, DOI 10.1017/S0033291709992145; McMahon EM, 2010, SOC SCI MED, V71, P1300, DOI 10.1016/j.socscimed.2010.06.034; Melchior M, 2009, PEDIATRICS, V124, pE564, DOI 10.1542/peds.2009-0583; Milne BJ, 2008, PSYCHOL MED, V38, P1793, DOI 10.1017/S0033291708003115; Milne BJ, 2009, AM J MED GENET B, V150B, P41, DOI 10.1002/ajmg.b.30764; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Nansel TR, 2003, ARCH PEDIAT ADOL MED, V157, P348, DOI 10.1001/archpedi.157.4.348; Nock MK, 2009, CURR DIR PSYCHOL SCI, V18, P78, DOI 10.1111/j.1467-8721.2009.01613.x; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Radford L., 2011, CHILD ABUSE NEGLECT; Rivera CL, 2005, INT J CLIN HLTH PSYC, V5, P485; Sattler J., 2004, ASSESSMENT CHILDRE S; SATTLER JM, 1992, ASSESSMENT CHILDRE S; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Shakoor S, 2011, J ABNORM CHILD PSYCH, V39, P379, DOI 10.1007/s10802-010-9463-5; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Smith PK, 2003, CAN J PSYCHIAT, V48, P591, DOI 10.1177/070674370304800905; Steinhausen HC, 2006, J CHILD PSYCHOL PSYC, V47, P713, DOI 10.1111/j.1469-7610.2005.01569.x; Trouton A, 2002, TWIN RES, V5, P444, DOI 10.1375/136905202320906255; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 1991, WECHSLER PRESCHOOL P; Wedig MM, 2007, J AM ACAD CHILD PSY, V46, P1171, DOI 10.1097/chi.0b013e3180ca9aaf; Westen D, 2003, AM J PSYCHIAT, V160, P952, DOI 10.1176/appi.ajp.160.5.952; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	58	181	185	5	102	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 26	2012	344								e2683	10.1136/bmj.e2683	http://dx.doi.org/10.1136/bmj.e2683			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539176	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000303433900005
J	Gravitz, L				Gravitz, Lauren			VECTOR CONTROL The last bite	NATURE			English	Editorial Material																		Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412	4	14	15	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S26	S27		10.1038/484S26a	http://dx.doi.org/10.1038/484S26a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534530	Bronze			2022-12-28	WOS:000303200400005
J	Puig, A; Mino-Kenudson, M; Dighe, AS				Puig, Alberto; Mino-Kenudson, Mari; Dighe, Anand S.			Case 13-2012: A 62-Year-Old Man with Paresthesias, Weight Loss, Jaundice, and Anemia Vitamin B-12 deficiency due to pernicious anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Puig, Alberto] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mino-Kenudson, Mari; Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Puig, Alberto] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Mino-Kenudson, Mari; Dighe, Anand S.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Puig, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758				Antony AC, 2008, HEMATOLOGY BASIC PRI, P491; CARMEL R, 1987, JAMA-J AM MED ASSOC, V257, P1081, DOI 10.1001/jama.257.8.1081; Hemmer B, 1998, J NEUROL NEUROSUR PS, V65, P822, DOI 10.1136/jnnp.65.6.822; HUSSEIN S, 1978, SCAND J HAEMATOL, V20, P241; Illarioshkin SN, 2010, INT NEUROLOGY CLIN A, P187; Kaferle J, 2009, AM FAM PHYSICIAN, V79, P203; Kokkola A, 1998, SCAND J GASTROENTERO, V33, P88; Lahner E, 2009, WORLD J GASTROENTERO, V15, P5121, DOI 10.3748/wjg.15.5121; Rebelo Pontes HA, 2009, ORAL MANIFESTATION B; Schick P, 2011, PERNICIOUS ANEMIA; Singh NN, 2010, VITAMIN B 12 ASS NEU; Toh BH, 2007, AUTOANTIBODIES, 2ND EDITION, P479, DOI 10.1016/B978-044452763-9/50064-0; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007; Wickramasinghe SN, 2006, BLOOD REV, V20, P299, DOI 10.1016/j.blre.2006.02.002	14	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1626	1633		10.1056/NEJMcpc1111575	http://dx.doi.org/10.1056/NEJMcpc1111575			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533579				2022-12-28	WOS:000303200100013
J	Pronyk, PM; Muniz, M; Nemser, B; Somers, MA; McClellan, L; Palm, CA; Huynh, UK; Ben Amor, Y; Begashaw, B; McArthur, JW; Niang, A; Sachs, SE; Singh, P; Teklehaimanot, A; Sachs, JD				Pronyk, Paul M.; Muniz, Maria; Nemser, Ben; Somers, Marie-Andree; McClellan, Lucy; Palm, Cheryl A.; Uyen Kim Huynh; Ben Amor, Yanis; Begashaw, Belay; McArthur, John W.; Niang, Amadou; Sachs, Sonia Ehrlich; Singh, Prabhjot; Teklehaimanot, Awash; Sachs, Jeffrey D.		Millennium Villages Study Grp	The effect of an integrated multisector model for achieving the Millennium Development Goals and improving child survival in rural sub-Saharan Africa: a non-randomised controlled assessment	LANCET			English	Article							INTERVENTIONS; MORTALITY; PROGRAM	Background Simultaneously addressing multiple Millennium Development Goals (MDGs) has the potential to complement essential health interventions to accelerate gains in child survival. The Millennium Villages project is an integrated multisector approach to rural development operating across diverse sub-Saharan African sites. Our aim was to assess the effects of the project on MDG-related outcomes including child mortality 3 years after implementation and compare these changes to local comparison data. Methods Village sites averaging 35 000 people were selected from rural areas across diverse agroecological zones with high baseline levels of poverty and undernutrition. Starting in 2006, simultaneous investments were made in agriculture, the environment, business development, education, infrastructure, and health in partnership with communities and local governments at an annual projected cost of US$120 per person. We assessed MDG-related progress by monitoring changes 3 years after implementation across Millenium Village sites in nine countries. The primary outcome was the mortality rate of children younger than 5 years of age. To assess plausibility and attribution, we compared changes to reference data gathered from matched randomly selected comparison sites for the mortality rate of children younger than 5 years of age. Analyses were done on a per-protocol basis. This trial is registered with ClinicalTrials.gov, number NCT01125618. Findings Baseline levels of MDG-related spending averaged $ 27 per head, increasing to $ 116 by year 3 of which $ 25 was spent on health. After 3 years, reductions in poverty, food insecurity, stunting, and malaria parasitaemia were reported across nine Millennium Village sites. Access to improved water and sanitation increased, along with coverage for many maternal-child health interventions. Mortality rates in children younger than 5 years of age decreased by 22% in Millennium Village sites relative to baseline (absolute decrease 25 deaths per 1000 livebirths, p=0.015) and 32% relative to matched comparison sites (30 deaths per 1000 livebirths, p=0.033). Interpretation An integrated multisector approach for addressing the MDGs can produce rapid declines in child mortality in the first 3 years of a long-term effort in rural sub-Saharan Africa.	[Pronyk, Paul M.; Muniz, Maria; Nemser, Ben; Somers, Marie-Andree; McClellan, Lucy; Palm, Cheryl A.; Uyen Kim Huynh; Ben Amor, Yanis; McArthur, John W.; Sachs, Sonia Ehrlich; Singh, Prabhjot; Teklehaimanot, Awash; Sachs, Jeffrey D.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Begashaw, Belay] MDG Ctr E & So Africa, Nairobi, Kenya; [Niang, Amadou] MDG Ctr W & Cent Africa, Bamako, Mali; [McArthur, John W.] Millennium Promise, New York, NY USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, 314 Low Lib,535 W 116th St, New York, NY 10027 USA.	sachs@columbia.edu			UN Human Security Trust Fund; Lenfest Foundation; Bill & Melinda Gates Foundation; Becton Dickinson	UN Human Security Trust Fund; Lenfest Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Becton Dickinson	UN Human Security Trust Fund, the Lenfest Foundation, Bill & Melinda Gates Foundation, and Becton Dickinson.	Allison P.D., 2001, MISSING DATA QUANTIT, V136; [Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2001, ANTHROPOMETRIC INDIC; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Fotso JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-218; Gibbon D., 2001, FARMING SYSTEMS POVE; Grieve R, 2009, HEALTH ECON, V19, P939; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Nziguheba G, 2010, ADV AGRON, V109, P75, DOI 10.1016/S0065-2113(10)09003-6; Remans R, 2011, AM J CLIN NUTR, V94, P1632, DOI 10.3945/ajcn.111.020099; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; The Earth Institute Millennium Promise, 2010, HARV DEV RUR AFR MIL; UN Development Group, 2003, IND MON MILL DEV GOA; UN Millennium Project, 2005, INV DEV PRACT PLAN A; UN Millennium Project, 2005, HALV HUNG CAN IT BE; UNICEF, 2008, STAT WORLDS CHILDR C; United Nations General Assembly, UN MILL DECL; United Nations Inter-agency Group for Child Mortality Estimation Levels & Trends in Child Mortality, 2011, LEV TRENDS CHILD MOR; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; WHO, 2000, BENCH AIDS MAL DIAGN; *WHO, 2005, WHO ANTHR 2005 SOFTW; WHO, 2010, GUID TREATM MAL, V2nd; Willett JB, 2003, APPL LONGITUDINAL DA; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	37	53	53	1	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2179	2188		10.1016/S0140-6736(12)60207-4	http://dx.doi.org/10.1016/S0140-6736(12)60207-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955BA	22572602				2022-12-28	WOS:000304990900034
J	Snyder, EY; Teng, YD				Snyder, Evan Y.; Teng, Yang D.			Stem Cells and Spinal Cord Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECOVERY; INJURY		[Snyder, Evan Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Teng, Yang D.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Teng, Yang D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Teng, Yang D.] Vet Affairs Boston Healthcare Syst, Div Spinal Cord Injury Res, Boston, MA USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Snyder, EY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.							Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899	5	48	52	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1940	1942		10.1056/NEJMcibr1200138	http://dx.doi.org/10.1056/NEJMcibr1200138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WU	22591301				2022-12-28	WOS:000304083000015
J	Venna, N; Coyle, CM; Gonzalez, RG; Hedley-Whyte, ET				Venna, Nagagopal; Coyle, Christina M.; Gonzalez, R. Gilberto; Hedley-Whyte, E. Tessa			Case 15-2012: A 48-Year-Old Woman with Diplopia, Headaches, and Papilledema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOSCOPIC MANAGEMENT; EXTRAPARENCHYMAL NEUROCYSTICERCOSIS; HYDROCEPHALUS SECONDARY; CEREBROSPINAL-FLUID; CYSTICERCOSIS; DIAGNOSIS; ANTIGEN; SERUM		[Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Coyle, Christina M.] Jacobi Med Ctr, Div Infect Dis, Dept Med, New York, NY USA; [Coyle, Christina M.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Venna, Nagagopal] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Jacobi Medical Center; Yeshiva University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Venna, N (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905				Alsina George A, 2002, Neurosurg Focus, V12, pe8; Anandh B, 2001, MINIM INVAS NEUROSUR, V44, P194, DOI 10.1055/s-2001-19928; APUZZO MLJ, 1984, J NEUROSURG, V60, P400, DOI 10.3171/jns.1984.60.2.0400; BANDRES JC, 1992, CLIN INFECT DIS, V15, P799, DOI 10.1093/clind/15.5.799; Barinagarrementeria F, 1998, STROKE, V29, P123, DOI 10.1161/01.STR.29.1.123; Bergsneider M, 1999, Neurosurg Focus, V6, pe7; Bergsneider M, 2000, J NEUROSURG, V92, P14, DOI 10.3171/jns.2000.92.1.0014; BICKERSTAFF ER, 1952, BRAIN, V75, P1, DOI 10.1093/brain/75.1.1; Cardenas G, 2010, AM J TROP MED HYG, V82, P121, DOI 10.4269/ajtmh.2010.09-0347; Carpio A, 2002, LANCET INFECT DIS, V2, P751, DOI 10.1016/S1473-3099(02)00454-1; Colli BO., 2002, NEUROSURG FOCUS, V12, pe9; DELBRUTTO OH, 1992, J NEUROL NEUROSUR PS, V55, P252, DOI 10.1136/jnnp.55.4.252; Figueroa JJ, 2011, J NEUROIMAGING, V21, P38, DOI 10.1111/j.1552-6569.2009.00452.x; Garcia HH, 2000, T ROY SOC TROP MED H, V94, P673, DOI 10.1016/S0035-9203(00)90228-1; Garcia HH, 2005, AM J TROP MED HYG, V72, P3, DOI 10.4269/ajtmh.2005.72.3; Garcia HH, 2002, AM J TROP MED HYG, V66, P427, DOI 10.4269/ajtmh.2002.66.427; Goel RK, 2008, J CLIN NEUROSCI, V15, P1096, DOI 10.1016/j.jocn.2007.10.004; Graeff-Teixeira C, 2009, CLIN MICROBIOL REV, V22, P322, DOI 10.1128/CMR.00044-08; Jang JW, 2010, SPINE, V35, pE172, DOI 10.1097/BRS.0b013e3181b9d8b6; Kelley R, 2002, NEUROSURGERY, V50, P757, DOI 10.1097/00006123-200204000-00014; MADRAZO I, 1983, NEUROSURGERY, V12, P148, DOI 10.1227/00006123-198302000-00003; Mitre E, 2007, CLIN INFECT DIS, V44, P549, DOI 10.1086/511040; Nguekam, 2003, PARASITE, V10, P65, DOI 10.1051/parasite/2003101p65; Proano JV, 1997, J NEUROSURG, V87, P29, DOI 10.3171/jns.1997.87.1.0029; Proano JV, 2001, NEW ENGL J MED, V345, P879, DOI 10.1056/NEJMoa010212; Psarros TG, 2003, MINIM INVAS NEUROSUR, V46, P331, DOI 10.1055/s-2003-812470; Rajshekhar V, 2010, INT J SURG, V8, P100, DOI 10.1016/j.ijsu.2009.12.006; Rangel-Castilla L, 2009, AM J TROP MED HYG, V80, P373, DOI 10.4269/ajtmh.2009.80.373; Rodriguez S, 2009, J INFECT DIS, V199, P1345, DOI 10.1086/597757; RUBALCAVA MA, 1995, NEUROSURGERY, V37, P668, DOI 10.1227/00006123-199510000-00009; Torres-Corzo JG, 2006, J NEUROSURG, V104, P746, DOI 10.3171/jns.2006.104.5.746; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3	32	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1924	1934		10.1056/NEJMcpc1111573	http://dx.doi.org/10.1056/NEJMcpc1111573			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591299				2022-12-28	WOS:000304083000012
J	McCabe, ME; Siddique, A; Kowdley, KV				McCabe, Marshall E.; Siddique, Asma; Kowdley, Kris V.			Adding N-acetylcysteine to prednisolone reduced early mortality in severe alcoholic hepatitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CORTICOSTEROIDS; METAANALYSIS; TRIAL		[McCabe, Marshall E.; Kowdley, Kris V.] Virginia Mason Med Ctr, Liver Ctr Excellence, Inst Digest Dis, Seattle, WA 98101 USA	Virginia Mason Medical Center	McCabe, ME (corresponding author), Virginia Mason Med Ctr, Liver Ctr Excellence, Inst Digest Dis, Seattle, WA 98101 USA.		Kowdley, Kris/AAF-5202-2019					CHRISTENSEN E, 1995, GUT, V37, P113, DOI 10.1136/gut.37.1.113; Labonne BEF, 2009, CELL BIOL TOXICOL, V25, P599, DOI 10.1007/s10565-008-9115-5; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Moreno C, 2010, J HEPATOL, V53, P1117, DOI 10.1016/j.jhep.2010.05.030; Stewart S, 2007, J HEPATOL, V47, P277, DOI 10.1016/j.jhep.2007.03.027	6	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-5	10.7326/0003-4819-156-10-201205150-02005	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586023				2022-12-28	WOS:000304193400004
J	Kato, M; Han, TNW; Xie, SH; Shi, K; Du, XL; Wu, LC; Mirzaei, H; Goldsmith, EJ; Longgood, J; Pei, JM; Grishin, NV; Frantz, DE; Schneider, JW; Chen, S; Li, L; Sawaya, MR; Eisenberg, D; Tycko, R; McKnight, SL				Kato, Masato; Han, Tina W.; Xie, Shanhai; Shi, Kevin; Du, Xinlin; Wu, Leeju C.; Mirzaei, Hamid; Goldsmith, Elizabeth J.; Longgood, Jamie; Pei, Jimin; Grishin, Nick V.; Frantz, Douglas E.; Schneider, Jay W.; Chen, She; Li, Lin; Sawaya, Michael R.; Eisenberg, David; Tycko, Robert; McKnight, Steven L.			Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels	CELL			English	Article							MESSENGER-RNA; AMYLOID FIBRILS; STRESS GRANULES; P GRANULES; PROTEIN; DROSOPHILA; LOCALIZATION; AGGREGATION; GERMLINE; REGIONS	Eukaryotic cells contain assemblies of RNAs and proteins termed RNA granules. Many proteins within these bodies contain KH or RRM RNA-binding domains as well as low complexity (LC) sequences of unknown function. We discovered that exposure of cell or tissue lysates to a biotinylated isoxazole (b-isox) chemical precipitated hundreds of RNA-binding proteins with significant overlap to the constituents of RNA granules. The LC sequences within these proteins are both necessary and sufficient for b-isox-mediated aggregation, and these domains can undergo a concentration-dependent phase transition to a hydrogel-like state in the absence of the chemical. X-ray diffraction and EM studies revealed the hydrogels to be composed of uniformly polymerized amyloid-like fibers. Unlike pathogenic fibers, the LC sequence-based polymers described here are dynamic and accommodate heterotypic polymerization. These observations offer a framework for understanding the function of LC sequences as well as an organizing principle for cellular structures that are not membrane bound.	[Kato, Masato; Han, Tina W.; Xie, Shanhai; Shi, Kevin; Du, Xinlin; Wu, Leeju C.; Mirzaei, Hamid; Goldsmith, Elizabeth J.; Longgood, Jamie; Pei, Jimin; Grishin, Nick V.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pei, Jimin; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Frantz, Douglas E.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Chen, She; Li, Lin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas at San Antonio (UTSA); National Institute of Biological Sciences, Beijing; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Sawaya, Michael/0000-0003-0874-9043	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 2010, R LANG ENV STAT COMP; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Knowles RB, 1996, J NEUROSCI, V16, P7812; LEHMANN R, 1991, DEVELOPMENT, V112, P679; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Micklem DR, 1995, DEV BIOL, V172, P377, DOI 10.1006/dbio.1995.8048; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Voronina E, 2010, DEVELOPMENT, V137, P1441, DOI 10.1242/dev.047654; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	51	1247	1262	17	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					753	767		10.1016/j.cell.2012.04.017	http://dx.doi.org/10.1016/j.cell.2012.04.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579281	Green Accepted, Bronze			2022-12-28	WOS:000303934700010
J	Langelier, MF; Planck, JL; Roy, S; Pascal, JM				Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.			Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1	SCIENCE			English	Article							CRYSTAL-STRUCTURES; BINDING DOMAIN; POLYMERASE; INHIBITION; MECHANISM; ACCEPTOR	Poly(ADP-ribose) polymerase-1 (PARP-1) (ADP, adenosine diphosphate) has a modular domain architecture that couples DNA damage detection to poly(ADP-ribosyl)ation activity through a poorly understood mechanism. Here, we report the crystal structure of a DNA double-strand break in complex with human PARP-1 domains essential for activation (Zn1, Zn3, WGR-CAT). PARP-1 engages DNA as a monomer, and the interaction with DNA damage organizes PARP-1 domains into a collapsed conformation that can explain the strong preference for automodification. The Zn1, Zn3, and WGR domains collectively bind to DNA, forming a network of interdomain contacts that links the DNA damage interface to the catalytic domain (CAT). The DNA damage-induced conformation of PARP-1 results in structural distortions that destabilize the CAT. Our results suggest that an increase in CAT protein dynamics underlies the DNA-dependent activation mechanism of PARP-1.	[Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	john.pascal@kimmelcancercenter.org			NIH [R01087282]; American Cancer Society [RSG0918301]; Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the NIH (R01087282), the American Cancer Society (RSG0918301), and the Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University (P30CA56036). We thank the National Synchrotron Light Source staff for access and assistance with data collection (beamlines X6A and X29A, Brookhaven National Laboratory); G. Cingolani, Y.-M. Hou, and J. D. Steffen for helpful discussions; and S. Carney for cloning the Zn1-Zn3 interface mutants. The structure of the complex has been deposited under accession number 4DQY in the Protein Data Bank (PDB).	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; MIRANDA EA, 1995, BIOCHEM BIOPH RES CO, V212, P317, DOI 10.1006/bbrc.1995.1972; OGATA N, 1981, J BIOL CHEM, V256, P4135; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Spagnolo L, 2012, NUCLEIC ACIDS RES, V40, P4168, DOI 10.1093/nar/gkr1231; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07	23	391	412	5	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					728	732		10.1126/science.1216338	http://dx.doi.org/10.1126/science.1216338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582261	Green Accepted			2022-12-28	WOS:000303872300052
J	Gezari, S; Chornock, R; Rest, A; Huber, ME; Forster, K; Berger, E; Challis, PJ; Neill, JD; Martin, DC; Heckman, T; Lawrence, A; Norman, C; Narayan, G; Foley, RJ; Marion, GH; Scolnic, D; Chomiuk, L; Soderberg, A; Smith, K; Kirshner, RP; Riess, AG; Smartt, SJ; Stubbs, CW; Tonry, JL; Wood-Vasey, WM; Burgett, WS; Chambers, KC; Grav, T; Heasley, JN; Kaiser, N; Kudritzki, RP; Magnier, EA; Morgan, JS; Price, PA				Gezari, S.; Chornock, R.; Rest, A.; Huber, M. E.; Forster, K.; Berger, E.; Challis, P. J.; Neill, J. D.; Martin, D. C.; Heckman, T.; Lawrence, A.; Norman, C.; Narayan, G.; Foley, R. J.; Marion, G. H.; Scolnic, D.; Chomiuk, L.; Soderberg, A.; Smith, K.; Kirshner, R. P.; Riess, A. G.; Smartt, S. J.; Stubbs, C. W.; Tonry, J. L.; Wood-Vasey, W. M.; Burgett, W. S.; Chambers, K. C.; Grav, T.; Heasley, J. N.; Kaiser, N.; Kudritzki, R. -P.; Magnier, E. A.; Morgan, J. S.; Price, P. A.			An ultraviolet-optical flare from the tidal disruption of a helium-rich stellar core	NATURE			English	Article							MASSIVE BLACK-HOLE; STAR; LUMINOSITY; EVOLUTION; OUTBURST; GALAXIES	The flare of radiation from the tidal disruption and accretion of a star can be used as a marker for supermassive black holes that otherwise lie dormant and undetected in the centres of distant galaxies(1). Previous candidate flares(2-6) have had declining light curves in good agreement with expectations, but with poor constraints on the time of disruption and the type of star disrupted, because the rising emission was not observed. Recently, two 'relativistic' candidate tidal disruption events were discovered, each of whose extreme X-ray luminosity and synchrotron radio emission were interpreted as the onset of emission from a relativistic jet(7-10). Here we report a luminous ultraviolet-optical flare from the nuclear region of an inactive galaxy at a redshift of 0.1696. The observed continuum is cooler than expected for a simple accreting debris disk, but the well-sampled rise and decay of the light curve follow the predicted mass accretion rate and can be modelled to determine the time of disruption to an accuracy of two days. The black hole has a mass of about two million solar masses, modulo a factor dependent on the mass and radius of the star disrupted. On the basis of the spectroscopic signature of ionized helium from the unbound debris, we determine that the disrupted star was a helium-rich stellar core.	[Gezari, S.; Heckman, T.; Norman, C.; Scolnic, D.; Riess, A. G.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Chornock, R.; Berger, E.; Challis, P. J.; Narayan, G.; Foley, R. J.; Marion, G. H.; Chomiuk, L.; Soderberg, A.; Kirshner, R. P.; Stubbs, C. W.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Rest, A.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Huber, M. E.; Tonry, J. L.; Burgett, W. S.; Chambers, K. C.; Heasley, J. N.; Kaiser, N.; Kudritzki, R. -P.; Magnier, E. A.; Morgan, J. S.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Forster, K.; Neill, J. D.; Martin, D. C.] CALTECH, Pasadena, CA 91125 USA; [Lawrence, A.] Univ Edinburgh, Royal Observ, Scottish Univ Phys Alliance, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Smith, K.; Smartt, S. J.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Wood-Vasey, W. M.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh Particle Phys Astrophys & Cosmol Ctr, Pittsburgh, PA 15260 USA; [Grav, T.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Price, P. A.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Johns Hopkins University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Space Telescope Science Institute; University of Hawaii System; California Institute of Technology; University of Edinburgh; Queens University Belfast; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Gezari, S (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, 3400 N Charles St, Baltimore, MD 21218 USA.	suvi@pha.jhu.edu	Stubbs, Christopher W/C-2829-2012; Rest, Armin/ABE-6469-2020; Riess, Adam/ABF-2480-2020	Stubbs, Christopher W/0000-0003-0347-1724; Magnier, Eugene/0000-0002-7965-2815; Chornock, Ryan/0000-0002-7706-5668; Tonry, John/0000-0003-2858-9657; Chambers, Kenneth/0000-0001-6965-7789; Norman, Colin/0000-0002-5222-5717; Foley, Ryan/0000-0002-2445-5275; Narayan, Gautham/0000-0001-6022-0484	NASA; National Science Foundation; UK Science and Technology Facilities Council; Space Telescope Science Institute; Planetary Science Division of the NASA Science Mission Directorate; Direct For Mathematical & Physical Scien [1009749] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/G009465/1, ST/I001123/1] Funding Source: researchfish; STFC [ST/G009465/1, ST/I001123/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Space Telescope Science Institute(Space Telescope Science Institute); Planetary Science Division of the NASA Science Mission Directorate; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank H. Tananbaum for approving our Chandra Director's Discretionary Time request. We are grateful to G. Lodato for providing the tidal disruption event models in tabular form, and to S. Moran for running software to calculate the host-galaxy K-corrections. We thank R. E. Williams for discussions on the line emission in the spectra. S. G. was supported by NASA through a Hubble Fellowship grant awarded by the Space Telescope Science Institute, which is operated by AURA Inc. for NASA. Partial support for this work was provided by the National Science Foundation. The PS1 survey has been made possible through contributions of the Institute for Astronomy, the University of Hawaii, the Pan-STARRS Project Office, the Max-Planck Society and its participating institutes, The Johns Hopkins University, Durham University, the University of Edinburgh, Queen's University Belfast, the Harvard-Smithsonian Center for Astrophysics, the Las Cumbres Observatory Global Telescope Network Inc. and the National Central University of Taiwan, and by NASA under a grant issued through the Planetary Science Division of the NASA Science Mission Directorate. We acknowledge NASA's support for construction, operation, and science analysis of the GALEX mission, which was developed in cooperation with Centre National d'Etudes Spatiales of France and the Korean Ministry of Science and Technology. Some of the observations reported here were obtained at the MMT Observatory, which is a joint facility of the Smithsonian Institution and the University of Arizona, and at the Liverpool Telescope, which is operated with financial support from the UK Science and Technology Facilities Council. The computations in this paper were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University. R.J.F. is a Clay Fellow.	Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Ayal S, 2000, ASTROPHYS J, V545, P772, DOI 10.1086/317835; Blanton MR, 2007, ASTRON J, V133, P734, DOI 10.1086/510127; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Cenko S. B., 2011, SWIFT J20584 0516 DI; Davies MB, 2005, ASTROPHYS J, V624, pL25, DOI 10.1086/430308; Esquej P, 2008, ASTRON ASTROPHYS, V489, P543, DOI 10.1051/0004-6361:200810110; EVANS CR, 1989, ASTROPHYS J, V346, pL13, DOI 10.1086/185567; Gezari S, 2009, ASTROPHYS J, V698, P1367, DOI 10.1088/0004-637X/698/2/1367; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Kaiser N, 2010, PROC SPIE, V7733, DOI 10.1117/12.859188; Kobayashi S, 2004, ASTROPHYS J, V615, P855, DOI 10.1086/424684; Komossa S, 2004, ASTROPHYS J, V603, pL17, DOI 10.1086/382046; Komossa S, 1999, ASTRON ASTROPHYS, V343, P775; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Lawrence A., 2011, UV PEAK ACTIVE GALAC; Lodato G, 2009, MON NOT R ASTRON SOC, V392, P332, DOI 10.1111/j.1365-2966.2008.14049.x; Loeb A, 1997, ASTROPHYS J, V489, P573, DOI 10.1086/304814; Maxted PFL, 2011, MON NOT R ASTRON SOC, V418, P1156, DOI 10.1111/j.1365-2966.2011.19567.x; Phinney E. S., 1989, IAU S, V136, P543; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Steffen AT, 2006, ASTRON J, V131, P2826, DOI 10.1086/503627; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; Ulmer A, 1999, ASTROPHYS J, V514, P180, DOI 10.1086/306909; van Velzen S, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/73; Zauderer BA, 2011, NATURE, V476, P425, DOI 10.1038/nature10366	29	324	326	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					217	220		10.1038/nature10990	http://dx.doi.org/10.1038/nature10990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575962	Green Submitted, Green Accepted			2022-12-28	WOS:000303799800036
J	Pacanowski, M; Amur, S; Zineh, I				Pacanowski, Michael; Amur, Shashi; Zineh, Issam			New Genetic Discoveries and Treatment for Hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION		[Pacanowski, Michael; Amur, Shashi; Zineh, Issam] US FDA, Genom Grp, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Pacanowski, M (corresponding author), US FDA, Genom Grp, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak Bldg 51,Room 31, Silver Spring, MD 20993 USA.	michael.pacanowski@fda.hhs.gov						Armstrong K, 2012, JAMA-J AM MED ASSOC, V307, P1031, DOI 10.1001/jama.2012.261; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; US Food and Drug Administration, GUID IND CHRON HEP C	6	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1921	1922		10.1001/jama.2012.3516	http://dx.doi.org/10.1001/jama.2012.3516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570460				2022-12-28	WOS:000303741900024
J	Brewer, C				Brewer, Colin			The golden age of the placebo	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.	brewerismo@gmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 30	2012	344								e3016	10.1136/bmj.e3016	http://dx.doi.org/10.1136/bmj.e3016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MY	22547647				2022-12-28	WOS:000303816600006
J	[Anonymous]				[Anonymous]			Putting adolescents at the centre of health and development	LANCET			English	Editorial Material																			0	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1561	1561						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538175				2022-12-28	WOS:000303452600001
J	Marks, H; Kalkan, T; Menafra, R; Denissov, S; Jones, K; Hofemeister, H; Nichols, J; Kranz, A; Stewart, AF; Smith, A; Stunnenberg, HG				Marks, Hendrik; Kalkan, Tuezer; Menafra, Roberta; Denissov, Sergey; Jones, Kenneth; Hofemeister, Helmut; Nichols, Jennifer; Kranz, Andrea; Stewart, A. Francis; Smith, Austin; Stunnenberg, Hendrik G.			The Transcriptional and Epigenomic Foundations of Ground State Pluripotency	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MOUSE ES CELLS; SELF-RENEWAL; SIGNALING PATHWAYS; RAT BLASTOCYSTS; GENE-REGULATION; GERMLINE; DIFFERENTIATION; HETEROGENEITY	Mouse embryonic stem (ES) cells grown in serum exhibit greater heterogeneity in morphology and expression of pluripotency factors than ES cells cultured in defined medium with inhibitors of two kinases (Mek and GSK3), a condition known as "2i" postulated to establish a naive ground state. We show that the transcriptome and epigenome profiles of serum-and 2i-grown ES cells are distinct. 2i-treated cells exhibit lower expression of lineage-affiliated genes, reduced prevalence at promoters of the repressive histone modification H3K27me3, and fewer bivalent domains, which are thought to mark genes poised for either up-or downregulation. Nonetheless, serum- and 2i-grown ES cells have similar differentiation potential. Precocious transcription of developmental genes in 2i is restrained by RNA polymerase II promoter-proximal pausing. These findings suggest that transcriptional potentiation and a permissive chromatin context characterize the ground state and that exit from it may not require a metastable intermediate or multilineage priming.	[Kalkan, Tuezer; Jones, Kenneth; Nichols, Jennifer; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr, Stem Cell Res & Stem Cell Inst, Cambridge CB2 1QR, England; [Marks, Hendrik; Menafra, Roberta; Denissov, Sergey; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Hofemeister, Helmut; Kranz, Andrea; Stewart, A. Francis] Tech Univ Dresden, BioInnovat Zentrum, D-01307 Dresden, Germany	University of Cambridge; Radboud University Nijmegen; University of Cambridge; University of Cambridge; Technische Universitat Dresden	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr, Stem Cell Res & Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk; h.stunnenberg@ncmls.ru.nl	Kranz, Andrea/D-3617-2012; Marks, Hendrik/E-2801-2012; Stewart, A. Francis/E-7789-2010; Stunnenberg, Hendrik G./D-6875-2012	Marks, Hendrik/0000-0002-4198-3731; Stunnenberg, Hendrik G./0000-0002-0066-1576; Smith, Austin/0000-0002-3029-4682; Nichols, Jennifer/0000-0002-8650-1388	European Union [18883, 223485, 200720, 221952]; Deutsche Forschungsgemeinschaft [SPP1356]; Wellcome Trust; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G1100526, G0800784, MC_PC_12009, G0800784B] Funding Source: researchfish	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Eva Janssen-Megens, Anita Kaan, and Yan Tan for sequencing; Kees-Jan Francoijs, Hinri Kerstens, Simon van Heeringen, and Arjen Brinkman for bioinformatic assistance; and Rachel Walker for help with flow cytometry. We thank Paul Bertone for comments on the manuscript. Tatyana Nesterova and Neil Brockdorff provided the XT67E1 cells and Olga Ujhelly and Andras Dinnyes the HM1 cells. The pThr345-Ezh2 antibody was a gift from Danny Reinberg. The research leading to these results has received funding from the European Union grants HEROIC (18883; FP6/2005-2010), PluriSys (223485; FP7/2009), EuroSyStem (200720; FP7/2008), and ATLAS (221952; FP7/2009), the Deutsche Forschungsgemeinschaft SPP1356 Pluripotency and Reprogramming, and The Wellcome Trust. A. S. is a Medical Research Council Professor.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith A, 2010, EMBO MOL MED, V2, P113, DOI 10.1002/emmm.201000065; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	61	596	606	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					590	604		10.1016/j.cell.2012.03.026	http://dx.doi.org/10.1016/j.cell.2012.03.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541430	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000303443100011
J	Welker, J; Giessibl, FJ				Welker, Joachim; Giessibl, Franz J.			Revealing the Angular Symmetry of Chemical Bonds by Atomic Force Microscopy	SCIENCE			English	Article							ELECTRONIC-STRUCTURE; GIANT CORRUGATIONS; RESOLUTION; SURFACE; MOLECULES	We have measured the angular dependence of chemical bonding forces between a carbon monoxide molecule that is adsorbed to a copper surface and the terminal atom of the metallic tip of a combined scanning tunneling microscope and atomic force microscope. We provide tomographic maps of force and current as a function of distance that revealed the emergence of strongly directional chemical bonds as tip and sample approach. The force maps show pronounced single, dual, or triple minima depending on the orientation of the tip atom, whereas tunneling current maps showed a single minimum for all three tip conditions. We introduce an angular dependent model for the bonding energy that maps the observed experimental data for all observed orientations and distances.	[Welker, Joachim; Giessibl, Franz J.] Univ Regensburg, D-93053 Regensburg, Germany	University of Regensburg	Giessibl, FJ (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	franz.giessibl@ur.de	Giessibl, Franz J/K-8022-2013	Giessibl, Franz J/0000-0002-5585-1326	Deutsche Forschungsgemeinschaft [Graduiertenkolleg 1570, Sonderforschungsbereich 689]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	F.J.G. thanks A. Heinrich for an invitation to several research visits to the IBM Almaden Research Center, where the first experiments to the angular force dependence were conducted in parallel to the work published in (7, 28). We thank C. Lutz, A. Heinrich, M. Ternes, and J. Repp for helpful discussions and editorial suggestions; G. Binnig for suggesting the differential current analysis presented in Fig. 2, A, C, and E; T. Hofmann for assembling the sensor that was used in the experiment and for acquiring the tip symmetry histogram shown in fig. S10; and the Deutsche Forschungsgemeinschaft for funding through Graduiertenkolleg 1570 and Sonderforschungsbereich 689.	Albers BJ, 2009, NAT NANOTECHNOL, V4, P307, DOI [10.1038/nnano.2009.57, 10.1038/NNANO.2009.57]; [Anonymous], D65232 OM NANOTECHNO; Bartels L, 1997, APPL PHYS LETT, V71, P213, DOI 10.1063/1.119503; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Braun J, 1996, J CHEM PHYS, V105, P3258, DOI 10.1063/1.471841; Campbellova A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295710; de Lozanne A, 2004, SCIENCE, V305, P348; Feynman RP, 1939, PHYS REV, V56, P340, DOI 10.1103/PhysRev.56.340; Giessibl FJ, 2000, SCIENCE, V289, P422, DOI 10.1126/science.289.5478.422; Giessibl FJ, 2000, PHYS REV B, V61, P9968, DOI 10.1103/PhysRevB.61.9968; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; Hembacher S, 2004, SCIENCE, V305, P380, DOI 10.1126/science.1099730; Hofer WA, 2004, CHEM PHYS LETT, V397, P354, DOI 10.1016/j.cplett.2004.08.110; Holscher H, 2002, APPL PHYS LETT, V81, P4428, DOI 10.1063/1.1525056; Huang MH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.256101; Ibach H., 2003, SOLID STATE PHYS; ISHI S, 1985, SURF SCI, V161, P349, DOI 10.1016/0039-6028(85)90815-5; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; MATTHEISS LF, 1984, PHYS REV B, V29, P5372, DOI 10.1103/PhysRevB.29.5372; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Morita S, 2009, NANOSCI TECHNOL, V2, P1, DOI 10.1007/978-3-642-01495-6_1; Morse PM, 1929, PHYS REV, V34, P57, DOI 10.1103/PhysRev.34.57; POSTERNAK M, 1980, PHYS REV B, V21, P5601, DOI 10.1103/PhysRevB.21.5601; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; SOLER JM, 1986, PHYS REV LETT, V57, P444, DOI 10.1103/PhysRevLett.57.444; STILLINGER FH, 1985, PHYS REV B, V31, P5262, DOI 10.1103/PhysRevB.31.5262; STOLL E, 1984, SURF SCI, V143, pL411, DOI 10.1016/0039-6028(84)90540-5; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Sun ZX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046104; Temirov R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053012; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; Ternes M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.016802; Wright CA, 2011, NANO LETT, V11, P5026, DOI 10.1021/nl2030773; Zotti LA, 2006, CHEM PHYS LETT, V420, P177, DOI 10.1016/j.cplett.2005.12.065	38	110	110	0	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					444	449		10.1126/science.1219850	http://dx.doi.org/10.1126/science.1219850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539715				2022-12-28	WOS:000303233400039
J	Ailon, J				Ailon, Jonathan			Pneumoperitoneum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Toronto, Toronto, ON, Canada	University of Toronto	Ailon, J (corresponding author), Univ Toronto, Toronto, ON, Canada.	jonathan.ailon@utoronto.ca							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					E26	E26		10.1056/NEJMicm1112622	http://dx.doi.org/10.1056/NEJMicm1112622			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533601				2022-12-28	WOS:000303200100012
J	Jadhav, SP; Kemere, C; German, PW; Frank, LM				Jadhav, Shantanu P.; Kemere, Caleb; German, P. Walter; Frank, Loren M.			Awake Hippocampal Sharp-Wave Ripples Support Spatial Memory	SCIENCE			English	Article							REACTIVATION; EXPERIENCE; REPLAY; DYNAMICS; PATTERNS; SPACE	The hippocampus is critical for spatial learning and memory. Hippocampal neurons in awake animals exhibit place field activity that encodes current location, as well as sharp-wave ripple (SWR) activity during which representations based on past experiences are often replayed. The relationship between these patterns of activity and the memory functions of the hippocampus is poorly understood. We interrupted awake SWRs in animals learning a spatial alternation task. We observed a specific learning and performance deficit that persisted throughout training. This deficit was associated with awake SWR activity, as SWR interruption left place field activity and post-experience SWR reactivation intact. These results provide a link between awake SWRs and hippocampal memory processes, which suggests that awake replay of memory-related information during SWRs supports learning and memory-guided decision-making.	[Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Frank, Loren/0000-0002-1752-5677; Kemere, Caleb/0000-0003-2054-0234	Wheeler Center; Helen Hay Whitney Foundation; NIH [RO1 MH080283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER	Wheeler Center; Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a Wheeler Center Fellowship (S.P.J.), a Helen Hay Whitney Foundation grant (C.K.), and NIH grant RO1 MH080283. The authors declare no competing financial interests.	BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	29	478	483	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1454	1458		10.1126/science.1217230	http://dx.doi.org/10.1126/science.1217230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22555434	Green Accepted, Bronze			2022-12-28	WOS:000305211700050
J	St Louis, C; Zorlu, G				St Louis, Connie; Zorlu, Gozde			PUBLIC HEALTH Can Twitter predict disease outbreaks?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[St Louis, Connie] City Univ London, London EC1V 0HB, England	City University London	St Louis, C (corresponding author), City Univ London, London EC1V 0HB, England.	c.stlouis@city.ac.uk						Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Guy S, 2011, EHEALTH; Szomszor MN, 2010, 3 INT ICST C EL HEAL; Tamura Y, 2011, LANCET, V377, P1652, DOI 10.1016/S0140-6736(11)60672-7	5	48	50	0	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 17	2012	344								e2353	10.1136/bmj.e2353	http://dx.doi.org/10.1136/bmj.e2353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946NT	22597352				2022-12-28	WOS:000304359400007
J	Kaye, J; Meslin, EM; Knoppers, BM; Juengst, ET; Deschenes, M; Cambon-Thomsen, A; Chalmers, D; De Vries, J; Edwards, K; Hoppe, N; Kent, A; Adebamowo, C; Marshall, P; Kato, K				Kaye, Jane; Meslin, Eric M.; Knoppers, Bartha M.; Juengst, Eric T.; Deschenes, Mylene; Cambon-Thomsen, Anne; Chalmers, Donald; De Vries, Jantina; Edwards, Kelly; Hoppe, Nils; Kent, Alastair; Adebamowo, Clement; Marshall, Patricia; Kato, Kazuto			ELSI 2.0 for Genomics and Society	SCIENCE			English	Editorial Material							HEALTH		[Kaye, Jane] Univ Oxford, Dept Publ Hlth, HeLEX, Oxford OX3 7LF, England; [Meslin, Eric M.] Indiana Univ, IU Ctr Bioeth, Bloomington, IN 46202 USA; [Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Juengst, Eric T.] Univ N Carolina, UNC Ctr Bioeth, Chapel Hill, NC 27599 USA; [Deschenes, Mylene] P3G, Montreal, PQ H3V 1A2, Canada; [Cambon-Thomsen, Anne] INSERM, UMR 1027, F-31000 Toulouse, France; [Cambon-Thomsen, Anne] Univ Toulouse 3, Fac Med Purpan, UMR 1027, F-31000 Toulouse, France; [Chalmers, Donald] Univ Tasmania, Fac Law, Hobart, Tas 7000, Australia; [De Vries, Jantina] Univ Cape Town, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa; [Edwards, Kelly] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Hoppe, Nils] Leibniz Univ Hannover, CELLS, D-30167 Hannover, Germany; [Kent, Alastair] Genet Alliance UK, London N1 3QP, England; [Adebamowo, Clement] Inst Human Virol, Garki, Abuja, Nigeria; [Adebamowo, Clement] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Marshall, Patricia] Case Western Reserve Univ, Dept Bioeth, Cleveland, OH 44106 USA; [Kato, Kazuto] Osaka Univ, Suita, Osaka 5650871, Japan	University of Oxford; Indiana University System; Indiana University Bloomington; McGill University; University of North Carolina; University of North Carolina Chapel Hill; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Tasmania; University of Cape Town; University of Washington; University of Washington Seattle; Leibniz University Hannover; University System of Maryland; University of Maryland Baltimore; Case Western Reserve University; Osaka University	Kaye, J (corresponding author), Univ Oxford, Dept Publ Hlth, HeLEX, Oxford OX3 7LF, England.	jane.kaye@law.ox.ac.uk	Kaye, Jane/AAG-4679-2020; Hoppe, Nils/C-9050-2014; Chalmers, Don R/J-7658-2014; De Vries, Jantina/I-2752-2014; Adebamowo, Clement/C-8778-2011	Kaye, Jane/0000-0002-7311-4725; Hoppe, Nils/0000-0001-7051-294X; Chalmers, Don R/0000-0002-7925-8818; De Vries, Jantina/0000-0001-7192-2633; Adebamowo, Clement/0000-0002-6571-2880; Kato, Kazuto/0000-0001-9006-9551; Juengst, Eric/0000-0002-8374-5774	FIC NIH HHS [R25TW007091, R25 TW007091] Funding Source: Medline; NCRR NIH HHS [UL1RR025761-01, UL1 RR025761] Funding Source: Medline; NHGRI NIH HHS [P50 HG3374, P50 HG003390, P50 HG003374, P50-HG-03390-07] Funding Source: Medline; Wellcome Trust [096599/2/11/Z, 097671/Z/11/Z, 096599] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R25TW007091] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003390, P50HG003374] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Birney E., 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c; Calva Edmundo, 2002, Trends in Biotechnology, V20, P368, DOI 10.1016/S0167-7799(02)02013-9; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Juengst ET, 1996, SOC PHILOS POLICY, V13, P63, DOI 10.1017/S0265052500003460; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Mehlman M.J., 2002, ENCY ETHICAL LEGAL P, P234, DOI [DOI 10.1002/0471250597.MUR045, 10.1002/0471250597.mur045]; Meslin EM, 1997, KENNEDY INST ETHIC J, V7, P291; Ogundiran T. O., 2005, SOC POLICY, V1, P66; Phelan J.C., 2011, PSYCHIAT REHABILITAT, V6, P159, DOI [DOI 10.1080/10973430208408431, 10.1080/10973430208408431]; Sankar P, 2006, GENET MED, V8, P33, DOI 10.1097/01.gim.0000195894.67756.8b; Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633; WULF WA, 1993, SCIENCE, V261, P854, DOI 10.1126/science.8346438	15	25	28	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					673	674		10.1126/science.1218015	http://dx.doi.org/10.1126/science.1218015			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940EH	22582247	Green Accepted			2022-12-28	WOS:000303872300032
J	Reddy, V; Nathues, A; Le Corre, L; Sierks, H; Li, JY; Gaskell, R; McCoy, T; Beck, AW; Schroder, SE; Pieters, CM; Becker, KJ; Buratti, BJ; Denevi, B; Blewett, DT; Christensen, U; Gaffey, MJ; Gutierrez-Marques, P; Hicks, M; Keller, HU; Maue, T; Mottola, S; McFadden, LA; McSween, HY; Mittlefehldt, D; O'Brien, DP; Raymond, C; Russell, C				Reddy, Vishnu; Nathues, Andreas; Le Corre, Lucille; Sierks, Holger; Li, Jian-Yang; Gaskell, Robert; McCoy, Timothy; Beck, Andrew W.; Schroeder, Stefan E.; Pieters, Carle M.; Becker, Kris J.; Buratti, Bonnie J.; Denevi, Brett; Blewett, David T.; Christensen, Ulrich; Gaffey, Michael J.; Gutierrez-Marques, Pablo; Hicks, Michael; Keller, Horst Uwe; Maue, Thorsten; Mottola, Stefano; McFadden, Lucy A.; McSween, Harry Y.; Mittlefehldt, David; O'Brien, David P.; Raymond, Carol; Russell, Christopher			Color and Albedo Heterogeneity of Vesta from Dawn	SCIENCE			English	Article							PARENT BODY; EUCRITE; SIZE	Multispectral images (0.44 to 0.98 mm) of asteroid (4) Vesta obtained by the Dawn Framing Cameras reveal global color variations that uncover and help understand the north-south hemispherical dichotomy. The signature of deep lithologies excavated during the formation of the Rheasilvia basin on the south pole has been preserved on the surface. Color variations (band depth, spectral slope, and eucrite-diogenite abundance) clearly correlate with distinct compositional units. Vesta displays the greatest variation of geometric albedo (0.10 to 0.67) of any asteroid yet observed. Four distinct color units are recognized that chronicle processes-including impact excavation, mass wasting, and space weathering-that shaped the asteroid's surface. Vesta's color and photometric diversity are indicative of its status as a preserved, differentiated protoplanet.	[Reddy, Vishnu; Nathues, Andreas; Le Corre, Lucille; Sierks, Holger; Schroeder, Stefan E.; Christensen, Ulrich; Gutierrez-Marques, Pablo; Maue, Thorsten] Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; [Reddy, Vishnu; Gaffey, Michael J.] Univ N Dakota, Dept Space Studies, Grand Forks, ND 58202 USA; [Li, Jian-Yang] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Gaskell, Robert; O'Brien, David P.] Planetary Sci Inst, Tucson, AZ 85719 USA; [McCoy, Timothy; Beck, Andrew W.] Smithsonian Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; [Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Becker, Kris J.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Buratti, Bonnie J.; Hicks, Michael; Raymond, Carol] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Denevi, Brett; Blewett, David T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Keller, Horst Uwe] TU Braunschweig, Inst Geophys & Extraterr Phys, DE-38106 Braunschweig, Germany; [Mottola, Stefano] Deutsch Zentrum Luft & Raumfahrt DLR, German Aerosp Ctr, Inst Planetary Res, D-12489 Berlin, Germany; [McFadden, Lucy A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [McSween, Harry Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Mittlefehldt, David] NASA, Lyndon B Johnson Space Ctr, Astromat Res Off, Houston, TX 77058 USA; [Russell, Christopher] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA	Max Planck Society; University of North Dakota Grand Forks; University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; Brown University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Braunschweig University of Technology; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of California System; University of California Los Angeles	Reddy, V (corresponding author), Max Planck Inst Solar Syst Res, Max Planck Str 2, D-37191 Katlenburg Lindau, Germany.	reddy@mps.mpg.de	Russell, Christopher T/E-7745-2012; Blewett, David T/I-4904-2012; Schröder, Stefan/D-9709-2013; Nathues, Andreas/AAW-4340-2020; Beck, Andrew W/J-7215-2015; Denevi, Brett W./I-6502-2012; McFadden, Lucy-Ann/I-4902-2013	Russell, Christopher T/0000-0003-1639-8298; Blewett, David T/0000-0002-9241-6358; Schröder, Stefan/0000-0003-0323-8324; Beck, Andrew W/0000-0003-4455-2299; Denevi, Brett W./0000-0001-7837-6663; McFadden, Lucy-Ann/0000-0002-0537-9975; Li, Jian-Yang/0000-0003-3841-9977; Le Corre, Lucille/0000-0003-0349-7932; Reddy, Vishnu/0000-0002-7743-3491; McCoy, Timothy/0000-0002-4573-3553	Max Planck Society; German Space Agency, DLR; Dawn at Vesta; NASA	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Space Agency, DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); Dawn at Vesta; NASA(National Aeronautics & Space Administration (NASA))	We thank the Dawn team for the development, cruise, orbital insertion, and operations of the Dawn spacecraft at Vesta. The Framing Camera project is financially supported by the Max Planck Society and the German Space Agency, DLR. We also thank the Dawn at Vesta Participating Scientist Program for funding the research. A portion of this work was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Dawn data are archived with the NASA Planetary Data System.	BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; GAFFEY MJ, 1976, J GEOPHYS RES, V81, P905, DOI 10.1029/JB081i005p00905; Keil K., 2002, ASTEROIDS 3, P573; Le Corre L, 2011, ICARUS, V216, P376, DOI 10.1016/j.icarus.2011.09.014; Li JY, 2010, ICARUS, V208, P238, DOI 10.1016/j.icarus.2010.02.008; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; Mittlefehldt D. W., 1998, REV MINERAL, V6, P4; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825, DOI 10.1111/j.1945-5100.1997.tb01573.x; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Sierks H, 2011, SPACE SCI REV, V163, P263, DOI 10.1007/s11214-011-9745-4; Thomas PC, 1997, ICARUS, V128, P88, DOI 10.1006/icar.1997.5736; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0	14	152	152	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					700	704		10.1126/science.1219088	http://dx.doi.org/10.1126/science.1219088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582258				2022-12-28	WOS:000303872300044
J	Segall, P				Segall, Paul			Understanding Earthquakes	SCIENCE			English	Editorial Material							PARKFIELD; CALIFORNIA; RECURRENCE; PREDICTION; FRICTION; FAULT		Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Segall, P (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	segall@stanford.edu						Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; BAKUN WH, 1984, J GEOPHYS RES, V89, P3051, DOI 10.1029/JB089iB05p03051; BAKUN WH, 1985, SCIENCE, V229, P619, DOI 10.1126/science.229.4714.619; Barbot S, 2012, SCIENCE, V336, P707, DOI 10.1126/science.1218796; Dunham EM, 2011, B SEISMOL SOC AM, V101, P2296, DOI 10.1785/0120100075; Fletcher JB, 1998, J GEOPHYS RES-SOL EA, V103, P835, DOI 10.1029/97JB01797; Gilbert G.K., 1884, AM J SCI 3, V27, P49, DOI [10.2475/ajs.s3-27.157.49, DOI 10.2475/AJS.S3-27.157.49]; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Murray J, 2002, NATURE, V419, P287, DOI 10.1038/nature00984; Noda H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006143; REID HF, 1910, CALIFORNIA EARTHQUAK, V2, P3; Thurber C, 2006, B SEISMOL SOC AM, V96, pS38, DOI 10.1785/0120050825; Toda S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000172	13	7	7	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					676	677		10.1126/science.1220946	http://dx.doi.org/10.1126/science.1220946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582249				2022-12-28	WOS:000303872300034
J	Nakatsuji, S; Kuga, K; Kimura, K; Satake, R; Katayama, N; Nishibori, E; Sawa, H; Ishii, R; Hagiwara, M; Bridges, F; Ito, TU; Higemoto, W; Karaki, Y; Halim, M; Nugroho, AA; Rodriguez-Rivera, JA; Green, MA; Broholm, C				Nakatsuji, S.; Kuga, K.; Kimura, K.; Satake, R.; Katayama, N.; Nishibori, E.; Sawa, H.; Ishii, R.; Hagiwara, M.; Bridges, F.; Ito, T. U.; Higemoto, W.; Karaki, Y.; Halim, M.; Nugroho, A. A.; Rodriguez-Rivera, J. A.; Green, M. A.; Broholm, C.			Spin-Orbital Short-Range Order on a Honeycomb-Based Lattice	SCIENCE			English	Article							FRUSTRATED MAGNETS; QUANTUM; MODEL; ANTIFERROMAGNETS; FLUCTUATIONS; LIQUIDS; STATES	Frustrated magnetic materials, in which local conditions for energy minimization are incompatible because of the lattice structure, can remain disordered to the lowest temperatures. Such is the case for Ba3CuSb2O9, which is magnetically anisotropic at the atomic scale but curiously isotropic on mesoscopic length and time scales. We find that the frustration of Wannier's Ising model on the triangular lattice is imprinted in a nanostructured honeycomb lattice of Cu2+ ions that resists a coherent static Jahn-Teller distortion. The resulting two-dimensional random-bond spin-1/2 system on the honeycomb lattice has a broad spectrum of spin-dimer-like excitations and low-energy spin degrees of freedom that retain overall hexagonal symmetry.	[Nakatsuji, S.; Kuga, K.; Kimura, K.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Satake, R.; Katayama, N.; Nishibori, E.; Sawa, H.] Nagoya Univ, Grad Sch Engn, Dept Appl Phys, Nagoya, Aichi 4648603, Japan; [Ishii, R.; Hagiwara, M.] Osaka Univ, KYOKUGEN, Toyonaka, Osaka 5608531, Japan; [Bridges, F.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Ito, T. U.; Higemoto, W.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Karaki, Y.] Univ Ryukyus, Fac Educ, Nishihara, Okinawa 9030213, Japan; [Halim, M.; Nugroho, A. A.] Inst Teknol Bandung, Fac Math & Nat Sci, Bandung 40132, Indonesia; [Rodriguez-Rivera, J. A.; Green, M. A.; Broholm, C.] Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Rodriguez-Rivera, J. A.; Green, M. A.] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Broholm, C.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Broholm, C.] Johns Hopkins Univ, IQM, Baltimore, MD 21218 USA	University of Tokyo; Nagoya University; Osaka University; University of California System; University of California Santa Cruz; Japan Atomic Energy Agency; University of the Ryukyus; Institute Technology of Bandung; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University	Nakatsuji, S (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	satoru@issp.u-tokyo.ac.jp	Nugroho, Agustinus Agung/E-5977-2010; Kimura, Kenta/GQY-8904-2022; Nishibori, Eiji/M-1362-2018; Kimura, Kenta/F-4267-2017; Rodriguez-Rivera, Jose/A-4872-2013; Broholm, Collin Leslie/E-8228-2011; Katayama, Naoyuki/ABB-1411-2021	Nugroho, Agustinus Agung/0000-0002-1785-4008; Nishibori, Eiji/0000-0002-4192-6577; Rodriguez-Rivera, Jose/0000-0002-8633-8314; Broholm, Collin Leslie/0000-0002-1569-9892; Katayama, Naoyuki/0000-0002-9456-2201; Green, Mark/0000-0002-7886-6205; Ito, Takashi/0000-0003-1971-4313; Nakatsuji, Satoru/0000-0001-9134-659X	Japan Society for the Promotion of Science (JSPS) [20340089, 21684019, 23244074]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [19051010, 19051015, 19052003]; MEXT; Toray Science and Technology grant; U.S.-Japan, ISSP; U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-08ER46544]; NSF [DMR-0944772]; DOE; Grants-in-Aid for Scientific Research [23244074] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science and Technology grant(Toray Industries, Inc.); U.S.-Japan, ISSP; U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Uesu, J. Kaneshiro, and H. Yokota for scanning SHG microscope measurements; Y. Kiuchi for ICP analysis; T. Nakano and Y. Nozue for X-band ESR measurements; and V. Thampy for assistance in neutron-scattering data analysis. We are also grateful for fruitful discussions with N. Drichko, Z. Hao, D. Hamane, S. Ishihara, M. Isobe, T. M. McQueen, T. Mizokawa, Y. Nakanishi, N. Nagaosa, S. Onoda, K. Takada, O. Tchernyshyov, Y. Wakabayashi, and J. Yamaura. This work is partially supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) (nos. 20340089, 21684019, and 23244074) and from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) on Priority Areas (nos. 19051010, 19051015, and 19052003), by Global Centers of Excellence (COE) programs "the Physical Sciences Frontier" and "Core Research and Engineering Science of Advanced Materials" MEXT, by a Toray Science and Technology grant, and by the U.S.-Japan Cooperative Program, ISSP. Work at IQM was supported by U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-FG02-08ER46544. This work used facilities supported in part by the NSF (no. DMR-0944772). Part of this work was conducted while C.B. was a JSPS fellow at ISSP. The x-ray diffraction experiments were carried out at SPring-8 (Super Photon ring-8 GeV). The EXAFS experiments were carried out at Stanford Synchrotron Radiation Lightsource, supported by DOE. Muon spin relaxation experiments were performed at TRIUMF (Canada's national laboratory for particle and nuclear physics).	Aharen T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224409; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Carlo JP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.100404; Doi YS, 2004, J PHYS-CONDENS MAT, V16, P8923, DOI 10.1088/0953-8984/16/49/009; Enderle M, 2005, EUROPHYS LETT, V70, P237, DOI 10.1209/epl/i2004-10484-x; Feiner LF, 1997, PHYS REV LETT, V78, P2799, DOI 10.1103/PhysRevLett.78.2799; FISHER DS, 1994, PHYS REV B, V50, P3799, DOI 10.1103/PhysRevB.50.3799; Fritsch V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.116401; HAM FS, 1968, PHYS REV, V166, P307, DOI 10.1103/PhysRev.166.307; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; Kaneshiro J, 2008, J APPL PHYS, V104, DOI 10.1063/1.2975218; Kitaev A, 2006, ANN PHYS-NEW YORK, V321, P2, DOI 10.1016/j.aop.2005.10.005; Kohl V. P., 1978, Z ANORG ALLG CHEM, V442, P280; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; Li YQ, 1998, PHYS REV LETT, V81, P3527, DOI 10.1103/PhysRevLett.81.3527; METCALF BD, 1974, PHYS LETT A, VA 46, P325, DOI 10.1016/0375-9601(74)90247-3; Morita H, 2002, J PHYS SOC JPN, V71, P2109, DOI 10.1143/JPSJ.71.2109; Nasu J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024416; Reynaud F, 2001, PHYS REV LETT, V86, P3638, DOI 10.1103/PhysRevLett.86.3638; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Schiffer P, 1997, PHYS REV B, V56, P13712, DOI 10.1103/PhysRevB.56.13712; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Vernay F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014428; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wen XG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165113; Willans AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.237203; Yamashita M, 2010, SCIENCE, V328, P1246, DOI 10.1126/science.1188200; Zhou HD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147204	29	110	111	5	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					559	563		10.1126/science.1212154	http://dx.doi.org/10.1126/science.1212154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556246				2022-12-28	WOS:000303498800038
J	Oxtoby, K				Oxtoby, Kathy			Inspirational leaders	BRITISH MEDICAL JOURNAL			English	Editorial Material												kathyoxtoby@blueyonder.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e3062	10.1136/bmj.e3062	http://dx.doi.org/10.1136/bmj.e3062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NG	22556051				2022-12-28	WOS:000303817700012
J	Leipzig, RM; Hall, WJ; Fried, LP				Leipzig, Rosanne M.; Hall, William J.; Fried, Linda P.			Treating Our Societal Scotoma: The Case for Investing in Geriatrics, Our Nation's Future, and Our Patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; PHYSICIANS; CONSENSUS; DELIRIUM; FALLS; LIFE		[Leipzig, Rosanne M.] Mt Sinai Sch Med, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Univ Rochester, Sch Med, Ctr Healthy Aging, Rochester, NY USA	Icahn School of Medicine at Mount Sinai; Columbia University; University of Rochester	Leipzig, RM (corresponding author), Mt Sinai Sch Med, Brookdale Dept Geriatr & Palliat Med, 1468 Madison Ave,Box 1070, New York, NY 10029 USA.							American Board of Internal Medicine, SUBSP GER MED POL; Arora VM, 2007, J AM GERIATR SOC, V55, pS347, DOI 10.1111/j.1532-5415.2007.01342.x; Boult C, 2010, HEALTH AFFAIR, V29, P811, DOI 10.1377/hlthaff.2010.0095; Caplan GA, 2007, INTERN MED J, V37, P95, DOI 10.1111/j.1445-5994.2007.01265.x; Committee on the Future Health Care Workforce for Older Americans, 2008, RET AG AM BUILD HLTH, P75; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Fried LP, 2008, J AM GERIATR SOC, V56, P1791, DOI 10.1111/j.1532-5415.2008.01939.x; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Geriatrics Workforce Policy Studies Center, 2011, COMP NUMB CERT AW NU; Geriatrics Workforce Policy Studies Center, 2011, TOT ANN COMP PRIV PR; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Leigh JP, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-166; Leipzig RM, 2009, ACAD MED, V84, P604, DOI 10.1097/ACM.0b013e31819fab70; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Siu AL, 2009, HEALTH AFFAIR, V28, P113, DOI 10.1377/hlthaff.28.1.113; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Warshaw GA, 2008, J AM GERIATR SOC, V56, P1796, DOI 10.1111/j.1532-5415.2008.01940.x	23	30	30	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					657	+		10.7326/0003-4819-156-9-201205010-00010	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933YR	22547475				2022-12-28	WOS:000303403700007
J	McCourt, C; Feighery, C; McKenna, K				McCourt, Collette; Feighery, Cliona; McKenna, Kevin			PICTURE QUIZ Multiple annular lesions on the legs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYME-DISEASE; ERYTHEMA MIGRANS; BORRELIOSIS		[McCourt, Collette; Feighery, Cliona; McKenna, Kevin] Belfast City Hosp, Belfast BT12 6BA, Antrim, North Ireland	Belfast City Hospital	McCourt, C (corresponding author), Belfast City Hosp, Belfast BT12 6BA, Antrim, North Ireland.	collmccourt@hotmail.com						Bolognia JL, 2008, DERMATOLOGY, V2nd; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Coumou J, 2011, NETH J MED, V69, P101; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Dillon R, 2010, CLIN MED, V10, P454, DOI 10.7861/clinmedicine.10-5-454; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Kluger N, 2007, J EUR ACAD DERMATOL, V21, P283, DOI 10.1111/j.1468-3083.2006.01856.x; Lipsker D, 2002, BRIT J DERMATOL, V146, P872, DOI 10.1046/j.1365-2133.2002.04628.x; Marques AR, 2010, CURR ALLERGY ASTHM R, V10, P13, DOI 10.1007/s11882-009-0077-3; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stricker RB, 2007, BRIT MED J, V335, P1008, DOI 10.1136/bmj.39394.676227.BE; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	13	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2012	344								e2832	10.1136/bmj.e2832	http://dx.doi.org/10.1136/bmj.e2832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HE	22544832				2022-12-28	WOS:000303434000001
J	Pfau, H; Hartmann, S; Stockert, U; Sun, PJ; Lausberg, S; Brando, M; Friedemann, S; Krellner, C; Geibel, C; Wirth, S; Kirchner, S; Abrahams, E; Si, QM; Steglich, F				Pfau, Heike; Hartmann, Stefanie; Stockert, Ulrike; Sun, Peijie; Lausberg, Stefan; Brando, Manuel; Friedemann, Sven; Krellner, Cornelius; Geibel, Christoph; Wirth, Steffen; Kirchner, Stefan; Abrahams, Elihu; Si, Qimiao; Steglich, Frank			Thermal and electrical transport across a magnetic quantum critical point	NATURE			English	Article							WIEDEMANN-FRANZ LAW; FERMI-SURFACE; HEAVY; PHASE; TEMPERATURE; VIOLATION	A quantum critical point (QCP) arises when a continuous transition between competing phases occurs at zero temperature. Collective excitations at magnetic QCPs give rise to metallic properties that strongly deviate from the expectations of Landau's Fermi-liquid description(1), which is the standard theory of electron correlations in metals. Central to this theory is the notion of quasiparticles, electronic excitations that possess the quantum numbers of the non-interacting electrons. Here we report measurements of thermal and electrical transport across the field-induced magnetic QCP in the heavy-fermion compound YbRh2Si2 (refs 2, 3). We show that the ratio of the thermal to electrical conductivities at the zero-temperature limit obeys the Wiedemann-Franz law for magnetic fields above the critical field at which the QCP is attained. This is also expected for magnetic fields below the critical field, where weak antiferromagnetic order and a Fermi-liquid phase form below 0.07 K (at zero field). At the critical field, however, the low-temperature electrical conductivity exceeds the thermal conductivity by about 10 per cent, suggestive of a non-Fermi-liquid ground state. This apparent violation of the Wiedemann-Franz law provides evidence for an unconventional type of QCP at which the fundamental concept of Landau quasiparticles no longer holds(4-6). These results imply that Landau quasiparticles break up, and that the origin of this disintegration is inelastic scattering associated with electronic quantum critical fluctuations-these insights could be relevant to understanding other deviations from Fermi-liquid behaviour frequently observed in various classes of correlated materials.	[Pfau, Heike; Hartmann, Stefanie; Stockert, Ulrike; Sun, Peijie; Lausberg, Stefan; Brando, Manuel; Friedemann, Sven; Krellner, Cornelius; Geibel, Christoph; Wirth, Steffen; Kirchner, Stefan; Steglich, Frank] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Kirchner, Stefan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Abrahams, Elihu] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Si, Qimiao] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Max Planck Society; Max Planck Society; University of California System; University of California Los Angeles; Rice University	Steglich, F (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.	steglich@cpfs.mpg.de	Krellner, Cornelius/A-5389-2009; Stockert, Ulrike/M-9510-2019; Kirchner, Stefan/L-5971-2013; Brando, Manuel/B-4234-2009; Friedemann, Sven/D-4889-2013; Pfau, Heike/O-7873-2014	Krellner, Cornelius/0000-0002-0671-7729; Stockert, Ulrike/0000-0002-0155-5265; Friedemann, Sven/0000-0002-0606-4991; Pfau, Heike/0000-0001-6579-4188; Kirchner, Stefan/0000-0003-1958-0810	DFG Research Unit [960]; NSF [DMR-1006985, 1066293]; Robert A. Welch Foundation [C-1411]; Division Of Materials Research [1006985] Funding Source: National Science Foundation	DFG Research Unit(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank P. Coleman, R. Daou, P. Gegenwart, N. E. Hussey, K. Ingersent, G. Kotliar, A. P. Mackenzie, H. von Lohneysen, J. Schmalian, A. J. Schofield, T. Senthil, S. Shastry and Z. Tesanovic for discussions. The work was in part supported by the DFG Research Unit 960 'Quantum Phase Transitions', NSF grant DMR-1006985 and the Robert A. Welch Foundation grant C-1411. E. A., S. K., Q. S. and F. S. acknowledge support in part by the NSF under grant 1066293 and the hospitality of the Aspen Center for Physics.	ARONSON MC, 1995, PHYS REV LETT, V75, P725, DOI 10.1103/PhysRevLett.75.725; Casey PA, 2008, NAT PHYS, V4, P210, DOI 10.1038/nphys833; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Einstein A., 1922, THEORETICAL REMARK S; Friedemann S, 2010, P NATL ACAD SCI USA, V107, P14547, DOI 10.1073/pnas.1009202107; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; LANDAU LD, 1957, SOV PHYS JETP-USSR, V3, P920; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Moriya T., 1985, SPIN FLUCTUATIONS IT; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Schofield AJ, 2010, PHYS STATUS SOLIDI B, V247, P563, DOI 10.1002/pssb.200983084; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Shishido H, 2005, J PHYS SOC JPN, V74, P1103, DOI 10.1143/JPSJ.74.1103; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Smith MF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.266403; Smith RP, 2008, NATURE, V455, P1220, DOI 10.1038/nature07401; Tanatar MA, 2007, SCIENCE, V316, P1320, DOI 10.1126/science.1140762; Tomokuni K, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJS.80SA.SA096; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; VONLOHNEYSEN H, 1994, PHYS REV LETT, V72, P3262, DOI 10.1103/PhysRevLett.72.3262; Wakeham N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1406; Wolfle P, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.041101; Zaum S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.087003	30	62	64	0	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					493	497		10.1038/nature11072	http://dx.doi.org/10.1038/nature11072			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538612	Green Submitted			2022-12-28	WOS:000303200400046
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Springtime for open access in academia	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						2001, BRIT MED J, V322, P1, DOI DOI 10.1136/BMJ.322.7277.1; 2012, BRIT MED J, V344, pE1469, DOI DOI 10.1136/BMJ.E1469	2	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 25	2012	344								e2937	10.1136/bmj.e2937	http://dx.doi.org/10.1136/bmj.e2937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HC	22535740				2022-12-28	WOS:000303433800005
J	Salisbury, C				Salisbury, Chris			Multimorbidity: redesigning health care for people who use it	LANCET			English	Editorial Material							MULTIPLE CONDITIONS; DECISION-MAKING; GUIDELINES; QUALITY; COMORBIDITY; COSTS		Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England	University of Bristol	Salisbury, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	c.salisbury@bristol.ac.uk	Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960				Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2008, FAM PRACT, V25, P287, DOI 10.1093/fampra/cmn040; Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braithwaite RS, 2007, ARCH INTERN MED, V167, P2361, DOI 10.1001/archinte.167.21.2361; Burgers JS, 2010, EVAL HEALTH PROF, V33, P343, DOI 10.1177/0163278710375695; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929	14	168	173	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2012	380	9836					7	9		10.1016/S0140-6736(12)60482-6	http://dx.doi.org/10.1016/S0140-6736(12)60482-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22579042				2022-12-28	WOS:000306115900007
J	Whitaker, M; Guo, J; Kehoe, T; Benson, G				Whitaker, Marcea; Guo, Jia; Kehoe, Theresa; Benson, George			Bisphosphonates for Osteoporosis - Where Do We Go from Here?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRACTURE; TRIAL; ALENDRONATE; EXTENSION; WOMEN; FLEX		[Whitaker, Marcea; Kehoe, Theresa; Benson, George] US FDA, Div Reprod & Urol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Guo, Jia] US FDA, Div Biometr 3, Off Biostat, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Whitaker, M (corresponding author), US FDA, Div Reprod & Urol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Food and Drug Administration, 2011, BACKGR DOC M ADV COM; Mellstrom DD, 2004, CALCIFIED TISSUE INT, V75, P462, DOI 10.1007/s00223-004-0286-7; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11	5	246	253	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2048	2051		10.1056/NEJMp1202619	http://dx.doi.org/10.1056/NEJMp1202619			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22571168				2022-12-28	WOS:000304613400003
J	Schirle, NT; MacRae, IJ				Schirle, Nicole T.; MacRae, Ian J.			The Crystal Structure of Human Argonaute2	SCIENCE			English	Article							GUIDE RNA; GW182; RECOGNITION; BINDING; DNA; REQUIRES; DOMAIN; DEADENYLASE; MICRORNAS; CLEAVAGE	Argonaute proteins form the functional core of the RNA-induced silencing complexes that mediate RNA silencing in eukaryotes. The 2.3 angstrom resolution crystal structure of human Argonaute2 (Ago2) reveals a bilobed molecule with a central cleft for binding guide and target RNAs. Nucleotides 2 to 6 of a heterogeneous mixture of guide RNAs are positioned in an A-form conformation for base pairing with target messenger RNAs. Between nucleotides 6 and 7, there is a kink that may function in microRNA target recognition or release of sliced RNA products. Tandem tryptophan-binding pockets in the PIWI domain define a likely interaction surface for recruitment of glycine-tryptophan-182 (GW182) or other tryptophan-rich cofactors. These results will enable structure-based approaches for harnessing the untapped therapeutic potential of RNA silencing in humans.	[Schirle, Nicole T.; MacRae, Ian J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022		National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM074898]; NIGMS [R01 GM086701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, R01GM086701] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the laboratories of D. Stout, E. O. Saphire, and I. Wilson for sharing synchrotron time and for helpful discussions. Crystallization screens were carried out at the Joint Center for Structural Genomics, supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative (U54 GM074898). Diffraction data were collected on beamlines 24-ID-E at the Advanced Photon Source and 11-1 at the Stanford Synchrotron Radiation Lightsource. This work was supported by NIGMS grant R01 GM086701 to I.J.M. I.J.M. is a Pew Scholar in the Biomedical Sciences. Coordinates of Ago2 and Ago2 bound to tryptophan have been deposited in the Protein Data Bank (4EI1 and 4EI3).	Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Deleavey GF, 2010, NUCLEIC ACIDS RES, V38, P4547, DOI 10.1093/nar/gkq181; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	29	444	470	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1037	1040		10.1126/science.1221551	http://dx.doi.org/10.1126/science.1221551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22539551	Green Accepted			2022-12-28	WOS:000304406800046
J	Kim, HG				Kim, Helen G.			Drowning in Plain Sight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIPOLAR DISORDER; ANXIETY		Hennepin Cty Med Ctr, Dept Psychiat, Hennepin Womens Mental Hlth Program, Minneapolis, MN 55415 USA	Hennepin County Medical Center	Kim, HG (corresponding author), Hennepin Cty Med Ctr, Dept Psychiat, Hennepin Womens Mental Hlth Program, Minneapolis, MN 55415 USA.	kimxx237@umn.edu						Cunnington MC, 2011, NEUROLOGY, V76, P1817, DOI 10.1212/WNL.0b013e31821ccd18; Holmes LB, 2008, NEUROLOGY, V70, P2152, DOI 10.1212/01.wnl.0000304343.45104.d6; Kahneman D., 2011, THINKING FAST SLOW; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Viguera AC, 2000, AM J PSYCHIAT, V157, P179, DOI 10.1176/appi.ajp.157.2.179; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5; Yonkers KA, 2004, AM J PSYCHIAT, V161, P608, DOI 10.1176/appi.ajp.161.4.608	8	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1923	1924		10.1001/jama.2012.3445	http://dx.doi.org/10.1001/jama.2012.3445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570461				2022-12-28	WOS:000303741900025
J	Sanders, DL; Kingsnorth, AN				Sanders, David L.; Kingsnorth, Andrew N.			The modern management of incisional hernias	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED-CONTROLLED-TRIAL; MIDLINE LAPAROTOMY; WOUND DEHISCENCE; VENTRAL HERNIA; CLOSURE; COMPLICATIONS; METAANALYSIS; REPAIR; LENGTH		[Sanders, David L.] Royal Cornwall Hosp, Truro TR1 3LJ, England; [Kingsnorth, Andrew N.] Peninsula Coll Med & Dent, Plymouth, Devon, England	Royal Cornwall Hospital; University of Plymouth	Sanders, DL (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	dsanders@doctors.org.uk						BUCKNALL TE, 1982, BMJ-BRIT MED J, V284, P931, DOI 10.1136/bmj.284.6320.931; CARLSON MA, 1995, SOUTHERN MED J, V88, P450, DOI 10.1097/00007611-199504000-00013; Cengiz Y, 2001, ARCH SURG-CHICAGO, V136, P272, DOI 10.1001/archsurg.136.3.272; Ceydeli Adil, 2005, Curr Surg, V62, P220, DOI 10.1016/j.cursur.2004.08.014; Fitzgibbons RJ, 2007, ACS SURG PRINCIPLES; Girotto JA, 2000, PLAST RECONSTR SURG, V106, P1520, DOI 10.1097/00006534-200012000-00012; HALL KA, 1995, AM J SURG, V170, P572, DOI 10.1016/S0002-9610(99)80018-X; Hall KA, 1995, AM J SURG, V170, P75; Harlaar JJ, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-20; Harlaar JJ, 2009, AM J SURG, V198, P392, DOI 10.1016/j.amjsurg.2008.10.018; Henriksen NA, 2011, BRIT J SURG, V98, P210, DOI 10.1002/bjs.7339; Hodgson NCF, 2000, ANN SURG, V231, P436, DOI 10.1097/00000658-200003000-00018; ISRAELSSON LA, 1993, BRIT J SURG, V80, P1284, DOI 10.1002/bjs.1800801020; JENKINS TPN, 1976, BRIT J SURG, V63, P873, DOI 10.1002/bjs.1800631110; Klinge U, 2006, Hernia, V10, P472, DOI 10.1007/s10029-006-0145-8; MAKELA JT, 1995, AM J SURG, V170, P387, DOI 10.1016/S0002-9610(99)80309-2; Millbourn D, 2009, ARCH SURG-CHICAGO, V144, P1056, DOI 10.1001/archsurg.2009.189; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Sanders DL, 2012, HERNIA, V16, P1, DOI 10.1007/s10029-011-0870-5; SANDERS RJ, 1977, ARCH SURG-CHICAGO, V112, P1188; STEVICK CA, 1988, AM SURGEON, V54, P287; van Ramshorst GH, 2010, WORLD J SURG, V34, P20, DOI 10.1007/s00268-009-0277-y; van't Riet M, 2002, BRIT J SURG, V89, P1350, DOI 10.1046/j.1365-2168.2002.02258.x; Veljkovic R, 2010, J AM COLL SURGEONS, V210, P210, DOI 10.1016/j.jamcollsurg.2009.10.013; Welsh A, 2008, SURG SITE INFECT PRE	26	68	68	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e2843	10.1136/bmj.e2843	http://dx.doi.org/10.1136/bmj.e2843			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XB	22573647				2022-12-28	WOS:000304083800002
J	Gulland, A				Gulland, Anne			BMJ GROUP IMPROVING HEALTH AWARDS 2012: EXCELLENCE IN HEALTHCARE EDUCATION Filling the gaps in learning	BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 4	2012	344								e3113	10.1136/bmj.e3113	http://dx.doi.org/10.1136/bmj.e3113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NN	22563095				2022-12-28	WOS:000303818500009
J	Schuetz, R; Zamboni, N; Zampieri, M; Heinemann, M; Sauer, U				Schuetz, Robert; Zamboni, Nicola; Zampieri, Mattia; Heinemann, Matthias; Sauer, Uwe			Multidimensional Optimality of Microbial Metabolism	SCIENCE			English	Article							GENOME-SCALE MODELS; ESCHERICHIA-COLI; INTRACELLULAR FLUXES; OBJECTIVE FUNCTIONS; OPTIMAL-GROWTH; NETWORKS; DIVERSIFICATION; MICROORGANISMS; PERTURBATIONS; MINIMIZATION	Although the network topology of metabolism is well known, understanding the principles that govern the distribution of fluxes through metabolism lags behind. Experimentally, these fluxes can be measured by C-13-flux analysis, and there has been a long-standing interest in understanding this functional network operation from an evolutionary perspective. On the basis of C-13-determined fluxes from nine bacteria and multi-objective optimization theory, we show that metabolism operates close to the Pareto-optimal surface of a three-dimensional space defined by competing objectives. Consistent with flux data from evolved Escherichia coli, we propose that flux states evolve under the trade-off between two principles: optimality under one given condition and minimal adjustment between conditions. These principles form the forces by which evolution shapes metabolic fluxes in microorganisms' environmental context.	[Schuetz, Robert; Zamboni, Nicola; Zampieri, Mattia; Heinemann, Matthias; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@ethz.ch	Sauer, Uwe/Y-3556-2019; Heinemann, Matthias/B-9421-2008; Zamboni, Nicola/K-3042-2012; Zampieri, Mattia/ABF-5590-2020	Heinemann, Matthias/0000-0002-5512-9077; Zamboni, Nicola/0000-0003-1271-1021; Zampieri, Mattia/0000-0002-9339-068X	ETH	ETH(ETH Zurich)	R.S. is in the Life Science Zurich Ph.D. program on Systems Physiology and Metabolic Diseases, Zurich, Switzerland. We thank M. Doebeli for the mutants, E. Michlig for flux analysis, J. Banga for initial discussion on Pareto optimality, and V. Chubukov for proofreading. We acknowledge financial support via an ETH grant to U.S. Data and model described in this paper are presented in the supplementary materials.	Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Lu SY, 2009, J BIOTECHNOL, V143, P213, DOI 10.1016/j.jbiotec.2009.07.012; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Spencer CC, 2008, P NATL ACAD SCI USA, V105, P1585, DOI 10.1073/pnas.0708504105; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	27	270	271	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					601	604		10.1126/science.1216882	http://dx.doi.org/10.1126/science.1216882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556256				2022-12-28	WOS:000303498800049
J	Squyres, SW; Arvidson, RE; Bell, JF; Calef, F; Clark, BC; Cohen, BA; Crumpler, LA; de Souza, PA; Farrand, WH; Gellert, R; Grant, J; Herkenhoff, KE; Hurowitz, JA; Johnson, JR; Jolliff, BL; Knoll, AH; Li, R; McLennan, SM; Ming, DW; Mittlefehldt, DW; Parker, TJ; Paulsen, G; Rice, MS; Ruff, SW; Schroder, C; Yen, AS; Zacny, K				Squyres, S. W.; Arvidson, R. E.; Bell, J. F., III; Calef, F., III; Clark, B. C.; Cohen, B. A.; Crumpler, L. A.; de Souza, P. A., Jr.; Farrand, W. H.; Gellert, R.; Grant, J.; Herkenhoff, K. E.; Hurowitz, J. A.; Johnson, J. R.; Jolliff, B. L.; Knoll, A. H.; Li, R.; McLennan, S. M.; Ming, D. W.; Mittlefehldt, D. W.; Parker, T. J.; Paulsen, G.; Rice, M. S.; Ruff, S. W.; Schroeder, C.; Yen, A. S.; Zacny, K.			Ancient Impact and Aqueous Processes at Endeavour Crater, Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; SUEVITE BRECCIA; RIES CRATER; GERMANY; ORIGIN; VEINS; HISTORY; GYPSUM; WATER; ROCK	The rover Opportunity has investigated the rim of Endeavour Crater, a large ancient impact crater on Mars. Basaltic breccias produced by the impact form the rim deposits, with stratigraphy similar to that observed at similar-sized craters on Earth. Highly localized zinc enrichments in some breccia materials suggest hydrothermal alteration of rim deposits. Gypsum-rich veins cut sedimentary rocks adjacent to the crater rim. The gypsum was precipitated from low-temperature aqueous fluids flowing upward from the ancient materials of the rim, leading temporarily to potentially habitable conditions and providing some of the waters involved in formation of the ubiquitous sulfate-rich sandstones of the Meridiani region.	[Squyres, S. W.; Rice, M. S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Arvidson, R. E.; Jolliff, B. L.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; [Bell, J. F., III; Ruff, S. W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Calef, F., III; Hurowitz, J. A.; Parker, T. J.; Yen, A. S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Clark, B. C.; Farrand, W. H.] Space Sci Inst, Boulder, CO 80301 USA; [Cohen, B. A.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Crumpler, L. A.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [de Souza, P. A., Jr.] Univ Tasmania, Human Interface Technol Lab, Launceston, Tas 7250, Australia; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Grant, J.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Johnson, J. R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Knoll, A. H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Li, R.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D. W.; Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Paulsen, G.; Zacny, K.] Honeybee Robot & Spacecraft Mech Corp, Pasadena, CA 91103 USA; [Schroeder, C.] Univ Bayreuth, D-72076 Tubingen, Germany; [Schroeder, C.] Univ Tubingen, D-72076 Tubingen, Germany	Cornell University; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Tasmania; University of Guelph; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Harvard University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Bayreuth; Eberhard Karls University of Tubingen	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	de Souza, Paulo A/B-8961-2008; Johnson, Jeffrey R/F-3972-2015; COHEN, BARBARA/AAV-8199-2021; de Souza, Paulo/W-2993-2019; Schröder, Christian/B-3870-2009; de Souza, Paulo/P-7294-2019	de Souza, Paulo A/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Grant, John/0000-0001-8276-1281; Rice, Melissa/0000-0002-8370-4139; McLennan, Scott/0000-0003-4259-7178; Cohen, Barbara/0000-0001-5896-5903	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was carried out for the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Arvidson RE, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003746; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bons PD, 2005, J STRUCT GEOL, V27, P231, DOI 10.1016/j.jsg.2004.08.009; BUNDY WM, 1956, J SEDIMENT PETROL, V26, P240; Clark R. N., 2007, 06 USGS DIG SPECTR L; DEEVEY ES, 1970, SCI AM, V223, P148, DOI 10.1038/scientificamerican0970-148; Durney D.W., 1973, GRAVITY TECTONICS, P67; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; El Tabakh M, 1998, J SEDIMENT RES, V68, P88, DOI 10.2110/jsr.68.88; Franklin J.M., 1981, EC GEOL, P485; Freyer D, 2003, MONATSH CHEM, V134, P693, DOI 10.1007/s00706-003-0590-3; GUSTAVSON TC, 1994, J SEDIMENT RES A, V64, P88; HORZ F, 1983, REV GEOPHYS, V21, P1667, DOI 10.1029/RG021i008p01667; Meyer C, 2011, GEOL SOC AM BULL, V123, P2312, DOI 10.1130/B30393.1; Mittlefehldt D. W., 2009, LUNAR PLANET SCI, V41, P2109; Myrick T., 2004, P AIAA SPAC 2004 C E, P1; NEWSOM HE, 1986, J GEOPHYS RES-SOLID, V91, pE239, DOI 10.1029/JB091iB13p0E239; Philipp SL, 2008, GEOL MAG, V145, P831, DOI 10.1017/S0016756808005451; Pohl J., 1977, IMPACT EXPLOSION CRA, P343; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Rice MS, 2010, ICARUS, V205, P375, DOI 10.1016/j.icarus.2009.03.035; Schmidt ME, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003027; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002771; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stoffler D., 2007, METAMORPHIC ROCKS CL; Taber S, 1918, J GEOL, V26, P56, DOI 10.1086/622561; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; VONENGELHARDT W, 1990, TECTONOPHYSICS, V171, P259, DOI 10.1016/0040-1951(90)90104-G; VONENGELHARDT W, 1995, METEORITICS, V30, P279, DOI 10.1111/j.1945-5100.1995.tb01126.x; vonEngelhardt W, 1997, METEORIT PLANET SCI, V32, P545; Wang A, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003126; Wheat CG, 1996, GEOCHIM COSMOCHIM AC, V60, P3593, DOI 10.1016/0016-7037(96)00189-5; Wray JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040734; Zipfel J, 2011, METEORIT PLANET SCI, V46, P1, DOI 10.1111/j.1945-5100.2010.01127.x	36	152	153	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					570	576		10.1126/science.1220476	http://dx.doi.org/10.1126/science.1220476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556248	Green Submitted			2022-12-28	WOS:000303498800041
J	Califf, RM; Zarin, DA; Kramer, JM; Sherman, RE; Aberle, LH; Tasneem, A				Califf, Robert M.; Zarin, Deborah A.; Kramer, Judith M.; Sherman, Rachel E.; Aberle, Laura H.; Tasneem, Asba			Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIALS; MEDICAL-JOURNAL-EDITORS; INTERNATIONAL-COMMITTEE; RESEARCH ENTERPRISE; PRACTICE GUIDELINES; REGISTRATION; STATEMENT; RECOMMENDATIONS; GLOBALIZATION; QUALITY	Context Recent reports highlight gaps between guidelines-based treatment recommendations and evidence from clinical trials that supports those recommendations. Strengthened reporting requirements for studies registered with ClinicalTrials.gov enable a comprehensive evaluation of the national trials portfolio. Objective To examine fundamental characteristics of interventional clinical trials registered in the ClinicalTrials.gov database. Methods A data set comprising 96 346 clinical studies from ClinicalTrials.gov was downloaded on September 27, 2010, and entered into a relational database to analyze aggregate data. Interventional trials were identified and analyses were focused on 3 clinical specialties-cardiovascular, mental health, and oncology-that together encompass the largest number of disability-adjusted life-years lost in the United States. Main Outcome Measures Characteristics of registered clinical trials as reported data elements in the trial registry; how those characteristics have changed over time; differences in characteristics as a function of clinical specialty; and factors associated with use of randomization, blinding, and data monitoring committees (DMCs). Results The number of registered interventional clinical trials increased from 28 881(October 2004-September 2007) to 40 970 (October 2007-September 2010), and the number of missing data elements has generally declined. Most interventional trials registered between 2007 and 2010 were small, with 62% enrolling 100 or fewer participants. Many clinical trials were single-center (66%; 24 788/37 520) and funded by organizations other than industry or the National Institutes of Health (NIH) (47%; 17 592/37 520). Heterogeneity in the reported methods by clinical specialty; sponsor type; and the reported use of DMCs, randomization, and blinding was evident. For example, reported use of DMCs was less common in industry-sponsored vs NIH-sponsored trials (adjusted odds ratio [OR], 0.11; 95% CI, 0.09-0.14), earlier-phase vs phase 3 trials (adjusted OR, 0.83; 95% CI, 0.76-0.91), and mental health trials vs those in the other 2 specialties. In similar comparisons, randomization and blinding were less frequently reported in earlier-phase, oncology, and device trials. Conclusion Clinical trials registered in ClinicalTrials.gov are dominated by small trials and contain significant heterogeneity in methodological approaches, including reported use of randomization, blinding, and DMCs. JAMA. 2012;307(17):1838-1847 www.jama.com	[Califf, Robert M.; Kramer, Judith M.] Duke Translat Med Inst, Durham, NC 27710 USA; [Zarin, Deborah A.] NIH, Natl Lib Med, Bethesda, MD 20892 USA; [Sherman, Rachel E.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Kramer, Judith M.; Aberle, Laura H.; Tasneem, Asba] Duke Clin Res Inst, Durham, NC USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Food & Drug Administration (FDA); Duke University	Califf, RM (corresponding author), Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg, Durham, NC 27710 USA.	robert.califf@duke.edu			Amylin; Johnson & Johnson (Scios); Merck; Novartis Pharma; Schering Plough; Bristol-Myers Squibb Foundation; Aterovax; Bayer; Roche; Lilly; Kowa Research Institute; Nile; Parkview; Orexigen Therapeutics; Pozen; Servier International; WebMD; AstraZeneca; Bayer-OrthoMcNeil; BMS; Boerhinger Ingelheim; Daiichi Sankyo; GlaxoSmithKline; Li Ka Shing Knowledge Institute; Medtronic; Novartis; sanofi-aventis; XOMA; University of Florida; Duke Clinical Research Institute; CTTI; Pfizer; US Food and Drug Administration [U19FD003800]; FOOD AND DRUG ADMINISTRATION [U19FD003800] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER	Amylin; Johnson & Johnson (Scios)(Johnson & JohnsonJohnson & Johnson USA); Merck(Merck & Company); Novartis Pharma; Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb Foundation(Bristol-Myers Squibb); Aterovax; Bayer(Bayer AG); Roche(Roche Holding); Lilly(Eli Lilly); Kowa Research Institute; Nile; Parkview; Orexigen Therapeutics; Pozen; Servier International(Servier); WebMD; AstraZeneca(AstraZeneca); Bayer-OrthoMcNeil(Bayer AG); BMS(Bristol-Myers Squibb); Boerhinger Ingelheim; Daiichi Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Li Ka Shing Knowledge Institute(University of Toronto); Medtronic(Medtronic); Novartis(Novartis); sanofi-aventis(Sanofi-Aventis); XOMA; University of Florida(University of Florida); Duke Clinical Research Institute; CTTI; Pfizer(Pfizer); US Food and Drug Administration; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Califf reports receiving research grants that partially support his salary from Amylin, Johnson & Johnson (Scios), Merck, Novartis Pharma, Schering Plough, Bristol-Myers Squibb Foundation, Aterovax, Bayer, Roche, and Lilly; all grants are paid to Duke University. Dr Califf also consults for TheHeart.org, Johnson & Johnson (Scios), Kowa Research Institute, Nile, Parkview, Orexigen Therapeutics, Pozen, Servier International, WebMD, Bristol-Myers Squibb Foundation, AstraZeneca, Bayer-OrthoMcNeil, BMS, Boerhinger Ingelheim, Daiichi Sankyo, GlaxoSmithKline, Li Ka Shing Knowledge Institute, Medtronic, Merck, Novartis, sanofi-aventis, XOMA, and University of Florida; all income from these consultancies is donated to nonprofit organizations, with the majority going to the clinical research fellowship fund of the Duke Clinical Research Institute. Dr Califf holds equity in Nitrox LLC. Dr Kramer is the executive director of the Clinical Trials Transformation Institute (CTTI), a public-private partnership. A portion of Dr Kramer's salary is supported by pooled funds from CTTI members (https://www.ctticlinicaltrials.org/about/membership). Dr Kramer reports receiving a research grant from Pfizer that supports a small percentage of her salary; this grant is paid to Duke University. Dr Kramer also served on an advisory board for the "Pharmacovigilance Center of Excellence" at GlaxoSmithKline, for which she received an honorarium. Financial disclosure information for Drs Califf and Kramer is also publicly available at https://www.dcri.org/about-us/conflict-of-interest. No other disclosures were reported.; Financial support for this project was provided by grant U19FD003800 from the US Food and Drug Administration awarded to Duke University for the Clinical Trials Transformation Initiative.	[Anonymous], STUD TOP SEL LOC; [Anonymous], FAIR TESTS TREATM HL; [Anonymous], 2011, PROT DAT EL IN PRESS; [Anonymous], AACT DAT AGGR AN CLI; Califf RM, 2002, CIRCULATION, V106, P1015, DOI 10.1161/01.CIR.0000023260.78078.BB; Califf RM, 2011, J AM COLL CARDIOL, V58, P677, DOI 10.1016/j.jacc.2011.03.048; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; DeMets DL, 2011, JAMA-J AM MED ASSOC, V305, P713, DOI 10.1001/jama.2011.175; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; English RA, TRANSFORMING CLIN RE; Gillen JE, 2004, STUD HEALTH TECHNOL, V107, P1466; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; International Committee of Medical Journal Editors, UN REQ MAN SUBM BIOM; Kim ESH, 2011, J AM COLL CARDIOL, V58, P671, DOI 10.1016/j.jacc.2011.01.066; Kris MG, ACCELERATING PROGR C; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; Menikoff J., 2006, WHAT DOCTOR DIDNT SA; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Pasquali SK, 2010, PEDIATRICS, V126, pE687, DOI 10.1542/peds.2010-0098; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tasneem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033677; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; WHO, INT CLIN TRIALS REG; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	33	311	316	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1838	1847		10.1001/jama.2012.3424	http://dx.doi.org/10.1001/jama.2012.3424			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550198				2022-12-28	WOS:000303386800023
J	Blum, RW; Bastos, FIPM; Kabiru, CW; Le, LC				Blum, Robert W.; Bastos, Francisco I. P. M.; Kabiru, Caroline W.; Le, Linh C.			Adolescent health in the 21st century	LANCET			English	Editorial Material									[Blum, Robert W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Bastos, Francisco I. P. M.] Oswaldo Cruz Fdn FIOCRUZ, Rio De Janeiro, Brazil; [Kabiru, Caroline W.] African Populat & Hlth Res Ctr, Urbanizat & Wellbeing Res Programme, Nairobi, Kenya; [Le, Linh C.] Hanoi Sch Publ Hlth, Dept Demog, Hanoi, Vietnam	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fundacao Oswaldo Cruz; African Population & Health Research Centre; Hanoi University of Public Health	Blum, RW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	rblum@jhsph.edu	Le, Linh C/G-5957-2012	Le, Linh/0000-0003-2978-936X; Bastos, Francisco/0000-0001-5970-8896; Kabiru, Caroline/0000-0002-0735-9839				Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Kabiru CW, 2010, ROUTLEDGE HDB GLOBAL, P182; Labonte R, 2011, ANNU REV PUBL HEALTH, V32, P263, DOI 10.1146/annurev-publhealth-031210-101225; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Pickles A., 2007, EPIDEMIOLOGICAL METH; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Spear L.P., 2010, BEHAV NEUROSCIENCE A; UNFPA, 2010, CAS INV YOUNG PEOPL; *UNFPA, 2011, STAT WORLD POP 2011; UNICEF, 2011, STAT WORLDS CHILDR 2; United Nations Population Fund (UNFPA), 2007, GROW URB STAT WORLD; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4	15	103	109	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1567	1568		10.1016/S0140-6736(12)60407-3	http://dx.doi.org/10.1016/S0140-6736(12)60407-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538177	Green Published			2022-12-28	WOS:000303452600006
J	Nelson, JR; Wellikson, L; Wachter, RM				Nelson, John R.; Wellikson, Laurence; Wachter, Robert M.			Specialty Hospitalists Analyzing an Emerging Phenomenon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Nelson, John R.] Overlake Hosp, Med Ctr, Bellevue, WA 98004 USA; [Wellikson, Laurence] Soc Hosp Med, Philadelphia, PA USA; [Wachter, Robert M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Nelson, JR (corresponding author), Overlake Hosp, Med Ctr, 1034 NE 116th Ave, Bellevue, WA 98004 USA.	jrnelson@overlakehospital.org						American Hospital Association, 2010, ANN SURV AM HOSP ASS; Kuo YF, 2011, ANN INTERN MED, V155, P152, DOI 10.7326/0003-4819-155-3-201108020-00005; Maa J, 2007, J AM COLL SURGEONS, V205, P704, DOI 10.1016/j.jamcollsurg.2007.05.008; Seiler A, 2012, J HOSP MED, V7, P131, DOI 10.1002/jhm.973; Veltman Larry, 2011, J Healthc Risk Manag, V31, P19, DOI 10.1002/jhrm.20075; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Wachter RM, NEW HOME TEAM	7	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1699	1700		10.1001/jama.2012.526	http://dx.doi.org/10.1001/jama.2012.526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535853				2022-12-28	WOS:000303147500021
J	Ley, B; Ryerson, CJ; Vittinghoff, E; Ryu, JH; Tomassetti, S; Lee, JS; Poletti, V; Buccioli, M; Elicker, BM; Jones, KD; King, TE; Collard, HR				Ley, Brett; Ryerson, Christopher J.; Vittinghoff, Eric; Ryu, Jay H.; Tomassetti, Sara; Lee, Joyce S.; Poletti, Venerino; Buccioli, Matteo; Elicker, Brett M.; Jones, Kirk D.; King, Talmadge E., Jr.; Collard, Harold R.			A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-COURSE; PROGNOSTIC MODELS; SURVIVAL; RISK; STANDARDIZATION; CLASSIFICATION; PREDICTION	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an overall poor prognosis. A simple-to-use staging system for IPF may improve prognostication, help guide management, and facilitate research. Objective: To develop a multidimensional prognostic staging system for IPF by using commonly measured clinical and physiologic variables. Design: A clinical prediction model was developed and validated by using retrospective data from 3 large, geographically distinct cohorts. Setting: Interstitial lung disease referral centers in California, Minnesota, and Italy. Patients: 228 patients with IPF at the University of California, San Francisco (derivation cohort), and 330 patients at the Mayo Clinic and Morgagni-Pierantoni Hospital (validation cohort). Measurements: The primary outcome was mortality, treating transplantation as a competing risk. Model discrimination was assessed by the c-index, and calibration was assessed by comparing predicted and observed cumulative mortality at 1, 2, and 3 years. Results: Four variables were included in the final model: gender (G), age (A), and 2 lung physiology variables (P) (FVC and DLCO). A model using continuous predictors (GAP calculator) and a simple point-scoring system (GAP index) performed similarly in derivation (c-index of 70.8 and 69.3, respectively) and validation (c-index of 69.1 and 68.7, respectively). Three stages (stages I, II, and III) were identified based on the GAP index with 1-year mortality of 6%, 16%, and 39%, respectively. The GAP models performed similarly in pooled follow-up visits (c-index >= 71.9). Limitation: Patients were drawn from academic centers and analyzed retrospectively. Conclusion: The GAP models use commonly measured clinical and physiologic variables to predict mortality in patients with IPF.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Mayo Clin, Rochester, MN USA; Morgagni Pierantoni Hosp, Forli, Italy	University of California System; University of California San Francisco; Mayo Clinic	Ley, B (corresponding author), 505 Parnassus Ave,Box 0111, San Francisco, CA 94143 USA.	brett.ley@ucsf.edu	Lee, Joyce/ABC-9834-2021; Poletti, Venerino/K-8821-2016; Buccioli, Matteo/K-6648-2016	Lee, Joyce/0000-0002-5758-8365; Poletti, Venerino/0000-0002-8634-2284; Ryu, Jay/0000-0002-9576-2272; Buccioli, Matteo/0000-0002-6844-8413	University of California, San Francisco Clinical and Translational Science Institute; National Institutes of Health [HL086516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL086516] Funding Source: NIH RePORTER	University of California, San Francisco Clinical and Translational Science Institute(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the University of California, San Francisco Clinical and Translational Science Institute Resident Research Award and the National Institutes of Health (HL086516).	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Erbes R, 1997, CHEST, V111, P51, DOI 10.1378/chest.111.1.51; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Global Strategy for the Diagnosis Management and Prevention of COPD, 2008, GLOB STRAT DIAGN MAN; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Lederer DJ, 2006, AM J RESP CRIT CARE, V174, P659, DOI 10.1164/rccm.200604-520OC; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Heart Lung and Blood Institute, 2007, NIH PUBL; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schoop R, 2011, BIOMETRICAL J, V53, P88, DOI 10.1002/bimj.201000073; Thabut G, 2009, ANN INTERN MED, V151, P767, DOI 10.7326/0003-4819-151-11-200912010-00004; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	28	708	727	3	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					684	U58		10.7326/0003-4819-156-10-201205150-00004	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586007				2022-12-28	WOS:000304193400014
J	Dennis, MY; Nuttle, X; Sudmant, PH; Antonacci, F; Graves, TA; Nefedov, M; Rosenfeld, JA; Sajjadian, S; Malig, M; Kotkiewicz, H; Curry, CJ; Shafer, S; Shaffer, LG; de Jong, PJ; Wilson, RK; Eichler, EE				Dennis, Megan Y.; Nuttle, Xander; Sudmant, Peter H.; Antonacci, Francesca; Graves, Tina A.; Nefedov, Mikhail; Rosenfeld, Jill A.; Sajjadian, Saba; Malig, Maika; Kotkiewicz, Holland; Curry, Cynthia J.; Shafer, Susan; Shaffer, Lisa G.; de Jong, Pieter J.; Wilson, Richard K.; Eichler, Evan E.			Evolution of Human-Specific Neural SRGAP2 Genes by Incomplete Segmental Duplication	CELL			English	Article							COPY-NUMBER VARIATION; UPPER MIOCENE; DNA-SEQUENCE; HOMINID; GENOME; CONSTRUCTION; POLYMORPHISM; MIGRATION; RESOURCE; ORIGIN	Gene duplication is an important source of phenotypic change and adaptive evolution. We leverage a haploid hydatidiform mole to identify highly identical sequences missing from the reference genome, confirming that the cortical development gene Slit-Robo RhoGTPase-activating protein 2 (SRGAP2) duplicated three times exclusively in humans. We show that the promoter and first nine exons of SRGAP2 duplicated from 1q32.1 (SRGAP2A) to 1q21.1 (SRGAP2B) similar to 3.4 million years ago (mya). Two larger duplications later copied SRGAP2B to chromosome 1p12 (SRGAP2C) and to proximal 1q21.1 (SRGAP2D) similar to 2.4 and similar to 1 mya, respectively. Sequence and expression analyses show that SRGAP2C is the most likely duplicate to encode a functional protein and is among the most fixed human-specific duplicate genes. Our data suggest a mechanism where incomplete duplication created a novel gene function-antagonizing parental SRGAP2 function-immediately "at birth'' 2-3 mya, which is a time corresponding to the transition from Australopithecus to Homo and the beginning of neocortex expansion.	[Dennis, Megan Y.; Nuttle, Xander; Sudmant, Peter H.; Antonacci, Francesca; Sajjadian, Saba; Malig, Maika; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Graves, Tina A.; Kotkiewicz, Holland; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Nefedov, Mikhail; de Jong, Pieter J.] Childrens Hosp & Res Ctr Oakland, Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Fresno, CA 93701 USA; [Shafer, Susan] Carle Clin Assoc, Urbana, IL 61801 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California San Francisco at Fresno	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Antonacci, Francesca/F-5457-2013	Wilson, Richard K./0000-0002-1992-1358; Sudmant, Peter/0000-0002-9573-8248; Antonacci, Francesca/0000-0002-5833-6186	U.S. National Institutes of Health (NIH) [1F32HD071698-01]; NIH NRSA [2T32HG000035-16]; NIH [HG002385, GM058815]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071698] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG002385, P01HG004120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Coe for assistance in CNV analysis and the 1000 Genomes Project for access to sequence data of the SRGAP2 loci. For DNA samples used in paralog-specific CNV screening and detailed phenotypic information of patients, we would like to thank C. Romano, M. Fichera, J. Gecz, B. de Vries, R. Bernier, the Simons Foundation, Autism Speaks, the National Institute of Mental Health, and the ClinSeq Project. We acknowledge C. Baker, L. Vives, and J. Huddleston for technical assistance, T. Brown for manuscript editing, and the laboratory of S. Fields for use of their Roche LC480. We also thank J. Akey, T. Marques-Bonet, A. Andres, S. Girirajan, and K. Meltz Steinberg for helpful discussion, as well as the laboratory of F. Polleux for comments and kindly sharing human RNA samples for expression studies. The BAC clones from the complete hydatidiform mole were derived from a cell line created by U. Surti. M.Y.D. is supported by U.S. National Institutes of Health (NIH) Ruth L. Kirchstein National Research Service Award (NRSA) Fellowship (1F32HD071698-01). X.N. is supported by an NIH NRSA Genome Training Grant to the University of Washington (2T32HG000035-16). P. H. S. is a Howard Hughes Medical Institute International Student Research Fellow. This work was supported by NIH Grants HG002385 and GM058815. E. E. E. is an investigator of the Howard Hughes Medical Institute. J. A. R. and L. G. S. are employees of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. E. E. E. is on the scientific advisory boards for Pacific Biosciences, Inc. and SynapDx Corp.	Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ohno S., 1970, P1; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; RZHETSKY A, 1994, COMPUT APPL BIOSCI, V10, P409; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Szamalek JM, 2006, HUM GENET, V120, P126, DOI 10.1007/s00439-006-0209-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102	55	233	241	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4								10.1016/j.cell.2012.03.033	http://dx.doi.org/10.1016/j.cell.2012.03.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22559943	Green Accepted, Bronze			2022-12-28	WOS:000303934700022
J	Hao, HX; Xie, Y; Zhang, Y; Charlat, O; Oster, E; Avello, M; Lei, H; Mickanin, C; Liu, D; Ruffner, H; Mao, XH; Ma, QC; Zamponi, R; Bouwmeester, T; Finan, PM; Kirschner, MW; Porter, JA; Serluca, FC; Cong, F				Hao, Huai-Xiang; Xie, Yang; Zhang, Yue; Charlat, Olga; Oster, Emma; Avello, Monika; Lei, Hong; Mickanin, Craig; Liu, Dong; Ruffner, Heinz; Mao, Xiaohong; Ma, Qicheng; Zamponi, Raffaella; Bouwmeester, Tewis; Finan, Peter M.; Kirschner, Marc W.; Porter, Jeffery A.; Serluca, Fabrizio C.; Cong, Feng			ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner	NATURE			English	Article							BETA-CATENIN FUNCTION; WNT/BETA-CATENIN; LENS MORPHOGENESIS; R-SPONDIN1; PATHWAY; LRP6; LGR5; PHOSPHORYLATION; INHIBITION; DISRUPTION	R-spondin proteins strongly potentiate Wnt signalling and function as stem-cell growth factors. Despite the biological and therapeutic significance, the molecular mechanism of R-spondin action remains unclear. Here we show that the cell-surface transmembrane E3 ubiquitin ligase zinc and ring finger 3 (ZNRF3) and its homologue ring finger 43 (RNF43) are negative feedback regulators of Wnt signalling. ZNRF3 is associated with the Wnt receptor complex, and inhibits Wnt signalling by promoting the turnover of frizzled and LRP6. Inhibition of ZNRF3 enhances Wnt/beta-catenin signalling and disrupts Wnt/ planar cell polarity signalling in vivo. Notably, R-spondin mimics ZNRF3 inhibition by increasing the membrane level of Wnt receptors. Mechanistically, R-spondin interacts with the extracellular domain of ZNRF3 and induces the association between ZNRF3 and LGR4, which results in membrane clearance of ZNRF3. These data suggest that R-spondin enhances Wnt signalling by inhibiting ZNRF3. Our study provides new mechanistic insights into the regulation of Wnt receptor turnover, and reveals ZNRF3 as a tractable target for therapeutic exploration.	[Hao, Huai-Xiang; Xie, Yang; Zhang, Yue; Charlat, Olga; Oster, Emma; Avello, Monika; Lei, Hong; Mickanin, Craig; Liu, Dong; Mao, Xiaohong; Ma, Qicheng; Zamponi, Raffaella; Finan, Peter M.; Porter, Jeffery A.; Serluca, Fabrizio C.; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Ruffner, Heinz; Bouwmeester, Tewis] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	feng.cong@novartis.com	Zamponi, Raffaella/V-5683-2018	Zamponi, Raffaella/0000-0002-3313-1387				Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gurney A. L., 2011, US patent, Patent No. 201037041; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nasevicius A, 1998, DEVELOPMENT, V125, P4283; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	37	582	627	12	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					195	U76		10.1038/nature11019	http://dx.doi.org/10.1038/nature11019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575959				2022-12-28	WOS:000303799800032
J	Baker, J; McClelland, D; Dempsey, OJ				Baker, John; McClelland, David; Dempsey, O. J.			CASE REPORT A persisting puzzling pneumonia in a young man	BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY CARCINOID-TUMORS		[Baker, John; McClelland, David; Dempsey, O. J.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Baker, J (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	john.baker1@nhs.net						Bertino EM, 2009, CANCER-AM CANCER SOC, V115, P4434, DOI 10.1002/cncr.24498; Coe SG, 2008, J GEN INTERN MED, V23, P875, DOI 10.1007/s11606-008-0587-z; De Dosso S, 2007, ONCOLOGY-BASEL, V73, P162, DOI 10.1159/000127382; Hage R, 2003, ANN SURG ONCOL, V10, P697, DOI 10.1245/ASO.2003.09.019; Watts RA, 2009, ARTHRIT CARE RES, V61, P1412, DOI 10.1002/art.24544	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e2690	10.1136/bmj.e2690	http://dx.doi.org/10.1136/bmj.e2690			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WY	22569863				2022-12-28	WOS:000304083400001
J	Garelli, A; Gontijo, AM; Miguela, V; Caparros, E; Dominguez, M				Garelli, Andres; Gontijo, Alisson M.; Miguela, Veronica; Caparros, Esther; Dominguez, Maria			Imaginal Discs Secrete Insulin-Like Peptide 8 to Mediate Plasticity of Growth and Maturation	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENES; DISKS; PUPARIATION; SIZE	Developing animals frequently adjust their growth programs and/or their maturation or metamorphosis to compensate for growth disturbances (such as injury or tumor) and ensure normal adult size. Such plasticity entails tissue and organ communication to preserve their proportions and symmetry. Here, we show that imaginal discs autonomously activate DILP8, a Drosophila insulin-like peptide, to communicate abnormal growth and postpone maturation. DILP8 delays metamorphosis by inhibiting ecdysone biosynthesis, slowing growth in the imaginal discs, and generating normal-sized animals. Loss of dilp8 yields asymmetric individuals with an unusually large variation in size and a more varied time of maturation. Thus, DILP8 is a fundamental element of the hitherto ill-defined machinery governing the plasticity that ensures developmental stability and robustness.	[Garelli, Andres; Gontijo, Alisson M.; Miguela, Veronica; Caparros, Esther; Dominguez, Maria] Univ Miguel Hernandez de Elche, CSIC, Inst Neurociencias, Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Dominguez, M (corresponding author), Univ Miguel Hernandez de Elche, CSIC, Inst Neurociencias, Alicante 03550, Spain.	m.dominguez@umh.es	Dominguez, Maria/G-2171-2014; Caparrós, Esther/AHD-3233-2022; Gontijo, Alisson/G-6719-2011	Dominguez, Maria/0000-0002-3329-7862; Caparrós, Esther/0000-0002-9681-0408; Gontijo, Alisson/0000-0002-2530-3708; Garelli, Andres/0000-0001-7023-0117	Marie Curie Fellowship; Fundacion Botin; Ministerio de Ciencia e Innovacion [BFU2009-09074, MEC-CONSOLIDER/CSD2007-00023]; Generalitat Valenciana [PROMETEO/2008/134]; European Commission [HEALTH-F2-2008-201666]	Marie Curie Fellowship(European Commission); Fundacion Botin; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank E. Hafen, L. Garcia-Alonso, B. Lakowski, and F. Heredia for their comments and suggestions; J. Colombani, D. S. Andersen, and P. Leopold for sharing unpublished data; and I. Gutierrez and E. Ballesta for technical help. V.M. is a Generalitat Valenciana fellow, and A.M.G. was supported by a Marie Curie Fellowship. This work was supported by grants from the Fundacion Botin, the Ministerio de Ciencia e Innovacion (BFU2009-09074 and MEC-CONSOLIDER/CSD2007-00023), Generalitat Valenciana (PROMETEO/2008/134), and the European Commission (HEALTH-F2-2008-201666) to M.D. The microarray data are deposited in the Gene Expression Omnibus (GEO) repository (accession GSE35471). A.M.G. and M.D. designed the research; A.G., A.M.G., V.M., E.C., and M.D. performed the experiments and analyzed the data. A.G., A.M.G., and M.D. wrote the manuscript.	ABBOTT LA, 1983, RADIAT RES, V96, P611, DOI 10.2307/3576126; BRYANT PJ, 1990, J CELL SCI, P169; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4	19	323	334	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					579	582		10.1126/science.1216735	http://dx.doi.org/10.1126/science.1216735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556250				2022-12-28	WOS:000303498800043
J	Thoreen, CC; Chantranupong, L; Keys, HR; Wang, T; Gray, NS; Sabatini, DM				Thoreen, Carson C.; Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Gray, Nathanael S.; Sabatini, David M.			A unifying model for mTORC1-mediated regulation of mRNA translation	NATURE			English	Article							RIBOSOME ENTRY SITES; LARGE GENE LISTS; CELL-PROLIFERATION; INDEPENDENT MANNER; MAMMALIAN TARGET; MTOR PATHWAY; AKT ACTIVITY; CYCLIN D1; RAPAMYCIN; INHIBITION	The mTOR complex 1 (mTORC1) kinase nucleates a pathway that promotes cell growth and proliferation and is the target of rapamycin, a drug with many clinical uses(1). mTORC1 regulates messenger RNA translation, but the overall translational program is poorly defined and no unifying model exists to explain how mTORC1 differentially controls the translation of specific mRNAs. Here we use high-resolution transcriptome-scale ribosome profiling to monitor translation in mouse cells acutely treated with the mTOR inhibitor Torin 1, which, unlike rapamycin, fully inhibits mTORC1 (ref. 2). Our data reveal a surprisingly simple model of the mRNA features and mechanisms that confer mTORC1-dependent translation control. The subset of mRNAs that are specifically regulated by mTORC1 consists almost entirely of transcripts with established 5' terminal oligopyrimidine (TOP) motifs, or, like Hsp90ab1 and Ybx1, with previously unrecognized TOP or related TOP-like motifs that we identified. We find no evidence to support proposals that mTORC1 preferentially regulates mRNAs with increased 5' untranslated region length or complexity(3). mTORC1 phosphorylates a myriad of translational regulators, but how it controls TOP mRNA translation is unknown(4). Remarkably, loss of just the 4E-BP family of translational repressors, arguably the best characterized mTORC1 substrates, is sufficient to render TOP and TOP-like mRNA translation resistant to Torin 1. The 4E-BPs inhibit translation initiation by interfering with the interaction between the cap-binding protein eIF4E and eIF4G1. Loss of this interaction diminishes the capacity of eIF4E to bind TOP and TOP-like mRNAs much more than other mRNAs, explaining why mTOR inhibition selectively suppresses their translation. Our results clarify the translational program controlled by mTORC1 and identify 4E-BPs and eIF4G1 as its master effectors.	[Thoreen, Carson C.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Thoreen, Carson C.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thoreen, Carson C.; Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Keys, Heather R.; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 250 Longwood Ave, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu; sabatini@wi.mit.edu		/0000-0002-1446-7256; Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [CA103866, CA129105]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Dana Farber Cancer Institute; American Cancer Society; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Dana Farber Cancer Institute; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Gray and Sabatini laboratories for helpful discussions, H. Guo, S. Hawthorne, G. Brar, J. Damon, C. Miller and W. Gilbert for advice and N. Sonenberg for providing 4EBP1/2 wild-type and double-knockout MEFs. This work was supported by the National Institutes of Health (CA103866 and CA129105 to D. M. S.), Department of Defense (W81XWH-07-0448 to D. M. S.), the W.M. Keck Foundation (D. M. S.), LAM Foundation (D. M. S.), Dana Farber Cancer Institute (N. S. G., C. C. T.), and fellowship support from the American Cancer Society (C. C. T.), and the National Science Foundation (L. C. and T. W.). D. M. S. is an investigator of the Howard Hughes Medical Institute.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	936	953	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					109	U142		10.1038/nature11083	http://dx.doi.org/10.1038/nature11083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22552098	Green Submitted, Green Accepted			2022-12-28	WOS:000303451900044
J	Bradley, EH; Curry, LA; Spatz, ES; Herrin, J; Cherlin, EJ; Curtis, JP; Thompson, JW; Ting, HH; Wang, YF; Krumholz, HM				Bradley, Elizabeth H.; Curry, Leslie A.; Spatz, Erica S.; Herrin, Jeph; Cherlin, Emily J.; Curtis, Jeptha P.; Thompson, Jennifer W.; Ting, Henry H.; Wang, Yongfei; Krumholz, Harlan M.			Hospital Strategies for Reducing Risk-Standardized Mortality Rates in Acute Myocardial Infarction	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ASSOCIATION TASK-FORCE; BETA-BLOCKER USE; AMERICAN-COLLEGE; 30-DAY MORTALITY; PERFORMING HOSPITALS; IMPROVE QUALITY; OUTCOMES; MANAGEMENT; GUIDELINES	Background: Despite recent improvements in survival after acute myocardial infarction (AMI), U. S. hospitals vary 2-fold in their 30-day risk-standardized mortality rates (RSMRs). Nevertheless, information is limited on hospital-level factors that may be associated with RSMRs. Objective: To identify hospital strategies that were associated with lower RSMRs. Design: Cross-sectional survey of 537 hospitals (91% response rate) and weighted multivariate regression by using data from the Centers for Medicare & Medicaid Services to determine the associations between hospital strategies and hospital RSMRs. Setting: Acute care hospitals with an annualized AMI volume of at least 25 patients. Participants: Patients hospitalized with AMI between 1 January 2008 and 31 December 2009. Measurements: Hospital performance improvement strategies, characteristics, and 30-day RSMRs. Results: In multivariate analysis, several hospital strategies were significantly associated with lower RSMRs and in aggregate were associated with clinically important differences in RSMRs. These strategies included holding monthly meetings to review AMI cases between hospital clinicians and staff who transported patients to the hospital (RSMR lower by 0.70 percentage points), having cardiologists always on site (lower by 0.54 percentage points), fostering an organizational environment in which clinicians are encouraged to solve problems creatively (lower by 0.84 percentage points), not cross-training nurses from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percentage points), and having physician and nurse champions rather than nurse champions alone (lower by 0.88 percentage points). Fewer than 10% of hospitals reported using at least 4 of these 5 strategies. Limitation: The cross-sectional design demonstrates statistical associations but cannot establish causal relationships. Conclusion: Several strategies, which are currently implemented by relatively few hospitals, are associated with significantly lower 30-day RSMRs for patients with AMI.	Yale Univ, Sch Med, Sch Publ Hlth, New Haven, CT USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Mayo Clin, Rochester, MN USA	Yale University; Yale University; Mayo Clinic	Bradley, EH (corresponding author), 60 Coll St,POB 208034, New Haven, CT 06520 USA.	elizabeth.bradley@yale.edu	, Harlan/AAI-2875-2020; curry, leslie/AAA-6100-2022	curry, leslie/0000-0002-3419-4654	Agency for Healthcare Research and Quality [R01-HS0-16929]; United Health Foundation; Commonwealth Fund; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [U01 HL105270-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016929] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); United Health Foundation; Commonwealth Fund; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Agency for Healthcare Research and Quality (R01-HS0-16929), the United Health Foundation, and the Commonwealth Fund. Dr. Krumholz was supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bradley EH, 2004, MED CARE, V42, P591, DOI 10.1097/01.mlr.0000128006.27364.a9; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; Chassin MR, 1997, HEALTH AFFAIR, V16, P151, DOI 10.1377/hlthaff.16.3.151; Creswell W. C., 2011, DESIGNING CONDUCTING; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Daniels MJ, 1999, J AM STAT ASSOC, V94, P29, DOI 10.2307/2669675; Ellerbeck EF, 2006, AM HEART J, V152, P579, DOI 10.1016/j.ahj.2006.02.011; Ellrodt Gray, 2007, Crit Pathw Cardiol, V6, P106, DOI 10.1097/HPC.0b013e318073bd3c; Krause N, 2002, J GERONTOL B-PSYCHOL, V57, pS263, DOI 10.1093/geronb/57.5.S263; Krumholz HM, 2011, AM HEART J, V162, P981, DOI 10.1016/j.ahj.2011.09.004; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; O'Mahony S, 2007, J GEN INTERN MED, V22, P1073, DOI 10.1007/s11606-007-0225-1; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Ross JS, 2008, HEALTH AFFAIR, V27, P1707, DOI 10.1377/hlthaff.27.6.1707; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; U.S. Department of Health and Human Services, 2012, CALC 30 DAY RISK STA; Welsch R, 1980, REGRESSION DIAGNOSTI	39	91	92	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					618	U53		10.7326/0003-4819-156-9-201205010-00003	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933YR	22547471	Green Accepted			2022-12-28	WOS:000303403700002
J	Nelson, HD; Zakher, B; Cantor, A; Fu, RW; Griffin, J; O'Meara, ES; Buist, DSM; Kerlikowske, K; van Ravesteyn, NT; Trentham-Dietz, A; Mandelblatt, JS; Miglioretti, DL				Nelson, Heidi D.; Zakher, Bernadette; Cantor, Amy; Fu, Rongwei; Griffin, Jessica; O'Meara, Ellen S.; Buist, Diana S. M.; Kerlikowske, Karla; van Ravesteyn, Nicolien T.; Trentham-Dietz, Amy; Mandelblatt, Jeanne S.; Miglioretti, Diana L.			Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ORAL-CONTRACEPTIVE USE; PHYSICAL-ACTIVITY; BODY-SIZE; MAMMOGRAPHIC DENSITY; REPRODUCTIVE FACTORS; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; PREMENOPAUSAL WOMEN; MENSTRUAL FACTORS; RELATIVE WEIGHT	Background: Identifying risk factors for breast cancer specific to women in their 40s could inform screening decisions. Purpose: To determine what factors increase risk for breast cancer in women aged 40 to 49 years and the magnitude of risk for each factor. Data Sources: MEDLINE (January 1996 to the second week of November 2011), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (fourth quarter of 2011), Scopus, reference lists of published studies, and the Breast Cancer Surveillance Consortium. Study Selection: English-language studies and systematic reviews of risk factors for breast cancer in women aged 40 to 49 years. Additional inclusion criteria were applied for each risk factor. Data Extraction: Data on participants, study design, analysis, follow-up, and outcomes were abstracted. Study quality was rated by using established criteria, and only studies rated as good or fair were included. Results were summarized by using meta-analysis when sufficient studies were available or from the best evidence based on study quality, size, and applicability when meta-analysis was not possible. Data from the Breast Cancer Surveillance Consortium were analyzed with proportional hazards models by using partly conditional Cox regression. Reference groups for comparisons were set at U. S. population means. Data Synthesis: Sixty-six studies provided data for estimates. Extremely dense breasts on mammography or first-degree relatives with breast cancer were associated with at least a 2-fold increase in risk for breast cancer. Prior breast biopsy, second-degree relatives with breast cancer, or heterogeneously dense breasts were associated with a 1.5- to 2.0-fold increased risk; current use of oral contraceptives, nulliparity, and age 30 years or older at first birth were associated with a 1.0- to 1.5-fold increased risk. Limitations: Studies varied by measures, reference groups, and adjustment for confounders, which could bias combined estimates. Effects of multiple risk factors were not considered. Conclusion: Extremely dense breasts and first-degree relatives with breast cancer were each associated with at least a 2-fold increase in risk for breast cancer in women aged 40 to 49 years. Identification of these risk factors may be useful for personalized mammography screening.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Providence Canc Ctr, Portland, OR USA; Grp Hlth Res Inst, Seattle, WA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Erasmus MC, Rotterdam, Netherlands; Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; Lombardi Comprehens Canc Ctr, Washington, DC USA	Oregon Health & Science University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Wisconsin System; University of Wisconsin Madison	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mail Code BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Cantor, Amy/0000-0002-4467-8484	National Cancer Institute [U01CA086076-10S1]; BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; Providence Health Services; Veterans Affairs Fellowship in Health Issues of Women Veterans; NATIONAL CANCER INSTITUTE [U01CA069976, U01CA086082, U01CA086076, U01CA070013, U01CA063731, U01CA063736, P01CA154292, U01CA063740, U01CA070040] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCSC; Providence Health Services; Veterans Affairs Fellowship in Health Issues of Women Veterans; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By a National Cancer Institute Activities to Promote Research Collaboration supplement (U01CA086076-10S1). Data collection was supported by the National Cancer Institute-funded BCSC co-operative agreements (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040). Providence Health & Services provided additional support for Dr. Nelson, and the Veterans Affairs Fellowship in Health Issues of Women Veterans provided support for Dr. Cantor. The collection of BCSC cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see www.breastscreening.cancer.gov/work/acknowledgement.html.	Al-Delaimy WK, 2004, CANCER EPIDEM BIOMAR, V13, P398; Althuis MD, 2003, CANCER CAUSE CONTROL, V14, P151, DOI 10.1023/A:1023006000760; American College of Radiology, 2003, AM COLL RAD BREAT IM; Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; [Anonymous], 2009, Ann Intern Med, V151, pI, DOI 10.7326/0003-4819-151-9-200911030-00002; [Anonymous], 2011, Obstet Gynecol, V118, P372, DOI 10.1097/AOG.0b013e31822c98e5; Ashbeck EL, 2007, CANCER EPIDEM BIOMAR, V16, P467, DOI 10.1158/1055-9965.EPI-06-0394; Atkins D, 2011, J CLIN EPIDEMIOL, V64, P1198, DOI 10.1016/j.jclinepi.2010.11.021; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Band PR, 2002, LANCET, V360, P1044, DOI 10.1016/S0140-6736(02)11140-8; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Baron JA, 1996, CANCER EPIDEM BIOMAR, V5, P399; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Berg AO, 2002, ANN INTERN MED, V137, P56, DOI 10.7326/0003-4819-137-1-200207020-00016; Berstad P, 2008, BREAST CANCER RES TR, V108, P113, DOI 10.1007/s10549-007-9578-8; Bowlin SJ, 1997, INT J EPIDEMIOL, V26, P915, DOI 10.1093/ije/26.5.915; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Braga C, 1996, EUR J CANCER PREV, V5, P159, DOI 10.1097/00008469-199606000-00003; Brinton LA, 1997, CONTRACEPTION, V55, P197, DOI 10.1016/S0010-7824(97)00012-7; Brown LM, 2010, BREAST CANCER RES TR, V120, P203, DOI 10.1007/s10549-009-0464-4; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Centers for Disease Control and Prevention, 2010, OV OB HLTH WEIGHT PE; Chang-Claude J, 2000, CANCER CAUSE CONTROL, V11, P687, DOI 10.1023/A:1008907901087; Chen CL, 1997, CANCER CAUSE CONTROL, V8, P77, DOI 10.1023/A:1018439306604; Chen JB, 2006, J NATL CANCER I, V98, P1215, DOI 10.1093/jnci/djj332; Clavel-Chapelon F, 2002, BRIT J CANCER, V86, P723, DOI 10.1038/sj.bjc.6600124; Colditz GA, 2003, BRIT J CANCER, V89, P847, DOI 10.1038/sj.bjc.6601175; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dumeaux V, 2004, CANCER EPIDEM BIOMAR, V13, P1302; Ferraroni M, 1998, EUR J CANCER, V34, P1403, DOI 10.1016/S0959-8049(98)00163-4; Franceschi S, 1996, INT J CANCER, V67, P181, DOI 10.1002/(SICI)1097-0215(19960717)67:2<181::AID-IJC5>3.0.CO;2-P; Freudenheim JL, 1997, AM J EPIDEMIOL, V146, P932, DOI 10.1093/oxfordjournals.aje.a009219; Friedenreich CM, 2002, INT J CANCER, V99, P445, DOI 10.1002/ijc.10389; Gammon MD, 1998, CANCER CAUSE CONTROL, V9, P583, DOI 10.1023/A:1008868922799; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.009; Gammon MD, 1998, AM J EPIDEMIOL, V147, P273; Garland M, 1999, CANCER EPIDEM BIOMAR, V8, P1017; Gilliland FD, 2001, AM J EPIDEMIOL, V154, P442, DOI 10.1093/aje/154.5.442; Gilliland FD, 1998, AM J EPIDEMIOL, V148, P683, DOI 10.1093/aje/148.7.683; GovTrack.us, 2020, S 3817 111 C CAPTA R; Hankinson SE, 1997, CANCER CAUSE CONTROL, V8, P65, DOI 10.1023/A:1018435205695; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howard RA, 2009, CANCER CAUSE CONTROL, V20, P323, DOI 10.1007/s10552-008-9246-2; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Kaaks R, 1998, INT J CANCER, V76, P647, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;647::AID-IJC6&gt;3.0.CO;2-Q; Kerlikowske K, 2010, J CLIN ONCOL, V28, P3830, DOI 10.1200/JCO.2009.26.4770; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Lahmann PH, 2007, CANCER EPIDEM BIOMAR, V16, P36, DOI 10.1158/1055-9965.EPI-06-0582; Lahmann PH, 2004, INT J CANCER, V111, P762, DOI 10.1002/ijc.20315; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Lee E, 1992, COX TYPE REGRESSION; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mannisto S, 2000, PUBLIC HEALTH NUTR, V3, P11, DOI 10.1017/S1368980000000033; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Marcus PM, 1999, AM J PUBLIC HEALTH, V89, P1244, DOI 10.2105/AJPH.89.8.1244; Maruti SS, 2008, JNCI-J NATL CANCER I, V100, P728, DOI 10.1093/jnci/djn135; Matthews TJ, 2009, NCHS DATA BRIEF, P1; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McCredie M, 1998, INT J CANCER, V76, P182, DOI 10.1002/(SICI)1097-0215(19980413)76:2<182::AID-IJC3>3.0.CO;2-T; McDonald JA, 2004, CANCER EPIDEM BIOMAR, V13, P2106; Michels KB, 2006, ARCH INTERN MED, V166, P2395, DOI 10.1001/archinte.166.21.2395; Michels KB, 1996, LANCET, V347, P431, DOI 10.1016/S0140-6736(96)90010-0; Mishell D R Jr, 1991, Int J Fertil, V36 Suppl 1, P7; Moorman PG, 2001, J NATL MED ASSOC, V93, P329; Mosher William D, 2010, Vital Health Stat 23, P1; National Heart Lung and Blood Institute, 2011, CALC YOUR BOD MASS I; Negri E, 1996, INT J CANCER, V67, P161, DOI 10.1002/(SICI)1097-0215(19960717)67:2<161::AID-IJC1>3.3.CO;2-J; Nelson HD, 2009, COMP EFFECTIVENESS M; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Newcomb PA, 1996, CANCER CAUSE CONTROL, V7, P525, DOI 10.1007/BF00051885; Nicholson BT, 2006, ACAD RADIOL, V13, P1143, DOI 10.1016/j.acra.2006.06.005; Palmer JR, 2003, J NATL CANCER I, V95, P478, DOI 10.1093/jnci/95.6.478; Peacock SL, 1999, AM J EPIDEMIOL, V149, P339, DOI 10.1093/oxfordjournals.aje.a009818; Pernoll ML, 2001, BENSON PERNOLLS HDB; Petri AL, 2004, ALCOHOL CLIN EXP RES, V28, P1084, DOI 10.1097/01.ALC.0000130812.85638.E1; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Prescott J, 2007, CANCER EPIDEM BIOMAR, V16, P620, DOI 10.1158/1055-9965.EPI-06-0873; Reinier KS, 2007, BREAST CANCER RES TR, V103, P343, DOI 10.1007/s10549-006-9375-9; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rosenberg L, 2009, AM J EPIDEMIOL, V169, P473, DOI 10.1093/aje/kwn360; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Shantakumar S, 2007, BREAST CANCER RES TR, V102, P365, DOI 10.1007/s10549-006-9343-4; Skegg DCG, 1996, CANCER CAUSE CONTROL, V7, P513, DOI 10.1007/BF00051883; Smith RA, 2003, CA-CANCER J CLIN, V53, P141, DOI 10.3322/canjclin.53.3.141; Steindorf K, 2003, AM J EPIDEMIOL, V157, P121, DOI 10.1093/aje/kwf181; Stuver SO, 1997, INT J CANCER, V71, P166, DOI 10.1002/(SICI)1097-0215(19970410)71:2<166::AID-IJC7>3.0.CO;2-Z; Substance Abuse and Mental Health Services Administration, 2008, NSDUH SER H; Sun LM, 2007, AM J EPIDEMIOL, V165, P271, DOI [10.1093/aje/kwm271, 10.1093/aje/kwk008]; Swanson CA, 1996, AM J EPIDEMIOL, V143, P698; Swanson CA, 1997, EPIDEMIOLOGY, V8, P231, DOI 10.1097/00001648-199705000-00001; Sweeney C, 2008, CANCER CAUSE CONTROL, V19, P391, DOI 10.1007/s10552-007-9098-1; Talamini R, 1996, EUR J CANCER, V32A, P303, DOI 10.1016/0959-8049(95)00615-X; Tehard B, 2004, INT J CANCER, V111, P264, DOI 10.1002/ijc.20213; Thomas DB, 2002, CANCER EPIDEM BIOMAR, V11, P565; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Titus-Ernstoff L, 1998, CANCER EPIDEM BIOMAR, V7, P783; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Troisi R, 1998, EPIDEMIOLOGY, V9, P641, DOI 10.1097/00001648-199811000-00014; Tryggvadottir L, 2002, INT J CANCER, V98, P604, DOI 10.1002/ijc.10217; Ursin G, 2004, CANCER, V101, P353, DOI 10.1002/cncr.20373; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vacek PM, 2004, CANCER EPIDEM BIOMAR, V13, P715; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Verla-Tebit E, 2005, EUR J CANCER PREV, V14, P419, DOI 10.1097/00008469-200508000-00016; Verloop J, 2000, J NATL CANCER I, V92, P128, DOI 10.1093/jnci/92.2.128; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; Wenten M, 2002, ANN EPIDEMIOL, V12, P435, DOI 10.1016/S1047-2797(01)00293-9; Wrensch M, 2003, BREAST CANCER RES, V5, pR88, DOI 10.1186/bcr605; Wu AH, 1996, BRIT J CANCER, V73, P680, DOI 10.1038/bjc.1996.118; Zheng YY, 2005, BIOMETRICS, V61, P379, DOI 10.1111/j.1541-0420.2005.00323.x; Ziegler RG, 1996, J NATL CANCER I, V88, P650, DOI 10.1093/jnci/88.10.650	120	252	265	2	86	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					635	U79		10.7326/0003-4819-156-9-201205010-00006	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547473				2022-12-28	WOS:000303403700004
J	Eisenbarth, SC; Williams, A; Colegio, OR; Meng, HL; Strowig, T; Rongvaux, A; Henao-Mejia, J; Thaiss, CA; Joly, S; Gonzalez, DG; Xu, L; Zenewicz, LA; Haberman, AM; Elinav, E; Kleinstein, SH; Sutterwala, FS; Flavell, RA				Eisenbarth, Stephanie C.; Williams, Adam; Colegio, Oscar R.; Meng, Hailong; Strowig, Till; Rongvaux, Anthony; Henao-Mejia, Jorge; Thaiss, Christoph A.; Joly, Sophie; Gonzalez, David G.; Xu, Lan; Zenewicz, Lauren A.; Haberman, Ann M.; Elinav, Eran; Kleinstein, Steven H.; Sutterwala, Fayyaz S.; Flavell, Richard A.			NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells	NATURE			English	Article							CUTTING EDGE; AUTOIMMUNE ENCEPHALOMYELITIS; LYMPH-NODES; DC SUBSETS; MIGRATION; ANTIGEN; INFLAMMASOME; EXPRESSION; CHEMOKINE; SPHINGOSINE-1-PHOSPHATE	NLRs (nucleotide-binding domain leucine-rich-repeat-containing receptors; NOD-like receptors) are a class of pattern recognition receptor (PRR) that respond to host perturbation from either infectious agents or cellular stress(1,2). The function of most NLR family members has not been characterized and their role in instructing adaptive immune responses remains unclear(2,3). NLRP10 (also known as PYNOD, NALP10, PAN5 and NOD8) is the only NLR lacking the putative ligand-binding leucine-rich-repeat domain, and has been postulated to be a negative regulator of other NLR members, including NLRP3 (refs 4-6). We did not find evidence that NLRP10 functions through an inflammasome to regulate caspase-1 activity nor that it regulates other inflammasomes. Instead, Nlrp10(-/-) mice had a profound defect in helper T-cell-driven immune responses to a diverse array of adjuvants, including lipopolysaccharide, aluminium hydroxide and complete Freund's adjuvant. Adaptive immunity was impaired in the absence of NLRP10 because of a dendritic cell (DC) intrinsic defect in emigration from inflamed tissues, whereas upregulation of DC costimulatory molecules and chemotaxis to CCR7-dependent and -independent ligands remained intact. The loss of antigen transport to the draining lymph nodes by a subset of migratory DCs resulted in an almost absolute loss in naive CD4(+) T-cell priming, highlighting the critical link between diverse innate immune stimulation, NLRP10 activity and the immune function of mature DCs.	[Eisenbarth, Stephanie C.; Gonzalez, David G.; Xu, Lan; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Williams, Adam; Strowig, Till; Rongvaux, Anthony; Henao-Mejia, Jorge; Thaiss, Christoph A.; Zenewicz, Lauren A.; Elinav, Eran; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Colegio, Oscar R.; Xu, Lan] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Meng, Hailong; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Joly, Sophie; Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Inflammat Program, Iowa City, IA 52242 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdep Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52241 USA	Yale University; Yale University; Yale University; Yale University; University of Iowa; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	stephanie.eisenbarth@yale.edu; richard.flavell@yale.edu	Cassel, Suzanne/AAI-3947-2021; Elinav, Eran/ABE-8881-2020; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Elinav, Eran/0000-0002-5775-2110; Colegio, Oscar/0000-0002-9524-6235; Eisenbarth, Stephanie/0000-0002-1244-208X; Colegio, Oscar/0000-0002-6519-3718; Zenewicz, Lauren/0000-0002-8787-5955; Strowig, Till/0000-0003-0185-1459	Yale CTSA [UL1 RR024139, 5KL2RR024138]; Damon Runyon Cancer Research Foundation [DRG 108-09]; Yale SPORE in Skin Cancer [1 P50 CA121974]; Dermatology Foundation; Cancer Research Institute; American Physicians for Medicine in Israel Foundation; United States-Israel binational Foundation; Yale Rheumatologic Disease Research Core Center [P30AR053495]; Edward Mallinckrodt, Jr. Foundation;  [T32HL007974];  [K08AI085038];  [R01AI087630]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, KL2RR024138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087630, K08AI085038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	Yale CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Damon Runyon Cancer Research Foundation; Yale SPORE in Skin Cancer; Dermatology Foundation; Cancer Research Institute; American Physicians for Medicine in Israel Foundation; United States-Israel binational Foundation; Yale Rheumatologic Disease Research Core Center; Edward Mallinckrodt, Jr. Foundation; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank R. Medzhitov and M. Albert for discussion and review of this manuscript, and F. Duffy for assistance with manuscript preparation. S. C. E. was supported by T32HL007974, K08AI085038 and Yale CTSA (UL1 RR024139). O.R.C. was supported by the Damon Runyon Cancer Research Foundation (DRG 108-09), the Yale CTSA (UL1 RR024139 and 5KL2RR024138), the Yale SPORE in Skin Cancer (1 P50 CA121974) and the Dermatology Foundation. E. E. is supported by Cancer Research Institute, the American Physicians for Medicine in Israel Foundation, and the United States-Israel binational Foundation grant. A. M. H., D. G. G. and in vivo imaging were supported by Yale Rheumatologic Disease Research Core Center P30AR053495. F. S. S. was supported by R01AI087630 and an Edward Mallinckrodt, Jr. Foundation scholarship. A. W. was a Howard Hughes fellow and R. A. F. is an Investigator of the Howard Hughes Medical Institute.	Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Medzhitov R, 1999, COLD SPRING HARB SYM, V64, P429, DOI 10.1101/sqb.1999.64.429; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Plantinga M, 2010, EUR J IMMUNOL, V40, P2112, DOI 10.1002/eji.201040562; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	36	96	100	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					510	U133		10.1038/nature11012	http://dx.doi.org/10.1038/nature11012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538615	Green Accepted			2022-12-28	WOS:000303200400050
J	Git, A				Git, Anna			A recipe for disaster	NATURE			English	Editorial Material							MINIMUM INFORMATION; MIQE GUIDELINES		Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Git, A (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England.	anna.git@cancer.org.uk						Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797	3	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					439	440		10.1038/484439a	http://dx.doi.org/10.1038/484439a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538584	Bronze			2022-12-28	WOS:000303200400019
J	Khunti, K; Gray, LJ; Skinner, T; Carey, ME; Realf, K; Dallosso, H; Fisher, H; Campbell, M; Heller, S; Davies, MJ				Khunti, Kamlesh; Gray, Laura J.; Skinner, Timothy; Carey, Marian E.; Realf, Kathryn; Dallosso, Helen; Fisher, Harriet; Campbell, Michael; Heller, Simon; Davies, Melanie J.			Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT EDUCATION; LIFE-STYLE; INTERVENTION; OUTCOMES; METAANALYSIS; EMPOWERMENT; EUROPE; COST	Objective To measure whether the benefits of a single education and self management structured programme for people with newly diagnosed type 2 diabetes mellitus are sustained at three years. Design Three year follow-up of a multicentre cluster randomised controlled trial in primary care, with randomisation at practice level. Setting 207 general practices in 13 primary care sites in the United Kingdom. Participants 731 of the 824 participants included in the original trial were eligible for follow-up. Biomedical data were collected on 604 (82.6%) and questionnaire data on 513 (70.1%) participants. Intervention A structured group education programme for six hours delivered in the community by two trained healthcare professional educators compared with usual care. Main outcome measures The primary outcome was glycated haemoglobin (HbA(1c)) levels. The secondary outcomes were blood pressure, weight, blood lipid levels, smoking status, physical activity, quality of life, beliefs about illness, depression, emotional impact of diabetes, and drug use at three years. Results HbA1c levels at three years had decreased in both groups. After adjusting for baseline and cluster the difference was not significant (difference -0.02, 95% confidence interval -0.22 to 0.17). The groups did not differ for the other biomedical and lifestyle outcomes and drug use. The significant benefits in the intervention group across four out of five health beliefs seen at 12 months were sustained at three years (P<0.01). Depression scores and quality of life did not differ at three years. Conclusion A single programme for people with newly diagnosed type 2 diabetes mellitus showed no difference in biomedical or lifestyle outcomes at three years although there were sustained improvements in some illness beliefs.	[Khunti, Kamlesh; Gray, Laura J.; Fisher, Harriet] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Skinner, Timothy] Univ Tasmania, Rural Clin Sch, Hobart, Tas 7001, Australia; [Carey, Marian E.; Realf, Kathryn; Dallosso, Helen] Univ Hosp Leicester, Leicester, Leics, England; [Campbell, Michael] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England; [Heller, Simon] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 6TP, Leics, England	University of Leicester; University of Tasmania; University Hospitals of Leicester NHS Trust; University of Leicester; University of Sheffield; University of Sheffield; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	kk22@le.ac.uk	Albertin, Paloma C/X-1093-2018; Skinner, Timothy C/N-2221-2013; /ABC-9527-2021; Davies, Michael/AGX-9184-2022; Davies, Michael/GWV-2527-2022; Campbell, Michael J/I-4253-2014	Skinner, Timothy C/0000-0002-0018-6963; Davies, Michael/0000-0002-5196-6919; Campbell, Michael J/0000-0003-3529-2739; Heller, Simon/0000-0002-2425-9565; Khunti, Kamlesh/0000-0003-2343-7099; Gray, Laura/0000-0002-9284-9321; Davies, Melanie/0000-0002-9987-9371; Fisher, Harriet/0000-0002-5639-0955	Diabetes UK; National Institute for Health Research [RP-DG-1210-10183, RP-PG-0606-1272] Funding Source: researchfish	Diabetes UK(Diabetes UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a grant from Diabetes UK secured by a joint team from Leicester University and the University Hospitals of Leicester NHS Trust. The writing of the report and the decision to submit the article for publication was entirely independent of the funder. The study funder had no input into the study design or analysis, nor the interpretation of data.	Alshamsan R, 2010, PRIM CARE DIABETES, V4, P73, DOI 10.1016/j.pcd.2010.02.003; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; ANDERSON RM, 1995, DIABETES CARE, V18, P412, DOI 10.2337/diacare.18.3.412; Audit Commission, 2000, TEST TIM REV DIAB SE; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Chaiken S., 1996, SOCIAL PSYCHOL HDB B; Craig C, 2008, BRIT MED J, V337, P1655; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x; Department of Health, 2001, NAT SERV FRAM DIAB S; Department of Health, 2002, NAT SERV FRAM DIAB D; Department of Health and Diabetes UK, 2005, STRUCT PAT ED DIAB R; Egenmann C, 2007, OUTCOMES INDICATORS; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gillett M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4093; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Jarvis J, 2010, DIABETES OBES METAB, V12, P12, DOI 10.1111/j.1463-1326.2009.01098.x; Khunti K, 2008, DIABETIC MED, V25, P1454, DOI 10.1111/j.1464-5491.2008.02620.x; Leventhal H., 1980, COMMON SENSE REPRESE; Lorig K, 2002, LANCET, V359, P814, DOI 10.1016/S0140-6736(02)07959-X; Massi-Benedetti M, 2002, DIABETOLOGIA, V45, pS1, DOI 10.1007/s00125-002-0860-3; Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033; Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; NICE, 2003, GUID US PAT ED MOD D; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2002, AM J PREV MED, V22, P39, DOI 10.1016/S0749-3797(02)00424-5; Rutten G, 2005, DIABETIC MED, V22, P671, DOI 10.1111/j.1464-5491.2005.01497.x; Skinner T, 2003, DIABETES SPECTRUM, V16, P75, DOI [DOI 10.2337/DIASPECT.16.2.75, 10.2337/diaspect.16.2.75]; Skinner TC, 2006, PATIENT EDUC COUNS, V64, P369, DOI 10.1016/j.pec.2006.04.007; Skinner TC, 2003, DIABETIC MED, V20, P283, DOI 10.1046/j.1464-5491.2003.00923.x; Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017; Tapp R, 2003, COMPLICATIONS DIABET; Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760	40	203	212	2	75	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2012	344								e2333	10.1136/bmj.e2333	http://dx.doi.org/10.1136/bmj.e2333			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539172	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000303433900001
J	Thangaratinam, S; Rogozinska, E; Jolly, K; Glinkowski, S; Roseboom, T; Tomlinson, JW; Kunz, R; Mol, BW; Coomarasamy, A; Khan, KS				Thangaratinam, S.; Rogozinska, E.; Jolly, K.; Glinkowski, S.; Roseboom, T.; Tomlinson, J. W.; Kunz, R.; Mol, B. W.; Coomarasamy, A.; Khan, K. S.			Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE INTERVENTION; GESTATIONAL DIABETES-MELLITUS; CORONARY-HEART-DISEASE; PRENATAL EXPOSURE; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; ENDURANCE EXERCISE; SYSTEMATIC REVIEWS; AEROBIC EXERCISE; DIETARY PATTERNS	Objective To evaluate the effects of dietary and lifestyle interventions in pregnancy on maternal and fetal weight and to quantify the effects of these interventions on obstetric outcomes. Design Systematic review and meta-analysis. Data sources Major databases from inception to January 2012 without language restrictions. Study selection Randomised controlled trials that evaluated any dietary or lifestyle interventions with potential to influence maternal weight during pregnancy and outcomes of pregnancy. Data synthesis Results summarised as relative risks for dichotomous data and mean differences for continuous data. Results We identified 44 relevant randomised controlled trials (7278 women) evaluating three categories of interventions: diet, physical activity, and a mixed approach. Overall, there was 1.42 kg reduction (95% confidence interval 0.95 to 1.89 kg) in gestational weight gain with any intervention compared with control. With all interventions combined, there were no significant differences in birth weight (mean difference -50 g, -100 to 0 g) and the incidence of large for gestational age (relative risk 0.85, 0.66 to 1.09) or small for gestational age (1.00, 0.78 to 1.28) babies between the groups, though by itself physical activity was associated with reduced birth weight (mean difference -60 g, -120 to -10 g). Interventions were associated with a reduced the risk of pre-eclampsia (0.74, 0.60 to 0.92) and shoulder dystocia (0.39, 0.22 to 0.70), with no significant effect on other critically important outcomes. Dietary intervention resulted in the largest reduction in maternal gestational weight gain (3.84 kg, 2.45 to 5.22 kg), with improved pregnancy outcomes compared with other interventions. The overall evidence rating was low to very low for important outcomes such as pre-eclampsia, gestational diabetes, gestational hypertension, and preterm delivery. Conclusions Dietary and lifestyle interventions in pregnancy can reduce maternal gestational weight gain and improve outcomes for both mother and baby. Among the interventions, those based on diet are the most effective and are associated with reductions in maternal gestational weight gain and improved obstetric outcomes.	[Thangaratinam, S.; Rogozinska, E.; Khan, K. S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London, England; [Jolly, K.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Glinkowski, S.] Arcana Inst, Krakow, Poland; [Roseboom, T.; Mol, B. W.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Tomlinson, J. W.; Coomarasamy, A.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Kunz, R.] Univ Basel, BICE, Basel, Switzerland	University of London; Queen Mary University London; University of Birmingham; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Basel	Thangaratinam, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, Womens Hlth Res Unit, London, England.	s.thangaratinam@qmul.ac.uk	Khan, Khalid S/AAT-8824-2020; Thangaratinam, Shakila/AAP-3724-2021; Mol, Ben/I-4526-2012; Jolly, Kate/AAA-1341-2019; Rogozinska, Ewelina/C-1096-2018	Khan, Khalid S/0000-0001-5084-7312; Thangaratinam, Shakila/0000-0002-4254-460X; Jolly, Kate/0000-0002-6224-2115; Rogozinska, Ewelina/0000-0003-3455-0644; Tomlinson, Jeremy/0000-0002-3170-8533; Roseboom, Tessa/0000-0003-0564-5994	National Institute for Health Research (NIHR) HTA (Health Technology Assessment) UK [09/27/06]; National Institute for Health Research [09/27/06] Funding Source: researchfish	National Institute for Health Research (NIHR) HTA (Health Technology Assessment) UK; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) HTA (Health Technology Assessment) UK programme 09/27/06. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health.	[Anonymous], 2006, NICE CLIN GUID 43 OB; [Anonymous], 2003, STAT STAT SOFTW REL; [Anonymous], 2011, REV MAN COMP PROGR V; Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef; Baciuk Erica P, 2008, Reprod Health, V5, P10, DOI 10.1186/1742-4755-5-10; Badrawi H, 1992, J PERINAT MED, V20, P203; Barakat R, 2009, INT J OBESITY, V33, P1048, DOI 10.1038/ijo.2009.150; Barakat R, 2011, BR J SPORTS MED 0926; Bechtel-Blackwell Deborah A, 2002, Clin Nurs Res, V11, P450, DOI 10.1177/105477302237456; Bell R, 2000, AUST NZ J OBSTET GYN, V40, P70, DOI 10.1111/j.1479-828X.2000.tb03171.x; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Briley C, 2002, J AM DIET ASSOC, V102, P984, DOI 10.1016/S0002-8223(02)90225-7; BUNG P, 1991, DIABETES, V40, P182, DOI 10.2337/diab.40.2.S182; Campbell F, 2009, SYSTEMATIC REV DIETA; Carmichael SL, 2003, AM J EPIDEMIOL, V158, P1127, DOI 10.1093/aje/kwg286; Cavalcante Sergio R, 2009, Reprod Health, V6, P1, DOI 10.1186/1742-4755-6-1; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Clapp JF, 1997, ARCH GYNECOL OBSTET, V260, P101; CLAPP JF, 1990, AM J OBSTET GYNECOL, V163, P1805, DOI 10.1016/0002-9378(90)90754-U; CLAPP JF, 1990, AM J OBSTET GYNECOL, V163, P1799, DOI 10.1016/0002-9378(90)90753-T; Clarke PE, 2004, MIDWIFERY, V20, P133, DOI 10.1016/j.midw.2003.11.003; Cochrane Adverse Effects Sub-Group of the Cochrane Non-Randomised Study Methods Group, 2011, INCL ADV EFF SYST RE; Dale E, 1982, Can J Appl Sport Sci, V7, P98; de Rooij SR, 2007, AM J CLIN NUTR, V86, P1219, DOI 10.1093/ajcn/86.4.1219; de Rooij SR, 2006, PSYCHONEUROENDOCRINO, V31, P1257, DOI 10.1016/j.psyneuen.2006.09.007; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; ERKKOLA R, 1976, SCAND J CLIN LAB INV, V36, P747, DOI 10.3109/00365517609081933; ERKKOLA R, 1976, ANN CLIN RES, V8, P15; Ferrara A, 2011, DIABETES CARE, V34, P1519, DOI 10.2337/dc10-2221; Garshasbi A, 2005, INT J GYNECOL OBSTET, V88, P271, DOI 10.1016/j.ijgo.2004.12.001; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Gomez-Tabarez G, 1994, REV COLOMB OBSTET GI, V45, P313; GREGORY PB, 1987, AM J PERINAT, V4, P365, DOI 10.1055/s-2007-999810; Gross H, 2004, CLIN EFFECTIVENESS N, V8, P161, DOI DOI 10.1016/J.CEIN.2005.03.002; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haakstad LAH, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-66; HATCH MC, 1993, AM J EPIDEMIOL, V137, P1105, DOI 10.1093/oxfordjournals.aje.a116614; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Huang TT, 2011, MIDWIFERY, V27, P257, DOI 10.1016/j.midw.2009.06.009; Hui A, 2012, BJOG-INT J OBSTET GY, V119, P70, DOI 10.1111/j.1471-0528.2011.03184.x; Hui HL., 2006, CAN J DIABETES, V30, P169, DOI DOI 10.1016/S1499-2671(06)02010-7; Jackson RA, 2011, PATIENT EDUC COUNS, V83, P203, DOI 10.1016/j.pec.2010.05.019; Jeffries K, 2009, MED J AUSTRALIA, V191, P429, DOI 10.5694/j.1326-5377.2009.tb02877.x; Khaledan A, 2010, HAYAT, V16, P55; KHAN K, 2001, UNDERTAKING SYSTEMAT; Khan KS, 2003, BRIT J ANAESTH, V91, P767; Khoury J, 2005, AM J OBSTET GYNECOL, V193, P1292, DOI 10.1016/j.ajog.2005.05.016; Knudsen VK, 2008, EUR J CLIN NUTR, V62, P463, DOI 10.1038/sj.ejcn.1602745; KULPA PJ, 1987, AM J OBSTET GYNECOL, V156, P1395, DOI 10.1016/0002-9378(87)90006-8; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lee G, 1996, Mod Midwife, V6, P28; LENDERS CM, 1994, J ADOLESCENT HEALTH, V15, P596, DOI 10.1016/1054-139X(94)90145-S; Lenders CM, 1997, J NUTR, V127, P1113, DOI 10.1093/jn/127.6.1113; Lewis G., 2007, SAVING MOTHERS LIVES; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; Lumey LH, 2009, AM J CLIN NUTR, V89, P1737, DOI 10.3945/ajcn.2008.27038; Magann EF, 2002, OBSTET GYNECOL, V99, P466, DOI 10.1016/S0029-7844(01)01754-9; Marquez-Sterling S, 2000, MED SCI SPORT EXER, V32, P58; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; *NAT AUD OFF, 2001, TACKL OB ENGL; National Institute for Health and Clinical Excellence (NICE), 2010, DIET INT PHYS ACT IN; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; NEY D, 1982, DIABETES CARE, V5, P529, DOI 10.2337/diacare.5.5.529; NHS Information Centre, 2008, HLTH SURV ENGL 2006; Ong MJ, 2009, DIABETES METAB, V35, P418, DOI 10.1016/j.diabet.2009.04.008; Painter RC, 2006, AM J HUM BIOL, V18, P853, DOI 10.1002/ajhb.20564; Phelan S, 2011, AM J CLIN NUTR, V93, P772, DOI 10.3945/ajcn.110.005306; Polley BA, 2002, INT J OBESITY, V26, P1494, DOI 10.1038/sj.ijo.0802130; Prevedel Tânia Terezinha Scudeller, 2003, Rev. Bras. Ginecol. Obstet., V25, P53, DOI 10.1590/S0100-72032003000100008; Qiu CF, 2008, AM J HYPERTENS, V21, P903, DOI 10.1038/ajh.2008.209; Quinlivan JA, 2011, AUST NZ J OBSTET GYN, V51, P141, DOI 10.1111/j.1479-828X.2010.01268.x; Rae A, 2000, AUST NZ J OBSTET GYN, V40, P416, DOI 10.1111/j.1479-828X.2000.tb01172.x; Ramachenderan J, 2008, AUST NZ J OBSTET GYN, V48, P228, DOI 10.1111/j.1479-828X.2008.00860.x; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Santos IA, 2005, OBSTET GYNECOL, V106, P243, DOI 10.1097/01.AOG.0000171113.36624.86; Schramm WF, 1996, AM J EPIDEMIOL, V143, P211; Sedaghati P., 2007, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V166, P209; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein AD, 2007, AM J CLIN NUTR, V85, P869, DOI 10.1093/ajcn/85.3.869; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Streuling I, 2010, AM J CLIN NUTR, V92, P678, DOI 10.3945/ajcn.2010.29363; Thangaratinam S, 2010, BJOG-INT J OBSTET GY, V117, P1309, DOI 10.1111/j.1471-0528.2010.02670.x; Thangaratinam S, HLTH TECHNO IN PRESS; Thompson SG, 2005, LANCET, V365, P341, DOI 10.1016/S0140-6736(05)17790-3; Thornton YS, 2009, J NATL MED ASSOC, V101, P569, DOI 10.1016/S0027-9684(15)30942-1; Vinter CA, 2011, DIABETES CARE, V34, P2502, DOI 10.2337/dc11-1150; Vujkovic M, 2007, OBSTET GYNECOL, V110, P378, DOI 10.1097/01.AOG.0000268799.37044.c3; Wolff S, 2008, INT J OBESITY, V32, P495, DOI 10.1038/sj.ijo.0803710; Yazdy MM, 2010, AM J EPIDEMIOL, V171, P407, DOI 10.1093/aje/kwp395; Yeo S, 2000, J REPROD MED, V45, P293	99	527	539	9	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2012	344								e2088	10.1136/bmj.e2088	http://dx.doi.org/10.1136/bmj.e2088			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946NT	22596383	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000304359400001
J	Mukherjee, D				Mukherjee, Debabrata			Review: Enoxaparin during PCI is better than unfractionated heparin for reducing mortality in coronary heart disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TASK-FORCE; ASSOCIATION; GUIDELINES; SOCIETY		Texas Tech Univ, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Mukherjee, D (corresponding author), Texas Tech Univ, El Paso, TX 79905 USA.		Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mukherjee D, 2011, LANCET, V377, P2154, DOI 10.1016/S0140-6736(11)60707-1; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277	4	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-2	10.7326/0003-4819-156-10-201205150-02002	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586020				2022-12-28	WOS:000304193400001
J	Han, TNW; Kato, M; Xie, SH; Wu, LC; Mirzaei, H; Pei, JM; Chen, M; Xie, Y; Allen, J; Xiao, GH; McKnight, SL				Han, Tina W.; Kato, Masato; Xie, Shanhai; Wu, Leeju C.; Mirzaei, Hamid; Pei, Jimin; Chen, Min; Xie, Yang; Allen, Jeffrey; Xiao, Guanghua; McKnight, Steven L.			Cell-free Formation of RNA Granules: Bound RNAs Identify Features and Components of Cellular Assemblies	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; DENDRITIC LOCALIZATION; BINDING PROTEINS; AMPA RECEPTOR; APLYSIA CPEB; DROSOPHILA; NEURONS; PUMILIO	Cellular granules lacking boundary membranes harbor RNAs and their associated proteins and play diverse roles controlling the timing and location of protein synthesis. Formation of such granules was emulated by treatment of mouse brain extracts and human cell lysates with a biotinylated isoxazole (b-isox) chemical. Deep sequencing of the associated RNAs revealed an enrichment for mRNAs known to be recruited to neuronal granules used for dendritic transport and localized translation at synapses. Precipitated mRNAs contain extended 30 UTR sequences and an enrichment in binding sites for known granule-associated proteins. Hydrogels composed of the low complexity (LC) sequence domain of FUS recruited and retained the same mRNAs as were selectively precipitated by the b-isox chemical. Phosphorylation of the LC domain of FUS prevented hydrogel retention, offering a conceptual means of dynamic, signal-dependent control of RNA granule assembly.	[Han, Tina W.; Kato, Masato; Xie, Shanhai; Wu, Leeju C.; Mirzaei, Hamid; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Min; Xie, Yang; Allen, Jeffrey; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Pei, Jimin] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Chen, Min/0000-0002-0676-3143	NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; [Anonymous], 2010, R LANG ENV STAT COMP; BERNARDI A, 1972, P NATL ACAD SCI USA, V69, P3033, DOI 10.1073/pnas.69.10.3033; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Feng Y, 1997, J NEUROSCI, V17, P1539; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hegner RW, 1908, BIOL BULL-US, V16, P19, DOI 10.2307/1536121; Hegner RW, 1911, BIOL BULL-US, V20, P237, DOI 10.2307/1536101; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; ILLMENSEE K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Knowles RB, 1996, J NEUROSCI, V16, P7812; Koyano S, 1999, NEUROSCI LETT, V273, P117, DOI 10.1016/S0304-3940(99)00656-4; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; OKADA M, 1974, DEV BIOL, V37, P43, DOI 10.1016/0012-1606(74)90168-7; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; WANG H, 1994, J NEUROSCI, V14, P4588; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	53	530	535	7	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					768	779		10.1016/j.cell.2012.04.016	http://dx.doi.org/10.1016/j.cell.2012.04.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579282	Bronze			2022-12-28	WOS:000303934700011
J	Davies, MJ; Moore, VM; Willson, KJ; Van Essen, P; Priest, K; Scott, H; Haan, EA; Chan, A				Davies, Michael J.; Moore, Vivienne M.; Willson, Kristyn J.; Van Essen, Phillipa; Priest, Kevin; Scott, Heather; Haan, Eric A.; Chan, Annabelle			Reproductive Technologies and the Risk of Birth Defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; CHILDREN BORN; SAFETY ISSUES; CONGENITAL-MALFORMATIONS; IVF-METHODS; HEALTH; INFANTS; METAANALYSIS; FERTILITY	Background The extent to which birth defects after infertility treatment may be explained by underlying parental factors is uncertain. Methods We linked a census of treatment with assisted reproductive technology in South Australia to a registry of births and terminations with a gestation period of at least 20 weeks or a birth weight of at least 400 g and registries of birth defects (including cerebral palsy and terminations for defects at any gestational period). We compared risks of birth defects (diagnosed before a child's fifth birthday) among pregnancies in women who received treatment with assisted reproductive technology, spontaneous pregnancies (i.e., without assisted conception) in women who had a previous birth with assisted conception, pregnancies in women with a record of infertility but no treatment with assisted reproductive technology, and pregnancies in women with no record of infertility. Results Of the 308,974 births, 6163 resulted from assisted conception. The unadjusted odds ratio for any birth defect in pregnancies involving assisted conception (513 defects, 8.3%) as compared with pregnancies not involving assisted conception (17,546 defects, 5.8%) was 1.47 (95% confidence interval [CI], 1.33 to 1.62); the multivariate-adjusted odds ratio was 1.28 (95% CI, 1.16 to 1.41). The corresponding odds ratios with in vitro fertilization (IVF) (165 birth defects, 7.2%) were 1.26 ( 95% CI, 1.07 to 1.48) and 1.07 (95% CI, 0.90 to 1.26), and the odds ratios with intracytoplasmic sperm injection (ICSI) (139 defects, 9.9%) were 1.77 (95% CI, 1.47 to 2.12) and 1.57 (95% CI, 1.30 to 1.90). A history of infertility, either with or without assisted conception, was also significantly associated with birth defects. Conclusions The increased risk of birth defects associated with IVF was no longer significant after adjustment for parental factors. The risk of birth defects associated with ICSI remained increased after multivariate adjustment, although the possibility of residual confounding cannot be excluded.	[Davies, Michael J.] Univ Adelaide, Med Sch S, Robinson Inst, Adelaide, SA 5005, Australia; [Davies, Michael J.; Moore, Vivienne M.; Willson, Kristyn J.] Univ Adelaide, Res Ctr Early Origins Hlth & Dis, Adelaide, SA, Australia; [Moore, Vivienne M.; Willson, Kristyn J.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Davies, Michael J.; Haan, Eric A.] Univ Adelaide, Discipline Paediat & Reprod Hlth, Adelaide, SA, Australia; [Priest, Kevin; Chan, Annabelle] S Australian Dept Hlth, Epidemiol Branch, Adelaide, SA, Australia; [Haan, Eric A.] SA Pathol, S Australian Clin Genet Serv, Adelaide, SA, Australia; [Van Essen, Phillipa; Scott, Heather; Haan, Eric A.; Chan, Annabelle] Womens & Childrens Hosp, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; SA Pathology; Womens & Childrens Hospital Australia	Davies, MJ (corresponding author), Univ Adelaide, Med Sch S, Robinson Inst, Frome Rd, Adelaide, SA 5005, Australia.	michael.davies@adelaide.edu.au	Davies, Michael/GWV-2527-2022; Davies, Michael John/Y-3542-2018	Davies, Michael John/0000-0003-1526-0801	National Health and Medical Research Council [349475, 349548, 453556, 465455]; Australian Research Council [FT100101018]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Funded by the National Health and Medical Research Council and the Australian Research Council.; Supported by grants from the National Health and Medical Research Council (349475, 349548, 453556, and 465455) and the Australian Research Council (FT100101018).	Australian Bureau of Statistics, 2006, CENS POP HOUS SOC IN; Australian Standard Classification of Occupations (ASCO), 1990, AUSTR STAND CLASS OC; Bonduelle M, 2005, HUM REPROD, V20, P413, DOI 10.1093/humrep/deh592; CZEIZEL A, 1989, LANCET, V2, P167; Davies M, 2002, LANCET, V360, P718, DOI 10.1016/S0140-6736(02)09849-5; El-Chaar D, 2009, FERTIL STERIL, V92, P1557, DOI 10.1016/j.fertnstert.2008.08.080; Elizur SE, 2008, FERTIL STERIL, V89, P1595, DOI 10.1016/j.fertnstert.2008.02.092; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; Halliday JL, 2010, HUM REPROD, V25, P59, DOI 10.1093/humrep/dep364; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Kallen B, 2005, FERTIL STERIL, V84, P611, DOI 10.1016/j.fertnstert.2005.02.038; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Kurinczuk JJ, 2004, CURR OPIN OBSTET GYN, V16, P201, DOI 10.1097/00001703-200406000-00002; Kurinczuk JJ, 2003, HUM REPROD, V18, P925, DOI 10.1093/humrep/deg217; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; Lambert RD, 2003, HUM REPROD, V18, P1987, DOI 10.1093/humrep/deg361; Lambert RD, 2002, HUM REPROD, V17, P3011, DOI 10.1093/humrep/17.12.3011; Lidegaard O, 2006, CURR OPIN OBSTET GYN, V18, P293; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyh363; Marino JL, 2011, HUM REPROD, V26, P473, DOI 10.1093/humrep/deq305; National Health and Medical Research Council, 2007, ETH GUID US ASS REPR; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Reefhuis J, 2011, HUM REPROD, V26, P451, DOI 10.1093/humrep/deq313; Rimm AA, 2004, J ASSIST REPROD GEN, V21, P437, DOI 10.1007/s10815-004-8760-8; Schieve LA, 2005, FERTIL STERIL, V84, P1320, DOI 10.1016/j.fertnstert.2005.04.066; Schieve LA, 2004, OBSTET GYNECOL, V103, P1154, DOI 10.1097/01.AOG.0000124571.04890.67; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; Wennerholm UB, 2009, HUM REPROD, V24, P2158, DOI 10.1093/humrep/dep125; Westergaard HB, 1999, HUM REPROD, V14, P1896, DOI 10.1093/humrep/14.7.1896; Yang Q, 2007, HUM REPROD, V22, P696, DOI 10.1093/humrep/del453; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	33	525	556	14	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1803	1813		10.1056/NEJMoa1008095	http://dx.doi.org/10.1056/NEJMoa1008095			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22559061	Bronze			2022-12-28	WOS:000303817000009
J	Petrov, DB				Petrov, Daniel B.			An Electrocardiographic Sine Wave in Hyperkalemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Pirogov Emergency Hosp, Sofia, Bulgaria	Medical University Sofia	Petrov, DB (corresponding author), Pirogov Emergency Hosp, Sofia, Bulgaria.	dpetrov@techno-link.com							0	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1824	1824		10.1056/NEJMicm1113009	http://dx.doi.org/10.1056/NEJMicm1113009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571204				2022-12-28	WOS:000303817000011
J	Morgan, IG; Ohno-Matsui, K; Saw, SM				Morgan, Ian G.; Ohno-Matsui, Kyoko; Saw, Seang-Mei			Ophthalmology 2 Myopia	LANCET			English	Article							REFRACTIVE ERRORS; RISK-FACTORS; CHOROIDAL NEOVASCULARIZATION; RETINAL-DETACHMENT; PATHOLOGICAL MYOPIA; DEPRIVATION MYOPIA; ETHNIC-DIFFERENCES; VISUAL IMPAIRMENT; SPECTACLE LENSES; PARENTAL MYOPIA	Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now affects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside. There are no reported major genes for school myopia, although there are several genes associated with high myopia. Any genetic contribution to ethnic differences may be small. However, to what extent many genes of small effect and gene-environment interactions contribute to variations in school myopia within populations remains to be established. There are promising optical and pharmacological interventions for preventing the development of myopia or slowing its progression, which require further validation, and promising vision-sparing treatments for pathological myopia.	[Morgan, Ian G.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Australian Res Council Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Morgan, Ian G.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Dept Prevent Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Saw, Seang-Mei] Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Saw, Seang-Mei] Singapore Eye Res Inst, Singapore, Singapore	Australian National University; Sun Yat Sen University; Tokyo Medical & Dental University (TMDU); National University of Singapore; National University of Singapore; Singapore National Eye Center	Morgan, IG (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Australian Res Council Ctr Excellence Vis Sci, Canberra, ACT, Australia.	ian.morgan@anu.edu.au	Morgan, Ian G/D-1190-2009	Morgan, Ian G/0000-0002-4548-3574	Australian Research Council [CEO561903]; Japan Society for the Promotion of Science, Tokyo, Japan [23659808, 22390322]; Singapore's National Medical Research Council [NMRC/1176/2008, EDG/NMRC/10May040]	Australian Research Council(Australian Research Council); Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Singapore's National Medical Research Council(National Medical Research Council, Singapore)	The authors have been supported by grants from the Australian Research Council (CEO561903), the Japan Society for the Promotion of Science, Tokyo, Japan (grants 23659808 and 22390322), and Singapore's National Medical Research Council (grants NMRC/1176/2008 and EDG/NMRC/10May040). The authors are grateful to Damian Czepita (Department of Ophthalmology, Pomeranian Medical Academy, Szczecin, Poland), Akbar Fotouhi (Department of Statistics, Tehran University Medical School, Tehran, Iran), Donald Mutti (College of Optometry, Ohio State University, Columbus, Ohio, USA), and Penimpol Yingyong (Department of Ophthalmology, Mettapracharak Eye Center, Nakhon Pathom, Thailand) and Kathryn Rose (Discipline of Orthoptics, Univesity of Sydney, Sydney, Australia) for providing recalculated results on the prevalence of myopia.	Algvere PV, 1999, GRAEF ARCH CLIN EXP, V237, P137, DOI 10.1007/s004170050208; Anstice NS, 2011, OPHTHALMOLOGY, V118, P1152, DOI 10.1016/j.ophtha.2010.10.035; Ashby R, 2009, INVEST OPHTH VIS SCI, V50, P5348, DOI 10.1167/iovs.09-3419; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P5247, DOI 10.1167/iovs.09-4689; Au Eong K G, 1993, Singapore Med J, V34, P29; Baba T, 2003, AM J OPHTHALMOL, V135, P338, DOI 10.1016/S0002-9394(02)01937-2; Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; BENJAMIN B, 1957, Spec Rep Ser Med Res Counc (G B), V11, P1; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Chen CY, 2007, INVEST OPHTH VIS SCI, V48, P4433, DOI 10.1167/iovs.06-1188; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Chia A, 2012, OPHTHALMOLOGY, V119, P347, DOI 10.1016/j.ophtha.2011.07.031; Cohen SY, 2009, RETINA-J RET VIT DIS, V29, P1062, DOI 10.1097/IAE.0b013e3181b1bb1a; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241, DOI 10.1016/S0161-6420(96)30515-0; COOK RC, 1951, AM J OPHTHALMOL, V34, P1407, DOI 10.1016/0002-9394(51)90481-3; Cumberland PM, 2007, BRIT J OPHTHALMOL, V91, P151, DOI 10.1136/bjo.2006.102277; Duke-Elder S., 1970, SYSTEMS OPHTHALMOLOG, P297; Ganesan P, 2010, EXPERT REV OPHTHALMO, V5, P759, DOI 10.1586/EOP.10.67; Gao LQ, 2011, ARCH OPHTHALMOL-CHIC, V129, P1199, DOI 10.1001/archophthalmol.2011.230; GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785; Guggenheim JA, 2000, J MED GENET, V37, P227, DOI 10.1136/jmg.37.3.227; Guggenheim JA, 2007, BRIT J OPHTHALMOL, V91, P781, DOI 10.1136/bjo.2006.107441; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; Gwiazda J, 2003, INVEST OPHTH VIS SCI, V44, P1492, DOI 10.1167/iovs.02-0816; Gwiazda J, 2011, INVEST OPHTH VIS SCI, V52, P2749, DOI 10.1167/iovs.10-6631; Gwiazda JE, 2004, INVEST OPHTH VIS SCI, V45, P2143, DOI 10.1167/iovs.03-1306; Hayashi K, 2010, OPHTHALMOLOGY, V117, pe1, DOI DOI 10.1016/j.ophtha.2009.11.003; Hayashi K, 2010, OPHTHALMOLOGY, V117, P1595, DOI 10.1016/j.ophtha.2009.11.003; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; HOYT CS, 1981, AM J OPHTHALMOL, V91, P197, DOI 10.1016/0002-9394(81)90173-2; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P2520, DOI 10.1167/iovs.06-0716; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Lavanya R, 2010, INVEST OPHTH VIS SCI, V51, P6247, DOI 10.1167/iovs.10-5229; Lee TT, 2010, OPTOMETRY VISION SCI, V87, P1053, DOI 10.1097/OPX.0b013e3181fd5efc; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; Liu Y, 2011, INVEST OPHTH VIS SCI, V52, P1078, DOI 10.1167/iovs.10-5716; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mayer DL, 2001, ARCH OPHTHALMOL-CHIC, V119, P1625; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; McBrien NA, 2011, OPHTHAL PHYSL OPT, V31, P529, DOI 10.1111/j.1475-1313.2011.00841.x; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Moriyama M, 2007, OPHTHALMOLOGY, V114, P1755, DOI 10.1016/j.ophtha.2006.11.034; Moriyama M, 2011, OPHTHALMOLOGY, V118, P1626, DOI 10.1016/j.ophtha.2011.01.018; Mutti DO, 2006, INVEST OPHTH VIS SCI, V47, P837, DOI 10.1167/iovs.05-0888; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2002, AM J MED GENET, V112, P355, DOI 10.1002/ajmg.10683; Mutti DO, 2011, INVEST OPHTH VIS SCI, V52, P3818, DOI 10.1167/iovs.10-6534; Mutti DO, 2011, OPTOMETRY VISION SCI, V88, P377, DOI 10.1097/OPX.0b013e31820b0385; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P76, DOI 10.1097/OPX.0b013e31819974ae; Nishimura A, 2011, AM J OPHTHALMOL, V151, P148, DOI 10.1016/j.ajo.2010.07.023; Ohno-Matsui K, 2003, BRIT J OPHTHALMOL, V87, P570, DOI 10.1136/bjo.87.5.570; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Sankaridurg P, 2010, OPTOMETRY VISION SCI, V87, P631, DOI 10.1097/OPX.0b013e3181ea19c7; Saw S-M, 2011, INCREASE MYOPIA PREV; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Shih YF, 2006, BRIT J OPHTHALMOL, V90, P546, DOI 10.1136/bjo.2005.081992; Shimada N, 2006, AM J OPHTHALMOL, V142, P497, DOI 10.1016/j.ajo.2006.03.048; Smith EL, 2012, INVEST OPHTH VIS SCI, V53, P421, DOI 10.1167/iovs.11-8652; Smith EL, 2011, OPTOMETRY VISION SCI, V88, P1029, DOI 10.1097/OPX.0b013e3182279cfa; Sng CCA, 2011, INVEST OPHTH VIS SCI, V52, P1181, DOI 10.1167/iovs.10-5601; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Song YY, 2011, J OCUL PHARMACOL TH, V27, P361, DOI 10.1089/jop.2011.0017; Sorsby A, 1962, MED RES COUNCIL SPEC; Suda K, 2011, AM J OPHTHALMOL, V151, P118, DOI 10.1016/j.ajo.2010.07.007; Takano M, 1999, AM J OPHTHALMOL, V128, P472, DOI 10.1016/S0002-9394(99)00186-5; Tay M T, 1992, Ann Acad Med Singap, V21, P785; Tse DY, 2011, INVEST OPHTH VIS SCI, V52, P8056, DOI 10.1167/iovs.10-5207; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Vitart V, 2010, INVEST OPHTH VIS SCI, V51, P737, DOI 10.1167/iovs.09-3720; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Walline JJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004916.pub3; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Ward B, 2009, EYE, V23, P2169, DOI 10.1038/eye.2008.433; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu MMM, 1999, OPTOMETRY VISION SCI, V76, P387, DOI 10.1097/00006324-199906000-00018; YOUNG FA, 1969, AMER J OPT ARCH AM A, V46, P676; ZYLBERMANN R, 1993, J PEDIATR OPHTHALMOL, V30, P319	102	997	1052	20	303	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1739	1748		10.1016/S0140-6736(12)60272-4	http://dx.doi.org/10.1016/S0140-6736(12)60272-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22559900				2022-12-28	WOS:000303658500034
J	Ratajczak, Z; Nippert, JB				Ratajczak, Zak; Nippert, Jesse B.			Comment on "Global Resilience of Tropical Forest and Savanna to Critical Transitions"	SCIENCE			English	Editorial Material							AFRICAN SAVANNA; TREE COVER; FIRE; ENCROACHMENT; DYNAMICS; CLIMATE		[Ratajczak, Zak; Nippert, Jesse B.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Ratajczak, Z (corresponding author), Kansas State Univ, Div Biol, 116 Ackert Hall, Manhattan, KS 66506 USA.	zarata@ksu.edu		Nippert, Jesse/0000-0002-7939-342X				Ansley RJ, 2010, RANGELAND ECOL MANAG, V63, P286, DOI 10.2111/08-172.1; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Barger NN, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001506; Bond WJ, 2003, S AFR J BOT, V69, P79, DOI 10.1016/S0254-6299(15)30362-8; Browning DM, 2011, INT J GEOGR INF SCI, V25, P913, DOI 10.1080/13658816.2010.498789; Clifford MJ, 2011, ECOSYSTEMS, V14, P949, DOI 10.1007/s10021-011-9458-2; D'Odorico P., 2011, ECOHYDROLOGY, DOI [10.1002/eco259, DOI 10.1002/ECO259]; Hansen MC, 2003, EARTH INTERACT, V7; Hirota M, 2010, NEW PHYTOL, V187, P707, DOI 10.1111/j.1469-8137.2010.03352.x; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Kalwij JM, 2010, ECOL APPL, V20, P222, DOI 10.1890/09-0541.1; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; Ratajczak Z, 2012, ECOLOGY, V93, P697, DOI 10.1890/11-1199.1; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465	15	17	18	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081								10.1126/science.1219346	http://dx.doi.org/10.1126/science.1219346			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556235	Bronze			2022-12-28	WOS:000303498800025
J	Slavin, JA				Slavin, James A.			A Dynamic Twist in the Tail	SCIENCE			English	Editorial Material							VENUS MAGNETOTAIL; MAGNETIC-FIELD; RECONNECTION		Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48176 USA	University of Michigan System; University of Michigan	Slavin, JA (corresponding author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48176 USA.	jaslavin@umich.edu	Slavin, James A/H-3170-2012	Slavin, James A/0000-0002-9206-724X				Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Burch JL, 2009, AM SCI, V97, P392, DOI 10.1511/2009.80.392; Cassak PA, 2012, SPACE SCI REV, V172, P283, DOI 10.1007/s11214-011-9755-2; Hesse M, 2011, SPACE SCI REV, V160, P3, DOI 10.1007/s11214-010-9740-1; Jia YD, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012175; Neidner Jr. M. B., 1978, ASTROPHYS J, V223, P655; NISHIDA A, 1995, J GEOPHYS RES-SPACE, V100, P23663, DOI 10.1029/95JA02519; RUSSELL CT, 1986, J GEOPHYS RES, V91, P1417, DOI 10.1029/JA091iA02p01417; SAUNDERS MA, 1986, J GEOPHYS RES, V91, P5589, DOI 10.1029/JA091iA05p05589; SCARF FL, 1981, NATURE, V292, P585, DOI 10.1038/292585a0; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; SLAVIN JA, 1989, J GEOPHYS RES, V94, P2383, DOI 10.1029/JA094iA03p02383; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; SMITH EJ, 1986, SCIENCE, V232, P382, DOI 10.1126/science.232.4748.382; Zhang TL, 2012, SCIENCE, V336, P567, DOI 10.1126/science.1217013	15	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					548	549		10.1126/science.1221805	http://dx.doi.org/10.1126/science.1221805			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556240				2022-12-28	WOS:000303498800032
J	Mallick, U; Harmer, C; Yap, B; Wadsley, J; Clarke, S; Moss, L; Nicol, A; Clark, PM; Farnell, K; McCready, R; Smellie, J; Franklyn, JA; John, R; Nutting, CM; Newbold, K; Lemon, C; Gerrard, G; Abdel-Hamid, A; Hardman, J; Macias, E; Roques, T; Whitaker, S; Vijayan, R; Alvarez, P; Beare, S; Forsyth, S; Kadalayil, L; Hackshaw, A				Mallick, Ujjal; Harmer, Clive; Yap, Beng; Wadsley, Jonathan; Clarke, Susan; Moss, Laura; Nicol, Alice; Clark, Penelope M.; Farnell, Kate; McCready, Ralph; Smellie, James; Franklyn, Jayne A.; John, Rhys; Nutting, Christopher M.; Newbold, Kate; Lemon, Catherine; Gerrard, Georgina; Abdel-Hamid, Abdel; Hardman, John; Macias, Elena; Roques, Tom; Whitaker, Stephen; Vijayan, Rengarajan; Alvarez, Pablo; Beare, Sandy; Forsyth, Sharon; Kadalayil, Latha; Hackshaw, Allan			Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IODINE REMNANT ABLATION; RADIOACTIVE IODINE; PROGNOSTIC-SIGNIFICANCE; SERUM THYROGLOBULIN; CONSENSUS REPORT; CARCINOMA; THERAPY; PAPILLARY; I-131; SURVEILLANCE	Background It is not known whether low-dose radioiodine (1.1 GBq [30 mCi]) is as effective as high-dose radioiodine (3.7 GBq [100 mCi]) for treating patients with differentiated thyroid cancer or whether the effects of radioiodine (especially at a low dose) are influenced by using either recombinant human thyrotropin (thyrotropin alfa) or thyroid hormone withdrawal. Methods At 29 centers in the United Kingdom, we conducted a randomized noninferiority trial comparing low-dose and high-dose radioiodine, each in combination with either thyrotropin alfa or thyroid hormone withdrawal before ablation. Patients (age range, 16 to 80 years) had tumor stage T1 to T3, with possible spread to nearby lymph nodes but without metastasis. End points were the rate of success of ablation at 6 to 9 months, adverse events, quality of life, and length of hospital stay. Results A total of 438 patients underwent randomization; data could be analyzed for 421. Ablation success rates were 85.0% in the group receiving low-dose radioiodine versus 88.9% in the group receiving the high dose and 87.1% in the thyrotropin alfa group versus 86.7% in the group undergoing thyroid hormone withdrawal. All 95% confidence intervals for the differences were within +/- 10 percentage points, indicating noninferiority. Similar results were found for low-dose radioiodine plus thyrotropin alfa (84.3%) versus high-dose radioiodine plus thyroid hormone withdrawal (87.6%) or high-dose radioiodine plus thyrotropin alfa (90.2%). More patients in the high-dose group than in the low-dose group were hospitalized for at least 3 days (36.3% vs. 13.0%, P<0.001). The proportions of patients with adverse events were 21% in the low-dose group versus 33% in the high-dose group (P = 0.007) and 23% in the thyrotropin alfa group versus 30% in the group undergoing thyroid hormone withdrawal (P = 0.11). Conclusions Low-dose radioiodine plus thyrotropin alfa was as effective as high-dose radioiodine, with a lower rate of adverse events. (Funded by Cancer Research UK; ClinicalTrials.gov number, NCT00415233.)	[Mallick, Ujjal] Freeman Rd Hosp, No Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Yap, Beng] Christie Natl Hlth Serv NHS Fdn Trust, Manchester, Lancs, England; [Wadsley, Jonathan] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Moss, Laura] Velindre Canc Ctr, Cardiff, S Glam, Wales; [John, Rhys] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales; [Nicol, Alice] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; [Clark, Penelope M.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Franklyn, Jayne A.] Univ Birmingham Edgbaston, Dept Med, Birmingham, W Midlands, England; [Farnell, Kate] Butterfly Canc Trust UK, Rowlands Gill, Tyne & Wear, England; [McCready, Ralph] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England; [Clarke, Susan] Guys & St Thomas Hosp, London SE1 9RT, England; [Smellie, James] Chelsea & Westminster Hosp, London, England; [Alvarez, Pablo; Beare, Sandy; Forsyth, Sharon; Kadalayil, Latha; Hackshaw, Allan] UCL, London, England; [Nutting, Christopher M.] Inst Canc Res, Sutton, Surrey, England; [Harmer, Clive; Newbold, Kate] Royal Marsden Hosp, Sutton, Surrey, England; [Lemon, Catherine] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England; [Gerrard, Georgina] Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England; [Abdel-Hamid, Abdel] Castle Hill Hosp, Cottingham, E Riding Yorksh, England; [Hardman, John] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Macias, Elena] E Kent Hosp Univ NHS Fdn Trust, Canterbury, Kent, England; [Roques, Tom] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Whitaker, Stephen] Royal Surrey Cty Hosp, Guildford, Surrey, England; [Vijayan, Rengarajan] Royal Derby Hosp, Derby, England	Newcastle Freeman Hospital; Newcastle University - UK; Christie NHS Foundation Trust; Weston Park Hospital; Velindre Cancer Centre; Cardiff University; University of Glasgow; University of Birmingham; University of Birmingham; Brighton and Sussex University Hospitals NHS Trust; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; University College London; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Cookridge Hospital; University of Hull; James Cook University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Royal Surrey County Hospital; University of Nottingham	Mallick, U (corresponding author), Freeman Rd Hosp, No Ctr Canc Care, Level 4,Freeman Rd, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	ujjal.mallick@nuth.nhs.uk	Newbold, Kate/AAA-9176-2022	wadsley, jonathan/0000-0002-1499-1277; Nicol, Alice/0000-0001-5215-9898; Kadalayil, Latha/0000-0002-3757-5487	Cancer Research UK [C18243/A5802]; University College London; University College London Hospital Comprehensive Biomedical Research Centre	Cancer Research UK(Cancer Research UK); University College London(General Electric); University College London Hospital Comprehensive Biomedical Research Centre	Supported by grants from Cancer Research UK (C18243/A5802) and University College London and the University College London Hospital Comprehensive Biomedical Research Centre.	Barbaro D, 2010, EUR J NUCL MED MOL I, V37, P1251, DOI 10.1007/s00259-010-1402-8; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P1352, DOI 10.1210/jc.2010-2708; British Thyroid Association, 2007, GUID MAN THYR CANC; Cancer Research UK, THYR CANC STAT UK; Cancer Therapy Evaluation Program, COMM TERM CRIT ADV E; Catargi B, 2010, 14 INT THYR C PAR SE; Cooper DS, 2010, THYROID, V20, P674, DOI 10.1089/thy.2009.0110.cxn; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Globocan 2008, 2008, MOST FREQ CANC MEN; Hackshaw A, 2007, J CLIN ENDOCR METAB, V92, P28, DOI 10.1210/jc.2006-1345; Haymart MR, 2011, JAMA-J AM MED ASSOC, V306, P721, DOI 10.1001/jama.2011.1139; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jury HPT, 2010, J CLIN ENDOCR METAB, V95, P230, DOI 10.1210/jc.2009-1624; Kloos RT, 2011, THYROID, V21, P97, DOI 10.1089/thy.2010.2102.com; Kukulska A, 2010, THYROID RES, V3, DOI 10.1186/1756-6614-3-9; Lee J, 2010, THYROID, V20, P173, DOI 10.1089/thy.2009.0187; Lim Dong-Jun, 2010, Korean Journal of Internal Medicine, V25, P408, DOI 10.3904/kjim.2010.25.4.408; Maenpaa HO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001885; Mallick U, 2012, CLIN ONCOL-UK, V24, P159, DOI 10.1016/j.clon.2012.01.001; Mazzaferri EL, 2001, J CLIN ENDOCR METAB, V86, P1447, DOI 10.1210/jc.86.4.1447; Mazzaferri EL, 2003, J CLIN ENDOCR METAB, V88, P1433, DOI 10.1210/jc.2002-021702; Molinaro E, 2009, Q J NUCL MED MOL IM, V53, P490; National Cancer Institute, THYR CANC; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2005, EUR J ENDOCRINOL, V153, P651, DOI 10.1530/eje.1.02014; Pacini F, 2001, J CLIN ENDOCR METAB, V86, P4092, DOI 10.1210/jc.86.9.4092; Pacini F, 2006, EUR J ENDOCRINOL, V155, P385, DOI 10.1530/eje.1.02158e; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Powell C, 2011, EUR THYR ASS 35 ANN; QualityMetric, SF 36V2 HLTH SURV; Rosario PW, 2012, AM J CLIN ONCOL-CANC, V35, P101, DOI 10.1097/COC.0b013e318201a41a; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Salvatori M, 2010, EUR J NUCL MED MOL I, V37, P1039, DOI 10.1007/s00259-010-1414-4; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Sawka AM, 2008, ENDOCRIN METAB CLIN, V37, P457, DOI 10.1016/j.ecl.2008.02.007; Spencer CA, 1998, J CLIN ENDOCR METAB, V83, P1121, DOI 10.1210/jc.83.4.1121; Tamilia M, 2011, NUCL MED COMMUN, V32, P212, DOI 10.1097/MNM.0b013e328341c802; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; Verburg FA, 2005, EUR J ENDOCRINOL, V152, P33, DOI 10.1530/eje.1.01819; Willegaignon J, 2011, CLIN NUCL MED, V36, P440, DOI 10.1097/RLU.0b013e3182184fa0	43	378	394	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1674	1685		10.1056/NEJMoa1109589	http://dx.doi.org/10.1056/NEJMoa1109589			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551128				2022-12-28	WOS:000303434300007
J	Schlumberger, M; Catargi, B; Borget, I; Deandreis, D; Zerdoud, S; Bridji, B; Bardet, S; Leenhardt, L; Bastie, D; Schvartz, C; Vera, P; Morel, O; Benisvy, D; Bournaud, C; Bonichon, F; Dejax, C; Toubert, ME; Leboulleux, S; Ricard, M; Benhamou, E				Schlumberger, Martin; Catargi, Bogdan; Borget, Isabelle; Deandreis, Desiree; Zerdoud, Slimane; Bridji, Boumediene; Bardet, Stephane; Leenhardt, Laurence; Bastie, Delphine; Schvartz, Claire; Vera, Pierre; Morel, Olivier; Benisvy, Danielle; Bournaud, Claire; Bonichon, Francoise; Dejax, Catherine; Toubert, Marie-Elisabeth; Leboulleux, Sophie; Ricard, Marcel; Benhamou, Ellen		Tumeurs Thyroide Refractaires	Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT HUMAN THYROTROPIN; SERUM THYROGLOBULIN LEVELS; QUALITY-OF-LIFE; REMNANT ABLATION; HORMONE WITHDRAWAL; STIMULATED THYROGLOBULIN; RADIOACTIVE IODINE; FOLLOW-UP; CARCINOMA PATIENTS; PREDICTIVE-VALUE	Background It is not clear whether the administration of radioiodine provides any benefit to patients with low-risk thyroid cancer after a complete surgical resection. The administration of the smallest possible amount of radioiodine would improve care. Methods In our randomized, phase 3 trial, we compared two thyrotropin-stimulation methods (thyroid hormone withdrawal and use of recombinant human thyrotropin) and two radioiodine (I-131) doses (i.e., administered activities) (1.1 GBq and 3.7 GBq) in a 2-by-2 design. Inclusion criteria were an age of 18 years or older; total thyroidectomy for differentiated thyroid carcinoma; tumor-node-metastasis (TNM) stage, ascertained on pathological examination (p) of a surgical specimen, of pT1 (with tumor diameter <= 1 cm) and N1 or Nx, pT1 (with tumor diameter >1 to 2 cm) and any N stage, or pT2N0; absence of distant metastasis; and no iodine contamination. Thyroid ablation was assessed 8 months after radioiodine administration by neck ultrasonography and measurement of recombinant human thyrotropin-stimulated thyroglobulin. Comparisons were based on an equivalence framework. Results There were 752 patients enrolled between 2007 and 2010; 92% had papillary cancer. There were no unexpected serious adverse events. In the 684 patients with data that could be evaluated, ultrasonography of the neck was normal in 652 (95%), and the stimulated thyroglobulin level was 1.0 ng per milliliter or less in 621 of the 652 patients (95%) without detectable thyroglobulin antibodies. Thyroid ablation was complete in 631 of the 684 patients (92%). The ablation rate was equivalent between the I-131 doses and between the thyrotropin-stimulation methods. Conclusions The use of recombinant human thyrotropin and low-dose (1.1 GBq) postoperative radioiodine ablation may be sufficient for the management of low-risk thyroid cancer. (Funded by the French National Cancer Institute [INCa] and the French Ministry of Health; ClinicalTrials.gov number, NCT00435851; INCa number, RECF0447.)	[Schlumberger, Martin; Deandreis, Desiree; Leboulleux, Sophie; Ricard, Marcel] Inst Gustave Roussy, Dept Nucl Med, Villejuif, France; [Schlumberger, Martin; Deandreis, Desiree; Leboulleux, Sophie; Ricard, Marcel] Inst Gustave Roussy, Dept Endocrine Oncol, Villejuif, France; [Schlumberger, Martin; Deandreis, Desiree; Leboulleux, Sophie; Ricard, Marcel] Univ Paris 11, Villejuif, France; [Borget, Isabelle; Benhamou, Ellen] Inst Gustave Roussy, Dept Biostat, Villejuif, France; [Borget, Isabelle; Benhamou, Ellen] Inst Gustave Roussy, Dept Epidemiol, Villejuif, France; [Catargi, Bogdan] CHU, Dept Endocrinol, Bordeaux, France; [Bonichon, Francoise] Inst Bergonie, Dept Nucl Med, Bordeaux, France; [Zerdoud, Slimane] Ctr Claudius Regaud, Dept Nucl Med, Toulouse, France; [Bridji, Boumediene] Ctr Rene Gauducheau, Dept Nucl Med, F-44035 Nantes, France; [Bardet, Stephane] Ctr Francois Baclesse, Dept Nucl Med, F-14021 Caen, France; [Leenhardt, Laurence] Hop La Pitie Salpetriere, Dept Endocrinol, Paris, France; [Toubert, Marie-Elisabeth] Hop St Louis, Dept Nucl Med, Paris, France; [Bastie, Delphine] CHU, Dept Nucl Med, Toulouse, France; [Schvartz, Claire] Inst Jean Godinot, Dept Nucl Med, Reims, France; [Vera, Pierre] Ctr Henri Becquerel, Dept Nucl Med, F-76038 Rouen, France; [Morel, Olivier] Inst Cancerol Ouest Paul Papin, Dept Nucl Med, Angers, France; [Benisvy, Danielle] Ctr Antoine Lacassagne, Dept Nucl Med, F-06054 Nice, France; [Bournaud, Claire] CHU, Dept Endocrinol, Lyon, France; [Dejax, Catherine] Ctr Jean Perrin, Dept Nucl Med, Clermont Ferrand, France	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CHU Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Claudius Regaud; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Centre Francois Baclesse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; UNICANCER; Institut Jean Godinot; UNICANCER; Centre Henri Becquerel; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Centre Antoine Lacassagne; CHU Lyon; UNICANCER; Centre Jean Perrin	Schlumberger, M (corresponding author), Inst Cancerol Gustave Roussy, Serv Med Nucl & Cancerol Endocrinienne, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	schlumbg@igr.fr	leboulleux, sophie/AAW-6534-2020; Deandreis, Desiree/AAA-3136-2022; ZERDOUD, Slimane/Q-5961-2018	DEANDREIS, Desiree'/0000-0002-3817-6648; ZERDOUD, Slimane/0000-0002-1851-8970; Borget, Isabelle/0000-0002-6295-6361; , Sophie/0000-0002-4824-8502	French National Cancer Institute (INCa); French Ministry of Health; Genzyme	French National Cancer Institute (INCa)(Institut National du Cancer (INCA) France); French Ministry of Health; Genzyme(Sanofi-AventisGenzyme Corporation)	Supported by the French National Cancer Institute (INCa) and the French Ministry of Health under the framework of the Soutien aux Therapeutiques Innovantes et Couteuses (STIC) program.; Drs. Leboulleux and Schlumberger report receiving lecture fees from Genzyme. No other potential conflict of interest relevant to this article was reported.	Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Barbaro D, 2003, J CLIN ENDOCR METAB, V88, P4110, DOI 10.1210/jc.2003-030298; Baudin E, 2003, J CLIN ENDOCR METAB, V88, P1107, DOI 10.1210/jc.2002-021365; BILLEWICZ WZ, 1969, Q J MED, V38, P255; Bonnet S, 2009, J CLIN ENDOCR METAB, V94, P1162, DOI 10.1210/jc.2008-1931; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P1352, DOI 10.1210/jc.2010-2708; Cailleux AF, 2000, J CLIN ENDOCR METAB, V85, P175, DOI 10.1210/jc.85.1.175; Castagna MG, 2008, J CLIN ENDOCR METAB, V93, P76, DOI 10.1210/jc.2007-1404; Chianelli M, 2009, EUR J ENDOCRINOL, V160, P431, DOI 10.1530/EJE-08-0669; Chiovato L, 2003, ANN INTERN MED, V139, P346, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00010; Cooper DS, 2010, THYROID, V20, P674, DOI 10.1089/thy.2009.0110.cxn; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Elisei R, 2009, J CLIN ENDOCR METAB, V94, P4171, DOI 10.1210/jc.2009-0869; Hackshaw A, 2007, J CLIN ENDOCR METAB, V92, P28, DOI 10.1210/jc.2006-1345; Hanscheid H, 2006, J NUCL MED, V47, P648; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Hedinger C, 1988, WHO INT HISTOLOGICAL, P1; HiLo Mallick U., 2011, 14 INT THYR C PAR SE; Jonklaas J, 2010, THYROID, V20, P1423, DOI 10.1089/thy.2010.0308; Kim TY, 2005, J CLIN ENDOCR METAB, V90, P1440, DOI 10.1210/jc.2004-1771; Kloos RT, 2002, J CLIN ENDOCR METAB, V87, P5817, DOI 10.1210/jc.2002-020210; Leboulleux S, 2007, J CLIN ENDOCR METAB, V92, P3590, DOI 10.1210/jc.2007-0444; Lee J, 2010, THYROID, V20, P173, DOI 10.1089/thy.2009.0187; Mandel SJ, 2003, THYROID, V13, P265, DOI 10.1089/105072503321582060; Mernagh P, 2010, VALUE HEALTH, V13, P180, DOI 10.1111/j.1524-4733.2009.00650.x; Nascimento C, 2011, ENDOCR-RELAT CANCER, V18, pR29, DOI 10.1677/ERC-10-0292; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P1499, DOI 10.1210/jc.87.4.1499; Pacini F, 2002, J CLIN ENDOCR METAB, V87, P4063, DOI 10.1210/jc.2001-011918; Pacini F, 2006, EUR J ENDOCRINOL, V155, P385, DOI 10.1530/eje.1.02158e; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Pilli T, 2007, J CLIN ENDOCR METAB, V92, P3542, DOI 10.1210/jc.2007-0225; Rosario PW, 2008, J NUCL MED, V49, P1776, DOI 10.2967/jnumed.108.050591; Rosario PW, 2012, AM J CLIN ONCOL-CANC, V35, P101, DOI 10.1097/COC.0b013e318201a41a; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Schlumberger M, 2007, J CLIN ENDOCR METAB, V92, P2487, DOI 10.1210/jc.2006-0723; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Schroeder PR, 2006, J CLIN ENDOCR METAB, V91, P878, DOI 10.1210/jc.2005-2064; Shah JP, 2002, AJCC CANC STAGING HD, P89; Spencer C, 2010, THYROID, V20, P587, DOI 10.1089/thy.2009.0338; Toubeau M, 2004, J NUCL MED, V45, P988; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	42	422	437	4	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1663	1673		10.1056/NEJMoa1108586	http://dx.doi.org/10.1056/NEJMoa1108586			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551127				2022-12-28	WOS:000303434300006
J	Solomon, DA; Fanta, CH; Levy, BD; Loscalzo, J				Solomon, Daniel A.; Fanta, Christopher H.; Levy, Bruce D.; Loscalzo, Joseph			Whistling in the Dark	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELAPSING POLYCHONDRITIS; MULTIDETECTOR CT; TRACHEOBRONCHOMALACIA; TRACHEOMALACIA		[Levy, Bruce D.] Brigham & Womens Hosp, Harvard Inst Med Bldg, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg, Dept Med, HIM855,77 Ave Louis Pasteur, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Adliff M, 1997, CHEST, V112, P1701, DOI 10.1378/chest.112.6.1701; Boiselle PM, 2009, RADIOLOGY, V252, P255, DOI 10.1148/radiol.2521081958; Carden KA, 2005, CHEST, V127, P984, DOI 10.1378/chest.127.3.984; Ernst A, 2007, CHEST, V132, P609, DOI 10.1378/chest.06-2708; Ernst A, 2009, CHEST, V135, P1024, DOI 10.1378/chest.08-1180; Gangadharan SP, 2011, ANN THORAC SURG, V91, P1574, DOI 10.1016/j.athoracsur.2011.01.009; Gilkeson RC, 2001, AM J ROENTGENOL, V176, P205, DOI 10.2214/ajr.176.1.1760205; JOKINEN K, 1977, ANN CLIN RES, V9, P52; Kandaswamy C, 2009, CURR OPIN PULM MED, V15, P113, DOI 10.1097/MCP.0b013e328321832d; Menon B, 2008, SOUTH MED J, V101, P83, DOI 10.1097/SMJ.0b013e31815d4259; Murgu SD, 2006, RESPIROLOGY, V11, P388, DOI 10.1111/j.1440-1843.2006.00862.x; Ranu H, 2009, POSTGRAD MED J, V85, P682, DOI 10.1136/pgmj.2009.089011	12	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1725	1730		10.1056/NEJMcps1106363	http://dx.doi.org/10.1056/NEJMcps1106363			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551132				2022-12-28	WOS:000303434300014
J	McColl, K				McColl, Karen			Stan Brock: providing free care to America's uninsured	BRITISH MEDICAL JOURNAL			English	Editorial Material												karenmccoll@gmail.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 30	2012	344								e2834	10.1136/bmj.e2834	http://dx.doi.org/10.1136/bmj.e2834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MY	22547645				2022-12-28	WOS:000303816600007
J	Chen, HT; Xu, Z; Mei, C; Yu, DY; Small, S				Chen, Hongtao; Xu, Zhe; Mei, Constance; Yu, Danyang; Small, Stephen			A System of Repressor Gradients Spatially Organizes the Boundaries of Bicoid-Dependent Target Genes	CELL			English	Article							EARLY DROSOPHILA EMBRYO; DPP MORPHOGEN GRADIENT; 2 DISTINCT MECHANISMS; POSITIONAL INFORMATION; NEURAL-TUBE; EXPRESSION; SEGMENTATION; PROTEIN; PATTERN; DETERMINES	The homeodomain (HD) protein Bicoid (Bcd) is thought to function as a gradient morphogen that positions boundaries of target genes via threshold-dependent activation mechanisms. Here, we analyze 66 Bcd-dependent regulatory elements and show that their boundaries are positioned primarily by repressive gradients that antagonize Bcd-mediated activation. A major repressor is the pair-rule protein Runt (Run), which is expressed in an opposing gradient and is necessary and sufficient for limiting Bcd-dependent activation. Evidence is presented that Run functions with the maternal repressor Capicua and the gap protein Kruppel as the principal components of a repression system that correctly orders boundaries throughout the anterior half of the embryo. These results put conceptual limits on the Bcd morphogen hypothesis and demonstrate how the Bcd gradient functions within the gene network that patterns the embryo.	[Chen, Hongtao; Xu, Zhe; Mei, Constance; Yu, Danyang; Small, Stephen] NYU, Dept Biol, New York, NY 10003 USA	New York University	Small, S (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	sjs1@nyu.edu			NIH [RO1 GM51946]; National Center for Research Resources, National Institutes of Health [C06 RR-15518-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerry Huang for assistance with computer searches for clusters of Bcd-binding motifs, Hsiao-lan Liang for run expression data, and Peter Gergen, Stas Shvartsman, Jack Bateman, and Gary Struhl for fly stocks. We thank Claude Desplan, Justin Blau, Jens Rister, and Rhea Datta for suggestions that improved the manuscript; Thomas Gregor, Eric Wieschaus, Jim Jaynes, and Christine Rushlow for insightful discussions; and Kristin Gunsalus for help with the graphical abstract. This work was supported by NIH Grant RO1 GM51946 to S. S., and was conducted in a facility constructed with support from Research Facilities Improvement Grant C06 RR-15518-01 from the National Center for Research Resources, National Institutes of Health.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Andrioli LP, 2004, DEV BIOL, V276, P541, DOI 10.1016/j.ydbio.2004.09.025; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224; Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7; Gao Q, 1998, DEVELOPMENT, V125, P4185; GERGEN JP, 1988, GENE DEV, V2, P1179, DOI 10.1101/gad.2.9.1179; GERGEN JP, 1985, DEV BIOL, V109, P321, DOI 10.1016/0012-1606(85)90459-2; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jimenez G, 2000, GENE DEV, V14, P224; Kim Y, 2011, DEV CELL, V20, P880, DOI 10.1016/j.devcel.2011.05.009; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lohr U, 2009, P NATL ACAD SCI USA, V106, P21695, DOI 10.1073/pnas.0910225106; MELNIKOVA IN, 1993, J VIROL, V67, P2408, DOI 10.1128/JVI.67.4.2408-2411.1993; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Namba R, 1997, DEVELOPMENT, V124, P1393; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Robin S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-84; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sinha S, 2006, NUCLEIC ACIDS RES, V34, pW555, DOI 10.1093/nar/gkl224; Small S, 2000, METHOD ENZYMOL, V326, P146; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; Wu XL, 1998, DEVELOPMENT, V125, P3765; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050	62	104	105	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					618	629		10.1016/j.cell.2012.03.018	http://dx.doi.org/10.1016/j.cell.2012.03.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541432	Bronze, Green Accepted			2022-12-28	WOS:000303443100013
J	Kose, S; Furuta, M; Imamoto, N				Kose, Shingo; Furuta, Maiko; Imamoto, Naoko			Hikeshi, a Nuclear Import Carrier for Hsp70s, Protects Cells from Heat Shock-Induced Nuclear Damage	CELL			English	Article							PORE-TARGETING COMPLEX; MOLECULAR CHAPERONES; MAMMALIAN-CELLS; TRANSPORT; STRESS; INHIBITION; MECHANISM; CYTOPLASM; GRADIENT; RECOVERY	During heat shock stress, importin beta family-mediated nucleocytoplasmic trafficking is downregulated, whereas nuclear import of the molecular chaperone Hsp70s is upregulated. Here, we identify a nuclear import pathway that operates during heat shock stress and is mediated by an evolutionarily conserved protein named "Hikeshi," which does not belong to the importin beta family. Hikeshi binds to FG-Nups and translocates through nuclear pores on its own, showing characteristic features of nuclear transport carriers. In reconstituted transport, Hikeshi supports the nuclear import of the ATP form of Hsp70s, but not the ADP form, indicating the importance of the Hsp70 ATPase cycle in the import cycle. In living cells, depletion of Hikeshi inhibits heat shock-induced nuclear import of Hsp70s, reduces cell viability after heat shock stress, and significantly delays the attenuation and reversion of multiple heat shock-induced nuclear phenotypes. Nuclear Hsp70s rescue the effect of Hikeshi depletion at least in part. Thus, Hsp70s counteract heat shock-induced damage by acting inside of the nucleus.	[Kose, Shingo; Furuta, Maiko; Imamoto, Naoko] RIKEN, Adv Sci Inst, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	RIKEN	Kose, S (corresponding author), RIKEN, Adv Sci Inst, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	skose@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022	Japanese Ministry of Education, Culture, Sports, Science, and Technology; RIKEN; Japan Society for the Promotion of Science (JSPS)	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Ai Watanabe and Tomoko Funakoshi for their efficient technical assistance with this work and the members of the Cellular Dynamics Laboratory for discussions throughout the experiments. This work was supported by a Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid (to N.I. and S. K.), RIKEN Special Funding for Basic Science (Cellular System), and funding was awarded to N.I. by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP).	Cotto JJ, 1997, J CELL SCI, V110, P2925; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Fernandez-Valdivia R, 2006, GENETICS, V172, P389, DOI 10.1534/genetics.105.048736; Furuta M, 2004, GENES CELLS, V9, P429, DOI 10.1111/j.1356-9597.2004.00734.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hancock LC, 2006, GENETICS, V173, P621, DOI 10.1534/genetics.106.057489; HATTORI H, 1993, J CELL SCI, V104, P629; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Lamian V, 1996, EXP CELL RES, V228, P84, DOI 10.1006/excr.1996.0302; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nakielny S, 1998, CURR BIOL, V8, P89, DOI 10.1016/S0960-9822(98)70039-9; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893	34	98	102	3	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					578	589		10.1016/j.cell.2012.02.058	http://dx.doi.org/10.1016/j.cell.2012.02.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541429	Bronze			2022-12-28	WOS:000303443100010
J	Recouvreux, P; Dogterom, M				Recouvreux, Pierre; Dogterom, Marileen			Dissecting Spindle Architecture with a Laser	CELL			English	Editorial Material							ORGANIZATION; XENOPUS	Microtubules in spindles are too dense to resolve by light microscopy, even with super-resolution methods. Using a new method based on laser-ablation techniques, Brugues et al. present the first quantitative characterization of the vertebrate meiotic spindle and propose an assembly mechanism for building this architecture.	[Recouvreux, Pierre; Dogterom, Marileen] FOM Inst AMOLF, NL-1098 XG Amsterdam, Netherlands	AMOLF	Dogterom, M (corresponding author), FOM Inst AMOLF, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	dogterom@amolf.nl		Recouvreux, Pierre/0000-0002-0747-5821				Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376	8	0	0	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					507	509		10.1016/j.cell.2012.04.006	http://dx.doi.org/10.1016/j.cell.2012.04.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541422	Bronze, Green Submitted			2022-12-28	WOS:000303443100001
J	Shetty, P				Shetty, Priya			The numbers game	NATURE			English	Editorial Material																			0	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S14	S14		10.1038/484S14a	http://dx.doi.org/10.1038/484S14a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22534525	Bronze			2022-12-28	WOS:000303200400064
J	Barnett, K; Mercer, SW; Norbury, M; Watt, G; Wyke, S; Guthrie, B				Barnett, Karen; Mercer, Stewart W.; Norbury, Michael; Watt, Graham; Wyke, Sally; Guthrie, Bruce			Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study	LANCET			English	Article							QUALITY-OF-CARE; CHRONIC DISEASES; GENERAL-PRACTICE; DETERMINANTS; COMORBIDITY; DEPRESSION; PREVALENCE; GUIDELINES; LAW	Background Long-term disorders are the main challenge facing health-care systems worldwide, but health systems are largely configured for individual diseases rather than multimorbidity. We examined the distribution of multimorbidity, and of comorbidity of physical and mental health disorders, in relation to age and socioeconomic deprivation. Methods In a cross-sectional study we extracted data on 40 morbidities from a database of 1 751 841 people registered with 314 medical practices in Scotland as of March, 2007. We analysed the data according to the number of morbidities, disorder type (physical or mental), sex, age, and socioeconomic status. We defined multimorbidity as the presence of two or more disorders. Findings 42.2% (95% CI 42.1-42.3) of all patients had one or more morbidities, and 23.2% (23.08-23.21) were multimorbid. Although the prevalence of multimorbidity increased substantially with age and was present in most people aged 65 years and older, the absolute number of people with multimorbidity was higher in those younger than 65 years (210 500 vs 194 996). Onset of multimorbidity occurred 10-15 years earlier in people living in the most deprived areas compared with the most affluent, with socioeconomic deprivation particularly associated with multimorbidity that included mental health disorders (prevalence of both physical and mental health disorder 11.0%, 95% CI 10.9-11.2% in most deprived area vs 5.9%, 5.8%-6.0% in least deprived). The presence of a mental health disorder increased as the number of physical morbidities increased (adjusted odds ratio 6.74, 95% CI 6.59-6.90 for five or more disorders vs 1.95, 1.93-1.98 for one disorder), and was much greater in more deprived than in less deprived people (2.28, 2.21-2.32 vs 1.08, 1.05-1.11). Interpretation Our findings challenge the single-disease framework by which most health care, medical research, and medical education is configured. A complementary strategy is needed, supporting generalist clinicians to provide personalised, comprehensive continuity of care, especially in socioeconomically deprived areas.	[Barnett, Karen; Norbury, Michael; Guthrie, Bruce] Univ Dundee, Populat Hlth Sci Div, Qual Safety & Informat Res Grp, Dundee DD2 4BF, Scotland; [Wyke, Sally] Univ Glasgow, Inst Hlth & Wellbeing, Coll Social Sci, Glasgow, Lanark, Scotland	University of Dundee; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Populat Hlth Sci Div, Qual Safety & Informat Res Grp, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022	Guthrie, Bruce/0000-0003-4191-4880; Mercer, Stewart William/0000-0002-1703-3664	Scottish Government Chief Scientist Office; Chief Scientist Office of the Scottish Government Health Directorates [ARPG/07/1)]; Chief Scientist Office [ARPG/07/01] Funding Source: researchfish	Scottish Government Chief Scientist Office; Chief Scientist Office of the Scottish Government Health Directorates; Chief Scientist Office	Scottish Government Chief Scientist Office.; We thank the Chief Scientist Office of the Scottish Government Health Directorates (Applied Research Programme Grant ARPG/07/1), which funded the work; the Scottish School of Primary Care, which part supported SWM's post and the development of the Applied Research Programme; and the Primary Care Clinical Informatics Unit at the University of Aberdeen, which provided the data contained herein. The views in this publication are not necessarily the views of the University of Aberdeen, its agents, or employees. We thank Katie Wilde and Fiona Chaloner of the University of Aberdeen, who did the initial data extraction and management.	Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Carstairs V., 1991, DEPRIVATION HLTH SCO; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Elder R, 2007, MEASURING QUALITY PR; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Information Services Division NHS Scotland, 2008, MEAS LONG TERM COND; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NHS- Primary Care Commissioning, QOF IMPL BUS RUL V 1; Organization WH, 2016, GLOBAL STATUS REPORT; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schoen C, 2010, 2010 COMMONWEALTH FU; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; The Scottish Government, 2010, LONG TERM MON HLTH I; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; WHO, 2008, PHARMAFORUM 0121; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	30	3388	3467	40	458	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					37	43		10.1016/S0140-6736(12)60240-2	http://dx.doi.org/10.1016/S0140-6736(12)60240-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22579043				2022-12-28	WOS:000306115900031
J	Downing, NS; Aminawung, JA; Shah, ND; Braunstein, JB; Krumholz, HM; Ross, JS				Downing, Nicholas S.; Aminawung, Jenerius A.; Shah, Nilay D.; Braunstein, Joel B.; Krumholz, Harlan M.; Ross, Joseph S.			Regulatory Review of Novel Therapeutics - Comparison of Three Regulatory Agencies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; DRUGS; DEADLINES	BACKGROUND The upcoming reauthorization of the Prescription Drug User Fee Act focuses on improving the review process for new drug applications at the Food and Drug Administration (FDA). METHODS Using publicly available information from the FDA, the European Medicines Agency (EMA), and Health Canada, we compared the time for completion of the first review and the total review time for all applications involving novel therapeutic agents approved by the three regulatory agencies from 2001 through 2010 and determined the geographic area in which each novel therapeutic agent was first approved for use. RESULTS There were 510 applications for novel therapeutic agents approved from 2001 through 2010 - 225 by the FDA, 186 by the EMA, and 99 by Health Canada; among the applications, there were 289 unique agents. The median length of time for completion of the first review was 303 days (interquartile range, 185 to 372) for applications approved by the FDA, 366 days (interquartile range, 310 to 445) for those approved by the EMA, and 352 days (interquartile range, 255 to 420) for those approved by Health Canada (P<0.001 for the comparison across the three agencies). The median total review time was also shorter at the FDA than at the EMA or Health Canada (P=0.002). Among the 289 unique novel therapeutic agents, 190 were approved in both the United States and Europe (either by the EMA or through the mutual recognition process), of which 121 (63.7%) were first approved in the United States; similarly, 154 were approved in both the United States and Canada, of which 132 (85.7%) were first approved in the United States. CONCLUSIONS For novel therapeutic agents approved between 2001 and 2010, the FDA reviewed applications involving novel therapeutics more quickly, on average, than did the EMA or Health Canada, and the vast majority of these new therapeutic agents were first approved for use in the United States. (Funded by the Pew Charitable Trusts.)	[Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA; [Braunstein, Joel B.] LifeTech Res, Baltimore, MD USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Mayo Clinic	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	Pew Charitable Trusts; Cardiovascular Outcomes Center from the National Heart, Lung, and Blood Institute [1U01HL105270-02]; National Institute on Aging [K08 AG032886]; American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Pew Charitable Trusts; Cardiovascular Outcomes Center from the National Heart, Lung, and Blood Institute; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Pew Charitable Trusts. Dr. Krumholz is supported by a Cardiovascular Outcomes Center Award (1U01HL105270-02) from the National Heart, Lung, and Blood Institute. Dr. Ross is supported by a grant (K08 AG032886) from the National Institute on Aging and by the American Federation for Aging Research through the Paul B. Beeson Career Development Award Program.	[Anonymous], SUMM BAS DEC SBD DOC; ATC/DDD Index, 2012, ATC DDD IND 2012; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150; Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; European Medicines Agency, APPL EU MARK AUTH ME; European Medicines Agency, EUR PUBL ASS REP; Faden LB, 2008, DRUG INF J, V42, P45, DOI 10.1177/009286150804200108; Food and Drug Administration, DRUGS FDA FDA APPR D; Food and Drug Administration, PDUFA REAUTH PERF GO; Food and Drug Administration, FY 2010 PDUFA PERF R; Fox JL, 2011, NAT BIOTECHNOL, V29, P1062, DOI 10.1038/nbt1211-1062; GAO (Government Accountability Office), 2002, GAO02958; Generic Pharmaceutical Association, 2011, GPHA SAYS CUTS FDA G; Heads of Medicines Agencies, HUM MUT REC PROD IND; Health Canada, DRUG PROD DAT DPD; Hirako M, 2007, DRUG INF J, V41, P291, DOI 10.1177/009286150704100302; Institute of Medicine, 2006, FUT DRUG SAF PROM PR; Rawson NSB, 2000, CAN MED ASSOC J, V162, P501; Roberts SA, 2011, HEALTH AFFAIR, V30, P1375, DOI 10.1377/hlthaff.2011.0231; Suter LG, 2011, NEW ENGL J MED, V365, P1464, DOI 10.1056/NEJMp1109285	22	120	123	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2284	2293		10.1056/NEJMsa1200223	http://dx.doi.org/10.1056/NEJMsa1200223			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22591257	Bronze, Green Accepted			2022-12-28	WOS:000305174100009
J	Orenstein, WA; Hinman, AR				Orenstein, Walter A.; Hinman, Alan R.			Measles: the burden of preventable deaths	LANCET			English	Editorial Material							ELIMINATION		[Orenstein, Walter A.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Orenstein, Walter A.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Hinman, Alan R.] Task Force Global Hlth, Ctr Vaccine Equ, Decatur, GA USA	Emory University; Emory University	Orenstein, WA (corresponding author), Emory Univ, Sch Med, Atlanta, GA 30322 USA.	worenst@emory.edu						Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321; [Anonymous], 2008, VACCINES-BASEL, DOI DOI 10.1016/B978-1-4160-3611-1.50022-2; Bellini WJ, 2011, VIRUS RES, V162, P72, DOI 10.1016/j.virusres.2011.09.023; Fine PEM, 2008, VACCINES, P1573; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Orenstein WA, 2006, PEDIATR INFECT DIS J, V25, P1093, DOI 10.1097/01.inf.0000246840.13477.28; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Strebel PM, 2011, J INFECT DIS, V204, pS1, DOI 10.1093/infdis/jir111; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224	11	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2130	2131		10.1016/S0140-6736(12)60638-2	http://dx.doi.org/10.1016/S0140-6736(12)60638-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22534000				2022-12-28	WOS:000304990900010
J	Thompson, AA; Liu, W; Chun, E; Katritch, V; Wu, HX; Vardy, E; Huang, XP; Trapella, C; Guerrini, R; Calo, G; Roth, BL; Cherezov, V; Stevens, RC				Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic	NATURE			English	Article							ORL1 RECEPTOR; ORPHANIN-FQ; CRYSTALLIZING MEMBRANE; PROTEIN; BINDING; ANTAGONIST; AGONIST; SITE; IDENTIFICATION; MUTAGENESIS	Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia. Unlike the 'classical' opioid receptors, delta, kappa and mu (delta-OR, kappa-OR and mu-OR), which were delineated by pharmacological criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by molecular cloning and characterization of an orphan GPCR(1). Although it shares high sequence similarity with classical opioid GPCR subtypes (similar to 60%), NOP has a markedly distinct pharmacology, featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands(2,3). Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compound-24 (C-24) (ref. 4), revealing atomic details of ligand-receptor recognition and selectivity. Compound-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close derivative of N/OFQ, and provides important clues to the binding of these peptides. The X-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors k (ref. 5) and m (ref. 6), and these are probably due to a small number of residues that vary between these receptors. The NOP-compound-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.	[Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, Dept Pharmaceut Sci, I-44121 Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, LTTA, I-44121 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44121 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Natl Inst Neurosci, I-44121 Ferrara, Italy	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Roth, Bryan L/F-3928-2010; Wu, Huixian/N-6353-2014; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Roth, Bryan/ABE-7032-2020; Trapella, Claudio/I-2128-2012	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Wu, Huixian/0000-0003-1357-9747; Katritch, Vsevolod/0000-0003-3883-4505; Roth, Bryan/0000-0002-0561-6520; Trapella, Claudio/0000-0002-6666-143X; Huang, Xi-Ping/0000-0002-2585-653X; Thompson, Aaron/0000-0003-4314-4242; Guerrini, Remo/0000-0002-7619-0918	PSI:Biology [U54 GM094618]; NIH [P50 GM073197, R01 DA017204, R01 DA27170]; NIMH; Michael Hooker Chair of Pharmacology; University of Ferrara (FAR); Italian Ministry of University (FIRB); National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170, R01DA017204] Funding Source: NIH RePORTER	PSI:Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; University of Ferrara (FAR); Italian Ministry of University (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by PSI:Biology grant U54 GM094618 for biological studies and structure production, NIH Roadmap grant P50 GM073197 for technology development and R01 DA017204, R01 DA27170, and the NIMH Psychoactive Drug Screening Program(X.-P. H., E. V. and B. L. R.) and the Michael Hooker Chair of Pharmacology (B. L. R.), University of Ferrara (FAR grant to G. C.), Italian Ministry of University (FIRB Futuro in Ricerca 2010 grant to C. T.). We thank J. Francis for suggesting the idea to pursue the NOP receptor; J. Velasquez for help on molecular biology; T. Trinh, K. Allin and M. Chu for help on baculovirus expression; A. Walker and E. Abola for assistance with manuscript preparation; J. Smith, R. Fischetti and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akuzawa N, 2007, J BIOCHEM, V141, P907, DOI 10.1093/jb/mvm100; [Anonymous], 2011, PYMOL MOL GRAPHICS S; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bes B, 2003, BIOCHEM BIOPH RES CO, V310, P992, DOI 10.1016/j.bbrc.2003.09.113; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischetti C, 2009, EUR J PHARMACOL, V614, P50, DOI 10.1016/j.ejphar.2009.04.054; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Goto Y, 2006, J MED CHEM, V49, P847, DOI 10.1021/jm0509851; Guerrini R, 2000, J MED CHEM, V43, P2805, DOI 10.1021/jm990075h; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lapalu S, 1997, FEBS LETT, V417, P333, DOI 10.1016/S0014-5793(97)01318-5; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng F, 1996, J BIOL CHEM, V271, P32016, DOI 10.1074/jbc.271.50.32016; Meng F, 1998, MOL PHARMACOL, V53, P772, DOI 10.1124/mol.53.4.772; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Mouledous L, 2000, MOL PHARMACOL, V57, P495, DOI 10.1124/mol.57.3.495; Orsini MJ, 2005, J BIOL CHEM, V280, P8134, DOI 10.1074/jbc.M406405200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Tancredi T, 2005, CHEM-EUR J, V11, P2061, DOI 10.1002/chem.200401095; Topham CM, 1998, PROTEIN ENG, V11, P1163, DOI 10.1093/protein/11.12.1163; Totrov M, 1997, PROTEINS, P215; Trapella C, 2009, BIOORGAN MED CHEM, V17, P5080, DOI 10.1016/j.bmc.2009.05.068; Varty GB, 2008, J PHARMACOL EXP THER, V326, P672, DOI 10.1124/jpet.108.136937; Volta M, 2011, EXP NEUROL, V228, P126, DOI 10.1016/j.expneurol.2010.12.024; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	41	377	390	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					395	U150		10.1038/nature11085	http://dx.doi.org/10.1038/nature11085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596163	Green Accepted, Green Submitted			2022-12-28	WOS:000304099100048
J	Salisbury, DM				Salisbury, David M.			Should childhood vaccination be mandatory? No	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHILOSOPHICAL EXEMPTIONS		Dept Hlth, London SE1 8UG, England		Salisbury, DM (corresponding author), Dept Hlth, London SE1 8UG, England.	david.salisbury@dh.gsi.gov.uk						Department of Health, IMM INF DIS PERT; Department of Health, 2010, CHILDH IMM TRACK PAR; Department of Health, OP FRAM VIT SIGNS; Department of Health and Ageing, IMM AUSTR PROGR HIST; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Health Protection Agency, Q COVER REP; Health States Initiative, 2007, EX SCH IMM REQ; *HLTH PROT AG, CONF CAS MEASL REG A; National Center for Education Statistics, 2008, 1 5 MILL HOM STUD US; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Salmon DA, 2001, PUBLIC HEALTH REP, V116, P289, DOI 10.1016/S0033-3549(04)50050-X; Vitek CR, EMERG INFECT DIS, V4, P539; World Health Organization, VACC PREV DIS MON SY	13	9	9	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e2435	10.1136/bmj.e2435	http://dx.doi.org/10.1136/bmj.e2435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589520				2022-12-28	WOS:000304086900002
J	von Hippel, F; Ewing, R; Garwin, R; Macfarlane, A				von Hippel, Frank; Ewing, Rodney; Garwin, Richard; Macfarlane, Allison			Time to bury plutonium	NATURE			English	Editorial Material									[von Hippel, Frank] Princeton Univ, Princeton, NJ 08544 USA; [Ewing, Rodney] Univ Michigan, Ann Arbor, MI 48109 USA; [Garwin, Richard] IBM Corp, Thomas J Watson Res Ctr, New York, NY USA; [Macfarlane, Allison] George Mason Univ, Fairfax, VA 22030 USA	Princeton University; University of Michigan System; University of Michigan; International Business Machines (IBM); George Mason University	von Hippel, F (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	fvhippel@princeton.edu		Ewing, Rodney/0000-0001-9472-4031				Charpin J.M., 2000, EC FORECAST STUDY NU; Committee on International Security and Arms Control, 1994, MAN DISP EXC WEAP PL; Ewing RC, 2011, CHEM ACTINIDE TRANSA, P3813; Gibb FGF, 2008, J NUCL MATER, V374, P364, DOI 10.1016/j.jnucmat.2007.08.018; Halsey WG, 1995, DISPOSITION PLUTONIU; International Panel on Fissile Materials, 2011, GLOB FISS MAT REP 20; US Department of Energy, 2012, FY 2013 C BUDG REQ, V1, P460; Wigeland R. A., 2005, P GLOBAL 05 TSUK JAP; Yudintsev S. V., 2007, STRUCTURAL CHEM INOR, P457	9	20	20	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					167	168		10.1038/485167a	http://dx.doi.org/10.1038/485167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575941	Bronze			2022-12-28	WOS:000303799800015
J	Hempel, S; Newberry, SJ; Maher, AR; Wang, Z; Miles, JNV; Shanman, R; Johnsen, B; Shekelle, PG				Hempel, Susanne; Newberry, Sydne J.; Maher, Alicia R.; Wang, Zhen; Miles, Jeremy N. V.; Shanman, Roberta; Johnsen, Breanne; Shekelle, Paul G.			Probiotics for the Prevention and Treatment of Antibiotic-Associated Diarrhea A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HELICOBACTER-PYLORI ERADICATION; LACTOBACILLUS-ACIDOPHILUS CL1285; SACCHAROMYCES-BOULARDII; DOUBLE-BLIND; TRIPLE THERAPY; CONTROLLED-TRIAL; BIFIDOBACTERIUM-LACTIS; CONTAINING YOGURT; FECAL MICROBIOTA; CLINICAL-TRIAL	Context Probiotics are live microorganisms intended to confer a health benefit when consumed. One condition for which probiotics have been advocated is the diarrhea that is a common adverse effect of antibiotic use. Objective To evaluate the evidence for probiotic use in the prevention and treatment of antibiotic-associated diarrhea (AAD). Data Sources Twelve electronic databases were searched (DARE, Cochrane Library of Systematic Reviews, CENTRAL, PubMed, EMBASE, CINAHL, AMED, MANTIS, TOXLINE, ToxFILE, NTIS, and AGRICOLA) and references of included studies and reviews were screened from database inception to February 2012, without language restriction. Study Selection Two independent reviewers identified parallel randomized controlled trials (RCTs) of probiotics (Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, and/or Bacillus) for the prevention or treatment of AAD. Data Extraction Two independent reviewers extracted the data and assessed trial quality. Results A total of 82 RCTs met inclusion criteria. The majority used Lactobacillus-based interventions alone or in combination with other genera; strains were poorly documented. The pooled relative risk in a DerSimonian-Laird random-effects meta-analysis of 63 RCTs, which included 11 811 participants, indicated a statistically significant association of probiotic administration with reduction in AAD (relative risk, 0.58; 95% CI, 0.50 to 0.68; P<.001; I-2, 54%; [risk difference, -0.07; 95% CI, -0.10 to -0.05], [number needed to treat, 13; 95% CI, 10.3 to 19.1]) in trials reporting on the number of patients with AAD. This result was relatively insensitive to numerous subgroup analyses. However, there exists significant heterogeneity in pooled results and the evidence is insufficient to determine whether this association varies systematically by population, antibiotic characteristic, or probiotic preparation. Conclusions The pooled evidence suggests that probiotics are associated with a reduction in AAD. More research is needed to determine which probiotics are associated with the greatest efficacy and for which patients receiving which specific antibiotics. JAMA. 2012;307(18):1959-1969 www.jama.com	[Hempel, Susanne; Newberry, Sydne J.; Shanman, Roberta; Johnsen, Breanne; Shekelle, Paul G.] RAND Hlth, So Calif Evidence Based Practice Ctr, Santa Monica, CA 90401 USA; [Maher, Alicia R.; Wang, Zhen; Miles, Jeremy N. V.] RAND Corp, Santa Monica, CA USA; [Shekelle, Paul G.] W Los Angeles VA Med Ctr, Los Angeles, CA USA; [Maher, Alicia R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	RAND Corporation; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; Cedars Sinai Medical Center	Hempel, S (corresponding author), RAND Hlth, So Calif Evidence Based Practice Ctr, 1776 Main St, Santa Monica, CA 90401 USA.	susanne_hempel@rand.org	Zhen, Wang/S-7244-2019; Wang, Zhen/D-5991-2013	Wang, Zhen/0000-0002-9368-6149; Hempel, Susanne/0000-0003-1597-5110	HHSA [290-2007-10062-I]; National Institutes of Health (NIH) Office of Dietary Supplements; NIH National Center for Complementary and Alternative Medicine; US Food and Drug Administration (USFDA) Center for Food Safety and Applied Nutrition; Department of Veterans Affairs; RAND Corporation	HHSA; National Institutes of Health (NIH) Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); US Food and Drug Administration (USFDA) Center for Food Safety and Applied Nutrition; Department of Veterans Affairs(US Department of Veterans Affairs); RAND Corporation	The RAND Corporation internally funded this review, building on the literature database established for contract HHSA 290-2007-10062-I, an evidence report on the safety of probiotics commissioned by the Agency for Healthcare Research and Quality and funded jointly by the National Institutes of Health (NIH) Office of Dietary Supplements, the NIH National Center for Complementary and Alternative Medicine, and the US Food and Drug Administration (USFDA) Center for Food Safety and Applied Nutrition. Dr Shekelle reports support from the Department of Veterans Affairs.	Adam J, 1977, GAZ MED FR, V84, P2072; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Barbut F, 2002, BMJ-BRIT MED J, V324, P1345, DOI 10.1136/bmj.324.7350.1345; Beausoleil M, 2007, CAN J GASTROENTEROL, V21, P732, DOI 10.1155/2007/720205; Beckly John, 2002, BMJ, V325, P901; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benhamou PH, 1999, MED CHIR DIG, V28, P163; Bhalla A, 2011, J CLIN PHARMACOL, V51, P1327; BORGIA M, 1982, CURR THER RES CLIN E, V31, P265; Bravo MV, 2008, REV MED CHILE, V136, P981, DOI /S0034-98872008000800004; Can M, 2006, MED SCI MONITOR, V12, pPI19; Cimperman L, 2011, J CLIN GASTROENTEROL, V45, P785, DOI 10.1097/MCG.0b013e3182166a42; Cindoruk M, 2007, HELICOBACTER, V12, P309, DOI 10.1111/j.1523-5378.2007.00516.x; Conway S, 2007, BRIT J GEN PRACT, V57, P953, DOI 10.3399/096016407782604811; Correa NBO, 2005, J CLIN GASTROENTEROL, V39, P385, DOI 10.1097/01.mcg.0000159217.47419.5b; Cremonini F, 2002, AM J GASTROENTEROL, V97, P2744, DOI 10.1111/j.1572-0241.2002.07063.x; Cremonini F, 2002, DIGEST LIVER DIS, V34, pS78, DOI 10.1016/S1590-8658(02)80171-2; D'Souza AL, 2002, BRIT MED J, V324, P1361, DOI 10.1136/bmj.324.7350.1361; de Bortoli N, 2007, AM J GASTROENTEROL, V102, P951, DOI 10.1111/j.1572-0241.2007.01085.x; de Vrese M, 2011, J DAIRY RES, V78, P396, DOI 10.1017/S002202991100063X; Duman DG, 2005, EUR J GASTROEN HEPAT, V17, P1357, DOI 10.1097/00042737-200512000-00015; Dylewski J, 2010, ARCH MED SCI, V6, P56, DOI 10.5114/aoms.2010.13508; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Erdeve O, 2004, J TROP PEDIATRICS, V50, P234, DOI 10.1093/tropej/50.4.234; Felley CP, 2001, EUR J GASTROEN HEPAT, V13, P25, DOI 10.1097/00042737-200101000-00005; Fredenucci I, 1998, CLIN INFECT DIS, V27, P222, DOI 10.1086/517685; FRIGERIO G, 1986, DIGEST DIS SCI, V31, pS496; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; GOTZ V, 1979, AM J HOSP PHARM, V36, P754, DOI 10.1093/ajhp/36.6.754; Guslandi M, 2006, NAT CLIN PRACT GASTR, V3, P606, DOI 10.1038/ncpgasthep0627; Hao QK, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006895.pub2, 10.1002/14651858.CD006895.pub3]; Hempel S, 2011, AHRQ PUBLICATION, V11-EHC045-EF; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jirapinyo Pipop, 2002, Journal of the Medical Association of Thailand, V85, pS739; Johnston BC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub3; Katz JA, 2010, J CLIN GASTROENTEROL, V44, P83, DOI 10.1097/MCG.0b013e3181bdf010; Kim MN, 2008, HELICOBACTER, V13, P261, DOI 10.1111/j.1523-5378.2008.00601.x; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; Koning CJM, 2010, BRIT J NUTR, V103, P1452, DOI 10.1017/S0007114509993497; Kotowska M, 2005, ALIMENT PHARM THER, V21, P583, DOI 10.1111/j.1365-2036.2005.02356.x; La Rosa M, 2003, Minerva Pediatr, V55, P447; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Lestin F, 2003, DEUT MED WOCHENSCHR, V128, P2531, DOI 10.1055/s-2003-44948; Lewis SJ, 1998, J INFECTION, V36, P171, DOI 10.1016/S0163-4453(98)80008-X; Li D, 2010, CHIN J GASTROENTEROL, V15, P154; Lighthouse J, 2004, HEPATOL RES, V28, P155, DOI 10.1016/j.hepres.2003.11.005; Ligny G, 1976, ARS MED, V31, P989; Lonnermark E, 2010, J CLIN GASTROENTEROL, V44, P106, DOI 10.1097/MCG.0b013e3181b2683f; McFarland LV, 1998, DIGEST DIS, V16, P292, DOI 10.1159/000016879; McFarland LV, 2006, AM J GASTROENTEROL, V101, P812, DOI 10.1111/j.1572-0241.2006.00465.x; MCFARLAND LV, 1995, AM J GASTROENTEROL, V90, P439; McFarland LV, 2008, FUTURE MICROBIOL, V3, P563, DOI 10.2217/17460913.3.5.563; McFarland LV, 2009, ANAEROBE, V15, P274, DOI 10.1016/j.anaerobe.2009.09.002; Merenstein DJ, 2009, ARCH PEDIAT ADOL MED, V163, P750, DOI 10.1001/archpediatrics.2009.119; Monteiro E, 1981, Acta Med Port, V3, P143; Myllyluoma E, 2005, ALIMENT PHARM THER, V21, P1263, DOI 10.1111/j.1365-2036.2005.02448.x; Park SK, 2007, HEPATO-GASTROENTEROL, V54, P2032; Piechno S, 2007, CAN J ANAESTH, V54, P245, DOI 10.1007/BF03022650; Plummer S, 2004, INT MICROBIOL, V7, P59; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REID G, 1992, CLIN THER, V14, P11; Riquelme AJ, 2003, J CLIN GASTROENTEROL, V36, P41, DOI 10.1097/00004836-200301000-00013; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Ruszczynski M, 2008, ALIMENT PHARM THER, V28, P154, DOI 10.1111/j.1365-2036.2008.03714.x; Safdar N, 2008, J CLIN PHARM THER, V33, P663, DOI 10.1111/j.1365-2710.2008.00980.x; Saneeyan H., 2011, MAJALLAH I DANISHKAD, V146, P882; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Schrezenmeir J, 2004, CLIN PEDIATR, V43, P239, DOI 10.1177/000992280404300305; Selinger C, 2011, GUT, V60, pA4, DOI 10.1136/gut.2011.239301.7; Sheu BS, 2002, ALIMENT PHARM THER, V16, P1669, DOI 10.1046/j.1365-2036.2002.01335.x; Song HJ, 2010, J KOREAN MED SCI, V25, P1784, DOI 10.3346/jkms.2010.25.12.1784; Song MJ, 2010, HELICOBACTER, V15, P206, DOI 10.1111/j.1523-5378.2010.00751.x; Stein G. Y., 2007, HAREFUAH, V146, P575; Stein Gideon Y, 2007, Harefuah, V146, P520; Sullivan A, 2003, J ANTIMICROB CHEMOTH, V52, P308, DOI 10.1093/jac/dkg346; Surawicz CM, 2003, BEST PRACT RES CL GA, V17, P775, DOI 10.1016/S1521-6918(03)00054-4; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; Szajewska H, 2006, J PEDIATR-US, V149, P367, DOI 10.1016/j.jpeds.2006.04.053; Szajewska Hania, 2003, J Pediatr, V142, P85; Szajewska H, 2009, J PEDIATR GASTR NUTR, V48, P431, DOI 10.1097/MPG.0b013e318182e716; Szymanski H, 2008, DIGESTION, V78, P13, DOI 10.1159/000151300; TANKANOW RM, 1990, DICP ANN PHARMAC, V24, P382, DOI 10.1177/106002809002400408; Thomas MR, 2001, MAYO CLIN PROC, V76, P883; Trautmann M, 2008, CHEMOTHERAPIE J, V17, P57; Turck D, 2003, J PEDIATR GASTR NUTR, V37, P22, DOI 10.1097/00005176-200307000-00004; Tursi A, 2004, MED SCI MONITOR, V10, pCR662; Vanderhoof JA, 1999, J PEDIATR-US, V135, P564, DOI 10.1016/S0022-3476(99)70053-3; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wenus C, 2008, EUR J CLIN NUTR, V62, P299, DOI 10.1038/sj.ejcn.1602718; WUNDERLICH PF, 1989, J INT MED RES, V17, P333, DOI 10.1177/030006058901700405; Yasar B, 2010, TURK J GASTROENTEROL, V21, P212, DOI 10.4318/tjg.2010.0090; Yoon H, 2011, J GASTROEN HEPATOL, V26, P44, DOI 10.1111/j.1440-1746.2010.06477.x; Zoppi G, 2001, CURR THER RES CLIN E, V62, P418, DOI 10.1016/S0011-393X(01)89006-8; ZUNIC P, 1991, THERAPIE, V46, P498	96	477	535	13	213	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1959	1969		10.1001/jama.2012.3507	http://dx.doi.org/10.1001/jama.2012.3507			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570464	Bronze			2022-12-28	WOS:000303741900030
J	Tsui, E; Salcone, EM				Tsui, Edmund; Salcone, Erin M.			Corneal Trauma in a 6-Year-Old Boy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ANTERIOR-CHAMBER		[Salcone, Erin M.] Dartmouth Hitchcock Med Ctr, Dept Surg, Sect Ophthalmol, Lebanon, NH 03756 USA; [Tsui, Edmund] Geisel Sch Med Dartmouth, Hanover, NH USA	Dartmouth College; Dartmouth College	Salcone, EM (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Surg, Sect Ophthalmol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Erin.M.Salcone@hitchcock.org		Tsui, Edmund/0000-0001-7532-9191				Gopal L, 2000, Indian J Ophthalmol, V48, P33; HUMAYUN M, 1993, ARCH OPHTHALMOL-CHIC, V111, P1396, DOI 10.1001/archopht.1993.01090100104036; Kargi SH, 2003, OCUL IMMUNOL INFLAMM, V11, P73, DOI 10.1076/ocii.11.1.73.15576; SNIR M, 1992, ANN OPHTHALMOL, V24, P9; Solomon A, 1998, EYE, V12, P1031, DOI 10.1038/eye.1998.270; Yalniz-Akkaya Zuleyha, 2011, J Med Case Rep, V5, P527, DOI 10.1186/1752-1947-5-527	6	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1970	1971		10.1001/jama.2012.3457	http://dx.doi.org/10.1001/jama.2012.3457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570465				2022-12-28	WOS:000303741900031
J	Allan, MP; Rost, AW; Mackenzie, AP; Xie, Y; Davis, JC; Kihou, K; Lee, CH; Iyo, A; Eisaki, H; Chuang, TM				Allan, M. P.; Rost, A. W.; Mackenzie, A. P.; Xie, Yang; Davis, J. C.; Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.; Chuang, T. -M.			Anisotropic Energy Gaps of Iron-Based Superconductivity from Intraband Quasiparticle Interference in LiFeAs	SCIENCE			English	Article								If strong electron-electron interactions between neighboring Fe atoms mediate the Cooper pairing in iron-pnictide superconductors, then specific and distinct anisotropic superconducting energy gaps Delta(i)((k) over right arrow) should appear on the different electronic bands i. Here, we introduce intraband Bogoliubov quasiparticle scattering interference (QPI) techniques for determination of Delta(i)((k) over right arrow) in such materials, focusing on lithium iron arsenide (LiFeAs). We identify the three hole-like bands assigned previously as gamma, alpha(2), and alpha(1), and we determine the anisotropy, magnitude, and relative orientations of their Delta(i)((k) over right arrow): These measurements will advance quantitative theoretical analysis of the mechanism of Cooper pairing in iron-based superconductivity.	[Allan, M. P.; Davis, J. C.; Chuang, T. -M.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci CMPMS Dept, Upton, NY 11973 USA; [Allan, M. P.; Rost, A. W.; Xie, Yang; Davis, J. C.; Chuang, T. -M.] Cornell Univ, Dept Phys, Solid State Phys Lab, Ithaca, NY 14853 USA; [Allan, M. P.; Rost, A. W.; Mackenzie, A. P.; Davis, J. C.] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Davis, J. C.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Kihou, K.; Lee, C. H.; Iyo, A.; Eisaki, H.] Japan Sci & Technol Agcy JST, Transformat Res Project Iron Pnictides TRIP, Tokyo 1020075, Japan; [Chuang, T. -M.] Acad Sinica, Inst Phys, Taipei 11529, Taiwan	United States Department of Energy (DOE); Brookhaven National Laboratory; Cornell University; University of St Andrews; Cornell University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Academia Sinica - Taiwan	Davis, JC (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci CMPMS Dept, Upton, NY 11973 USA.	jcdavis@ccmr.cornell.edu; chuangtm@phys.sinica.edu.tw	Chuang, Tien-Ming/AAP-3917-2021; Iyo, Akira/L-6417-2018; Rost, Andreas/F-3004-2011; Rost, Andreas/B-8379-2008; Kihou, Kunihiro/AAQ-3541-2020; Eisaki, Hiroshi/F-6317-2018; Lee, Chul-Ho/I-7162-2018; Mackenzie, Andrew P/K-6742-2015; Allan, Milan Peter/D-7763-2012	Chuang, Tien-Ming/0000-0002-4524-1380; Iyo, Akira/0000-0002-9610-647X; Rost, Andreas/0000-0002-1688-4109; Rost, Andreas/0000-0002-1688-4109; Kihou, Kunihiro/0000-0003-3065-4147; Eisaki, Hiroshi/0000-0002-8299-6416; Lee, Chul-Ho/0000-0001-6918-976X; Mackenzie, Andrew P/0000-0001-8000-4949; Allan, Milan Peter/0000-0002-5437-1945	Center for Emergent Superconductivity, an Energy Frontier Research Center; U.S. Department of Energy [DE-2009-BNL-PM015]; UK Engineering and Physical Sciences Research Council (EPSRC); Japan Society for the Promotion of Science [22540380]; Cornell Center for Materials Research (CCMR) [NSF/DMR-0520404]; Academia Sinica; Royal Society; EPSRC [EP/I031014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish	Center for Emergent Superconductivity, an Energy Frontier Research Center; U.S. Department of Energy(United States Department of Energy (DOE)); UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cornell Center for Materials Research (CCMR); Academia Sinica(Academia Sinica - Taiwan); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are particularly grateful to D.-H. Lee for advice and discussions, and we acknowledge and thank F. Baumberger, A. Carrington, P. C. Canfield, A. V. Chubukov, A. I. Coldea, M. H. Fischer, T. Hanaguri, P. J. Hirschfeld, B. Keimer, E.-A. Kim, M. J. Lawler, C. Putzke, J. Schmalian, H. Takagi, Z. Tesanovic, R. Thomale, S. Uchida, and F. Wang for helpful discussions and communications. Studies were supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center, funded by the U.S. Department of Energy under DE-2009-BNL-PM015; by the UK Engineering and Physical Sciences Research Council (EPSRC); and by a Grant-in-Aid for Scientific Research C (no. 22540380) from the Japan Society for the Promotion of Science. Y.X. acknowledges support by the Cornell Center for Materials Research (CCMR) under NSF/DMR-0520404. T.-M.C. acknowledges support by Academia Sinica Research Program on Nanoscience and Nanotechnology, and A.P.M. the receipt of a Royal Society-Wolfson Research Merit Award. The data described in the paper are archived by the Davis Research Group at Cornell University.	Akbari A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224506; Borisenko SV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067002; Borisenko SV, 2012, SYMMETRY-BASEL, V4, P251, DOI 10.3390/sym4010251; Capriotti L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014508; Christianson AD, 2008, NATURE, V456, P930, DOI 10.1038/nature07625; Chu CW, 2009, PHYSICA C, V469, P326, DOI 10.1016/j.physc.2009.03.016; Hanke T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.127001; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hanaguri T., 2010, M PHYS SOC JAP, V65, P617; Hirschfeld PJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124508; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Maier TA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224510; Maiti S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214515; Mazin II, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.052501; Nunner TS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104511; Pitcher MJ, 2010, J AM CHEM SOC, V132, P10467, DOI 10.1021/ja103196c; Putzke C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047002; Raghu S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.220503; Reid JP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064501; Singh DJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094511; Sknepnek R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054511; Sykora S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054501; Tanatar MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.067002; Thomale R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180505; Umezawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037002; Wang F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047005; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Wang XC, 2008, SOLID STATE COMMUN, V148, P538, DOI 10.1016/j.ssc.2008.09.057; Zeng B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1115; Zhang YY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094528	30	136	137	0	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					563	567		10.1126/science.1218726	http://dx.doi.org/10.1126/science.1218726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556247	Green Submitted			2022-12-28	WOS:000303498800039
J	Willis, JK; Church, JA				Willis, Josh K.; Church, John A.			Regional Sea-Level Projection	SCIENCE			English	Editorial Material							IMPACTS; RISE		[Willis, Josh K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Church, John A.] Ctr Australian Weather & Climate Res, Hobart, Tas, Australia	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Willis, JK (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	joshua.k.willis@jpl.nasa.gov; john.church@csiro.au	Willis, Josh/AGY-7817-2022; Church, John A/A-1541-2012	Church, John A/0000-0002-7037-8194				Alley RB, 2012, SCIENCE, V336, P551, DOI 10.1126/science.1220530; Ardent A., 2012, RANDOLPH GLACIER INV; Church JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048794; Church JA, 2011, OCEANOGRAPHY, V24, P130, DOI 10.5670/oceanog.2011.33; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; FitzGerald DM, 2008, ANNU REV EARTH PL SC, V36, P601, DOI 10.1146/annurev.earth.35.031306.140139; Ivins ER, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030003; Jevrejeva S, 2012, GLOBAL PLANET CHANGE, V80-81, P14, DOI 10.1016/j.gloplacha.2011.09.006; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI [10.1098/rsta.2010.0291, 10.1098/rsta.2010.029]; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Rahmstorf S., 2011, CLIM DYNAM, V39, P861, DOI DOI 10.1007/S00382-011-1226-7; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106	14	49	50	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					550	551		10.1126/science.1220366	http://dx.doi.org/10.1126/science.1220366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22556241				2022-12-28	WOS:000303498800033
J	Gilard, M; Eltchaninoff, H; Iung, B; Donzeau-Gouge, P; Chevreul, K; Fajadet, J; Leprince, P; Leguerrier, A; Lievre, M; Prat, A; Teiger, E; Lefevre, T; Himbert, D; Tchetche, D; Carrie, D; Albat, B; Cribier, A; Rioufol, G; Sudre, A; Blanchard, D; Collet, F; Dos Santos, P; Meneveau, N; Tirouvanziam, A; Caussin, C; Guyon, P; Boschat, J; Le Breton, H; Collart, F; Houel, R; Delpine, S; Souteyrand, G; Favereau, X; Ohlmann, P; Doisy, V; Grollier, G; Gommeaux, A; Claudel, JP; Bourlon, F; Bertrand, B; Van Belle, E; Laskar, M				Gilard, Martine; Eltchaninoff, Helene; Iung, Bernard; Donzeau-Gouge, Patrick; Chevreul, Karine; Fajadet, Jean; Leprince, Pascal; Leguerrier, Alain; Lievre, Michel; Prat, Alain; Teiger, Emmanuel; Lefevre, Thierry; Himbert, Dominique; Tchetche, Didier; Carrie, Didier; Albat, Bernard; Cribier, Alain; Rioufol, Gilles; Sudre, Arnaud; Blanchard, Didier; Collet, Frederic; Dos Santos, Pierre; Meneveau, Nicolas; Tirouvanziam, Ashok; Caussin, Christophe; Guyon, Philippe; Boschat, Jacques; Le Breton, Herve; Collart, Frederic; Houel, Remi; Delpine, Stephane; Souteyrand, Geraud; Favereau, Xavier; Ohlmann, Patrick; Doisy, Vincent; Grollier, Gilles; Gommeaux, Antoine; Claudel, Jean-Philippe; Bourlon, Francois; Bertrand, Bernard; Van Belle, Eric; Laskar, Marc		FRANCE 2 Investigators	Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOME SOURCE REGISTRY; VALVULAR HEART-DISEASE; EUROPEAN REGISTRY; STENOSIS; REPLACEMENT; SOCIETY; PROSTHESIS; GUIDELINES; MANAGEMENT; COREVALVE	Background Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2. Methods All TAVIs performed in France, as listed in the FRANCE 2 registry, were prospectively included in the study. The primary end point was death from any cause. Results A total of 3195 patients were enrolled between January 2010 and October 2011 at 34 centers. The mean (+/- SD) age was 82.7 +/- 7.2 years; 49% of the patients were women. All patients were highly symptomatic and were at high surgical risk for aortic-valve replacement. Edwards SAPIEN and Medtronic CoreValve devices were implanted in 66.9% and 33.1% of patients, respectively. Approaches were either transarterial (transfemoral, 74.6%; subclavian, 5.8%; and other, 1.8%) or transapical (17.8%). The procedural success rate was 96.9%. Rates of death at 30 days and 1 year were 9.7% and 24.0%, respectively. At 1 year, the incidence of stroke was 4.1%, and the incidence of periprosthetic aortic regurgitation was 64.5%. In a multivariate model, a higher logistic risk score on the European System for Cardiac Operative Risk Evaluation (EuroSCORE), New York Heart Association functional class III or IV symptoms, the use of a transapical TAVI approach, and a higher amount of periprosthetic regurgitation were significantly associated with reduced survival. Conclusions This prospective registry study reflected real-life TAVI experience in high-risk elderly patients with aortic stenosis, in whom TAVI appeared to be a reasonable option. (Funded by Edwards Lifesciences and Medtronic.)	[Gilard, Martine; Boschat, Jacques] CHU Brest, F-29285 Brest, France; [Eltchaninoff, Helene; Cribier, Alain] Univ Rouen, Hop Charles Nicolle, INSERM, U1096, Rouen, France; [Iung, Bernard; Himbert, Dominique] Hop Bichat Claude Bernard, F-75877 Paris, France; [Chevreul, Karine; Teiger, Emmanuel] CHU Henri Mondor, Paris, France; [Leprince, Pascal] Hop La Pitie Salpetriere, Paris, France; [Donzeau-Gouge, Patrick; Lefevre, Thierry] Inst Jacques Cartier, Massy, France; [Fajadet, Jean; Tchetche, Didier] Clin Pasteur, Toulouse, France; [Carrie, Didier] CHU Toulouse, Toulouse, France; [Leguerrier, Alain; Le Breton, Herve] CHU Rennes, Rennes, France; [Lievre, Michel] Univ Lyon 1, F-69365 Lyon, France; [Doisy, Vincent] Clin Tonkin, Lyon, France; [Claudel, Jean-Philippe] Infirm Protestante, Lyon, France; [Prat, Alain; Sudre, Arnaud; Van Belle, Eric] CHU Lille, F-59037 Lille, France; [Albat, Bernard] CHU Montpellier, Montpellier, France; [Blanchard, Didier] Clin St Gatien, Tours, France; [Rioufol, Gilles] CHU Lyon, Bron, France; [Collet, Frederic] Hop Clairval, Marseille, France; [Houel, Remi] Hop St Joseph, Marseille, France; [Collet, Frederic] Hop Enfants La Timone, Marseille, France; [Caussin, Christophe] Hop Marie Lannelongue, F-92350 Le Plessis Robinson, France; [Meneveau, Nicolas] CHU Besancon, F-25030 Besancon, France; [Guyon, Philippe] Ctr Cardiol Nord, St Denis, France; [Dos Santos, Pierre] CHU Bordeaux, Bordeaux, France; [Tirouvanziam, Ashok] CHU Nantes, F-44035 Nantes 01, France; [Delpine, Stephane] CHU Angers, Angers, France; [Souteyrand, Geraud] CHU Clermont Ferrand, Clermont Ferrand, France; [Favereau, Xavier] Parly 2, Le Chesnay, France; [Ohlmann, Patrick] CHU Strasbourg, F-67000 Strasbourg, France; [Grollier, Gilles] CHU Caen, F-14000 Caen, France; [Gommeaux, Antoine] Polyclin Bois Bernard, Bois Bernard, France; [Bertrand, Bernard] CHU Grenoble, F-38043 Grenoble, France; [Laskar, Marc] CHU Dupuytren, Limoges, France; [Bourlon, Francois] Ctr Cardiothorac, Monte Carlo, Monaco	CHU Brest; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Jacques Cartier Private Hospital; CHU de Toulouse; CHU Rennes; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hopital Marie Lannelongue; Universite de Franche-Comte; CHU Besancon; CHU Bordeaux; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Clermont Ferrand; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Limoges	Gilard, M (corresponding author), Univ Bretagne Occidentale, Dept Cardiol, CHU Cavale Blanche, EA 4524, Blvd Tanguy Prigent, F-29609 Brest, France.	martine.gilard@chu-brest.fr	banfi, carlo/P-5697-2019; chevreul, karine/AAN-2380-2020; Prunier, Fabrice/A-5210-2011; Sudre, Arnaud/ABF-7614-2020; Iung, Bernard/AAQ-9004-2020; Doğan, Ali/AAN-5331-2020; Chavanon, Olivier/AAC-8171-2019; Carrie, Didier/M-5781-2014; Le Breton, Herve/ABD-8171-2020	banfi, carlo/0000-0003-1134-2068; Iung, Bernard/0000-0002-9127-348X; Chavanon, Olivier/0000-0001-8625-691X; TEIGER, emmanuel/0000-0001-7515-4344; jegaden, olivier/0000-0002-9031-0920; CARRIE, didier/0000-0003-2479-8144; Juthier, Francis/0000-0002-5072-9073; Dos Santos, Pierre/0000-0002-0811-3099; VAN BELLE, ERIC/0000-0001-6509-443X; Piot, Christophe/0000-0001-7497-0294; patrick, nataf/0000-0002-8412-6182; Gilard, Martine/0000-0002-2794-7953	Edwards Lifesciences; Medtronic	Edwards Lifesciences; Medtronic(Medtronic)	Supported by Edwards Lifesciences and Medtronic.	American College of Cardiology/American Heart Association Task Force on Practice Guidelines Society of Cardiovascular Anesthesiologists Society for Cardiovascular Angiography and Interventions, 2007, CIRCULATION, V115, pe409; Bonow RO, 2010, CIRCULATION, V121, pE443, DOI 10.1161/CIR.0b013e3181e3e359; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Bosmans JM, 2011, INTERACT CARDIOV TH, V12, P762, DOI 10.1510/icvts.2010.253773; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Eltchaninoff H, 2008, ARCH CARDIOVASC DIS, V101, P126, DOI 10.1016/S1875-2136(08)70270-5; Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Gotzmann M, 2011, AM HEART J, V162, P238, DOI 10.1016/j.ahj.2011.05.011; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kahlert P, 2011, CIRCULATION, V123, P239, DOI 10.1161/CIRCULATIONAHA.110.004713; Kempfert J, 2011, CIRCULATION, V124, pS124, DOI 10.1161/CIRCULATIONAHA.110.013425; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Melby SJ, 2007, ANN THORAC SURG, V83, P1651, DOI 10.1016/j.athoracsur.2006.09.068; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Rodes-Cabau J, 2008, AM J CARDIOL, V102, P1240, DOI 10.1016/j.amjcard.2008.06.061; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	30	958	985	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1705	1715		10.1056/NEJMoa1114705	http://dx.doi.org/10.1056/NEJMoa1114705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551129				2022-12-28	WOS:000303434300010
J	Fijnvandraat, K; Cnossen, MH; Leebeek, FWG; Peters, M				Fijnvandraat, Karin; Cnossen, Marjon H.; Leebeek, Frank W. G.; Peters, Marjolein			Diagnosis and management of haemophilia	BRITISH MEDICAL JOURNAL			English	Review							CENTER-DOCTORS-ORGANIZATION; FACTOR-VIII; BLEEDING DISORDERS; FACTOR-IX; BRITISH-COMMITTEE; RISK-FACTORS; PROPHYLAXIS; GUIDELINE; INHIBITORS; DISEASE		[Fijnvandraat, Karin; Peters, Marjolein] Acad Med Ctr, Amsterdam Haemophilia Treatment Ctr, NL-1100 DD Amsterdam, Netherlands; [Fijnvandraat, Karin; Peters, Marjolein] Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol, NL-1100 DD Amsterdam, Netherlands; [Cnossen, Marjon H.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Paediat Haematol & Oncol, Rotterdam, Netherlands; [Leebeek, Frank W. G.] Erasmus MC, Dept Haematol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC	Fijnvandraat, K (corresponding author), Acad Med Ctr, Amsterdam Haemophilia Treatment Ctr, NL-1100 DD Amsterdam, Netherlands.	c.j.fijnvandraat@amc.nl		Cnossen, Marjon H./0000-0003-1557-2995	CSL Behring; Bayer; Pfizer; Baxter; Novartis	CSL Behring; Bayer(Bayer AG); Pfizer(Pfizer); Baxter; Novartis(Novartis)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; KF is a member of the European Hemophilia Treatment and Standardisation Board sponsored by Baxter, has received unrestricted research grants from CSL Behring and Bayer, and has given lectures at educational symposiums organised by Pfizer and Bayer; MHC has received unrestricted research or educational funding from Pfizer, Baxter, Bayer, and Novartis and has given lectures at educational symposiums organised by Novartis; FWGL has been a member of the advisory boards of CSL Behring and Baxter and received unrestricted research grants from CSL Behring; MP declares no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Astermark J, 2010, HAEMOPHILIA, V16, P747, DOI 10.1111/j.1365-2516.2010.02231.x; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Centers for Disease Control and Prevention, HEM A MUT PROJ; Chalmers E, 2011, BRIT J HAEMATOL, V154, P208, DOI 10.1111/j.1365-2141.2010.08545.x; Colvin BT, 2008, HAEMOPHILIA, V14, P361, DOI 10.1111/j.1365-2516.2007.01625.x; Fischer K, 2007, HAEMOPHILIA, V13, P345, DOI 10.1111/j.1365-2516.2007.01521.x; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Hermans C, 2009, HAEMOPHILIA, V15, P639, DOI 10.1111/j.1365-2516.2008.01950.x; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Keeling D, 2008, HAEMOPHILIA, V14, P671, DOI 10.1111/j.1365-2516.2008.01695.x; Kouides PA, 2007, J THROMB HAEMOST, V5, P175, DOI 10.1111/j.1538-7836.2007.02494.x; Laffan M, 2004, HAEMOPHILIA, V10, P199, DOI 10.1111/j.1365-2516.2004.00894.x; Lee CA, 2006, HAEMOPHILIA, V12, P301, DOI 10.1111/j.1365-2516.2006.01314.x; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; LJUNG R, 1994, ACTA PAEDIATR, V83, P609; MacLean PE, 2004, HAEMOPHILIA, V10, P560, DOI 10.1111/j.1365-2516.2004.00955.x; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; MANNUCCI PM, 1981, BRIT J HAEMATOL, V47, P283, DOI 10.1111/j.1365-2141.1981.tb02789.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Negrier C, 2011, BLOOD, V118, P2695, DOI 10.1182/blood-2011-02-335596; Oldenburg J, 2006, HAEMOPHILIA, V12, P15, DOI 10.1111/j.1365-2516.2006.01361.x; Peyvandi F, 2011, HAEMOPHILIA, V17, P14, DOI 10.1111/j.1365-2516.2011.02559.x; Plug I, 2008, BLOOD, V111, P1811, DOI 10.1182/blood-2007-07-102202; Plug I, 2006, BLOOD, V108, P52, DOI 10.1182/blood-2005-09-3879; Richards M, 2012, BRIT J HAEMATOL, V156, P374, DOI 10.1111/j.1365-2141.2011.08967.x; Richards M, 2010, BRIT J HAEMATOL, V149, P498, DOI 10.1111/j.1365-2141.2010.08139.x; Srivastava A, 2005, SEMIN THROMB HEMOST, V31, P495, DOI 10.1055/s-2005-922219; Teitel JM, 2004, HAEMOPHILIA, V10, P118, DOI 10.1046/j.1365-2516.2003.00853.x; Trigg DE, 2012, HAEMOPHILIA, V18, P25, DOI 10.1111/j.1365-2516.2011.02573.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Witmer C, 2011, BRIT J HAEMATOL, V152, P211, DOI 10.1111/j.1365-2141.2010.08469.x; 2004, HAEMOPHILIA B MUTATI	34	61	61	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e2707	10.1136/bmj.e2707	http://dx.doi.org/10.1136/bmj.e2707			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NC	22551712	Green Submitted			2022-12-28	WOS:000303817200004
J	Offit, PA				Offit, Paul A.			Studying Complementary and Alternative Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Offit, Paul A.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Offit, Paul A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 34th St & Civ Ctr Blvd,ARB,Room 1202C, Philadelphia, PA 19104 USA.	offit@email.chop.edu						Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Mielczarek E. V., 2012, SKEPTICAL INQUIRER, V36, P36; Moyer CS, 2012, AMEDNEWS        0220; Offit PaulA., 2008, AUTISMS FALSE PROPHE, DOI 10.7312/offi14636; Park Robert L., 2000, VOODOO SCI ROAD FOOL; Shapiro R., 2008, SUCKERS ALTERNATIVE; Wang SS, 2011, WALL STREET J   1025, pD1	7	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1803	1804		10.1001/jama.2012.518	http://dx.doi.org/10.1001/jama.2012.518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550193				2022-12-28	WOS:000303386800017
J	Golden, AG; Silverman, MA; Mintzer, MJ				Golden, Adam G.; Silverman, Michael A.; Mintzer, Michael J.			Is Geriatric Medicine Terminally Ill?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FACULTY-DEVELOPMENT PROGRAM; GENERAL INTERNISTS; CARE; HOSPITALISTS; CONSENSUS		Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; Orlando Vet Affairs Med Ctr, Orlando, FL USA; W Palm Beach Vet Affairs Med Ctr, W Palm Beach, FL USA; Univ Miami, Miller Sch Med, Miami, FL 33136 USA; Bruce W Carter Vet Affairs Med Ctr, Miami Geriatr Res Educ & Clin Ctr, Miami, FL USA	State University System of Florida; University of Central Florida; University of Miami; Geriatric Research Education & Clinical Center	Golden, AG (corresponding author), 5201 Raymond St,CLC-136, Orlando, FL 32803 USA.	adam.golden@ucf.edu						Caprio TV, 2009, J AM MED DIR ASSOC, V10, P93, DOI 10.1016/j.jamda.2008.07.007; Chin MH, 1998, J AM GERIATR SOC, V46, P1349, DOI 10.1111/j.1532-5415.1998.tb06000.x; Christmas C, 2008, J GEN INTERN MED, V23, P1048, DOI 10.1007/s11606-008-0585-1; Eckstrom E, 2008, J GEN INTERN MED, V23, P1053, DOI 10.1007/s11606-008-0593-1; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; Hazzard WR, 2003, ANN INTERN MED, V139, P597, DOI 10.7326/0003-4819-139-7-200310070-00014; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Kane RL, 2002, J GERONTOL A-BIOL, V57, pM803, DOI 10.1093/gerona/57.12.M803; Leipzig RM, 2009, ACAD MED, V84, P604, DOI 10.1097/ACM.0b013e31819fab70; Libow LS, 2005, NEW ENGL J MED, V352, P750, DOI 10.1056/NEJMp048140; Mazotti L, 2010, J HOSP MED, V5, P541, DOI 10.1002/jhm.791; Phelan EA, 2008, J AM GERIATR SOC, V56, P1807, DOI 10.1111/j.1532-5415.2008.01942.x; Phillips Steven L, 2005, J Am Med Dir Assoc, V6, P396, DOI 10.1016/j.jamda.2005.05.016; Podrazik PM, 2008, J HOSP MED, V3, P384, DOI 10.1002/jhm.348; Torres Carol, 2001, International Urology and Nephrology, V33, P549, DOI 10.1023/A:1019580322555; Vladeck BC, 2011, JAMA-J AM MED ASSOC, V306, P1802, DOI 10.1001/jama.2011.1527; Warshaw GA, 2011, ADGAP NATL SURVEY GE; Warshaw GA, 2008, J AM GERIATR SOC, V56, P1796, DOI 10.1111/j.1532-5415.2008.01940.x; Williams Brent C, 2010, J Grad Med Educ, V2, P373, DOI 10.4300/JGME-D-10-00065.1	20	34	34	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					654	657		10.7326/0003-4819-156-9-201205010-00009	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933YR	22547474				2022-12-28	WOS:000303403700006
J	Resnick, MD; Catalano, RF; Sawyer, SM; Viner, R; Patton, GC				Resnick, Michael D.; Catalano, Richard F.; Sawyer, Susan M.; Viner, Russell; Patton, George C.			Seizing the opportunities of adolescent health	LANCET			English	Editorial Material									[Resnick, Michael D.] Univ Minnesota, Dept Pediat, Div Adolescent Hlth & Med, Minneapolis, MN 55414 USA; [Catalano, Richard F.] Univ Washington, Sch Social Work, Social Dev Res Grp, Seattle, WA 98195 USA; [Sawyer, Susan M.; Patton, George C.] Univ Melbourne, Dept Paediat, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Sawyer, Susan M.; Patton, George C.] Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; [Viner, Russell] UCL Inst Child Hlth, London, England	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of London; University College London	Resnick, MD (corresponding author), Univ Minnesota, Dept Pediat, Div Adolescent Hlth & Med, Minneapolis, MN 55414 USA.	resni001@umn.edu	Viner, Russell M/A-1441-2009; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022	Viner, Russell M/0000-0003-3047-2247; Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376				Aratani Yumiko, 2011, Adolesc Med State Art Rev, V22, P367; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Din-Dzietham R, 2007, CIRCULATION, V116, P1488, DOI 10.1161/CIRCULATIONAHA.106.683243; Johnson MK, 2011, J RES ADOLESCENCE, V21, P273, DOI 10.1111/j.1532-7795.2010.00728.x; Knowles JC., 2005, EC RETURNS INVESTING; Lawrence RS, 2009, ADOLESCENT HEALTH SERVICES: MISSING OPPORTUNITIES, P194; Little AW, 2009, INT J EDUC DEV, V29, P166, DOI 10.1016/j.ijedudev.2008.09.011; Lloyd C., 2005, GROWING GLOBAL CHANG; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Resnick MD, 2008, FAM COMMUNITY HEALTH, V31, pS5, DOI 10.1097/01.FCH.0000304013.82760.71; Resnick MD, 2007, LANCET, V369, P1058, DOI 10.1016/S0140-6736(07)60372-9; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; UNICEF, 2011, STAT WORLDS CHILDR 2; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wilson KM, 2011, PREV CHRONIC DIS, V8; World Bank, 2006, WORLD DEV REP 2007 D	20	73	73	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1564	1567		10.1016/S0140-6736(12)60472-3	http://dx.doi.org/10.1016/S0140-6736(12)60472-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538176				2022-12-28	WOS:000303452600005
J	Meng, YC; Tanaka, S; Poon, CS				Meng, Yicong; Tanaka, Shigeru; Poon, Chi-Sang			Comment on "Universality in the Evolution of Orientation Columns in the Visual Cortex"	SCIENCE			English	Editorial Material							CATS; MAPS; DOMAINS; AREA-17; FERRETS; LAYOUT	Kaschube et al. (Reports, 19 November 2010, p. 1113) argue that pinwheel density in three mammalian species follows a universal constant of p as predicted by their orientation-selective suppressive long-range connectivity model. We dispute their conclusions and suggest that a simple brain size-pinwheel density scaling law suffices in predicting the self-organized and disorganized orientation maps from primates to rodents.	[Meng, Yicong; Poon, Chi-Sang] MIT, Harvard Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Tanaka, Shigeru] Univ Electrocommun, Dept Informat & Commun Engn, Tokyo, Japan	Massachusetts Institute of Technology (MIT); University of Electro-Communications - Japan	Poon, CS (corresponding author), MIT, Harvard Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cpoon@mit.edu			NEI NIH HHS [EY06821, EY11488] Funding Source: Medline; NIGMS NIH HHS [P50 GM071508] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006821, R01EY011488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Engelmann R, 2002, VISUAL NEUROSCI, V19, P39, DOI 10.1017/S0952523801191042; GRIGONIS AM, 1988, DEV BRAIN RES, V40, P315, DOI 10.1016/0165-3806(88)90145-9; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; Martin RD, 1996, NEWS PHYSIOL SCI, V11, P149, DOI 10.1152/physiologyonline.1996.11.4.149; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Rao SC, 1997, J COMP NEUROL, V387, P358; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Van Hooser SD, 2007, NEUROSCIENTIST, V13, P639, DOI 10.1177/1073858407306597; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736	13	8	8	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080								10.1126/science.1205737	http://dx.doi.org/10.1126/science.1205737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539703				2022-12-28	WOS:000303233400026
J	Pritchard, HD; Ligtenberg, SRM; Fricker, HA; Vaughan, DG; van den Broeke, MR; Padman, L				Pritchard, H. D.; Ligtenberg, S. R. M.; Fricker, H. A.; Vaughan, D. G.; van den Broeke, M. R.; Padman, L.			Antarctic ice-sheet loss driven by basal melting of ice shelves	NATURE			English	Article							CIRCUMPOLAR DEEP-WATER; INFLOW; TRENDS; OCEAN	Accurate prediction of global sea-level rise requires that we understand the cause of recent, widespread and intensifying(1,2) glacier acceleration along Antarctic ice-sheet coastal margins(3). Atmospheric and oceanic forcing have the potential to reduce the thickness and extent of floating ice shelves, potentially limiting their ability to buttress the flow of grounded tributary glaciers(4). Indeed, recent ice-shelf collapse led to retreat and acceleration of several glaciers on the Antarctic Peninsula(5). But the extent and magnitude of ice-shelf thickness change, the underlying causes of such change, and its link to glacier flow rate are so poorly understood that its future impact on the ice sheets cannot yet be predicted(3). Here we use satellite laser altimetry and modelling of the surface firn layer to reveal the circum-Antarctic pattern of ice-shelf thinning through increased basal melt. We deduce that this increased melt is the primary control of Antarctic ice-sheet loss, through a reduction in buttressing of the adjacent ice sheet leading to accelerated glacier flow(2). The highest thinning rates occur where warm water at depth can access thick ice shelves via submarine troughs crossing the continental shelf. Wind forcing could explain the dominant patterns of both basal melting and the surface melting and collapse of Antarctic ice shelves, through ocean upwelling in the Amundsen(6) and Bellingshausen(7) seas, and atmospheric warming on the Antarctic Peninsula(8). This implies that climate forcing through changing winds influences Antarctic ice-sheet mass balance, and hence global sea level, on annual to decadal timescales.	[Pritchard, H. D.; Vaughan, D. G.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Ligtenberg, S. R. M.; van den Broeke, M. R.] Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TA Utrecht, Netherlands; [Fricker, H. A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Padman, L.] Earth & Space Res, Corvallis, OR 97333 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Utrecht University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Pritchard, HD (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	h.pritchard@bas.ac.uk	Vaughan, David/C-8348-2011; Ligtenberg, Stefan/AAF-8290-2020; Padman, Laurence/AAH-3808-2021; Van den Broeke, Michiel R./F-7867-2011; Pritchard, Hamish Daniel/AAU-4696-2021	Van den Broeke, Michiel R./0000-0003-4662-7565; Vaughan, David/0000-0002-9065-0570; Fricker, Helen Amanda/0000-0002-0921-1432; Padman, Laurence/0000-0003-2010-642X	European Union [226375]; Natural Environment Research Council [bas0100027] Funding Source: researchfish	European Union(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funding from the ice2sea programme from the European Union 7th Framework Programme, grant number 226375. This is ice2sea contribution number 056. We thank NASA's ICESat Science Project for distribution of the ICESat data (see http://icesat.gsfc.nasa.gov and http://nsidc.org/data/icesat). We also thank T. Urban for providing ICESat bias corrections and R. Arthern for assistance with error assessment. This paper is ESR contribution 146.	Bindschadler R, 2011, CRYOSPHERE, V5, P569, DOI 10.5194/tc-5-569-2011; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Fyfe JC, 2005, J CLIMATE, V18, P3068, DOI 10.1175/JCLI3447.1; Gagliardini O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043334; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Hogg AM, 2008, J CLIMATE, V21, P608, DOI 10.1175/2007JCLI1925.1; Holland PR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047245; Holland PR, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005219; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004449; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Marshall GJ, 2006, J CLIMATE, V19, P5388, DOI 10.1175/JCLI3844.1; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Meredith MP, 2010, PROG OCEANOGR, V87, P127, DOI 10.1016/j.pocean.2010.09.019; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Pritchard H. D., 2012, CORRECTED ICESAT ALT; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Schneider DP, 2012, CLIM DYNAM, V38, P323, DOI 10.1007/s00382-010-0985-x; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Shuman CA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025227; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steig EJ, 2012, ANN GLACIOL, V53, P19, DOI 10.3189/2012AoG60A110; Tedesco M, 2009, REMOTE SENS ENVIRON, V113, P979, DOI 10.1016/j.rse.2009.01.009; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Timmermann R., 2010, EARTH SYST SCI DATA, V2, P261, DOI [10.5194/essd-2-261-2010, DOI 10.5194/ESSD-2-261-2010]; Wahlin AK, 2010, J PHYS OCEANOGR, V40, P1427, DOI 10.1175/2010JPO4431.1; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219	31	813	825	20	407	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					502	505		10.1038/nature10968	http://dx.doi.org/10.1038/nature10968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538614				2022-12-28	WOS:000303200400048
J	Stern, A				Stern, Alan			Commercial space flight is a game-changer	NATURE			English	Editorial Material									[Stern, Alan] NASA, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA)	Stern, A (corresponding author), NASA, Washington, DC 20546 USA.	astern2010@aol.com							0	6	6	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					417	417		10.1038/484417a	http://dx.doi.org/10.1038/484417a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538563	Bronze			2022-12-28	WOS:000303200400009
J	Psaty, BM; Meslin, EM; Breckenridge, A				Psaty, Bruce M.; Meslin, Eric M.; Breckenridge, Alasdair			A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions Opportunities Provided by a New IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46204 USA; [Breckenridge, Alasdair] Med & Healthcare Prod Regulatory Agcy MHRA, London, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Indiana University System; Indiana University-Purdue University Indianapolis; The Medicines & Healthcare Products Regulatory Agency	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NCRR NIH HHS [UL1RR025761-01] Funding Source: Medline; NHLBI NIH HHS [HL080295, HL078888, HL103612, HL087652, HL105756, HL085251] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, U01HL080295, R01HL087652, R01HL078888, R01HL080295, R01HL105756, R01HL103612] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], POT SIGN SER RISKS N; Briesacher BA, 2012, METHODS EVALUATE IMP; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Food and Drug Administration, 2008, GUID IND DIAB MELL E; [Institute of Medicine of the National Academies Committee on the Assessment of the U. S. Drug Safety System], 2006, FUT DRUG SAF PROM PR; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Powers A, 2012, ARCH INTERN MED, V172, P72, DOI 10.1001/archinternmed.2011.525; U.S. Department of Health and Human Services; U.S. Food and Drug Administration, 2011, ADV REG SCI FDA STRA	8	30	30	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2491	2492		10.1001/jama.2012.5545	http://dx.doi.org/10.1001/jama.2012.5545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22563032				2022-12-28	WOS:000305391400022
J	Zeitler, P; Hirst, K; Pyle, L; Linder, B; Copeland, K; Arslanian, S; Cuttler, L; Nathan, DM; Tollefsen, S; Wilfley, D; Kaufman, F				Zeitler, Phil; Hirst, Kathryn; Pyle, Laura; Linder, Barbara; Copeland, Kenneth; Arslanian, Silva; Cuttler, Leona; Nathan, David M.; Tollefsen, Sherida; Wilfley, Denise; Kaufman, Francine		TODAY Study Grp	A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBESE BLACK; INSULIN; ADOLESCENTS; METFORMIN; AMERICAN; MELLITUS; CHILDREN; FAT	BACKGROUND Despite the increasing prevalence of type 2 diabetes in youth, there are few data to guide treatment. We compared the efficacy of three treatment regimens to achieve durable glycemic control in children and adolescents with recent-onset type 2 diabetes. METHODS Eligible patients 10 to 17 years of age were treated with metformin (at a dose of 1000 mg twice daily) to attain a glycated hemoglobin level of less than 8% and were randomly assigned to continued treatment with metformin alone or to metformin combined with rosiglitazone (4 mg twice a day) or a lifestyle-intervention program focusing on weight loss through eating and activity behaviors. The primary outcome was loss of glycemic control, defined as a glycated hemoglobin level of at least 8% for 6 months or sustained metabolic decompensation requiring insulin. RESULTS Of the 699 randomly assigned participants (mean duration of diagnosed type 2 diabetes, 7.8 months), 319 (45.6%) reached the primary outcome over an average follow-up of 3.86 years. Rates of failure were 51.7% (120 of 232 participants), 38.6% (90 of 233), and 46.6% (109 of 234) for metformin alone, metformin plus rosiglitazone, and metformin plus lifestyle intervention, respectively. Metformin plus rosiglitazone was superior to metformin alone (P = 0.006); metformin plus lifestyle intervention was intermediate but not significantly different from metformin alone or metformin plus rosiglitazone. Prespecified analyses according to sex and race or ethnic group showed differences in sustained effectiveness, with metformin alone least effective in non-Hispanic black participants and metformin plus rosiglitazone most effective in girls. Serious adverse events were reported in 19.2% of participants. CONCLUSIONS Monotherapy with metformin was associated with durable glycemic control in approximately half of children and adolescents with type 2 diabetes. The addition of rosiglitazone, but not an intensive lifestyle intervention, was superior to metformin alone. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; TODAY ClinicalTrials.gov number, NCT00081328.)	[Zeitler, Phil] Univ Colorado, Denver, CO 80202 USA; [Hirst, Kathryn; Pyle, Laura] George Washington Univ, Washington, DC USA; [Linder, Barbara] NIDDK, Bethesda, MD USA; [Copeland, Kenneth] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Arslanian, Silva] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Cuttler, Leona] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Nathan, David M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tollefsen, Sherida] St Louis Univ, St Louis, MO 63103 USA; [Wilfley, Denise] Washington Univ, St Louis, MO 63130 USA; [Kaufman, Francine] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Colorado System; University of Colorado Denver; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; Harvard University; Massachusetts General Hospital; Saint Louis University; Washington University (WUSTL); Children's Hospital Los Angeles	Hirst, K (corresponding author), George Washington Univ, Ctr Biostat, 6110 Execut Blvd,Suite 750, Rockville, MD 20850 USA.	khirst@bsc.gwu.edu	Shepherd, John/S-3146-2018; Pyle, Laura/I-8733-2019	Shepherd, John/0000-0003-2280-2541; Pyle, Laura/0000-0001-5577-8221; Kelsey, Megan/0000-0002-0755-1951; Domalpally, Amitha/0000-0002-8145-9619; Songer, Thomas/0000-0002-5253-2514; Willi, Steven/0000-0002-4910-2425; Gidding, Samuel/0000-0002-8557-7225; Kriska, Andrea/0000-0002-3522-0869; Zeitler, Philip/0000-0001-5756-7858; Ievers-Landis, Carolyn/0000-0002-9116-3774; Higgins, Janine/0000-0002-4273-194X	NIDDK [U01-DK61212, U01-DK61230, U01-DK61239, U01-DK61242, U01-DK61254]; National Center for Research Resources (NCRR) [M01-RR00036, M01-RR00043-45, M01-RR00069, M01-RR00084, M01-RR01066, M01-RR00125, M01-RR14467, UL1-RR024134, UL1-RR024139, UL1-RR024153, UL1-RR024989, UL1-RR024992, UL1-RR025758, UL1-RR025780]; Sanofi-Aventis; Novo Nordisk; Bristol-Myers Squibb; Daiichi Sankyo (Clinical Trial Steering Committee); DPS Health; UnitedHealth Group; Jenny Craig; Nestle; Shire on; Merck; National Institute of Diabetes and Digestive and Kidney Diseases [NCT00081328]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, UL1TR000130] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, M01RR000125, UL1RR024992, M01RR014467, M01RR000036, M01RR000084, UL1RR024139, M01RR000043, M01RR000069, UL1RR025780, UL1RR024989, UL1RR025758, UL1RR024134, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061254, U01DK061239, U01DK061212, P30DK092950, U01DK061242, U01DK061230] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Sanofi-Aventis(Sanofi-Aventis); Novo Nordisk(Novo Nordisk); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo (Clinical Trial Steering Committee)(Daiichi Sankyo Company Limited); DPS Health; UnitedHealth Group; Jenny Craig; Nestle(Nestle SA); Shire on; Merck(Merck & Company); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the NIDDK (U01-DK61212, U01-DK61230, U01-DK61239, U01-DK61242, and U01-DK61254) and the National Center for Research Resources (NCRR) (M01-RR00036, to the Washington University School of Medicine; M01-RR00043-45, to Children's Hospital Los Angeles; M01-RR00069, to the University of Colorado Denver; M01-RR00084, to Children's Hospital of Pittsburgh; M01-RR01066, to Massachusetts General Hospital; M01-RR00125, to Yale University; and M01-RR14467, to the University of Oklahoma Health Sciences Center); by NCRR Clinical and Translational Science Awards (UL1-RR024134, to Children's Hospital of Philadelphia; UL1-RR024139, to Yale University; UL1-RR024153, to Children's Hospital of Pittsburgh; UL1-RR024989, to Case Western Reserve University; UL1-RR024992, to Washington University in St. Louis; UL1-RR025758, to Massachusetts General Hospital; and UL1-RR025780, to the University of Colorado Denver); and by donations from Becton Dickinson, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, LifeScan, Pfizer, and Sanofi-Aventis.; Dr. Arslanian reports receiving consulting fees from Sanofi-Aventis, Novo Nordisk, and Bristol-Myers Squibb and serving on the data and safety monitoring board of Boehringer Ingelheim. Dr. Copeland reports receiving consulting fees from Novo Nordisk (advisory board membership) and from Daiichi Sankyo (Clinical Trial Steering Committee). Dr. Kaufman reports receiving consulting fees from DPS Health and being an employee of Medtronic. Dr. Wilfley reports receiving consulting fees from UnitedHealth Group, Jenny Craig, and Nestle and receiving grant support from Shire on behalf of her institution. Dr. Zeitler reports receiving consulting fees from Daiichi Sankyo, Merck, and Bristol-Myers Squibb on behalf of his institution. No other potential conflict of interest relevant to this article was reported.; Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; TODAY ClinicalTrials.gov number, NCT00081328.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Andreacci JL, 2005, PEDIATR RES, V58, P478, DOI 10.1203/01.pdr.0000176909.66057.a3; Bacha F, 2003, J CLIN ENDOCR METAB, V88, P2534, DOI 10.1210/jc.2002-021267; Bacha F, 2011, PEDIAT DIABETES 0920; Brown JB, 2010, DIABETES CARE, V33, P501, DOI 10.2337/dc09-1749; Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Grey M, 2009, DIABETES EDUCATOR, V35, P108, DOI 10.1177/0145721708325156; Hasson RE, 2010, J CLIN ENDOCR METAB, V95, P4048, DOI 10.1210/jc.2010-0018; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Klingensmith GJ, 2010, DIABETES CARE, V33, P1970, DOI 10.2337/dc10-0373; Lee S, 2006, DIABETES CARE, V29, P51, DOI 10.2337/diacare.29.1.51; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Pinhas-Hamiel O, 1999, ARCH PEDIAT ADOL MED, V153, P1063, DOI 10.1001/archpedi.153.10.1063; Pinhas-Hamiel O, 2007, PEDIATR DIABETES, V8, P16, DOI 10.1111/j.1399-5448.2007.00330.x; Pinhas-Hamiel Orit, 2003, Pediatr Diabetes, V4, P24, DOI 10.1034/j.1399-5448.2003.00027.x; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Wilfley DE, 2010, INT J OBESITY, V34, P217, DOI 10.1038/ijo.2009.195	20	567	571	3	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2247	2256		10.1056/NEJMoa1109333	http://dx.doi.org/10.1056/NEJMoa1109333			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22540912	Green Accepted			2022-12-28	WOS:000305174100005
J	Nambi, V; Pedroza, C; Kao, LS				Nambi, Vijay; Pedroza, Claudia; Kao, Lillian S.			Carotid intima-media thickness and cardiovascular events	LANCET			English	Editorial Material							META-REGRESSION; METAANALYSIS; RISK; ATHEROSCLEROSIS		[Nambi, Vijay] Baylor Coll Med, Dept Med, Div Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Nambi, Vijay] Ben Taub Gen Hosp, Ctr Cardiovasc Prevent, Methodist DeBakey Heart & Vasc Ctr, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Hlth Sci Ctr, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Kao, Lillian S.] Univ Texas Hlth Sci Ctr, Dept Surg, Houston, TX USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Nambi, V (corresponding author), Baylor Coll Med, Dept Med, Div Atherosclerosis & Vasc Med, Houston, TX 77030 USA.	vnambi@bcm.edu	Kao, Lillian/GOV-7076-2022	Pedroza, Claudia/0000-0003-4235-1282				Costanzo P, 2010, J AM COLL CARDIOL, V56, P2006, DOI 10.1016/j.jacc.2010.05.059; Goldberger ZD, 2010, AM HEART J, V160, P701, DOI 10.1016/j.ahj.2010.06.029; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Simmonds MC, 2007, STAT MED, V26, P2982, DOI 10.1002/sim.2768; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sud Sachin, 2009, Evid Based Med, V14, P100, DOI 10.1136/ebm.14.4.100	9	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2028	2030		10.1016/S0140-6736(12)60652-7	http://dx.doi.org/10.1016/S0140-6736(12)60652-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22541276				2022-12-28	WOS:000304759100009
J	Koskela, HLM; Eldfors, S; Ellonen, P; van Adrichem, AJ; Kuusanmaki, H; Andersson, EI; Lagstrom, S; Clemente, MJ; Olson, T; Jalkanen, SE; Majumder, MM; Almusa, H; Edgren, H; Lepisto, M; Mattila, P; Guinta, K; Koistinen, P; Kuittinen, T; Penttinen, K; Parsons, A; Knowles, J; Saarela, J; Wennerberg, K; Kallioniemi, O; Porkka, K; Loughran, TP; Heckman, CA; Maciejewski, JP; Mustjoki, S				Koskela, Hanna L. M.; Eldfors, Samuli; Ellonen, Pekka; van Adrichem, Arjan J.; Kuusanmaki, Heikki; Andersson, Emma I.; Lagstrom, Sonja; Clemente, Michael J.; Olson, Thomas; Jalkanen, Sari E.; Majumder, Muntasir Mamun; Almusa, Henrikki; Edgren, Henrik; Lepisto, Maija; Mattila, Pirkko; Guinta, Kathryn; Koistinen, Pirjo; Kuittinen, Taru; Penttinen, Kati; Parsons, Alun; Knowles, Jonathan; Saarela, Janna; Wennerberg, Krister; Kallioniemi, Olli; Porkka, Kimmo; Loughran, Thomas P., Jr.; Heckman, Caroline A.; Maciejewski, Jaroslaw P.; Mustjoki, Satu			Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LGL LEUKEMIA; ACTIVATION; APOPTOSIS; CELLS; NEUTROPENIA; EXPANSION; SURVIVAL; TRANSPLANTATION; CYTOKINES; PROTECTS	BACKGROUND T-cell large granular lymphocytic leukemia is a rare lymphoproliferative disorder characterized by the expansion of clonal CD3+CD8+ cytotoxic T lymphocytes (CTLs) and often associated with autoimmune disorders and immune-mediated cytopenias. METHODS We used next-generation exome sequencing to identify somatic mutations in CTLs from an index patient with large granular lymphocytic leukemia. Targeted resequencing was performed in a well-characterized cohort of 76 patients with this disorder, characterized by clonal T-cell-receptor rearrangements and increased numbers of large granular lymphocytes. RESULTS Mutations in the signal transducer and activator of transcription 3 gene (STAT3) were found in 31 of 77 patients (40%) with large granular lymphocytic leukemia. Among these 31 patients, recurrent mutational hot spots included Y640F in 13 (17%), D661V in 7 (9%), D661Y in 7 (9%), and N647I in 3 (4%). All mutations were located in exon 21, encoding the Src homology 2 (SH2) domain, which mediates the dimerization and activation of STAT protein. The amino acid changes resulted in a more hydrophobic protein surface and were associated with phosphorylation of STAT3 and its localization in the nucleus. In vitro functional studies showed that the Y640F and D661V mutations increased the transcriptional activity of STAT3. In the affected patients, downstream target genes of the STAT3 pathway (IFNGR2, BCL2L1, and JAK2) were up-regulated. Patients with STAT3 mutations presented more often with neutropenia and rheumatoid arthritis than did patients without these mutations. CONCLUSIONS The SH2 dimerization and activation domain of STAT3 is frequently mutated in patients with large granular lymphocytic leukemia; these findings suggest that aberrant STAT3 signaling underlies the pathogenesis of this disease.	[Koskela, Hanna L. M.; Andersson, Emma I.; Jalkanen, Sari E.; Penttinen, Kati; Porkka, Kimmo; Mustjoki, Satu] Univ Helsinki, Hematol Res Unit Helsinki, Dept Med, FIN-00029 Helsinki, Finland; [Koskela, Hanna L. M.; Andersson, Emma I.; Jalkanen, Sari E.; Penttinen, Kati; Porkka, Kimmo; Mustjoki, Satu] Univ Helsinki, Cent Hosp, FIN-00029 Helsinki, Finland; [Eldfors, Samuli; Ellonen, Pekka; van Adrichem, Arjan J.; Kuusanmaki, Heikki; Lagstrom, Sonja; Majumder, Muntasir Mamun; Almusa, Henrikki; Edgren, Henrik; Lepisto, Maija; Mattila, Pirkko; Parsons, Alun; Knowles, Jonathan; Saarela, Janna; Wennerberg, Krister; Kallioniemi, Olli; Heckman, Caroline A.] Univ Helsinki, Inst Mol Med Finland, FIN-00029 Helsinki, Finland; [Mattila, Pirkko] Univ Helsinki, Haartman Inst, FIN-00029 Helsinki, Finland; [Koistinen, Pirjo] Oulu Univ Hosp, Dept Med, Oulu, Finland; [Koistinen, Pirjo] Univ Oulu, Oulu, Finland; [Kuittinen, Taru] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Clemente, Michael J.; Guinta, Kathryn; Maciejewski, Jaroslaw P.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Olson, Thomas; Loughran, Thomas P., Jr.] Penn State Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mustjoki, S (corresponding author), Univ Helsinki, Hematol Res Unit Helsinki, Dept Med, POB 700,Haartmaninkatu 8, FIN-00029 Helsinki, Finland.	satu.mustjoki@helsinki.fi	He, Liye/C-8843-2015; Wennerberg, Krister/AFM-0539-2022; Mustjoki, Satu/AAD-9974-2020; Eldfors, Samuli/AAB-3029-2019; Kallioniemi, Olli P/H-5111-2011; Wennerberg, Krister/AAH-2919-2022; Saarela, Janna S/E-5369-2014; Porkka, Kimmo/O-2323-2016	He, Liye/0000-0002-6632-2112; Wennerberg, Krister/0000-0002-1352-4220; Mustjoki, Satu/0000-0002-0816-8241; Eldfors, Samuli/0000-0001-5056-4750; Kallioniemi, Olli P/0000-0002-3231-0332; Wennerberg, Krister/0000-0002-1352-4220; Clemente, Michael/0000-0003-4345-3934; Andersson, Emma/0000-0002-3986-9892; Olson, Thomas/0000-0001-7906-205X; Saarela, Janna/0000-0002-0853-6219; Lepisto, Maija Helena/0000-0002-2595-1465; Ellonen, Pekka/0000-0001-6072-0489; Kuusanmaki, Heikki/0000-0002-1903-0408; Rajala, Hanna/0000-0003-2675-2385; Porkka, Kimmo/0000-0003-4112-5902; Heckman, Caroline/0000-0002-4324-8706; Majumder, Muntasir Mamun/0000-0002-5550-2951	Academy of Finland and others; Finnish government; Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Association of Hematology; National Clinical Graduate School; Finnish Funding Agency for Technology and Innovation; European Regional Development Fund; Jane and Aatos Erkko Foundation; K.A. Johansson Foundation; Signe and Ane Gyllenberg Foundation; National Institutes of Health [R01 CA127264A, R01AI085578, CA98472, 2K24HL077522]; Cancer Foundation Finland sr [100118, 110101] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA127264, R01CA098472] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL077522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085578] Funding Source: NIH RePORTER	Academy of Finland and others; Finnish government; Academy of Finland(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Association of Hematology; National Clinical Graduate School; Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); European Regional Development Fund(European Commission); Jane and Aatos Erkko Foundation; K.A. Johansson Foundation; Signe and Ane Gyllenberg Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Academy of Finland and others.; Supported by a special subsidy for health sciences, research, and training provided by the Finnish government and by grants from the Academy of Finland, the Finnish Cancer Societies, the Sigrid Juselius Foundation, the Finnish Association of Hematology, the National Clinical Graduate School, the Finnish Funding Agency for Technology and Innovation, the European Regional Development Fund, the Jane and Aatos Erkko Foundation, the K.A. Johansson Foundation, and the Signe and Ane Gyllenberg Foundation, and by grants from the National Institutes of Health (R01 CA127264A, to Mr. Clemente; R01AI085578, to Ms. Guinta; CA98472, to Dr. Loughran; and 2K24HL077522, to Dr. Maciejewski).	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burks EJ, 2006, BLOOD REV, V20, P245, DOI 10.1016/j.blre.2006.01.003; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Clemente MJ, 2011, BLOOD, V118, P4384, DOI 10.1182/blood-2011-02-338517; Epling-Burnett PK, 2004, ONCOGENE, V23, P9220, DOI 10.1038/sj.onc.1208122; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gentile TC, 1998, BRIT J HAEMATOL, V101, P507, DOI 10.1046/j.1365-2141.1998.00712.x; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hayakawa F, 2011, 53 AM SOC HEM ANN M; Kothapalli R, 2005, INT J ONCOL, V26, P529; Lamy T, 1998, BLOOD, V92, P4771, DOI 10.1182/blood.V92.12.4771.424k32_4771_4777; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu JH, 2000, BLOOD, V95, P3219; LOUGHRAN TP, 1985, ANN INTERN MED, V102, P169, DOI 10.7326/0003-4819-102-2-169; LOUGHRAN TP, 1993, BLOOD, V82, P1; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mohty M, 2002, LEUKEMIA, V16, P2129, DOI 10.1038/sj.leu.2402645; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Ramos HL, 2008, SCAND J RHEUMATOL, V37, P35, DOI 10.1080/03009740701606010; Rossi D, 2007, AM J HEMATOL, V82, P1103, DOI 10.1002/ajh.20981; Scarzello AJ, 2007, MOL BIOL CELL, V18, P2455, DOI 10.1091/mbc.E06-09-0843; Schade AE, 2006, CELL CYCLE, V5, P2571, DOI 10.4161/cc.5.22.3449; Schade AE, 2006, BLOOD, V107, P4834, DOI 10.1182/blood-2005-08-3076; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Sokol L, 2006, ONCOLOGIST, V11, P263, DOI 10.1007/s11899-007-0038-7; Takeda K, 1998, J IMMUNOL, V161, P4652; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; WANG F, 1995, J EXP MED, V182, P1825, DOI 10.1084/jem.182.6.1825; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yang J, 2008, BLOOD, V111, P1610, DOI 10.1182/blood-2007-06-093823; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105	35	519	538	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1905	1913		10.1056/NEJMoa1114885	http://dx.doi.org/10.1056/NEJMoa1114885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591296	Bronze, Green Accepted			2022-12-28	WOS:000304083000009
J	Shafir, D; Soifer, H; Bruner, BD; Dagan, M; Mairesse, Y; Patchkovskii, S; Ivanov, MY; Smirnova, O; Dudovich, N				Shafir, Dror; Soifer, Hadas; Bruner, Barry D.; Dagan, Michal; Mairesse, Yann; Patchkovskii, Serguei; Ivanov, Misha Yu.; Smirnova, Olga; Dudovich, Nirit			Resolving the time when an electron exits a tunnelling barrier	NATURE			English	Article							ATTOSECOND; IONIZATION; FIELD; MOLECULES; DYNAMICS; WAVE; DIFFRACTION; ATOMS; DELAY	The tunnelling of a particle through a barrier is one of the most fundamental and ubiquitous quantum processes. When induced by an intense laser field, electron tunnelling from atoms and molecules initiates a broad range of phenomena such as the generation of attosecond pulses(1), laser-induced electron diffraction(2,3) and holography(2,4). These processes evolve on the attosecond timescale (1 attosecond equivalent to 1 as = 10(-18) seconds) and are well suited to the investigation of a general issue much debated since the early days of quantum mechanics(5-7)-the link between the tunnelling of an electron through a barrier and its dynamics outside the barrier. Previous experiments have measured tunnelling rates with attosecond time resolution(8) and tunnelling delay times(9). Here we study laser-induced tunnelling by using a weak probe field to steer the tunnelled electron in the lateral direction and then monitor the effect on the attosecond light bursts emitted when the liberated electron re-encounters the parent ion(10). We show that this approach allows us to measure the time at which the electron exits from the tunnelling barrier. We demonstrate the high sensitivity of the measurement by detecting subtle delays in ionization times from two orbitals of a carbon dioxide molecule. Measurement of the tunnelling process is essential for all attosecond experiments where strong-field ionization initiates ultrafast dynamics(10). Our approach provides a general tool for time-resolving multi-electron rearrangements in atoms and molecules(11-13)-one of the key challenges in ultrafast science.	[Shafir, Dror; Soifer, Hadas; Bruner, Barry D.; Dagan, Michal; Dudovich, Nirit] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Mairesse, Yann] Univ Bordeaux 1, CEA, CNRS, CELIA,UMR5107, F-33400 Talence, France; [Patchkovskii, Serguei] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Ivanov, Misha Yu.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Ivanov, Misha Yu.; Smirnova, Olga] Max Born Inst Nonlinear Opt & Short Pulse Spect, D-12489 Berlin, Germany	Weizmann Institute of Science; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; National Research Council Canada; Imperial College London; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Dudovich, N (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	nirit.dudovich@weizmann.ac.il	Soifer, Hadas/G-5522-2010; Mairesse, Yann/B-3049-2015; Ivanov, Mikhail/AAG-1727-2021	Soifer, Hadas/0000-0001-8879-0577; Mairesse, Yann/0000-0002-9098-7421; Bruner, Barry/0000-0003-3915-6304	Minerva Foundation; Israeli Science Foundation; Crown Center of Photonics; Israeli Ministry of Science; Israel Academy of Sciences and Humanities; DFG [Sm292/2-1]; EPSRC [EP/I032517/1, EP/I0325171/1]; ANR [ANR-08-JCJC-0029 HarModyn]; Conseil Regional d'Aquitaine [20091304003 AttoMol]; Engineering and Physical Sciences Research Council [EP/I032517/1, EP/E036112/1] Funding Source: researchfish; EPSRC [EP/E036112/1] Funding Source: UKRI	Minerva Foundation; Israeli Science Foundation(Israel Science Foundation); Crown Center of Photonics; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Israel Academy of Sciences and Humanities; DFG(German Research Foundation (DFG)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ANR(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	N.D. acknowledges the Minerva Foundation, the Israeli Science Foundation and the Crown Center of Photonics for financial support. N.D. and O.S. acknowledge the German-Israeli Foundation, and D. S. acknowledges support from the Converging Technologies Fellowship of the Israeli Ministry of Science. H. S. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. O.S. acknowledges the support of the DFG grant Sm292/2-1, and M.Yu.I. acknowledges the support of the EPSRC programme grant EP/I032517/1. Y.M. acknowledges financial support from the ANR (ANR-08-JCJC-0029 HarModyn) and the Conseil Regional d'Aquitaine (20091304003 AttoMol). M. I. acknowledges support of the EPSRC Programme Grant EP/I0325171/1.	Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; BUTTIKER M, 1982, PHYS REV LETT, V49, P1739, DOI 10.1103/PhysRevLett.49.1739; Chirila CC, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.033412; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dahlstrom JM, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/9/095602; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Haessler S, 2010, NAT PHYS, V6, P200, DOI 10.1038/NPHYS1511; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Huismans Y, 2011, SCIENCE, V331, P61, DOI 10.1126/science.1198450; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; LANDAUER R, 1994, REV MOD PHYS, V66, P217, DOI 10.1103/RevModPhys.66.217; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Mairesse Y, 2003, SCIENCE, V302, P1540, DOI 10.1126/science.1090277; Mairesse Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.213601; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Murray R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.173001; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Perelomov M. A., 1967, SOV PHYS JETP, V24, P207; Pfeiffer AN, 2012, NAT PHYS, V8, P76, DOI 10.1038/nphys2125; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Shafir D, 2009, NAT PHYS, V5, P412, DOI 10.1038/NPHYS1251; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Spanner M, 2004, J PHYS B-AT MOL OPT, V37, pL243, DOI 10.1088/0953-4075/37/12/L02; Steinberg M. A., 1993, PHYS REV LETT, V71, P708; Tong XM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233203; Uiberacker M, 2007, NATURE, V446, P627, DOI 10.1038/nature05648; Walters ZB, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/16/161002	30	350	354	8	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					343	346		10.1038/nature11025	http://dx.doi.org/10.1038/nature11025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596157				2022-12-28	WOS:000304099100036
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Can a simple blood test really predict breast cancer?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Breast Cancer Campaign, 2012, BREAST CANC RISK CAN; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Hope J., 2012, DAILY MAIL      0501; In Touch, 2012, BBC RADIO 4     0501; Quinn B, 2012, GUARDIAN        0430; Smith R., 2012, TELEGRAPH       0430	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e3374	10.1136/bmj.e3374	http://dx.doi.org/10.1136/bmj.e3374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589526				2022-12-28	WOS:000304086900020
J	Keinan, A; Clark, AG				Keinan, Alon; Clark, Andrew G.			Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants	SCIENCE			English	Article							MISSING HERITABILITY; COALESCENT; SPECTRUM; DISEASE; SAMPLE; COMMON; RISK	Human populations have experienced recent explosive growth, expanding by at least three orders of magnitude over the past 400 generations. This departure from equilibrium skews patterns of genetic variation and distorts basic principles of population genetics. We characterized the empirical signatures of explosive growth on the site frequency spectrum and found that the discrepancy in rare variant abundance across demographic modeling studies is mostly due to differences in sample size. Rapid recent growth increases the load of rare variants and is likely to play a role in the individual genetic burden of complex disease risk. Hence, the extreme recent human population growth needs to be taken into consideration in studying the genetics of complex diseases and traits.	[Keinan, Alon; Clark, Andrew G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	ak735@cornell.edu		Keinan, Alon/0000-0002-9760-1122; Clark, Andrew/0000-0001-7159-8511	NIH [U01-HG005715, GM065509, HL102419]; Alfred P. Sloan Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, U01HG005715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Blekhman, E. Boerwinkle, C. D. Bustamante, A. Coventry, E. Gazave, S. Gravel, H. Hunter-Zinck, J. M. Kidd, L. Ma, C. F. Sing, and the 1000 Genomes Project for discussion and ongoing collaborations that substantively advanced this project. Supported by NIH grants U01-HG005715, GM065509, and HL102419, and by an Alfred P. Sloan Research Fellowship (A.K.).	Akey J, 2011, GENOME BIOL, V12, P1, DOI 10.1186/1465-6906-12-S1-I1; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Cohen J. E., 1995, MANY PEOPLE CAN EART; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fawcett KA, 2010, DIABETES, V59, P741, DOI 10.2337/db09-0920; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haub C, 1995, Popul Today, V23, P4; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Novembre J., 2011, 12 INT C HUM GEN 12; Pitman J, 1999, ANN PROBAB, V27, P1870, DOI 10.1214/aop/1022677552; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Sagitov S, 1999, J APPL PROBAB, V36, P1116, DOI 10.1239/jap/1032374759; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schweinsberg J, 2000, ELECTRON COMMUN PROB, V5, P1, DOI 10.1214/EJP.v5-68; Tennessen JA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-127; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	30	362	367	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					740	743		10.1126/science.1217283	http://dx.doi.org/10.1126/science.1217283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582263	Green Accepted			2022-12-28	WOS:000303872300055
J	Bornscheuer, UT; Huisman, GW; Kazlauskas, RJ; Lutz, S; Moore, JC; Robins, K				Bornscheuer, U. T.; Huisman, G. W.; Kazlauskas, R. J.; Lutz, S.; Moore, J. C.; Robins, K.			Engineering the third wave of biocatalysis	NATURE			English	Review							DIRECTED EVOLUTION; AMINO-ACID; ENANTIOSELECTIVE BIOCATALYSTS; SATURATION MUTAGENESIS; COMPUTATIONAL DESIGN; FLUORESCENS ESTERASE; ASYMMETRIC-SYNTHESIS; MICROBIAL-PRODUCTION; ESCHERICHIA-COLI; ENZYME EVOLUTION	Over the past ten years, scientific and technological advances have established biocatalysis as a practical and environmentally friendly alternative to traditional metallo- and organocatalysis in chemical synthesis, both in the laboratory and on an industrial scale. Key advances in DNA sequencing and gene synthesis are at the base of tremendous progress in tailoring biocatalysts by protein engineering and design, and the ability to reorganize enzymes into new biosynthetic pathways. To highlight these achievements, here we discuss applications of protein-engineered biocatalysts ranging from commodity chemicals to advanced pharmaceutical intermediates that use enzyme catalysis as a key step.	[Bornscheuer, U. T.] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, D-17487 Greifswald, Germany; [Huisman, G. W.] Codexis Inc, Redwood City, CA 94063 USA; [Kazlauskas, R. J.] Univ Minnesota, Inst Biotechnol, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [Kazlauskas, R. J.] Seoul Natl Univ, Dept Chem & Biol Engn, Seoul 151744, South Korea; [Lutz, S.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Moore, J. C.] Merck & Co Inc, Merck Res Labs, Rahway, NJ 07065 USA; [Robins, K.] Lonza AG, Valais Works, CH-3930 Visp, Switzerland	Ernst Moritz Arndt Universitat Greifswald; University of Minnesota System; University of Minnesota Twin Cities; Seoul National University (SNU); Emory University; Merck & Company; Lonza Group	Bornscheuer, UT (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Felix Hausdorff Str 4, D-17487 Greifswald, Germany.	uwe.bornscheuer@uni-greifswald.de	Lutz, Stefan/H-7853-2013; Bornscheuer, Uwe T/C-4612-2012	Bornscheuer, Uwe T/0000-0003-0685-2696; Huisman, Gjalt/0000-0003-1955-1120; Kazlauskas, Romas/0000-0002-3570-2411	US National Science Foundation [CBET-0932762, CBET-0730312]; Korea Science and Engineering Foundation; Ministry of Education, Science and Technology [R32-2008-000-10213-0]; German Research Foundation [SPP 1170, Bo1864/4-1]; Directorate For Engineering [0932762] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); German Research Foundation(German Research Foundation (DFG)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank H.-P. Meyer and R. Fox for discussions. R.J.K. thanks the US National Science Foundation (CBET-0932762) and the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (WCU programme R32-2008-000-10213-0). U. T. B. and S. L. thank the German Research Foundation (SPP 1170, Bo1864/4-1) and, respectively, the US National Science Foundation (CBET-0730312) for financial support.	Anastas P. T., 1998, GREEN CHEM THEORY PR; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Asano Y, 1999, J MOL CATAL B-ENZYM, V6, P271, DOI 10.1016/S1381-1177(98)00081-2; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Becker S, 2008, ANGEW CHEM INT EDIT, V47, P5085, DOI 10.1002/anie.200705236; Bernath K, 2004, ANAL BIOCHEM, V325, P151, DOI 10.1016/j.ab.2003.10.005; Bloom JD, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-17; Bohmert-Tatarev K, 2011, PLANT PHYSIOL, V155, P1690, DOI 10.1104/pp.110.169581; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Brocklehurst CE, 2011, ORG PROCESS RES DEV, V15, P294, DOI 10.1021/op1002424; Bruggink A, 1998, ORG PROCESS RES DEV, V2, P128, DOI 10.1021/op9700643; Buchholz K., 2012, BIOCATALYSTS ENZYME; Chen YJ, 2011, ORG PROCESS RES DEV, V15, P241, DOI 10.1021/op1001534; Cobley CJ, 2011, ORG PROCESS RES DEV, V15, P284, DOI 10.1021/op100258j; de Lange B, 2011, CHEMCATCHEM, V3, P289, DOI 10.1002/cctc.201000435; Desai AA, 2011, ANGEW CHEM INT EDIT, V50, P1974, DOI 10.1002/anie.201007051; DeSantis G, 2003, J AM CHEM SOC, V125, P11476, DOI 10.1021/ja035742h; Drauz K., 2012, ENZYME CATALYSIS ORG, V1; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; ESTELL DA, 1985, J BIOL CHEM, V260, P6518; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fernandez-Alvaro E, 2011, ANGEW CHEM INT EDIT, V50, P8584, DOI 10.1002/anie.201102360; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; FRANCIS JC, 1972, GENETICS, V70, P59; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gooding OW, 2010, ORG PROCESS RES DEV, V14, P119, DOI 10.1021/op9002246; Greenberg WA, 2004, P NATL ACAD SCI USA, V101, P5788, DOI 10.1073/pnas.0307563101; Griengl H, 2000, TRENDS BIOTECHNOL, V18, P252, DOI 10.1016/S0167-7799(00)01452-9; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Hermann M, 2008, J BIOTECHNOL, V133, P301, DOI 10.1016/j.jbiotec.2007.10.010; Hibi M, 2011, APPL ENVIRON MICROB, V77, P6926, DOI 10.1128/AEM.05035-11; Hills G, 2003, EUR J LIPID SCI TECH, V105, P601, DOI 10.1002/ejlt.200300853; Hohne M, 2010, NAT CHEM BIOL, V6, P807, DOI [10.1038/nchembio.447, 10.1038/NCHEMBIO.447]; Horinouchi N, 2006, APPL MICROBIOL BIOT, V71, P615, DOI 10.1007/s00253-005-0205-5; Horsman GP, 2003, CHEM-EUR J, V9, P1933, DOI 10.1002/chem.200204551; Iding H., 2010, ASYMMETRIC CATALYSIS, P377; Ikenaka Y, 1999, BIOSCI BIOTECH BIOCH, V63, P91, DOI 10.1271/bbb.63.91; JENSEN VJ, 1987, METHOD ENZYMOL, V136, P356; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Liang J, 2010, ORG PROCESS RES DEV, V14, P193, DOI 10.1021/op900272d; Liang J, 2010, ORG PROCESS RES DEV, V14, P188, DOI 10.1021/op9002714; Liese A., 2006, IND BIOTRANSFORMATIO; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; LUTZ S, 2009, PROTEIN ENG HDB; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Ma SK, 2010, GREEN CHEM, V12, P81, DOI 10.1039/b919115c; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Martinez-Gomez AI, 2007, APPL ENVIRON MICROB, V73, P1525, DOI 10.1128/AEM.02365-06; McDonald TJ, 2007, NANO LETT, V7, P3528, DOI 10.1021/nl072319o; McKenna R, 2011, METAB ENG, V13, P544, DOI 10.1016/j.ymben.2011.06.005; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Moore JC, 2007, ACCOUNTS CHEM RES, V40, P1412, DOI 10.1021/ar700167a; Morikawa S, 2005, BIOSCI BIOTECH BIOCH, V69, P544, DOI 10.1271/bbb.69.544; NAGASAWA T, 1990, APPL MICROBIOL BIOT, V34, P322; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Panke S, 2005, CURR OPIN CHEM BIOL, V9, P188, DOI 10.1016/j.cbpa.2005.02.007; Park S, 2005, CHEM BIOL, V12, P45, DOI 10.1016/j.chembiol.2004.10.012; Patel RN, 2003, TETRAHEDRON-ASYMMETR, V14, P3105, DOI 10.1016/j.tetasy.2003.07.016; Rana S, 2010, CURR OPIN CHEM BIOL, V14, P828, DOI 10.1016/j.cbpa.2010.10.001; Randolph J., 2008, NUCL ACIDS S SER, V52, P479; Reetz MT, 2008, CHEMBIOCHEM, V9, P2260, DOI 10.1002/cbic.200800371; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rosenthaler L, 1908, BIOCHEM Z, V14, P238; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Rousseau AL, 2011, ORG PROCESS RES DEV, V15, P249, DOI 10.1021/op1001947; Savile CK, 2011, CURR OPIN BIOTECH, V22, P818, DOI 10.1016/j.copbio.2011.06.006; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; SEDLACZEK L, 1988, Critical Reviews in Biotechnology, V7, P187, DOI 10.3109/07388558809146602; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Strohmeier GA, 2011, CHEM REV, V111, P4141, DOI 10.1021/cr100386u; Truppo MD, 2011, ORG PROCESS RES DEV, V15, P1033, DOI 10.1021/op200157c; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Urano N, 2011, J BIOSCI BIOENG, V111, P266, DOI 10.1016/j.jbiosc.2010.11.005; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wenda S, 2011, GREEN CHEM, V13, P3007, DOI 10.1039/c1gc15579b; Wetterstrand KA, 2011, DNA SEQUENCING COSTS; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; Wiese A, 2001, APPL MICROBIOL BIOT, V55, P750, DOI 10.1007/s002530000574; Xie XK, 2006, CHEM BIOL, V13, P1161, DOI 10.1016/j.chembiol.2006.09.008; Yang TH, 2010, BIOTECHNOL BIOENG, V105, P150, DOI 10.1002/bit.22547; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	100	1647	1702	47	1580	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					185	194		10.1038/nature11117	http://dx.doi.org/10.1038/nature11117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575958				2022-12-28	WOS:000303799800031
J	McCarthy, PL; Owzar, K; Hofmeister, CC; Hurd, DD; Hassoun, H; Richardson, PG; Giralt, S; Stadtmauer, EA; Weisdorf, DJ; Vij, R; Moreb, JS; Callander, NS; Van Besien, K; Gentile, T; Isola, L; Maziarz, RT; Gabriel, DA; Bashey, A; Landau, H; Martin, T; Qazilbash, MH; Levitan, D; McClune, B; Schlossman, R; Hars, V; Postiglione, J; Jiang, C; Bennett, E; Barry, S; Bressler, L; Kelly, M; Seiler, M; Rosenbaum, C; Hari, P; Pasquini, MC; Horowitz, MM; Shea, TC; Devine, SM; Anderson, KC; Linker, C				McCarthy, Philip L.; Owzar, Kouros; Hofmeister, Craig C.; Hurd, David D.; Hassoun, Hani; Richardson, Paul G.; Giralt, Sergio; Stadtmauer, Edward A.; Weisdorf, Daniel J.; Vij, Ravi; Moreb, Jan S.; Callander, Natalie Scott; Van Besien, Koen; Gentile, Teresa; Isola, Luis; Maziarz, Richard T.; Gabriel, Don A.; Bashey, Asad; Landau, Heather; Martin, Thomas; Qazilbash, Muzaffar H.; Levitan, Denise; McClune, Brian; Schlossman, Robert; Hars, Vera; Postiglione, John; Jiang, Chen; Bennett, Elizabeth; Barry, Susan; Bressler, Linda; Kelly, Michael; Seiler, Michele; Rosenbaum, Cara; Hari, Parameswaran; Pasquini, Marcelo C.; Horowitz, Mary M.; Shea, Thomas C.; Devine, Steven M.; Anderson, Kenneth C.; Linker, Charles			Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERGROUPE FRANCOPHONE; CONSOLIDATION THERAPY; RESPONSE CRITERIA; IMPROVES SURVIVAL; MAINTENANCE; THALIDOMIDE; BORTEZOMIB; DEXAMETHASONE; LEUKEMIA; PREDNISONE	Background Data are lacking on whether lenalidomide maintenance therapy prolongs the time to disease progression after autologous hematopoietic stem-cell transplantation in patients with multiple myeloma. Methods Between April 2005 and July 2009, we randomly assigned 460 patients who were younger than 71 years of age and had stable disease or a marginal, partial, or complete response 100 days after undergoing stem-cell transplantation to lenalidomide or placebo, which was administered until disease progression. The starting dose of lenalidomide was 10 mg per day (range, 5 to 15). Results The study-drug assignments were unblinded in 2009, when a planned interim analysis showed a significantly longer time to disease progression in the lenalidomide group. At unblinding, 20% of patients who received lenalidomide and 44% of patients who received placebo had progressive disease or had died (P<0.001); of the remaining 128 patients who received placebo and who did not have progressive disease, 86 crossed over to lenalidomide. At a median follow-up of 34 months, 86 of 231 patients who received lenalidomide (37%) and 132 of 229 patients who received placebo (58%) had disease progression or had died. The median time to progression was 46 months in the lenalidomide group and 27 months in the placebo group (P<0.001). A total of 35 patients who received lenalidomide (15%) and 53 patients who received placebo (23%) died (P=0.03). More grade 3 or 4 hematologic adverse events and grade 3 non-hematologic adverse events occurred in patients who received lenalidomide (P<0.001 for both comparisons). Second primary cancers occurred in 18 patients who received lenalidomide (8%) and 6 patients who received placebo (3%). Conclusions Lenalidomide maintenance therapy, initiated at day 100 after hematopoietic stem-cell transplantation, was associated with more toxicity and second cancers but a significantly longer time to disease progression and significantly improved overall survival among patients with myeloma.	[McCarthy, Philip L.] Roswell Pk Canc Inst, BMT Program, Buffalo, NY 14263 USA; [Gentile, Teresa] SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA; [Hassoun, Hani; Giralt, Sergio; Landau, Heather] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Isola, Luis] Mt Sinai Med Ctr, BMT, New York, NY 10029 USA; [Owzar, Kouros] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Owzar, Kouros; Hars, Vera; Postiglione, John; Jiang, Chen; Bennett, Elizabeth; Barry, Susan] Duke Univ, Canc & Leukemia Grp B CALGB, Ctr Stat, Durham, NC USA; [Hurd, David D.; Levitan, Denise] Wake Forest Univ, Winston Salem, NC 27109 USA; [Gabriel, Don A.; Shea, Thomas C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hofmeister, Craig C.; Devine, Steven M.] Ohio State Univ, Div Hematol, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Richardson, Paul G.; Schlossman, Robert; Anderson, Kenneth C.] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA; [Stadtmauer, Edward A.] Univ Penn, Myeloma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Weisdorf, Daniel J.; McClune, Brian] Univ Minnesota, Med Ctr, Dept Hematol & Oncol, Minneapolis, MN 55455 USA; [Vij, Ravi] Washington Univ, Div Oncol, Sch Med, St Louis, MO 63130 USA; [Moreb, Jan S.] Univ Florida, Bone Marrow Transplant Program, Gainesville, FL USA; [Callander, Natalie Scott] Univ Wisconsin, Dept Hematol, Madison, WI 53706 USA; [Hari, Parameswaran; Pasquini, Marcelo C.; Horowitz, Mary M.] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Van Besien, Koen; Rosenbaum, Cara] Univ Chicago Hosp, Dept Med, Chicago, IL 60637 USA; [Bressler, Linda; Kelly, Michael; Seiler, Michele] Univ Chicago, CALGB, Chicago, IL 60637 USA; [Maziarz, Richard T.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Bashey, Asad] BMT Grp Georgia, Atlanta, GA USA; [Martin, Thomas; Linker, Charles] Univ Calif San Francisco, Dept Hematol & Oncol, San Francisco, CA 94143 USA; [Qazilbash, Muzaffar H.] Univ Texas MD Anderson Canc Ctr, Unit 423, Houston, TX 77030 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Duke University; Duke University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; University of Chicago; University of Illinois System; University of Chicago; Oregon Health & Science University; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	McCarthy, PL (corresponding author), Roswell Pk Canc Inst, BMT Program, Buffalo, NY 14263 USA.	philip.mccarthy@roswellpark.org	Hofmeister, Craig/O-4988-2019; McCarthy, Philip/ABA-5329-2020; Hofmeister, Craig/E-3256-2011; Devine, Steven/AAS-7644-2021; horowitz, Mary/ABH-2173-2021; van Besien, Koen/G-4221-2012	Hofmeister, Craig/0000-0003-4816-1607; Hofmeister, Craig/0000-0003-4816-1607; Callander, Natalie/0000-0002-6975-1086; Hari, Parameswaran/0000-0002-8800-297X; van Besien, Koen/0000-0002-8164-6211	National Cancer Institute; NATIONAL CANCER INSTITUTE [U10CA031946, U10CA021115, U24CA076518, U10CA033601, P50CA100707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL069330, U01HL069294, U10HL069294, U10HL069290, U10HL069334, U10HL069286, U10HL109526, U10HL069301, U10HL069315, U10HL069348] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00114101.; Supported by the National Cancer Institute.	ANDERSEN E, 1970, SCAND J HAEMATOL, V7, P201; [Anonymous], 1975, ARCH INTERN MED, V135, P147; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Barlogie B, 2008, BLOOD, V112, P3115, DOI 10.1182/blood-2008-03-145235; Barlogie B, 2010, J CLIN ONCOL, V28, P3543, DOI 10.1200/JCO.2010.31.0862; Barlogie B, 2010, J CLIN ONCOL, V28, P1209, DOI 10.1200/JCO.2009.25.6081; BELCH A, 1988, BRIT J CANCER, V57, P94, DOI 10.1038/bjc.1988.17; Berenson JR, 2002, BLOOD, V99, P3163, DOI 10.1182/blood.V99.9.3163; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Cavo M, 2011, LANCET, V378, P1846; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Cox D. R., 1984, ANAL SURVIVAL DATA; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2006, LEUKEMIA, V20, P2220, DOI 10.1038/sj.leu.2404428; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Fritz E, 2000, ANN ONCOL, V11, P1427, DOI 10.1023/A:1026548226770; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harousseau JL, 2009, J CLIN ONCOL, V27, P5720, DOI 10.1200/JCO.2008.21.1060; Hasskarl J, 2011, LEUKEMIA LYMPHOMA, V52, P247, DOI 10.3109/10428194.2010.529207; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P248, DOI DOI 10.1002/LT.21509; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; KYLE RA, 1970, NEW ENGL J MED, V283, P1121, DOI 10.1056/NEJM197011192832101; Ladetto M, 2010, J CLIN ONCOL, V28, P2077, DOI 10.1200/JCO.2009.23.7172; Lokhorst HM, 2010, BLOOD, V115, P1113, DOI 10.1182/blood-2009-05-222539; Mailankody S, 2011, BLOOD, V118, P4086, DOI 10.1182/blood-2011-05-355743; Martinez-Lopez J, 2011, BLOOD, V118, P529, DOI 10.1182/blood-2011-01-332320; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; Neben K, 2012, BLOOD, V119, P940, DOI 10.1182/blood-2011-09-379164; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paiva B, 2008, BLOOD, V112, P4017, DOI 10.1182/blood-2008-05-159624; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, J CLIN ONCOL, V28, P800, DOI 10.1200/JCO.2009.22.7561; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; Stewart KA, 2010, BLOOD, V115, P4006	43	815	832	0	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1770	1781		10.1056/NEJMoa1114083	http://dx.doi.org/10.1056/NEJMoa1114083			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571201	Green Published, Green Accepted			2022-12-28	WOS:000303817000006
J	McWilliams, JM; Song, ZR				McWilliams, J. Michael; Song, Zirui			Implications for ACOs of Variations in Spending Growth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McWilliams, J. Michael; Song, Zirui] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [Song, Zirui] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Bureau of Economic Research	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.				NATIONAL INSTITUTE ON AGING [F30AG039175, K08AG038354] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG038354, F30 AG039175] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Center for Medicare and Medicaid Innovation, 2011, SEL PART PION ACO MO; Center for Medicare & Medicaid Innovation, 2011, PION ACO AL FIN REC; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P67802; Chernew ME, 2010, NEW ENGL J MED, V362, P1, DOI 10.1056/NEJMp0910194; The Center for Medicare and Medicaid Innovation, 2011, PION ACC CAR ORG ACO	5	14	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					E29	U21		10.1056/NEJMp1202004	http://dx.doi.org/10.1056/NEJMp1202004			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NB	22533535	Green Accepted			2022-12-28	WOS:000303817000004
J	Stock, SJ; Ferguson, E; Duffy, A; Ford, I; Chalmers, J; Norman, JE				Stock, Sarah J.; Ferguson, Evelyn; Duffy, Andrew; Ford, Ian; Chalmers, James; Norman, Jane E.			Outcomes of elective induction of labour compared with expectant management: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEONATAL RESPIRATORY MORBIDITY; CESAREAN DELIVERY; PERINATAL DEATH; POSTTERM PREGNANCY; NULLIPAROUS WOMEN; GESTATIONAL-AGE; TERM INFANTS; RISK; SECTION; COHORT	Objective To determine neonatal outcomes (perinatal mortality and special care unit admission) and maternal outcomes (mode of delivery, delivery complications) of elective induction of labour compared with expectant management. Design Retrospective cohort study using an unselected population database. Setting Consultant and midwife led obstetric units in Scotland 1981-2007. Participants 1 271 549 women with singleton pregnancies of 37 weeks or more gestation. Interventions Outcomes of elective induction of labour (induction of labour with no recognised medical indication) at 37, 38, 39, 40, and 41 weeks' gestation compared with those of expectant management (continuation of pregnancy to either spontaneous labour, induction of labour or caesarean section at a later gestation). Main outcome measures Extended perinatal mortality, mode of delivery, postpartum haemorrhage, obstetric anal sphincter injury, and admission to a neonatal or special care baby unit. Outcomes were adjusted for age at delivery, parity, year of birth, birth weight, deprivation category, and, where appropriate, mode of delivery. Results At each gestation between 37 and 41 completed weeks, elective induction of labour was associated with a decreased odds of perinatal mortality compared with expectant management (at 40 weeks' gestation 0.08% (37/44 764) in the induction of labour group versus 0.18% (627/350 643) in the expectant management group; adjusted odds ratio 0.39, 99% confidence interval 0.24 to 0.63), without a reduction in the odds of spontaneous vertex delivery (at 40 weeks' gestation 79.9% (35 775/44 778) in the induction of labour group versus 73.7% (258 665/350 791) in the expectant management group; adjusted odds ratio 1.26, 1.22 to 1.31). Admission to a neonatal unit was, however, increased in association with elective induction of labour at all gestations before 41 weeks (at 40 weeks' gestation 8.0% (3605/44 778) in the induction of labour group compared with 7.3% (25 572/350 791) in the expectant management group; adjusted odds ratio 1.14, 1.09 to 1.20). Conclusion Although residual confounding may remain, our findings indicate that elective induction of labour at term gestation can reduce perinatal mortality in developed countries without increasing the risk of operative delivery.	[Stock, Sarah J.; Norman, Jane E.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh EH16 4SA, Midlothian, Scotland; [Ferguson, Evelyn] NHS Lanarkshire, Wishaw Gen Hosp, Wishaw, Lanark, Scotland; [Duffy, Andrew; Chalmers, James] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; NHS National Services Scotland; University of Glasgow	Stock, SJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh EH16 4SA, Midlothian, Scotland.	sarah.stock@ed.ac.uk	Ford, Ian/ABE-6145-2020	Norman, Jane/0000-0001-6031-6953	Chief Scientist Office of the Scottish Government Health Directorate [CZG/2/292]; Medical Research Council [G1002033] Funding Source: researchfish; MRC [G1002033] Funding Source: UKRI	Chief Scientist Office of the Scottish Government Health Directorate; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by research grant CZG/2/292 from the Chief Scientist Office of the Scottish Government Health Directorate. A report was submitted to the funders following completion of the study and peer reviewed. The funders had no role in study design, data collection or analysis, or the decision to publish.	[Anonymous], 1994, Am J Obstet Gynecol, V170, P716; Caughey AB, 2006, AM J OBSTET GYNECOL, V195, P700, DOI 10.1016/j.ajog.2006.07.003; Caughey Aaron B, 2009, Evid Rep Technol Assess (Full Rep), P1; Caughey AB, 2009, ANN INTERN MED, V151, P252, DOI 10.7326/0003-4819-151-4-200908180-00007; Glantz JC, 2010, OBSTET GYNECOL, V115, P70, DOI 10.1097/AOG.0b013e3181c4ef96; Glantz JC, 2005, J REPROD MED, V50, P235; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hankins GDV, 2006, SEMIN PERINATOL, V30, P276, DOI 10.1053/j.semperi.2006.07.009; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Lampe L G, 1986, Acta Chir Hung, V27, P143; Luthy DA, 2004, AM J OBSTET GYNECOL, V191, P1511, DOI 10.1016/j.ajog.2004.07.001; Mason M, 2010, DATA QUALITY ASSURAN; Mealing NM, 2009, AUST NZ J OBSTET GYN, V49, P599, DOI 10.1111/j.1479-828X.2009.01086.x; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Pasupathy D, 2009, JAMA-J AM MED ASSOC, V302, P660, DOI 10.1001/jama.2009.1111; Royal College of Obstetricians and Gynaecologists, 2009, RCOG STAT SAV BAB LI; Scott J, 2009, SAVING BABIES LIVES; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b; Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1080/08035250410026671, 10.1111/j.1651-2227.2004.tb02990.x]	26	190	192	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2012	344								e2838	10.1136/bmj.e2838	http://dx.doi.org/10.1136/bmj.e2838			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XR	22577197	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000304085400002
J	Lim, LS; Mitchell, P; Seddon, JM; Holz, FG; Wong, TY				Lim, Laurence S.; Mitchell, Paul; Seddon, Johanna M.; Holz, Frank G.; Wong, Tien Y.			Age-related macular degeneration	LANCET			English	Article							BLUE MOUNTAINS EYE; SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; INDOCYANINE GREEN ANGIOGRAPHY; RANDOMIZED CLINICAL-TRIALS; ENDOTHELIAL GROWTH-FACTOR; GEOGRAPHIC ATROPHY; RISK-FACTORS; CIGARETTE-SMOKING; 10-YEAR INCIDENCE; CATARACT-SURGERY	Age-related macular degeneration is a major cause of blindness worldwide. With ageing populations in many countries, more than 20% might have the disorder. Advanced age-related macular degeneration, including neovascular age-related macular degeneration (wet) and geographic atrophy (late dry), is associated with substantial, progressive visual impairment. Major risk factors include cigarette smoking, nutritional factors, cardiovascular diseases, and genetic markers, including genes regulating complement, lipid, angiogenic, and extracellular matrix pathways. Some studies have suggested a declining prevalence of age-related macular degeneration, perhaps due to reduced exposure to modifiable risk factors. Accurate diagnosis combines clinical examination and investigations, including retinal photography, angiography, and optical coherence tomography. Dietary anti-oxidant supplementation slows progression of the disease. Treatment for neovascular age-related macular degeneration incorporates intra ocular injections of anti-VEGF agents, occasionally combined with other modalities. Evidence suggests that two commonly used anti-VEGF therapies, ranibizumab and bevacizumab, have similar efficacy, but possible differences in systemic safety are difficult to assess. Future treatments include inhibition of other angiogenic factors, and regenerative and topical therapies.	[Lim, Laurence S.; Wong, Tien Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; [Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Sydney, NSW 2006, Australia; [Seddon, Johanna M.] Tufts Med Ctr, Dept Ophthalmol, Ophthalm Epidemiol & Genet Serv, Boston, MA USA; [Seddon, Johanna M.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore	National University of Singapore; Singapore National Eye Center; University of Sydney; Westmead Institute for Medical Research; Tufts Medical Center; Tufts University; University of Bonn; National University of Singapore	Wong, TY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, 3rd Hosp Ave, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264	Allergan; Bayer; Novartis; Pfizer; Solvay; Genentech; Acucela; Alcon; GlaxoSmithKline; Heidelberg Engineering; Optos; NATIONAL EYE INSTITUTE [R01EY011309] Funding Source: NIH RePORTER	Allergan(AbbVieAllergan); Bayer(Bayer AG); Novartis(Novartis); Pfizer(Pfizer); Solvay(Solvay SA); Genentech(Roche HoldingGenentech); Acucela; Alcon(Novartis); GlaxoSmithKline(GlaxoSmithKline); Heidelberg Engineering; Optos; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	LSL has received travel support from Novartis. PM is on advisory boards for Allergan, Bayer, Novartis, Pfizer, and Solvay, and has received travel, honorarium and research support from these companies. JMS has received grant support from Genentech; Tufts Medical Center has filed patent applications regarding some of her research. FGH is on advisory boards for Acucela, Alcon, Allergan, Bayer, GlaxoSmithKline, Genentech, Heidelberg Engineering, Optos, Novartis, and Pfizer and has received travel, honorarium, and research support from these companies. TYW is on advisory boards for Allergan, Bayer, Novartis, Pfizer, and Solvay, and has received travel, honorarium, and research support from these companies. None of the authors have stocks, equity, contract of employment or named position on company boards.	Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; [Anonymous], 1986, Arch Ophthalmol, V104, P694; Arnold J, 2002, RETINA-J RET VIT DIS, V22, P6; Avila MP, 2011, RETINA, V32, P10; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chew EY, 2009, OPHTHALMOLOGY, V116, P297, DOI 10.1016/j.ophtha.2008.09.019; Choudhury F, 2011, AM J OPHTHALMOL, V152, P385, DOI 10.1016/j.ajo.2011.02.025; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Delcourt C, 2007, EUR J CLIN NUTR, V61, P1341, DOI 10.1038/sj.ejcn.1602685; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; Do DV, 2009, OPHTHALMOLOGY, V116, pS24, DOI 10.1016/j.ophtha.2009.06.049; Dowling J, 2009, EYE, V23, P1999, DOI 10.1038/eye.2008.385; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Gupta B, 2010, BRIT J OPHTHALMOL, V94, P672, DOI 10.1136/bjo.2009.166975; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Hooper P, 2008, CAN J OPHTHALMOL, V43, P180, DOI 10.3129/i08-001; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jorzik JJ, 2005, RETINA-J RET VIT DIS, V25, P405, DOI 10.1097/00006982-200506000-00003; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; KONDO S, 1993, BIOCHEM BIOPH RES CO, V194, P1234, DOI 10.1006/bbrc.1993.1955; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Lamoureux EL, 2011, BRIT J OPHTHALMOL, V95, P666, DOI 10.1136/bjo.2010.185207; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lim LS, 2011, AM J OPHTHALMOL, V152, P329, DOI 10.1016/j.ajo.2011.05.040; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; Mitchell P, 2002, OPHTHALMOLOGY, V109, P1092, DOI 10.1016/S0161-6420(02)01055-2; Mitchell P, 1998, OPHTHALMOLOGY, V105, P1359, DOI 10.1016/S0161-6420(98)98013-7; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Parmeggiani F, 2011, CURR DRUG TARGETS, V12, P138, DOI 10.2174/138945011794182773; Quellec G, 2011, INVEST OPHTH VIS SCI, V52, P9195, DOI 10.1167/iovs.10-6793; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Reynolds R, 2010, OPHTHALMOLOGY, V117, P1989, DOI 10.1016/j.ophtha.2010.07.009; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SANDBERG MA, 1993, OPHTHALMOLOGY, V100, P1009; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Schmitz-Valckenberg S, 2010, OPHTHALMOLOGY, V117, P1169, DOI 10.1016/j.ophtha.2009.10.044; Schmucker C, 2011, BRIT J OPHTHALMOL, V95, P308, DOI 10.1136/bjo.2009.178574; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wickremasinghe SS, 2011, INVEST OPHTH VIS SCI, V52, P4072, DOI 10.1167/iovs.10-6550; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Wong WT, 2010, INVEST OPHTH VIS SCI, V51, P6131, DOI 10.1167/iovs.10-5637; Wormald R, 2007, COCHRANE DB SYST REV, V3; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yannuzzi LA, 2011, AM J OPHTHALMOL, V151, P745, DOI 10.1016/j.ajo.2011.01.043; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	80	1152	1219	21	306	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2012	379	9827					1728	1738		10.1016/S0140-6736(12)60282-7	http://dx.doi.org/10.1016/S0140-6736(12)60282-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22559899				2022-12-28	WOS:000303658500033
J	Johnson, TP; Wislar, JS				Johnson, Timothy P.; Wislar, Joseph S.			Response Rates and Nonresponse Errors in Surveys	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TELEPHONE SURVEY; RESPONDENTS		[Johnson, Timothy P.] Univ Illinois, Survey Res Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Johnson, TP (corresponding author), Univ Illinois, Survey Res Lab, 412 S Peoria St, Chicago, IL 60607 USA.	timj@uic.edu		Johnson, Timothy/0000-0001-9745-9683				[Anonymous], STAND DEF FIN DISP C; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; GROVES RM, 2005, VITAL HLTH STAT, V1, P1; Johnson TP, 2006, AM J PREV MED, V31, P427, DOI 10.1016/j.amepre.2006.07.011; Johnson TP, 2004, 2003 P SECT SURV RES, P127; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Purdie DM, 2002, J EPIDEMIOL COMMUN H, V56, P748, DOI 10.1136/jech.56.10.748; Voigt LF, 2003, AM J EPIDEMIOL, V157, P66, DOI 10.1093/aje/kwf185	8	418	419	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1805	1806		10.1001/jama.2012.3532	http://dx.doi.org/10.1001/jama.2012.3532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933TV	22550194				2022-12-28	WOS:000303386800018
J	Caffrey, DR; Fitzgerald, KA				Caffrey, Daniel R.; Fitzgerald, Katherine A.			Select Inflammasome Assembly	SCIENCE			English	Editorial Material							GAMMA		[Caffrey, Daniel R.; Fitzgerald, Katherine A.] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Caffrey, DR (corresponding author), Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X				Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Masters SL, 2010, EMBO REP, V11, P640, DOI 10.1038/embor.2010.93; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759	13	5	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					420	421		10.1126/science.1222362	http://dx.doi.org/10.1126/science.1222362			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539706				2022-12-28	WOS:000303233400029
J	Grueter, CE; van Rooij, E; Johnson, BA; DeLeon, SM; Sutherland, LB; Qi, XX; Gautron, L; Elmquist, JK; Bassel-Duby, R; Olson, EN				Grueter, Chad E.; van Rooij, Eva; Johnson, Brett A.; DeLeon, Susan M.; Sutherland, Lillian B.; Qi, Xiaoxia; Gautron, Laurent; Elmquist, Joel K.; Bassel-Duby, Rhonda; Olson, Eric N.			A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13	CELL			English	Article							THYROID-HORMONE ACTION; TRANSCRIPTIONAL ACTIVATION; INSULIN SENSITIVITY; COACTIVATOR COMPLEX; RECEPTOR FUNCTION; MEDIATOR COMPLEX; OBESITY; MICE; METABOLISM; RESISTANCE	Obesity, type 2 diabetes, and heart failure are associated with aberrant cardiac metabolism. We show that the heart regulates systemic energy homeostasis via MED13, a subunit of the Mediator complex, which controls transcription by thyroid hormone and other nuclear hormone receptors. MED13, in turn, is negatively regulated by a heart-specific microRNA, miR-208a. Cardiac-specific overexpression of MED13 or pharmacologic inhibition of miR-208a in mice confers resistance to high-fat diet-induced obesity and improves systemic insulin sensitivity and glucose tolerance. Conversely, genetic deletion of MED13 specifically in cardiomyocytes enhances obesity in response to high-fat diet and exacerbates metabolic syndrome. The metabolic actions of MED13 result from increased energy expenditure and regulation of numerous genes involved in energy balance in the heart. These findings reveal a role of the heart in systemic metabolic control and point to MED13 and miR-208a as potential therapeutic targets for metabolic disorders.	[Grueter, Chad E.; Johnson, Brett A.; DeLeon, Susan M.; Sutherland, Lillian B.; Qi, Xiaoxia; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gautron, Laurent; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [van Rooij, Eva] miRagen Therapeut Inc, Boulder, CO 80301 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021	Grueter, Chad/0000-0001-8950-742X; DeLeon, Susan/0000-0002-9716-9026	National Institute of Health [PL1 DK081182, UL1 RR024923]; UT Southwestern; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation [I-0025]; Fondation Leducq; American Heart Association-Jon Holden DeHaan Foundation; American Diabetes Association [7-09-CVD-04];  [RL1DK081185]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R37HL053351, R01HL077439, R01HL061544, R01HL053351, R01HL083371, R01HL111665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RL1DK081185, PL1DK081182] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); Fondation Leducq(Leducq Foundation); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); American Diabetes Association(American Diabetes Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Carrie A. Grueter, Jose Cabrera, John McAnally, Evelyn Tennison, and Jennifer Brown for their assistance. We appreciate the services of the UT Southwestern Mouse Metabolic Phenotyping Core, supported by National Institute of Health Grants PL1 DK081182 and UL1 RR024923, and the UT Southwestern Transgenic Core Facility. We thank James Richardson and the histology group for their assistance. This work was supported, in part, by grants from National Institutes of Health, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Robert A. Welch Foundation (grant I-0025), the Fondation Leducq-Transatlantic of Excellence in Cardiovascular Research Program, and the American Heart Association-Jon Holden DeHaan Foundation to E.N.O. C. E. G. was supported by a fellowship from the American Diabetes Association (7-09-CVD-04). J.K.E. was supported by RL1DK081185. E.N.O. and E. v. R. are cofounders of miRagen Therapeutics, a company focused on developing miRNA-based therapies for cardiovascular disease.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mitchell CS, 2010, J CLIN INVEST, V120, P1345, DOI 10.1172/JCI38793; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Philibert R, 2002, COMPR PSYCHIAT, V43, P404, DOI 10.1053/comp.2002.33489; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song YY, 2011, PROTEIN CELL, V2, P358, DOI 10.1007/s13238-011-1046-x; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tancevski I, 2011, PHARMACOL THERAPEUT, V131, P33, DOI 10.1016/j.pharmthera.2011.04.003; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Xu ZP, 2002, MOL CELL BIOL, V22, P6142, DOI 10.1128/MCB.22.17.6142-6147.2002; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	53	268	281	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					671	683		10.1016/j.cell.2012.03.029	http://dx.doi.org/10.1016/j.cell.2012.03.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541436	Green Accepted, Bronze			2022-12-28	WOS:000303443100017
J	Kesson, EM; Allardice, GM; George, WD; Burns, HJG; Morrison, DS				Kesson, Eileen M.; Allardice, Gwen M.; George, W. David; Burns, Harry J. G.; Morrison, David S.			Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE-RECEPTOR STATUS; IMPROVE SURVIVAL; HEALTH-CARE; MANAGEMENT; MORTALITY; OUTCOMES; TRENDS; SURGERY; IMPACT; DIAGNOSIS	Objectives To describe the effect of multidisciplinary care on survival in women treated for breast cancer. Design Retrospective, comparative, non-randomised, interventional cohort study. Setting NHS hospitals, health boards in the west of Scotland, UK. Participants 14 358 patients diagnosed with symptomatic invasive breast cancer between 1990 and 2000, residing in health board areas in the west of Scotland. 13 722 (95.6%) patients were eligible (excluding 16 diagnoses of inflammatory cancers and 620 diagnoses of breast cancer at death). Intervention In 1995, multidisciplinary team working was introduced in hospitals throughout one health board area (Greater Glasgow; intervention area), but not in other health board areas in the west of Scotland (non-intervention area). Main outcome measures Breast cancer specific mortality and all cause mortality. Results Before the introduction of multidisciplinary care (analysed time period January 1990 to September 1995), breast cancer mortality was 11% higher in the intervention area than in the non-intervention area (hazard ratio adjusted for year of incidence, age at diagnosis, and deprivation, 1.11; 95% confidence interval 1.00 to 1.20). After multidisciplinary care was introduced (time period October 1995 to December 2000), breast cancer mortality was 18% lower in the intervention area than in the non-intervention area (0.82, 0.74 to 0.91). All cause mortality did not differ significantly between populations in the earlier period, but was 11% lower in the intervention area than in the non-interventional area in the later period (0.89, 0.82 to 0.97). Interrupted time series analyses showed a significant improvement in breast cancer survival in the intervention area in 1996, compared with the expected survival in the same year had the pre-intervention trend continued (P=0.004). This improvement was maintained after the intervention was introduced. Conclusion Introduction of multidisciplinary care was associated with improved survival and reduced variation in survival among hospitals. Further analysis of clinical audit data for multidisciplinary care could identify which aspects of care are most associated with survival benefits.	[Kesson, Eileen M.; Allardice, Gwen M.] Gartnavel Royal Hosp, NHS Greater Glasgow & Clyde, Glasgow G12 0YN, Lanark, Scotland; [George, W. David] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland; [Burns, Harry J. G.] Scottish Govt, Publ Hlth Div, Edinburgh, Midlothian, Scotland; [Kesson, Eileen M.; Allardice, Gwen M.; Morrison, David S.] Univ Glasgow, W Scotland Canc Surveillance Unit, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland	Gartnavel Royal Hospital; University of Glasgow; University of Glasgow	Kesson, EM (corresponding author), Gartnavel Royal Hosp, NHS Greater Glasgow & Clyde, Glasgow G12 0YN, Lanark, Scotland.	Eileen.Kesson@nhs.net		Morrison, David/0000-0002-0617-3047	NHS Scotland; University of Glasgow	NHS Scotland; University of Glasgow	This study was supported by NHS Scotland and University of Glasgow. They had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Anderson BO, 2008, DIS MANAG HEALTH OUT, V16, P7, DOI 10.2165/00115677-200816010-00002; [Anonymous], 1986, BRIT MED J, V293, P946; Atun R, 2009, ANAL NATL CANC CONTR; Bilimoria KY, 2008, J CLIN ONCOL, V26, P4626, DOI 10.1200/JCO.2007.15.6356; Botha JL, 2003, EUR J CANCER, V39, P1718, DOI 10.1016/S0959-8049(03)00118-7; Brown SBF, 2009, BRIT J CANCER, V100, P807, DOI 10.1038/sj.bjc.6604934; Carstairs V., 1991, DEPRIVATION HLTH SCO; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; Clinical Oncological Society of Australia (COSA) The Cancer Council Australia the National Cancer Control Initiative, 2003, OPT CANC CAR AUSTR; COX DR, 1972, J R STAT SOC B, V34, P187; Deasy C, 2011, RESUSCITATION, V82, P984, DOI 10.1016/j.resuscitation.2011.04.005; Department of Health (UK), 2007, CANC REF STRAT; Enger SM, 2006, J CLIN ONCOL, V24, P4377, DOI 10.1200/JCO.2006.06.3065; Fleissig A, 2006, LANCET ONCOL, V7, P935, DOI 10.1016/S1470-2045(06)70940-8; Forrest LM, 2005, BRIT J CANCER, V93, P977, DOI 10.1038/sj.bjc.6602825; Fosker CJ, 2010, MULTIDISCIPLINARY TE; Friedland PL, 2011, BRIT J CANCER, V104, P1246, DOI 10.1038/bjc.2011.92; Gillis CR, 1996, BRIT MED J, V312, P145, DOI 10.1136/bmj.312.7024.145; Hong NJL, 2010, J SURG ONCOL, V102, P125, DOI 10.1002/jso.21589; Houssami N, 2006, EUR J CANCER, V42, P2480, DOI 10.1016/j.ejca.2006.05.023; JUNOR EJ, 1994, BRIT J CANCER, V70, P363, DOI 10.1038/bjc.1994.307; KENDRICK S, 1999, RECORD LINKAGE TECHN, P319; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kingsmore D, 2004, BRIT J CANCER, V90, P1920, DOI 10.1038/sj.bjc.6601846; Kingsmore D, 2003, BRIT J CANCER, V88, P1708, DOI 10.1038/sj.bjc.6600949; Laki F, 2010, ANN SURG ONCOL, V17, P1530, DOI 10.1245/s10434-010-0967-6; Li CI, 2003, J CLIN ONCOL, V21, P28, DOI 10.1200/JCO.2003.03.088; McCarthy M, 2008, J EPIDEMIOL COMMUN H, V62, P650, DOI 10.1136/jech.2007.066258; McLaren G, 1998, DEPRIVATION HLTH SCO; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NHS Scotland, 1999, INTR MAN CLIN NETW N; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015; Ruhstaller T, 2006, EUR J CANCER, V42, P2459, DOI 10.1016/j.ejca.2006.03.034; Saini KS, 2012, ANN ONCOL, V23, P853, DOI 10.1093/annonc/mdr352; SCHRIJVERS CTM, 1995, BRIT J CANCER, V72, P738, DOI 10.1038/bjc.1995.403; Selby P, 1996, LANCET, V348, P313, DOI 10.1016/S0140-6736(96)02482-8; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755; Stephens MR, 2006, DIS ESOPHAGUS, V19, P164, DOI 10.1111/j.1442-2050.2006.00559.x; Stitzenberg KB, 2010, ANN SURG ONCOL, V17, P2824, DOI 10.1245/s10434-010-1159-0; Taylor C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c951; Thomson CS, 2004, EUR J CANCER, V40, P743, DOI 10.1016/j.ejca.2003.08.029; Thomson CS, 2001, J EPIDEMIOL COMMUN H, V55, P308, DOI 10.1136/jech.55.5.308; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652	45	336	347	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2012	344								e2718	10.1136/bmj.e2718	http://dx.doi.org/10.1136/bmj.e2718			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HD	22539013	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000303433900006
J	Kellermann, AL; Weinick, RM				Kellermann, Arthur L.; Weinick, Robin M.			Emergency Departments, Medicaid Costs, and Access to Primary Care - Understanding the Link	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kellermann, Arthur L.; Weinick, Robin M.] RAND Corp, Santa Monica, CA USA	RAND Corporation	Kellermann, AL (corresponding author), RAND Corp, Santa Monica, CA USA.							[Anonymous], 2011, NON CAR ER 2011 FACT; Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; Young GP, 1996, JAMA-J AM MED ASSOC, V276, P460, DOI 10.1001/jama.276.6.460	4	71	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2141	2143		10.1056/NEJMp1203247	http://dx.doi.org/10.1056/NEJMp1203247			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953JO	22591255				2022-12-28	WOS:000304863400001
J	Freedman, ND; Park, Y; Abnet, CC; Hollenbeck, AR; Sinha, R				Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Hollenbeck, Albert R.; Sinha, Rashmi			Association of Coffee Drinking with Total and Cause-Specific Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; TEA CONSUMPTION; CARDIOVASCULAR-DISEASE; NATIONAL-INSTITUTES; FOLLOW-UP; RISK; METAANALYSIS; CAFFEINE	BACKGROUND Coffee is one of the most widely consumed beverages, but the association between coffee consumption and the risk of death remains unclear. METHODS We examined the association of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health-AARP Diet and Health Study who were 50 to 71 years of age at baseline. Participants with cancer, heart disease, and stroke were excluded. Coffee consumption was assessed once at baseline. RESULTS During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died. In age-adjusted models, the risk of death was increased among coffee drinkers. However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse association between coffee consumption and mortality. Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the respective hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend). Inverse associations were observed for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer. Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline. CONCLUSIONS In this large prospective study, coffee consumption was inversely associated with total and cause-specific mortality. Whether this was a causal or associational finding cannot be determined from our data.	[Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Sinha, Rashmi] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20852 USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Freedman, ND (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, 6120 Execut Blvd,EPS 320,MSC 7232, Rockville, MD 20852 USA.	freedmanne@mail.nih.gov	Freedman, Neal David/B-9741-2015; Hollenbeck, Albert/AAG-9461-2020; Abnet, Christian C/C-4111-2015; Sinha, Rashmi/G-7446-2015	Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843; Sinha, Rashmi/0000-0002-2466-7462; Park, Yikyung/0000-0002-6281-489X	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.Supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P8284, DOI 10.1021/jf078006w; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046; GREENLAND S, 1993, EPIDEMIOLOGY, V4, P366, DOI 10.1097/00001648-199307000-00013; Happonen P, 2008, BRIT J NUTR, V99, P1354, DOI 10.1017/S0007114507871650; HEYDEN S, 1978, ARCH INTERN MED, V138, P1472, DOI 10.1001/archinte.138.10.1472; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Iwai Nobuo, 2002, J Epidemiol, V12, P191; JACOBSEN BK, 1986, J NATL CANCER I, V76, P823; Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353; JICK H, 1973, NEW ENGL J MED, V289, P63, DOI 10.1056/NEJM197307122890203; Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521; Klatsky A L, 1993, Ann Epidemiol, V3, P375, DOI 10.1016/1047-2797(93)90064-B; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183; Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787; LEGRADY D, 1987, AM J EPIDEMIOL, V126, P803, DOI 10.1093/oxfordjournals.aje.a114717; LINDSTED KD, 1992, J CLIN EPIDEMIOL, V45, P733, DOI 10.1016/0895-4356(92)90051-N; Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164; Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311; Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Paganini-Hill A, 2007, PREV MED, V44, P305, DOI 10.1016/j.ypmed.2006.12.011; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; VESSEY MP, 1972, LANCET, V2, P1278; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481; Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051; Yanagimoto K, 2002, J AGR FOOD CHEM, V50, P5480, DOI 10.1021/jf025616h; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	39	359	368	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1891	1904		10.1056/NEJMoa1112010	http://dx.doi.org/10.1056/NEJMoa1112010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591295	Green Accepted			2022-12-28	WOS:000304083000008
J	Duncan, CJA; Carle, G; Seaton, RA				Duncan, Christopher J. A.; Carle, George; Seaton, R. Andrew			10-MINUTE CONSULTATION Tick bite and early Lyme borreliosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Duncan, Christopher J. A.; Seaton, R. Andrew] Gartnaval Hosp, Brownlee Ctr Infect Trop Med & Counselling, Glasgow G12 0YN, Lanark, Scotland; [Duncan, Christopher J. A.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Carle, George] Kyles Med Ctr, Tighnabruaich PA21 2BE, Argyll, Scotland	University of Oxford	Duncan, CJA (corresponding author), Gartnaval Hosp, Brownlee Ctr Infect Trop Med & Counselling, Glasgow G12 0YN, Lanark, Scotland.	chrisduncan@doctors.net.uk			Onmedica	Onmedica	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work and no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. RAS has received fees for expert testimony relating to medicolegal work about Lyme borreliosis, and GC has received fees from Onmedica for development of educational materials relating to Lyme borreliosis.	British Infection Assoc, 2011, J INFECTION, V62, P329, DOI 10.1016/j.jinf.2011.03.006; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; McAteer A, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548910; O'Connell S, 2010, CURR OPIN INFECT DIS, V23, P231, DOI 10.1097/QCO.0b013e32833890e2; Skogman BH, 2008, PEDIATR INFECT DIS J, V27, P1089, DOI 10.1097/INF.0b013e31817fd423; Slack GS, 2011, J ROY COLL PHYS EDIN, V41, P5, DOI 10.4997/JRCPE.2011.102; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	7	5	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2012	344								e3124	10.1136/bmj.e3124	http://dx.doi.org/10.1136/bmj.e3124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XW	22586232				2022-12-28	WOS:000304085900003
J	Kourtis, AP; Bulterys, M; Hu, DJ; Jamieson, DJ				Kourtis, Athena P.; Bulterys, Marc; Hu, Dale J.; Jamieson, Denise J.			HIV-HBV Coinfection - A Global Challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATITIS-B; TRANSMISSION		[Kourtis, Athena P.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Hu, Dale J.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Bulterys, Marc] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Bulterys, Marc] CDC Global AIDS Program, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kourtis, AP (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.			Jamieson, Denise/0000-0003-2597-1201; Hu, Dale/0000-0002-0519-1032; Kourtis, Athena/0000-0003-1585-1310	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Unal ER, 2011, OBSTET GYNECOL, V118, P655, DOI 10.1097/AOG.0b013e31822ad2c2; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x	5	141	155	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1749	1752		10.1056/NEJMp1201796	http://dx.doi.org/10.1056/NEJMp1201796			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NB	22571198	Green Accepted			2022-12-28	WOS:000303817000001
J	Sivis, M; Duwe, M; Abel, B; Ropers, C				Sivis, M.; Duwe, M.; Abel, B.; Ropers, C.			Nanostructure-enhanced atomic line emission	NATURE			English	Letter							HARMONIC GENERATION		[Sivis, M.; Duwe, M.; Ropers, C.] Univ Gottingen, Courant Res Ctr Nanospect & Xray Imaging, D-37077 Gottingen, Germany; [Abel, B.] Univ Leipzig, Ostwald Inst Phys & Theoret Chem, D-04103 Leipzig, Germany	University of Gottingen; Leipzig University	Ropers, C (corresponding author), Univ Gottingen, Courant Res Ctr Nanospect & Xray Imaging, D-37077 Gottingen, Germany.	cropers@gwdg.de	Ropers, Claus/D-4843-2015	Ropers, Claus/0000-0002-9539-3817				Boyce JC, 1936, PHYS REV, V49, P0730, DOI 10.1103/PhysRev.49.730; Fischer H, 2008, OPT EXPRESS, V16, P9144, DOI 10.1364/OE.16.009144; Fromm DP, 2004, NANO LETT, V4, P957, DOI 10.1021/nl049951r; Genov DA, 2004, NANO LETT, V4, P153, DOI 10.1021/nl0343710; Hanke T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257404; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Kim S, 2010, SPRINGER SER CHEM PH, V99, P129, DOI 10.1007/978-3-642-15054-8_7; Li KR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.227402; LI XF, 1989, PHYS REV A, V39, P5751, DOI 10.1103/PhysRevA.39.5751; Merlein J, 2008, NAT PHOTONICS, V2, P230, DOI 10.1038/nphoton.2008.27; MINNHAGEN L, 1973, J OPT SOC AM, V63, P1185, DOI 10.1364/JOSA.63.001185; MINNHAGEN L, 1971, J OPT SOC AM, V61, P1257, DOI 10.1364/JOSA.61.001257; Park IY, 2011, NAT PHOTONICS, V5, P678, DOI [10.1038/NPHOTON.2011.258, 10.1038/nphoton.2011.258]; Sansonetti JE, 2005, J PHYS CHEM REF DATA, V34, P1559, DOI 10.1063/1.1800011	14	124	124	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					E1	E2		10.1038/nature10978	http://dx.doi.org/10.1038/nature10978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575967				2022-12-28	WOS:000303799800001
J	Kirby, T				Kirby, Tony			Profile Elizabeth Elliott: champion of child health in Australia	LANCET			English	Biographical-Item																		ELLIOTT E, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					1695	1695		10.1016/S0140-6736(12)60706-5	http://dx.doi.org/10.1016/S0140-6736(12)60706-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937KX	22559886	Bronze			2022-12-28	WOS:000303658500014
J	Murakami, M; Ohishi, Y; Hirao, N; Hirose, K				Murakami, Motohiko; Ohishi, Yasuo; Hirao, Naohisa; Hirose, Kei			A perovskitic lower mantle inferred from high-pressure, high-temperature sound velocity data	NATURE			English	Article							ALUMINOUS MGSIO3 PEROVSKITE; EARTHS LOWER MANTLE; EQUATION-OF-STATE; CHEMICAL-COMPOSITION; ELASTICITY; PHASE; GPA; FERROPERICLASE; HETEROGENEITY; TRANSITION	The determination of the chemical composition of Earth's lower mantle is a long-standing challenge in earth science. Accurate knowledge of sound velocities in the lower-mantle minerals under relevant high-pressure, high-temperature conditions is essential in constraining the mineralogy and chemical composition using seismological observations(1), but previous acoustic measurements were limited to a range of low pressures and temperatures. Here we determine the shear-wave velocities for silicate perovskite and ferropericlase under the pressure and temperature conditions of the deep lower mantle using Brillouin scattering spectroscopy(2). The mineralogical model that provides the best fit to a global seismic velocity profile(1) indicates that perovskite constitutes more than 93 per cent by volume of the lower mantle, which is a much higher proportion than that predicted by the conventional peridotitic mantle model. It suggests that the lower mantle is enriched in silicon relative to the upper mantle, which is consistent with the chondritic Earth model. Such chemical stratification implies layered-mantle convection with limited mass transport between the upper and the lower mantle.	[Murakami, Motohiko] Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan; [Ohishi, Yasuo; Hirao, Naohisa] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Hirose, Kei] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Hirose, Kei] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan	Tohoku University; Japan Synchrotron Radiation Research Institute; Tokyo Institute of Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Murakami, M (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan.	motohiko@m.tohoku.ac.jp	Murakami, Motohiko/G-2806-2010; Hirose, Kei/C-2165-2009	Hirose, Kei/0000-0003-4366-7721; Murakami, Motohiko/0000-0002-2165-2994	SPring-8 [2008B0099, 2009A0087]; Grants-in-Aid for Scientific Research [19674003] Funding Source: KAKEN	SPring-8(SPring-8); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We greatly appreciate the comments by I. Jackson. Suggestions from E. Ohtani, C. Bina, S. Karato and S.-H. Shim improved the manuscript. We also thank N. Sata and Y. Asahara for their experimental assistance at SPring-8. This study was performed under the approval of SPring-8 (proposals no. 2008B0099 and 2009A0087).	Akahama Y, 2004, J APPL PHYS, V96, P3748, DOI 10.1063/1.1778482; ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; ANDERSON OL, 1982, PHILOS T R SOC A, V306, P21, DOI 10.1098/rsta.1982.0063; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Brodholt JP, 2000, NATURE, V407, P620, DOI 10.1038/35036565; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; CHRISTENSEN UR, 1985, J GEOPHYS RES-SOLID, V90, P291, DOI 10.1029/JB090iB12p10291; Crowhurst JC, 2008, SCIENCE, V319, P451, DOI 10.1126/science.1149606; Dewaele A, 2000, J GEOPHYS RES-SOL EA, V105, P2869, DOI 10.1029/1999JB900364; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fei YW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030712; HOLMES NC, 1989, J APPL PHYS, V66, P2962, DOI 10.1063/1.344177; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; Jackson I., 1998, EARTHS MANTLE COMPOS, P405; Jackson JM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004052; Jackson JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023522; Jackson JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019918; Jacobsen SD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000490; Kennett BLN, 2009, PHYS EARTH PLANET IN, V176, P98, DOI 10.1016/j.pepi.2009.04.005; Kung J, 2002, EARTH PLANET SC LETT, V203, P557, DOI 10.1016/S0012-821X(02)00838-5; Li L, 2006, PHYS EARTH PLANET IN, V155, P249, DOI 10.1016/j.pepi.2005.12.006; Marquardt H, 2009, EARTH PLANET SC LETT, V287, P345, DOI 10.1016/j.epsl.2009.08.017; Mattern E, 2005, GEOPHYS J INT, V160, P973, DOI 10.1111/j.1365-246X.2004.02549.x; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Murakami M, 2007, EARTH PLANET SC LETT, V259, P18, DOI 10.1016/j.epsl.2007.04.015; Murakami M, 2007, EARTH PLANET SC LETT, V256, P47, DOI 10.1016/j.epsl.2007.01.011; Murakami M, 2009, PHYS EARTH PLANET IN, V174, P282, DOI 10.1016/j.pepi.2008.07.030; Murakami M, 2009, EARTH PLANET SC LETT, V277, P123, DOI 10.1016/j.epsl.2008.10.010; Ricolleau A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036759; Ringwood A.E, 1975, COMPOSITION PETROLOG; RINGWOOD AE, 1989, EARTH PLANET SC LETT, V95, P1, DOI 10.1016/0012-821X(89)90162-3; Sata N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.104114; Stixrude L, 2005, GEOPHYS J INT, V162, P610, DOI 10.1111/j.1365-246X.2005.02642.x; Stixrude L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024108; SUN SS, 1982, GEOCHIM COSMOCHIM AC, V46, P179, DOI 10.1016/0016-7037(82)90245-9; Tange Y, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007959; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; VANDERHILST R, 1991, NATURE, V353, P37, DOI 10.1038/353037a0	38	180	190	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					90	U118		10.1038/nature11004	http://dx.doi.org/10.1038/nature11004			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22552097				2022-12-28	WOS:000303451900040
J	Tan, SK; Tay, YK				Tan, Siew-Kiang; Tay, Yong-Kwang			Lymphangioma Circumscriptum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tan, Siew-Kiang; Tay, Yong-Kwang] Changi Gen Hosp, Singapore, Singapore	Changi General Hospital	Tan, SK (corresponding author), Changi Gen Hosp, Singapore, Singapore.	siewkiang@hotmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1724	1724		10.1056/NEJMicm1101005	http://dx.doi.org/10.1056/NEJMicm1101005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551131				2022-12-28	WOS:000303434300012
J	Suh, YS; Kennedy, BK				Suh, Yousin; Kennedy, Brian K.			Dialing Down SUN1 for Laminopathies	CELL			English	Editorial Material							A-TYPE; DEFECTS; DISEASE	Laminopathies, caused by mutations in A-type nuclear lamins, encompass a range of diseases, including forms of progeria and muscular dystrophy. In this issue, Chen et al. provide evidence that elevated expression of the nuclear inner membrane protein SUN1 drives pathology in multiple laminopathies.	[Suh, Yousin] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Suh, Yousin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Suh, Yousin; Kennedy, Brian K.] Guangdong Med Coll, Aging Res Inst, Dongguan 523808, Guangdong, Peoples R China; [Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Guangdong Medical University; Buck Institute for Research on Aging	Suh, YS (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.	yousin.suh@einstein.yu.edu; bkennedy@buckinstitute.org		Kennedy, Brian/0000-0002-5754-1874				Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059; Cohen TV, 2008, CURR TOP DEV BIOL, V84, P351, DOI 10.1016/S0070-2153(08)00607-8; Delbarre E, 2006, HUM MOL GENET, V15, P1113, DOI 10.1093/hmg/ddl026; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Vaughan OA, 2001, J CELL SCI, V114, P2577	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					509	510		10.1016/j.cell.2012.04.003	http://dx.doi.org/10.1016/j.cell.2012.04.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541423	Bronze			2022-12-28	WOS:000303443100002
J	Grayson, M				Grayson, Michelle			MALARIA	NATURE			English	Editorial Material																			0	6	6	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S13	S13		10.1038/484S13a	http://dx.doi.org/10.1038/484S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22534524	Bronze			2022-12-28	WOS:000303200400063
J	Huber, D; Gutnisky, DA; Peron, S; O'Connor, DH; Wiegert, JS; Tian, L; Oertner, TG; Looger, LL; Svoboda, K				Huber, D.; Gutnisky, D. A.; Peron, S.; O'Connor, D. H.; Wiegert, J. S.; Tian, L.; Oertner, T. G.; Looger, L. L.; Svoboda, K.			Multiple dynamic representations in the motor cortex during sensorimotor learning	NATURE			English	Article							CELLULAR RESOLUTION; OBJECT LOCALIZATION; NEURAL ACTIVITY; BARREL CORTEX; NEURONS; ORGANIZATION; MOUSE; MICROSTIMULATION; CONNECTIONS; PLASTICITY	The mechanisms linking sensation and action during learning are poorly understood. Layer 2/3 neurons in the motor cortex might participate in sensorimotor integration and learning; they receive input from sensory cortex and excite deep layer neurons, which control movement. Here we imaged activity in the same set of layer 2/3 neurons in the motor cortex over weeks, while mice learned to detect objects with their whiskers and report detection with licking. Spatially intermingled neurons represented sensory (touch) and motor behaviours (whisker movements and licking). With learning, the population-level representation of task-related licking strengthened. In trained mice, population-level representations were redundant and stable, despite dynamism of single-neuron representations. The activity of a subpopulation of neurons was consistent with touch driving licking behaviour. Our results suggest that ensembles of motor cortex neurons couple sensory input to multiple, related motor programs during learning.	[Huber, D.; Gutnisky, D. A.; Peron, S.; O'Connor, D. H.; Tian, L.; Looger, L. L.; Svoboda, K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Wiegert, J. S.; Oertner, T. G.] Ctr Mol Neurobiol Hamburg, D-20251 Hamburg, Germany	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Wiegert, J. Simon/ABE-4199-2020; Huber, Daniel/C-2932-2013; Oertner, Thomas/F-2214-2010; Gutnisky, Diego/E-3846-2012	Oertner, Thomas/0000-0002-2312-7528; Gutnisky, Diego/0000-0002-8578-0039; Peron, Simon/0000-0001-8265-6940; Tian, Lin/0000-0001-7012-6926; Wiegert, J. Simon/0000-0003-0893-9349; Huber, Daniel/0000-0002-0744-7679				Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Graziano M.S.A., 2009, INTELLIGENT MOVEMENT; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Salinas E, 2009, J NEUROSCI, V29, P4369, DOI 10.1523/JNEUROSCI.0164-09.2009; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	59	328	330	6	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					473	U95		10.1038/nature11039	http://dx.doi.org/10.1038/nature11039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538608	Green Accepted			2022-12-28	WOS:000303200400042
J	Pickup, JC				Pickup, John C.			Insulin-Pump Therapy for Type 1 Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE DAILY INJECTIONS; RANDOMIZED CONTROLLED-TRIALS; BLOOD-GLUCOSE VARIABILITY; GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; INFUSION CSII; METAANALYSIS; MANAGEMENT; CHILDREN; POPULATION	A 39-year-old man with type 1 diabetes of 27 years' duration visits his endocrinologist for review of his blood glucose control. He is overweight (body-mass index [the weight in kilograms divided by the square of the height in meters], 28.4). The overall glycemic control has been suboptimal, with glycated hemoglobin values of 7.5 to 8.0% in recent years. He reports unpredictable swings in self-monitored blood glucose concentrations and frequent episodes of severe hypoglycemia, which markedly disrupt his work and home life. He also reports that he now has fewer warning symptoms of hypoglycemia than he had previously. These findings are present despite the patient's best efforts to achieve glycemic control with intensified insulin-injection therapy, regular visits to a diabetes clinic, and input from diabetes nurse educators. He attended a structured diabetes education course 1 year previously, which he found to be useful and which led to slight improvements in glycated hemoglobin levels; however, the frequency of hypoglycemic episodes was unchanged. His endocrinologist has ruled out coexisting illnesses, including celiac disease and Addison's disease, as causes of poor glycemic control and wonders whether a trial of insulin-pump therapy is appropriate. Since the endocrinologist has little experience with this type of therapy himself, he refers the patient to a center with a specialized insulin-pump clinic.	[Pickup, John C.] Kings Coll London, Guys Hosp, Diabet Res Grp, London SE1 1UL, England; [Pickup, John C.] Kings Coll London, Sch Med, Diabet Res Grp, Div Diabet & Nutr Sci, London SE1 1UL, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London	Pickup, JC (corresponding author), Kings Coll London, Guys Hosp, Diabet Res Grp, London SE1 1UL, England.	john.pickup@kcl.ac.uk						Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Borus JS, 2010, CURR OPIN PEDIATR, V22, P405, DOI 10.1097/MOP.0b013e32833a46a7; Bruttomesso D, 2008, DIABETIC MED, V25, P326, DOI 10.1111/j.1464-5491.2007.02365.x; Bruttomesso D, 2009, DIABETES-METAB RES, V25, P99, DOI 10.1002/dmrr.931; Bryant W, 2006, MED J AUSTRALIA, V185, P305, DOI 10.5694/j.1326-5377.2006.tb00583.x; Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293; Campbell F, 2009, PRACT DIABETES INT, V26, P24, DOI [10.1002/pdi.1324, DOI 10.1002/PDI.1324]; Carroll Mary F, 2005, Endocr Pract, V11, P55; Charles MES, 2009, CLIN THER, V31, P657, DOI 10.1016/j.clinthera.2009.03.013; Choudhary P, 2011, POSTGRAD MED J, V87, P298, DOI 10.1136/pgmj.2008.068197; Cohen N, 2007, PHARMACOECONOMICS, V25, P881, DOI 10.2165/00019053-200725100-00006; Cook CB, 2006, DIABETES ED, V32, P130; Corriveau EA, 2008, PEDIATR DIABETES, V9, P360, DOI 10.1111/j.1399-5448.2008.00363.x; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Gonzalez-Romero S, 2010, DIABETES TECHNOL THE, V12, P263, DOI 10.1089/dia.2009.0140; Govan L, 2011, DIABETES CARE, V34, P1992, DOI 10.2337/dc10-2099; Heinemann Lutz, 2002, Diabetes Technol Ther, V4, P673, DOI 10.1089/152091502320798312; Hirsch IB, 2005, DIABETES CARE, V28, P533, DOI 10.2337/diacare.28.3.533; Jones Susan M, 2005, Diabetes Technol Ther, V7, P233, DOI 10.1089/dia.2005.7.233; Joubert M, 2011, DIABETES RES CL 1228; Kilpatrick ES, 2007, DIABETOLOGIA, V50, P2553, DOI 10.1007/s00125-007-0820-z; Kordonouri O, 2011, DIABETES RES CLIN PR, V93, pS118, DOI 10.1016/S0168-8227(11)70027-4; Lassmann-Vague V, 2010, DIABETES METAB, V36, P79, DOI 10.1016/j.diabet.2009.09.002; LAURITZEN T, 1983, DIABETOLOGIA, V24, P326; Linkeschova R, 2002, DIABETIC MED, V19, P746, DOI 10.1046/j.1464-5491.2002.00713.x; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; Mukhopadhyay A, 2007, AM J OBSTET GYNECOL, V197, P447, DOI 10.1016/j.ajog.2007.03.062; National Institute for Health and Clinical Excellence, 2008, CONT SUBC INS INF TR; Nixon R, 2011, DIABETES TECHNOL THE, V13, P93, DOI 10.1089/dia.2010.0192; Pankowska E, 2009, PEDIATR DIABETES, V10, P52, DOI 10.1111/j.1399-5448.2008.00440.x; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; Pickup J, 2002, BMJ-BRIT MED J, V324, P705, DOI 10.1136/bmj.324.7339.705; Pickup J, 2009, INSULIN PUMP THERAPY, P23; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Pickup J. C., 2011, OXFORD TXB ENDOCRINO, P1861; PICKUP JC, 1978, BRIT MED J, V1, P204, DOI 10.1136/bmj.1.6107.204; Pickup JC, 2005, PRACT DIABET INT, V22, P10; Pickup JC, 2006, DIABETES-METAB RES, V22, P232, DOI 10.1002/dmrr.614; Pickup JC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3805; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; Roze S, 2005, DIABETIC MED, V22, P1239, DOI 10.1111/j.1464-5491.2005.01576.x; Scheiner G, 2009, DIABETES EDUCATOR, V35, p29S, DOI 10.1177/0145721709333493; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shashaj B, 2008, DIABETIC MED, V25, P1036, DOI 10.1111/j.1464-5491.2008.02549.x; TAMBORLANE WV, 1979, NEW ENGL J MED, V300, P573, DOI 10.1056/NEJM197903153001101; Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079; Yogev Y, 2007, AM J OBSTET GYNECOL, V197, pS44, DOI 10.1016/j.ajog.2007.10.121	50	157	164	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1616	1624		10.1056/NEJMct1113948	http://dx.doi.org/10.1056/NEJMct1113948			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533577				2022-12-28	WOS:000303200100010
J	Sperandio, V				Sperandio, Vanessa			Virulence or Competition?	SCIENCE			English	Editorial Material							HOST		[Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Sperandio, Vanessa] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sperandio, V (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	vanessa.sperandio@utsouthwestern.edu						Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791	10	7	7	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1238	1239		10.1126/science.1223303	http://dx.doi.org/10.1126/science.1223303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582015				2022-12-28	WOS:000304905300024
J	Reijns, MAM; Rabe, B; Rigby, RE; Mill, P; Astell, KR; Lettice, LA; Boyle, S; Leitch, A; Keighren, M; Kilanowski, F; Devenney, PS; Sexton, D; Grimes, G; Holt, IJ; Hill, RE; Taylor, MS; Lawson, KA; Dorin, JR; Jackson, AP				Reijns, Martin A. M.; Rabe, Bjoern; Rigby, Rachel E.; Mill, Pleasantine; Astell, Katy R.; Lettice, Laura A.; Boyle, Shelagh; Leitch, Andrea; Keighren, Margaret; Kilanowski, Fiona; Devenney, Paul S.; Sexton, David; Grimes, Graeme; Holt, Ian J.; Hill, Robert E.; Taylor, Martin S.; Lawson, Kirstie A.; Dorin, Julia R.; Jackson, Andrew P.			Enzymatic Removal of Ribonucleotides from DNA Is Essential for Mammalian Genome Integrity and Development	CELL			English	Article							AICARDI-GOUTIERES-SYNDROME; RNASE-H; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; DAMAGE RESPONSE; HISTONE H2AX; REPLICATION; REPAIR; PHOSPHORYLATION; MUTATIONS	The presence of ribonucleotides in genomic DNA is undesirable given their increased susceptibility to hydrolysis. Ribonuclease (RNase) H enzymes that recognize and process such embedded ribonucleotides are present in all domains of life. However, in unicellular organisms such as budding yeast, they are not required for viability or even efficient cellular proliferation, while in humans, RNase H2 hypomorphic mutations cause the neuroinflammatory disorder Aicardi-Goutie res syndrome. Here, we report that RNase H2 is an essential enzyme in mice, required for embryonic growth from gastrulation onward. RNase H2 null embryos accumulate large numbers of single (or di-) ribonucleotides embedded in their genomic DNA (> 1,000,000 per cell), resulting in genome instability and a p53-dependent DNA-damage response. Our findings establish RNase H2 as a key mammalian genome surveillance enzyme required for ribonucleotide removal and demonstrate that ribonucleotides are the most commonly occurring endogenous nucleotide base lesion in replicating cells.	[Reijns, Martin A. M.; Rabe, Bjoern; Rigby, Rachel E.; Mill, Pleasantine; Astell, Katy R.; Lettice, Laura A.; Boyle, Shelagh; Leitch, Andrea; Keighren, Margaret; Kilanowski, Fiona; Devenney, Paul S.; Sexton, David; Grimes, Graeme; Hill, Robert E.; Taylor, Martin S.; Lawson, Kirstie A.; Dorin, Julia R.; Jackson, Andrew P.] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Holt, Ian J.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Edinburgh	Jackson, AP (corresponding author), Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@igmm.ed.ac.uk	Jackson, Andrew P/D-3442-2009; Taylor, Martin S/C-3825-2009; Mill, Pleasantine/AAE-4718-2019; Reijns, Martin/L-4355-2013	Jackson, Andrew P/0000-0002-8739-2646; Taylor, Martin S/0000-0001-7656-330X; Reijns, Martin/0000-0002-5048-2752; Mill, Pleasantine/0000-0001-5218-134X; Rigby, Rachel Elizabeth/0000-0001-5201-9422; holt, ian/0000-0001-5468-0193	MRC; Lister Institute for Preventative Medicine; MRC [MC_PC_U127584494, MC_EX_G0601852, MC_U127584494, MC_U105663140, MC_PC_U127580972, MC_PC_U127527201, MC_PC_U127597124, MC_U127597124] Funding Source: UKRI; Medical Research Council [MC_U127597124, MC_U105663140, MC_PC_U127580972, MC_PC_U127597124, MC_PC_U127527201, MC_U127584494, MC_EX_G0601852, MC_PC_U127584494] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute for Preventative Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Adams, N. Gilbert, N. Hastie, and I. Jackson for commenting on the manuscript; W. Bickmore, M. Ansari, D. Fitzpatrick, and T. Kunkel for helpful discussions; A. Ross, G. Waugh, J. Young, A. Hart, and C. A. Martin for technical assistance; A. Pearce, E. Maher, and E. Freyer for assistance with cytogenetic and FACS analysis; and C. Graham for statistical advice. We also thank Aurelio Reyes and Stuart Wood for providing mouse mitochondrial DNA and the Wellcome Trust Clinical Research Facility, Edinburgh for performing microarrays. This work was supported by funding from the MRC and Lister Institute for Preventative Medicine. A.P.J. is a MRC Senior Clinical Fellow and Lister Institute Prize Fellow.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bhoj VG, 2008, CELL, V134, P569, DOI 10.1016/j.cell.2008.08.010; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BUSEN W, 1980, J BIOL CHEM, V255, P9434; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cech T.R., 2011, RNA WORLDS CONTEXT; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; MACAULEY A, 1993, DEVELOPMENT, V117, P873; MACHIDA Y, 1977, P NATL ACAD SCI USA, V74, P2776, DOI 10.1073/pnas.74.7.2776; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; TANG MS, 1989, J BIOL CHEM, V264, P14455; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	77	315	322	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5								10.1016/j.cell.2012.04.011	http://dx.doi.org/10.1016/j.cell.2012.04.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22579044	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000304453900008
J	Wu, LQ; Dickman, JD				Wu, Le-Qing; Dickman, J. David			Neural Correlates of a Magnetic Sense	SCIENCE			English	Article							MAGNETORECEPTION; COMPASS; BIRDS; FIELD; ANIMALS; PIGEONS; ORIENTATION; TRANSDUCER; BRAIN	Many animals rely on Earth's magnetic field for spatial orientation and navigation. However, how the brain receives and interprets magnetic field information is unknown. Support for the existence of magnetic receptors in the vertebrate retina, beak, nose, and inner ear has been proposed, and immediate gene expression markers have identified several brain regions activated by magnetic stimulation, but the central neural mechanisms underlying magnetoreception remain unknown. Here we describe neuronal responses in the pigeon's brainstem that show how single cells encode magnetic field direction, intensity, and polarity; qualities that are necessary to derive an internal model representing directional heading and geosurface location. Our findings demonstrate that there is a neural substrate for a vertebrate magnetic sense.	[Wu, Le-Qing; Dickman, J. David] Baylor Coll Med, Dept Neurosci, Houston, TX 77024 USA	Baylor College of Medicine	Dickman, JD (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77024 USA.	dickman@bcm.edu	Wu, Le-Qing/G-6664-2012		National Institute for Deafness and Other Communication Disorders [DC007618]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007618, R01DC012813] Funding Source: NIH RePORTER	National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Angelaki for comments and guidance in the analyses; K. Reed and J. Chen for technical assistance; C. Fetsch and B. Lindseth for help in pilot investigations; and S. Aamodt for critical review. Much of the work was conducted at Washington University in St. Louis and was supported by a National Institute for Deafness and Other Communication Disorders grant (DC007618) to J. D. D. Data are made available as part of the supplementary materials.	Cadiou H, 2010, J R SOC INTERFACE, V7, pS193, DOI 10.1098/rsif.2009.0423.focus; Dickman JD, 1996, J COMP NEUROL, V367, P110; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V249, P27, DOI 10.1098/rspb.1992.0079; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Harada Y, 2001, ACTA OTO-LARYNGOL, V121, P590, DOI 10.1080/000164801316878872; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; McArthur KL, 2011, J NEUROPHYSIOL, V105, P1689, DOI 10.1152/jn.00981.2010; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; Vargas JP, 2006, BRAIN RES BULL, V70, P158, DOI 10.1016/j.brainresbull.2006.03.018; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; Walker MM, 2002, CURR OPIN NEUROBIOL, V12, P735, DOI 10.1016/S0959-4388(02)00389-6; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058	24	119	124	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1054	1057		10.1126/science.1216567	http://dx.doi.org/10.1126/science.1216567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22539554				2022-12-28	WOS:000304406800050
J	Marchi, S; McSween, HY; O'Brien, DP; Schenk, P; De Sanctis, MC; Gaskell, R; Jaumann, R; Mottola, S; Preusker, F; Raymond, CA; Roatsch, T; Russell, CT				Marchi, S.; McSween, H. Y.; O'Brien, D. P.; Schenk, P.; De Sanctis, M. C.; Gaskell, R.; Jaumann, R.; Mottola, S.; Preusker, F.; Raymond, C. A.; Roatsch, T.; Russell, C. T.			The Violent Collisional History of Asteroid 4 Vesta	SCIENCE			English	Article							BELT; IMPACT; EXCITATION; EVOLUTION; ORIGIN; EJECTA; CRATER; FAMILY	Vesta is a large differentiated rocky body in the main asteroid belt that accreted within the first few million years after the formation of the earliest solar system solids. The Dawn spacecraft extensively imaged Vesta's surface, revealing a collision-dominated history. Results show that Vesta's cratering record has a strong north-south dichotomy. Vesta's northern heavily cratered terrains retain much of their earliest history. The southern hemisphere was reset, however, by two major collisions in more recent times. We estimate that the youngest of these impact structures, about 500 kilometers across, formed about 1 billion years ago, in agreement with estimates of Vesta asteroid family age based on dynamical and collisional constraints, supporting the notion that the Vesta asteroid family was formed during this event.	[Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO USA; [McSween, H. Y.] Univ Tennessee, Knoxville, TN USA; [O'Brien, D. P.; Gaskell, R.] Planetary Sci Inst, Tucson, AZ USA; [Schenk, P.] Lunar & Planetary Inst, Houston, TX 77058 USA; [De Sanctis, M. C.] Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, Rome, Italy; [Jaumann, R.; Mottola, S.; Preusker, F.; Roatsch, T.] German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Russell, C. T.] Univ Calif Los Angeles, Los Angeles, CA USA	National Aeronautics & Space Administration (NASA); University of Tennessee System; University of Tennessee Knoxville; Istituto Nazionale Astrofisica (INAF); Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Marchi, S (corresponding author), NASA, Lunar Sci Inst, Boulder, CO USA.	marchi@boulder.swri.edu	Jaumann, Ralf/N-1001-2018; De Sanctis, Maria Cristina/G-5232-2013; Russell, Christopher T/E-7745-2012	Jaumann, Ralf/0000-0002-9759-6597; De Sanctis, Maria Cristina/0000-0002-3463-4437; Russell, Christopher T/0000-0003-1639-8298	Dawn Science, Instrument, and Operations Teams; Italian Space Agency; NASA's Dawn; NASA; Istituto Nazionale d'Astrofisica	Dawn Science, Instrument, and Operations Teams; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA's Dawn; NASA(National Aeronautics & Space Administration (NASA)); Istituto Nazionale d'Astrofisica	We thank the Dawn Science, Instrument, and Operations Teams for support. This work was supported by the Italian Space Agency and NASA's Dawn at Vesta Participating Scientists Program. A portion of this work was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. S. Marchi thanks Istituto Nazionale d'Astrofisica for the support in carrying on this work.	Bierhaus EB, 2012, ICARUS, V218, P602, DOI 10.1016/j.icarus.2011.12.011; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; Burbine TH, 2001, METEORIT PLANET SCI, V36, P761, DOI 10.1111/j.1945-5100.2001.tb01915.x; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; De Sanctis MC, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117136; FARINELLA P, 1992, ICARUS, V97, P111, DOI 10.1016/0019-1035(92)90060-K; GAULT DE, 1970, RADIO SCI, V5, P273, DOI 10.1029/RS005i002p00273; Holsapple KA, 2007, ICARUS, V187, P345, DOI 10.1016/j.icarus.2006.08.029; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Jutzi M., 2011, J GEOPHYS RES, V38; Marchi S, 2010, PLANET SPACE SCI, V58, P1116, DOI 10.1016/j.pss.2010.03.017; Marzari F, 1996, ASTRON ASTROPHYS, V316, P248; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween Harry Y.  Jr., 2011, Space Science Reviews, V163, P141, DOI 10.1007/s11214-010-9637-z; Melosh H. J, 1989, OXFORD MONOGRAPHS GE, V11; Nesvorny D, 2008, ICARUS, V193, P85, DOI 10.1016/j.icarus.2007.08.034; O'Brien DP, 2007, ICARUS, V191, P434, DOI 10.1016/j.icarus.2007.05.005; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Turrini D, 2011, MON NOT R ASTRON SOC, V413, P2439, DOI 10.1111/j.1365-2966.2011.18316.x; WETHERILL GW, 1992, ICARUS, V100, P307, DOI 10.1016/0019-1035(92)90103-E	24	176	178	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					690	694		10.1126/science.1218757	http://dx.doi.org/10.1126/science.1218757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582255				2022-12-28	WOS:000303872300041
J	Bion, J				Bion, Julian			Are doctors justified in taking industrial action in defence of their pensions? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Bion, J (corresponding author), Univ Birmingham, Birmingham B15 2TH, W Midlands, England.	J.F.Bion@bham.ac.uk		Bion, Julian/0000-0003-0344-5403				Ipsos MORI, 2011, TRUST PROF; Jaques H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2505; Thompson SL, 2006, INT J HEALTH SERV, V36, P331, DOI 10.2190/B5CX-UX69-45LY-2D6D; TRELOAR S, 1981, J SOC POLICY, V10, P1, DOI 10.1017/S0047279400010357	4	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3175	10.1136/bmj.e3175	http://dx.doi.org/10.1136/bmj.e3175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569865				2022-12-28	WOS:000304083400006
J	Bosch, X				Bosch, Xavier			Research integrity on the Horizon	LANCET			English	Editorial Material									[Bosch, Xavier] Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain; [Bosch, Xavier] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bosch, X (corresponding author), Univ Barcelona, Dept Internal Med, Hosp Clin, E-08036 Barcelona, Spain.	xavbosch@clinic.ub.es						[Anonymous], 2011, INTERIM REPORT REGAR; [Anonymous], 2006, REP INV COMM APP RIK; [Anonymous], 2011, PROPOSAL COUNCIL DEC; Bosch X, 2012, AM J MED, V125, P324, DOI 10.1016/j.amjmed.2011.07.015; Bosch X, 2010, EMBO REP, V11, P252, DOI 10.1038/embor.2010.32; Community Research and Development Information Service, 7 FRAM PROGR ETH SHE; European Commission, HOR 2020; European Science Foundation & All European Academies, 2011, EUR COD COND RES INT; House of Commons Science and Technology Committee, 8 HOUS COMM SCI TECH; National Sciences Foundation, KEY REG RES MISC; Reardon S, 2011, SCIENCE, V334, P1331, DOI 10.1126/science.334.6061.1331; Singapore Statement on Research Integrity, 2010, 2 WORLD C RES INT SI	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2012	379	9827					1679	1680		10.1016/S0140-6736(12)60317-1	http://dx.doi.org/10.1016/S0140-6736(12)60317-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	937KX	22559884				2022-12-28	WOS:000303658500005
J	Colombani, J; Andersen, DS; Leopold, P				Colombani, Julien; Andersen, Ditte S.; Leopold, Pierre			Secreted Peptide Dilp8 Coordinates Drosophila Tissue Growth with Developmental Timing	SCIENCE			English	Article							WING IMAGINAL DISCS; PATTERN FORMATION; MELANOGASTER; REGENERATION; DISKS; PUPARIATION; ORGANS	Little is known about how organ growth is monitored and coordinated with the developmental timing in complex organisms. In insects, impairment of larval tissue growth delays growth and morphogenesis, revealing a coupling mechanism. We carried out a genetic screen in Drosophila to identify molecules expressed by growing tissues participating in this coupling and identified dilp8 as a gene whose silencing rescues the developmental delay induced by abnormally growing tissues. dilp8 is highly induced in conditions where growth impairment produces a developmental delay. dilp8 encodes a peptide for which expression and secretion are sufficient to delay metamorphosis without affecting tissue integrity. We propose that Dilp8 peptide is a secreted signal that coordinates the growth status of tissues with developmental timing.	[Andersen, Ditte S.] Univ Nice, CNRS 7277, INSERM 1091, F-06108 Nice, France; France Inst Biol, F-06108 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Andersen, DS (corresponding author), Univ Nice, CNRS 7277, INSERM 1091, Parc Valrose, F-06108 Nice, France.	andersen@unice.fr; leopold@unice.fr		Colombani, Julien/0000-0002-8250-4899; Andersen, Ditte/0000-0003-1209-6102	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; European Research Council [268813]; Danish Research Council [272-08-0064]; Marie Curie Life Long Training [252373]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); Danish Research Council(Det Frie Forskningsrad (DFF)); Marie Curie Life Long Training	We thank P. O'Farrell for initial insightful discussions; G. Jarretou and J. Villalba for technical assistance; V. Pantesco and L. Vallar for microarray data and analysis; the Vienna Drosophila RNAi Center, Drosophila Genetics Resource Center, and Bloomington stock centers; I. Bourget for gamma-ray experiments; S. Leevers, N. Tapon, and laboratory members for comments on the manuscript; and M. Dominguez, A. Garelli, and A. Gontijo for communicating unpublished results. This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, European Research Council (grant no. 268813), Danish Research Council (grant no. 272-08-0064 for D.S.A.) and Marie Curie Life Long Training (grant no. 252373 for D.S.A.). The microarray data are presented at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36862 (accession no. GSE36862).	Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin FA, 2006, DEVELOPMENT, V133, P4421, DOI 10.1242/dev.02618; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Parker NF, 2011, DEV BIOL, V357, P318, DOI 10.1016/j.ydbio.2011.07.002; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; RUSSELL MA, 1974, DEV BIOL, V40, P24, DOI 10.1016/0012-1606(74)90104-3; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; SIMPSON P, 1975, ROUX ARCH DEV BIOL, V178, P247, DOI 10.1007/BF00848432; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556	19	348	353	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					582	585		10.1126/science.1216689	http://dx.doi.org/10.1126/science.1216689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556251				2022-12-28	WOS:000303498800044
J	London, AJ; Kimmelman, J; Carlisle, B				London, Alex John; Kimmelman, Jonathan; Carlisle, Benjamin			Rethinking Research Ethics: The Case of Postmarketing Trials	SCIENCE			English	Editorial Material							RISK		[Kimmelman, Jonathan; Carlisle, Benjamin] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada; [London, Alex John] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA	McGill University; Carnegie Mellon University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmelman@mcgill.ca	Carlisle, Benjamin/AAD-6332-2020	Carlisle, Benjamin/0000-0001-8975-0649; London, Alex/0000-0002-6450-0309				Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2018, ETHICAL CONDUCT RES; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D., 2005, HLTH AFFAIRS W, VW5, P469; Department of Health and Human Services, 2011, FED REGISTER, V76, P44512; Department of Health United Kingdom, 2005, RES GOV FRAM HLTH SO; Elliott C., 2010, MOTHER JONES     SEP, V2010, P55; Falit Benjamin P, 2007, Seton Hall Law Rev, V37, P969; Hasford J, 1998, EUR J CLIN PHARMACOL, V53, P369, DOI 10.1007/s002280050395; London AJ, 2010, SCIENCE, V328, P829, DOI 10.1126/science.1189369; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P2787, DOI 10.1001/jama.295.23.2787; Rao JN, 2002, BRIT MED J, V325, P36, DOI 10.1136/bmj.325.7354.36; Sox HC, 2008, ANN INTERN MED, V149, P279, DOI 10.7326/0003-4819-149-4-200808190-00012; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; TEEHAN M, 1994, CAN J PSYCHIAT, V39, P629; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	17	26	26	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					544	545		10.1126/science.1216086	http://dx.doi.org/10.1126/science.1216086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22556237	Green Accepted			2022-12-28	WOS:000303498800029
J	Gerszten, RE; Tager, AM				Gerszten, Robert E.; Tager, Andrew M.			The Monocyte in Atherosclerosis-Should I Stay or Should I Go Now?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEFICIENT MICE; REGRESSION; PROMOTES; PLAQUES; CELLS		[Gerszten, Robert E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gerszten, RE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Franzeck, Fabian C/B-5055-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL108975] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205	6	34	37	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1734	1736		10.1056/NEJMcibr1200164	http://dx.doi.org/10.1056/NEJMcibr1200164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551134				2022-12-28	WOS:000303434300016
J	Schyma, BM; Kerr, R; Alam, S				Schyma, Barry M.; Kerr, Robin; Alam, Shirjel			At either end of the tube	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schyma, Barry M.] Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland; [Alam, Shirjel] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Schyma, BM (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland.	Barryschyma@hotmail.com; robinkerr@nhs.net; shirjel@doctors.org.uk		Schyma, Barry/0000-0002-8333-2339; Kerr, Robin/0000-0003-2480-2748					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e2971	10.1136/bmj.e2971	http://dx.doi.org/10.1136/bmj.e2971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NG	22556047	Bronze			2022-12-28	WOS:000303817700008
J	Lok, CE; Moist, L; Hemmelgarn, BR; Tonelli, M; Vazquez, MA; Dorval, M; Oliver, M; Donnelly, S; Allon, M; Stanley, K				Lok, Charmaine E.; Moist, Louise; Hemmelgarn, Brenda R.; Tonelli, Marcello; Vazquez, Miguel A.; Dorval, Marc; Oliver, Matthew; Donnelly, Sandra; Allon, Michael; Stanley, Kenneth		Fish Oil Inhibition Stenosis Hemod	Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; VASCULAR ACCESS THROMBOSIS; DOUBLE-BLIND; PLUS ASPIRIN; SURVIVAL; DIALYSIS; DISEASE; THERAPY; OMEGA-3-FATTY-ACIDS; MORTALITY	Context Synthetic arteriovenous grafts, an important option for hemodialysis vascular access, are prone to recurrent stenosis and thrombosis. Supplementation with fish oils has theoretical appeal for preventing these outcomes. Objective To determine the effect of fish oil on synthetic hemodialysis graft patency and cardiovascular events. Design, Setting, and Participants The Fish Oil Inhibition of Stenosis in Hemodialysis Grafts (FISH) study, a randomized, double-blind, controlled clinical trial conducted at 15 North American dialysis centers from November 2003 through December 2010 and enrolling 201 adults with stage 5 chronic kidney disease (50% women, 63% white, 53% with diabetes), with follow-up for 12 months after graft creation. Interventions Participants were randomly allocated to receive fish oil capsules (four 1-g capsules/d) or matching placebo on day 7 after graft creation. Main Outcome Measure Proportion of participants experiencing graft thrombosis or radiological or surgical intervention during 12 months' follow-up. Results The risk of the primary outcome did not differ between fish oil and placebo recipients (48/99 [48%] vs 60/97 [62%], respectively; relative risk, 0.78 [95% CI, 0.60 to 1.03; P=.06]). However, the rate of graft failure was lower in the fish oil group (3.43 vs 5.95 per 1000 access-days; incidence rate ratio [IRR], 0.58 [95% CI, 0.44 to 0.75; P<.001]). In the fish oil group, there were half as many thromboses (1.71 vs 3.41 per 1000 access-days; IRR, 0.50 [95% CI, 0.35 to 0.72; P<.001]); fewer corrective interventions (2.89 vs 4.92 per 1000 access-days; IRR, 0.59 [95% CI, 0.44 to 0.78; P<.001]); improved cardiovascular event-free survival (hazard ratio, 0.43 [95% CI, 0.19 to 0.96; P=.04]); and lower mean systolic blood pressure (-3.61 vs 4.49 mm Hg; difference, -8.10 [95% CI, -15.4 to -0.85]; P=.01). Conclusions Among patients with new hemodialysis grafts, daily fish oil ingestion did not decrease the proportion of grafts with loss of native patency within 12 months. Although fish oil improved some relevant secondary outcomes such as graft patency, rates of thrombosis, and interventions, other potential benefits on cardiovascular events require confirmation in future studies.	[Lok, Charmaine E.] Toronto Gen Hosp, Dept Med, Div Nephrol, Toronto, ON M5G 2C4, Canada; [Lok, Charmaine E.] Univ Toronto, Toronto, ON, Canada; [Moist, Louise] Univ Western Ontario, London, ON, Canada; [Moist, Louise] London Hlth Sci Ctr, London, ON, Canada; [Hemmelgarn, Brenda R.] Univ Calgary, Calgary, AB, Canada; [Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada; [Vazquez, Miguel A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Dorval, Marc] Dr Georges L Dumont Univ Hosp Ctr, Moncton, NB, Canada; [Oliver, Matthew] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; [Donnelly, Sandra] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Allon, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Stanley, Kenneth] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Western University (University of Western Ontario); London Health Sciences Centre; University of Calgary; University of Alberta; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard T.H. Chan School of Public Health	Lok, CE (corresponding author), Toronto Gen Hosp, Dept Med, Div Nephrol, 8NU-844,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	charmaine.lok@uhn.ca	Tonelli, Marcello/B-3028-2009; Dorval, Marc/M-7219-2015; Moist, Louise/G-3334-2011; Hemmelgarn, Brenda R./I-6894-2012	Tonelli, Marcello/0000-0002-0846-3187; Dorval, Marc/0000-0002-9548-978X; Lok, Charmaine/0000-0001-5365-0064	Roche; Merck; Gambro; Baxter; Novartis; University of Alabama at Birmingham; Physician's Services Incorporated Foundation; Canadian Institutes for Health Research (CIHR); Alberta Heritage Foundation; Government of Canada Research Chair; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K24 DK59818-01, 5UO1 DK082240, R34 DK094115]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R34DK094115, U01DK082240, K24DK059818, R01DK085027] Funding Source: NIH RePORTER	Roche(Roche Holding); Merck(Merck & Company); Gambro; Baxter; Novartis(Novartis); University of Alabama at Birmingham; Physician's Services Incorporated Foundation; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Government of Canada Research Chair; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Moist reported serving as a consultant for Amgen and Leo and receiving payment for lectures from Roche and Merck. Dr Dorval reported serving as a board member for Gambro; serving as a consultant for Gambro; receiving grants or grants pending from Gambro and Baxter; and receiving payment for lectures from Gambro and Novartis. Dr Oliver reported receiving author royalties from UpToDate and that he is the sole owner of Oliver Medical Management Inc, which manufactures dialysis-related software. Dr Allon reported receiving a grant and travel support from the University of Alabama at Birmingham. Dr Stanley reported serving as the FISH study's independent statistician and that he served as Executive Director of the Center for Biostatistics and AIDS Research at Harvard School of Public Health before retiring. No other authors reported disclosures.; This study was supported by peer-reviewed grant funding from the Physician's Services Incorporated Foundation and the Canadian Institutes for Health Research (CIHR). During the study, Drs Lok, Hemmelgarn, and Tonelli were supported by CIHR New Investigator Awards. Dr Lok was also supported by the CIHR Randomized Clinical Trials Mentoring Program. Currently, Drs Hemmelgarn and Tonelli are also supported by Alberta Heritage Foundation for Medical Research Population Scholar Awards; Dr Tonelli is supported by a Government of Canada Research Chair. Dr Allon is supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant K24 DK59818-01. Dr Vazquez is supported by NIDDK grants 5UO1 DK082240 and R34 DK094115.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; AGRESTI A, 2007, BUILDING APPL LOGIST; Akoh JA, 2009, J VASC ACCESS, V10, P137; [Anonymous], 2001, Am J Kidney Dis, V37, pS137; [Anonymous], 2020, VOLUME MODE TRAVELIN, V2; [Anonymous], 2012, PRIV IMP ASS APP B C; Bowden RG, 2007, J RENAL NUTR, V17, P126, DOI 10.1053/j.jrn.2006.07.009; Christensen R, 1997, LOG LINEAR MODELS LO; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Crowther MA, 2002, J AM SOC NEPHROL, V13, P2331, DOI 10.1097/01.ASN.0000027356.16598.99; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Dember LM, 2004, KIDNEY INT, V66, P390, DOI 10.1111/j.1523-1755.2004.00743.x; DISKIN CJ, 1993, NEPHRON, V64, P1, DOI 10.1159/000187272; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Ethier J, 2008, NEPHROL DIAL TRANSPL, V23, P3219, DOI 10.1093/ndt/gfn261; Friedman A, 2006, CLIN J AM SOC NEPHRO, V1, P182, DOI 10.2215/CJN.00740805; Garwood F, 1936, BIOMETRIKA, V28, P437; HOLM S, 1979, SCAND J STAT, V6, P65; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kaufman JS, 2003, J AM SOC NEPHROL, V14, P2313, DOI 10.1097/01.ASN.0000081661.10246.33; Khajehdehi P, 2000, J Ren Nutr, V10, P191, DOI 10.1053/jren.2000.16326; KOBAYASHI K, 1980, THROMB RES, V20, P255, DOI 10.1016/0049-3848(80)90390-4; Kolakowski S, 2003, J VASC SURG, V38, P719, DOI 10.1016/S0741-5214(03)00947-9; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Lee T, 2011, SEMIN DIALYSIS, V24, P515, DOI 10.1111/j.1525-139X.2011.00969.x; Lok CE, 2007, CLIN TRIALS, V4, P357, DOI 10.1177/1740774507081218; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; Miller PE, 2000, AM J KIDNEY DIS, V36, P68, DOI 10.1053/ajkd.2000.8269; Moist LM, 2003, J AM SOC NEPHROL, V14, P2645, DOI 10.1097/01.ASN.0000089562.98338.60; Moist LM, 2008, CLIN J AM SOC NEPHRO, V3, P1726, DOI 10.2215/CJN.01240308; MUNDA R, 1983, JAMA-J AM MED ASSOC, V249, P219, DOI 10.1001/jama.249.2.219; Nordoy A, 2001, LIPIDS, V36, pS127, DOI 10.1007/s11745-001-0695-7; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Paulson WD, 2012, KIDNEY INT, V81, P132, DOI 10.1038/ki.2011.337; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; RYLANCE PB, 1986, NEPHRON, V43, P196, DOI 10.1159/000183829; Schmitz PG, 2002, J AM SOC NEPHROL, V13, P184, DOI 10.1681/ASN.V131184; Schwab SJ, 1999, KIDNEY INT, V55, P2078, DOI 10.1046/j.1523-1755.1999.00409.x; SIMOPOULOS AP, 1991, AM J CLIN NUTR, V54, P438, DOI 10.1093/ajcn/54.3.438; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; SREEDHARA R, 1994, KIDNEY INT, V45, P1477, DOI 10.1038/ki.1994.192; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; van Acker B A, 1987, Nephrol Dial Transplant, V2, P557; Woods JD, 1997, AM J KIDNEY DIS, V30, P50, DOI 10.1016/S0272-6386(97)90564-3; Yevzlin AS, 2010, TRANSL RES, V156, P216, DOI 10.1016/j.trsl.2010.07.004	49	97	98	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1809	1816		10.1001/jama.2012.3473	http://dx.doi.org/10.1001/jama.2012.3473			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550196	Green Accepted, Bronze			2022-12-28	WOS:000303386800020
J	DeLong, EF				DeLong, Edward F.			Microbial Evolution in the Wild	SCIENCE			English	Editorial Material							BACTERIA; ENVIRONMENT; COMMUNITY; DYNAMICS		[DeLong, Edward F.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [DeLong, Edward F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DeLong, EF (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu						Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bateson G., 1972, STEPS ECOLOGY MIND C; Denef VJ, 2012, SCIENCE, V336, P462, DOI 10.1126/science.1218389; Denef VJ, 2009, ENVIRON MICROBIOL, V11, P313, DOI 10.1111/j.1462-2920.2008.01769.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	15	9	9	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					422	424		10.1126/science.1221822	http://dx.doi.org/10.1126/science.1221822			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539708				2022-12-28	WOS:000303233400031
J	Pearse, RM; Ackland, GL				Pearse, Rupert M.; Ackland, Gareth L.			Perioperative fluid therapy Intravenous fluid therapy is an important aspect of perioperative care, but doctors often prescribe fluid with limited knowledge of its benefits and risks. This article provides an evidence based summary of current best practice in the prescription of fluid for patients undergoing major non-cardiac surgery.	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTOPERATIVE OUTCOMES; TRANSFUSION; ADULTS		[Pearse, Rupert M.] Queen Marys Univ London, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Ackland, Gareth L.] UCL, Univ Coll Hosp NHS Trust, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; Queen Mary University London; University of London; University College London	Pearse, RM (corresponding author), Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England.	r.pearse@qmul.ac.uk	Pearse, Rupert/H-5426-2011	Pearse, Rupert/0000-0002-4373-5934; ACKLAND, GARETH/0000-0003-0565-5164	Department of Health [CS/08/08/17] Funding Source: Medline; Academy of Medical Sciences (AMS) [AMS-CSF3-Ackland] Funding Source: researchfish; National Institute for Health Research [CS/08/08/17] Funding Source: researchfish	Department of Health; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))		Amato A, 2006, COCHRANE DB SYST REV, DOI 10.1002/1465158.CD005033.pub2; Anderson I, 2011, HIGHER RISK GEN SURG; [Anonymous], 2011, BRIT CONSENSUS GUIDE; Brady M., 2003, COCHRANE DB SYST REV, V4, pCD004423, DOI [10.1002/14651858.CD004423, DOI 10.1002/14651858.CD004423, 10.1002/14651858.cd004423]; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; Dart AB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007594.pub2; Findlay GP, 2011, KNOWING RISK REV PER; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Freedman J, 2008, TRANSFUSION, V48, P237, DOI 10.1111/j.1537-2995.2007.01515.x; Guenaga KF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001544.pub4; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Henry DA, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003602; Itobi E, 2006, BRIT J SURG, V93, P354, DOI 10.1002/bjs.5259; Knowles S., 2011, 2010 ANN SHOT REPORT; Liu B, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2418; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Mythen MG, 2010, DELIVERING ENHANCED; National Institute for Health and Clinical Excellence, 2011, CARDIOQ ODM OES DOPP; Neary WD, 2003, BRIT J SURG, V90, P157, DOI 10.1002/bjs.4041; Pearse RM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5759; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Rosenberg Andrew L, 2009, J Intensive Care Med, V24, P35, DOI 10.1177/0885066608329850; Stroud M, 2006, NUTR SUPPORT ADULTS; Thomas D, 2008, BLOOD TRANSFUSION AN; Toomtong P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000991.pub2; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Yunos NM, 2011, CRIT CARE MED, V39, P2419, DOI 10.1097/CCM.0b013e31822571e5	30	25	25	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2012	344								e2865	10.1136/bmj.e2865	http://dx.doi.org/10.1136/bmj.e2865			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539015				2022-12-28	WOS:000303433900009
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Global child survival: beyond numbers	LANCET			English	Editorial Material							MORTALITY; COUNTDOWN; NEWBORN		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu						Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45; Lahariya C, 2010, INDIAN J PEDIATR, V77, P1303, DOI 10.1007/s12098-010-0246-3; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Macro International and National Institute of Population Studies, PAK DEM HLTH SURV 20; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Theodoratou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025095; UNICEF, MAT CHILD HLTH SERV; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2126	2128		10.1016/S0140-6736(12)60686-2	http://dx.doi.org/10.1016/S0140-6736(12)60686-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22579124				2022-12-28	WOS:000304990900008
J	Lorenz, MW; Polak, JF; Kavousi, M; Mathiesen, EB; Volzke, H; Tuomainen, TP; Sander, D; Plichart, M; Catapano, AL; Robertson, CM; Kiechl, S; Rundek, T; Desvarieux, M; Lind, L; Schmid, C; DasMahapatra, P; Gao, L; Ziegelbauer, K; Bots, ML; Thompson, SG				Lorenz, Matthias W.; Polak, Joseph F.; Kavousi, Maryam; Mathiesen, Ellisiv B.; Voelzke, Henry; Tuomainen, Tomi-Pekka; Sander, Dirk; Plichart, Matthieu; Catapano, Alberico L.; Robertson, Christine M.; Kiechl, Stefan; Rundek, Tatjana; Desvarieux, Moise; Lind, Lars; Schmid, Caroline; DasMahapatra, Pronabesh; Gao, Lu; Ziegelbauer, Kathrin; Bots, Michiel L.; Thompson, Simon G.		PROG-IMT Study Grp	Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data	LANCET			English	Article							RISK-FACTORS; ARTERY INTIMA; HYPERTENSIVE MEN; VASCULAR RISK; ATHEROSCLEROSIS; DISEASE; STROKE; PLAQUE; HISTORY	Background Carotid intima-media thickness (cIMT) is related to the risk of cardiovascular events in the general population. An association between changes in cIMT and cardiovascular risk is frequently assumed but has rarely been reported. Our aim was to test this association. Methods We identified general population studies that assessed cIMT at least twice and followed up participants for myocardial infarction, stroke, or death. The study teams collaborated in an individual participant data meta-analysis. Excluding individuals with previous myocardial infarction or stroke, we assessed the association between cIMT progression and the risk of cardiovascular events (myocardial infarction, stroke, vascular death, or a combination of these) for each study with Cox regression. The log hazard ratios (HRs) per SD difference were pooled by random effects meta-analysis. Findings Of 21 eligible studies, 16 with 36 984 participants were included. During a mean follow-up of 7.0 years, 1519 myocardial infarctions, 1339 strokes, and 2028 combined endpoints (myocardial infarction, stroke, vascular death) occurred. Yearly cIMT progression was derived from two ultrasound visits 2-7 years (median 4 years) apart. For mean common carotid artery intima-media thickness progression, the overall HR of the combined endpoint was 0.97 (95% CI 0.94-1.00) when adjusted for age, sex, and mean common carotid artery intima-media thickness, and 0.98 (0.95-1.01) when also adjusted for vascular risk factors. Although we detected no associations with cIMT progression in sensitivity analyses, the mean cIMT of the two ultrasound scans was positively and robustly associated with cardiovascular risk (HR for the combined endpoint 1.16, 95% CI 1.10-1.22, adjusted for age, sex, mean common carotid artery intima-media thickness progression, and vascular risk factors). In three studies including 3439 participants who had four ultrasound scans, cIMT progression did not correlate between occassions (reproducibility correlations between r=-0.06 and r=-0.02). Interpretation The association between cIMT progression assessed from two ultrasound scans and cardiovascular risk in the general population remains unproven. No conclusion can be derived for the use of cIMT progression as a surrogate in clinical trials.	[Lorenz, Matthias W.; Ziegelbauer, Kathrin] Goethe Univ Frankfurt, Dept Neurol, Univ Hosp, D-60528 Frankfurt, Germany; [Polak, Joseph F.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Kavousi, Maryam; Bots, Michiel L.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Mathiesen, Ellisiv B.] Univ Tromso, Dept Clin Med, N-9001 Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp No Norway, Dept Neurol & Neurophysiol, Tromso, Norway; [Voelzke, Henry] SHIP Clin Epidemiol Res, Inst Community Med, Greifswald, Germany; [Tuomainen, Tomi-Pekka] Univ Eastern Finland, Inst Publ Hlth & Clin, Kuopio, Finland; [Sander, Dirk] Univ Technol, Dept Neurol, Munich, Germany; [Plichart, Matthieu] Univ Paris 05, Inst Natl Sante & Rech Med, Paris Cardiovasc Res Ctr, Paris, France; [Plichart, Matthieu] Hop Broca, Assistance Publ Hop Paris, Paris, France; [Catapano, Alberico L.] IRCSS Multimed Sesto S Giovanni, Milan, Italy; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Robertson, Christine M.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Desvarieux, Moise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Desvarieux, Moise] Inst Natl Sante & Rech Med, Paris, France; [Desvarieux, Moise] Ecole Hautes Etud Sante Publ, Paris, France; [Lind, Lars] Uppsala Univ, Dept Med, Uppsala, Sweden; [Schmid, Caroline] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden; [DasMahapatra, Pronabesh] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Cardiovasc Hlth, Dept Epidemiol, New Orleans, LA USA; [Gao, Lu; Thompson, Simon G.] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Tufts Medical Center; Tufts University; Erasmus University Rotterdam; Erasmus MC; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Eastern Finland; Technical University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Milan; University of Edinburgh; Medical University of Innsbruck; University of Miami; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Uppsala University; University of Gothenburg; Tulane University; MRC Biostatistics Unit; University of Cambridge; Utrecht University; Utrecht University Medical Center	Lorenz, MW (corresponding author), Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany.	matthias.lorenz@em.uni-frankfurt.de	Catapano, alberico/AAC-2827-2019; Kavousi, Maryam/F-1174-2018; Desvarieux, Moise/C-4991-2019; Breteler, Monique M.B./J-5058-2014	Catapano, alberico/0000-0002-7593-2094; Kavousi, Maryam/0000-0001-5976-6519; Breteler, Monique M.B./0000-0002-0626-9305; Dorr, Marcus/0000-0001-7471-475X; Poppert, Holger/0000-0003-2189-7681; Norata, Giuseppe Danilo/0000-0002-6081-1257	AstraZeneca; Dutch Heart Foundation; Organon; Pfizer; Servier; Netherlands Organisation for Health Research and Development; TNO-Zeist; Boeringher; Schering-Plough; Unilever; National Heart, Lung and Blood Institute (Bethesda, MD, USA); Pustertaler Verein zur Praevention von Herz- und Hirngefaesserkrankungen; Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit (Province of Bolzano, Italy); Stiftung Deutsche Schlaganfall-Hilfe; National Heart, Lung, and Blood Institute [HHSN268201200036C, N01-HC-85239, N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295]; National Institute of Neurological Disorders and Stroke [R37 NS 029993]; National Institute of Dental and Craniofacial Research (Bethesda, MD, USA) [R01 DE 13094]; AOK Bayern; Netherlands Foundation for Scientific Research, ZonMw [Vici 918-76-619]; Federal Ministry of Education and Research (BMBF) [01ZZ9603, 01ZZ0103]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsche Forschungsgemeinschaft (DFG) [Lo 1569/2-1]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105260792] Funding Source: researchfish; MRC [MC_U105260792] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC085084, N01HC085083, N01HC085082, N01HC085081, N01HC085080, N01HC085079, N01HC015103, N01HC045133, N01HC085085, N01HC075150, N01HC035129, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083, R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020098, R56AG023629, R01AG020098, R01AG023629, R01AG027058, R01AG015928] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Dutch Heart Foundation(Netherlands Heart Foundation); Organon; Pfizer(Pfizer); Servier(Servier); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); TNO-Zeist; Boeringher; Schering-Plough(Merck & CompanySchering Plough Corporation); Unilever(Unilever); National Heart, Lung and Blood Institute (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pustertaler Verein zur Praevention von Herz- und Hirngefaesserkrankungen; Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit (Province of Bolzano, Italy)(Pronvincia Autonoma di Bolzano); Stiftung Deutsche Schlaganfall-Hilfe; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); AOK Bayern; Netherlands Foundation for Scientific Research, ZonMw; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michiel Bots has received grants from AstraZeneca, Dutch Heart Foundation, Organon, Pfizer, Servier, the Netherlands Organisation for Health Research and Development, and TNO-Zeist, and consultancy fees from AstraZeneca, Boeringher, Organon, Pfizer, Servier, Schering-Plough, and Unilever. He runs the Vascular Imaging Center in Utrecht, a core laboratory for cIMT measurements in national and international observational and intervention studies. All other authors declare that they have no conflicts of interest.; We used a restricted access dataset of the Atherosclerosis Risk In Communities (ARIC) Study. The ARIC Study was supported by National Heart, Lung and Blood Institute (Bethesda, MD, USA) in collaboration with the ARIC study investigators. This Article does not necessarily convey the opinions or views of the ARIC Study or the National Heart, Lung and Blood Institute. The Bruneck study was supported by the Pustertaler Verein zur Praevention von Herz- und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck, and the Assessorat fuer Gesundheit (Province of Bolzano, Italy). The Carotid Atherosclerosis Progression Study was supported by the Stiftung Deutsche Schlaganfall-Hilfe. The Cardiovascular Health Study research reported in this article was supported by contracts HHSN268201200036C, N01-HC-85239, N01-HC-85079 to N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant HL080295 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke (Bethesda, MD, USA). Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the National Institute on Aging (Bethesda, MD, USA). A full list of principal Cardiovascular Health Study investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. Etude sur le vieillissement arteriel was organised with an agreement between INSERM and Merck, Sharp, and Dohme-Chibret. The Northern Manhattan Study/The Oral Infections and Vascular Disease Epidemiology Study is funded by the National Institute of Neurological Disorders and Stroke grant R37 NS 029993 and the Oral Infections, Carotid Atherosclerosis, and Stroke study by the National Institute of Dental and Craniofacial Research (Bethesda, MD, USA) grant R01 DE 13094. The Interventionsprojekt zerebrovaskul re Erkrankungen und Demenz im Landkreis Ebersberg study was supported by AOK Bayern. The Rotterdam Study was supported by the Netherlands Foundation for Scientific Research, ZonMw, Vici 918-76-619. The Study of Health in Pomerania is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (BMBF 01ZZ9603 and 01ZZ0103), the Ministry of Cultural Affairs, and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The PROG-IMT project was funded by the Deutsche Forschungsgemeinschaft (DFG Lo 1569/2-1).	Agewall S, 2001, J INTERN MED, V249, P305, DOI 10.1046/j.1365-2796.2001.00818.x; BonithonKopp C, 1996, ARTERIOSCL THROM VAS, V16, P310, DOI 10.1161/01.ATV.16.2.310; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dogan S, 2010, J ATHEROSCLER THROMB, V17, P526, DOI 10.5551/jat.3269; Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Landsberger HA, 1958, CORNELL STUDIES IND, V9, P119; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2010, AM HEART J, V159, P730, DOI 10.1016/j.ahj.2010.02.008; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lynch J, 1997, ARTERIOSCL THROM VAS, V17, P513, DOI 10.1161/01.ATV.17.3.513; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Peters SAE, 2012, J INTERN MED, V271, P247, DOI 10.1111/j.1365-2796.2011.02422.x; Peters SAE, 2011, J HYPERTENS, V29, P1145, DOI 10.1097/HJH.0b013e328345d85e; Polak JF, 2011, STROKE, V42, P3017, DOI 10.1161/STROKEAHA.111.625186; Polak JF, 2011, STROKE, V42, P1912, DOI 10.1161/STROKEAHA.110.603449; Rodondi N, 2012, ARCH INTERN MED, V172, P344, DOI 10.1001/archinternmed.2011.1326; Rodriguez-Macias KA, 2006, ATHEROSCLEROSIS, V189, P393, DOI 10.1016/j.atherosclerosis.2006.02.020; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sander D, 2000, CIRCULATION, V102, P1536, DOI 10.1161/01.CIR.102.13.1536; Schmidt C, 2003, J INTERN MED, V253, P430, DOI 10.1046/j.1365-2796.2003.01129.x; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; von Sarnowski B, 2010, STROKE, V41, P2375, DOI 10.1161/STROKEAHA.110.593244; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Yamasaki Y, 2010, J ATHEROSCLER THROMB, V17, P1132, DOI 10.5551/jat.4663	43	428	437	2	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2053	2062		10.1016/S0140-6736(12)60441-3	http://dx.doi.org/10.1016/S0140-6736(12)60441-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22541275	Green Accepted, Green Submitted			2022-12-28	WOS:000304759100030
J	Doubleday, R; Wilsdon, J				Doubleday, Robert; Wilsdon, James			Beyond the great and good	NATURE			English	Editorial Material									[Doubleday, Robert] Univ Cambridge, Ctr Sci & Policy, Cambridge CB2 1TN, England; [Wilsdon, James] Univ Sussex, Sci Policy Res Unit, Brighton, E Sussex, England	University of Cambridge; University of Sussex	Doubleday, R (corresponding author), Univ Cambridge, Ctr Sci & Policy, Cambridge CB2 1TN, England.	j.wilsdon@sussex.ac.uk	Wilsdon, James/AAF-6379-2019	Wilsdon, James/0000-0002-5395-5949				House of Lords Select Committee on Science and Technology, 2012, ROL FUNCT DEP CHIEF; Jasanoff S., 2011, POLITICS SCI ADVIC 1; Pielke R, 2010, PRESIDENTIAL SCIENCE ADVISORS: PERSPECTIVES AND REFLECTIONS ON SCIENCE, POLICY AND POLITICS, P149, DOI 10.1007/978-90-481-3898-2_11; Stirling A, 2010, NATURE, V468, P1029, DOI 10.1038/4681029a; Sutherland WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031824; United Nations Secretary-General's High-Level Panel on Global Sustainability, 2012, RES PEOPL RES PLAN F	6	17	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					301	302		10.1038/485301a	http://dx.doi.org/10.1038/485301a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596137	Bronze			2022-12-28	WOS:000304099100014
J	Imperiale, TF; Ransohoff, DF				Imperiale, Thomas F.; Ransohoff, David F.			Risk for Colorectal Cancer in Persons With a Family History of Adenomatous Polyps A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							COLLEGE-OF-RADIOLOGY; SOCIETY-TASK-FORCE; 1ST-DEGREE RELATIVES; AMERICAN-COLLEGE; JOINT GUIDELINE; SURVEILLANCE; PREVALENCE; TUMORS; METAANALYSIS; POPULATION	Background: The risk for colorectal cancer (CRC) is unclear for persons who have first-degree relatives with adenomatous polyps (adenomas). Purpose: To determine the validity of studies about this issue. Data Sources: MEDLINE and Cochrane databases from 1966 through 2011. Study Selection: Sequential review of titles, abstracts, and text from retrieved articles. Data Extraction: Study objective, study design, and numbers in study groups. Data Synthesis: Ten studies were identified that have been used to answer the question, "Does having a first-degree relative with an adenoma increase the risk for CRC?" We determined that they instead answer the question, "Does having a first-degree relative with CRC increase the risk for an adenoma?" We identified 2 additional studies that provide more relevant information. One study showed that the risk for CRC in persons who have first-degree relatives with adenomas is greater than the risk in persons who do not have first-degree relatives with adenomas (2.31% vs. 0.53%; relative risk, 4.36 [95% CI, 1.60 to 10.21]). The other study showed that the risk for CRC or large adenomas (>= 1 cm) in persons who have first-degree relatives with large adenomas is greater than the risk in persons whose first-degree relatives do not have adenomas or CRC (8.3% vs. 4.2%; adjusted odds ratio, 2.27 [CI, 1.01 to 5.09]). Limitation: Even the 2 relevant studies have design problems that affect validity and generalizability. Conclusion: Most studies that are cited for the risk for CRC when relatives have adenomas do not address the issue. The 2 studies that do address the issue suggest an increased risk but have important methodological limitations. Properly designed studies are needed to measure the risk and identify the factors that modify it.	[Imperiale, Thomas F.] Indiana Univ, Regenstrief Inst, Med Ctr, Indianapolis, IN 46202 USA; Richard L Roudebush Vet Affairs Med Ctr, Ctr Excellence Implementing Evidence Based Practi, Indianapolis, IN 46202 USA; Regenstrief Inst Inc, Indianapolis, IN USA; Univ N Carolina, Chapel Hill, NC USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of North Carolina; University of North Carolina Chapel Hill	Imperiale, TF (corresponding author), Indiana Univ, Regenstrief Inst, Med Ctr, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	National Cancer Institute [R01-CA 104459]; NATIONAL CANCER INSTITUTE [R01CA104459] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (R01-CA 104459).	Ahsan H, 1998, ANN INTERN MED, V128, P900, DOI 10.7326/0003-4819-128-11-199806010-00006; AITKEN J, 1995, AM J EPIDEMIOL, V141, P863, DOI 10.1093/oxfordjournals.aje.a117522; Aitken JF, 1996, GUT, V39, P105, DOI 10.1136/gut.39.1.105; Austin GL, 2011, CLIN GASTROENTEROL H, V9, P308, DOI 10.1016/j.cgh.2011.01.004; BAZZOLI F, 1995, GASTROENTEROLOGY, V109, P783, DOI 10.1016/0016-5085(95)90385-2; BONELLI L, 1988, INT J CANCER, V41, P513; BOUTRON MC, 1995, GUT, V37, P830, DOI 10.1136/gut.37.6.830; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Colorectal cancer screening, 2001, CAN FAM PHYS, V47, P1815; Cottet V, 2007, GASTROENTEROLOGY, V133, P1086, DOI 10.1053/j.gastro.2007.07.023; Davila RE, 2006, GASTROINTEST ENDOSC, V63, P546, DOI 10.1016/j.gie.2006.02.002; DELEON MP, 1987, CANCER, V60, P2848, DOI 10.1002/1097-0142(19871201)60:11<2848::AID-CNCR2820601141>3.0.CO;2-F; FISHER G, 1989, MED J AUSTRALIA, V150, P22, DOI 10.5694/j.1326-5377.1989.tb136314.x; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Ko C, 2006, DIS COLON RECTUM, V49, P299, DOI 10.1007/s10350-005-0289-0; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lynch KL, 2003, CLIN GASTROENTEROL H, V1, P96, DOI 10.1053/cgh.2003.50018; MAIRE P, 1984, GASTROEN CLIN BIOL, V8, P22; Mitchell RJ, 2005, BRIT J SURG, V92, P1161, DOI 10.1002/bjs.5084; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Nakama H, 2000, EUR J CANCER, V36, P2111, DOI 10.1016/S0959-8049(00)00293-8; National Guideline Clearinghouse, 2007, PRACT GUID COL CANC; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; Waye JD, 2003, COLONOSCOPY PRINCIPL; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204	29	41	43	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					703	U79		10.7326/0003-4819-156-10-201205150-00006	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586009				2022-12-28	WOS:000304193400016
J	Cabianca, DS; Casa, V; Bodega, B; Xynos, A; Ginelli, E; Tanaka, Y; Gabellini, D				Cabianca, Daphne S.; Casa, Valentina; Bodega, Beatrice; Xynos, Alexandros; Ginelli, Enrico; Tanaka, Yujiro; Gabellini, Davide			A Long ncRNA Links Copy Number Variation to a Polycomb/Trithorax Epigenetic Switch in FSHD Muscular Dystrophy	CELL			English	Article							DROSOPHILA BITHORAX COMPLEX; GENE-EXPRESSION; NONCODING RNAS; TRITHORAX PROTEINS; RESPONSE ELEMENTS; POLYCOMB COMPLEX; MAMMALIAN-CELLS; TANDEM REPEATS; CANDIDATE GENE; HUMAN GENOME	Repetitive sequences account for more than 50% of the human genome. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease associated with reduction in the copy number of the D4Z4 repeat mapping to 4q35. By an unknown mechanism, D4Z4 deletion causes an epigenetic switch leading to de-repression of 4q35 genes. Here we show that the Polycomb group of epigenetic repressors targets D4Z4 in healthy subjects and that D4Z4 deletion is associated with reduced Polycomb silencing in FSHD patients. We identify DBE-T, a chromatin-associated noncoding RNA produced selectively in FSHD patients that coordinates de-repression of 4q35 genes. DBE-T recruits the Trithorax group protein Ash1L to the FSHD locus, driving histone H3 lysine 36 dimethylation, chromatin remodeling, and 4q35 gene transcription. This study provides insights into the biological function of repetitive sequences in regulating gene expression and shows how mutations of such elements can influence the progression of a human genetic disease.	[Cabianca, Daphne S.; Casa, Valentina; Xynos, Alexandros; Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Casa, Valentina] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bodega, Beatrice; Ginelli, Enrico] Univ Milan, Dept Biol & Genet Med Sci, I-20133 Milan, Italy; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo 1138510, Japan	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Tokyo Medical & Dental University (TMDU)	Gabellini, D (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy.	gabellini.davide@hsr.it	Bodega, Beatrice/I-4644-2018; Gabellini, Davide/I-4551-2018	Bodega, Beatrice/0000-0003-0527-9234; Gabellini, Davide/0000-0002-3811-4121; Cabianca, Daphne Selvaggia/0000-0002-1834-7868	Telethon [GGP07078]; Association Francaise contre les Myopathies (AFM) [13160, 14464]; European Research Council (ERC); Italian Ministry of Health; Muscular Dystrophy Association USA (MDA); AFM; FSHD Global Research Foundation; Facio Scapulo Humeral Muscular Dystrophy Society	Telethon(Fondazione Telethon); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); European Research Council (ERC)(European Research Council (ERC)); Italian Ministry of Health(Ministry of Health, Italy); Muscular Dystrophy Association USA (MDA)(Muscular Dystrophy Association); AFM(Association Francaise contre les Myopathies); FSHD Global Research Foundation; Facio Scapulo Humeral Muscular Dystrophy Society	We thank W. Bickmore, M. Carmo-Fonseca, C. Carvalho, G. Cavalli, M. Crippa, J. Mattick, T. Misteli, K. Morris, and V. Orlando for helpful discussions. Anti-Rae28 antibody was a kind gift of Y. Takihara. Part of this work was carried out in Alembic (Advanced Light and Electron Microscopy Bio-Imaging Centre), San Raffaele Scientific Instutute. This study is a partial fulfillment of Valentina Casa's PhD in Molecular Medicine, Program in Neuroscience, San Raffaele University, Milan, Italy. The Ginelli lab is supported by Telethon (GGP07078) and Association Francaise contre les Myopathies (AFM) (13160 and 14464). Support for the Gabellini lab came from the European Research Council (ERC), the Italian Ministry of Health, the Muscular Dystrophy Association USA (MDA), AFM, the FSHD Global Research Foundation, and the Facio Scapulo Humeral Muscular Dystrophy Society. D. G. is a Dulbecco Telethon Institute Assistant Scientist.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; BAKKER E, 1995, MUSCLE NERVE, pS39; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Bruce HA, 2009, PSYCHIAT GENET, V19, P64, DOI 10.1097/YPG.0b013e3283207ff6; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Cacurri S, 1998, AM J HUM GENET, V63, P181, DOI 10.1086/301906; Chadwick BP, 2009, CHROMOSOMA, V118, P675, DOI 10.1007/s00412-009-0233-5; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; Custodio N., 2006, CELL BIOL LAB MANUAL; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Eskeland R, 2010, COLD SH Q B, V75, P71, DOI 10.1101/sqb.2010.75.053; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Neguembor MV, 2010, EPIGENOMICS-UK, V2, P271, DOI [10.2217/epi.10.8, 10.2217/EPI.10.8]; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V365, P589, DOI 10.1016/j.bbrc.2007.10.159; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; Turner AMW, 2010, BIOTECHNIQUES, V48, pIX, DOI 10.2144/000113442; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu SL, 2010, DEV DYNAM, V239, P927, DOI 10.1002/dvdy.22210; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	77	277	306	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4								10.1016/j.cell.2012.03.035	http://dx.doi.org/10.1016/j.cell.2012.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22541069	Green Published, hybrid			2022-12-28	WOS:000303934700015
J	Szymanska, MH				Szymanska, Marzena H.			Intertwining Electron Tunneling with Light	SCIENCE			English	Editorial Material							BOSE-EINSTEIN CONDENSATION; EXCITONS		Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick	Szymanska, MH (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	m.h.szymanska@warwick.ac.uk			Engineering and Physical Sciences Research Council [EP/H032258/1] Funding Source: researchfish; EPSRC [EP/H032258/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Butov LV, 2002, NATURE, V417, P47, DOI 10.1038/417047a; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Cristofolini P, 2012, SCIENCE, V336, P704, DOI 10.1126/science.1219010; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Hammack AT, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227402; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; KELDYSH LV, 1965, FIZ TVERD TELA, V6, P2219; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Snoke DW, 2011, ADV COND MATTER PHYS, V2011, DOI 10.1155/2011/938609; Voros Z, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016803	12	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					679	680		10.1126/science.1221416	http://dx.doi.org/10.1126/science.1221416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582251				2022-12-28	WOS:000303872300036
J	Gawande, A				Gawande, Atul			Two Hundred Years of Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									[Gawande, Atul] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gawande, Atul] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Gawande, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176				[Anonymous], 1812, N ENGL J MED SURG, V1, P98; BENNETT AH, 1884, LANCET, V2, P1090; Bigelow HJ., 1846, BOSTON MED SURG J, V35, P309, DOI DOI 10.1056/NEJM184611180351601; BLALOCK A, 1945, JAMA-J AM MED ASSOC, V128, P189, DOI 10.1001/jama.1945.02860200029009; Bobbs JS, 1868, T INDIANA M SOC, V18, P68; Caton D, 2011, ENCY LIFE SCI; Chan CC, 2010, SURV OPHTHALMOL, V55, P393, DOI 10.1016/j.survophthal.2010.02.001; Finney J. M. T., 1932, NEW ENGL J MED, V206, P263; Forssmann W., 1929, KLIN WOCHENSCHR, V8, P2085, DOI DOI 10.1007/BF01875120; Goss F, 1874, BOSTON MED SURG J, V91, P73; GROSS RE, 1952, NEW ENGL J MED, V247, P455, DOI 10.1056/NEJM195209252471301; HARKEN DE, 1948, NEW ENGL J MED, V239, P801, DOI 10.1056/NEJM194811252392201; Hollingham R, 2008, BLOOD GUTS HIST SURG; Hunter W, 1775, LANCET, V12, P769; Kimball G., 1855, BOSTON MED SURG J, V52, P249; Lee PH, 2008, J AM COLL SURGEONS, V207, pS75, DOI 10.1016/j.jamcollsurg.2008.06.186; Lister J., 1867, LANCET, V1, P326, DOI 10.1016/S0140-6736(02)51192-2; Lister J, 1867, LANCET, V90, P95; Lister J., 1867, LANCET, V1, P507; Lister Joseph, 1867, LANCET, Vi, P357, DOI [10.1016/S0140-6736(00)73482-9, DOI 10.1016/S0140-6736(00)73482-9]; Liston Robert, 1837, PRACTICAL SURG; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MASSA DJ, 1950, P STAFF M MAYO CLIN, V25, P413; Munro JC, 1902, NEW ENGL J MED, V146, P58; Nobelprize. org, NOB PRIZ PHYSL MED 1; Nuland SB, 2003, DOCTORS PLAGUE GERMS; Peaslee ER, 1851, BOSTON MED SURG J, V44, P429; Preston, 1831, BOSTON MED SURG J, P92; Rehn L., 1884, BERL KLIN WOCHENSCHR, V21, P163; Richardson RG, 2004, STORY SURG HIST COMM; Robertson HR, 1989, ANN R COLL PHYS SURG, V22, P28; Rutkow IM, 1993, SURG ILLUSTRATED HIS, P333; Simpson JY, 1867, BOSTON MED SURG J, V77, P390; Stanley P., 2003, FEAR PAIN BRIT SURG; Tait RL, 1890, BIRM MED REV, V27, P76; TAIT RL, 1890, BGHAM MED REV, V27, P26; Wangensteen, 1978, RISE SURG EMPIRIC CR; Warren JC, 1812, N ENGL J MED SURG, V1, P194; Watson FS, 1889, BOSTON MED SURG J, V120, P237	39	106	114	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1716	1723		10.1056/NEJMra1202392	http://dx.doi.org/10.1056/NEJMra1202392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HH	22551130				2022-12-28	WOS:000303434300011
J	Gelijns, AC; Gabriel, SE				Gelijns, Annetine C.; Gabriel, Sherine E.			Looking beyond Translation - Integrating Clinical Research with Medical Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gelijns, Annetine C.] Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY 10029 USA; [Gabriel, Sherine E.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Icahn School of Medicine at Mount Sinai; Mayo Clinic	Gelijns, AC (corresponding author), Mt Sinai Sch Med, Dept Hlth Evidence & Policy, New York, NY 10029 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				BOWER JL, 1995, HARVARD BUS REV, V73, P43; Institute of Medicine, 2007, IOM ROUNDT LEARN WHA; Institute of Medicine (US), 2012, PUBL ENG CLIN TRIALS; Largent EA, 2011, HASTINGS CENT REP, V41, P37	4	49	49	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1659	1661		10.1056/NEJMp1201850	http://dx.doi.org/10.1056/NEJMp1201850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HH	22551126				2022-12-28	WOS:000303434300004
J	Day, MS				Day, Matthew S.			Late presentation, late diagnosis, late stage diagnosis, delayed diagnosis, delayed presentation: terminology confuses the message in UK cancer policy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Day, Matthew S.] Yorkshire & Humber Specialised Commissioning Grp, Barnsley S75 2PY, S Yorkshire, England; [Day, Matthew S.] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Day, MS (corresponding author), Yorkshire & Humber Specialised Commissioning Grp, Barnsley S75 2PY, S Yorkshire, England.	matthew.day2@nhs.net						Department of Health, 2011, IMPR OUTC STRAT CANC; Henley S. Jane, 2010, Morbidity and Mortality Weekly Report, V59, P1; National Patient Safety Agency, 2010, DEL DIAGN CANC THEM; Public Accounts Committee, 2011, 24 PUBL ACC COMM; Richards M., 2009, ACHIEVING WORLD CLAS	5	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e3017	10.1136/bmj.e3017	http://dx.doi.org/10.1136/bmj.e3017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NC	22551805				2022-12-28	WOS:000303817200005
J	Goodacre, S; Wilson, R; Shephard, N; Nicholl, J				Goodacre, Steve; Wilson, Richard; Shephard, Neil; Nicholl, Jon		DAVROS Res Team	Derivation and validation of a risk adjustment model for predicting seven day mortality in emergency medical admissions: mixed prospective and retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITALS; RATES; SEVERITY; QUALITY	Objectives To derive and validate a risk adjustment model for predicting seven day mortality in emergency medical admissions, to test the value of including physiology and blood parameters, and to explore the constancy of the risk associated with each model variable across a range of settings. Design Mixed prospective and retrospective cohort study. Setting Nine acute hospitals (n=3 derivation, n=9 validation) and associated ambulance services in England, Australia, and Hong Kong. Participants Adults with medical emergencies (n=5644 derivation, n=13 762 validation) who were alive and not in cardiac arrest when attended by an ambulance and either were admitted to hospital or died in the ambulance or emergency department. Interventions Data were either collected prospectively or retrospectively from routine sources and extraction from ambulance and emergency department records. Main outcome measure Mortality up to seven days after hospital admission. Results In the derivation phase, age, ICD-10 code, active malignancy, Glasgow coma score, respiratory rate, peripheral oxygen saturation, temperature, white cell count, and potassium and urea concentrations were independent predictors of seven day mortality. A model based on age and ICD-10 code alone had a C statistic of 0.80 (95% confidence interval 0.78 to 0.83), which increased to 0.81 (0.79 to 0.84) with the addition of active malignancy. This was markedly improved only when physiological variables (C statistic 0.87, 0.85 to 0.89), blood variables (0.87, 0.84 to 0.89), or both (0.90, 0.88 to 0.92) were added. In the validation phase, the models with physiology variables (physiology model) and all variables (full model) were tested in nine hospitals. Overall, the C statistics ranged across centres from 0.80 to 0.91 for the physiology model and from 0.83 to 0.93 for the full model. The rank order of hospitals based on adjusted mortality differed markedly from the rank order based on crude mortality. ICD-10 code, Glasgow coma score, respiratory rate, systolic blood pressure, oxygen saturation, haemoglobin concentration, white cell count, and potassium, urea, creatinine, and glucose concentrations all had statistically significant interactions with hospital. Conclusion A risk adjustment model for emergency medical admissions based on age, ICD-10 code, active malignancy, and routinely recorded physiological and blood variables can provide excellent discriminant value for seven day mortality across a range of settings. Using risk adjustment markedly changed hospitals' rankings. However, evidence was found that the association between key model variables and mortality were not constant.	[Goodacre, Steve; Wilson, Richard; Shephard, Neil; Nicholl, Jon; DAVROS Res Team] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield	Goodacre, S (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England.	s.goodacre@sheffield.ac.uk	Coats, Timothy/AAW-1254-2021; Rainer, Timothy/I-2591-2013; Gilthorpe, Mark S/C-1240-2008	Coats, Timothy/0000-0003-2736-2784; Rainer, Timothy/0000-0003-3355-3237; Gilthorpe, Mark S/0000-0001-8783-7695; Goodacre, Steve/0000-0003-0803-8444; Kelly, Anne-Maree/0000-0002-4655-5023; Shephard, Neil/0000-0001-8301-6857	Medical Research Council; Medical Research Council [G0600295] Funding Source: researchfish; MRC [G0600295] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The DAVROS project was funded by the Medical Research Council. The researchers were independent from the funders. The funders had no role in conducting the study, writing the paper, or the decision to submit the paper for publication.	Black N, 2010, BMJ-BRIT MED J, V340, P933; Blunt I, 2011, TRENDS EMERGENCY ADM; Bottle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7116; Cameron PA, 2011, EMERG MED J, V28, P735, DOI 10.1136/emj.2011.112250; Challen K, 2011, EMERG MED J, V28, P827, DOI 10.1136/emj.2010.099291; Department of Health, 2010, REV OP FRAM NHS ENGL; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; IEZZONI LI, 1995, INT J QUAL HEALTH C, V7, P81, DOI 10.1093/intqhc/7.2.81; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS, P1; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lilford R, 2010, BMJ-BRIT MED J, V340, P955; Lilford RJ, 2007, BMJ-BRIT MED J, V335, P648, DOI 10.1136/bmj.39317.641296.AD; Miyata H, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-229; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Stukenborg GJ, 2007, CIRCULATION, V116, P2960, DOI 10.1161/CIRCULATIONAHA.107.712323	20	23	24	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2012	344								e2904	10.1136/bmj.e2904	http://dx.doi.org/10.1136/bmj.e2904			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939MZ	22550349	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000303816700001
J	Sawyer, SM; Afifi, RA; Bearinger, LH; Blakemore, SJ; Dick, B; Ezeh, AC; Patton, GC				Sawyer, Susan M.; Afifi, Rima A.; Bearinger, Linda H.; Blakemore, Sarah-Jayne; Dick, Bruce; Ezeh, Alex C.; Patton, George C.			Adolescent Health 1 Adolescence: a foundation for future health	LANCET			English	Article							YOUNG-PEOPLE; SUBSTANCE USE; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; PSYCHIATRIC-DISORDERS; MIDDLE-INCOME; MORTALITY; PATTERNS; BEHAVIOR; ALCOHOL	Adolescence is a life phase in which the opportunities for health are great and future patterns of adult health are established. Health in adolescence is the result of interactions between prenatal and early childhood development and the specific biological and social-role changes that accompany puberty, shaped by social determinants and risk and protective factors that affect the uptake of health-related behaviours. The shape of adolescence is rapidly changing-the age of onset of puberty is decreasing and the age at which mature social roles are achieved is rising. New understandings of the diverse and dynamic effects on adolescent health include insights into the effects of puberty and brain development, together with social media. A focus on adolescence is central to the success of many public health agendas, including the Millennium Development Goals aiming to reduce child and maternal mortality and HIV/AIDS, and the more recent emphases on mental health, injuries, and non-communicable diseases. Greater attention to adolescence is needed within each of these public health domains if global health targets are to be met. Strategies that place the adolescent years centre stage-rather than focusing only on specific health agendas-provide important opportunities to improve health, both in adolescence and later in life.	[Sawyer, Susan M.; Patton, George C.] Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; [Sawyer, Susan M.; Patton, George C.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Sawyer, Susan M.; Patton, George C.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Afifi, Rima A.] Amer Univ Beirut, Fac Hlth Sci, Dept Hlth Promot & Community Hlth, Beirut, Lebanon; [Bearinger, Linda H.] Univ Minnesota, Sch Nursing, Ctr Adolescent Nursing, Minneapolis, MN 55455 USA; [Bearinger, Linda H.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Blakemore, Sarah-Jayne] UCL, Inst Cognit Neurosci, London, England; [Dick, Bruce] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Ezeh, Alex C.] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Ezeh, Alex C.] Univ Witwatersrand, Consortium Adv Res Training Africa, Johannesburg, South Africa	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; American University of Beirut; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of London; University College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; African Population & Health Research Centre; University of Witwatersrand	Sawyer, SM (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	susan.sawyer@rch.org.au	Patton, George C/B-5246-2013; Ezeh, Alex/AAN-8646-2020; Ribeiro, Ana Cristina/HHN-7466-2022; Afifi, Rima A/M-5615-2016; Blakemore, Sarah-Jayne/A-1792-2010	Patton, George C/0000-0001-5039-8326; Ezeh, Alex/0000-0002-1309-4697; Ribeiro, Ana Cristina/0000-0002-0493-8376; Afifi, Rima A/0000-0003-3154-3617; Blakemore, Sarah-Jayne/0000-0002-1690-2805				ABEL EL, 1980, HUM BIOL, V52, P593; [Anonymous], 2000, Bull World Health Organ, V78, P413; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], ADOLESCENT HLTH SERV; Asma S., 2009, Oxford textbook of public health, Volume 3: the practice of public health, P1277; Bamblett M, 2010, GROWING THEM STRONG; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bearsley-Smith CA, 2008, EUR CHILD ADOLES PSY, V17, P226, DOI 10.1007/s00787-007-0657-5; Becker AE, 2002, BRIT J PSYCHIAT, V180, P509, DOI 10.1192/bjp.180.6.509; Beiser M, 2010, SOC SCI MED, V71, P221, DOI 10.1016/j.socscimed.2010.03.039; Benson Peter L, 2002, New Dir Youth Dev, P123; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Block J.J., 2007, AM J FORENSIC PSYCH, V28, P5; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Catalano RF, 2012, LANCET, V379, P1653, DOI 10.1016/S0140-6736(12)60238-4; Chatterjee Sukanta, 2009, Indian J Public Health, V53, P115; CHRISTIE KA, 1988, AM J PSYCHIAT, V145, P971; Cicchetti D, 2006, DEV PSYCHOPATHOL, V1, P23, DOI DOI 10.1002/9780470939383.CH1; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064; Cohen P, 2003, DEV PSYCHOL, V39, P657, DOI 10.1037/0012-1649.39.4.657; Deibert R, 2012, INFORM REVOL GLOB PO, P1; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Garrib A, 2011, TROP MED INT HEALTH, V16, P439, DOI 10.1111/j.1365-3156.2011.02730.x; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Global Youth Tobacco Survey Collabor, 2003, J SCHOOL HEALTH, V73, P207; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Hall G. Stanley, 1905, ADOLESCENCE ITS PSYC; Hawkins JD, 2002, ADDICT BEHAV, V27, P951, DOI 10.1016/S0306-4603(02)00298-8; Hawton K, 2010, EUR CHILD ADOLES PSY, V19, P513, DOI 10.1007/s00787-009-0065-0; HAZELL P, 1993, AUST NZ J PSYCHIAT, V27, P653, DOI 10.3109/00048679309075828; Herman-Stahl MA, 2008, J ADOLESCENT HEALTH, V43, P141, DOI 10.1016/j.jadohealth.2008.01.010; Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Insel TR, 1997, AM J PSYCHIAT, V154, P726; JESSOR R, 1995, DEV PSYCHOL, V31, P923, DOI 10.1037/0012-1649.31.6.923; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kamieniecki GW, 2001, AUST NZ J PSYCHIAT, V35, P352, DOI 10.1046/j.1440-1614.2001.00910.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P129; Kraus B, 2003, MED EDUC, V37, P709, DOI 10.1046/j.1365-2923.2003.01565.x; Lau PWC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1533; Litt DM, 2011, PSYCHOL ADDICT BEHAV, V25, P708, DOI 10.1037/a0024226; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Lopez AD, 2011, TOB CONTROL, V3, P242; Makhoul J, 2012, HEALTH EDUC RES, V27, P914, DOI 10.1093/her/cyr011; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; Mathers CD, 1998, MED J AUSTRALIA, V168, P178, DOI 10.5694/j.1326-5377.1998.tb126776.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Morrell SL, 1998, MED J AUSTRALIA, V168, P236, DOI 10.5694/j.1326-5377.1998.tb140139.x; Mortimer JT, 2008, WORK OCCUPATION, V35, P44, DOI 10.1177/0730888407309761; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Office of the United Nations High Commissioner for Human Rights, 1989, CONV RIGHTS CHILD; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Patton GC, 2004, PEDIATRICS, V114, pE300, DOI 10.1542/peds.2003-0626-F; Patton GC, 2006, AM J PUBLIC HEALTH, V96, P1582, DOI 10.2105/AJPH.2004.047399; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Patton GC, 2010, J ADOLESCENT HEALTH, V47, P427, DOI 10.1016/j.jadohealth.2010.08.019; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; Poelen EAP, 2005, DRUG ALCOHOL DEPEN, V79, P413, DOI 10.1016/j.drugalcdep.2005.03.020; Prescott H M, 2000, Adolesc Med, V11, P1; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Reddy SP, 2009, PUBLIC HEALTH NUTR, V12, P203, DOI 10.1017/S1368980008002656; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Roudi-Fahimi F, 2007, POPULATION B, V62; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; RUTTER M, 1989, J CHILD PSYCHOL PSYC, V30, P23, DOI 10.1111/j.1469-7610.1989.tb00768.x; Sawyer SM, 2010, J PAEDIATR CHILD H, V46, P214, DOI 10.1111/j.1440-1754.2010.01729.x; Saxbe DE, 2009, J ADOLESCENCE, V32, P415, DOI 10.1016/j.adolescence.2008.06.009; Scales P.C., 2000, APPL DEV SCI, V4, P27, DOI [DOI 10.1207/S1532480XADS0401_3, 10.1207/S1532480XADS0401_3]; Scheepers E., 2004, HLTH PROM J AUSTR, V15, P121; Schiff M, 2010, J TRAUMA STRESS, V23, P657, DOI 10.1002/jts.20558; SCHMIDTKE A, 1988, PSYCHOL MED, V18, P665, DOI 10.1017/S0033291700008345; Schwartz S, 2010, YOUTH AND POST-CONFLICT RECONSTRUCTION: AGENTS OF CHANGE, P1; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Singh S, 2009, ADDING IT COSTS BENE; Smith L, 2009, DRINKING UK EXPLORAT; Staff J, 2010, DEV PSYCHOPATHOL, V22, P917, DOI 10.1017/S0954579410000544; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stratton K., 1996, FETAL ALCOHOL SYNDRO; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Taylor AL, 2000, B WORLD HEALTH ORGAN, V78, P920; Temin M., 2009, START GIRL NEW AGEND; Thor Craig P, 2010, Ann Adv Automot Med, V54, P295; Trucco EM, 2011, ADDICT BEHAV, V36, P729, DOI 10.1016/j.addbeh.2011.02.008; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; *UN, 2010, PREV CONTR NONC DIS; UN Department of Social and Economic Affairs Population Division, 2009, ESAPWP210 UN DEP SOC; UNAIDS, 2010, REP GLOB AIDS EP; UNICEF, 2007, CHILD POV PERSP OV C; UNICEF, 2011, STAT WORLDS CHILDR 2; US Department of Health and Human Services, WHAT IS AD; VEIT FCM, 1995, MED J AUSTRALIA, V163, P16, DOI 10.5694/j.1326-5377.1995.tb126081.x; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; WHO, 2010, GENDER, WOMEN, AND THE TOBACCO EPIDEMIC, P1; WHO, 2010, AD JOB AID HAND DESK; World Bank, 1999, CURB EP GOV EC TOB C; World Bank, 2007, WORLD DEV REP 2007 D; World Health Organisation, 2002, AD FRIENDL HLTH SERV; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 1997, TOB HLTH GLOB STAT R; World Health Organization, 2001, 2 DEC IMPR AD HLTH D; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization, 2009, MORT BURD DIS EST WH	129	1212	1237	15	266	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2012	379	9826					1630	1640		10.1016/S0140-6736(12)60072-5	http://dx.doi.org/10.1016/S0140-6736(12)60072-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934OB	22538178				2022-12-28	WOS:000303452600037
J	Couradeau, E; Benzerara, K; Gerard, E; Moreira, D; Bernard, S; Brown, GE; Lopez-Garcia, P				Couradeau, Estelle; Benzerara, Karim; Gerard, Emmanuelle; Moreira, David; Bernard, Sylvain; Brown, Gordon E., Jr.; Lopez-Garcia, Purificacion			An Early-Branching Microbialite Cyanobacterium Forms Intracellular Carbonates	SCIENCE			English	Article							CONCENTRATING MECHANISMS; CALCIFICATION; BARIUM	Cyanobacteria have affected major geochemical cycles (carbon, nitrogen, and oxygen) on Earth for billions of years. In particular, they have played a major role in the formation of calcium carbonates (i.e., calcification), which has been considered to be an extracellular process. We identified a cyanobacterium in modern microbialites in Lake Alchichica (Mexico) that forms intracellular amorphous calcium-magnesium-strontium-barium carbonate inclusions about 270 nanometers in average diameter, revealing an unexplored pathway for calcification. Phylogenetic analyses place this cyanobacterium within the deeply divergent order Gloeobacterales. The chemical composition and structure of the intracellular precipitates suggest some level of cellular control on the biomineralization process. This discovery expands the diversity of organisms capable of forming amorphous calcium carbonates.	[Couradeau, Estelle; Benzerara, Karim] Univ Paris 06, Inst Mineral & Phys Matiere Condensee, CNRS, UMR 7590, F-75005 Paris, France; [Couradeau, Estelle; Gerard, Emmanuelle] Univ Paris Diderot, CNRS, IPGP, UMR 7154, F-75005 Paris, France; [Couradeau, Estelle; Moreira, David; Lopez-Garcia, Purificacion] Univ Paris Sud, Unite Ecol Systemat & Evolut, CNRS, UMR 8079, F-91405 Orsay, France; [Bernard, Sylvain] CNRS, LMCM MNHN, UMR 7202, F-75231 Paris 5, France; [Brown, Gordon E., Jr.] Stanford Univ, Surface & Aqueous Geochem Grp, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Brown, Gordon E., Jr.] SLAC Natl Accelerator Lab, Dept Photon Sci, Menlo Pk, CA 94025 USA; [Brown, Gordon E., Jr.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Benzerara, K (corresponding author), Univ Paris 06, Inst Mineral & Phys Matiere Condensee, CNRS, UMR 7590, F-75005 Paris, France.	karim.benzerara@impmc.upmc.fr	GERARD, Emmanuelle/A-3828-2013; IMPMC, ROCKS @/U-8478-2017; Lopez-Garcia, Purificacion/B-6775-2012; Bernard, Sylvain/B-6756-2013; Moreira, David/F-7445-2012; Couradeau, Estelle/Q-6874-2018; Benzerara, Karim/J-1532-2016	GERARD, Emmanuelle/0000-0002-4910-747X; Lopez-Garcia, Purificacion/0000-0002-0927-0651; Moreira, David/0000-0002-2064-5354; Couradeau, Estelle/0000-0002-3947-2529; Benzerara, Karim/0000-0002-0553-0137	French Ministere de la Recherche et de l'Enseignement Superieur; CNRS; Institut National des Sciences de l'Univers (INSU); Region Ile de France [SESAME 2006 I-07-593/R]; INSU-CNRS; INP-CNRS; University Pierre et Marie Curie, Paris; NSF; U.S. Environmental Protection Agency through the Center for Environmental Implications of Nanotechnology [EF-0830093]; Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory; Office of Basic Energy Sciences of the U.S. Department of Energy [DE-AC02-05CH11231]	French Ministere de la Recherche et de l'Enseignement Superieur; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National des Sciences de l'Univers (INSU); Region Ile de France(Region Ile-de-France); INSU-CNRS(Centre National de la Recherche Scientifique (CNRS)); INP-CNRS(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie, Paris; NSF(National Science Foundation (NSF)); U.S. Environmental Protection Agency through the Center for Environmental Implications of Nanotechnology; Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	E.C. was recipient of a fellowship from the French Ministere de la Recherche et de l'Enseignement Superieur. This project was financed by the CNRS interdisciplinary program "Environnements planetaires et origines de la vie" (PID EPOV) and Institut National des Sciences de l'Univers (INSU) program "InteractionsTerre/Vie" (InterrVie). The SEM facility of the Institut de Mineralogie et de Physique des Milieux Condenses is supported by Region Ile de France grant SESAME 2006 I-07-593/R, INSU-CNRS, INP-CNRS, University Pierre et Marie Curie, Paris. Support was also provided by NSF and the U.S. Environmental Protection Agency under cooperative agreement EF-0830093 through the Center for Environmental Implications of Nanotechnology. Advanced Light Source (ALS) Molecular Environmental Science beamline 11.0.2 is supported by the Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory. Beamline 5.3.2 at ALS is supported by the Office of Basic Energy Sciences of the U.S. Department of Energy under contract DE-AC02-05CH11231. We thank R. Tavera (Universidad Autononoma de Mexico) for providing help as a field guide and the Laboratoire de Geochimie des Eaux at IPGP for providing the facility for Gran measurements. The sequence of the 16S rRNA gene of Candidatus Gloeomargarita lithophora has been deposited in GenBank under accession no. JQ733894. Data and enrichment cultures are available upon request.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Altermann W, 2006, GEOBIOLOGY, V4, P147, DOI 10.1111/j.1472-4669.2006.00076.x; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Benzerara K, 2004, GEOBIOLOGY, V2, P249, DOI 10.1111/j.1472-4677.2004.00039.x; Bittarello E, 2007, EUR J MINERAL, V19, P345, DOI 10.1127/0935-1221/2007/0019-1730; Couradeau E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028767; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; Fleet ME, 2009, AM MINERAL, V94, P1235, DOI 10.2138/am.2009.3228; Herrero A., 2008, CYANOBACTERIA MOL BI; Jansson C, 2010, CURR OPIN BIOTECH, V21, P365, DOI 10.1016/j.copbio.2010.03.017; Kazmierczak J, 2011, FACIES, V57, P543, DOI 10.1007/s10347-010-0255-8; Krejci MR, 2011, J STRUCT BIOL, V176, P192, DOI 10.1016/j.jsb.2011.08.006; Kupriyanova E, 2007, MICROBIOL-SGM, V153, P1149, DOI 10.1099/mic.0.2006/003905-0; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; Obst M, 2009, GEOCHIM COSMOCHIM AC, V73, P4180, DOI 10.1016/j.gca.2009.04.013; Planavsky N, 2009, GEOBIOLOGY, V7, P566, DOI 10.1111/j.1472-4669.2009.00216.x; Rez P, 2011, J PHYS CHEM B, V115, P11193, DOI 10.1021/jp203057y; RIDING R, 2006, GEOBIOLOGY, V4, P299, DOI DOI 10.1111/J.1472-4669.2006.00087.X; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; WALSBY AE, 1995, EUR J PHYCOL, V30, P87, DOI 10.1080/09670269500650851	25	158	168	7	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					459	462		10.1126/science.1216171	http://dx.doi.org/10.1126/science.1216171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539718				2022-12-28	WOS:000303233400043
J	Skoglund, P; Malmstrom, H; Raghavan, M; Stora, J; Hall, P; Willerslev, E; Gilbert, MTP; Gotherstrom, A; Jakobsson, M				Skoglund, Pontus; Malmstrom, Helena; Raghavan, Maanasa; Stora, Jan; Hall, Per; Willerslev, Eske; Gilbert, M. Thomas P.; Gotherstrom, Anders; Jakobsson, Mattias			Origins and Genetic Legacy of Neolithic Farmers and Hunter-Gatherers in Europe	SCIENCE			English	Article							POPULATION; ANCIENT; PATTERNS	The farming way of life originated in the Near East some 11,000 years ago and had reached most of the European continent 5000 years later. However, the impact of the agricultural revolution on demography and patterns of genomic variation in Europe remains unknown. We obtained 249 million base pairs of genomic DNA from similar to 5000-year-old remains of three hunter-gatherers and one farmer excavated in Scandinavia and find that the farmer is genetically most similar to extant southern Europeans, contrasting sharply to the hunter-gatherers, whose distinct genetic signature is most similar to that of extant northern Europeans. Our results suggest that migration from southern Europe catalyzed the spread of agriculture and that admixture in the wake of this expansion eventually shaped the genomic landscape of modern-day Europe.	[Skoglund, Pontus; Malmstrom, Helena; Gotherstrom, Anders; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Raghavan, Maanasa; Willerslev, Eske; Gilbert, M. Thomas P.] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Stora, Jan] Stockholm Univ, Osteoarchaeol Res Lab, Dept Archaeol & Class Studies, S-10691 Stockholm, Sweden; [Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gotherstrom, Anders; Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, Uppsala, Sweden	Uppsala University; University of Copenhagen; Stockholm University; Karolinska Institutet; Uppsala University	Skoglund, P (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden.	pontus.skoglund@ebc.uu.se; anders.gotherstrom@ebc.uu.se; mattias.jakobsson@ebc.uu.se	Willerslev, Eske/AAA-5686-2019; Jakobsson, Mattias/A-6116-2011; Malmström, Helena/C-2476-2017; Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013	Jakobsson, Mattias/0000-0001-7840-7853; Malmström, Helena/0000-0002-6456-8055; Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Raghavan, Maanasa/0000-0003-1997-0739; Gotherstrom, Anders/0000-0001-8579-1304; Skoglund, Pontus/0000-0002-3021-5913	Swedish National Infrastructure for Computing (SNIC-UPPMAX) [b2010050]; Lars Hierta Memorial Foundation [FO2010-0563]; Nilsson-Ehle Donationerna; Marie Curie Actions; Danish National Research Council; Royal Swedish Academy of Science; Swedish Research Council [2009-5129]	Swedish National Infrastructure for Computing (SNIC-UPPMAX); Lars Hierta Memorial Foundation; Nilsson-Ehle Donationerna; Marie Curie Actions(European Commission); Danish National Research Council(Danmarks Grundforskningsfond); Royal Swedish Academy of Science; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank M. Rasmussen, K. Magnussen, E. Salmela, A. Vargas Velasquez, L. Orlando, and K.-G. Sjogren for technical assistance and discussions; G. Burenhult, L. Drenzel, P. Persson, and J. Norderang for access to the Ajvide material; and the 1000 Genomes Project for access to population data. Computations were performed at the Swedish National Infrastructure for Computing (SNIC-UPPMAX) under project b2010050. The POPRES data were obtained from dbGaP (accession number phs000145.v1.p1). Per Hall (per.hall@ki.se), Karolinska Institutet, retains governance over the sample collection from Sweden. Supported by the Lars Hierta Memorial Foundation (grant FO2010-0563 to P. S.), the Nilsson-Ehle Donationerna (P. S.), Marie Curie Actions (M. R.), the Danish National Research Council (E. W. and M. T. P. G.), the Royal Swedish Academy of Science (A. G.), and the Swedish Research Council (grant 2009-5129 to M. J.). P. S., A. G., and M. J. conceived and designed the study; M. R. and H. M. performed experiments coordinated by P. S., E. W., M. T. P. G., A. G., and M. J.; P. S. and H. M. processed the data; P. S. and M. J. analyzed the data; J. S. described the archaeology; J. S. and P. H. contributed samples; and P. S., A. G., and M. J. wrote and edited the manuscript with input from all authors. Data are available from the European Nucleotide Archive under accession no. ERP001114 and data aligned to the human reference genome are available at www.ebc.uu.se/Research/IEG/evbiol/research/Jakobsson/. The authors declare no competing interests.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Childe GV, 1925, DAWN EUROPEAN CIVILI; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MALMER MP, 2002, NEOLITHIC S SWEDEN T; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Malmstrom H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-89; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2011, ANNU REV GENOM HUM G, V12, P245, DOI 10.1146/annurev-genom-090810-183123; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Renfrew, 1991, ARCHAEOLOGY THEORIES; Salmela E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016747; Sjogren K.-G., 2010, 3 EUR MEG STUD GROUP; Sjogren KG, 2009, J ANTHROPOL ARCHAEOL, V28, P85, DOI 10.1016/j.jaa.2008.10.001; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110	31	349	354	3	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					466	469		10.1126/science.1216304	http://dx.doi.org/10.1126/science.1216304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539720				2022-12-28	WOS:000303233400045
J	Feasey, NA; Dougan, G; Kingsley, RA; Heyderman, RS; Gordon, MA				Feasey, Nicholas A.; Dougan, Gordon; Kingsley, Robert A.; Heyderman, Robert S.; Gordon, Melita A.			Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa	LANCET			English	Review							BLOOD-STREAM INFECTIONS; COMMUNITY-ACQUIRED BACTEREMIA; SEROVAR TYPHIMURIUM INFECTION; NONTYPHOIDAL SALMONELLA; COTRIMOXAZOLE PROPHYLAXIS; BACTERIAL-INFECTIONS; FALCIPARUM-MALARIA; MALAWIAN CHILDREN; GLOBAL BURDEN; HIV-INFECTION	Invasive strains of non-typhoidal salmonellae have emerged as a prominent cause of bloodstream infection in African adults and children, with an associated case fatality of 20-25%. The clinical presentation of invasive non-typhoidal salmonella disease in Africa is diverse: fever, hepatosplenomegaly, and respiratory symptoms are common, and features of enterocolitis are often absent. The most important risk factors are HIV infection in adults, and malaria, HIV, and malnutrition in children. A distinct genotype of Salmonella enterica var Typhimurium, ST313, has emerged as a new pathogenic clade in sub-Saharan Africa, and might have adapted to cause invasive disease in human beings. Multidrug-resistant ST313 has caused epidemics in several African countries, and has driven the use of expensive antimicrobial drugs in the poorest health services in the world. Studies of systemic cellular and humoral immune responses in adults infected with HIV have revealed key host immune defects contributing to invasive non-typhoidal salmonella disease. This emerging pathogen might therefore have adapted to occupy an ecological and immunological niche provided by HIV, malaria, and malnutrition in Africa. A good understanding of the epidemiology of this neglected disease will open new avenues for development and implementation of vaccine and public health strategies to prevent infections and interrupt transmission.	[Gordon, Melita A.] Univ Liverpool, Henry Wellcome Labs, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3GE, Merseyside, England; [Feasey, Nicholas A.; Heyderman, Robert S.; Gordon, Melita A.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Dougan, Gordon; Kingsley, Robert A.] Wellcome Trust Sanger Inst, Hinxton, England; [Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Liverpool; University of Malawi; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; University of Liverpool	Gordon, MA (corresponding author), Univ Liverpool, Henry Wellcome Labs, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3GE, Merseyside, England.	magordon@liverpool.ac.uk	Gordon, Melita/F-5563-2012	Gordon, Melita/0000-0002-0629-0884; Kingsley, Robert/0000-0002-0194-6485; Feasey, Nicholas/0000-0003-4041-1405				ALAUSA KO, 1977, SCAND J INFECT DIS, V9, P181, DOI 10.3109/inf.1977.9.issue-3.05; Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P85; [Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001167; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Beyene G, 2011, J INFECT DEV COUNTR, V5, P23, DOI 10.3855/jidc.906; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; BOTTONE EJ, 1984, DIAGN MICR INFEC DIS, V2, P247, DOI 10.1016/0732-8893(84)90037-3; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; CHERUBIN CE, 1974, MEDICINE, V53, P365, DOI 10.1097/00005792-197409000-00003; Clemens John D, 2009, Emerg Infect Dis, V15, pe2, DOI 10.3201/eid1507.090416; CLUMECK N, 1983, LANCET, V1, P642; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Dowling JJ, 2002, ANN TROP MED PARASIT, V96, P203, DOI 10.1179/000349802125000277; DUGGAN MB, 1975, ARCH DIS CHILD, V50, P67, DOI 10.1136/adc.50.1.67; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Feasey N, 2010, BRIT MED BULL, V93, P179, DOI 10.1093/bmb/ldp046; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; GALOFRE J, 1994, CLIN INFECT DIS, V18, P873, DOI 10.1093/clinids/18.6.873; GENDREL D, 1994, CLIN INFECT DIS, V18, P103, DOI 10.1093/clinids/18.1.103; GENDREL D, 1984, AM J TROP MED HYG, V33, P1166, DOI 10.4269/ajtmh.1984.33.1166; Germani Y, 1998, AM J TROP MED HYG, V59, P1008, DOI 10.4269/ajtmh.1998.59.1008; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gilks CF, 1998, BRIT MED BULL, V54, P383, DOI 10.1093/oxfordjournals.bmb.a011695; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; GILL ON, 1983, LANCET, V1, P574; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Gordon MA, 2003, CLIN INFECT DIS, V37, pE177, DOI 10.1086/379828; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Gordon MA, 2007, AIDS, V21, P2399, DOI 10.1097/QAD.0b013e3282f25107; Gordon MA, 2010, CLIN INFECT DIS, V50, P953, DOI 10.1086/651080; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2009, LANCET, V373, P267, DOI 10.1016/S0140-6736(09)60073-8; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; GRUENEWALD R, 1994, CLIN INFECT DIS, V18, P358, DOI 10.1093/clinids/18.3.358; Hang'ombe BM, 1999, AVIAN DIS, V43, P597, DOI 10.2307/1592662; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hung CC, 2007, CLIN INFECT DIS, V45, pE60, DOI 10.1086/520681; Hutchinson E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S6; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; JONAS C, 1984, ACTA GASTRO-ENT BELG, V47, P396; Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Keddy KH, 2011, EPIDEMIOL INFECT, V139, P1239, DOI 10.1017/S0950268810002207; Khan MI, 2010, TROP MED INT HEALTH, V15, P960, DOI 10.1111/j.1365-3156.2010.02553.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; KLUGMAN KP, 1987, LANCET, V2, P1165; Larsen IK, 2011, SCAND J INFECT DIS, V43, P3, DOI 10.3109/00365548.2010.517780; Laupland KB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-95; LAZARUS GM, 1975, J PEDIATR-US, V86, P415, DOI 10.1016/S0022-3476(75)80975-9; Lebens M, 2011, VACCINE, V29, P7505, DOI 10.1016/j.vaccine.2011.06.121; LEEN CLS, 1986, J INFECTION, V12, P241, DOI 10.1016/S0163-4453(86)94216-7; LEPAGE P, 1987, LANCET, V1, P1458; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; LOVERDE PT, 1980, J INFECT DIS, V141, P177, DOI 10.1093/infdis/141.2.177; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; MELHEM RF, 1984, INFECT IMMUN, V44, P274, DOI 10.1128/IAI.44.2.274-281.1984; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Milledge J, 2005, ANN TROP PAEDIATR, V25, P101, DOI 10.1179/146532805X45692; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Molyneux EM, 2009, ANN TROP PAEDIATR, V29, P13, DOI 10.1179/146532809X401980; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; NEVES J, 1967, T ROY SOC TROP MED H, V61, P541, DOI 10.1016/0035-9203(67)90105-8; Obi CL, 1997, J DIARRHOEAL DIS RES, V15, P241; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; OFFENSTADT G, 1983, NEW ENGL J MED, V308, P775; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; PIOT P, 1984, LANCET, V2, P65; Pitter C, 2007, JAIDS-J ACQ IMM DEF, V44, P336, DOI 10.1097/QAI.0b013e31802f12b5; PROFETA S, 1985, ARCH INTERN MED, V145, P670, DOI 10.1001/archinte.145.4.670; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; ROCHA H, 1971, ARCH INTERN MED, V128, P254, DOI [10.1001/archinte.128.2.254, 10.1001/archinte.1971.00310200090009]; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Roux CM, 2010, INFECT IMMUN, V78, P1520, DOI 10.1128/IAI.00887-09; Salmon DE, 1885, 2 USDA BUR AN IND, P184; SAPHRA I, 1957, NEW ENGL J MED, V256, P1128, DOI 10.1056/NEJM195706132562402; Schreiber F, 2011, J INFECT DIS, V204, P1237, DOI 10.1093/infdis/jir512; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Shukla VK, 2000, DIGEST DIS SCI, V45, P900, DOI 10.1023/A:1005564822630; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Swindells S, 1996, J INTERF CYTOK RES, V16, P127, DOI 10.1089/jir.1996.16.127; Taulo S, 2008, INT J FOOD MICROBIOL, V125, P111, DOI 10.1016/j.ijfoodmicro.2008.02.025; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; Tennant SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018700; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; TODD WTA, 1983, SCOT MED J, V28, P176, DOI 10.1177/003693308302800217; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Valentiner-Branth P, 2003, J CLIN MICROBIOL, V41, P4238, DOI 10.1128/JCM.41.9.4238-4245.2003; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Varma JK, 2010, EMERG INFECT DIS, V16, P1569, DOI 10.3201/eid1610.091686; Wadula J, 2006, PEDIATR INFECT DIS J, V25, P843, DOI 10.1097/01.inf.0000233543.78070.a2; WAHDAN MH, 1980, B WORLD HEALTH ORGAN, V58, P469; WAMOLA IA, 1981, E AFR MED J, V58, P677; WELTON JC, 1979, LANCET, V1, P791; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	128	576	590	7	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2489	2499		10.1016/S0140-6736(11)61752-2	http://dx.doi.org/10.1016/S0140-6736(11)61752-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22587967	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000305915900034
J	Kamar, N; Bendall, R; Legrand-Abravanel, F; Xia, NS; Ijaz, S; Izopet, J; Dalton, HR				Kamar, Nassim; Bendall, Richard; Legrand-Abravanel, Florence; Xia, Ning-Shao; Ijaz, Samreen; Izopet, Jacques; Dalton, Harry R.			Hepatitis E	LANCET			English	Article							E VIRUS-INFECTION; CHRONIC LIVER-DISEASE; ORGAN-TRANSPLANT RECIPIENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; PEGYLATED INTERFERON-ALPHA; CELL-CULTURE-SYSTEM; BLOOD-DONORS; RISK-FACTORS; E VACCINE; NEUROLOGIC DISORDERS	Hepatitis E virus (HEV) was discovered during the Soviet occupation of Afghanistan in the 1980s, after an outbreak of unexplained hepatitis at a military camp. A pooled faecal extract from affected soldiers was ingested by a member of the research team. He became sick, and the new virus (named HEV), was detected in his stool by electron microscopy. Subsequently, endemic HEV has been identified in many resource-poor countries. Globally, HEV is the most common cause of acute viral hepatitis. The virus was not initially thought to occur in developed countries, but recent reports have shown this notion to be mistaken. The aim of this Seminar is to describe recent discoveries regarding HEV, and how they have changed our understanding of its effect on human health worldwide.	[Kamar, Nassim] CHU Rangueil, Dept Nephrol Dialysis & Organ Transplantat, F-31054 Toulouse, France; [Kamar, Nassim; Legrand-Abravanel, Florence; Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Kamar, Nassim; Legrand-Abravanel, Florence; Izopet, Jacques] Univ Toulouse 3, F-31062 Toulouse, France; [Dalton, Harry R.] Royal Cornwall Hosp Trust, Cornwall Gastrointestinal Unit, Truro, England; [Legrand-Abravanel, Florence; Izopet, Jacques] CHU Purpan, Dept Virol, Toulouse, France; [Xia, Ning-Shao] Xiamen Univ, Sch Publ Hlth, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Ijaz, Samreen] Hlth Protect Agcy, Microbiol Serv Colindale, Virus Reference Dept, London, England; [Dalton, Harry R.] Univ Exeter, Peninsula Coll Med & Dent, European Ctr Environm & Human Hlth, Truro, England; [Dalton, Harry R.] Univ Plymouth, Peninsula Coll Med & Dent, European Ctr Environm & Human Hlth, Truro, England	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Royal Cornwall Hospital; CHU de Toulouse; Xiamen University; Health Protection Agency; University of Exeter; University of Plymouth; University of Exeter; University of Plymouth	Dalton, HR (corresponding author), Royal Cornwall Hosp, Truro, England.	harry.dalton@rcht.cornwall.nhs.uk	Xia, NS/G-4647-2010; Aggarwal, Rakesh/D-1583-2009; IZOPET, Jacques/L-5756-2014; ABRAVANEL, Florence/AAC-2993-2021; Abrvaanel, florence/K-3776-2014; Kamar, Nassim/L-6462-2014	Aggarwal, Rakesh/0000-0001-9689-494X; ABRAVANEL, Florence/0000-0002-1753-1065; Xia, Ningshao/0000-0003-0179-5266; Dalton, Harry/0000-0001-7786-5457; Ijaz, Samreen/0000-0001-6658-3542; Kamar, Nassim/0000-0003-1930-8964	GlaxoSmithKlein; Wantai; Royal College of Physicians (London)	GlaxoSmithKlein; Wantai; Royal College of Physicians (London)	HRD has received travel and accommodation costs and consultancy fees from GlaxoSmithKlein and Wantai. All other authors declare no conflicts of interest.; We thank Debbie Morcom for preparing figures 2 and 4, and Jon White for figure 3, and Buddha Basnyat for his helpful comments. We also thank the Royal College of Physicians (London) who awarded HRD the Sheila Sherlock Travelling Fellowship to support this work.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Aggarwal Rakesh, 2002, Indian J Gastroenterol, V21, P14; Ali G, 2001, INDIAN J NEPHROL, V11, P70; Alric L, 2011, AM J GASTROENTEROL, V106, P1562, DOI 10.1038/ajg.2011.158; Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2011, J CLIN MICROBIOL, V49, P1234, DOI 10.1128/JCM.02578-10; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Bendall R, 2008, J MED VIROL, V80, P95, DOI 10.1002/jmv.21033; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; BILE K, 1994, AM J TROP MED HYG, V51, P466, DOI 10.4269/ajtmh.1994.51.466; Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07; Bouwknegt M, 2008, EPIDEMIOL INFECT, V136, P567, DOI 10.1017/S0950268807008941; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Bryan JP, 2002, AM J TROP MED HYG, V67, P662, DOI 10.4269/ajtmh.2002.67.662; CHAUHAN A, 1993, LANCET, V341, P149, DOI 10.1016/0140-6736(93)90008-5; Clayson ET, 1997, J INFECT DIS, V176, P763, DOI 10.1086/517296; Clayson ET, 1998, J MED VIROL, V54, P178, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;178::AID-JMV6&gt;3.0.CO;2-2; CLAYSON ET, 1995, J INFECT DIS, V172, P927, DOI 10.1093/infdis/172.4.927; Colson P, 2011, J VIRAL HEPATITIS, V18, P227, DOI 10.1111/j.1365-2893.2010.01311.x; Colson P, 2007, EMERG INFECT DIS, V13, P648, DOI 10.3201/eid1304.061387; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Colson P, 2009, J CLIN VIROL, V45, P269, DOI 10.1016/j.jcv.2009.06.002; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2007, ALIMENT PHARM THER, V26, P1429, DOI 10.1111/j.1365-2036.2007.03504.x; Dalton HR, 2007, LANCET, V369, P1260, DOI 10.1016/S0140-6736(07)60595-9; Dalton HR, 2010, EPIDEMIOL INFECT, V138, P174, DOI 10.1017/S0950268809990306; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2007, J GASTROEN HEPATOL, V22, P1236, DOI 10.1111/j.1440-1746.2007.04894.x; Dalton HR, 2011, EUR J GASTROEN HEPAT, V23, P1200, DOI 10.1097/MEG.0b013e32834ca4da; Dalton HR, 2011, ANN INTERN MED, V155, P479, DOI 10.7326/0003-4819-155-7-201110040-00017; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Deniel C, 2011, J CLIN VIROL, V51, P202, DOI 10.1016/j.jcv.2011.04.009; Despierres LA, 2011, EMERG INFECT DIS, V17, P1510, DOI 10.3201/eid1708.102028; Dixit V K, 2006, J Assoc Physicians India, V54, P418; Drobeniuc J, 2010, CLIN INFECT DIS, V51, pE24, DOI 10.1086/654801; Emerson SU, 2006, J GEN VIROL, V87, P697, DOI 10.1099/vir.0.81545-0; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Engle RE, 2002, J CLIN MICROBIOL, V40, P4576, DOI 10.1128/JCM.40.12.4576-4580.2002; Faramawi MF, 2011, EPIDEMIOL INFECT, V139, P1145, DOI 10.1017/S0950268810002177; Fong F, 2009, CLIN NEUROL NEUROSUR, V111, P193, DOI 10.1016/j.clineuro.2008.09.005; Fourquet E, 2010, J CLIN VIROL, V48, P73, DOI 10.1016/j.jcv.2010.02.016; Gerolami R, 2008, NEW ENGL J MED, V358, P859, DOI 10.1056/NEJMc0708687; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Gerolami R, 2009, J HEPATOL, V50, P622, DOI 10.1016/j.jhep.2008.12.008; Ghabrah TM, 1998, J MED VIROL, V55, P134, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;134::AID-JMV9&gt;3.0.CO;2-3; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Guu TSY, 2009, P NATL ACAD SCI USA, V106, P12992, DOI 10.1073/pnas.0904848106; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Haagsma EB, 2010, LIVER TRANSPLANT, V16, P474, DOI 10.1002/lt.22014; Hakze-van der Honing RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022673; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Howard CM, 2010, AM J TROP MED HYG, V83, P1170, DOI 10.4269/ajtmh.2010.10-0384; Huang SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013560; Husain MM, 2011, INTERVIROLOGY, V54, P139, DOI 10.1159/000319840; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Innis BL, 2002, CLIN DIAGN LAB IMMUN, V9, P639, DOI 10.1128/CDLI.9.3.639-648.2002; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kaba M, 2011, J MED VIROL, V83, P1704, DOI 10.1002/jmv.22177; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kamar N, 2010, AM J TRANSPLANT, V10, P1321, DOI 10.1111/j.1600-6143.2010.03068.x; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, TRANSPLANTATION, V93, P617, DOI 10.1097/TP.0b013e318245f14c; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kamar N, 2010, TRANSPLANTATION, V89, P353, DOI 10.1097/TP.0b013e3181c4096c; Kamar N, 2010, CLIN INFECT DIS, V50, pE30, DOI 10.1086/650488; Kantala T, 2009, J CLIN VIROL, V45, P109, DOI 10.1016/j.jcv.2009.03.006; Keane FE, 2012, HIV MED, V13, P83, DOI 10.1111/j.1468-1293.2011.00942.x; Kejariwal D, 2001, NEUROLOGY, V57, P1935, DOI 10.1212/WNL.57.10.1935; Kenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]; KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; le Coutre P, 2009, GUT, V58, P699, DOI 10.1136/gut.2008.165571; Legrand-Abravanel F, 2009, EMERG INFECT DIS, V15, P110, DOI 10.3201/eid1501.080296; Legrand-Abravanel F, 2011, EMERG INFECT DIS, V17, P30, DOI 10.3201/eid1701.100527; Legrand-Abravanel F, 2010, J INFECT DIS, V202, P835, DOI 10.1086/655899; Legrand-Abravanel F, 2009, CLIN VACCINE IMMUNOL, V16, P772, DOI 10.1128/CVI.00438-08; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Lockwood GL, 2008, EUR J GASTROEN HEPAT, V20, P800, DOI 10.1097/MEG.0b013e3282f1cbff; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mallet V, 2010, ANN INTERN MED, V153, P85, DOI 10.7326/0003-4819-153-2-201007200-00257; Mandal K, 2006, INDIAN PEDIATR, V43, P365; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Mansuy JM, 2004, J MED VIROL, V74, P419, DOI 10.1002/jmv.20206; Mansuy JM, 2004, J CLIN MICROBIOL, V42, P912, DOI 10.1128/JCM.42.2.912-913.2004; Matsubayashi K, 2004, TRANSFUSION, V44, P934, DOI 10.1111/j.1537-2995.2004.03300.x; Maurissen I, 2012, INFECTION, V40, P323, DOI 10.1007/s15010-011-0185-6; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Mitsui T, 2006, J MED VIROL, V78, P1015, DOI 10.1002/jmv.20657; Mizuo H, 2005, J MED VIROL, V76, P341, DOI 10.1002/jmv.20364; NAIK SR, 1992, B WORLD HEALTH ORGAN, V70, P597; NANJI AA, 1985, LANCET, V1, P681; Payne CJ, 1999, VET MICROBIOL, V68, P119, DOI 10.1016/S0378-1135(99)00067-X; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Peron JM, 2011, J HEPATOL, V54, P1323, DOI 10.1016/j.jhep.2011.01.009; Peron JM, 2006, J GASTROEN HEPATOL, V21, P1223, DOI 10.1111/j.1440-1746.2006.04209.x; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376; Renou C, 2010, AIDS, V24, P1493, DOI 10.1097/QAD.0b013e32833a29ab; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Schlosser B, 2012, J HEPATOL, V56, P500, DOI 10.1016/j.jhep.2011.06.021; Sharapov MB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-35; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Sood A, 2000, AM J GASTROENTEROL, V95, P3667; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tamura A, 2007, HEPATOL RES, V37, P113, DOI 10.1111/j.1872-034X.2007.00024.x; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Tanaka T, 2009, J CLIN MICROBIOL, V47, P1906, DOI 10.1128/JCM.00629-09; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Teshale EH, 2010, EMERG INFECT DIS, V16, P126, DOI 10.3201/eid1601.090764; Thoden J, 2008, AIDS, V22, P909, DOI 10.1097/QAD.0b013e3282f7cb9a; Tsang THF, 2000, CLIN INFECT DIS, V30, P618, DOI 10.1086/313730; TSEGA E, 1993, ETHIOPIAN MED J, V31, P173; VISWANATHAN R, 1957, Indian J Med Res, V45, P1; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; Wu T, 2008, INTERVIROLOGY, V51, P322, DOI 10.1159/000172627; Xing L, 2011, J VIROL, V85, P1117, DOI 10.1128/JVI.00657-10; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang J, 2009, VACCINE, V27, P1869, DOI 10.1016/j.vaccine.2008.12.061; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; Zhang W, 2010, EMERG INFECT DIS, V16, P1630, DOI 10.3201/eid1610.100873; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; ZHUANG H, 1991, GASTROENTEROL JPN, V26, P135	141	684	719	3	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2477	2488		10.1016/S0140-6736(11)61849-7	http://dx.doi.org/10.1016/S0140-6736(11)61849-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22549046				2022-12-28	WOS:000305915900033
J	Malenga, G; Molyneux, M				Malenga, Grace; Molyneux, Malcolm			The Millennium Villages project	LANCET			English	Editorial Material									[Molyneux, Malcolm] Coll Med, Blantyre 3, Malawi	University of Malawi	Molyneux, M (corresponding author), Coll Med, Blantyre 3, Malawi.	mmolyneux999@gmail.com						[Anonymous], 2010, MILL DEV GOALS REP; [Anonymous], 2005, NATURE, V435, P1137; Clemens MA, DOES RIGOROUS IMPACT; Pronyk PM, 2012, LANCET, V379, P2179, DOI 10.1016/S0140-6736(12)60207-4; Pronyk PM, PERSPECTIVES MONITOR; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; Streeter AK, DONT YOU WONDER WHAT; UN Millennium Project, 2005, INV DEV PRACT PLAN A; United Nations, 2000, UN MILL DECL GEN ASS	9	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2131	2133		10.1016/S0140-6736(12)60369-9	http://dx.doi.org/10.1016/S0140-6736(12)60369-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	955BA	22572601				2022-12-28	WOS:000304990900011
J	Biere, SSAY; Henegouwen, MIV; Maas, KW; Bonavina, L; Rosman, C; Garcia, JR; Gisbertz, SS; Klinkenbijl, JHG; Hollmann, MW; de Lange, ESM; Bonjer, HJ; van der Peet, DL; Cuesta, MA				Biere, Surya S. A. Y.; Henegouwen, Mark I. van Berge; Maas, Kirsten W.; Bonavina, Luigi; Rosman, Camiel; Roig Garcia, Josep; Gisbertz, Suzanne S.; Klinkenbijl, Jean H. G.; Hollmann, Markus W.; de lange, Elly S. M.; Bonjer, H. Jaap; van der Peet, Donald L.; Cuesta, Miguel A.			Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; EXTENDED TRANSTHORACIC RESECTION; PRONE; CHEMORADIOTHERAPY; ADENOCARCINOMA; MOBILIZATION; EXPERIENCE; SURVIVAL	Background Surgical resection is regarded as the only curative option for resectable oesophageal cancer, but pulmonary complications occurring in more than half of patients after open oesophagectomy are a great concern. We assessed whether minimally invasive oesophagectomy reduces morbidity compared with open oesophagectomy. Methods We did a multicentre, open-label, randomised controlled trial at five study centres in three countries between June 1, 2009, and March 31, 2011. Patients aged 18-75 years with resectable cancer of the oesophagus or gastro-oesophageal junction were randomly assigned via a computer-generated randomisation sequence to receive either open transthoracic or minimally invasive transthoracic oesophagectomy. Randomisation was stratified by centre. Patients, and investigators undertaking interventions, assessing outcomes, and analysing data, were not masked to group assignment. The primary outcome was pulmonary infection within the first 2 weeks after surgery and during the whole stay in hospital. Analysis was by intention to treat. This trial is registered with the Netherlands Trial Register, NTR TC 2452. Findings We randomly assigned 56 patients to the open oesophagectomy group and 59 to the minimally invasive oesophagectomy group. 16 (29%) patients in the open oesophagectomy group had pulmonary infection in the first 2 weeks compared with five (9%) in the minimally invasive group (relative risk [RR] 0.30, 95% CI 0.12-0.76; p=0.005). 19 (34%) patients in the open oesophagectomy group had pulmonary infection in-hospital compared with seven (12%) in the minimally invasive group (0.35, 0.16-0.78; p = 0.005). For in-hospital mortality, one patient in the open oesophagectomy group died from anastomotic leakage and two in the minimally invasive group from aspiration and mediastinitis after anastomotic leakage. Interpretation These findings provide evidence for the short-term benefits of minimally invasive oesophagectomy for patients with resectable oesophageal cancer.	[Biere, Surya S. A. Y.; Maas, Kirsten W.; Gisbertz, Suzanne S.; Bonjer, H. Jaap; van der Peet, Donald L.; Cuesta, Miguel A.] Vrije Univ Amsterdam Med Ctr, Dept Surg, NL-1081 HV Amsterdam, Netherlands; [de lange, Elly S. M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands; [Henegouwen, Mark I. van Berge; Klinkenbijl, Jean H. G.] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Bonavina, Luigi] Univ Milan, Dept Surg, Ist Ricovero & Cura, Carattere Sci Policlin San Donato, Milan, Italy; [Rosman, Camiel] Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; [Roig Garcia, Josep] Hosp Univ Girona Dr Josep Trueta, Dept Surg, Girona, Spain	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan; Canisius-Wilhelmina Hospital; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Cuesta, MA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Surg, NL-1081 HV Amsterdam, Netherlands.	ma.cuesta@vumc.nl	rosman, camiel/F-9059-2016; Bonavina, Luigi/H-2841-2019; Gisbertz, Suzanne/AAG-5370-2020	rosman, camiel/0000-0002-9152-3987; Bonavina, Luigi/0000-0002-4880-1670; Gisbertz, Suzanne/0000-0001-9655-7601; van der Peet, Donald L./0000-0003-3883-3705; van Berge Henegouwen, Mark/0000-0001-8689-3134	Digestive Surgery Foundation of the Unit of Digestive Surgery of the VU University Medical Centre	Digestive Surgery Foundation of the Unit of Digestive Surgery of the VU University Medical Centre	Funding Digestive Surgery Foundation of the Unit of Digestive Surgery of the VU University Medical Centre.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Biere SSAY, 2009, MINERVA CHIR, V64, P121; Biere SSAY, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-2; Biere Surya S A Y, 2010, Ned Tijdschr Geneeskd, V154, pA820; Blazeby JM, 2003, EUR J CANCER, V39, P1384, DOI 10.1016/S0959-8049(03)00270-3; Cuschieri A, 1994, Endosc Surg Allied Technol, V2, P21; de Boer AGEM, 2004, J CLIN ONCOL, V22, P4202, DOI 10.1200/jco.2004.11.102; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fabian T, 2008, SURG ENDOSC, V22, P2485, DOI 10.1007/s00464-008-9799-x; Grogan Eric L, 2008, Thorac Surg Clin, V18, P249, DOI 10.1016/j.thorsurg.2008.04.007; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Knoll H, 2006, ANESTHESIOLOGY, V105, P471, DOI 10.1097/00000542-200609000-00009; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Nguyen NT, 2008, ANN SURG, V248, P1081, DOI 10.1097/SLA.0b013e31818b72b5; Overholt RA, 1946, J INT COLL SURG, V10, P216; Palanivelu C, 2006, J AM COLL SURGEONS, V203, P7, DOI 10.1016/j.jamcollsurg.2006.03.016; Parameswaran R, 2010, BRIT J SURG, V97, P525, DOI 10.1002/bjs.6908; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Portale G, 2006, J AM COLL SURGEONS, V202, P588, DOI 10.1016/j.jamcollsurg.2005.12.022; Ruol A, 2009, ARCH SURG-CHICAGO, V144, P247, DOI 10.1001/archsurg.2008.574; Scheepers JJG, 2006, SCAND J GASTROENTERO, V41, P123, DOI 10.1080/00365520600664425; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Yatabe T, 2010, J ANESTH, V24, P803, DOI 10.1007/s00540-010-0968-4; Zhong T, 2009, ANAESTH INTENS CARE, V37, P441; Zingg U, 2009, ANN THORAC SURG, V87, P911, DOI 10.1016/j.athoracsur.2008.11.060	27	1027	1133	5	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1887	1892		10.1016/S0140-6736(12)60516-9	http://dx.doi.org/10.1016/S0140-6736(12)60516-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22552194				2022-12-28	WOS:000304194200030
J	Garcia, C				Garcia, Carlos			2-cm and 4-cm surgical excision margins did not differ for survival in cutaneous melanoma > 2 mm thick	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Dawson Med Grp, Oklahoma City, OK 73109 USA		Garcia, C (corresponding author), Dawson Med Grp, Oklahoma City, OK 73109 USA.							Sladden MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004835.pub2	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-7	10.7326/0003-4819-156-10-201205150-02007	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586025				2022-12-28	WOS:000304193400006
J	Offit, PA				Offit, Paul A.			Should childhood vaccination be mandatory? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEASLES OUTBREAK; IMMUNIZATION; EXEMPTIONS; RISK		[Offit, Paul A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Offit, Paul A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	offit@email.chop.edu						[Anonymous], 2001, INDEPENDENT     1204; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Collier Melissa, 2011, Morbidity and Mortality Weekly Report, V60, P1169; Coppes MJ, 1998, NEW ENGL J MED, V339, P846, DOI 10.1056/NEJM199809173391213; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Fraser Caroline, 1999, GODS PERFECT CHILD L; Glanz JM, 2009, PEDIATRICS, V123, P1446, DOI 10.1542/peds.2008-2150; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; RODGERS DV, 1993, PEDIATR INFECT DIS J, V12, P288, DOI 10.1097/00006454-199304000-00006; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Thomas J., 2010, PSYCHIAT TIMES, V27, P1; YOUNG JH, 1992, AM HLTH QUACKERY	12	7	7	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e2434	10.1136/bmj.e2434	http://dx.doi.org/10.1136/bmj.e2434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589519				2022-12-28	WOS:000304086900001
J	Saade, G				Saade, George			SSRI use in late pregnancy was associated with increased persistent pulmonary hypertension in newborns	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Saade, G (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.							Koren G, 2012, AM J OBSTET GYN 0221	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-11	10.7326/0003-4819-156-10-201205150-02011	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586029				2022-12-28	WOS:000304193400010
J	Rufener, J; Schulze, CC; Tanzler, K; Aeberli, D; Sendi, P				Rufener, Janine; Schulze, Christina Claudia; Taenzler, Kristina; Aeberli, Daniel; Sendi, Parham			Sterile spondylodiscitis	LANCET			English	Editorial Material							GOUT		[Schulze, Christina Claudia; Sendi, Parham] Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland; [Rufener, Janine; Taenzler, Kristina] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Aeberli, Daniel] Univ Hosp Bern, Dept Rheumatol & Clin Immunol Allergol, CH-3010 Bern, Switzerland; Univ Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Sendi, P (corresponding author), Univ Hosp Bern, Univ Clin Infect Dis, CH-3010 Bern, Switzerland.	sendi-pa@magnet.ch	Sendi, Parham/R-3286-2018	Sendi, Parham/0000-0002-7347-6312				Agudelo CA, 2001, CURR OPIN RHEUMATOL, V13, P234, DOI 10.1097/00002281-200105000-00015; Barrett K, 2001, NEUROSURGERY, V48, P1170, DOI 10.1097/00006123-200105000-00046; Hou LC, 2007, SURG NEUROL, V67, P65, DOI 10.1016/j.surneu.2006.03.038; Konatalapalli RM, 2009, J RHEUMATOL, V36, P609, DOI 10.3899/jrheum.080374; Suk KS, 2007, SPINE J, V7, P94, DOI 10.1016/j.spinee.2006.01.009	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1850	1850		10.1016/S0140-6736(11)61924-7	http://dx.doi.org/10.1016/S0140-6736(11)61924-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22579321				2022-12-28	WOS:000303937700040
J	Okuno, H; Akashi, K; Ishii, Y; Yagishita-Kyo, N; Suzuki, K; Nonaka, M; Kawashima, T; Fujii, H; Takemoto-Kimura, S; Abe, M; Natsume, R; Chowdhury, S; Sakimura, K; Worley, PF; Bito, H				Okuno, Hiroyuki; Akashi, Kaori; Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Fujii, Hajime; Takemoto-Kimura, Sayaka; Abe, Manabu; Natsume, Rie; Chowdhury, Shoaib; Sakimura, Kenji; Worley, Paul F.; Bito, Haruhiko			Inverse Synaptic Tagging of Inactive Synapses via Dynamic Interaction of Arc/Arg3.1 with CaMKII beta	CELL			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CYTOSKELETAL-ASSOCIATED PROTEIN; IN-VIVO; KINASE-II; TRANSCRIPTION FACTORS; MEMORY CONSOLIDATION; MESSENGER-RNA; ARC; EXPRESSION	The Arc/Arg3.1 gene product is rapidly upregulated by strong synaptic activity and critically contributes to weakening synapses by promoting AMPA-R endocytosis. However, how activity-induced Arc is redistributed and determines the synapses to be weakened remains unclear. Here, we show targeting of Arc to inactive synapses via a high-affinity interaction with CaMKII beta that is not bound to calmodulin. Synaptic Arc accumulates in inactive synapses that previously experienced strong activation and correlates with removal of surface GluA1 from individual synapses. A lack of CaMKII beta either in vitro or in vivo resulted in loss of Arc upregulation in the silenced synapses. The discovery of Arc's role in "inverse'' synaptic tagging that is specific for weaker synapses and prevents undesired enhancement of weak synapses in potentiated neurons reconciles essential roles of Arc both for the late phase of long-term plasticity and for reduction of surface AMPA-Rs in stimulated neurons.	[Okuno, Hiroyuki; Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Fujii, Hajime; Takemoto-Kimura, Sayaka; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; [Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Global Ctr Educ & Res Chem Biol Dis, Bunkyo Ku, Tokyo 1130033, Japan; [Akashi, Kaori; Abe, Manabu; Natsume, Rie; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [Takemoto-Kimura, Sayaka] PRESTO JST, Kawaguchi, Saitama 3320012, Japan; [Chowdhury, Shoaib; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Okuno, Hiroyuki; Nonaka, Mio; Fujii, Hajime; Sakimura, Kenji; Bito, Haruhiko] CREST JST, Chiyoda Ku, Tokyo 1020076, Japan	University of Tokyo; University of Tokyo; Niigata University; Japan Science & Technology Agency (JST); Johns Hopkins University; Japan Science & Technology Agency (JST)	Okuno, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.	okuno@m.u-tokyo.ac.jp; hbito@m.u-tokyo.ac.jp	Bito, Haruhiko/A-8635-2008	Kawashima, Takashi/0000-0001-7741-3995; OKUNO, HIROYUKI/0000-0001-6237-6503; Bito, Haruhiko/0000-0001-6315-9594	JSPS; MEXT of Japan; MHLW of Japan; NIMH; HFSP; Shimadzu Foundation; Kowa Life Science Foundation; Takeda Science Foundation; Mitsubishi Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20670002, 24700321, 10J04788, 11J04506] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MHLW of Japan; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HFSP(Human Frontier Science Program); Shimadzu Foundation; Kowa Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Schulman and T. Meyer for several CaMKII constructs, R.Y. Tsien for mCherry cDNA, A. Miyawaki for Venus cDNA, M. Yamamoto for GFP-TeNT cDNA, K. U. Bayer for pmEGFP-CaMKII beta e cDNA, and M. Watanabe for an anti-vGlut1 antibody, and all members of the Bito laboratory for support. BDNF was provided by Dainippon Sumitomo Pharma, Osaka, Japan. We thank T. Bonhoeffer, K. Deisseroth, R. G. M. Morris, V. Naegerl, R. Redondo, M. van Rossum, M. Schnitzer, and R. W. Tsien for valuable comments on an earlier version of this work, and R. Huganir for critical reading of the manuscript. We are indebted to Y. Kondo, K. Saiki, A. Adachi-Morishima, R. Gyobu, and T. Kinbara for assistance. This work was supported in part by Grants-in-Aid (WAKATE, KIBAN, START, CBSN) from JSPS and MEXT of Japan (to H.O., M.N., S. T-K., K. Sakimura, and H. B.), from the MHLW of Japan (to H.O. and H. B.), by a grant from NIMH (to P. F. W.), and by awards from the HFSP (to H.O. and H. B.) and from the Shimadzu Foundation, Kowa Life Science Foundation, Takeda Science Foundation, and the Mitsubishi Foundation (to H. B.). Y. I., N.Y-K., K. Suzuki, and T. K. are JSPS predoctoral fellows.	Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Matsuzaki M., 2004, NAT NEUROSCI, V429, p[450, 761]; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Navakkode S, 2004, J NEUROSCI, V24, P7740, DOI 10.1523/JNEUROSCI.1796-04.2004; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Shen K, 1998, J NEUROCHEM, V70, P96; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	43	198	204	3	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					886	898		10.1016/j.cell.2012.02.062	http://dx.doi.org/10.1016/j.cell.2012.02.062			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579289	Bronze, Green Accepted			2022-12-28	WOS:000303934700020
J	Saturno, WA; Stuart, D; Aveni, AF; Rossi, F				Saturno, William A.; Stuart, David; Aveni, Anthony F.; Rossi, Franco			Ancient Maya Astronomical Tables from Xultun, Guatemala	SCIENCE			English	Article								Maya astronomical tables are recognized in bark-paper books from the Late Postclassic period (1300 to 1521 C. E.), but Classic period (200 to 900 C. E.) precursors have not been found. In 2011, a small painted room was excavated at the extensive ancient Maya ruins of Xultun, Guatemala, dating to the early 9th century C. E. The walls and ceiling of the room are painted with several human figures. Two walls also display a large number of delicate black, red, and incised hieroglyphs. Many of these hieroglyphs are calendrical in nature and relate astronomical computations, including at least two tables concerning the movement of the Moon, and perhaps Mars and Venus. These apparently represent early astronomical tables and may shed light on the later books.	[Saturno, William A.; Rossi, Franco] Boston Univ, Dept Archaeol, Boston, MA 02215 USA; [Stuart, David] Univ Texas Austin, Dept Art & Art Hist, Austin, TX 78712 USA; [Aveni, Anthony F.] Colgate Univ, Dept Sociol & Anthropol, Dept Phys & Astron, Hamilton, NY 13346 USA	Boston University; University of Texas System; University of Texas Austin; Colgate University	Saturno, WA (corresponding author), Boston Univ, Dept Archaeol, Boston, MA 02215 USA.	saturno@bu.edu			Boston University; National Geographic Society, Committee for Research and Exploration [8782-10, 8931-11, 9091-12]; National Geographic Society, Expeditions Council [EC0497-11]; Guatemalan Ministerio de Cultura; Instituto de Antropologia e Historia; Departamento de Monumnetos Prehisanicos	Boston University; National Geographic Society, Committee for Research and Exploration(National Geographic Society); National Geographic Society, Expeditions Council(National Geographic Society); Guatemalan Ministerio de Cultura; Instituto de Antropologia e Historia; Departamento de Monumnetos Prehisanicos	The data reported in this paper are available in the supplementary materials. Excavations by the Proyecto Regional San Bartolo-Xultun between 2008 and 2012 were supported by Boston University as well as through grants from the National Geographic Society, Committee for Research and Exploration (grants 8782-10, 8931-11, 9091-12), and the National Geographic Society, Expeditions Council (EC0497-11). We also thank the Guatemalan Ministerio de Cultura, Instituto de Antropologia e Historia, and the Departamento de Monumnetos Prehisanicos for their support.	Astronomy Calendrical, 1978, DICT SCI BIOGRAPHY, V15, p[759, 787, 804]; Bricker H., 2011, ASTRONOMY MAYA CODIC, P76; Bricker H., 2011, ASTRONOMY MAYA CODIC, p275ff; Bricker H. M., 2011, ASTRONOMY MAYA CODIC, P235; BRICKER HM, 1983, CURR ANTHROPOL, V24, P1, DOI 10.1086/202931; Forstemann Ernst, 1906, PAPERS PEABODY MUSEU, V4; Linden John H., 1996, 8 PALENQUE ROUND TAB, P343; Morley S., 1938, INSCRIPTIONS PETEN, V1-4, P383; Satterthwaite L., 1947, JOINT PUBLICATION U; Saturno W., 2008, 7 I ANTR HIST PROYEC; Saturno W., 2010, 9 I ANTR HIST, P106; Schele L., 1992, TEXAS NOTES PRECOLUM; Stuart D., 2011, ORDER DAYS; Teeple J., 1930, CONTRIBUTIONS AM ARC, Vi; Thompson E. J., 1970, MAYA HIST RELIG; Thompson J. E. S., 1972, APS MEMOIR, P20; Thompson J. Eric S., 1950, CARNEGIE I WASHINGTO, V589; von Euw Eric, 1978, CORPUS MAYA HIEROGLY, V5; von Euw Eric, 1984, CORPUS MAYA HIEROGLY, V5	19	34	35	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					714	717		10.1126/science.1221444	http://dx.doi.org/10.1126/science.1221444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	940EH	22582260				2022-12-28	WOS:000303872300048
J	Lidegaard, O; Nielsen, LH; Skovlund, CW; Lokkegaard, E				Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel; Lokkegaard, Ellen			Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL-CONTRACEPTIVES; TRANSDERMAL PATCH; VAGINAL RING; RISK; THROMBOEMBOLISM; NORGESTIMATE	Objective To assess the risk of venous thrombosis in current users of non-oral hormonal contraception. Design Historical national registry based cohort study. Setting Four national registries in Denmark. Participants All Danish non-pregnant women aged 15-49 (n=1 626 158), free of previous thrombotic disease or cancer, were followed from 2001 to 2010. Main outcome measures Incidence rate of venous thrombosis in users of transdermal, vaginal, intrauterine, or subcutaneous hormonal contraception, relative risk of venous thrombosis compared with non-users, and rate ratios of venous thrombosis in current users of non-oral products compared with the standard reference oral contraceptive with levonorgestrel and 30-40 mu g oestrogen. Diagnoses were confirmed by at least four weeks of anticoagulation therapy after the diagnosis. Results Within 9 429 128 woman years of observation, 5287 first ever venous thrombosis events were recorded, of which 3434 were confirmed. In non-users of hormonal contraception the incidence rate of confirmed events was 2.1 per 10 000 woman years. Compared with non-users of hormonal contraception, and after adjustment for age, calendar year, and education, the relative risk of confirmed venous thrombosis in users of transdermal combined contraceptive patches was 7.9 (95% confidence interval 3.5 to 17.7) and of the vaginal ring was 6.5 (4.7 to 8.9). The corresponding incidences per 10 000 exposure years were 9.7 and 7.8 events. The relative risk was increased in women who used subcutaneous implants (1.4, 0.6 to 3.4) but not in those who used the levonorgestrel intrauterine system (0.6, 0.4 to 0.8). Compared with users of combined oral contraceptives containing levonorgestrel, the adjusted relative risk of venous thrombosis in users of transdermal patches was 2.3 (1.0 to 5.2) and of the vaginal ring was 1.9 (1.3 to 2.7). Conclusion Women who use transdermal patches or vaginal rings for contraception have a 7.9 and 6.5 times increased risk of confirmed venous thrombosis compared with non-users of hormonal contraception of the same age, corresponding to 9.7 and 7.8 events per 10 000 exposure years. The risk was slightly increased in women using subcutaneous implants but not in those using the levonorgestrel intrauterine system.	[Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel] Gynaecol Clin 4232, DK-2100 Copenhagen O, Denmark; [Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-1168 Copenhagen, Denmark; [Lokkegaard, Ellen] Univ Copenhagen, Hillerod Hosp, Dept Obstet & Gynaecol, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Lidegaard, O (corresponding author), Gynaecol Clin 4232, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	Lidegaard@rh.regionh.dk		Lokkegaard, Ellen/0000-0003-4149-5663	Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet; Bayer Pharma Denmark; MSD Denmark; Theramex, Monaco	Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet; Bayer Pharma Denmark; MSD Denmark; Theramex, Monaco	The expenses were covered by the Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work. The primary investigator has within the last three years received honorariums for speeches in pharmacoepidemiological issues, including fees from Bayer Pharma Denmark, MSD Denmark, and Theramex, Monaco, and has been expert witness for plaintiff in a legal US case in 2011. EL has within the last three years participated in two congresses the expenses of which were covered by pharmaceutical companies. LHN and CWS declared no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.	Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Cole JA, 2007, OBSTET GYNECOL, V109, P339, DOI 10.1097/01.AOG.0000250968.82370.04; Dore DD, 2010, CONTRACEPTION, V81, P408, DOI 10.1016/j.contraception.2009.12.009; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Fleischer K, 2009, THROMB RES, V123, P429, DOI 10.1016/j.thromres.2008.04.022; Food and Drug Administration Office of Surveillance and Epidemiology, 2011, COMB HORM CONTR CHCS; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Jick S, 2007, CONTRACEPTION, V76, P4, DOI 10.1016/j.contraception.2007.03.003; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Jick SS, 2010, CONTRACEPTION, V81, P452, DOI 10.1016/j.contraception.2009.12.016; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Odlind V, 2002, ACTA OBSTET GYN SCAN, V81, P482, DOI 10.1034/j.1600-0412.2002.810603.x; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; POULTER NR, 1995, LANCET, V346, P1575; Spitzer WO, 1996, BRIT MED J, V312, P83; van den Heuvel MW, 2005, CONTRACEPTION, V72, P168, DOI 10.1016/j.contraception.2005.03.005; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921	20	136	145	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2012	344								e2990	10.1136/bmj.e2990	http://dx.doi.org/10.1136/bmj.e2990			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XR	22577198	Green Published, hybrid			2022-12-28	WOS:000304085400004
J	Sarewitz, D				Sarewitz, Daniel			Beware the creeping cracks of bias	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com						Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124	2	43	44	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					149	149		10.1038/485149a	http://dx.doi.org/10.1038/485149a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939HJ	22575922	Bronze			2022-12-28	WOS:000303799800006
J	van de Port, IGL; Wevers, LEG; Lindeman, E; Kwakkel, G				van de Port, Ingrid G. L.; Wevers, Lotte E. G.; Lindeman, Eline; Kwakkel, Gert			Effects of circuit training as alternative to usual physiotherapy after stroke: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							6-MINUTE WALK TEST; COMMUNITY AMBULATION; GAIT; IMPACT; REHABILITATION; SPEED; COMPETENCE; THERAPY; TIME	Objective To analyse the effect of task oriented circuit training compared with usual physiotherapy in terms of self reported walking competency for patients with stroke discharged from a rehabilitation centre to their own home. Design Randomised controlled trial with follow-up to 24 weeks. Setting Multicentre trial in nine outpatient rehabilitation centres in the Netherlands Participants Patients with stroke who were able to walk a minimum of 10 m without physical assistance and were discharged from inpatient rehabilitation to an outpatient rehabilitation clinic. Patients were randomly allocated to circuit training or usual physiotherapy, after stratification by rehabilitation centre, with an online randomisation procedure. Intervention Patients in the intervention group received circuit training in 90 minute sessions twice a week for 12 weeks. The training included eight different workstations in a gym and was intended to improve performance in tasks relating to walking competency. The control group received usual outpatient physiotherapy. Main outcome measures The primary outcome was the mobility domain of the stroke impact scale (SIS, version 3.0). Secondary outcomes were standing balance, self reported abilities, gait speed, walking distance, stair climbing, instrumental activities of daily living, fatigue, anxiety, and depression. Differences between groups were analysed according to the intention to treat principle. All outcomes were assessed by blinded observers in a repeated measurement design lasting 24 weeks. Results 126 patients were included in the circuit training group and 124 in the usual care group (control), with data from 125 and 117, respectively, available for analysis. One patient from the circuit training group and seven from the control group dropped out. Circuit training was a safe intervention, and no serious adverse events were reported. There were no significant differences between groups for the stroke impact scale mobility domain (beta=0.05 (SE 0.68), P=0.943) at 12 weeks. Circuit training was associated with significantly higher scores in terms of gait speed (0.09 m/s (SE 0.02), P<0.001), walking distance (20.0 m (SE 7.4), P=0.007), and modified stairs test (-1.6 s (SE 0.7), P=0.015). There were no significant differences between groups for the other secondary outcomes, except for the leisure domain of the Nottingham extended activities of daily living and the memory and thinking domain of the stroke impact scale. With the exception of gait speed (-0.04 m/s (SE 0.02), P=0.040), there were no significant differences between groups at follow-up. Conclusion Task oriented circuit training can safely replace usual physiotherapy for patients with stroke who are discharged from inpatient rehabilitation to the community and need further training in gait and gait related activities as an outpatient.	[van de Port, Ingrid G. L.; Wevers, Lotte E. G.; Lindeman, Eline; Kwakkel, Gert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3583 TM Utrecht, Netherlands; [van de Port, Ingrid G. L.; Wevers, Lotte E. G.; Lindeman, Eline; Kwakkel, Gert] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, NL-3583 TM Utrecht, Netherlands; [van de Port, Ingrid G. L.; Wevers, Lotte E. G.; Lindeman, Eline; Kwakkel, Gert] Rehabil Ctr, NL-3583 TM Utrecht, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam, Med Ctr, Res Inst MOVE, Dept Rehabil Med, NL-1081 HV Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Kwakkel, G (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Hoogstr,Utrecht Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands.	g.kwakkel@vumc.nl	sahely, ahmad/R-6293-2017	Kwakkel, Gert/0000-0002-4041-4043	Netherlands Organisation for Health Research and Development (ZonMw) [80-82310-98-08303]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was funded by the Netherlands Organisation for Health Research and Development (ZonMw), No 80-82310-98-08303.	Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI 10.1177/1545968308315997; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Duncan PW, 2002, STROKE, V33, P2593, DOI 10.1161/01.STR.0000034395.06874.3E; English C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007513.pub2; French B, 2008, HEALTH TECHNOL ASSES, V12, P1; Fulk George D., 2008, Physiotherapy Theory and Practice, V24, P195, DOI 10.1080/09593980701588284; Gordon NF, 2004, STROKE, V35, P1230, DOI 10.1161/01.STR.0000127303.19261.19; Kollen B, 2006, ARCH PHYS MED REHAB, V87, P358, DOI 10.1016/j.apmr.2005.11.007; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Outermans JC, 2010, CLIN REHABIL, V24, P979, DOI 10.1177/0269215509360647; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Tilson JK, 2010, PHYS THER, V90, P196, DOI 10.2522/ptj.20090079; Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769, DOI 10.1023/B:EJEP.0000036572.00663.f2; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; van de Port IGL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-43; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; Wevers LEG, 2011, J REHABIL MED, V43, P1027, DOI 10.2340/16501977-0881; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117	27	54	55	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2012	344								e2672	10.1136/bmj.e2672	http://dx.doi.org/10.1136/bmj.e2672			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XR	22577186	Green Published, hybrid			2022-12-28	WOS:000304085400001
J	Rao, VS				Rao, Veena S.			PERSONAL VIEW India's food bill will not provide the security it claims	BRITISH MEDICAL JOURNAL			English	Editorial Material									Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India		Rao, VS (corresponding author), Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						*COAL SUST NUTR SE, 2008, OV CURS MALN IND LEA; International Food Policy Research Institute, 2011 GLOB HUNG IND; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Programme Evaluation Organisation Planning Commission Government of India, 2005, PERF EV TARG PUBL DI; *UNICEF, STAT WORLDS CHILDR 2	6	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3194	10.1136/bmj.e3194	http://dx.doi.org/10.1136/bmj.e3194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569866				2022-12-28	WOS:000304083400011
J	Moon, T; Joughin, I; Smith, B; Howat, I				Moon, T.; Joughin, I.; Smith, B.; Howat, I.			21st-Century Evolution of Greenland Outlet Glacier Velocities	SCIENCE			English	Article							SURGE MECHANISM; HELHEIM GLACIER; ICE DYNAMICS; ACCELERATION; VARIABILITY; CIRCULATION; RETREAT; FJORD	Earlier observations on several of Greenland's outlet glaciers, starting near the turn of the 21st century, indicated rapid (annual-scale) and large (>100%) increases in glacier velocity. Combining data from several satellites, we produce a decade-long (2000 to 2010) record documenting the ongoing velocity evolution of nearly all (200+) of Greenland's major outlet glaciers, revealing complex spatial and temporal patterns. Changes on fast-flow marine-terminating glaciers contrast with steady velocities on ice-shelf-terminating glaciers and slow speeds on land-terminating glaciers. Regionally, glaciers in the northwest accelerated steadily, with more variability in the southeast and relatively steady flow elsewhere. Intraregional variability shows a complex response to regional and local forcing. Observed acceleration indicates that sea level rise from Greenland may fall well below proposed upper bounds.	[Moon, T.] Univ Washington, Seattle, WA 98195 USA; [Moon, T.; Joughin, I.; Smith, B.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Howat, I.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Howat, I.] Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Moon, T (corresponding author), Univ Washington, Seattle, WA 98195 USA.	twilap@uw.edu	Moon, Twila/AAZ-9302-2021; Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021; Howat, Ian M/A-3474-2008	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X; Howat, Ian M/0000-0002-8072-6260; Moon, Twila/0000-0003-0968-7008	NSF;  [NSF ANT-0852697];  [NNX08AQ83G]	NSF(National Science Foundation (NSF)); ; 	Velocity products were processed under NASA MEaSUREs (NNX08AL98A). Analysis was funded by an NSF Graduate Research Fellowship (T.M.) and grants NSF ANT-0852697 (I.J.) and NNX08AQ83G (B.S. and I.H.). Velocity data maps are or will be available via the MEaSUREs Earth Science Data Record at the National Snow and Ice Data Center, Boulder, CO (http://nsidc.org/data/nsidc-0478.html). We acknowledge the contributions of synthetic aperture radar data from the Canadian (CSA), German (DLR), and Japanese (JAXA) space agencies. We thank three anonymous reviewers and J. Carmichael for comments that improved the manuscript.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Andresen CS, 2012, NAT GEOSCI, V5, P37, DOI [10.1038/ngeo1349, 10.1038/NGEO1349]; Box JE, 2006, J CLIMATE, V19, P2783, DOI 10.1175/JCLI3738.1; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047565; Howat IM, 2008, J GLACIOL, V54, P646, DOI 10.3189/002214308786570908; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Jiskoot H, 2003, ANN GLACIOL, V36, P142, DOI 10.3189/172756403781816220; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2002, ANN GLACIOL-SER, V34, P195, DOI 10.3189/172756402781817978; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; KAMB B, 1985, SCIENCE, V227, P469, DOI 10.1126/science.227.4686.469; Mock S. J., 1966, J GLACIOL, V6, P369; Murray T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001906; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Murray T, 2002, ANN GLACIOL-SER, V34, P323, DOI 10.3189/172756402781817491; Nick FM, 2012, J GLACIOL, V58, P229, DOI 10.3189/2012JoG11J242; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2001, J GEOPHYS RES-ATMOS, V106, P34007, DOI 10.1029/2001JD900071; Rignot E, 2010, NAT GEOSCI, V3, P187, DOI 10.1038/NGEO765; Seale A, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001847; Shepherd A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035758; Solomon S., 2007, PHYS SCI BASIS WORKI; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682	33	253	255	10	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					576	578		10.1126/science.1219985	http://dx.doi.org/10.1126/science.1219985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556249				2022-12-28	WOS:000303498800042
J	Campbell, RJ; Dhalla, IA; Gill, SS; Bell, CM				Campbell, Robert J.; Dhalla, Irfan A.; Gill, Sudeep S.; Bell, Chaim M.			Implications of "not me" drugs for health systems: lessons from age related macular degeneration	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANIBIZUMAB; BEVACIZUMAB; COVERAGE		[Campbell, Robert J.] Hop Hotel Dieu, Dept Ophthalmol, Kingston, ON K7L 5G2, Canada; [Campbell, Robert J.; Gill, Sudeep S.] Queens Univ, Kingston, ON K7L 5G2, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Gill, Sudeep S.] St Marys Lake Hosp, Div Geriatr Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Campbell, RJ (corresponding author), Hop Hotel Dieu, Dept Ophthalmol, 166 Brock St, Kingston, ON K7L 5G2, Canada.	rob.campbell@queensu.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		[Anonymous], 2012, BMJ, V344, pe2959; Aron I, 2009, AVASTIN LUCENTIS UPD; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Campbell RJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P359, DOI 10.1001/archophthalmol.2010.19; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Foote SB, 2004, HEALTH AFFAIR, V23, P108, DOI 10.1377/hlthaff.23.4.108; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Lee TH, 2004, NEW ENGL J MED, V350, P211, DOI 10.1056/NEJMp038215; Levinson DR, 2011, REV MEDICARE B; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; National Institute for Health and Clinical Excellence, 2010, EXPL WORK BEV EYE CO; Pollack A, 2011, NY TIMES        1004; Pollack A, 2009, NY TIMES        1001; Pollack A, 2010, NY TIMES        1103; Pollack A, 2007, NY TIMES        1012; Roche, 2010, FIN REP 2010; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459	21	5	5	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 1	2012	344								e2941	10.1136/bmj.e2941	http://dx.doi.org/10.1136/bmj.e2941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MZ	22549055				2022-12-28	WOS:000303816700013
J	Adler-Milstein, J; Jha, AK				Adler-Milstein, Julia; Jha, Ashish K.			Sharing Clinical Data Electronically A Critical Challenge for Fixing the Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMATION EXCHANGE; HOSPITALS		[Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Sch Med, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA; [Adler-Milstein, Julia] Univ Michigan, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Michigan System; University of Michigan	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Sch Med, 665 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Adler-Milstein J, 2011, AM J MANAG CARE, V17, P761; Adler-Milstein J, 2009, HEALTH AFFAIR, V28, P483, DOI 10.1377/hlthaff.28.2.483; Blumenthal D, 2011, NEW ENGL J MED, V365, P2426, DOI 10.1056/NEJMsr1112158; Grossman Joy M, 2008, Res Brief, P1; Health Information Technology Policy Committee, MEAN US WORKGR REQ C; Kuperman GJ, 2011, J AM MED INFORM ASSN, V18, P678, DOI 10.1136/amiajnl-2010-000021; US Dept of Health and Human Services, STAT HLTH INF EXCH C; Wolf L, 2012, HEALTH AFFAIR, V31, P505, DOI 10.1377/hlthaff.2011.0351	8	50	50	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1695	1696		10.1001/jama.2012.525	http://dx.doi.org/10.1001/jama.2012.525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930OA	22535851				2022-12-28	WOS:000303147500019
J	Liu, L; Johnson, HL; Cousens, S; Perin, J; Scott, S; Lawn, JE; Rudan, I; Campbell, H; Cibulskis, R; Li, MY; Mathers, C; Black, RE				Liu, Li; Johnson, Hope L.; Cousens, Simon; Perin, Jamie; Scott, Susana; Lawn, Joy E.; Rudan, Igor; Campbell, Harry; Cibulskis, Richard; Li, Mengying; Mathers, Colin; Black, Robert E.		WHO; UNICEF	Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000	LANCET			English	Article							DEATHS; COUNTRIES; INTERVENTIONS; PROGRESS; CHINA; GOAL	Background Information about the distribution of causes of and time trends for child mortality should be periodically updated. We report the latest estimates of causes of child mortality in 2010 with time trends since 2000. Methods Updated total numbers of deaths in children aged 0-27 days and 1-59 months were applied to the corresponding country-specific distribution of deaths by cause. We did the following to derive the number of deaths in children aged 1-59 months: we used vital registration data for countries with an adequate vital registration system; we applied a multinomial logistic regression model to vital registration data for low-mortality countries without adequate vital registration; we used a similar multinomial logistic regression with verbal autopsy data for high-mortality countries; for India and China, we developed national models. We aggregated country results to generate regional and global estimates. Findings Of 7.6 million deaths in children younger than 5 years in 2010, 64.0% (4.879 million) were attributable to infectious causes and 40.3% (3.072 million) occurred in neonates. Preterm birth complications (14.1%; 1.078 million, uncertainty range [UR] 0.916-1.325), intrapartum-related complications (9.4%; 0.717 million, 0.610-0.876), and sepsis or meningitis (5.2%; 0.393 million, 0.252-0.552) were the leading causes of neonatal death. In older children, pneumonia (14.1%; 1.071 million, 0.977-1.176), diarrhoea (9.9%; 0.751 million, 0.538-1.031), and malaria (7.4%; 0.564 million, 0.432-0.709) claimed the most lives. Despite tremendous efforts to identify relevant data, the causes of only 2.7% (0.205 million) of deaths in children younger than 5 years were medically certified in 2010. Between 2000 and 2010, the global burden of deaths in children younger than 5 years decreased by 2 million, of which pneumonia, measles, and diarrhoea contributed the most to the overall reduction (0.451 million [0.339-0.547], 0.363 million [0.283-0.419], and 0.359 million [0.215-0.476], respectively). However, only tetanus, measles, AIDS, and malaria (in Africa) decreased at an annual rate sufficient to attain the Millennium Development Goal 4. Interpretation Child survival strategies should direct resources toward the leading causes of child mortality, with attention focusing on infectious and neonatal causes. More rapid decreases from 2010-15 will need accelerated reduction for the most common causes of death, notably pneumonia and preterm birth compli cations. Continued efforts to gather high-quality data and enhance estimation methods are essential for the improvement of future estimates.	[Liu, Li; Johnson, Hope L.; Perin, Jamie; Li, Mengying; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Cousens, Simon; Scott, Susana] London Sch Hyg & Trop Med, London WC1, England; [Lawn, Joy E.] Save Children, Saving Newborn Live, Cape Town, South Africa; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Cibulskis, Richard] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Mathers, Colin] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Save the Children; University of Edinburgh; World Health Organization; World Health Organization	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	rblack@jhsph.edu	Rudan, Igor/I-1467-2012; Theodoratou, Evropi/C-3430-2014; liu, li/HGC-0900-2022; Campbell, Harry/E-2959-2010; pan, tao/O-7308-2014; Lawn, Joy/ABE-6382-2020	Rudan, Igor/0000-0001-6993-6884; Theodoratou, Evropi/0000-0001-5887-9132; Campbell, Harry/0000-0002-6169-6262; Lawn, Joy/0000-0002-4573-1443; Mathers, Colin/0000-0002-0617-6731; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Bill & Melinda Gates Foundation.	Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 2012, LANCET, V379, P385, DOI 10.1016/S0140-6736(12)60169-X; [Anonymous], WHO MORT DAT TABL; [Anonymous], 2008, WORLD MAL REP 2008; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chen S, 2012, J R STAT SOC C-APPL, V61, P117, DOI 10.1111/j.1467-9876.2011.01001.x; China Ministry of Health, 2010, CHIN HLTH STAT YB 20; Cleveland W.S., 1996, P STAT THEORY COMPUT, P10; Commission on information and accountability for Women's and Children's Health, KEEP PROM MEAS RES; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Guillot M., 2001, BASIC CONCEPTS MEASU; Heidelberg Institute on International Conflict Research, 2008, CONFL BAR 2008 17 AN; International Peace Research Institute, UCDP PRIO ARM CONFL; Johnson HL, 2010, INT J EPIDEMIOL, V39, P1103, DOI 10.1093/ije/dyq074; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 4 MILLION NEONATAL D; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Liu L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-43; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Obermeyer Z, 2008, BMJ-BRIT MED J, V336, p1482A, DOI 10.1136/bmj.a137; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Project Ploughshares, 2009, ARM CONFL REP 2008; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; The Countdown Group, 2010, COUNTD 2015 DEC REP; The Inter-Agency Group for Child Mortality Estimation (IGME), EST UND 5 MORT RAT C; UNAIDS, 2010, REP GLOB AIDS EP; UNICEF, LEV TRENDS CHILD MOR; United Nations, 2010, MILL DEV GOALS REP 2; United Nations Childrens Fund, MAT NEWB HLTH DISP C; United Nations Population Division, 2011, WORLD POP PROSP 2010; WHO, 2006, WKLY EPIDEMIOL REC, V81, P208; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X	42	2496	2619	5	303	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2012	379	9832					2151	2161		10.1016/S0140-6736(12)60560-1	http://dx.doi.org/10.1016/S0140-6736(12)60560-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955BA	22579125				2022-12-28	WOS:000304990900031
J	Shoval, O; Sheftel, H; Shinar, G; Hart, Y; Ramote, O; Mayo, A; Dekel, E; Kavanagh, K; Alon, U				Shoval, O.; Sheftel, H.; Shinar, G.; Hart, Y.; Ramote, O.; Mayo, A.; Dekel, E.; Kavanagh, K.; Alon, U.			Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space	SCIENCE			English	Article							GROWTH; SHAPE; SIZE	Biological systems that perform multiple tasks face a fundamental trade-off: A given phenotype cannot be optimal at all tasks. Here we ask how trade-offs affect the range of phenotypes found in nature. Using the Pareto front concept from economics and engineering, we find that best-trade-off phenotypes are weighted averages of archetypes-phenotypes specialized for single tasks. For two tasks, phenotypes fall on the line connecting the two archetypes, which could explain linear trait correlations, allometric relationships, as well as bacterial gene-expression patterns. For three tasks, phenotypes fall within a triangle in phenotype space, whose vertices are the archetypes, as evident in morphological studies, including on Darwin's finches. Tasks can be inferred from measured phenotypes based on the behavior of organisms nearest the archetypes.	[Shoval, O.; Sheftel, H.; Shinar, G.; Hart, Y.; Ramote, O.; Mayo, A.; Dekel, E.; Alon, U.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Kavanagh, K.] Univ Massachusetts Dartmouth, Dept Biol, Dartmouth, MA 02747 USA	Weizmann Institute of Science; University of Massachusetts System; University Massachusetts Dartmouth	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	mayo, avi/N-3756-2019; Hart, Yuval/HGD-6424-2022; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; 	Israel Science Foundation; European Research Council	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank N. Barkai, R. Milo, O. Feinerman, C. Tabin, J. Losos, M. Khammash, T. Dayan, and N. Ulanovski for discussion. U. A. holds the Abisch-Frenkel Professorial Chair; O. S. is an Azrieli Fellow. This work was supported by the Israel Science Foundation and the European Research Council (FP7).	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; El Samad H, 2005, P 16 IFAC WORLD C; FARNSWORTH KD, 1995, FUNCT ECOL, V9, P355, DOI 10.2307/2389997; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Kennedy MC, 2010, ECOL RES, V25, P723, DOI 10.1007/s11284-009-0658-6; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; McGhee GR., 2007, GEOMETRY EVOLUTION A; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Steuer R. E., 1986, MULTIPLE CRITERIA OP; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	19	350	349	6	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1157	1160		10.1126/science.1217405	http://dx.doi.org/10.1126/science.1217405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22539553				2022-12-28	WOS:000304647900049
J	Kenter, MJH; Cohen, AF				Kenter, M. J. H.; Cohen, A. F.			Re-engineering the European Union Clinical Trials Directive	LANCET			English	Editorial Material									[Cohen, A. F.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Cohen, A. F.] Ctr Human Drug Res, NL-2333 CL Leiden, Netherlands; [Kenter, M. J. H.] Cent Comm Res Involving Human Subjects, The Hague, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cohen, AF (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	ac@chdr.nl						Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Central Committee on Research Involving Human Subjects, 2011, ANN REV RES INV HUM; Christina MC, 2002, NEW ENGL J MED, V236, P1405; European Forum for Good Clinical Practice, 2007, INT J PHARM MED, V21, P3; Ghersi D, 2008, IMPACT SHARED SCI ET, DOI [10.1002/14651858.MR000017.pub2, DOI 10.1002/14651858.MR000017.PUB2]; Godlee F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7452; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Kenter MJH, 2009, J ACAD ETHICS, V7, P33, DOI 10.1007/s10805-009-9091-2; Nature, 2006, NATURE, P790; Rawlins M, 2011, LANCET, V377, P190, DOI 10.1016/S0140-6736(10)62315-X	10	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 12	2012	379	9828					1765	1767		10.1016/S0140-6736(12)60430-9	http://dx.doi.org/10.1016/S0140-6736(12)60430-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	941BR	22579309				2022-12-28	WOS:000303937700006
J	Alley, RB; Joughin, I				Alley, Richard B.; Joughin, Ian			Modeling Ice-Sheet Flow	SCIENCE			English	Editorial Material							COLLAPSE; SHELF		[Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Joughin, Ian] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle	Alley, RB (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	rba6@psu.edu; ian@apl.washington.edu	Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X				Albrecht T, 2012, J GLACIOL, V58, P165, DOI 10.3189/2012JoG11J191; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; Held IM, 2005, B AM METEOROL SOC, V86, P1609, DOI 10.1175/BAMS-86-11-1609; Huber M, 2012, NAT GEOSCI, V5, P31, DOI [10.1038/ngeo1327, 10.1038/NGEO1327]; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Larour E, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002140; Leng W, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF001962; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Morlighem M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043853; Pattyn F, 2008, CRYOSPHERE, V2, P95, DOI 10.5194/tc-2-95-2008; Pierrehumbert R. T., 2007, GLOBAL CIRCULATION A, P150; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rutt IC, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001015; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366; Winkelmann R, 2011, CRYOSPHERE, V5, P715, DOI 10.5194/tc-5-715-2011	17	32	32	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					551	552		10.1126/science.1220530	http://dx.doi.org/10.1126/science.1220530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556242				2022-12-28	WOS:000303498800034
J	Bottke, WF; Vokrouhlicky, D; Minton, D; Nesvorny, D; Morbidelli, A; Brasser, R; Simonson, B; Levison, HF				Bottke, William F.; Vokrouhlicky, David; Minton, David; Nesvorny, David; Morbidelli, Alessandro; Brasser, Ramon; Simonson, Bruce; Levison, Harold F.			An Archaean heavy bombardment from a destabilized extension of the asteroid belt	NATURE			English	Article							INNER SOLAR-SYSTEM; ORIGIN; IMPACT; SHERGOTTITE; EVOLUTION; PLANETS; EJECTA; PERIOD; LAYERS; AGES	The barrage of comets and asteroids that produced many young lunar basins (craters over 300 kilometres in diameter) has frequently been called the Late Heavy Bombardment(1) (LHB). Many assume the LHB ended about 3.7 to 3.8 billion years (Gyr) ago with the formation of Orientale basin(2,3). Evidence for LHB-sized blasts on Earth, however, extend into the Archaean and early Proterozoic eons, in the form of impact spherule beds: globally distributed ejecta layers created by Chicxulub-sized or larger cratering events(4). At least seven spherule beds have been found that formed between 3.23 and 3.47 Gyr ago, four between 2.49 and 2.63 Gyr ago, and one between 1.7 and 2.1 Gyr ago(5-9). Here we report that the LHB lasted much longer than previously thought, with most late impactors coming from the E belt, an extended and now largely extinct portion of the asteroid belt between 1.7 and 2.1 astronomical units from Earth. This region was destabilized by late giant planet migration(10-13). E-belt survivors now make up the high-inclination Hungaria asteroids(14,15). Scaling from the observed Hungaria asteroids, we find that E-belt projectiles made about ten lunar basins between 3.7 and 4.1 Gyr ago. They also produced about 15 terrestrial basins between 2.5 and 3.7 Gyr ago, as well as around 70 and four Chicxulub-sized or larger craters on the Earth and Moon, respectively, between 1.7 and 3.7 Gyr ago. These rates reproduce impact spherule bed and lunar crater constraints.	[Bottke, William F.; Vokrouhlicky, David; Minton, David; Nesvorny, David; Morbidelli, Alessandro; Brasser, Ramon; Levison, Harold F.] SW Res Inst, Boulder, CO 80302 USA; [Bottke, William F.; Vokrouhlicky, David; Minton, David; Nesvorny, David; Morbidelli, Alessandro; Brasser, Ramon; Levison, Harold F.] NASA, Lunar Sci Inst, Boulder, CO 80302 USA; [Vokrouhlicky, David] Charles Univ Prague, Inst Astron, CR-18000 Prague 8, Czech Republic; [Minton, David] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Morbidelli, Alessandro; Brasser, Ramon] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Cassiopee, F-06304 Nice 4, France; [Brasser, Ramon] Acad Sinica, Inst Astron & Astrophys, Taipei 106, Taiwan; [Simonson, Bruce] Oberlin Coll, Dept Geol, Oberlin, OH 44074 USA	National Aeronautics & Space Administration (NASA); Charles University Prague; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Academia Sinica - Taiwan; Oberlin College	Bottke, WF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	bottke@boulder.swri.edu	Levison, Harold F/C-6061-2013; Vokrouhlický, David/Q-4359-2017	Levison, Harold F/0000-0001-5847-8099; Vokrouhlický, David/0000-0002-6034-5452; Minton, David A/0000-0003-1656-9704	University of Hawaii; NASA's Lunar Science Institute (Center for Lunar Origin and Evolution) [NNA09DB32A]; Grant Agency of the Czech Republic; Germany's Helmholtz Alliance; NASA [NNX08AI29G]; NASA through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center	University of Hawaii; NASA's Lunar Science Institute (Center for Lunar Origin and Evolution); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Germany's Helmholtz Alliance; NASA(National Aeronautics & Space Administration (NASA)); NASA through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center	We thank B. Cohen, C. Chapman, M. Cuk, L. Dones, D. Kring, S. Marchi, R. Malhotra, M. Norman, E. Scott, J. Taylor and K. Walsh for discussions and comments. We also thank the University of Hawaii for sponsoring W.F.B.'s recent visit, during which these ideas were first developed. This project was supported by NASA's Lunar Science Institute (Center for Lunar Origin and Evolution, grant number NNA09DB32A). D.V.'s contribution was supported by the Grant Agency of the Czech Republic. A. M. and R. B. thank Germany's Helmholtz Alliance for providing support through their "Planetary Evolution and Life" programme. B.S.'s contribution was supported by NASA grant NNX08AI29G. Resources supporting this work were provided by the NASA High-End Computing (HEC) Program through the NASA Advanced Supercomputing (NAS) Division at Ames Research Center.	BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; Bogard DD, 2008, METEORIT PLANET SCI, V43, P1113, DOI 10.1111/j.1945-5100.2008.tb01116.x; Bogard DD, 2011, CHEM ERDE-GEOCHEM, V71, P207, DOI 10.1016/j.chemer.2011.03.001; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; Bottke WF, 2007, ICARUS, V190, P203, DOI 10.1016/j.icarus.2007.02.010; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Glass BP, 2012, ELEMENTS, V8, P43, DOI 10.2113/gselements.8.1.43; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Hassler SW, 2011, GEOLOGY, V39, P307, DOI 10.1130/G31526.1; Kring DA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001529; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Lowe DR, 2003, ASTROBIOLOGY, V3, P7, DOI 10.1089/153110703321632408; LOWE DR, 2010, LUNAR PLANET SCI, V41, P2563; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; MCEWEN AS, 1993, J GEOPHYS RES-PLANET, V98, P17207, DOI 10.1029/93JE01137; Melosh H. J., 1989, IMPACT CRATERING GEO, pCh; Milani A, 2010, ICARUS, V207, P769, DOI 10.1016/j.icarus.2009.12.022; Minton DA, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/53; Minton DA, 2010, ICARUS, V207, P744, DOI 10.1016/j.icarus.2009.12.008; Norman MD, 2010, GEOCHIM COSMOCHIM AC, V74, P763, DOI 10.1016/j.gca.2009.10.024; Simonson BM, 2004, ANNU REV EARTH PL SC, V32, P329, DOI 10.1146/annurev.earth.32.101802.120458; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; Warner BD, 2009, ICARUS, V204, P172, DOI 10.1016/j.icarus.2009.06.004; Wilhelms D. E, 1987, US GEOL SURV PROF PA, V1348, P1987	30	243	251	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					78	81		10.1038/nature10967	http://dx.doi.org/10.1038/nature10967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22535245				2022-12-28	WOS:000303451900037
J	Orme, C; Imaeda, S				Orme, Charisse; Imaeda, Suguru			Eschar Formation from Testosterone Patch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Orme, Charisse; Imaeda, Suguru] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Orme, C (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					E28	E28		10.1056/NEJMicm1111054	http://dx.doi.org/10.1056/NEJMicm1111054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551148				2022-12-28	WOS:000303434300013
J	Lin, SY; Li, TY; Liu, Q; Zhang, CX; Li, XT; Chen, Y; Zhang, SM; Lian, GL; Liu, Q; Ruan, K; Wang, Z; Zhang, CS; Chien, KY; Wu, JW; Li, QX; Han, JH; Lin, SC				Lin, Shu-Yong; Li, Terytty Yang; Liu, Qing; Zhang, Cixiong; Li, Xiaotong; Chen, Yan; Zhang, Shi-Meng; Lian, Guili; Liu, Qi; Ruan, Ka; Wang, Zhen; Zhang, Chen-Song; Chien, Kun-Yi; Wu, Jiawei; Li, Qinxi; Han, Jiahuai; Lin, Sheng-Cai			GSK3-TIP60-ULK1 Signaling Pathway Links Growth Factor Deprivation to Autophagy	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-SURVIVAL; MTOR; PHOSPHORYLATION; INACTIVATION; INHIBITION; INSULIN	In metazoans, cells depend on extracellular growth factors for energy homeostasis. We found that glycogen synthase kinase-3 (GSK3), when deinhibited by default in cells deprived of growth factors, activates acetyltransferase TIP60 through phosphorylating TIP60-Ser(86), which directly acetylates and stimulates the protein kinase ULK1, which is required for autophagy. Cells engineered to express TIP60(S86A) that cannot be phosphorylated by GSK3 could not undergo serum deprivation-induced autophagy. An acetylation-defective mutant of ULK1 failed to rescue autophagy in ULK1(-/-) mouse embryonic fibroblasts. Cells used signaling from GSK3 to TIP60 and ULK1 to regulate autophagy when deprived of serum but not glucose. These findings uncover an activating pathway that integrates protein phosphorylation and acetylation to connect growth factor deprivation to autophagy.	[Lin, Shu-Yong; Li, Terytty Yang; Liu, Qing; Zhang, Cixiong; Li, Xiaotong; Chen, Yan; Lian, Guili; Liu, Qi; Ruan, Ka; Wang, Zhen; Zhang, Chen-Song; Li, Qinxi; Han, Jiahuai; Lin, Sheng-Cai] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Zhang, Shi-Meng] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Chien, Kun-Yi] Chang Gung Univ, Mol Med Res Ctr, Grad Inst Biomed Sci, Coll Med, Tao Yuan 333, Taiwan; [Wu, Jiawei] Tsinghua Univ, Sch Life Sci, Beijing 100101, Peoples R China	Xiamen University; Academy of Military Medical Sciences - China; Chang Gung University; Tsinghua University	Lin, SC (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	linsc@xmu.edu.cn	Lin, SC/G-4666-2010; Li, xiaotong/GYV-4890-2022; Han, J/G-4671-2010; Li, QX/G-4669-2010; Li, Terytty Yang/HCI-2446-2022; Lin, Shu-Yong/B-7726-2012	Li, Terytty Yang/0000-0003-3684-7935; Lin, Shu-Yong/0000-0002-4419-1713	973 Program [2011CB910800]; National Natural Science Foundation of China [31130016, 30921005, 31000621]; Fundamental Research Funds for the Central Universities [2010121094]; Ministry of Education of China [B06016]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China)	We thank D. Luo for help with statistical analyses, M. Kundu and H. Zhang for providing ULK1<SUP>-/-</SUP> and TSC2<SUP>-/-</SUP> MEFs, and B. Viollet and K. R. Laderoute for providing AMPK alpha 1/2-DKO MEFs. This work was supported by grants from the 973 Program (2011CB910800), National Natural Science Foundation of China (31130016, 30921005, and 31000621), Fundamental Research Funds for the Central Universities (2010121094), and the 111 Project of Ministry of Education of China (B06016). S.-C. L. is a Cheung Kong Scholar.	Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	27	245	261	8	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					477	481		10.1126/science.1217032	http://dx.doi.org/10.1126/science.1217032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539723				2022-12-28	WOS:000303233400048
J	Rasmussen, B; Fletcher, IR; Bekker, A; Muhling, JR; Gregory, CJ; Thorne, AM				Rasmussen, Birger; Fletcher, Ian R.; Bekker, Andrey; Muhling, Janet R.; Gregory, Courtney J.; Thorne, Alan M.			Deposition of 1.88-billion-year-old iron formations as a consequence of rapid crustal growth	NATURE			English	Article							BILLION YEARS AGO; CONTINENTAL GROWTH; WESTERN-AUSTRALIA; MANTLE; OCEAN; ZIRCON; TRANSITION; ISOTOPES; PROVINCE; EVENTS	Iron formations are chemical sedimentary rocks comprising layers of iron-rich and silica-rich minerals whose deposition requires anoxic and iron-rich (ferruginous) sea water. Their demise after the rise in atmospheric oxygen by 2.32 billion years (Gyr) ago(1) has been attributed to the removal of dissolved iron through progressive oxidation(2) or sulphidation(3,4) of the deep ocean. Therefore, a sudden return of voluminous iron formations nearly 500 million years later poses an apparent conundrum(3,5). Most late Palaeoproterozoic iron formations are about 1.88 Gyr old(6-8) and occur in the Superior region of North America(5,9,10). Major iron formations are also preserved in Australia, but these were apparently deposited(11) after the transition to a sulphidic ocean at 1.84 Gyr ago that should have terminated iron formation deposition(4), implying that they reflect local marine conditions(5,12). Here we date zircons in tuff layers to show that iron formations in the Frere Formation of Western Australia are about 1.88 Gyr old, indicating that the deposition of iron formations from two disparate cratons was coeval and probably reflects global ocean chemistry. The sudden reappearance of major iron formations at 1.88 Gyr ago-contemporaneous with peaks in global mafic-ultramafic magmatism(13,14), juvenile continental and oceanic crust formation(15,16), mantle depletion(17,18) and volcanogenic massive sulphide formation(5,19)-suggests deposition of iron formations as a consequence of major mantle activity and rapid crustal growth(5,10,15,20). Our findings support the idea that enhanced submarine volcanism and hydrothermal activity linked to a peak in mantle melting released large volumes of ferrous iron and other reductants that overwhelmed the sulphate and oxygen reservoirs of the ocean, decoupling atmospheric and seawater redox states, and causing the return of widespread ferruginous conditions. Iron formations formed on clastic-starved coastal shelves where dissolved iron upwelled and mixed with oxygenated surface water. The disappearance of iron formations after this event may reflect waning mafic-ultramafic magmatism and a diminished flux of hydrothermal iron relative to seawater oxidants.	[Rasmussen, Birger; Fletcher, Ian R.; Gregory, Courtney J.] Curtin Univ Technol, Dept Appl Geol, Bentley, WA 6102, Australia; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada; [Muhling, Janet R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia; [Thorne, Alan M.] Geol Survey Western Australia, Dept Mines & Petr, Perth, WA 6004, Australia	Curtin University; University of Manitoba; University of Western Australia; Geological Survey of Western Australia	Rasmussen, B (corresponding author), Curtin Univ Technol, Dept Appl Geol, Kent St, Bentley, WA 6102, Australia.	b.rasmussen@curtin.edu.au	Muhling, Janet/C-4687-2011	Muhling, Janet/0000-0003-1890-9119; Bekker, Andrey/0000-0002-1154-0585; Rasmussen, Birger/0000-0002-2745-0904	ARC; Western Australian government; NSERC	ARC(Australian Research Council); Western Australian government; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an ARC Linkage Grant and the Western Australian government Exploration Incentive Scheme Grant to B. R., I. R. F., J.R.M., C.J.G. and A. M. T. A. B. was supported by a NSERC Discovery Grant. A. M. T. publishes with the permission of the Executive Director of the Geological Survey of Western Australia (GSWA). We thank P. Fralick for comments. Scanning electron microscopy imaging was performed at the Centre for Microscopy, Characterisation and Analysis at the University of Western Australia. Zircon U-Th-Pb analyses were conducted using the SHRIMP ion microprobe of the John de Laeter Centre at Curtin University, Perth, Australia.	Addison WD, 2005, GEOLOGY, V33, P193, DOI 10.1130/G21048.1; [Anonymous], 2005, EC GEOL; Barley ME, 1997, NATURE, V385, P55, DOI 10.1038/385055a0; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Condie KC, 2002, J GEODYN, V34, P249, DOI 10.1016/S0264-3707(02)00023-6; FINDLAY JM, 1995, CAN J EARTH SCI, V32, P1208, DOI 10.1139/e95-099; Fralick P, 2002, CAN J EARTH SCI, V39, P1085, DOI 10.1139/E02-028; Gross G.A., 2009, 5987 GEOL SURV CAN, V5987; Heaman LM, 2009, PRECAMBRIAN RES, V172, P143, DOI 10.1016/j.precamres.2009.03.015; Holland HD., 1984, CHEM EVOLUTION ATMOS; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Meert JG, 2011, GONDWANA RES, V20, P335, DOI 10.1016/j.gr.2011.03.005; Parman SW, 2007, NATURE, V446, P900, DOI 10.1038/nature05691; Pearson DG, 2007, NATURE, V449, P202, DOI 10.1038/nature06122; Pirajno F, 2009, EARTH-SCI REV, V94, P39, DOI 10.1016/j.earscirev.2009.03.003; Planavsky N, 2010, GEOCHIM COSMOCHIM AC, V74, P6387, DOI 10.1016/j.gca.2010.07.021; Planavsky N, 2009, EARTH PLANET SC LETT, V286, P230, DOI 10.1016/j.epsl.2009.06.033; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Pufahl PK, 2010, GEOLOGY, V38, P659, DOI 10.1130/G30747.1; Rasmussen B, 2002, EARTH PLANET SC LETT, V197, P287, DOI 10.1016/S0012-821X(02)00501-0; Rasmussen B, 2010, GEOLOGY, V38, P299, DOI 10.1130/G30567.1; Schneider DA, 2002, CAN J EARTH SCI, V39, P999, DOI 10.1139/E02-016	30	85	94	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					498	501		10.1038/nature11021	http://dx.doi.org/10.1038/nature11021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538613				2022-12-28	WOS:000303200400047
J	Gwatkin, DR				Gwatkin, Davidson R.			Paying for health care: moving beyond the user-fee debate	LANCET			English	Editorial Material							BENEFITS; AFRICA		Results Dev Inst, Washington, DC 20005 USA		Gwatkin, DR (corresponding author), Results Dev Inst, Washington, DC 20005 USA.	dgwatkin@resultsfordevelopment.org						Akazili J, 2012, HEALTH POLICY PLANN, V27, pi13, DOI 10.1093/heapol/czs004; Ataguba JE, 2012, HEALTH POLICY PLANN, V27, pi35, DOI 10.1093/heapol/czs005; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Mills A, 2012, LANCET, DOI 10.1016/S0140-6736(12)60357-2; Mtei G, 2012, HEALTH POLICY PLANN, V27, pi23, DOI 10.1093/heapol/czs018; O'Donnell O, 2005, 3 EQ PROJ; PAHO (Pan American Health Organization), 2001, INV HLTH SOC EC RET; Van de Walle N, 1995, PUBLIC SPENDING POOR	9	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					88	90		10.1016/S0140-6736(12)60684-9	http://dx.doi.org/10.1016/S0140-6736(12)60684-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22591541				2022-12-28	WOS:000306359100012
J	Gontan, C; Achame, EM; Demmers, J; Barakat, TS; Rentmeester, E; van IJcken, W; Grootegoed, JA; Gribnau, J				Gontan, Cristina; Achame, Eskeatnaf Mulugeta; Demmers, Jeroen; Barakat, Tahsin Stefan; Rentmeester, Eveline; van IJcken, Wilfred; Grootegoed, J. Anton; Gribnau, Joost			RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation	NATURE			English	Article							CELLS; GENE; PLURIPOTENCY; REX1/ZFP42; ACTIVATOR; MOTIFS; YY1	Evolution of the mammalian sex chromosomes has resulted in a heterologous X and Y pair, where the Y chromosome has lost most of its genes. Hence, there is a need for X-linked gene dosage compensation between XY males and XX females. In placental mammals, this is achieved by random inactivation of one X chromosome in all female somatic cells(1). Upregulation of Xist transcription on the future inactive X chromosome acts against Tsix antisense transcription, and spreading of Xist RNA in cis triggers epigenetic changes leading to X-chromosome inactivation. Previously, we have shown that the X-encoded E3 ubiquitin ligase RNF12 is upregulated in differentiating mouse embryonic stem cells and activates Xist transcription and X-chromosome inactivation(2). Here we identify the pluripotency factor REX1 as a key target of RNF12 in the mechanism of X-chromosome inactivation. RNF12 causes ubiquitination and proteasomal degradation of REX1, and Rnf12 knockout embryonic stem cells show an increased level of REX1. Using chromatin immunoprecipitation sequencing, REX1 binding sites were detected in Xist and Tsix regulatory regions. Overexpression of REX1 in female embryonic stem cells was found to inhibit Xist transcription and X-chromosome inactivation, whereas male Rex1(+/-) embryonic stem cells showed ectopic X-chromosome inactivation. From this, we propose that RNF12 causes REX1 breakdown through dose-dependent catalysis, thereby representing an important pathway to initiate X-chromosome inactivation. Rex1 and Xist are present only in placental mammals, which points to co-evolution of these two genes and X-chromosome inactivation.	[Gontan, Cristina; Achame, Eskeatnaf Mulugeta; Barakat, Tahsin Stefan; Rentmeester, Eveline; Grootegoed, J. Anton; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Univ Med Ctr, Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [van IJcken, Wilfred] Univ Med Ctr, Erasmus MC, Bi Dept, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl	van ijcken, willem/N-9805-2018; Barakat, Stefan/X-8234-2019; Demmers, Jeroen AA/F-4046-2016; Mulugeta, Eskeatnaf/H-2640-2016; Mulugeta, Eskeatnaf/AAZ-7471-2020	van ijcken, willem/0000-0002-0421-8301; Barakat, Stefan/0000-0003-1231-1562; Demmers, Jeroen AA/0000-0002-8757-9611; Mulugeta, Eskeatnaf/0000-0003-4045-4835; Mulugeta, Eskeatnaf/0000-0003-4045-4835; Gontan, Cristina/0000-0002-3918-0024	Netherlands Organisation for Scientific Research (NWO-TOP); Netherlands Organisation for Scientific Research (NWO-VICI); European Research Council	Netherlands Organisation for Scientific Research (NWO-TOP)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank R. van der Linden and C. Maduro for their help with some of the experiments, A. Inagaki, C. Andrieu-Soler, D. Warmerdam, L. Zhang and A. Mohd-Sarip for experimental advice, and C. Rougeulle and R. Jaenisch for providing the Tsix-stop cells. This work was supported by grants from the Netherlands Organisation for Scientific Research (NWO-TOP and NWO-VICI) and the European Research Council to J.G.	Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Do Kim J, 2011, HUM MOL GENET, V20, P1353, DOI 10.1093/hmg/ddr017; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Monkhorst K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005616; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Soler E, 2011, METHODS, V53, P151, DOI 10.1016/j.ymeth.2010.08.002; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014	17	149	152	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					386	U138		10.1038/nature11070	http://dx.doi.org/10.1038/nature11070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596162				2022-12-28	WOS:000304099100046
J	Granier, S; Manglik, A; Kruse, AC; Kobilka, TS; Thian, FS; Weis, WI; Kobilka, BK				Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.			Structure of the delta-opioid receptor bound to naltrindole	NATURE			English	Article							SELECTIVITY; PEPTIDE; SITE; MUTAGENESIS; LIGANDS	The opioid receptor family comprises three members, the mu-, delta- and kappa-opioid receptors, which respond to classical opioid alkaloids such as morphine and heroin as well as to endogenous peptide ligands like endorphins. They belong to the G-protein-coupled receptor (GPCR) superfamily, and are excellent therapeutic targets for pain control. The delta-opioid receptor (delta-OR) has a role in analgesia, as well as in other neurological functions that remain poorly understood(1). The structures of the mu-OR and kappa-OR have recently been solved(2,3). Here we report the crystal structure of the mouse d delta-OR, bound to the subtype-selective antagonist naltrindole. Together with the structures of the mu-OR and kappa-OR, the delta-OR structure provides insights into conserved elements of opioid ligand recognition while also revealing structural features associated with ligand-subtype selectivity. The binding pocket of opioid receptors can be divided into two distinct regions. Whereas the lower part of this pocket is highly conserved among opioid receptors, the upper part contains divergent residues that confer subtype selectivity. This provides a structural explanation and validation for the 'message-address' model of opioid receptor pharmacology(4,5), in which distinct 'message' (efficacy) and 'address' (selectivity) determinants are contained within a single ligand. Comparison of the address region of the delta-OR with other GPCRs reveals that this structural organization may be a more general phenomenon, extending to other GPCR families as well.	[Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Granier, Sebastien] CNRS, UMR 5203, F-34094 Montpellier, France; [Granier, Sebastien] INSERM, U661, F-34094 Montpellier, France; [Granier, Sebastien] Univ Montpellier I, Inst Genom Fonctionnelle, F-34094 Montpellier, France; [Granier, Sebastien] Univ Montpellier 2, Inst Genom Fonctionnelle, F-34094 Montpellier, France; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Stanford University	Granier, S (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	granier@stanford.edu; kobilka@stanford.edu	Granier, Sebastien/J-1089-2016; Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990	INSERM; Stanford Medical Scientist Training Program; National Science Foundation; National Institutes of Health [NS028471, DA031418]; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031418] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Stanford Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Sunahara for helpful suggestions on opioid receptor pharmacology and biochemistry. We acknowledge support from INSERM (S. G.), the Stanford Medical Scientist Training Program (A. M.), the National Science Foundation (A. C. K.), National Institutes of Health grants NS028471 (B. K. K.) and DA031418 (B. K. K.), and from the Mathers Foundation (B. K. K. and W.I.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox B. M., 2009, OPIOID RECEPTORS INT; Eguchi M, 2004, MED RES REV, V24, P182, DOI 10.1002/med.10059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; LIPKOWSKI AW, 1986, J MED CHEM, V29, P1222, DOI 10.1021/jm00157a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng F, 1998, MOL PHARMACOL, V53, P772, DOI 10.1124/mol.53.4.772; Metzger TG, 2001, J MED CHEM, V44, P857, DOI 10.1021/jm000381r; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pepin MC, 1997, J BIOL CHEM, V272, P9260; PORTOGHESE PS, 1980, J MED CHEM, V23, P233, DOI 10.1021/jm00177a002; PORTOGHESE PS, 1988, J MED CHEM, V31, P281, DOI 10.1021/jm00397a001; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Satoh M, 1995, PHARMACOL THERAPEUT, V68, P343, DOI 10.1016/0163-7258(95)02011-X; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; XUE JC, 1994, J BIOL CHEM, V269, P30195	24	518	531	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					400	U171		10.1038/nature11111	http://dx.doi.org/10.1038/nature11111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596164	Green Accepted			2022-12-28	WOS:000304099100049
J	Hoffmann, T; Erueti, C; Thorning, S; Glasziou, P				Hoffmann, Tammy; Erueti, Chrissy; Thorning, Sarah; Glasziou, Paul			The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EVIDENCE DATABASE; PHYSICIANS; READ	Objective To estimate the degree of scatter of reports of randomised trials and systematic reviews, and how the scatter differs among medical specialties and subspecialties. Design Cross sectional analysis. Data source PubMed for all disease relevant randomised trials and systematic reviews published in 2009. Study selection Randomised trials and systematic reviews of the nine diseases or disorders with the highest burden of disease, and the broader category of disease to which each belonged. Results The scatter across journals varied considerably among specialties and subspecialties: otolaryngology had the least scatter (363 trials across 167 journals) and neurology the most (2770 trials across 896 journals). In only three subspecialties (lung cancer, chronic obstructive pulmonary disease, hearing loss) were 10 or fewer journals needed to locate 50% of trials. The scatter was less for systematic reviews: hearing loss had the least scatter (10 reviews across nine journals) and cancer the most (670 reviews across 279 journals). For some specialties and subspecialties the papers were concentrated in specialty journals; whereas for others, few of the top 10 journals were a specialty journal for that area. Generally, little overlap occurred between the top 10 journals publishing trials and those publishing systematic reviews. The number of journals required to find all trials or reviews was highly correlated (r=0.97) with the number of papers for each specialty/subspecialty. Conclusions Publication rates of speciality relevant trials vary widely, from one to seven trials per day, and are scattered across hundreds of general and specialty journals. Although systematic reviews reduce the extent of scatter, they are still widely scattered and mostly in different journals to those of randomised trials. Personal subscriptions to journals, which are insufficient for keeping up to date with knowledge, need to be supplemented by other methods such as journal scanning services or systems that cover sufficient journals and filter articles for quality and relevance. Few current systems seem adequate.	[Hoffmann, Tammy; Erueti, Chrissy; Thorning, Sarah; Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia	Bond University	Hoffmann, T (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	Tammy_Hoffmann@bond.edu.au	Hoffmann, Tammy/E-8029-2010; Glasziou, Paul/A-7832-2008	Hoffmann, Tammy/0000-0001-5210-8548; Glasziou, Paul/0000-0001-7564-073X; Thorning, Sarah/0000-0002-3476-9796	National Health and Medical Research Council of Australia (NHMRC) [1033038, 527500]; Australian Department of Health and Ageing	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	TH is supported by a National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development career development fellowship (No 1033038) with funding provided by the Australian Department of Health and Ageing. PG is supported by a NHMRC Australia fellowship (No 527500). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, and approval of the manuscript.	Bailey P, 2011, NEUROLOGY, V76, P18, DOI 10.1212/WNL.0b013e3182068bf1; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Bennett S, 2003, AM J OCCUP THER, V57, P635, DOI 10.5014/ajot.57.6.635; Bennett S, 2007, INT J MED INFORM, V76, P507, DOI 10.1016/j.ijmedinf.2006.02.005; Booth A, 2011, LANCET, V377, P108, DOI 10.1016/S0140-6736(10)60903-8; BRADFORD SC, 1985, J INFORM SCI, V10, P176; Burke DT, 2004, AM J PHYS MED REHAB, V83, P551, DOI 10.1097/01.PHM.0000130035.54932.B9; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Garg AX, 2006, KIDNEY INT, V70, P1995, DOI 10.1038/sj.ki.5001896; Gesme DH, 2011, J ONCOL PRACT, V7, P199, DOI 10.1200/JOP.2011.000292; Grad R, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1683; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Jones T, 2004, BRIT J PSYCHIAT, V185, P251, DOI 10.1192/bjp.185.3.251; Jones Teresa H, 2007, BMC Pediatr, V7, P1, DOI 10.1186/1471-2431-7-1; Jones Teresa H, 2006, BMC Med Inform Decis Mak, V6, P24, DOI 10.1186/1472-6947-6-24; Mabe M., 2003, SERIALS, V16, P191, DOI [DOI 10.1629/16191, 10.1629/16191]; Mariani L, 2000, J CLIN ONCOL, V18, P429, DOI 10.1200/JCO.2000.18.2.429; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McKibbon KA, 2007, J MED LIBR ASSOC, V95, P246, DOI 10.3163/1536-5050.95.3.246; McKibbon KA, 2009, HEALTH INFO LIBR J, V26, P187, DOI 10.1111/j.1471-1842.2008.00827.x; McKinlay RJ, 2008, J CLIN EPIDEMIOL, V61, P449, DOI 10.1016/j.jclinepi.2007.10.016; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Schein, 2000, Curr Surg, V57, P252, DOI 10.1016/S0149-7944(00)00177-X; Sherrington C, 2000, MANUAL THER, V5, P223, DOI 10.1054/math.2000.0372; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849; Tenopir C, 2007, J MED LIBR ASSOC, V95, P56; Tricco AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003684; Tsay MY, 2005, J MED LIBR ASSOC, V93, P450	28	32	32	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2012	344								e3223	10.1136/bmj.e3223	http://dx.doi.org/10.1136/bmj.e3223			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946NT	22597353	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000304359400002
J	Homma, S; Thompson, JLP; Pullicino, PM; Levin, B; Freudenberger, RS; Teerlink, JR; Ammon, SE; Graham, S; Sacco, RL; Mann, DL; Mohr, JP; Massie, BM; Labovitz, AJ; Anker, SD; Lok, DJ; Ponikowski, P; Estol, CJ; Lip, GYH; Di Tullio, MR; Sanford, AR; Mejia, V; Gabriel, AP; del Valle, ML; Buchsbaum, R				Homma, Shunichi; Thompson, John L. P.; Pullicino, Patrick M.; Levin, Bruce; Freudenberger, Ronald S.; Teerlink, John R.; Ammon, Susan E.; Graham, Susan; Sacco, Ralph L.; Mann, Douglas L.; Mohr, J. P.; Massie, Barry M.; Labovitz, Arthur J.; Anker, Stefan D.; Lok, Dirk J.; Ponikowski, Piotr; Estol, Conrado J.; Lip, Gregory Y. H.; Di Tullio, Marco R.; Sanford, Alexandra R.; Mejia, Vilma; Gabriel, Andre P.; del Valle, Mirna L.; Buchsbaum, Richard		WARCEF Investigators	Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTITHROMBOTIC THERAPY; RANDOMIZED-TRIAL; DOUBLE-BLIND; ANTICOAGULATION; STROKE; PREVENTION; ENALAPRIL; SURVIVAL; DEATH; RISK	BACKGROUND It is unknown whether warfarin or aspirin therapy is superior for patients with heart failure who are in sinus rhythm. METHODS We designed this trial to determine whether warfarin (with a target international normalized ratio of 2.0 to 3.5) or aspirin (at a dose of 325 mg per day) is a better treatment for patients in sinus rhythm who have a reduced left ventricular ejection fraction (LVEF). We followed 2305 patients for up to 6 years (mean [+/- SD], 3.5 +/- 1.8). The primary outcome was the time to the first event in a composite end point of ischemic stroke, intracerebral hemorrhage, or death from any cause. RESULTS The rates of the primary outcome were 7.47 events per 100 patient-years in the warfarin group and 7.93 in the aspirin group (hazard ratio with warfarin, 0.93; 95% confidence interval [CI], 0.79 to 1.10; P=0.40). Thus, there was no significant overall difference between the two treatments. In a time-varying analysis, the hazard ratio changed over time, slightly favoring warfarin over aspirin by the fourth year of follow-up, but this finding was only marginally significant (P=0.046). Warfarin, as compared with aspirin, was associated with a significant reduction in the rate of ischemic stroke throughout the follow-up period (0.72 events per 100 patient-years vs. 1.36 per 100 patient-years; hazard ratio, 0.52; 95% CI, 0.33 to 0.82; P=0.005). The rate of major hemorrhage was 1.78 events per 100 patient-years in the warfarin group as compared with 0.87 in the aspirin group (P<0.001). The rates of intracerebral and intracranial hemorrhage did not differ significantly between the two treatment groups (0.27 events per 100 patient-years with warfarin and 0.22 with aspirin, P=0.82). CONCLUSIONS Among patients with reduced LVEF who were in sinus rhythm, there was no significant overall difference in the primary outcome between treatment with warfarin and treatment with aspirin. A reduced risk of ischemic stroke with warfarin was offset by an increased risk of major hemorrhage. The choice between warfarin and aspirin should be individualized.	[Homma, Shunichi; Thompson, John L. P.; Levin, Bruce; Mohr, J. P.; Di Tullio, Marco R.; Sanford, Alexandra R.; Mejia, Vilma; Gabriel, Andre P.; del Valle, Mirna L.; Buchsbaum, Richard] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Pullicino, Patrick M.] Univ Kent, Canterbury, Kent, England; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Freudenberger, Ronald S.] Lehigh Valley Hosp, Allentown, PA USA; [Teerlink, John R.; Massie, Barry M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Teerlink, John R.; Ammon, Susan E.; Massie, Barry M.] San Francisco VA Med Ctr, San Francisco, CA USA; [Graham, Susan] SUNY Buffalo, Buffalo, NY 14260 USA; [Sacco, Ralph L.] Univ Miami, Miami, FL USA; [Mann, Douglas L.] Washington Univ, St Louis, MO 63130 USA; [Labovitz, Arthur J.] Univ S Florida, Tampa, FL USA; [Anker, Stefan D.] Charite, D-13353 Berlin, Germany; [Anker, Stefan D.] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy; [Lok, Dirk J.] Hosp Deventer, Deventer, Netherlands; [Ponikowski, Piotr] Mil Hosp, Wroclaw, Poland; [Estol, Conrado J.] Ctr Neurol Tratamiento & Rehabil, Buenos Aires, DF, Argentina	Columbia University; University of Kent; University of Birmingham; Lehigh Valley Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Miami; Washington University (WUSTL); State University System of Florida; University of South Florida; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Deventer Hospital	Homma, S (corresponding author), Columbia Univ, Med Ctr, PH 3-342,622 W 168th St, New York, NY 10032 USA.		pullicino, Patrick/AAO-9018-2021; Sacco, Ralph/Y-9278-2019; Arenberger, Petr/C-7481-2018; Ponikowski, Piotr/O-6454-2015; Teerlink, John R/D-2986-2012; Mann, Douglas Lowell/AAQ-3524-2021; Mohr, J/AAO-9694-2020; Kozhukhov, Sergey/E-6498-2018; Mauceri, Daniela/C-4969-2014	Arenberger, Petr/0000-0002-4800-5877; Ponikowski, Piotr/0000-0002-3391-7064; Gutmann, Laurie/0000-0003-3926-4209; Mann, Douglas/0000-0002-2516-0145; Kovalenko, Volodymyr/0000-0003-3802-9207; Kozhukhov, Sergey/0000-0002-7973-7894; Kohsaka, Shun/0000-0003-3779-2972; Krobot, Zdenek/0000-0002-7911-5577; Kolomiets, Sergiy/0000-0002-3095-7386; Burgin, William/0000-0001-5376-8302; Mauceri, Daniela/0000-0003-1225-4633; Bozkurt, Biykem/0000-0002-6362-0253; Del Valle, Mirna L./0000-0003-2030-2762; Boehmer, John/0000-0002-8024-1589	National Institute of Neurological Disorders and Stroke [U01-NS-043975, U01-NS-039143]; St. Jude Medical; Boehringer Ingelheim; United Healthcare; Amgen; Cytokinetics; Novartis; NovaCardia/Merck; American College of Cardiology; Bosch Healthcare; GlaxoSmithKline; Helsinn; LoneStar Heart; Professional Dietetics; PsiOxus; Relypsa; SHL Telemedicine; Thermo Fisher; Vifor Pharma; Bayer; Coridea; Corthera; Johnson Johnson; Pfizer; Respicardia; Abbott; Merck Serono; Sanofi-Aventis; Servier; Astellas; AstraZeneca; Biotronik; Bristol-Myers Squibb; Merck; Portola; National Institute of Neurological Disorders and Stroke; WARCEF [NCT00041938]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS043975, U01NS039143, R01NS053716] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); St. Jude Medical(St. Jude Medical); Boehringer Ingelheim(Boehringer Ingelheim); United Healthcare; Amgen(Amgen); Cytokinetics; Novartis(Novartis); NovaCardia/Merck(Merck & Company); American College of Cardiology(General Electric); Bosch Healthcare; GlaxoSmithKline(GlaxoSmithKline); Helsinn; LoneStar Heart; Professional Dietetics; PsiOxus; Relypsa; SHL Telemedicine; Thermo Fisher; Vifor Pharma; Bayer(Bayer AG); Coridea; Corthera; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Pfizer(Pfizer); Respicardia; Abbott(Abbott Laboratories); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Biotronik; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck(Merck & Company); Portola; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); WARCEF; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke; WARCEF ClinicalTrials.gov number, NCT00041938.; Supported by grants (U01-NS-043975 [to Dr. Homma] and U01-NS-039143 [to Dr. Thompson]) from the National Institute of Neurological Disorders and Stroke.; Dr. Homma reports receiving payment from AGA Medical (now St. Jude Medical) for his work as a member of a data and safety monitoring board and consulting fees from Boehringer Ingelheim; Dr. Levin, receiving consulting fees from United Healthcare; Dr. Teerlink, receiving consulting fees from Amgen and grant support from Amgen, Cytokinetics, and Novartis on behalf of himself and from NovaCardia/Merck on behalf of himself and his institution; Dr. Graham, owning stock in March Pharmaceuticals, Medtronic, and Pfizer; Dr. Labovitz, receiving grant support from Boehringer Ingelheim on behalf of his institution, lecture fees from Boehringer Ingelheim, and fees for the development of educational presentations from the American College of Cardiology; Dr. Anker, receiving consulting fees from Amgen, Bosch Healthcare, GlaxoSmithKline, Helsinn, LoneStar Heart, Novartis, Professional Dietetics, PsiOxus, Relypsa, SHL Telemedicine, and Thermo Fisher, grant support from Vifor Pharma, and lecture fees from Novartis, holding patents with Brahms AG and Charite Berlin, and receiving royalties from Imperial College; Dr. Ponikowski, receiving consulting fees from Bayer, Boehringer Ingelheim, Coridea, Corthera, Johnson & Johnson, Pfizer, Respicardia, and Vifor Pharma, grant support from Vifor Pharma on behalf of himself and his institution, and lecture fees from Abbott, Boehringer Ingelheim, Merck Serono, Pfizer, Respicardia, Sanofi-Aventis, Servier, and Vifor Pharma; and Dr. Lip, receiving consulting fees from Astellas, AstraZeneca, Bayer, Biotronik, Boehringer Inhelheim, Bristol-Myers Squibb, Pfizer, Merck, Portola, and Sanofi-Aventis, speakers bureau fees from Bayer, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Sanofi-Aventis, and payment for the development of educational presentations from Bayer, Boehringer Ingelheim, and Merck. No other potential conflict of interest relevant to this article was reported.	Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P749, DOI 10.1016/S0735-1097(98)00006-0; ANDERSON GM, 1950, AM HEART J, V39, P697, DOI 10.1016/0002-8703(50)90129-3; Cleland JGF, 2004, AM HEART J, V148, P157, DOI 10.1016/j.ahj.2004.03.010; Cokkinos DV, 2006, EUR J HEART FAIL, V8, P428, DOI 10.1016/j.ejheart.2006.02.012; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DUNKMAN WB, 1993, CIRCULATION, V87, P94; Ezekowitz M, 1998, LANCET, V351, P1904, DOI 10.1016/S0140-6736(05)78610-4; Freudenberger RS, 2007, CIRCULATION, V115, P2637, DOI 10.1161/CIRCULATIONAHA.106.661397; Freudenberger RS, 2006, NAT CLIN PRACT CARD, V3, P580, DOI 10.1038/ncpcardio0688; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; GRIFFITH GC, 1952, ANN INTERN MED, V37, P867, DOI 10.7326/0003-4819-37-5-867; HALL D, 1992, J AM COLL CARDIOL, V20, P1549, DOI 10.1016/0735-1097(92)90449-W; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; HARVEY WP, 1950, NEW ENGL J MED, V242, P208, DOI 10.1056/NEJM195002092420603; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Kalaria VG, 1998, AM HEART J, V135, P215, DOI 10.1016/S0002-8703(98)70084-5; Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424; Loh E, 1997, NEW ENGL J MED, V336, P251, DOI 10.1056/NEJM199701233360403; Massie BM, 2009, CIRCULATION, V119, P1616, DOI 10.1161/CIRCULATIONAHA.108.801753; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pullicino P, 2006, J CARD FAIL, V12, P39, DOI 10.1016/j.cardfail.2005.07.007; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Spaulding C, 1998, CIRCULATION, V98, P757, DOI 10.1161/01.CIR.98.8.757; THOMPSON JLP, 1994, ANN NEUROL, V36, P305; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6	28	367	379	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1859	1869		10.1056/NEJMoa1202299	http://dx.doi.org/10.1056/NEJMoa1202299			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22551105	Green Accepted			2022-12-28	WOS:000304083000005
J	Kosa, T; Sukhomlinova, L; Su, LL; Taheri, B; White, TJ; Bunning, TJ				Kosa, Tamas; Sukhomlinova, Ludmila; Su, Linli; Taheri, Bahman; White, Timothy J.; Bunning, Timothy J.			Light-induced liquid crystallinity	NATURE			English	Article							PHASE; NAPHTHOPYRAN	Liquid crystals are traditionally classified as thermotropic, lyotropic or polymeric, based on the stimulus that governs the organization and order of the molecular system(1). The most widely known and applied class of liquid crystals are a subset of thermotropic liquid crystals known as calamitic, in which adding heat can result in phase transitions from or into the nematic, cholesteric and smectic mesophases. Photoresponsive liquid-crystal materials and mixtures can undergo isothermal phase transitions if light affects the order parameter of the system within a mesophase sufficiently. In nearly all previous examinations, light exposure of photoresponsive liquid-crystal materials and mixtures resulted in order-decreasing photo-induced isothermal phase transitions(2). Under specialized conditions, an increase in order with light exposure has been reported, despite the tendency of the photoresponsive liquid-crystal system to reduce order in the exposed state(3-7). A direct, photoinduced transition from the isotropic to the nematic phase has been observed in a mixture of spiropyran molecules and a nematic liquid crystal(8). Here we report a class of naphthopyran-based materials that exhibit photo-induced conformational changes in molecular structure capable of yielding order-increasing phase transitions. Appropriate functionalization of the naphthopyran molecules leads to an exceedingly large order parameter in the open form, which results in a clear to strongly absorbing dichroic state. The increase in order with light exposure has profound implications in optics, photonics, lasing and displays and will merit further consideration for applications in solar energy harvesting. The large, photoinduced dichroism exhibited by the material system has been long sought in ophthalmic applications such as photochromic and polarized variable transmission sunglasses.	[Kosa, Tamas; Sukhomlinova, Ludmila; Su, Linli; Taheri, Bahman] Alpha Micron Inc, Kent, OH 44240 USA; [White, Timothy J.; Bunning, Timothy J.] Mat & Mfg Directorate, AF Res Lab, Wright Patterson AFB, OH 45433 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Kosa, T (corresponding author), Alpha Micron Inc, Kent, OH 44240 USA.	tamas@alphamicron.com; timothy.white2@wpafb.af.mil	White, Timothy J/D-4392-2012; White, Timothy/O-7797-2019	White, Timothy J/0000-0001-8006-7173; White, Timothy/0000-0001-8006-7173	US Air Force Office of Scientific Research; Materials and Manufacturing Directorate of the US Air Force Office of Scientific Research; US Air Force [FA8650-05-D-5807]	US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Materials and Manufacturing Directorate of the US Air Force Office of Scientific Research; US Air Force(United States Department of Defense)	T.J.W. and T.J.B. were supported by the US Air Force Office of Scientific Research and the Materials and Manufacturing Directorate of the US Air Force Office of Scientific Research. T. K., L. Sukhomlinova, L. Su and B. T acknowledge partial support through US Air Force contract FA8650-05-D-5807.	Collings P. J., 1997, INTRO LIQUID CRYSTAL; Frigoli M, 2004, CHEM COMMUN, P2040, DOI 10.1039/b407561g; IKEDA T, 1995, SCIENCE, V268, P1873, DOI 10.1126/science.268.5219.1873; KURIHARA S, 1991, J CHEM SOC FARADAY T, V87, P3251, DOI 10.1039/ft9918703251; Maafi M, 2005, INT J CHEM KINET, V37, P717, DOI 10.1002/kin.20130; Ortica F, 2002, PHOTOCH PHOTOBIO SCI, V1, P803, DOI 10.1039/b205654b; Prasad SK, 2007, J PHYS CHEM B, V111, P345, DOI 10.1021/jp066404g; Prasad SK, 2005, ADV MATER, V17, P2086, DOI 10.1002/adma.200500161; Serak SV, 2007, J NONLINEAR OPT PHYS, V16, P471, DOI 10.1142/S0218863507003895; SHRAGINA L, 1990, LIQ CRYST, V7, P643, DOI 10.1080/02678299008036748; Zalar B, 2000, PHYS REV E, V62, P2252, DOI 10.1103/PhysRevE.62.2252	11	124	126	7	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					347	349		10.1038/nature11122	http://dx.doi.org/10.1038/nature11122			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596158				2022-12-28	WOS:000304099100037
J	Aung, K				Aung, KoKo			Review: Vitamin D supplementation improves some balance measures but not muscle strength in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Aung, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.		Aung, KoKo/I-1236-2019					Badgett R, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6126; IOM, 2011, DIET REF INT CALC VI; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-8	10.7326/0003-4819-156-10-201205150-02008	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586026				2022-12-28	WOS:000304193400007
J	Eck, MJ; Hahn, WC				Eck, Michael J.; Hahn, William C.			EGFR in Limbo	CELL			English	Editorial Material							GROWTH-FACTOR RECEPTOR; KINASE DOMAIN; LUNG-CANCER; ACTIVATION; INHIBITOR; CONTRIBUTES; MUTATIONS; MECHANISM	The epidermal growth factor receptor (EGFR) is normally activated by ligand-induced dimerization. Oncogenic mutations in EGFR promote activation in a largely ligand-independent manner. Shan et al. uncover a partially disordered state of EGFR kinase, providing evidence that oncogenic mutations counteract this intrinsic structural instability to promote dimerization and aberrant activation.	[Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hahn, William C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Eck, MJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 450 Brookline Ave, Boston, MA 02215 USA.	eck@red.dfci.harvard.edu; william_hahn@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA116020] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA116020] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	10	5	7	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					735	737		10.1016/j.cell.2012.04.015	http://dx.doi.org/10.1016/j.cell.2012.04.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579278	Bronze			2022-12-28	WOS:000303934700007
J	Payne, D				Payne, David			HEALTHCARE REFORM How Kizer healed the VA	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						[Anonymous], 2009, MED NEWS TODAY  0411; Cowling DW, 2010, TOB CONTROL, V19, pI62, DOI 10.1136/tc.2009.030791; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 11	2012	344								e3324	10.1136/bmj.e3324	http://dx.doi.org/10.1136/bmj.e3324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XU	22581630	Bronze			2022-12-28	WOS:000304085700004
J	Whittle, AJ; Carobbio, S; Martins, L; Slawik, M; Hondares, E; Vazquez, MJ; Morgan, D; Csikasz, RI; Gallego, R; Rodriguez-Cuenca, S; Dale, M; Virtue, S; Villarroya, F; Cannon, B; Rahmouni, K; Lopez, M; Vidal-Puig, A				Whittle, Andrew J.; Carobbio, Stefania; Martins, Luis; Slawik, Marc; Hondares, Elayne; Jesus Vazquez, Maria; Morgan, Donald; Csikasz, Robert I.; Gallego, Rosalia; Rodriguez-Cuenca, Sergio; Dale, Martin; Virtue, Samuel; Villarroya, Francesc; Cannon, Barbara; Rahmouni, Kamal; Lopez, Miguel; Vidal-Puig, Antonio			BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions	CELL			English	Article							ACTIVATED PROTEIN-KINASE; DIET-INDUCED THERMOGENESIS; BETA-ADRENERGIC-RECEPTORS; ENERGY-BALANCE; DIFFERENTIAL ACTIVATION; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC AMPK; ADULT HUMANS; FOOD-INTAKE; METABOLISM	Thermogenesis in brown adipose tissue (BAT) is fundamental to energy balance and is also relevant for humans. Bone morphogenetic proteins (BMPs) regulate adipogenesis, and, here, we describe a role for BMP8B in the direct regulation of thermogenesis. BMP8B is induced by nutritional and thermogenic factors in mature BAT, increasing the response to noradrenaline through enhanced p38MAPK/CREB signaling and increased lipase activity. Bmp8b(-/-) mice exhibit impaired thermogenesis and reduced metabolic rate, causing weight gain despite hypophagia. BMP8B is also expressed in the hypothalamus, and Bmp8b(-/-) mice display altered neuropeptide levels and reduced phosphorylation of AMP-activated protein kinase (AMPK), indicating an anorexigenic state. Central BMP8B treatment increased sympathetic activation of BAT, dependent on the status of AMPK in key hypothalamic nuclei. Our results indicate that BMP8B is a thermogenic protein that regulates energy balance in partnership with hypothalamic AMPK. BMP8B may offer a mechanism to specifically increase energy dissipation by BAT.	[Whittle, Andrew J.; Carobbio, Stefania; Slawik, Marc; Rodriguez-Cuenca, Sergio; Dale, Martin; Virtue, Samuel; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England; [Martins, Luis; Jesus Vazquez, Maria; Lopez, Miguel] Univ Santiago de Compostela, Dept Physiol, Sch Med CIMUS, Inst Invest Sanitaria, Santiago De Compostela 15782, Spain; [Martins, Luis; Hondares, Elayne; Jesus Vazquez, Maria; Villarroya, Francesc; Lopez, Miguel] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela 15706, Spain; [Slawik, Marc] Klinikum Univ, Med Klin & Poliklin 4, D-80336 Munich, Germany; [Hondares, Elayne; Villarroya, Francesc] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Hondares, Elayne; Villarroya, Francesc] Univ Barcelona, IBUB, E-08028 Barcelona, Spain; [Morgan, Donald; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Csikasz, Robert I.; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, SE-10691 Stockholm, Sweden; [Gallego, Rosalia] Univ Santiago de Compostela, Sch Med, Dept Morphol Sci, Santiago De Compostela 15782, Spain; [Cannon, Barbara] Univ London Royal Vet Coll, London NW1 0TU, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Munich; University of Barcelona; University of Barcelona; University of Iowa; University of Iowa; Stockholm University; Universidade de Santiago de Compostela; University of London; University of London Royal Veterinary College	Whittle, AJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England.	ajw232@cam.ac.uk; ajv22@medschl.cam.ac.uk	Morgan, Donald A/L-6907-2013; carobbio, stefania/E-7095-2018; Martins, Luis/AAB-5436-2020; Virtue, SAm/B-7578-2013; López, Miguel/ABF-4844-2021; Villarroya, Francesc/K-4357-2014; Rahmouni, Kamal/Y-1788-2019; Cannon, Barbara/B-3089-2016	Morgan, Donald A/0000-0003-3167-1643; Martins, Luis/0000-0002-2000-387X; Virtue, SAm/0000-0002-9545-5432; López, Miguel/0000-0002-7823-1648; Vidal-Puig, Antonio/0000-0003-4220-9577; Rosalia, Gallego/0000-0002-6015-4680; Rahmouni, Kamal/0000-0001-5136-6748; Whittle, Andrew/0000-0002-3181-8855; Cannon, Barbara/0000-0001-6594-2363; Villarroya, Francesc/0000-0003-1266-9142	MRC CORD; MRC; Wellcome Trust; European Community [281854]; Sixth Framework Programme (FP6 Hepadip); BBSRC; University of Cambridge School of the Biological Sciences; Marie Curie IEF; Ministerio de Ciencia e Innovacion [SAF2008-01896, RyC-2007-00211]; Generalitat de Catalunya, Spain [2009SGR284]; Xunta de Galicia [10PXIB208164PR]; Fondo Investigationes Sanitarias [PS09/01880]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/65379/2009]; Fritz Thyssen Foundation; National Heart, Lung, and Blood Institute [HL084207]; Swedish Science Research Council; EU; BBSRC [BB/J009865/1] Funding Source: UKRI; MRC [G0802051] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009865/1] Funding Source: researchfish; Medical Research Council [G0802051, G0600717B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER	MRC CORD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community(European Commission); Sixth Framework Programme (FP6 Hepadip); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge School of the Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie IEF(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fritz Thyssen Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swedish Science Research Council; EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Sarah Gray, Constanze Hammerle, and our animal technicians for their work on the project. Johannes Klein donated the brown adipocyte cell line. Thyroid receptor plasmids came from Krishna Chatterjee. A. V.-P. is supported by MRC CORD, MRC programme, and Wellcome Trust project grants, European Community's Seventh Framework Programmes (FP7 MITIN, FP7 BETABAT), and Sixth Framework Programme (FP6 Hepadip). A.J.W. is supported by BBSRC and the University of Cambridge School of the Biological Sciences. S. C. was funded by Marie Curie IEF. F. V. is funded by Ministerio de Ciencia e Innovacion (SAF2008-01896) and Generalitat de Catalunya (2009SGR284), Spain. M. L. was funded by Xunta de Galicia (10PXIB208164PR), Fondo Investigationes Sanitarias (PS09/01880), Ministerio de Ciencia e Innovacion (RyC-2007-00211), and European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 281854 (the ObERStress project). L. M. is a recipient of a fellowship from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/65379/2009). M. S. was funded by Fritz Thyssen Foundation fellowship. K. R. is supported by National Heart, Lung, and Blood Institute grant HL084207. B. C. is supported by The Swedish Science Research Council, the EU-project DIABAT, and BBSRC.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Alberts P., 2006, CURRENT PROTOCOLS NE, P1; Alonso G, 2000, J BIOL CHEM, V275, P40641, DOI 10.1074/jbc.M007835200; AMIR S, 1990, BRAIN RES, V508, P152, DOI 10.1016/0006-8993(90)91129-5; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Elia M, 1992, World Rev Nutr Diet, V70, P68; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; HALVORSON I, 1990, BRAIN RES, V522, P76, DOI 10.1016/0006-8993(90)91579-6; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Ribeiro MO, 2010, ENDOCRINOLOGY, V151, P432, DOI 10.1210/en.2009-0667; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; ROTHWELL NJ, 1986, BRIT J NUTR, V56, P123, DOI 10.1079/BJN19860092; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Torp-Pedersen C, 2007, EUR HEART J, V28, P2915, DOI 10.1093/eurheartj/ehm217; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Varela L, 2012, J PATHOL, V227, P209, DOI 10.1002/path.3984; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; WOODS AJ, 1994, AM J PHYSIOL, V266, pR328, DOI 10.1152/ajpregu.1994.266.2.R328; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657; Zhao GQ, 1996, MECH DEVELOP, V57, P159, DOI 10.1016/0925-4773(96)00543-6; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	57	424	438	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					871	885		10.1016/j.cell.2012.02.066	http://dx.doi.org/10.1016/j.cell.2012.02.066			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579288	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000303934700019
J	Dominissini, D; Moshitch-Moshkovitz, S; Schwartz, S; Salmon-Divon, M; Ungar, L; Osenberg, S; Cesarkas, K; Jacob-Hirsch, J; Amariglio, N; Kupiec, M; Sorek, R; Rechavi, G				Dominissini, Dan; Moshitch-Moshkovitz, Sharon; Schwartz, Schraga; Salmon-Divon, Mali; Ungar, Lior; Osenberg, Sivan; Cesarkas, Karen; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Kupiec, Martin; Sorek, Rotem; Rechavi, Gideon			Topology of the human and mouse m(6)A RNA methylomes revealed by m(6)A-seq	NATURE			English	Article							NUCLEIC-ACID COMPLEXES; MESSENGER-RNA; N-6-METHYLADENOSINE RESIDUES; IMMUNOSPECIFIC RETENTION; METHYLATED CONSTITUENTS; DNA METHYLATION; FACTOR-ALPHA; IN-VITRO; CELL; BINDING	An extensive repertoire of modifications is known to underlie the versatile coding, structural and catalytic functions of RNA, but it remains largely uncharted territory. Although biochemical studies indicate that N-6-methyladenosine (m(6)A) is the most prevalent internal modification in messenger RNA, an in-depth study of its distribution and functions has been impeded by a lack of robust analytical methods. Here we present the human and mouse m(6)A modification landscape in a transcriptome-wide manner, using a novel approach, m(6)A-seq, based on antibody-mediated capture and massively parallel sequencing. We identify over 12,000 m(6)A sites characterized by a typical consensus in the transcripts of more than 7,000 human genes. Sites preferentially appear in two distinct landmarks-around stop codons and within long internal exons-and are highly conserved between human and mouse. Although most sites are well preserved across normal and cancerous tissues and in response to various stimuli, a subset of stimulus-dependent, dynamically modulated sites is identified. Silencing the m(6)A methyltransferase significantly affects gene expression and alternative splicing patterns, resulting in modulation of the p53 (also known as TP53) signalling pathway and apoptosis. Our findings therefore suggest that RNA decoration by m(6)A has a fundamental role in regulation of gene expression.	[Dominissini, Dan; Moshitch-Moshkovitz, Sharon; Salmon-Divon, Mali; Osenberg, Sivan; Cesarkas, Karen; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Dominissini, Dan; Ungar, Lior; Osenberg, Sivan; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Schwartz, Schraga; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Ungar, Lior; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Tel Aviv University	Rechavi, G (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.	Gidi.Rechavi@sheba.health.gov.il	Salmon-Divon, Mali/AAG-4479-2019	Salmon-Divon, Mali/0000-0002-7272-0846; Dominissini, Dan/0000-0003-1121-5130; Schwartz, Schraga/0000-0002-3671-9709	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF [1942/08]; Israel Ministry for Science and Technology; ERC-StG [260432]	Flight Attendant Medical Research Institute (FAMRI); Bio-Med Morasha ISF; Israel Ministry for Science and Technology; ERC-StG	We thank H. Cedar (The Hebrew University, Jerusalem) for his comments. We thank the Kahn Family Foundation for their support. This work was supported in part by grants from the Flight Attendant Medical Research Institute (FAMRI), Bio-Med Morasha ISF (grant no. 1942/08), and The Israel Ministry for Science and Technology (Scientific Infrastructure Program). R. S. was supported by the ERC-StG program (grant 260432). G. R. holds the Djerassi Chair in Oncology at the Sackler Faculty of Medicine, Tel Aviv University. This work was performed in partial fulfilment of the requirements for a PhD degree to D. D., Sackler Faculty of Medicine, Tel Aviv University.	Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S., 2012, DETECTING DIFFERENTI; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bembom O., 2011, SEQLOGO SEQUENCE LOG; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; DANTE R, 1981, FEBS LETT, V130, P153, DOI 10.1016/0014-5793(81)80686-2; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; HAMBURGER AW, 1993, P SOC EXP BIOL MED, V202, P64; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298; KEITH JM, 1978, J BIOL CHEM, V253, P5033; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lenos K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/876173; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; MUJOO K, 1993, J IMMUNOTHER, V13, P166, DOI 10.1097/00002371-199304000-00003; MUNNS TW, 1979, J BIOL CHEM, V254, P4327; MUNNS TW, 1977, J BIOL CHEM, V252, P3102; MUNNS TW, 1978, BIOCHEMISTRY-US, V17, P2573, DOI 10.1021/bi00606a018; MUNNS TW, 1977, BIOCHEMISTRY-US, V16, P2163, DOI 10.1021/bi00629a019; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; PERRY RP, 1975, FEBS LETT, V57, P73, DOI 10.1016/0014-5793(75)80155-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rafalska I, 2004, HUM MOL GENET, V13, P1535, DOI 10.1093/hmg/ddh167; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuck MT, 1999, INT J BIOCHEM CELL B, V31, P837, DOI 10.1016/S1357-2725(99)00041-2; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	64	2512	2632	43	559	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					201	U84		10.1038/nature11112	http://dx.doi.org/10.1038/nature11112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575960				2022-12-28	WOS:000303799800033
J	Moreno-Razo, JA; Sambriski, EJ; Abbott, NL; Hernandez-Ortiz, JP; de Pablo, JJ				Moreno-Razo, J. A.; Sambriski, E. J.; Abbott, N. L.; Hernandez-Ortiz, J. P.; de Pablo, J. J.			Liquid-crystal-mediated self-assembly at nanodroplet interfaces	NATURE			English	Article							TRANSITIONS; MODEL	Technological applications of liquid crystals have generally relied on control of molecular orientation at a surface or an interface(1,2). Such control has been achieved through topography, chemistry and the adsorption of monolayers or surfactants(2,3). The role of the substrate or interface has been to impart order over visible length scales and to confine the liquid crystal in a device. Here, we report results from a computational study of a liquid-crystal-based system in which the opposite is true: the liquid crystal is used to impart order on the interfacial arrangement of a surfactant. Recent experiments on macroscopic interfaces have hinted that an interfacial coupling between bulk liquid crystal and surfactant can lead to a two-dimensional phase separation of the surfactant at the interface(4), but have not had the resolution to measure the structure of the resulting phases. To enhance that coupling, we consider the limit of nanodroplets, the interfaces of which are decorated with surfactant molecules that promote local perpendicular orientation of mesogens within the droplet. In the absence of surfactant, mesogens at the interface are all parallel to that interface. As the droplet is cooled, the mesogens undergo a transition from a disordered (isotropic) to an ordered (nematic or smectic) liquid-crystal phase. As this happens, mesogens within the droplet cause a transition of the surfactant at the interface, which forms new ordered nanophases with morphologies dependent on surfactant concentration. Such nanophases are reminiscent of those encountered in block copolymers(5), and include circular, striped and worm-like patterns.	[Abbott, N. L.; de Pablo, J. J.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Moreno-Razo, J. A.] Univ Autonoma Metropolitana Iztapalapa, Dept Fis, Mexico City 09340, DF, Mexico; [Sambriski, E. J.] Delaware Valley Coll, Dept Chem & Biochem, Doylestown, PA 18901 USA; [Hernandez-Ortiz, J. P.] Univ Nacl Colombia, Dept Mat, Medellin, Colombia	University of Wisconsin System; University of Wisconsin Madison; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional de Colombia	de Pablo, JJ (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	depablo@engr.wisc.edu	de Pablo, Juan/AAJ-9161-2021	Hernandez-Ortiz, Juan/0000-0003-0404-9947; Sambriski, Edward/0000-0002-5074-1881	Department of Energy, Basic Energy Sciences [DE-SC0004025]; National Science Foundation [DMR-1121288]	Department of Energy, Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	The continuum analysis of liquid crystal interfaces and the development of the corresponding theory were supported by the Department of Energy, Basic Energy Sciences, Biomaterials Program (DE-SC0004025). The calculations of surfactant organization at nanodroplet interfaces were supported by the National Science Foundation (DMR-1121288). The calculations reported here were performed on computational facilities supported by the National Science Foundation (DMR-1121288).	Allen M.P., 1991, COMPUTER SIMULATION; Baron M, 2001, PURE APPL CHEM, V73, P845, DOI 10.1351/pac200173050845; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; Collins P. J., 2004, INTRO LIQUID CRYSTAL; De Gennes, 1995, PHYS LIQUID CRYSTALS; Fernandez-Nieves A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2187430; Fernandez-Nieves A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157801; Fernandez-Nieves A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.087801; Frenkel D., 1996, UNDERSTANDING MOL SI, V2; GAY JG, 1981, J CHEM PHYS, V74, P3316, DOI 10.1063/1.441483; Gupta JK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048301; Gupta JK, 2009, ANGEW CHEM INT EDIT, V48, P1652, DOI 10.1002/anie.200804500; Humar M, 2009, NAT PHOTONICS, V3, P595, DOI 10.1038/NPHOTON.2009.170; Ilnytskyi JM, 2002, COMPUT PHYS COMMUN, V148, P43, DOI 10.1016/S0010-4655(02)00467-8; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; JUFFER AH, 1993, MOL PHYS, V79, P623, DOI 10.1080/00268979300101501; Kotov NA, 2008, ADV MATER, V20, P4221, DOI 10.1002/adma.200803045; Lin IH, 2011, SCIENCE, V332, P1297, DOI 10.1126/science.1195639; LUCKHURST GR, 1993, MOL PHYS, V80, P233, DOI 10.1080/00268979300102241; Park JS, 2008, ADV MATER, V20, P1185, DOI 10.1002/adma.200702012; Price AD, 2008, J AM CHEM SOC, V130, P8188, DOI 10.1021/ja0774055; Price AD, 2007, J PHYS CHEM B, V111, P1007, DOI 10.1021/jp066228b; Shah RR, 2001, SCIENCE, V293, P1296, DOI 10.1126/science.1062293; Singh C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.226106; Sivakumar S, 2009, ADV FUNCT MATER, V19, P2260, DOI 10.1002/adfm.200900399; Yamamoto J, 2001, NATURE, V409, P321, DOI 10.1038/35053035; Yokoyama H, 2009, NAT PHOTONICS, V3, P560, DOI 10.1038/nphoton.2009.179	28	71	71	7	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					86	89		10.1038/nature11084	http://dx.doi.org/10.1038/nature11084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22552096	Green Submitted			2022-12-28	WOS:000303451900039
J	Walden, M; Atroshi, I; Magnusson, H; Wagner, P; Hagglund, M				Walden, Markus; Atroshi, Isam; Magnusson, Henrik; Wagner, Philippe; Hagglund, Martin			Prevention of acute knee injuries in adolescent female football players: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRUCIATE LIGAMENT INJURY; SOCCER PLAYERS; NEUROMUSCULAR CONTROL; HIGH PREVALENCE; OSTEOARTHRITIS; PROGRAM; RISK; MODEL	Objective To evaluate the effectiveness of neuromuscular training in reducing the rate of acute knee injury in adolescent female football players. Design Stratified cluster randomised controlled trial with clubs as the unit of randomisation. Setting 230 Swedish football clubs (121 in the intervention group, 109 in the control group) were followed for one season (2009, seven months). Participants 4564 players aged 12-17 years (2479 in the intervention group, 2085 in the control group) completed the study. Intervention 15 minute neuromuscular warm-up programme (targeting core stability, balance, and proper knee alignment) to be carried out twice a week throughout the season. Main outcome measures The primary outcome was rate of anterior cruciate ligament injury; secondary outcomes were rates of severe knee injury (>4 weeks' absence) and any acute knee injury. Results Seven players (0.28%) in the intervention group, and 14 (0.67%) in the control group had an anterior cruciate ligament injury. By Cox regression analysis according to intention to treat, a 64% reduction in the rate of anterior cruciate ligament injury was seen in the intervention group (rate ratio 0.36, 95% confidence interval 0.15 to 0.85). The absolute rate difference was -0.07 (95% confidence interval -0.13 to 0.001) per 1000 playing hours in favour of the intervention group. No significant rate reductions were seen for secondary outcomes. Conclusions A neuromuscular warm-up programme significantly reduced the rate of anterior cruciate ligament injury in adolescent female football players. However, the absolute rate difference did not reach statistical significance, possibly owing to the small number of events.	[Walden, Markus] Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, S-58183 Linkoping, Sweden; [Walden, Markus; Atroshi, Isam] Hassleholm Kristianstad Ystad Hosp, Dept Orthopaed, S-28125 Hassleholm, Sweden; [Atroshi, Isam] Lund Univ, Dept Clin Sci, S-22184 Lund, Sweden; [Magnusson, Henrik; Hagglund, Martin] Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, S-58183 Linkoping, Sweden; [Wagner, Philippe] Lund Univ, Natl Competence Ctr Musculoskeletal Disorders, S-22100 Lund, Sweden	Linkoping University; Lund University; Linkoping University; Lund University	Walden, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, S-58183 Linkoping, Sweden.	markus.walden@telia.com			Swedish Football Association; Folksam Insurance Company; Swedish National Centre for Research in Sports; Hassleholm Hospital	Swedish Football Association; Folksam Insurance Company; Swedish National Centre for Research in Sports; Hassleholm Hospital	The study was financially supported by the Swedish Football Association and the Folksam Insurance Company. This research also received grants from the Swedish National Centre for Research in Sports and from the Hassleholm Hospital. None of the sponsors had any role in the design or conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, approval, and submission of the manuscript. No author or related institution has received any financial benefit from research in this study.	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Brophy RH, 2009, AM J SPORT MED, V37, P683, DOI 10.1177/0363546508328121; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Federation Internationale de Football Association, 2007, FIFA BIG COUNT 2006; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Greenland S, 2008, MODERN EPIDEMIOLOGY, P273; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hagglund M, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-75; Heidt RS, 2000, AM J SPORT MED, V28, P659, DOI 10.1177/03635465000280050601; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Janssen KW, 2012, SCAND J MED SCI SPOR, V22, P495, DOI 10.1111/j.1600-0838.2010.01253.x; Kiani A, 2010, ARCH INTERN MED, V170, P43, DOI 10.1001/archinternmed.2009.289; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Olsen OE, 2005, BRIT MED J, V330, P449, DOI 10.1136/bmj.38330.632801.8F; Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Pfeiffer RP, 2006, J BONE JOINT SURG AM, V88A, P1769, DOI 10.2106/JBJS.E.00616; Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003; Shea KG, 2004, J PEDIATR ORTHOPED, V24, P623, DOI 10.1097/01241398-200411000-00005; Soderman K, 2000, KNEE SURG SPORT TR A, V8, P356, DOI 10.1007/s001670000147; Soderman K, 2002, SCAND J MED SCI SPOR, V12, P65, DOI 10.1034/j.1600-0838.2002.120201.x; Soligard T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2469; Steffen K, 2008, SCAND J MED SCI SPOR, V18, P605, DOI 10.1111/j.1600-0838.2007.00703.x; Swedish Football Association, 2006, REK FOTB SVER; United States Youth Soccer Association, 2009, LARG YOUTH SPORTS OR; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Walden M, 2011, KNEE SURG SPORT TR A, V19, P11, DOI 10.1007/s00167-010-1170-9; Walden M, 2011, KNEE SURG SPORT TR A, V19, P3, DOI 10.1007/s00167-010-1172-7; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	33	230	232	2	51	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2012	344								e3042	10.1136/bmj.e3042	http://dx.doi.org/10.1136/bmj.e3042			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NG	22556050	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000303817700001
J	James, BD; Bennett, DA; Boyle, PA; Leurgans, S; Schneider, JA				James, Bryan D.; Bennett, David A.; Boyle, Patricia A.; Leurgans, Sue; Schneider, Julie A.			Dementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NEUROPATHOLOGY; AGE		[James, Bryan D.; Bennett, David A.; Boyle, Patricia A.; Leurgans, Sue; Schneider, Julie A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Rush University	James, BD (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	bryan_james@rush.edu		James, Bryan/0000-0003-1932-151X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009466, P01AG014449, P30AG010161, RC2AG036547, R01AG034374, R01AG033678, R01AG017917, R01AG015819] Funding Source: NIH RePORTER; NIA NIH HHS [RC2 AG036547, R01AG17917, P01 AG009466, P01AG09466, R01 AG033678, R01AG15819, P01AG14449, R01AG33678, P30 AG010161, R01AG34374, R01 AG017917, R01 AG015819, R01 AG034374, RC2AG36547, P01 AG014449, P30AG10161] Funding Source: Medline; NINDS NIH HHS [R01NS028127, R01 NS028127] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Imhof A, 2007, J NEUROL SCI, V257, P72, DOI 10.1016/j.jns.2007.01.025; Middleton LE, 2011, NEUROLOGY, V77, P1737, DOI 10.1212/WNL.0b013e318236f0cf; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24	5	106	107	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1798	1800		10.1001/jama.2012.3556	http://dx.doi.org/10.1001/jama.2012.3556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550192	Green Accepted, Bronze			2022-12-28	WOS:000303386800015
J	Pincock, S				Pincock, Stephen			Profile Linda Bearinger: creating healthy pathways for adolescents	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902				BEARINGER L, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 28	2012	379	9826					1581	1581		10.1016/S0140-6736(12)60664-3	http://dx.doi.org/10.1016/S0140-6736(12)60664-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934OB	22541568				2022-12-28	WOS:000303452600017
J	Lindgren, E; Andersson, Y; Suk, JE; Sudre, B; Semenza, JC				Lindgren, Elisabet; Andersson, Yvonne; Suk, Jonathan E.; Sudre, Bertrand; Semenza, Jan C.			Monitoring EU Emerging Infectious Disease Risk Due to Climate Change	SCIENCE			English	Editorial Material							EUROPE; FUTURE		[Suk, Jonathan E.; Sudre, Bertrand; Semenza, Jan C.] European Ctr Dis Prevent & Control, Off Chief Sci, SE-17183 Stockholm, Sweden; [Lindgren, Elisabet] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Andersson, Yvonne] Swedish Inst Communicable Dis Control 1, SE-17182 Solna, Sweden	European Centre for Disease Prevention & Control; Karolinska Institutet	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control, Off Chief Sci, SE-17183 Stockholm, Sweden.	jan.semenza@ecdc.europa.eu	Suk, Jonathan/L-2300-2017	Suk, Jonathan/0000-0003-4689-4583				Commission of the european communities, 2009, COM2009147 COMM EUR; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Marsh Inc, 2008, EC SOC IMP EM INF DI; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Semenza JC, 2012, ENVIRON HEALTH PERSP, V120, P385, DOI 10.1289/ehp.1103805; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150	12	142	145	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					418	419		10.1126/science.1215735	http://dx.doi.org/10.1126/science.1215735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539705				2022-12-28	WOS:000303233400028
J	Verret, L; Mann, EO; Hang, GB; Barth, AMI; Cobos, I; Ho, K; Devidze, N; Masliah, E; Kreitzer, AC; Mody, I; Mucke, L; Palop, JJ				Verret, Laure; Mann, Edward O.; Hang, Giao B.; Barth, Albert M. I.; Cobos, Inma; Ho, Kaitlyn; Devidze, Nino; Masliah, Eliezer; Kreitzer, Anatol C.; Mody, Istvan; Mucke, Lennart; Palop, Jorge J.			Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model	CELL			English	Article							INDUCED NEURONAL DYSFUNCTION; DISEASE MOUSE MODELS; TRANSGENIC MICE; HIPPOCAMPAL NETWORK; GAMMA-OSCILLATIONS; FEBRILE SEIZURES; SCN1A GENE; IN-VIVO; EPILEPSY; MUTATIONS	Alzheimer's disease (AD) results in cognitive decline and altered network activity, but the mechanisms are unknown. We studied human amyloid precursor protein (hAPP) transgenic mice, which simulate key aspects of AD. Electroencephalographic recordings in hAPP mice revealed spontaneous epileptiform discharges, indicating network hypersynchrony, primarily during reduced gamma oscillatory activity. Because this oscillatory rhythm is generated by inhibitory parvalbumin (PV) cells, network dysfunction in hAPP mice might arise from impaired PV cells. Supporting this hypothesis, hAPP mice and AD patients had decreased levels of the interneuron-specific and PV cell-predominant voltage-gated sodium channel subunit Nav1.1. Restoring Nav1.1 levels in hAPP mice by Nav1.1-BAC expression increased inhibitory synaptic activity and gamma oscillations and reduced hypersynchrony, memory deficits, and premature mortality. We conclude that reduced Nav1.1 levels and PV cell dysfunction critically contribute to abnormalities in oscillatory rhythms, network synchrony, and memory in hAPP mice and possibly in AD.	[Verret, Laure; Hang, Giao B.; Ho, Kaitlyn; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart; Palop, Jorge J.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Verret, Laure; Hang, Giao B.; Kreitzer, Anatol C.; Mucke, Lennart; Palop, Jorge J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Cobos, Inma] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Mann, Edward O.; Barth, Albert M. I.; Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Palop, JJ (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	jpalop@gladstone.ucsf.edu	Palop, Jorge J./D-8128-2011; Verret, Laure/D-9224-2017; Palop, Jorge/AAH-9014-2020; Verret, Laure/D-2219-2011	Verret, Laure/0000-0001-5272-6063; Verret, Laure/0000-0001-5272-6063; Palop, Jorge/0000-0001-6086-1070; Mann, Edward/0000-0002-2468-7148; Cobos, Inma/0000-0002-2043-1890	Stephen D. Bechtel, Jr. Foundation; National Institutes of Health [AG022074, AG011385, NS065780, NS002808, NS030549, AG5131, AG18440]; Philippe Foundation; Coelho Endowment; Pew Foundation; McKnight Foundation; Epilepsy Foundation; National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030549, R37NS030549, P30NS065780, P01NS002808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R01AG018440, P01AG022074, R37AG011385, P50AG005131, R37AG018440] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philippe Foundation; Coelho Endowment; Pew Foundation; McKnight Foundation; Epilepsy Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Stephen D. Bechtel, Jr. Foundation Young Investigator Award to J.J.P.; National Institutes of Health Grants AG022074, AG011385, and NS065780 to L. M. and NS002808, NS030549, AG5131, and AG18440 to E. M.; the Philippe Foundation Award to L. V.; the Coelho Endowment to I. M.; Pew and McKnight Foundations to A. C. K.; Epilepsy Foundation Postdoctoral Fellowship to E.O.M.; and facilities grants from Stephen D. Bechtel, Jr. and the National Center for Research Resources. We thank A. Escayg for the Nav1.1-BAC transgenic mice; J. Noebels and A. Gittis for helpful comments; G. Q. Yu, X. Wang, W. Guo, E. Pham, K. Bummer, I. Lo, and D. H. Kim for excellent technical support; and G. Howard and S. Ordway for editorial review.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Barth AMI, 2011, J NEUROSCI, V31, P851, DOI 10.1523/JNEUROSCI.5080-10.2011; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carter MD, 2007, J NEUROL SCI, V252, P169, DOI 10.1016/j.jns.2006.11.004; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Liao WP, 2010, EPILEPSIA, V51, P1669, DOI 10.1111/j.1528-1167.2010.02645.x; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Medvedev AV, 2002, BRAIN RES BULL, V58, P115, DOI 10.1016/S0361-9230(02)00768-2; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Striano P, 2008, LANCET NEUROL, V7, P278, DOI 10.1016/S1474-4422(08)70043-7; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tsiouris JA, 2002, NEUROLOGY, V59, P779, DOI 10.1212/WNL.59.5.779; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang WZ, 2011, BRAIN RES, V1389, P61, DOI 10.1016/j.brainres.2011.02.083; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	55	676	699	5	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					708	721		10.1016/j.cell.2012.02.046	http://dx.doi.org/10.1016/j.cell.2012.02.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541439	Bronze, Green Accepted			2022-12-28	WOS:000303443100020
J	Hajji, F; Janane, A				Hajji, Fouad; Janane, Abdellatif			Torsion of Undescended Testis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hajji, Fouad; Janane, Abdellatif] Mohammed V Mil Teaching Hosp, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Hajji, F (corresponding author), Mohammed V Mil Teaching Hosp, Rabat, Morocco.	fouad-shot@hotmail.com		Hajji, Fouad/0000-0002-3800-5398					0	5	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2012	366	17					1625	1625		10.1056/NEJMicm1111776	http://dx.doi.org/10.1056/NEJMicm1111776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931FC	22533578				2022-12-28	WOS:000303200100011
J	Piston, DW				Piston, David W.			Understand how it works	NATURE			English	Editorial Material									Vanderbilt Univ, Nashville, TN 37232 USA	Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu						[Anonymous], 2011, NATURE METHODS, V8, P983; Mervis J, 2010, SCIENCE, V328, P678, DOI 10.1126/science.328.5979.678; Stephan P, 2012, NATURE, V484, P29, DOI 10.1038/484029a	3	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					440	441		10.1038/484440a	http://dx.doi.org/10.1038/484440a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538585	Bronze			2022-12-28	WOS:000303200400020
J	Fridley, JD				Fridley, Jason D.			Extended leaf phenology and the autumn niche in deciduous forest invasions	NATURE			English	Article							NORTHERN HARDWOOD FOREST; EASTERN UNITED-STATES; EARTHWORM INVASION; SEASONAL-VARIATION; UNDERSTORY SHRUBS; NUTRIENT DYNAMICS; PLANT INVASIONS; CARBON-DIOXIDE; WOODY-PLANTS; TEMPERATE	The phenology of growth in temperate deciduous forests, including the timing of leaf emergence and senescence, has strong control over ecosystem properties such as productivity(1,2) and nutrient cycling(3,4), and has an important role in the carbon economy of understory plants(5-7). Extended leaf phenology, whereby understory species assimilate carbon in early spring before canopy closure or in late autumn after canopy fall, has been identified as a key feature of many forest species invasions(5,8-10), but it remains unclear whether there are systematic differences in the growth phenology of native and invasive forest species(11) or whether invaders are more responsive to warming trends that have lengthened the duration of spring or autumn growth(12). Here, in a 3-year monitoring study of 43 native and 30 non-native shrub and liana species common to deciduous forests in the eastern United States, I show that extended autumn leaf phenology is a common attribute of eastern US forest invasions, where non-native species are extending the autumn growing season by an average of 4 weeks compared with natives. In contrast, there was no consistent evidence that non-natives as a group show earlier spring growth phenology, and non-natives were not better able to track interannual variation in spring temperatures. Seasonal leaf production and photosynthetic data suggest that most non-native species capture a significant proportion of their annual carbon assimilate after canopy leaf fall, a behaviour that was virtually absent in natives and consistent across five phylogenetic groups. Pronounced differences in how native and non-native understory species use pre- and post-canopy environments suggest eastern US invaders are driving a seasonal redistribution of forest productivity that may rival climate change in its impact on forest processes.	Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Fridley, JD (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	fridley@syr.edu			Syracuse University	Syracuse University	I acknowledge technical assistance and advice from A. Craddock, S. Anderson, E. Fridley, S. Kelley, A. Surace, L. Giencke and D. Frank, and project support from Syracuse University.	ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Augspurger CK, 2005, FUNCT ECOL, V19, P537, DOI 10.1111/j.1365-2435.2005.01027.x; Augspurger CK, 2003, TREE PHYSIOL, V23, P517, DOI 10.1093/treephys/23.8.517; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CHAPIN FS, 1983, CAN J FOREST RES, V13, P773, DOI 10.1139/x83-107; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Frelich LE, 2006, BIOL INVASIONS, V8, P1235, DOI 10.1007/s10530-006-9019-3; Fridley JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003630; Gill DS, 1998, TREE PHYSIOL, V18, P281; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; HARRINGTON RA, 1989, OECOLOGIA, V80, P356, DOI 10.1007/BF00379037; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hothorn T, 2010, EXACTRANKTESTS EXACT; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HUTCHISON BA, 1977, ECOL MONOGR, V47, P185, DOI 10.2307/1942616; Koenker R., 2009, QUANTREG QUANTILE RE; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LECHOWICZ MJ, 1984, AM NAT, V124, P821, DOI 10.1086/284319; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Mack RN, 2003, ANN MO BOT GARD, V90, P77, DOI 10.2307/3298528; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; MAY JD, 1992, ECOLOGY, V73, P1868, DOI 10.2307/1940038; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MULLER RN, 1976, SCIENCE, V193, P1126, DOI 10.1126/science.193.4258.1126; Myers CV, 2003, AM MIDL NAT, V150, P231, DOI 10.1674/0003-0031(2003)150[0231:SVIPRI]2.0.CO;2; Nuzzo VA, 2009, CONSERV BIOL, V23, P966, DOI 10.1111/j.1523-1739.2009.01168.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Pinheiro J., 2011, NLME LINEAR NONLINEA; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rothstein DE, 2001, FUNCT ECOL, V15, P722, DOI 10.1046/j.0269-8463.2001.00584.x; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; SCHIERENBECK KA, 1993, AM J BOT, V80, P1292, DOI 10.2307/2445713; Webster CR, 2006, J FOREST, V104, P366; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y	41	236	248	9	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					359	U105		10.1038/nature11056	http://dx.doi.org/10.1038/nature11056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22535249				2022-12-28	WOS:000304099100040
J	Smith, SA				Smith, Steven A.			Educational messages on laboratory results improved diastolic BP but not systolic BP, HbA(1c), or cholesterol in diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Smith, SA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Smith, Steven/HDM-9496-2022					Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Centers for Medicare & Medicaid Services, CMS EHR MEAN US OV; Glenton C, 2010, MED DECIS MAKING, V30, P566, DOI 10.1177/0272989X10375853; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; O'Connor PJ, 2009, DIABETES CARE, V32, P1158, DOI 10.2337/dc08-2247	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-12	10.7326/0003-4819-156-10-201205150-02012	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586030				2022-12-28	WOS:000304193400011
J	Canto, C; Auwerx, J				Canto, Carles; Auwerx, Johan			FGF21 Takes a Fat Bite	SCIENCE			English	Editorial Material							ACTIVATED-RECEPTOR-GAMMA; FIBROBLAST GROWTH FACTOR-21; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; METABOLISM; EXPRESSION; MICE; PGC-1-ALPHA; PROMOTES; OBESITY		[Canto, Carles] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, SV IBI, CH-1015 Lausanne, Switzerland	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Canto, C (corresponding author), Nestle Inst Hlth Sci, Ecole Polytech Fed Lausanne EPFL Campus,Batiment, CH-1015 Lausanne, Switzerland.	carlos.cantoalvarez@rd.nestle.com; admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Canto, Carles/0000-0002-5167-7922	European Research Council [231138] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109	20	39	42	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					675	676		10.1126/science.1222646	http://dx.doi.org/10.1126/science.1222646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582248	Green Accepted			2022-12-28	WOS:000303872300033
J	Jaumann, R; Williams, DA; Buczkowski, DL; Yingst, RA; Preusker, F; Hiesinger, H; Schmedemann, N; Kneissl, T; Vincent, JB; Blewett, DT; Buratti, BJ; Carsenty, U; Denevi, BW; De Sanctis, MC; Garry, WB; Keller, HU; Kersten, E; Krohn, K; Li, JY; Marchi, S; Matz, KD; McCord, TB; McSween, HY; Mest, SC; Mittlefehldt, DW; Mottola, S; Nathues, A; Neukum, G; O'Brien, DP; Pieters, CM; Prettyman, TH; Raymond, CA; Roatsch, T; Russell, CT; Schenk, P; Schmidt, BE; Scholten, F; Stephan, K; Sykes, MV; Tricarico, P; Wagner, R; Zuber, MT; Sierks, H				Jaumann, R.; Williams, D. A.; Buczkowski, D. L.; Yingst, R. A.; Preusker, F.; Hiesinger, H.; Schmedemann, N.; Kneissl, T.; Vincent, J. B.; Blewett, D. T.; Buratti, B. J.; Carsenty, U.; Denevi, B. W.; De Sanctis, M. C.; Garry, W. B.; Keller, H. U.; Kersten, E.; Krohn, K.; Li, J. -Y.; Marchi, S.; Matz, K. D.; McCord, T. B.; McSween, H. Y.; Mest, S. C.; Mittlefehldt, D. W.; Mottola, S.; Nathues, A.; Neukum, G.; O'Brien, D. P.; Pieters, C. M.; Prettyman, T. H.; Raymond, C. A.; Roatsch, T.; Russell, C. T.; Schenk, P.; Schmidt, B. E.; Scholten, F.; Stephan, K.; Sykes, M. V.; Tricarico, P.; Wagner, R.; Zuber, M. T.; Sierks, H.			Vesta's Shape and Morphology	SCIENCE			English	Article							PONDED DEPOSITS; TOPOGRAPHY; EVOLUTION; ORIGIN; DAWN	Vesta's surface is characterized by abundant impact craters, some with preserved ejecta blankets, large troughs extending around the equatorial region, enigmatic dark material, and widespread mass wasting, but as yet an absence of volcanic features. Abundant steep slopes indicate that impact-generated surface regolith is underlain by bedrock. Dawn observations confirm the large impact basin (Rheasilvia) at Vesta's south pole and reveal evidence for an earlier, underlying large basin (Veneneia). Vesta's geology displays morphological features characteristic of the Moon and terrestrial planets as well as those of other asteroids, underscoring Vesta's unique role as a transitional solar system body.	[Jaumann, R.; Preusker, F.; Carsenty, U.; Kersten, E.; Krohn, K.; Matz, K. D.; Mottola, S.; Roatsch, T.; Scholten, F.; Stephan, K.; Wagner, R.] German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany; [Jaumann, R.; Schmedemann, N.; Kneissl, T.; Neukum, G.] Free Univ Berlin, Berlin, Germany; [Williams, D. A.] Arizona State Univ, Tempe, AZ 85287 USA; [Buczkowski, D. L.; Blewett, D. T.; Denevi, B. W.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Yingst, R. A.; Garry, W. B.; Mest, S. C.; O'Brien, D. P.; Prettyman, T. H.; Sykes, M. V.; Tricarico, P.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Hiesinger, H.] Univ Munster, D-4400 Munster, Germany; [Vincent, J. B.; Nathues, A.; Sierks, H.] Max Planck Inst Solar Syst Res MPS, Katlenburg Lindau, Germany; [Buratti, B. J.; Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [De Sanctis, M. C.] Ist Nazl Astrofis INAF, Ist Astrofis & Planetol Spaziali, Rome, Italy; [Keller, H. U.] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig, Germany; [Li, J. -Y.] Univ Maryland, College Pk, MD 20742 USA; [Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO 80309 USA; [McCord, T. B.] Bear Fight Inst, Winthrop, WA 98862 USA; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Astromat Res Off, Houston, TX 77058 USA; [Pieters, C. M.] Brown Univ, Planetary Geosci Dept, Providence, RI 02912 USA; [Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Schenk, P.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Schmidt, B. E.] Univ Texas Austin, Inst Geophys, Austin, TX 78712 USA; [Zuber, M. T.] MIT, Cambridge, MA 02139 USA	Helmholtz Association; German Aerospace Centre (DLR); Free University of Berlin; Arizona State University; Arizona State University-Tempe; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Munster; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Istituto Nazionale Astrofisica (INAF); Braunschweig University of Technology; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brown University; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin; Massachusetts Institute of Technology (MIT)	Jaumann, R (corresponding author), German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany.	ralf.jaumann@dlr.de	Denevi, Brett W./I-6502-2012; Russell, Christopher T/E-7745-2012; Garry, Brent/I-5920-2013; Tricarico, Pasquale/AAX-3321-2021; Stephan, Katrin/U-2524-2018; Buczkowski, Debra L/I-7842-2015; De Sanctis, Maria Cristina/G-5232-2013; Blewett, David T/I-4904-2012; Jaumann, Ralf/N-1001-2018; Nathues, Andreas/AAW-4340-2020	Denevi, Brett W./0000-0001-7837-6663; Russell, Christopher T/0000-0003-1639-8298; Tricarico, Pasquale/0000-0001-6540-512X; Buczkowski, Debra L/0000-0002-4729-7804; De Sanctis, Maria Cristina/0000-0002-3463-4437; Blewett, David T/0000-0002-9241-6358; Jaumann, Ralf/0000-0002-9759-6597; Vincent, Jean-Baptiste/0000-0001-6575-3079; Prettyman, Thomas/0000-0003-0072-2831; Li, Jian-Yang/0000-0003-3841-9977; Schmidt, Britney Elyce/0000-0001-7376-8510	NASA; NASA Dawn; DLR	NASA(National Aeronautics & Space Administration (NASA)); NASA Dawn; DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	We thank the Dawn team for the development, cruise, orbital insertion, and operations of the Dawn spacecraft at Vesta. Portions of this work were performed at the DLR Institute of Planetary Research and at the Jet Propulsion Laboratory under contract with NASA and were supported by the NASA Dawn participating scientist program and the DLR. Dawn data are archived with the NASA Planetary Data System.	Asphaug E, 1996, ICARUS, V120, P158, DOI 10.1006/icar.1996.0043; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095, DOI 10.1111/j.1945-5100.2002.tb00880.x; Cheng AF, 2002, ICARUS, V155, P51, DOI 10.1006/icar.2001.6750; De Sanctis MC, 2011, SPACE SCI REV, V163, P329, DOI 10.1007/s11214-010-9668-5; JOHNSON TV, 1973, ICARUS, V18, P612, DOI 10.1016/0019-1035(73)90064-X; Jutzi M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045517; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; McSween Harry Y.  Jr., 2011, Space Science Reviews, V163, P141, DOI 10.1007/s11214-010-9637-z; O'Brien DP, 2011, SPACE SCI REV, V163, P41, DOI 10.1007/s11214-011-9808-6; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Russell CT, 2011, SPACE SCI REV, V163, P3, DOI 10.1007/s11214-011-9836-2; Schmidt B. E., 2011, THESIS UCLA LOS ANGE; Sierks H, 2011, SPACE SCI REV, V163, P263, DOI 10.1007/s11214-011-9745-4; Thomas PC, 1997, ICARUS, V128, P88, DOI 10.1006/icar.1997.5736; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Wilson L, 1997, METEORIT PLANET SCI, V32, P813, DOI 10.1111/j.1945-5100.1997.tb01572.x; Zuber MT, 2011, SPACE SCI REV, V163, P77, DOI 10.1007/s11214-011-9806-8	18	173	173	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					687	690		10.1126/science.1219122	http://dx.doi.org/10.1126/science.1219122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582254				2022-12-28	WOS:000303872300040
J	Lee, MJ; Ye, AS; Gardino, AK; Heijink, AM; Sorger, PK; MacBeath, G; Yaffe, MB				Lee, Michael J.; Ye, Albert S.; Gardino, Alexandra K.; Heijink, Anne Margriet; Sorger, Peter K.; MacBeath, Gavin; Yaffe, Michael B.			Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks	CELL			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION PATTERNS; NEGATIVE BREAST-CANCER; ANTITUMOR-ACTIVITY; EGFR MUTATIONS; LINES; RESISTANCE; LAPATINIB; INHIBITION; ACTIVATION	Crosstalk and complexity within signaling pathways and their perturbation by oncogenes limit component-by-component approaches to understanding human disease. Network analysis of how normal and oncogenic signaling can be rewired by drugs may provide opportunities to target tumors with high specificity and efficacy. Using targeted inhibition of oncogenic signaling pathways, combined with DNA-damaging chemotherapy, we report that time-staggered EGFR inhibition, but not simultaneous coadministration, dramatically sensitizes a subset of triple-negative breast cancer cells to genotoxic drugs. Systems-level analysis-using high-density time-dependent measurements of signaling networks, gene expression profiles, and cell phenotypic responses in combination with mathematical modeling-revealed an approach for altering the intrinsic state of the cell through dynamic rewiring of oncogenic signaling pathways. This process converts these cells to a less tumorigenic state that is more susceptible to DNA damage-induced cell death by reactivation of an extrinsic apoptotic pathway whose function is suppressed in the oncogene-addicted state.	[Lee, Michael J.; Gardino, Alexandra K.; Heijink, Anne Margriet; Yaffe, Michael B.] MIT, Dept Biol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lee, Michael J.; Gardino, Alexandra K.; Heijink, Anne Margriet; Yaffe, Michael B.] MIT, Dept Biol Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lee, Michael J.; Ye, Albert S.; Gardino, Alexandra K.; Sorger, Peter K.; MacBeath, Gavin; Yaffe, Michael B.] MIT, Cell Decis Proc Ctr, Cambridge, MA 02139 USA; [Lee, Michael J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Sorger, Peter K.; MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu		MacBeath, Gavin/0000-0003-2585-6772; Sorger, Peter/0000-0002-3364-1838; Lee, Michael/0000-0003-3378-6196; Heijink, Anne Margriet/0000-0001-9229-0575	NIH [CA112967, GM68762, ES015339]; DOD [BC097884]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sandra Morandell, Kylie Huang, Jose McFaline, and Jessica Reddy for technical assistance in the early stages of this study and the Swanson Biotechnology Center at the Koch Institute for their technical support, including Eliza Vasile (microscopy), Glen Paradis (flow cytometry), and especially Charlie Whittaker (bioinformatics) for his guidance in analyzing microarray experiments. We further thank Doug Lauffenburger and members of the CDP community for fruitful discussions and advice throughout the development and execution of this study. This work was supported by NIH grants CA112967 and GM68762 to P. K. S. and M.B.Y, ES015339 to M.B.Y., and DOD fellowship BC097884 to M.J.L. P. K. S., G. M., and M.B.Y. are founders and shareholders of Merrimack Pharmaceuticals. P. K. S. and M.B.Y. are scientific advisory board members, and G. M. is a current employee. G. M. is also a scientific advisory board member of Aushon Biosystems.	Abeloff M. D., 2008, CLIN ONCOLOGY, P1875; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Carey L., 2008, J CLIN ONCOL, V26, P26; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diaz R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-188; Ekins S, 2007, METH MOL B, V356, P319; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kang N, 2010, CANCER LETT, V294, P147, DOI 10.1016/j.canlet.2010.01.032; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; LICHTER AS, 1995, NEW ENGL J MED, V332, P371, DOI 10.1056/NEJM199502093320607; Lopez JP, 2007, ARCH OTOLARYNGOL, V133, P1022, DOI 10.1001/archotol.133.10.1022; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Morgillo F, 2011, LUNG CANCER, V71, P283, DOI 10.1016/j.lungcan.2010.06.005; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Sevecka M, 2006, NAT METHODS, V3, P825, DOI 10.1038/nmeth931; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Winer E.P., 2007, SABCS 2007 IMPROVING; Woehlecke H, 2003, INT J CANCER, V107, P721, DOI 10.1002/ijc.11444; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069	42	480	491	1	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					780	794		10.1016/j.cell.2012.03.031	http://dx.doi.org/10.1016/j.cell.2012.03.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579283	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000303934700012
J	Russell, CT; Raymond, CA; Coradini, A; McSween, HY; Zuber, MT; Nathues, A; De Sanctis, MC; Jaumann, R; Konopliv, AS; Preusker, F; Asmar, SW; Park, RS; Gaskell, R; Keller, HU; Mottola, S; Roatsch, T; Scully, JEC; Smith, DE; Tricarico, P; Toplis, MJ; Christensen, UR; Feldman, WC; Lawrence, DJ; McCoy, TJ; Prettyman, TH; Reedy, RC; Sykes, ME; Titus, TN				Russell, C. T.; Raymond, C. A.; Coradini, A.; McSween, H. Y.; Zuber, M. T.; Nathues, A.; De Sanctis, M. C.; Jaumann, R.; Konopliv, A. S.; Preusker, F.; Asmar, S. W.; Park, R. S.; Gaskell, R.; Keller, H. U.; Mottola, S.; Roatsch, T.; Scully, J. E. C.; Smith, D. E.; Tricarico, P.; Toplis, M. J.; Christensen, U. R.; Feldman, W. C.; Lawrence, D. J.; McCoy, T. J.; Prettyman, T. H.; Reedy, R. C.; Sykes, M. E.; Titus, T. N.			Dawn at Vesta: Testing the Protoplanetary Paradigm	SCIENCE			English	Article							PARENT BODY; EVOLUTION; EUCRITE; ORIGIN; SHAPE; CORE; SIZE	The Dawn spacecraft targeted 4 Vesta, believed to be a remnant intact protoplanet from the earliest epoch of solar system formation, based on analyses of howardite-eucrite-diogenite (HED) meteorites that indicate a differentiated parent body. Dawn observations reveal a giant basin at Vesta's south pole, whose excavation was sufficient to produce Vesta-family asteroids (Vestoids) and HED meteorites. The spatially resolved mineralogy of the surface reflects the composition of the HED meteorites, confirming the formation of Vesta's crust by melting of a chondritic parent body. Vesta's mass, volume, and gravitational field are consistent with a core having an average radius of 107 to 113 kilometers, indicating sufficient internal melting to segregate iron. Dawn's results confirm predictions that Vesta differentiated and support its identification as the parent body of the HEDs.	[Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Raymond, C. A.; Konopliv, A. S.; Asmar, S. W.; Park, R. S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Coradini, A.; De Sanctis, M. C.] Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, Rome, Italy; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Zuber, M. T.; Smith, D. E.] MIT, Cambridge, MA 02139 USA; [Nathues, A.; Keller, H. U.; Christensen, U. R.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Jaumann, R.; Preusker, F.; Mottola, S.; Roatsch, T.] DLR, Inst Planetary Res, Berlin, Germany; [Scully, J. E. C.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Gaskell, R.; Tricarico, P.; Feldman, W. C.; Prettyman, T. H.; Reedy, R. C.; Sykes, M. E.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Toplis, M. J.] Univ Toulouse, Inst Rech Astrophys & Planetol, Toulouse, France; [Lawrence, D. J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [McCoy, T. J.] Smithsonian Inst, Washington, DC 20560 USA; [Titus, T. N.] US Geol Survey, Flagstaff, AZ 86001 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Istituto Nazionale Astrofisica (INAF); University of Tennessee System; University of Tennessee Knoxville; Massachusetts Institute of Technology (MIT); Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); University of California System; University of California Los Angeles; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Smithsonian Institution; United States Department of the Interior; United States Geological Survey	Russell, CT (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	ctrussell@igpp.ucla.edu	De Sanctis, Maria Cristina/G-5232-2013; Russell, Christopher T/E-7745-2012; Tricarico, Pasquale/AAX-3321-2021; Scully, Jennifer/L-5092-2019; Jaumann, Ralf/N-1001-2018; Lawrence, David J/E-7463-2015; Nathues, Andreas/AAW-4340-2020	De Sanctis, Maria Cristina/0000-0002-3463-4437; Russell, Christopher T/0000-0003-1639-8298; Tricarico, Pasquale/0000-0001-6540-512X; Jaumann, Ralf/0000-0002-9759-6597; Lawrence, David J/0000-0002-7696-6667; McCoy, Timothy/0000-0002-4573-3553; Reedy, Robert/0000-0002-2189-1303; Prettyman, Thomas/0000-0003-0072-2831	NASA;  [NNM05AA86C]	NASA(National Aeronautics & Space Administration (NASA)); 	We thank the Dawn team for the development, cruise, orbital insertion, and operations of the Dawn spacecraft at Vesta. C. T. R. is supported by the Discovery Program through contract NNM05AA86C to the University of California, Los Angeles. A portion of this work was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Dawn data are archived with the NASA Planetary Data System.	Beck AW, 2010, METEORIT PLANET SCI, V45, P850, DOI 10.1111/j.1945-5100.2010.01061.x; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Britt D., 2010, LUNAR PLANET SCI, V41, P1869; Buchwald V., 1975, HDB IRON METEORITES, P1426; Chabot N.L., 2006, METEORITES EARLY SOL, P747; Coradini A, 2011, SPACE SCI REV, V163, P25, DOI 10.1007/s11214-011-9792-x; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; DREIBUS G, 1980, Z NATURFORSCH A, V35, P204; Greeley R., 1990, PLANETARY MAPPING; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Kaula W.M., 2000, THEORY SATELLITE GEO; Konopliv AS, 2011, SPACE SCI REV, V163, P461, DOI 10.1007/s11214-011-9794-8; Konopliv AS, 2011, ICARUS, V211, P401, DOI 10.1016/j.icarus.2010.10.004; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; Marzari F, 1996, ASTRON ASTROPHYS, V316, P248; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; McSween H. Y., 2010, COSMOCHEMISTRY; McSween Harry Y.  Jr., 2011, Space Science Reviews, V163, P141, DOI 10.1007/s11214-010-9637-z; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Russell CT, 2011, SPACE SCI REV, V163, P1, DOI 10.1007/s11214-011-9853-1; Ruzicka A, 1997, METEORIT PLANET SCI, V32, P825, DOI 10.1111/j.1945-5100.1997.tb01573.x; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; Thomas PC, 1997, ICARUS, V128, P88, DOI 10.1006/icar.1997.5736; UREY HC, 1955, P NATL ACAD SCI USA, V41, P127, DOI 10.1073/pnas.41.3.127; Weiss BP, 2008, SCIENCE, V322, P713, DOI 10.1126/science.1162459; Zuber MT, 2011, SPACE SCI REV, V163, P77, DOI 10.1007/s11214-011-9806-8	27	357	360	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					684	686		10.1126/science.1219381	http://dx.doi.org/10.1126/science.1219381			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582253				2022-12-28	WOS:000303872300039
J	Mackool, BT; Goverman, J; Nazarian, RM				Mackool, Bonnie T.; Goverman, Jeremy; Nazarian, Rosalynn M.			Case 14-2012: A 43-Year-Old Woman with Fever and a Generalized Rash	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAPOSIS VARICELLIFORM ERUPTION; POTENTIALLY FATAL DISEASE; INNATE IMMUNE DEFECTS; ECZEMA-HERPETICUM; ATOPIC-DERMATITIS; PATIENT; SMALLPOX; INFECTIONS; MANAGEMENT; CONTACT		[Mackool, Bonnie T.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Goverman, Jeremy] Massachusetts Gen Hosp, Dept Surg, Div Burns, Boston, MA 02114 USA; [Nazarian, Rosalynn M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mackool, Bonnie T.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Goverman, Jeremy] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Nazarian, Rosalynn M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mackool, BT (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Nazarian, Rosalynn/AFL-3176-2022; Goverman, Jeremy/AAZ-6769-2020	Nazarian, Rosalynn/0000-0003-4003-7193; 				Akhyani M, 2005, BMC DERMATOL, V5, DOI 10.1186/1471-5945-5-5; ATHERTON DJ, 1982, PRACTITIONER, V226, P971; Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010; Bartralot R, 1996, CLIN EXP DERMATOL, V21, P127, DOI 10.1046/j.1365-2230.1996.d01-187.x; Boyd DA, 2009, EMERG INFECT DIS, V15, P1102, DOI 10.3201/eid1507.090093; Cushing R D, 1972, Mich Med, V71, P611; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; DUDGEON JA, 1987, BRIT MED J, V294, P905, DOI 10.1136/bmj.294.6576.905-b; Erdag G, 2011, J CUTAN PATHOL, V38, P919, DOI 10.1111/j.1600-0560.2011.01737.x; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Hayashi S, 1997, CLIN EXP DERMATOL, V22, P41, DOI 10.1046/j.1365-2230.1997.1920609.x; Herndon DN., 2017, TOTAL BURN CARE, V5th; Howell MD, 2006, J ALLERGY CLIN IMMUN, V117, P836, DOI 10.1016/j.jaci.2005.12.1345; HUFF JC, 1981, J AM ACAD DERMATOL, V5, P550, DOI 10.1016/S0190-9622(81)70115-4; HUR W, 1994, J AM ACAD DERMATOL, V30, P860, DOI 10.1016/S0190-9622(94)70099-0; Kang SH, 2004, J DERMATOL, V31, P60, DOI 10.1111/j.1346-8138.2004.tb00507.x; Kaposi M, 1887, PATHOLOGIE THERAPIE; Khundkar R, 2010, BURNS, V36, P751, DOI [10.1016/j.burns.2009.04.008, 10.1016/j.burns.2008.11.018]; Kosann MK, 2003, J AM ACAD DERMATOL, V49, P914, DOI 10.1016/S0190-9622(03)00854-5; Kucukyilmaz I, 2004, J AM ACAD DERMATOL, V51, P1040; Kucukyilmaz Isil, 2004, J Am Acad Dermatol, V51, pS169, DOI 10.1016/j.jaad.2004.05.011; Mallo-Garcia Susana, 2008, Dermatol Online J, V14, P21; MARTINSCASTRO R, 1974, INT J DERMATOL, V13, P271, DOI 10.1111/j.1365-4362.1974.tb05080.x; MASESSA JM, 1989, J AM ACAD DERMATOL, V21, P133, DOI 10.1016/S0190-9622(89)80352-4; McGirt LY, 2006, J ALLERGY CLIN IMMUN, V118, P202, DOI 10.1016/j.jaci.2006.04.033; MORGANROTH GS, 1992, J AM ACAD DERMATOL, V27, P1030, DOI 10.1016/S0190-9622(08)80278-2; NAHMIAS AJ, 1968, ARCH DERMATOL, V97, P147, DOI 10.1001/archderm.97.2.147; Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037; Ram-Wolff C, 2010, AM J DERMATOPATH, V32, P755, DOI 10.1097/DAD.0b013e3181cfbfbf; Rodriguez-Serna M, 2004, J EUR ACAD DERMATOL, V18, P711, DOI 10.1111/j.1468-3083.2004.01041.x; SANDERSON IR, 1987, BMJ-BRIT MED J, V294, P693, DOI 10.1136/bmj.294.6573.693; Santmyire-Rosenberger BR, 2005, J AM ACAD DERMATOL, V53, P52, DOI 10.1016/j.jaad.2005.01.140; VERBOV J, 1972, BRIT J DERMATOL, V86, P638, DOI 10.1111/j.1365-2133.1972.tb05082.x; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Wollenberg A, 2003, J ALLERGY CLIN IMMUN, V112, P667, DOI 10.1016/j.jaci.2003.07.001; Wollenberg A, 2003, J AM ACAD DERMATOL, V49, P198, DOI 10.1067/S0190-9622(03)00896-X; Wollenberg A, 2007, CLIN REV ALLERG IMMU, V33, P35, DOI 10.1007/s12016-007-0032-9; World Health Organization, SMALLP	38	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1825	1834		10.1056/NEJMcpc1111572	http://dx.doi.org/10.1056/NEJMcpc1111572			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571205				2022-12-28	WOS:000303817000013
J	Abel, F; Kilner, D; Sonnappa, S				Abel, F.; Kilner, D.; Sonnappa, S.			Unusual breathing in a 7 year old	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHIARI MALFORMATION		[Abel, F.; Kilner, D.; Sonnappa, S.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Sonnappa, S.] UCL Inst Child Hlth, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Abel, F (corresponding author), Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England.	frantoop@gmail.com		Abel, Francois/0000-0002-5764-3416				American Academy of Sleep Medicine, 2007, MAN SCOR SLEEP, P49; Caldarelli M, 2004, CHILD NERV SYST, V20, P332, DOI 10.1007/s00381-003-0880-4; Gagnadoux F, 2006, NEUROLOGY, V66, P136, DOI 10.1212/01.wnl.0000191394.53786.62; Murray C, 2006, ARCH DIS CHILD, V91, P342, DOI 10.1136/adc.2005.085324; Zolty P, 2000, SLEEP, V23, P637	5	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e3022	10.1136/bmj.e3022	http://dx.doi.org/10.1136/bmj.e3022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XB	22573698				2022-12-28	WOS:000304083800005
J	Minton, JW; Pickett, KE; Dorling, D				Minton, Jonathan William; Pickett, Kate E.; Dorling, Danny			Health, employment, and economic change, 1973-2009: repeated cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CONSEQUENCES; UNEMPLOYMENT; ILLNESS; SICKNESS; BRITAIN	Objective To see whether adverse relations between social class, health, and economic activity, observed between 1973 and 1993 and previously identified in a 1996 BMJ paper, were still apparent between 1994 and 2009 despite improvements in the general economic climate and overall population health. Design Replication of repeated cross sectional analysis from the original paper, using the same source (the General Household Survey) and occupation coding scheme, but extended from the period 1973-93 to 1973-2009, and including women as well as men. Subjects Men and women aged 20-59 years in each annual survey between 1973 and 2009. Main outcome measures Change over time in class specific rates of employment, unemployment, and economic inactivity within subgroups of respondents. Results Overall employment rates have decreased for men of working age while increasing for working age women. For men in particular, the gradient of these changes seems to depend on occupational group. Over 37 years, the differences in occupational group specific economic inactivity and employment rates between people reporting and those not reporting a limiting long term illness has increased substantially. Conclusion Between 1973 and 2009, the relation between good health and securing and sustaining employment has strengthened for both men and women. For men, this has been due to employment rates decreasing and economic inactivity rates increasing among men with poor health. For women, this has largely been due to a general trend of increased employment and reduced economic inactivity occurring among healthier women but not in women of poorer health. Some evidence suggests that, since 2005, the relation between health, employment, and economic inactivity for women in the top two occupational groups has become more like that for men, with poor health becoming associated with reducing employment rates.	[Minton, Jonathan William] Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; [Pickett, Kate E.] Univ York, Dept Hlth Sci, Heslington YO20 5DD, England; [Dorling, Danny] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of York - UK; University of Sheffield	Minton, JW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.	j.minton@sheffield.ac.uk			National Institute for Health Research [CSA/03/07/014] Funding Source: researchfish; Department of Health [CSA/03/07/014] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Aylward M, 2005, SCI CONCEPTUAL BASIS; Bambra C, 2009, J EPIDEMIOL COMMUN H, V63, P92, DOI 10.1136/jech.2008.077354; Bartley M, 1997, BRIT MED J, V314, P1194, DOI 10.1136/bmj.314.7088.1194; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; Bartley M, 1996, BRIT MED J, V313, P445; Barton J, 2001, SOCIAL SURV METHODOL, V49, P15; Beatty C, 2005, REG STUD, V39, P837, DOI 10.1080/00343400500289804; Beatty C, 2002, REG STUD, V36, P811, DOI 10.1080/0034340022000012261; Beatty C, 2000, REG STUD, V34, P617, DOI 10.1080/00343400050178429; Bellaby P, 1999, WORK EMPLOY SOC, V13, P461; Bockerman P, 2009, HEALTH ECON, V18, P161, DOI 10.1002/hec.1361; Burstrom B, 2010, SOC SCI MED, V70, P912, DOI 10.1016/j.socscimed.2009.11.014; Christensen U, 2008, EUR J PUBLIC HEALTH, V18, P454, DOI 10.1093/eurpub/ckn049; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Griffiths S, 2011, SOUNDINGS, V47, P7, DOI [10.3898/136266211795427503, DOI 10.3898/136266211795427503]; Kennedy S, 2011, WORK CAPABILITY ASSE; Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64; LAHELMA E, 2001, CURRENT SOCIOLOGY, V0049; Lindholm C, 2002, J EPIDEMIOL COMMUN H, V56, P188, DOI 10.1136/jech.56.3.188; Lindholm C, 2001, SCAND J PUBLIC HEALT, V29, P63, DOI 10.1177/14034948010290011201; Office for National Statistics, 2008, SUMM QUAL REP GEN HO; Office for National Statistics, 2011, FUT GEN LIF SURV UPD; Webster D, 2006, LOCAL ECON, V21, P107, DOI 10.1080/02690940600679300; WorkSafe Victoria, 2020, WORK RELATED VIOLENC	24	48	48	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e2316	10.1136/bmj.e2316	http://dx.doi.org/10.1136/bmj.e2316			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XB	22573646	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000304083800001
J	Robertson, A				Robertson, Alan			Are doctors justified in taking industrial action in defence of their pensions? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMA Pens Comm, London WC1H 9JP, England		Robertson, A (corresponding author), BMA Pens Comm, London WC1H 9JP, England.	alanjrobertson.uk@gmail.com						BMA, PENS SURV 2012; Office of Budget Responsibility, 2010, FISC SUPPL TABL 1 5; Public Accounts Committee, 2011, 38 PUBL ACC COMM	3	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3242	10.1136/bmj.e3242	http://dx.doi.org/10.1136/bmj.e3242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569869				2022-12-28	WOS:000304083400020
J	Van Langenhove, L				Van Langenhove, Luk			Make social sciences relevant	NATURE			English	Editorial Material									[Van Langenhove, Luk] United Nations Univ, Inst Comparat Reg Integrat Studies, Brugge, Belgium		Van Langenhove, L (corresponding author), United Nations Univ, Inst Comparat Reg Integrat Studies, Brugge, Belgium.	lvanlangenhove@cris.unu.edu		Van Langenhove, Luk/0000-0002-8202-5804				[Anonymous], 2010, WORLD SOC SCI REP 20; Jonkers K., 2011, BIBLIOMETRIC REPORT; Van Langenhove L., 2007, INNOVATING SOCIAL SC	3	9	9	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					442	442		10.1038/484442a	http://dx.doi.org/10.1038/484442a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538586	Bronze			2022-12-28	WOS:000303200400021
J	Fassnacht, M; Terzolo, M; Allolio, B; Baudin, E; Haak, H; Berruti, A; Welin, S; Schade-Brittinger, C; Lacroix, A; Jarzab, B; Sorbye, H; Torpy, DJ; Stepan, V; Schteingart, DE; Arlt, W; Kroiss, M; Leboulleux, S; Sperone, P; Sundin, A; Hermsen, I; Hahner, S; Willenberg, HS; Tabarin, A; Quinkler, M; de la Fouchardiere, C; Schlumberger, M; Mantero, F; Weismann, D; Beuschlein, F; Gelderblom, H; Wilmink, H; Sender, M; Edgerly, M; Kenn, W; Fojo, T; Muller, HH; Skogseid, B				Fassnacht, Martin; Terzolo, Massimo; Allolio, Bruno; Baudin, Eric; Haak, Harm; Berruti, Alfredo; Welin, Staffan; Schade-Brittinger, Carmen; Lacroix, Andre; Jarzab, Barbara; Sorbye, Halfdan; Torpy, David J.; Stepan, Vinzenz; Schteingart, David E.; Arlt, Wiebke; Kroiss, Matthias; Leboulleux, Sophie; Sperone, Paola; Sundin, Anders; Hermsen, Ilse; Hahner, Stefanie; Willenberg, Holger S.; Tabarin, Antoine; Quinkler, Marcus; de la Fouchardiere, Christelle; Schlumberger, Martin; Mantero, Franco; Weismann, Dirk; Beuschlein, Felix; Gelderblom, Hans; Wilmink, Hanneke; Sender, Monica; Edgerly, Maureen; Kenn, Werner; Fojo, Tito; Muller, Hans-Helge; Skogseid, Britt		FIRM-ACT Study Grp	Combination Chemotherapy in Advanced Adrenocortical Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; SOUTHWEST-ONCOLOGY-GROUP; CLINICAL MANAGEMENT; MITOTANE; CANCER; ENDOCRINE; CISPLATIN; ETOPOSIDE; DOXORUBICIN; SERIES	BACKGROUND Adrenocortical carcinoma is a rare cancer that has a poor response to cytotoxic treatment. METHODS We randomly assigned 304 patients with advanced adrenocortical carcinoma to receive mitotane plus either a combination of etoposide (100 mg per square meter of body-surface area on days 2 to 4), doxorubicin (40 mg per square meter on day 1), and cisplatin (40 mg per square meter on days 3 and 4) (EDP) every 4 weeks or streptozocin (streptozotocin) (1 g on days 1 to 5 in cycle 1; 2 g on day 1 in subsequent cycles) every 3 weeks. Patients with disease progression received the alternative regimen as second-line therapy. The primary end point was overall survival. RESULTS For first-line therapy, patients in the EDP-mitotane group had a significantly higher response rate than those in the streptozocin-mitotane group (23.2% vs. 9.2%, P<0.001) and longer median progression-free survival (5.0 months vs. 2.1 months; hazard ratio, 0.55; 95% confidence interval [CI], 0.43 to 0.69; P<0.001); there was no significant between-group difference in overall survival (14.8 months and 12.0 months, respectively; hazard ratio, 0.79; 95% CI, 0.61 to 1.02; P=0.07). Among the 185 patients who received the alternative regimen as second-line therapy, the median duration of progression-free survival was 5.6 months in the EDP-mitotane group and 2.2 months in the streptozocin-mitotane group. Patients who did not receive the alternative second-line therapy had better overall survival with first-line EDP plus mitotane (17.1 month) than with streptozocin plus mitotane (4.7 months). Rates of serious adverse events did not differ significantly between treatments. CONCLUSIONS Rates of response and progression-free survival were significantly better with EDP plus mitotane than with streptozocin plus mitotane as first-line therapy, with similar rates of toxic events, although there was no significant difference in overall survival. (Funded by the Swedish Research Council and others; FIRM-ACT ClinicalTrials.gov number, NCT00094497.)	[Fassnacht, Martin; Allolio, Bruno; Kroiss, Matthias; Hahner, Stefanie; Weismann, Dirk] Univ Hosp, Dept Internal Med 1, Wurzburg, Germany; [Kenn, Werner] Univ Hosp, Dept Radiol, Wurzburg, Germany; [Fassnacht, Martin; Allolio, Bruno; Kenn, Werner] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Terzolo, Massimo] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Baudin, Eric; Leboulleux, Sophie; Schlumberger, Martin] Inst Gustave Roussy, Serv Med Nucl & Cancerol Endocrinienne, Villejuif, France; [Haak, Harm; Hermsen, Ilse] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands; [Welin, Staffan] Univ Uppsala Hosp, Dept Endocrine Oncol, Uppsala, Sweden; [Schade-Brittinger, Carmen] Univ Marburg, Coordinating Ctr Clin Trials, Marburg, Germany; [Lacroix, Andre] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada; [Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med & Endocrine Oncol, Gliwice, Poland; [Jarzab, Barbara] Inst Oncol, Gliwice, Poland; [Sorbye, Halfdan] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Torpy, David J.] Royal Adelaide Hosp, Endocrine & Metab Unit, Adelaide, SA 5000, Australia; [Stepan, Vinzenz] Elisabethinen Hosp, Dept Internal Med, Graz, Austria; [Schteingart, David E.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Arlt, Wiebke] Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Sundin, Anders] Karolinska Inst, Dept Radiol, Inst Mol Med & Surg, Stockholm, Sweden; [Willenberg, Holger S.] Univ Dusseldorf, Dept Endocrinol Diabet & Rheumatol, Fac Med, D-40225 Dusseldorf, Germany; [Tabarin, Antoine] Univ Bordeaux, Dept Endocrinol, Bordeaux, France; [Quinkler, Marcus] Charite, Charite Campus Mitte, D-13353 Berlin, Germany; [de la Fouchardiere, Christelle] Ctr Leon Berard, F-69373 Lyon, France; [Mantero, Franco] Univ Padua, Sch Med, Endocrine Unit, Dept Med & Surg Sci, Padua, Italy; [Beuschlein, Felix] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Gelderblom, Hans] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [Wilmink, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [Sender, Monica] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden; [Edgerly, Maureen; Fojo, Tito] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Muller, Hans-Helge] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Skogseid, Britt] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Turin; UNICANCER; Gustave Roussy; Maxima Medical Center; Uppsala University; Uppsala University Hospital; Philipps University Marburg; Universite de Montreal; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Bergen; Haukeland University Hospital; Royal Adelaide Hospital; University of Michigan System; University of Michigan; Karolinska Institutet; Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Universite de Bordeaux; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UNICANCER; Centre Leon Berard; University of Padua; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Sahlgrenska University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Munich; Uppsala University	Fassnacht, M (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.	fassnacht_m@medizin.uni-wuerzburg.de	Sbiera, Silviu/E-8128-2019; Jarząb, Michał/G-4319-2012; Levesque, Isabelle/A-1899-2012; Fassnacht, Martin/N-9614-2019; Berruti, Alfredo/AAC-2069-2019; Lacroix, Andre/AAI-5645-2020; de la Fouchardiere, Christelle/AAW-7887-2021; leboulleux, sophie/AAW-6534-2020; Jarząb, Barbara/AAI-7942-2020; Kroiss, Matthias/AAF-1624-2019; Arlt, Wiebke/B-6310-2009; Barbara, Jarzab/I-4654-2019; Kroiss, Matthias/B-4785-2014; DO CAO, CHRISTINE/M-7950-2018; Terzolo, Massimo/D-5051-2015	Sbiera, Silviu/0000-0002-6271-5533; Jarząb, Michał/0000-0002-2642-9724; Fassnacht, Martin/0000-0001-6170-6398; Jarząb, Barbara/0000-0001-9811-9584; Kroiss, Matthias/0000-0002-7628-3161; Arlt, Wiebke/0000-0001-5106-9719; Kroiss, Matthias/0000-0002-7628-3161; Quinkler, Marcus/0000-0003-4028-1671; /0000-0001-9732-4543; della casa, silvia/0000-0002-1245-753X; Beuschlein, Felix/0000-0001-7826-3984; , Sophie/0000-0002-4824-8502; Gelderblom, Hans/0000-0001-9270-8636; DO CAO, CHRISTINE/0000-0002-1617-0149; DeVries, J. Hans/0000-0001-9196-9906; Hahner, Stefanie/0000-0003-1616-8986; CHABRE, Olivier/0000-0001-8756-7218; Terzolo, Massimo/0000-0002-4171-2851	German Ministry of Education and Research [01KG0501]; Italian Ministry of University and Research [PRIN 20085 P5S49]; Institut Gustave-Roussy Clinical Research Unit; Cortical and Medullary Endocrine Tumors Network of the French Institut National du Cancer; Swedish Cancer Society; Swedish Research Council; HRA Pharma; NATIONAL CANCER INSTITUTE [ZIABC010626] Funding Source: NIH RePORTER; MRC [G0801473] Funding Source: UKRI; Medical Research Council [G0801473] Funding Source: researchfish	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Institut Gustave-Roussy Clinical Research Unit; Cortical and Medullary Endocrine Tumors Network of the French Institut National du Cancer; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); HRA Pharma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the German Ministry of Education and Research (01KG0501), the Italian Ministry of University and Research (PRIN 20085 P5S49), Institut Gustave-Roussy Clinical Research Unit, the Cortical and Medullary Endocrine Tumors Network of the French Institut National du Cancer, the Swedish Cancer Society, and the Swedish Research Council. Nested in the FIRM-ACT trial, a study on the pharmacokinetics of mitotane was organized in 40 patients who were enrolled in the FIRM-ACT trial. This substudy was funded by HRA Pharma.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Abraham J, 2002, CANCER-AM CANCER SOC, V94, P2333, DOI 10.1002/cncr.10487.abs; Assie G, 2007, J CLIN ENDOCR METAB, V92, P148, DOI 10.1210/jc.2006-0706; Baudin E., 2011, Hormones & Cancer, V2, P363, DOI 10.1007/s12672-011-0094-2; Baudin E, 2001, CANCER, V92, P1385, DOI 10.1002/1097-0142(20010915)92:6&lt;1385::AID-CNCR1461&gt;3.0.CO;2-2; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P657, DOI 10.1677/erc.1.01025; Berruti A, 1998, CANCER, V83, P2194, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2194::AID-CNCR19>3.3.CO;2-V; Berruti A, 2008, EXPERT OPIN EMERG DR, V13, P497, DOI 10.1517/14728214.13.3.497 ; Berruti A, 2012, EUR J ENDOCRINOL, V166, P451, DOI 10.1530/EJE-11-0918; BUKOWSKI RM, 1993, J CLIN ONCOL, V11, P161, DOI 10.1200/JCO.1993.11.1.161; Cancer Therapy Evaluation Program, 1999, COMM TERM CRIT ADV E; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Fassnacht M, 2009, PHARMACOL THERAPEUT, V123, P117, DOI 10.1016/j.pharmthera.2009.03.013; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Gross DJ, 2006, ENDOCR-RELAT CANCER, V13, P535, DOI 10.1677/erc.1.01124; HAAK HR, 1994, BRIT J CANCER, V69, P947, DOI 10.1038/bjc.1994.183; Hermsen IG, 2011, J CLIN ENDOCR METAB, V96, P1844, DOI 10.1210/jc.2010-2676; Icard P, 2001, WORLD J SURG, V25, P891, DOI 10.1007/s00268-001-0047-y; Kebebew E, 2006, WORLD J SURG, V30, P872, DOI 10.1007/s00268-005-0329-x; Khan TS, 2000, ANN ONCOL, V11, P1281, DOI 10.1023/A:1008377915129; Kroiss M, 2011, CLIN ENDOCRINOL, V75, P585, DOI 10.1111/j.1365-2265.2011.04214.x; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Lughezzani G, 2010, EUR J CANCER, V46, P713, DOI 10.1016/j.ejca.2009.12.007; Malandrino P, 2010, ENDOCR-RELAT CANCER, V17, P797, DOI 10.1677/ERC-09-0341; Quinkler M, 2008, J CLIN ENDOCR METAB, V93, P2057, DOI 10.1210/jc.2007-2564; Schteingart DE, 2005, ENDOCR-RELAT CANCER, V12, P667, DOI 10.1677/erc.1.01029; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; van Erp NP, 2011, EUR J ENDOCRINOL, V164, P621, DOI 10.1530/EJE-10-0956; Williamson SK, 2000, CANCER, V88, P1159, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1159::AID-CNCR28>3.3.CO;2-I; Wortmann S, 2010, EUR J ENDOCRINOL, V162, P349, DOI 10.1530/EJE-09-0804; Zini L, 2011, EUR UROL, V60, P1055, DOI 10.1016/j.eururo.2011.07.062	34	491	511	3	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2012	366	23					2189	2197		10.1056/NEJMoa1200966	http://dx.doi.org/10.1056/NEJMoa1200966			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953JO	22551107	Green Published, Bronze			2022-12-28	WOS:000304863400008
J	Cifuentes, L; Ziai, M				Cifuentes, Liliana; Ziai, Mahzad			Nevus Sebaceous	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cifuentes, Liliana; Ziai, Mahzad] Tech Univ Munich, Munich, Germany	Technical University of Munich	Cifuentes, L (corresponding author), Tech Univ Munich, Munich, Germany.	mahzad_ziai@hotmail.com							0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1923	1923		10.1056/NEJMicm1111099	http://dx.doi.org/10.1056/NEJMicm1111099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591298				2022-12-28	WOS:000304083000011
J	Dyer, C				Dyer, Clare			MEDICAL REGULATION David Southall: anatomy of a wrecked career	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTORS; COUNCIL; STOKE; SAGA; CNEP		BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	claredyer@aol.com						[Anonymous], 2006, PEDIATRICS, V117, P2247; Catto G, 2010, J ROY SOC MED, V103, P313, DOI 10.1258/jrsm.2009.09k076; Dyer C, 2001, BRIT MED J, V322, P1266; Dyer C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6248; Gornall J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a907; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; Mayor S, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745; Modi N, 2011, ARCH DIS CHILD, V96, P500, DOI 10.1136/adc.2010.188243; Southall DP, 1997, PEDIATRICS, V100, P735, DOI 10.1542/peds.100.5.735	9	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 16	2012	344								e3377	10.1136/bmj.e3377	http://dx.doi.org/10.1136/bmj.e3377			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YO	22592849				2022-12-28	WOS:000304087800003
J	Bach, RG				Bach, Richard G.			Low-dose rivaroxaban reduced mortality in patients with a recent acute coronary syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Bach, RG (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.		Bach, Richard/AAI-2515-2021; Bach, Richard G/G-9764-2011					Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-3	10.7326/0003-4819-156-10-201205150-02003	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586021				2022-12-28	WOS:000304193400002
J	Hogan, DJ				Hogan, Daniel J.			Review: Limited evidence suggests that clobetasol or mometasone is effective in genital lichen sclerosus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hogan, Daniel J.] Bay Pines VA Healthcare Syst, Bay Pines, FL 33744 USA; [Hogan, Daniel J.] NOVA SE Univ Coll Osteopath Med, Bay Pines, FL USA	Nova Southeastern University	Hogan, DJ (corresponding author), Bay Pines VA Healthcare Syst, Bay Pines, FL 33744 USA.							Bunker CB, 2011, BRIT J DERMATOL, V164, P894, DOI 10.1111/j.1365-2133.2010.10183.x; Choschzick M, 2011, INT J GYNECOL PATHOL, V30, P497, DOI 10.1097/PGP.0b013e3182184c7a; Lewis F M, 1997, Am J Contact Dermat, V8, P137, DOI 10.1016/S1046-199X(97)90092-0; Schorge JO, 2008, WILLIAMS GYNECOLOGY	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-10	10.7326/0003-4819-156-10-201205150-02010	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586028				2022-12-28	WOS:000304193400009
J	Whalen, F				Whalen, Francis			A 5-item calculator predicted risk for postoperative respiratory failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SURGERY		Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Whalen, F (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			Morrow, Lee/0000-0001-9001-3419				Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Fernandez-Perez ER, 2009, THORAX, V64, P121, DOI 10.1136/thx.2008.102228; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-13	10.7326/0003-4819-156-10-201205150-02013	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586031				2022-12-28	WOS:000304193400012
J	Khan, KS; Champaneria, R; Latthe, PM				Khan, Khalid S.; Champaneria, Rita; Latthe, Pallavi M.			UNCERTAINTIES PAGE How effective are non-drug, non-surgical treatments for primary dysmenorrhoea?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UTEROSACRAL NERVE ABLATION; CHRONIC PELVIC PAIN; MEFENAMIC-ACID; TOPICAL HEAT; DOUBLE-BLIND; LOW-LEVEL; WOMEN; ACUPUNCTURE; EFFICACY; TRIAL		[Champaneria, Rita] Univ Birmingham, Sch Canc Sci, Robert Aitken Inst, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Khan, Khalid S.] Barts & London Queen Marys Sch Med & Dent, London E1 2DD, England; [Latthe, Pallavi M.] Birmingham Womens NHS Fdn Trust, Birmingham B15 2TG, W Midlands, England	University of Birmingham; University of London; Queen Mary University London	Champaneria, R (corresponding author), Univ Birmingham, Sch Canc Sci, Robert Aitken Inst, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England.	r.champaneria@bham.ac.uk	Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312; Latthe, Pallavi/0000-0003-0529-0409				Akin M, 2004, J REPROD MED, V49, P739; Akin MD, 2001, OBSTET GYNECOL, V97, P343, DOI 10.1016/S0029-7844(00)01163-7; Aslam N, 2009, BJOG-INT J OBSTET GY, V116, P1551, DOI 10.1111/j.1471-0528.2009.02305.x; Azlin MIN, 2008, J OBSTET GYNAECOL, V28, P424, DOI 10.1080/01443610802150051; Barbosa ICF, 2007, REV BRASILEIRA MED, V64, P318; Daniels JP, 2010, HUM REPROD UPDATE, V16, P568, DOI 10.1093/humupd/dmq031; Daniels J, 2009, JAMA-J AM MED ASSOC, V302, P955, DOI 10.1001/jama.2009.1268; Daniels JP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4834; Daniels S, 2008, J WOMENS HEALTH, V17, P423, DOI 10.1089/jwh.2007.0416; Daniels S, 2009, CLIN THER, V31, P1192, DOI 10.1016/j.clinthera.2009.06.003; Deutch B, 2000, NUTR RES, V20, P621, DOI 10.1016/S0271-5317(00)00152-4; Fugh-Berman A, 2003, REPROD TOXICOL, V17, P137, DOI 10.1016/S0890-6238(02)00128-4; GUYATT GH, 1990, CONTROL CLIN TRIALS, V11, P88, DOI 10.1016/0197-2456(90)90003-K; Kempf D, 2009, FORSCH KOMPLEMENTMED, V16, P6, DOI 10.1159/000193294; Khan KS., 2009, GYNECOLOGY RANDOMIZE, P519; Latthe PM, 2011, CLIN EVID ONLINE; Mandrekar SJ, 2009, J BIOPHARM STAT, V19, P530, DOI 10.1080/10543400902802458; Marjoribanks J, 2003, COCHRANE DB SYST REV, V4; Nahid K, 2009, J MIDWIFERY WOM HEAL, V54, P401, DOI 10.1016/j.jmwh.2008.12.006; Ozgoli G, 2009, J ALTERN COMPLEM MED, V15, P129, DOI 10.1089/acm.2008.0311; Proctor M, 2007, COCHRANE DB SYST REV, V3; Proctor M, 2006, COCHRANE DB SYST REV, V3; Proctor ML, 2005, COCHRANE DB SYST REV, V4; Proctor ML., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002123; Proctor ML, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002124; Vercellini P, 2005, CURR OPIN OBSTET GYN, V17, P359, DOI 10.1097/01.gco.0000175353.03061.7f; Wang MC, 2009, J ALTERN COMPLEM MED, V15, P235, DOI 10.1089/acm.2008.0164; Wang SF, 2009, NEUROMODULATION, V12, P302, DOI 10.1111/j.1525-1403.2009.00226.x; Witt CM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.041; WONG CL, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002120.PUB3; Wu Ren-Ding, 2007, Zhongguo Zhen Jiu, V27, P815; Yang H, 2008, ACTA OBSTET GYN SCAN, V87, P1114, DOI 10.1080/00016340802443798; Zhi Liang-xi, 2007, Zhongguo Zhen Jiu, V27, P18; Zhu X, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005288.pub3; Ziaei S, 2005, BJOG-INT J OBSTET GY, V112, P466, DOI 10.1111/j.1471-0528.2004.00495.x	35	9	9	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2012	344								e3011	10.1136/bmj.e3011	http://dx.doi.org/10.1136/bmj.e3011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XW	22586231				2022-12-28	WOS:000304085900002
J	Erler, JT; Linding, RN				Erler, Janine T.; Linding, Rune			Network Medicine Strikes a Blow against Breast Cancer	CELL			English	Editorial Material							REVEALS	Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time-and order-dependent drug combinations can be more efficacious in killing cancer cells.	[Erler, Janine T.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Linding, Rune] Tech Univ Denmark DTU, Dept Syst Biol, Ctr Biol Sequence Anal CBS, Cellular Signal Integrat Grp C SIG, DK-2800 Lyngby, Denmark	University of Copenhagen; Technical University of Denmark	Erler, JT (corresponding author), Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark.	janine.erler@bric.ku.dk; linding@cbs.dtu.dk		Erler, Janine/0000-0001-8675-6527; Linding, Rune/0000-0003-0420-4839	Danish Council for Independent Research; Lundbeck Foundation; Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Career Development Award from Human Frontier Science Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	Thanks to Pau Creixell (C-SIG, DTU) for essential input and help with the manuscript and creation of the figure. R. L. is supported by a Sapere Aude Starting Grant from The Danish Council for Independent Research, a Lundbeck Foundation Group Leader Fellowship, and a Career Development Award from Human Frontier Science Program. J.T.E. is supported by a Hallas Moller Stipend from the Novo Nordisk Foundation. See http://www.networkbio.org, http://www.lindinglab.org, and http://www.erlerlab.org for more information on cancer-related network biology.	Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Erler JT, 2010, J PATHOL, V220, P290, DOI 10.1002/path.2646; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jorgensen C, 2010, CURR OPIN GENET DEV, V20, P15, DOI 10.1016/j.gde.2009.12.003; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352	9	41	42	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					731	733		10.1016/j.cell.2012.04.014	http://dx.doi.org/10.1016/j.cell.2012.04.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579276	Bronze			2022-12-28	WOS:000303934700005
J	Mulholland, EK; Griffiths, UK; Biellik, R				Mulholland, E. Kim; Griffiths, Ulla Kou; Biellik, Robin			Measles in the 21st Century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mulholland, E. Kim; Griffiths, Ulla Kou] London Sch Hyg & Trop Med, London, England; [Mulholland, E. Kim] Menzies Sch Hlth Res, Darwin, NT, Australia; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of London; London School of Hygiene & Tropical Medicine; Charles Darwin University; Menzies School of Health Research; Murdoch Children's Research Institute	Mulholland, EK (corresponding author), London Sch Hyg & Trop Med, London, England.							[Anonymous], 2011, WKLY EPIDEMIOL REC, V86, P86; Martins CL, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a661; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; MULHOLLAND K, 1995, LANCET, V345, P305, DOI 10.1016/S0140-6736(95)90282-1; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X	5	33	34	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1755	1757		10.1056/NEJMp1202396	http://dx.doi.org/10.1056/NEJMp1202396			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NB	22571199	Green Published			2022-12-28	WOS:000303817000003
J	Kolodkin-Gal, I; Cao, SG; Chai, L; Bottcher, T; Kolter, R; Clardy, J; Losick, R				Kolodkin-Gal, Ilana; Cao, Shugeng; Chai, Liraz; Boettcher, Thomas; Kolter, Roberto; Clardy, Jon; Losick, Richard			RETRACTED: A Self-Produced Trigger for Biofilm Disassembly that Targets Exopolysaccharide (Retracted article. See vol. 161, pg. 946, 2015)	CELL			English	Article; Retracted Publication							D-AMINO ACIDS; BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; AMYLOID FIBERS; SUBSTANCES; MATRIX	Biofilms are structured communities of bacteria that are held together by an extracellular matrix consisting of protein and exopolysaccharide. Biofilms often have a limited lifespan, disassembling as nutrients become exhausted and waste products accumulate. D-amino acids were previously identified as a self-produced factor that mediates biofilm disassembly by causing the release of the protein component of the matrix in Bacillus subtilis. Here we report that B. subtilis produces an additional biofilm-disassembly factor, norspermidine. Dynamic light scattering and scanning electron microscopy experiments indicated that norspermidine interacts directly and specifically with exopolysaccharide. D-amino acids and norspermidine acted together to break down existing biofilms and mutants blocked in the production of both factors formed long-lived biofilms. Norspermidine, but not closely related polyamines, prevented biofilm formation by B. subtilis, Escherichia coli, and Staphylococcus aureus.	[Cao, Shugeng; Boettcher, Thomas; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kolodkin-Gal, Ilana; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chai, Liraz; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; losick@mcb.harvard.edu			German Academy of Sciences Leopoldina [LPDS 2009-45]; National Institutes of Health [GM18568, GM58213, GM82137, GM086258, AI057159]; BASF Advanced Research Initiative at Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082137, R01GM058213, R01GM086258, R01GM018568, R37GM018568] Funding Source: NIH RePORTER	German Academy of Sciences Leopoldina; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF Advanced Research Initiative at Harvard University(BASF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kodger for help with dynamic light scattering, C. Marks and A. Grahame for their help with sample preparation for electron microscopy imaging, and the Harvard Center for Nanoscale Systems for use of its Imaging Facility. I. K.-G. is a fellow of the Human Fronteir Science Program. T. B. was supported by German Academy of Sciences Leopoldina (LPDS 2009-45), Leopoldina Research Fellowship. This work was supported by National Institutes of Health grants GM18568 to R. L., GM58213 and GM82137 to R. K., GM086258 and AI057159 to J.C. and by the BASF Advanced Research Initiative at Harvard University to R. L. and R. K. Harvard University has filed a patent application based on this work.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; McSwain BS, 2005, APPL ENVIRON MICROB, V71, P1051, DOI 10.1128/AEM.71.2.1051-1057.2005; Molnar-Perl I, 2003, J CHROMATOGR A, V987, P291, DOI 10.1016/S0021-9673(02)01537-6; Nagorska K, 2007, ACTA BIOCHIM POL, V54, P495; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Orgad O, 2011, BIOFOULING, V27, P787, DOI 10.1080/08927014.2011.603145; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Romero D, 2011, TRENDS MICROBIOL, V19, P304, DOI 10.1016/j.tim.2011.03.003; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vinayahan T, 2010, BIOMACROMOLECULES, V11, P3367, DOI 10.1021/bm100486p; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008	31	118	136	2	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					684	692		10.1016/j.cell.2012.02.055	http://dx.doi.org/10.1016/j.cell.2012.02.055			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541437	Green Accepted, Bronze			2022-12-28	WOS:000303443100018
J	Mortimer, P				Mortimer, Philip			PERSONAL VIEW As with tuberculosis, earlier identification and treatment is the way to tackle HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION					pandjmortimer@gmail.com						Blattner WA, 2004, J INFECT DIS, V189, P1793, DOI 10.1086/386306; *HLTH PROT AG, NOT INF DIS NOIDS; Hoffstaedt EGW, 1950, LANCET, V256, P756; House of Lords Select Committee on HIV and AIDs in the United Kingdom, 2011, NO VACC NO CUR HIV A; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 27	2012	344								e2874	10.1136/bmj.e2874	http://dx.doi.org/10.1136/bmj.e2874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HE	22544833				2022-12-28	WOS:000303434000002
J	Ryan, AJ; Christensen, PR				Ryan, Andrew J.; Christensen, Philip R.			Coils and Polygonal Crust in the Athabasca Valles Region, Mars, as Evidence for a Volcanic History	SCIENCE			English	Article							FLOOD LAVAS; NEAR-SURFACE; FEATURES; HAWAII; FLOWS; ICE; EMPLACEMENT; INFLATION; DEPOSITS; EQUATOR	Athabasca Valles is a near-equatorial martian outflow channel that contains many well-preserved features whose formation and composition have been a point of contention. Large plates of terrain that have clearly fractured and drifted may have once been ice rafts or the rocky solidification crust of a large lava flow. We have identified 269 spiral coils ranging from 5 to 30 meters wide on the polygonally patterned interplate terrain that are morphologically consistent with terrestrial lava coils that form in zones of flow shear. This patterned terrain also exhibits signs of fracture and drift, indicating that it is platelike as well. The coils in the Athabasca region are inconsistent with ice rheology, and the plates, spirals, and polygons are interpreted to be of volcanic origin.	[Ryan, Andrew J.; Christensen, Philip R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Ryan, AJ (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	andy.ryan@asu.edu		Ryan, Andrew/0000-0002-7535-8416				Balme MR, 2009, EARTH PLANET SC LETT, V285, P1, DOI 10.1016/j.epsl.2009.05.031; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Burr DA, 2005, ICARUS, V178, P56, DOI 10.1016/j.icarus.2005.04.012; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Carr M.H., 1980, NASA SP, P1; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; HON K, 1994, GEOL SOC AM BULL, V106, P351, DOI 10.1130/0016-7606(1994)106<0351:EAIOPS>2.3.CO;2; Jaeger WL, 2007, SCIENCE, V317, P1709, DOI 10.1126/science.1143315; Jaeger WL, 2010, ICARUS, V205, P230, DOI 10.1016/j.icarus.2009.09.011; Katz RF, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/037; Keszthelyi L, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000758; Keszthelyi L, 2006, J GEOL SOC LONDON, V163, P253, DOI 10.1144/0016-764904-503; Keszthelyi LP, 2010, ICARUS, V205, P211, DOI 10.1016/j.icarus.2009.08.020; Levy JS, 2010, ICARUS, V206, P229, DOI 10.1016/j.icarus.2009.09.005; Lockwood J. P., 2000, US GEOL SURV PROF PA, V1613, P1; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P25617, DOI 10.1029/97JE02582; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Page DP, 2007, ICARUS, V189, P83, DOI 10.1016/j.icarus.2007.01.005; PECK DL, 1968, GEOL SOC AM BULL, V79, P1151, DOI 10.1130/0016-7606(1968)79[1151:TFOCJI]2.0.CO;2; PECK DL, 1966, US GEOL SURV PROF B, V550, P148; PLESCIA JB, 1990, ICARUS, V88, P465, DOI 10.1016/0019-1035(90)90095-Q; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; THORPE SA, 1971, J FLUID MECH, V46, P299, DOI 10.1017/S0022112071000557; WALKER GPL, 1991, B VOLCANOL, V53, P546, DOI 10.1007/BF00298155; Watters TR, 2007, SCIENCE, V318, P1125, DOI 10.1126/science.1148112; Zimbelman J., 2011, LUNAR PLANET SCI C, V42, P2443	29	18	18	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					449	452		10.1126/science.1219437	http://dx.doi.org/10.1126/science.1219437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539716				2022-12-28	WOS:000303233400040
J	Maxmen, A				Maxmen, Amy			PUBLIC HEALTH Death at the doorstep	NATURE			English	Editorial Material																		Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Okiro EA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-37; US President's Malaria Initiative, 2011, MAL OP PLAN RWAND FI	3	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S19	S21		10.1038/484S19a	http://dx.doi.org/10.1038/484S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534527	Bronze			2022-12-28	WOS:000303200400002
J	Vos, M; Esposito, G; Edirisinghe, JN; Vilain, S; Haddad, DM; Slabbaert, JR; Van Meensel, S; Schaap, O; De Strooper, B; Meganathan, R; Morais, VA; Verstreken, P				Vos, Melissa; Esposito, Giovanni; Edirisinghe, Janaka N.; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Meganathan, R.; Morais, Vanessa A.; Verstreken, Patrik			Vitamin K-2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency	SCIENCE			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; PARKINSONS-DISEASE; UBIAD1 GENE; MUTATIONS; SCHNYDER; DROSOPHILA-PINK1; IDENTIFICATION; MENAQUINONE-4; DYSFUNCTION	Human UBIAD1 localizes to mitochondria and converts vitamin K-1 to vitamin K-2. Vitamin K-2 is best known as a cofactor in blood coagulation, but in bacteria it is a membrane-bound electron carrier. Whether vitamin K-2 exerts a similar carrier function in eukaryotic cells is unknown. We identified Drosophila UBIAD1/Heix as a modifier of pink1, a gene mutated in Parkinson's disease that affects mitochondrial function. We found that vitamin K-2 was necessary and sufficient to transfer electrons in Drosophila mitochondria. Heix mutants showed severe mitochondrial defects that were rescued by vitamin K-2, and, similar to ubiquinone, vitamin K-2 transferred electrons in Drosophila mitochondria, resulting in more efficient adenosine triphosphate (ATP) production. Thus, mitochondrial dysfunction was rescued by vitamin K-2 that serves as a mitochondrial electron carrier, helping to maintain normal ATP production.	[Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] Leuven Res Inst Neurodegenerat Dis LIND, B-3000 Louvain, Belgium; [Edirisinghe, Janaka N.; Meganathan, R.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Northern Illinois University	Verstreken, P (corresponding author), VIB, Ctr Biol Dis, B-3000 Louvain, Belgium.	patrik.verstreken@med.kuleuven.be	Verstreken, Patrik/AAC-7591-2022; Vilain, Sven/AHA-7944-2022; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	Verstreken, Patrik/0000-0002-5073-5393; De Strooper, Bart/0000-0001-5455-5819; Morais, Vanessa/0000-0002-0830-0548	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen; European Research Council [260678]; Fonds Voor Wetenschappelijk Onderzoek [G074709-G095511-G094011]; KU Leuven; Methusalem grant; Hercules foundation; Francqui foundation; VIB	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen; European Research Council(European Research Council (ERC)European Commission); Fonds Voor Wetenschappelijk Onderzoek(FWO); KU Leuven(KU Leuven); Methusalem grant; Hercules foundation; Francqui foundation; VIB	We thank H. Bellen, J. Park, J. Chung, the Bloomington Drosophila stock center, and the Yale E. coli stock center. Support was provided by an Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen to M.V., a European Research Council Starting Grant (no. 260678), Fonds Voor Wetenschappelijk Onderzoek (G074709-G095511-G094011), the Research Fund KU Leuven, a Methusalem grant, KU Leuven, the Hercules and Francqui foundations, and VIB. The data reported in this paper are tabulated in the main paper and in the supplementary materials. B.D.S. is a paid consultant for Janssen Pharmaceutica (Johnson and Johnson) with regard to Alzheimer's disease and Parkinson's disease.	Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; GARNER A, 1972, BRIT J OPHTHALMOL, V56, P400, DOI 10.1136/bjo.56.5.400; Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Lin E. C. C., 1987, ESCHERICHIA COLI SAL, P202; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; USUI Y, 1989, J CHROMATOGR-BIOMED, V489, P291, DOI 10.1016/S0378-4347(00)82907-2; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Yellore VS, 2007, MOL VIS, V13, P1777	25	246	265	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1306	1310		10.1126/science.1218632	http://dx.doi.org/10.1126/science.1218632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582012	Green Accepted			2022-12-28	WOS:000304905300047
J	Allen, RJ; Sherwood, SC; Norris, JR; Zender, CS				Allen, Robert J.; Sherwood, Steven C.; Norris, Joel R.; Zender, Charles S.			Recent Northern Hemisphere tropical expansion primarily driven by black carbon and tropospheric ozone	NATURE			English	Article								Observational analyses have shown the width of the tropical belt increasing in recent decades as the world has warmed(1). This expansion is important because it is associated with shifts in large-scale atmospheric circulation(2-4) and major climate zones(5,6). Although recent studies have attributed tropical expansion in the Southern Hemisphere to ozone depletion(7-10), the drivers of Northern Hemisphere expansion are not well known and the expansion has not so far been reproduced by climate models(11). Here we use a climate model with detailed aerosol physics to show that increases in heterogeneous warming agents-including black carbon aerosols and tropospheric ozone-are noticeably better than greenhouse gases at driving expansion, and can account for the observed summertime maximum in tropical expansion. Mechanistically, atmospheric heating from black carbon and tropospheric ozone has occurred at the mid-latitudes, generating a poleward shift of the tropospheric jet(12), thereby relocating the main division between tropical and temperate air masses. Although we still underestimate tropical expansion, the true aerosol forcing is poorly known and could also be underestimated. Thus, although the insensitivity of models needs further investigation, black carbon and tropospheric ozone, both of which are strongly influenced by human activities, are the most likely causes of observed Northern Hemisphere tropical expansion.	[Allen, Robert J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Sherwood, Steven C.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven C.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Norris, Joel R.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Zender, Charles S.] Univ Calif Irvine, Irvine, CA 92697 USA	University of California System; University of California Riverside; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Irvine	Allen, RJ (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	rjallen@ucr.edu	Sherwood, Steven/B-5673-2008; Norris, Joel R/A-9785-2008; Zender, Charles S/D-4485-2012	Sherwood, Steven/0000-0001-7420-8216; Norris, Joel R/0000-0003-4384-0977; Zender, Charles S/0000-0003-0129-8024; Allen, Robert/0000-0003-1616-9719	University of California at Riverside	University of California at Riverside	This study was funded by R.J.A.'s University of California at Riverside initial complement. We acknowledge the individual modelling groups, the Program for Climate Model Diagnosis and Intercomparison and the Working Group on Coupled Modeling of the World Climate Research Programme (WCRP) for their part in making available the WCRP CMIP3 multimodel data set. Support of this data set is provided by the Office of Science, US Department of Energy.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Allen R. J., 2011, ATMOS CHEM PHYS DISC, V11, P31643; Allen RJ, 2011, CLIM DYNAM, V36, P1959, DOI 10.1007/s00382-010-0898-8; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Bender F., 2011, CLIM DYNAM; Bond TC, 2006, AEROSOL SCI TECH, V40, P27, DOI 10.1080/02786820500421521; Chung SH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001397; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Collins W.D., 2004, NCARTTN464STR226, DOI 10.5065/ D63N21CH; Durre I, 2006, J CLIMATE, V19, P53, DOI 10.1175/JCLI3594.1; Dwyer JG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012945; Flanner MG, 2009, ATMOS CHEM PHYS, V9, P2481, DOI 10.5194/acp-9-2481-2009; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Fu Q, 2011, J CLIMATE, V24, P5597, DOI 10.1175/JCLI-D-11-00027.1; Hu Y, 2007, ATMOS CHEM PHYS, V7, P5229, DOI 10.5194/acp-7-5229-2007; Jacobowitz H, 2003, B AM METEOROL SOC, V84, P785, DOI 10.1175/BAMS-84-6-785; Johanson CM, 2009, J CLIMATE, V22, P2713, DOI 10.1175/2008JCLI2620.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Lu J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036076; Ming Y, 2011, J CLIMATE, V24, P6077, DOI 10.1175/2011JCLI4111.1; Pavolonis MJ, 2005, J APPL METEOROL, V44, P804, DOI 10.1175/JAM2236.1; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Quaas J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008962; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sato M, 2003, P NATL ACAD SCI USA, V100, P6319, DOI 10.1073/pnas.0731897100; Schulz M, 2006, ATMOS CHEM PHYS, V6, P5225, DOI 10.5194/acp-6-5225-2006; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Son SW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014271; Son SW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038671; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wilks DS., 2006, STAT METHODS ATMOSPH, V3, P133; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Zhou YP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015197	43	174	176	3	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					350	U93		10.1038/nature11097	http://dx.doi.org/10.1038/nature11097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596159	Green Published			2022-12-28	WOS:000304099100038
J	Rao, M; Mant, D				Rao, Mala; Mant, David			Strengthening primary healthcare in India: white paper on opportunities for partnership	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DEVELOPING-COUNTRIES; OUTCOMES FRAMEWORK; CHILD SURVIVAL; PROGRAM; QUALITY; INTERVENTION; METAANALYSIS; MORTALITY; NEWBORN		[Rao, Mala] Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England; [Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2ET, England	University of East London; University of Oxford	Rao, M (corresponding author), Univ E London, Inst Hlth & Human Dev, London E15 4LZ, England.	m.rao@uel.ac.uk						[Anonymous], 2011, HINDU           1019; BAJPAI N, 2009, IMPROVING ACCESS SER; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bray EP, 2010, ANN MED, V42, P371, DOI 10.3109/07853890.2010.489567; Central Surrey Health, TREAT HLTH CAR DIFF; Das J, 2007, J DEV ECON, V83, P1, DOI 10.1016/j.jdeveco.2006.05.004; Department of Health, GP PAT SURV 2007; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Gill Kaveri, 2009, 12009 PEO PLANN COMM; Government of India, 11 5 YEAR PLAN; Government of India, FAST SUST MOR INCL G; Griffin S, 1998, BMJ-BRIT MED J, V317, P390; Gupta Sanjay Kumar, 2010, Indian J Community Med, V35, P396, DOI 10.4103/0970-0218.69262; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Harris M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4945; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Hurst K, 1997, Health Manpow Manage, V23, P197, DOI 10.1108/09552069710187109; International Institute of Population Sciences, 2008, DISTR LEV HOUS SURV; KAMAT VR, 1995, SOC SCI MED, V41, P87, DOI 10.1016/0277-9536(94)00309-H; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Lagarde M, 2011, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD009094; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Macinko J, 2006, J EPIDEMIOL COMMUN H, V60, P13, DOI 10.1136/jech.2005.038323; MANT D, 1994, LANCET, V344, P1343, DOI 10.1016/S0140-6736(94)90698-X; Medical Council of India, 2011, VIS 2015; Mickan S, 2010, J INTERPROF CARE, V24, P492, DOI 10.3109/13561821003676325; More NS, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-7; National Rural Health Mission, ANN REV 2010; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Patel V, 2005, J Postgrad Med, V51, P9; Patel V, 2011, LANCET, V377, P448, DOI 10.1016/S0140-6736(10)62044-2; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Paul VK, 2010, LANCET, V375, P1943, DOI 10.1016/S0140-6736(10)60901-4; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Rao K, 2009, INDIAS HLTH BEAT, V1; Rao M, 2006, BMJ-BRIT MED J, V333, P19, DOI 10.1136/bmj.38874.499167.7C; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Rawaf S, 2008, LANCET, V372, P1365, DOI 10.1016/S0140-6736(08)61524-X; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roland M, 2007, BRIT J GEN PRACT, V57, P525; Sinha Kounteya, 2010, HINDU           0127; Sinha Kouteya, 2011, TIMES INDIA     0926; STARFIELD B, 1994, LANCET, V344, P1129, DOI 10.1016/S0140-6736(94)90634-3; Starfield B, QATAR EMRO PRIM HEAL; Starfield B, 2008, NEW ENGL J MED, V359, P2087, DOI 10.1056/NEJMp0805763; Sudarshan H, 2011, LANCET, V377, P790, DOI 10.1016/S0140-6736(10)62041-7; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Thoolen B, 2007, DIABETES CARE, V30, P2832, DOI 10.2337/dc07-0777; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; USAID, KEY IND URB POOR IND; Victora CG, 2008, J EPIDEMIOL COMMUN H, V62, P938, DOI 10.1136/jech.2008.081653; WHO, 2011, PACK ESS NONC DIS IN; World Health Organization, 2007, HLTH WORKF IND, P42	55	14	14	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e3151	10.1136/bmj.e3151	http://dx.doi.org/10.1136/bmj.e3151			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589501	Bronze			2022-12-28	WOS:000304086900009
J	Zalis, ME; Blake, MA; Cai, WL; Hahn, PF; Halpern, EF; Kazam, IG; Keroack, M; Magee, C; Nappi, JJ; Perez-Johnston, R; Saltzman, JR; Vij, A; Yee, J; Yoshida, H				Zalis, Michael E.; Blake, Michael A.; Cai, Wenli; Hahn, Peter F.; Halpern, Elkan F.; Kazam, Imrana G.; Keroack, Myles; Magee, Cordula; Naeppi, Janne J.; Perez-Johnston, Rocio; Saltzman, John R.; Vij, Abhinav; Yee, Judy; Yoshida, Hiroyuki			Diagnostic Accuracy of Laxative-Free Computed Tomographic Colonography for Detection of Adenomatous Polyps in Asymptomatic Adults A Prospective Evaluation	ANNALS OF INTERNAL MEDICINE			English	Article							NONCATHARTIC CT COLONOGRAPHY; FECAL OCCULT BLOOD; COLORECTAL-CANCER; VIRTUAL COLONOSCOPY; CATHARTIC PREPARATION; SCREENING POPULATION; ADVANCED NEOPLASIA; BOWEL PREPARATION; FALSE-POSITIVES; AIDED DETECTION	Background: Colon screening by optical colonoscopy (OC) or computed tomographic colonography (CTC) requires a laxative bowel preparation, which inhibits screening participation. Objective: To assess the performance of detecting adenomas 6 mm or larger and patient experience of laxative-free, computer-aided CTC. Design: Prospective test comparison of laxative-free CTC and OC. The CTC included electronic cleansing and computer-aided detection. Optical colonoscopy examinations were initially blinded to CTC results, which were subsequently revealed during colonoscope withdrawal; this method permitted reexamination to resolve discrepant findings. Unblinded OC served as a reference standard. (ClinicalTrials.gov registration number: NCT01200303) Setting: Multicenter ambulatory imaging and endoscopy centers. Participants: 605 adults aged 50 to 85 years at average to moderate risk for colon cancer. Measurements: Per-patient sensitivity and specificity of CTC and first-pass OC for detecting adenomas at thresholds of 10 mm or greater, 8 mm or greater, and 6 mm or greater; per-lesion sensitivity and survey data describing patient experience with preparations and examinations. Results: For adenomas 10 mm or larger, per-patient sensitivity of CTC was 0.91 (95% CI, 0.71 to 0.99) and specificity was 0.85 (CI, 0.82 to 0.88); sensitivity of OC was 0.95 (CI, 0.77 to 1.00) and specificity was 0.89 (CI, 0.86 to 0.91). Sensitivity of CTC was 0.70 (CI, 0.53 to 0.83) for adenomas 8 mm or larger and 0.59 (CI, 0.47 to 0.70) for those 6 mm or larger; sensitivity of OC for adenomas 8 mm or larger was 0.88 (CI, 0.73 to 0.96) and 0.76 (CI, 0.64 to 0.85) for those 6 mm or larger. The specificity of OC at the threshold of 8 mm or larger was 0.91 and at 6 mm or larger was 0.94. Specificity for OC was greater than that for CTC, which was 0.86 at the threshold of 8 mm or larger and 0.88 at 6 mm or larger (P = 0.02). Reported participant experience for comfort and difficulty of examination preparation was better with CTC than OC. Limitations: There were 3 CTC readers. The survey instrument was not independently validated. Conclusion: Computed tomographic colonography was accurate in detecting adenomas 10 mm or larger but less so for smaller lesions. Patient experience was better with laxative-free CTC. These results suggest a possible role for laxative-free CTC as an alternate screening method.	[Zalis, Michael E.] Massachusetts Gen Hosp, Dept Imaging, Brigham & Womens Hosp, Boston, MA 02114 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; University of California System; University of California San Francisco	Zalis, ME (corresponding author), Massachusetts Gen Hosp, Dept Imaging, Brigham & Womens Hosp, Suite 400A,25 New Chardon St, Boston, MA 02114 USA.	mzalis@mgh.harvard.edu	Näppi, Janne J/B-9424-2008	Näppi, Janne J/0000-0002-0108-0992	GE Healthcare [03-OPQ-001]; American Cancer Society [RSG-08-221-01-CCE, RSG-05-088-01-CCE]; National Institutes of Health [1K22CA098422, 1 RO1 CA095279]; NATIONAL CANCER INSTITUTE [K22CA098422, R01CA095279] Funding Source: NIH RePORTER	GE Healthcare(General ElectricGE Healthcare); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Zalis is supported by GE Healthcare (03-OPQ-001), the American Cancer Society (RSG-08-221-01-CCE), and the National Institutes of Health (1K22CA098422). Drs. Zalis, Cai, Nappi, and Yoshida are supported by the National Institutes of Health (1 RO1 CA095279). Dr. Yoshida is supported by the American Cancer Society (RSG-05-088-01-CCE).	Beebe TJ, 2007, MAYO CLIN PROC, V82, P666; BOTTICELLI G, 1992, J ENDOCRINOL INVEST, V15, P839, DOI 10.1007/BF03348817; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Cai WL, 2008, MED PHYS, V35, P3259, DOI 10.1118/1.2936413; Callstrom MR, 2001, RADIOLOGY, V219, P693, DOI 10.1148/radiology.219.3.r01jn22693; Dachman AH, 2010, RADIOLOGY, V256, P827, DOI 10.1148/radiol.10091890; Department of Health and Human Services, 2006, CRCPD PUBL; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Iannaccone R, 2004, GASTROENTEROLOGY, V127, P1300, DOI 10.1053/j.gastro.2004.08.025; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Johnson CD, 2008, AM J ROENTGENOL, V190, P361, DOI 10.2214/AJR.07.2700; Johnson CD, 2000, RADIOLOGY, V216, P331, DOI 10.1148/radiology.216.2.r00au47331; Johnson CD, 2003, GASTROENTEROLOGY, V125, P311, DOI 10.1016/S0016-5085(03)00894-1; Johnson KT, 2007, AM J ROENTGENOL, V188, pW29, DOI 10.2214/AJR.05.1484; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman D, 2008, GASTROENTEROLOGY, V135, P1100, DOI 10.1053/j.gastro.2008.06.083; Liedenbaum MH, 2010, ABDOM IMAGING, V35, P661, DOI 10.1007/s00261-009-9586-8; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Nappi J, 2003, MED PHYS, V30, P1592, DOI 10.1118/1.1576393; Nappi J, 2007, ACAD RADIOL, V14, P287, DOI 10.1016/j.acra.2006.11.007; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Odom SR, 2005, AM SURGEON, V71, P1024; Park SH, 2007, RADIOLOGY, V244, P157, DOI 10.1148/radiol.2441060794; Pickhardt PJ, 2009, AM J ROENTGENOL, V193, P40, DOI 10.2214/AJR.08.1709; Pickhardt PJ, 2003, AM J ROENTGENOL, V181, P1599, DOI 10.2214/ajr.181.6.1811599; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Regge D, 2009, JAMA-J AM MED ASSOC, V301, P2453, DOI 10.1001/jama.2009.832; Ristvedt SL, 2003, AM J GASTROENTEROL, V98, P578, DOI 10.1016/S0002-9270(02)06024-0; Stoop EM, 2012, LANCET ONCOL, V13, P55, DOI 10.1016/S1470-2045(11)70283-2; Summers RM, 2005, GASTROENTEROLOGY, V129, P1832, DOI 10.1053/j.gastro.2005.08.054; Taylor SA, 2009, AM J ROENTGENOL, V192, P1682, DOI 10.2214/AJR.08.1625; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yoshida H, 2002, RADIOLOGY, V222, P327, DOI 10.1148/radiol.2222010506; Zalis ME, 2005, RADIOLOGY, V236, P118, DOI 10.1148/radiol.2361040231; Zalis ME, 2003, RADIOLOGY, V226, P911, DOI 10.1148/radiol.2263012059; Zalis ME, 2005, RADIOLOGY, V236, P3, DOI 10.1148/radiol.2361041926; Zauber A, 2008, CANC INTERVENTION SU	39	88	90	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					692	U71		10.7326/0003-4819-156-10-201205150-00005	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00005			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586008				2022-12-28	WOS:000304193400015
J	Charrier, C; Joshi, K; Coutinho-Budd, J; Kim, JE; Lambert, N; de Marchena, J; Jin, WL; Vanderhaeghen, P; Ghosh, A; Sassa, T; Polleux, F				Charrier, Cecile; Joshi, Kaumudi; Coutinho-Budd, Jaeda; Kim, Ji-Eun; Lambert, Nelle; de Marchena, Jacqueline; Jin, Wei-Lin; Vanderhaeghen, Pierre; Ghosh, Anirvan; Sassa, Takayuki; Polleux, Franck			Inhibition of SRGAP2 Function by Its Human-Specific Paralogs Induces Neoteny during Spine Maturation	CELL			English	Article							DENDRITIC SPINES; BAR-DOMAIN; SEGMENTAL DUPLICATIONS; MEMBRANE INVAGINATION; NEURONAL MIGRATION; ACTIN CYTOSKELETON; PYRAMIDAL CELLS; EVOLUTION; GENOME; NECK	Structural genomic variations represent a major driving force of evolution, and a burst of large segmental gene duplications occurred in the human lineage during its separation from nonhuman primates. SRGAP2, a gene recently implicated in neocortical development, has undergone two human-specific duplications. Here, we find that both duplications (SRGAP2B and SRGAP2C) are partial and encode a truncated F-BAR domain. SRGAP2C is expressed in the developing and adult human brain and dimerizes with ancestral SRGAP2 to inhibit its function. In the mouse neocortex, SRGAP2 promotes spine maturation and limits spine density. Expression of SRGAP2C phenocopies SRGAP2 deficiency. It underlies sustained radial migration and leads to the emergence of human-specific features, including neoteny during spine maturation and increased density of longer spines. These results suggest that inhibition of SRGAP2 function by its human-specific paralogs has contributed to the evolution of the human neocortex and plays an important role during human brain development.	[Charrier, Cecile; Joshi, Kaumudi; Sassa, Takayuki; Polleux, Franck] Scripps Res Inst, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA; [Coutinho-Budd, Jaeda; de Marchena, Jacqueline] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Kim, Ji-Eun; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Lambert, Nelle; Vanderhaeghen, Pierre] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Lambert, Nelle] Hop Erasme ULB, Dept Med Genet, B-1070 Brussels, Belgium; [Jin, Wei-Lin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Shanghai Jiao Tong University	Polleux, F (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA.	polleux@scripps.edu	SASSA, Takayuki/B-2519-2012; Kim, Jean Jieun/G-5774-2018; Jin, Wei-Lin/A-8355-2013; Polleux, Franck/H-9948-2014; Joshi, Kaumudi/P-1862-2018	SASSA, Takayuki/0000-0003-3145-9829; Kim, Jean Jieun/0000-0003-4709-262X; Jin, Wei-Lin/0000-0001-8011-2405; , Nelle/0000-0003-1137-9725; Polleux, Franck/0000-0003-4313-0481; Vanderhaeghen, Pierre/0000-0001-7899-5720; Charrier, Cecile/0000-0002-9053-1715	FNRS; Belgian Queen Elizabeth Foundation; Welbio and Excellence Programs of the Walloon Region; Fonds Erasme; Belgian Kids' Fund; NIH [RO1NS067557, F31NS061610, F31NS068038]; ADI-Novartis; NSFC [31171033]; "973'' Project [2011CB933101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067557, F31NS061610, F31NS068038] Funding Source: NIH RePORTER	FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Queen Elizabeth Foundation; Welbio and Excellence Programs of the Walloon Region(WELBIO); Fonds Erasme; Belgian Kids' Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADI-Novartis; NSFC(National Natural Science Foundation of China (NSFC)); "973'' Project(National Basic Research Program of China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Marie Rougie and Virginie Courchet for excellent technical support and management of the mouse colonies and members of the Polleux laboratory for useful discussions. We thank Maxime Camo for help with the initial characterization of the SRGAP2 KO, Daniel Choquet for providing HOMER1c expression plasmid, and Evan Eichler's lab for reagents and useful discussions. N.L. is a clinical scientist of the FNRS and P. V. is a Research Director of the FNRS. This work was partially supported by grants of the FNRS, Belgian Queen Elizabeth Foundation, Welbio and Excellence Programs of the Walloon Region (to P. V.), Fonds Erasme and the Belgian Kids' Fund (to N.L.), NIH RO1NS067557 (F. P.) and ADI-Novartis funds (F. P.), NIH F31NS061610 (J.d.M.), NIH F31NS068038 (J.C.-B.), by NSFC (No. 31171033), and "973'' Project (No. 2011CB933101) (W.-L.J.). C. C., K.J., T. S. and F. P. conceived the experiments, and C. C., K.J., J.C.-B., J.d.M., T. S., N.L., and P. V. performed the experiments. W.-L. J. provided the anti-SRGAP2 antibodies. J.-E.K. and A. G. provided RNA from cultured human ES cells. C. C., K. J., and F. P. prepared the manuscript. A. G. is currently an employee of F. Hoffmann La Roche.	Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elston GN, 2001, J NEUROSCI, V21; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	53	246	263	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					923	935		10.1016/j.cell.2012.03.034	http://dx.doi.org/10.1016/j.cell.2012.03.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22559944	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-28	WOS:000303934700023
J	Sawarkar, R; Sievers, C; Paro, R				Sawarkar, Ritwick; Sievers, Cem; Paro, Renato			Hsp90 Globally Targets Paused RNA Polymerase to Regulate Gene Expression in Response to Environmental Stimuli	CELL			English	Article							ELONGATION-FACTOR NELF; TRANSCRIPTION ELONGATION; P-TEFB; POL-II; PROMOTER; ACTIVATION; CELLS; PROLIFERATION; RECRUITMENT; COMPLEXES	The molecular chaperone Heat shock protein 90 (Hsp90) promotes the maturation of several important proteins and plays a key role in development, cancer progression, and evolutionary diversification. By mapping chromatin-binding sites of Hsp90 at high resolution across the Drosophila genome, we uncover an unexpected mechanism by which Hsp90 orchestrates cellular physiology. It localizes near promoters of many coding and noncoding genes including microRNAs. Using computational and biochemical analyses, we find that Hsp90 maintains and optimizes RNA polymerase II pausing via stabilization of the negative elongation factor complex (NELF). Inhibition of Hsp90 leads to upregulation of target genes, and Hsp90 is required for maximal activation of paused genes in Drosophila and mammalian cells in response to environmental stimuli. Our findings add a molecular dimension to the chaperone's functionality with wide ramifications into its roles in health, disease, and evolution.	[Sawarkar, Ritwick; Sievers, Cem; Paro, Renato] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Paro, Renato] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Paro, R (corresponding author), ETH, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	renato.paro@bsse.ethz.ch	Sawarkar, Ritwick/AGF-7365-2022		EU-NoE "EpiGeneSys''; ETH Zurich	EU-NoE "EpiGeneSys''; ETH Zurich(ETH Zurich)	We thank I. Nissen and C. Beisel for assistance with deep sequencing, M. Seimiya for lacZ staining of imaginal discs, S. Nechaev for help in permanganate footprinting, and Didier Picard and the Paro lab members for useful discussions. We thank the Bloomington stock centre, D. Ruden for fly stocks and J. Kreher and A. Brehm for Ecdysone-sensitive cell line. This work was supported by a grant from the EU-NoE "EpiGeneSys'' and the ETH Zurich.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cornwell WD, 2001, J CELL BIOCHEM, V82, P22, DOI 10.1002/jcb.1144; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Figeac N, 2010, DEVELOPMENT, V137, P1965, DOI 10.1242/dev.049080; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, METHODS, V48, P368, DOI 10.1016/j.ymeth.2009.02.020; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lis JT, 2000, GENE DEV, V14, P792; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nairz K, 2006, DEV BIOL, V291, P314, DOI 10.1016/j.ydbio.2005.11.047; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Renault AD, 2010, DEVELOPMENT, V137, P1815, DOI 10.1242/dev.046110; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	47	108	108	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					807	818		10.1016/j.cell.2012.02.061	http://dx.doi.org/10.1016/j.cell.2012.02.061			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579285	Bronze			2022-12-28	WOS:000303934700014
J	Tyler-Smith, C; Xue, YL				Tyler-Smith, Chris; Xue, Yali			Sibling Rivalry among Paralogs Promotes Evolution of the Human Brain	CELL			English	Editorial Material							NEOTENY; APE	Geneticists have long sought to identify the genetic changes that made us human, but pinpointing the functionally relevant changes has been challenging. Two papers in this issue suggest that partial duplication of SRGAP2, producing an incomplete protein that antagonizes the original, contributed to human brain evolution.	[Tyler-Smith, Chris; Xue, Yali] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	cts@sanger.ac.uk			Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	Our work is supported by The Wellcome Trust (098051).	Bufill E, 2011, AM J HUM BIOL, V23, P729, DOI 10.1002/ajhb.21225; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842	10	3	3	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					737	739		10.1016/j.cell.2012.04.020	http://dx.doi.org/10.1016/j.cell.2012.04.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579279	Green Accepted, Bronze			2022-12-28	WOS:000303934700008
J	Hellmer, HH; Kauker, F; Timmermann, R; Determann, J; Rae, J				Hellmer, Hartmut H.; Kauker, Frank; Timmermann, Ralph; Determann, Juergen; Rae, Jamie			Twenty-first-century warming of a large Antarctic ice-shelf cavity by a redirected coastal current	NATURE			English	Article							PINE ISLAND GLACIER; SEA-ICE; WEDDELL SEA; OCEAN CIRCULATION; NUMERICAL-MODEL; COUPLED MODEL; TRANSPORT; DEEP	The Antarctic ice sheet loses mass at its fringes bordering the Southern Ocean. At this boundary, warm circumpolar water can override the continental slope front, reaching the grounding line(1,2) through submarine glacial troughs and causing high rates of melting at the deep ice-shelf bases(3,4). The interplay between ocean currents and continental bathymetry is therefore likely to influence future rates of ice-mass loss. Here we show that a redirection of the coastal current into the Filchner Trough and underneath the Filchner-Ronne Ice Shelf during the second half of the twenty-first century would lead to increased movement of warm waters into the deep southern ice-shelf cavity. Water temperatures in the cavity would increase by more than 2 degrees Celsius and boost average basal melting from 0.2 metres, or 82 billion tonnes, per year to almost 4 metres, or 1,600 billion tonnes, per year. Our results, which are based on the output of a coupled ice-ocean model forced by a range of atmospheric outputs from the HadCM3(5) climate model, suggest that the changes would be caused primarily by an increase in ocean surface stress in the southeastern Weddell Sea due to thinning of the formerly consolidated sea-ice cover. The projected ice loss at the base of the Filchner-Ronne Ice Shelf represents 80 per cent of the present Antarctic surface mass balance(6). Thus, the quantification of basal mass loss under changing climate conditions is important for projections regarding the dynamics of Antarctic ice streams and ice shelves, and global sea level rise.	[Hellmer, Hartmut H.; Kauker, Frank; Timmermann, Ralph; Determann, Juergen] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Kauker, Frank] OASys, D-22767 Hamburg, Germany; [Rae, Jamie] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Met Office - UK; Hadley Centre	Hellmer, HH (corresponding author), Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany.	hartmut.hellmer@awi.de		Macario, Ana/0000-0003-3747-793X; Hellmer, Hartmut/0000-0002-9357-9853	European Union [226375]	European Union(European Commission)	We thank C. Wubber and W. Cohrs for providing stable computer facilities at the Alfred-Wegener-Institute for Polar and Marine Research; the Ice2Sea community for discussions during project meetings; and J. Ridley, M. Martin and A. Levermann for comments on the manuscript. This work was supported by funding to the Ice2Sea programme from the European Union Seventh Framework Programme, grant number 226375. This is Ice2Sea contribution number 41.	Assmann KM, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002797; Bamber JL, 2000, SCIENCE, V287, P1248, DOI 10.1126/science.287.5456.1248; Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Beckmann A, 1999, J GEOPHYS RES-OCEANS, V104, P23375, DOI 10.1029/1999JC900194; Collins M, 2011, CLIM DYNAM, V36, P1737, DOI 10.1007/s00382-010-0808-0; FOLDVIK A, 1985, ANTARCT RES SER, V43, P5, DOI DOI 10.1029/AR043P0005; Gordon AL, 2001, J GEOPHYS RES-OCEANS, V106, P9005, DOI 10.1029/2000JC000281; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Hellmer HH, 1998, ANTARCT RES SER, V75, P83; HIBLER WD, 1979, J PHYS OCEANOGR, V9, P815, DOI 10.1175/1520-0485(1979)009<0815:ADTSIM>2.0.CO;2; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johns TC, 2011, CLIM DYNAM, V37, P1975, DOI 10.1007/s00382-011-1005-5; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lichey C, 2001, J GLACIOL, V47, P452, DOI 10.3189/172756501781832133; Lowe JA, 2009, EOS T AGU, V90, P181, DOI DOI 10.1029/2009E0210001; Makinson K, 1999, J GEOPHYS RES-OCEANS, V104, P13449, DOI 10.1029/1999JC900008; Nakicevovic N., 2000, IPCC SPECIAL REPORT; Nicholls KW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035742; Nicholls KW, 1997, NATURE, V388, P460, DOI 10.1038/41302; PARKINSON CL, 1979, J GEOPHYS RES-OCEANS, V84, P311, DOI 10.1029/JC084iC01p00311; Payne AJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003733; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Schroder M, 1999, DEEP-SEA RES PT II, V46, P501, DOI 10.1016/S0967-0645(98)00112-X; Schroder M, 2002, DEEP-SEA RES PT II, V49, P4767, DOI 10.1016/S0967-0645(02)00158-3; Timmermann R, 2002, J GEOPHYS RES-OCEANS, V107, DOI [10.1029/2000JC000742, 10.1029/2000JC000741]; Timmermann R., 2010, EARTH SYST SCI DATA, V2, P261, DOI [10.5194/essd-2-261-2010, DOI 10.5194/ESSD-2-261-2010]; Timmermann R, 2009, OCEAN MODEL, V27, P114, DOI 10.1016/j.ocemod.2008.10.009; Walker DP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028154; Walker RT, 2007, OCEAN MODEL, V17, P123, DOI 10.1016/j.ocemod.2007.01.001	31	279	285	0	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					225	228		10.1038/nature11064	http://dx.doi.org/10.1038/nature11064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575964	Green Submitted			2022-12-28	WOS:000303799800038
J	Bird, JM				Bird, Jennifer M.			RATIONAL TESTING Investigating an incidental finding of a paraprotein	BRITISH MEDICAL JOURNAL			English	Editorial Material							UNDETERMINED SIGNIFICANCE MGUS; MONOCLONAL GAMMOPATHY; MULTIPLE-MYELOMA; PROGRESSION; GUIDELINES; MANAGEMENT; DISORDERS		Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol BS2 8ED, Avon, England	Bristol Haematology & Oncology Centre; University of Bristol	Bird, JM (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol BS2 8ED, Avon, England.	jenny.bird@uhbristol.nhs.uk	Bird, Jennifer/ABG-1748-2020					Bird J, 2010, BRIT J HAEMATOL, V148, P491; Bird J, 2009, BRIT J HAEMATOL, V147, P22, DOI 10.1111/j.1365-2141.2009.07807.x; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Cesana C, 2002, J CLIN ONCOL, V20, P1625, DOI 10.1200/JCO.20.6.1625; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, BRIT J HAEMATOL, V134, P573, DOI 10.1111/j.1365-2141.2006.06235.x; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Rawstron AC, 2007, BRIT J HAEMATOL, V139, P845, DOI 10.1111/j.1365-2141.2007.06864.x; Wadhera RK, 2010, MAYO CLIN PROC, V85, P933, DOI 10.4065/mcp.2010.0337	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 4	2012	344								e3033	10.1136/bmj.e3033	http://dx.doi.org/10.1136/bmj.e3033			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NN	22563093				2022-12-28	WOS:000303818500007
J	Richards-Kortum, R; Gray, LV; Oden, M				Richards-Kortum, Rebecca; Gray, Lauren Vestewig; Oden, Maria			Engaging Undergraduates in Global Health Technology Innovation	SCIENCE			English	Editorial Material									[Richards-Kortum, Rebecca; Oden, Maria] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Richards-Kortum, Rebecca; Gray, Lauren Vestewig; Oden, Maria] Rice Univ, Inst Global Hlth Technol, Houston, TX 77005 USA	Rice University; Rice University	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014	Richards-Kortum, Rebecca R/0000-0003-2347-9467	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Brown J, 2011, AM J TROP MED HYG, V85, P327, DOI 10.4269/ajtmh.2011.10-0399; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Oden M, 2010, ANN BIOMED ENG, V38, P3031, DOI 10.1007/s10439-010-0036-0; Richards-Kortum R., 2010, BIOMEDICAL ENG GLOBA; Sinha SR, 2011, NEW ENGL J MED, V365, P779, DOI 10.1056/NEJMp1108040; Colindres JV, 2012, J TROP PEDIATRICS, V58, P178, DOI 10.1093/tropej/fmr063	6	8	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					430	431		10.1126/science.1213947	http://dx.doi.org/10.1126/science.1213947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931QC	22539712				2022-12-28	WOS:000303233400036
J	Cappellari, M; McDermid, RM; Alatalo, K; Blitz, L; Bois, M; Bournaud, F; Bureau, M; Crocker, AF; Davies, RL; Davis, TA; de Zeeuw, PT; Duc, PA; Emsellem, E; Khochfar, S; Krajnovic, D; Kuntschner, H; Lablanche, PY; Morganti, R; Naab, T; Oosterloo, T; Sarzi, M; Scott, N; Serra, P; Weijmans, AM; Young, LM				Cappellari, Michele; McDermid, Richard M.; Alatalo, Katherine; Blitz, Leo; Bois, Maxime; Bournaud, Frederic; Bureau, M.; Crocker, Alison F.; Davies, Roger L.; Davis, Timothy A.; de Zeeuw, P. T.; Duc, Pierre-Alain; Emsellem, Eric; Khochfar, Sadegh; Krajnovic, Davor; Kuntschner, Harald; Lablanche, Pierre-Yves; Morganti, Raffaella; Naab, Thorsten; Oosterloo, Tom; Sarzi, Marc; Scott, Nicholas; Serra, Paolo; Weijmans, Anne-Marie; Young, Lisa M.			Systematic variation of the stellar initial mass function in early-type galaxies	NATURE			English	Article							DARK-MATTER HALOS; TO-LIGHT RATIOS; POPULATION SYNTHESIS; MODELS; SIMULATION; PROJECT; STARS	Much of our knowledge of galaxies comes from analysing the radiation-emitted by their stars, which depends on the present number of each type of star in the galaxy. The present number depends on the stellar initial mass function (IMF), which describes the distribution of stellar masses when the population formed, and knowledge of it is critical to almost every aspect of galaxy evolution. More than 50 years after the first IMF determination(1), no consensus has emerged on whether it is universal among different types of galaxies(2). Previous studies indicated that the IMF and the dark matter fraction in galaxy centres cannot both be universal(3-7), but they could not convincingly discriminate between the two possibilities. Only recently were indications found that massive elliptical galaxies may not have the same IMF as the Milky Way(8). Here we report a study of the two-dimensional stellar kinematics for the large representative ATLAS(3D) sample(9) of nearby early-type galaxies spanning two orders of magnitude in stellar mass, using detailed dynamical models. We find a strong systematic variation in IMF in early-type galaxies as a function of their stellar mass-to-light ratios, producing differences of a factor of up to three in galactic stellar mass. This implies that a galaxy's IMF depends intimately on the galaxy's formation history.	[Cappellari, Michele; Bureau, M.; Davies, Roger L.; Davis, Timothy A.; Scott, Nicholas] Univ Oxford, Dept Phys, Subdept Astrophys, Oxford OX1 3RH, England; [McDermid, Richard M.] Gemini Observ, No Operat Ctr, Hilo, HI 96720 USA; [Alatalo, Katherine; Blitz, Leo] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Bois, Maxime] Observ Paris, LERMA, F-75014 Paris, France; [Bois, Maxime] CNRS, F-75014 Paris, France; [Bournaud, Frederic; Duc, Pierre-Alain] Univ Paris Diderot, CNRS, CEA IRFU SAp, Lab AIM Paris Saclay, F-91191 Gif Sur Yvette, France; [Crocker, Alison F.] Univ Massachusetts, Dept Astrophys, Amherst, MA 01003 USA; [Davis, Timothy A.; de Zeeuw, P. T.; Emsellem, Eric; Krajnovic, Davor; Kuntschner, Harald; Lablanche, Pierre-Yves] European So Observ, D-85748 Garching, Germany; [de Zeeuw, P. T.] Leiden Univ, Sterrewacht Leiden, NL-2300 RA Leiden, Netherlands; [Emsellem, Eric; Lablanche, Pierre-Yves] Univ Lyon 1, Observ Lyon, Ctr Rech Astrophys Lyon, F-69230 St Genis Laval, France; [Emsellem, Eric; Lablanche, Pierre-Yves] Ecole Normale Super Lyon, F-69230 St Genis Laval, France; [Khochfar, Sadegh] Max Planck Inst Extraterr Phys, D-85478 Garching, Germany; [Morganti, Raffaella; Oosterloo, Tom; Serra, Paolo] Netherlands Inst Radio Astron, NL-7990 AA Dwingeloo, Netherlands; [Morganti, Raffaella; Oosterloo, Tom] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Naab, Thorsten] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Sarzi, Marc] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL1 9AB, Herts, England; [Scott, Nicholas] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Weijmans, Anne-Marie] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Young, Lisa M.] New Mexico Inst Min & Technol, Dept Phys, Socorro, NM 87801 USA	University of Oxford; University of California System; University of California Berkeley; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Massachusetts System; University of Massachusetts Amherst; European Southern Observatory; Leiden University; Leiden University - Excl LUMC; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Max Planck Society; University of Groningen; Max Planck Society; University of Hertfordshire; Swinburne University of Technology; University of Toronto; New Mexico Institute of Mining Technology	Cappellari, M (corresponding author), Univ Oxford, Dept Phys, Subdept Astrophys, Denys Wilkinson Bldg,Keble Rd, Oxford OX1 3RH, England.	cappellari@astro.ox.ac.uk	Scott, Nicholas/ABE-1523-2021; Cappellari, Michele/AAB-5062-2019; Bournaud, Frederic/K-1263-2013; Oosterloo, Tom/GVU-4543-2022; Young, Lisa Marie/AAB-5128-2019; Emsellem, Eric/ABE-6591-2020; McDermid, Richard/AAY-1946-2021; Morganti, Raffaella/GVU-5894-2022; Naab, Thorsten/AAE-9888-2019; Khochfar, Sadegh/AAD-6530-2022; Sarzi, Marc/HGB-2092-2022	Scott, Nicholas/0000-0001-8495-8547; Cappellari, Michele/0000-0002-1283-8420; Oosterloo, Tom/0000-0002-0616-6971; Young, Lisa Marie/0000-0002-5669-5038; Emsellem, Eric/0000-0002-6155-7166; McDermid, Richard/0000-0002-8175-7229; Morganti, Raffaella/0000-0002-9482-6844; Naab, Thorsten/0000-0002-7314-2558; Serra, Paolo/0000-0001-5965-252X; Davis, Timothy/0000-0003-4932-9379; Sarzi, Marc/0000-0003-2227-4902; Alatalo, Katherine/0000-0002-4261-2326; Kuntschner, Harald/0000-0002-2768-1198; Weijmans, Anne-Marie/0000-0002-5908-6852	Royal Society; UK Research Councils; Christ Church College, Oxford University; Gemini Observatory; DFG Cluster of Excellence 'Origin and Structure of the Universe'; STFC; Science and Technology Facilities Council [ST/H002456/1, PP/E003427/1, ST/F009186/1, ST/G004331/1, ST/I003673/1] Funding Source: researchfish; STFC [ST/H002456/1, ST/I003673/1, ST/G004331/1, ST/F009186/1, PP/E003427/1] Funding Source: UKRI	Royal Society(Royal Society of London); UK Research Councils; Christ Church College, Oxford University; Gemini Observatory; DFG Cluster of Excellence 'Origin and Structure of the Universe'(German Research Foundation (DFG)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	M.C. acknowledges support from a Royal Society University Research Fellowship. This work was supported by the rolling grants 'Astrophysics at Oxford' from the UK Research Councils. R. L. D. acknowledges support from Christ Church College, Oxford University, and from the Royal Society in the form of a Wolfson Merit Award. S. K. acknowledges support from the Royal Society Joint Projects Grant. R. M. M. is supported by the Gemini Observatory. T.N. and M. Bois acknowledge support from the DFG Cluster of Excellence 'Origin and Structure of the Universe'. M. S. acknowledges support from a STFC Advanced Fellowship. N.S. and T. A. D. acknowledge support from an STFC studentship.	Bastian N, 2010, ANNU REV ASTRON ASTR, V48, P339, DOI 10.1146/annurev-astro-082708-101642; Bell EF, 2001, ASTROPHYS J, V550, P212, DOI 10.1086/319728; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Cappellari M, 2006, MON NOT R ASTRON SOC, V366, P1126, DOI 10.1111/j.1365-2966.2005.09981.x; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Cappellari M, 2008, MON NOT R ASTRON SOC, V390, P71, DOI 10.1111/j.1365-2966.2008.13754.x; Cappellari M, 2011, MON NOT R ASTRON SOC, V416, P1680, DOI 10.1111/j.1365-2966.2011.18600.x; Cappellari M, 2011, MON NOT R ASTRON SOC, V413, P813, DOI 10.1111/j.1365-2966.2010.18174.x; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Deason AJ, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/2; Duffy AR, 2010, MON NOT R ASTRON SOC, V405, P2161, DOI 10.1111/j.1365-2966.2010.16613.x; Dutton AA, 2011, MON NOT R ASTRON SOC, V416, P322, DOI 10.1111/j.1365-2966.2011.19038.x; EMSELLEM E, 1994, ASTRON ASTROPHYS, V285, P723; Gnedin O. Y., 2011, HALO CONTRACTION EFF; Gunawardhana MLP, 2011, MON NOT R ASTRON SOC, V415, P1647, DOI 10.1111/j.1365-2966.2011.18800.x; Hoversten EA, 2008, ASTROPHYS J, V675, P163, DOI 10.1086/524095; Klypin AA, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/102; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Kroupa P, 2003, ASTROPHYS J, V598, P1076, DOI 10.1086/379105; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; Moster BP, 2010, ASTROPHYS J, V710, P903, DOI 10.1088/0004-637X/710/2/903; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Renzini A, 2005, ASTROPHYS SPACE SC L, V327, P221; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Thomas J, 2011, MON NOT R ASTRON SOC, V415, P545, DOI 10.1111/j.1365-2966.2011.18725.x; Tortora C, 2009, MON NOT R ASTRON SOC, V396, P1132, DOI 10.1111/j.1365-2966.2009.14789.x; Treu T, 2010, ASTROPHYS J, V709, P1195, DOI 10.1088/0004-637X/709/2/1195; van Dokkum PG, 2010, NATURE, V468, P940, DOI 10.1038/nature09578; Vazdekis A, 2010, MON NOT R ASTRON SOC, V404, P1639, DOI 10.1111/j.1365-2966.2010.16407.x	30	451	453	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					485	488		10.1038/nature10972	http://dx.doi.org/10.1038/nature10972			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538610	Green Submitted			2022-12-28	WOS:000303200400044
J	Robling, M; McNamara, R; Bennert, K; Butler, CC; Channon, S; Cohen, D; Crowne, E; Hambly, H; Hawthorne, K; Hood, K; Longo, M; Lowes, L; Pickles, T; Playle, R; Rollnick, S; Thomas-Jones, E; Gregory, JW				Robling, Mike; McNamara, Rachel; Bennert, Kristina; Butler, Christopher C.; Channon, Sue; Cohen, David; Crowne, Elizabeth; Hambly, Helen; Hawthorne, Kamila; Hood, Kerenza; Longo, Mirella; Lowes, Lesley; Pickles, Tim; Playle, Rebecca; Rollnick, Stephen; Thomas-Jones, Emma; Gregory, John W.			The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE PROFESSIONALS; COMMUNICATION-SKILLS; PSYCHOSOCIAL INTERVENTION; YOUNG-PEOPLE; TEENAGERS; SERVICES; UK	Objective To evaluate the effectiveness on glycaemic control of a training programme in consultation skills for paediatric diabetes teams. Design Pragmatic cluster randomised controlled trial. Setting 26 UK secondary and tertiary care paediatric diabetes services. Participants 79 healthcare practitioners (13 teams) trained in the intervention (359 young people with type 1 diabetes aged 4-15 years and their main carers) and 13 teams allocated to the control group (334 children and their main carers). Intervention Talking Diabetes programme, which promotes shared agenda setting and guiding communication style, through flexible menu of consultation strategies to support patient led behaviour change. Main outcome measures The primary outcome was glycated haemoglobin (HbA(1c)) level one year after training. Secondary outcomes were clinical measures (hypoglycaemic episodes, body mass index, insulin regimen), general and diabetes specific quality of life, self reported and proxy reported self care and enablement, perceptions of the diabetes team, self reported and carer reported importance of, and confidence in, undertaking diabetes self management measured over one year. Analysis was by intention to treat. An integrated process evaluation included audio recording a sample of 86 routine consultations to assess skills shortly after training (intervention group) and at one year follow-up (intervention and control group). Two key domains of skill assessment were use of the guiding communication style and shared agenda setting. Results 660/693 patients (95.2%) provided blood samples at follow-up. Training diabetes care teams had no effect on HbA(1c) levels (intervention effect 0.01, 95% confidence interval -0.02 to 0.04, P=0.5), even after adjusting for age and sex of the participants. At follow-up, trained staff (n=29) were more capable than controls (n=29) in guiding (difference in means 1.14, P<0.001) and agenda setting (difference in proportions 0.45, 95% confidence interval 0.22 to 0.62). Although skills waned over time for the trained practitioners, the reduction was not significant for either guiding (difference in means -0.33, P=0.128) or use of agenda setting (difference in proportions -0.20, -0.42 to 0.05). 390 patients (56%) and 441 carers (64%) completed follow-up questionnaires. Some aspects of diabetes specific quality of life improved in controls: reduced problems with treatment barriers (mean difference -4.6, 95% confidence interval -8.5 to -0.6, P=0.03) and with treatment adherence (-3.1, -6.3 to -0.01, P=0.05). Short term ability to cope with diabetes increased in patients in intervention clinics (10.4, 0.5 to 20.4, P=0.04). Carers in the intervention arm reported greater excitement about clinic visits (1.9, 1.05 to 3.43, P=0.03) and improved continuity of care (0.2, 0.1 to 0.3, P=0.01). Conclusions Improving glycaemic control in children attending specialist diabetes clinics may not be possible through brief, team-wide training in consultation skills.	[Robling, Mike; McNamara, Rachel; Bennert, Kristina; Hambly, Helen; Hood, Kerenza; Pickles, Tim; Playle, Rebecca; Thomas-Jones, Emma] Cardiff Univ, SE Wales Trials Unit, Dept Primary Care & Publ Hlth, Sch Med, Cardiff CF14 4YS, S Glam, Wales; [Channon, Sue; Gregory, John W.] Cardiff Univ, Dept Child Hlth, Sch Med, Cardiff CF14 4YS, S Glam, Wales; [Cohen, David; Longo, Mirella] Univ Glamorgan, Fac Hlth Sport & Sci, Pontypridd CF37 1DL, M Glam, Wales; [Crowne, Elizabeth] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Hosp Children, Bristol, Avon, England; [Lowes, Lesley] Cardiff Univ, Sch Nursing & Midwifery Studies, Cardiff CF14 4YS, S Glam, Wales	Cardiff University; Cardiff University; University of South Wales; Bristol Royal Hospital For Children; University of Bristol; Cardiff University	Robling, M (corresponding author), Cardiff Univ, SE Wales Trials Unit, Dept Primary Care & Publ Hlth, Sch Med, Cardiff CF14 4YS, S Glam, Wales.	roblingmr@cardiff.ac.uk	Hood, Kerenza/C-2528-2008; Cerviño, Alejandro/L-5853-2014; Robling, Michael/B-5516-2009	Hood, Kerenza/0000-0002-5268-8631; Cerviño, Alejandro/0000-0001-8014-3279; Robling, Michael/0000-0002-1004-036X; McNamara, Rachel/0000-0002-7280-1611; Pickles, Timothy/0000-0001-7743-0234; Channon, Sue/0000-0002-5394-1483; Playle, Rebecca/0000-0002-2989-1092; Butler, Christopher/0000-0002-0102-3453; Thomas-Jones, Emma/0000-0001-7716-2786	UK National Institute for Health Research; Novo Nordisk UK; Cardiff University	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk UK(Novo Nordisk); Cardiff University	The UK National Institute for Health Research Health Technology Assessment Programme funded the intervention development and trial phases. An educational grant from Novo Nordisk UK partially funded the production of some study materials. This study was sponsored by Cardiff University.	[Anonymous], [No title captured]; Carter BR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-65; Channon S, 2003, ARCH DIS CHILD, V88, P680, DOI 10.1136/adc.88.8.680; Channon S, 2010, DIABETIC MED, V27, P1209, DOI 10.1111/j.1464-5491.2010.03071.x; Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260; Diabetes UK, 2004, NAT PAED DIAB AUD RE; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dolovich LR, 2004, HEALTH SOC CARE COMM, V12, P475, DOI 10.1111/j.1365-2524.2004.00517.x; Gosden C, 2010, ARCH DIS CHILD, V95, P837, DOI 10.1136/adc.2009.176925; Gregory JW, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15290; Hambly H, 2009, DIABETIC MED, V26, P502, DOI 10.1111/j.1464-5491.2009.02708.x; Hampson S E, 2001, Health Technol Assess, V5, P1; Hawthorne K, 2011, DIABETIC MED, V28, P1103, DOI 10.1111/j.1464-5491.2011.03292.x; Howie JGR, 1998, FAM PRACT, V15, P165, DOI 10.1093/fampra/15.2.165; Ismail K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14220; Jefferson IG, 2003, ARCH DIS CHILD, V88, P53, DOI 10.1136/adc.88.1.53; La Greca A, 1990, J CHILD HEALTH CARE, V24, P239; Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138; Lowes L, 2011, HEALTH EXPECT, V14, P250, DOI 10.1111/j.1369-7625.2010.00625.x; McNamara R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-36; Medical Research Council, 2008, DEV EV COMPL INT NEW; METCALFE MA, 1991, BRIT MED J, V302, P960, DOI 10.1136/bmj.302.6782.960-b; Moyers TB, 2005, J SUBST ABUSE TREAT, V28, P19, DOI 10.1016/j.jsat.2004.11.001; Murphy HR, 2006, DIABETIC MED, V23, P935, DOI 10.1111/j.1464-5491.2006.01816.x; *NAT I CLIN EXC, 2004, TYP 1 DIAB DIAGN MAN; Northam EA, 2006, DIABETIC MED, V23, P113, DOI 10.1111/j.1464-5491.2005.01678.x; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Raab GM, 2001, STAT MED, V20, P351, DOI 10.1002/1097-0258(20010215)20:3<351::AID-SIM797>3.0.CO;2-C; Rollnick S, 2005, BMJ-BRIT MED J, V331, P961, DOI 10.1136/bmj.331.7522.961; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; SATIN W, 1989, J PEDIATR PSYCHOL, V14, P259, DOI 10.1093/jpepsy/14.2.259; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; WEISSBERGBENCHELL J, 1995, DIABETES CARE, V18, P77, DOI 10.2337/diacare.18.1.77; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Winkley K, 2006, BMJ-BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55	37	46	48	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2012	344								e2359	10.1136/bmj.e2359	http://dx.doi.org/10.1136/bmj.e2359			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HD	22539173	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000303433900002
J	Lake, ET; Staiger, D; Horbar, J; Cheung, R; Kenny, MJ; Patrick, T; Rogowski, JA				Lake, Eileen T.; Staiger, Douglas; Horbar, Jeffrey; Cheung, Robyn; Kenny, Michael J.; Patrick, Thelma; Rogowski, Jeannette A.			Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL INTENSIVE-CARE; MORTALITY; VOLUME; INFECTIONS; LEVEL	Context Infants born at very low birth weight (VLBW) require high levels of nursing intensity. The role of nursing in outcomes for these infants in the United States is not known. Objective To examine the relationships between hospital recognition for nursing excellence (RNE) and VLBW infant outcomes. Design, Setting, and Patients Cohort study of 72 235 inborn VLBW infants weighing 501 to 1500 g born in 558 Vermont Oxford Network hospital neonatal intensive care units between January 1, 2007, and December 31, 2008. Hospital RNE was determined from the American Nurses Credentialing Center. The RNE designation is awarded when nursing care achieves exemplary practice or leadership in 5 areas. Main Outcome Measures Seven-day, 28-day, and hospital stay mortality; nosocomial infection, defined as an infection in blood or cerebrospinal fluid culture occurring more than 3 days after birth; and severe (grade 3 or 4) intraventricular hemorrhage. Results Overall, the outcome rates were as follows: for 7-day mortality, 7.3% (5258/71 955); 28-day mortality, 10.4% (7450/71 953); hospital stay mortality, 12.9% (9278/71 936); severe intraventricular hemorrhage, 7.6% (4842/63 525); and infection, 17.9% (11 915/66 496). The 7-day mortality was 7.0% in RNE hospitals and 7.4% in non-RNE hospitals (adjusted odds ratio [OR], 0.87; 95% CI, 0.76-0.99; P=.04). The 28-day mortality was 10.0% in RNE hospitals and 10.5% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.80-1.01; P=.08). Hospital stay mortality was 12.4% in RNE hospitals and 13.1% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.81-1.01; P=.06). Severe intraventricular hemorrhage was 7.2% in RNE hospitals and 7.8% in non-RNE hospitals (adjusted OR, 0.88; 95% CI, 0.77-1.00; P=.045). Infection was 16.7% in RNE hospitals and 18.3% in non-RNE hospitals (adjusted OR, 0.86; 95% CI, 0.75-0.99; P=.04). Compared with RNE hospitals, the adjusted absolute decrease in risk of outcomes in RNE hospitals ranged from 0.9% to 2.1%. All 5 outcomes were jointly significant (P<.001). The mean effect across all 5 outcomes was OR, 0.88 (95% CI, 0.83-0.94; P<.001). In a subgroup of 68 253 infants with gestational age of 24 weeks or older, the ORs for RNE for all 3 mortality outcomes and infection were statistically significant. Conclusion Among VLBW infants born in RNE hospitals compared with non-RNE hospitals, there was a significantly lower risk-adjusted rate of 7-day mortality, nosocomial infection, and severe intraventricular hemorrhage but not of 28-day mortality or hospital stay mortality. JAMA. 2012; 307(16):1709-1716 www.jama.com	[Lake, Eileen T.] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Dept Sociol, Philadelphia, PA 19104 USA; [Lake, Eileen T.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Staiger, Douglas] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas; Rogowski, Jeannette A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Horbar, Jeffrey] Univ Vermont, Dept Pediat, Burlington, VT 05405 USA; [Kenny, Michael J.] Univ Vermont, Dept Med Biostat, Burlington, VT 05405 USA; [Horbar, Jeffrey] Vermont Oxford Network, Burlington, VT USA; [Cheung, Robyn] UK Healthcare Enterprise, Lexington, KY USA; [Patrick, Thelma] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Rogowski, Jeannette A.] Univ Med & Dent New Jersey, Dept Hlth Syst & Policy, Sch Publ Hlth, Piscataway, NJ 08854 USA	University of Pennsylvania; University of Pennsylvania; Dartmouth College; National Bureau of Economic Research; University of Vermont; University of Vermont; University System of Ohio; Ohio State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lake, ET (corresponding author), Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Dept Sociol, 418 Curie Blvd, Philadelphia, PA 19104 USA.	elake@nursing.upenn.edu	Patrick, Thelma/D-1423-2013; Patrick, Thelma/D-2482-2013; Kenny, Michael/N-3244-2013	Kenny, Michael/0000-0002-7750-654X	Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative; National Institute of Nursing Research, National Institutes of Health [R01NR010357]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010357] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative; National Institute of Nursing Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by a Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative grant (to Dr Lake) and grant R01NR010357 (to Dr Rogowski) from the National Institute of Nursing Research, National Institutes of Health.	AIKEN LH, 1994, MED CARE, V32, P771, DOI 10.1097/00005650-199408000-00002; American Hospital Association, 2010, AHA ANN SURV DAT; American Nurses Credentialing Center, MAGN REC PROGR OV; American Nurses Credentialing Center, HLTH CAR ORG MAGN RE; American Nurses Credentialing Center, 2011, APPL MAN MAGN REC PR; American Nurses Credentialing Center, JOURN MAGN EXC; *ASS WOM HLTH OBST, 2010, GUID PROF REG NURS S; BECKER PT, 1991, NURS RES, V40, P150; Boardman JD, 2002, DEMOGRAPHY, V39, P353, DOI 10.2307/3088343; Boxwell G., 2010, NEONATAL INTENSIVE C, V2nd; Chung JH, 2011, J PERINATOL, V31, P770, DOI 10.1038/jp.2011.29; Cimiotti JP, 2006, ARCH PEDIAT ADOL MED, V160, P832, DOI 10.1001/archpedi.160.8.832; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; Grandi C, 2010, ARCH ARGENT PEDIATR, V108, P499, DOI 10.1590/S0325-00752010000600005; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hamilton KES, 2007, ARCH DIS CHILD-FETAL, V92, pF99, DOI 10.1136/adc.2006.102988; Hickey P, 2010, J NURS ADMIN, V40, P226, DOI 10.1097/NNA.0b013e3181da3f71; *I MED, 2006, PRET BIRTH CAUS CONS; Lemnos JA, 2007, GUIDELINES PERINATAL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kilbride HW, 2003, PEDIATRICS, V111; Lake ET, 2010, RES NURS HEALTH, V33, P413, DOI 10.1002/nur.20399; March of Dimes, 2010, IMPR OUTC PREGN; Maternal and Child Health Bureau Health Resources and Services Administration US Department of Health and Human Services, 2010, CHILD HLTH US 2010; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; McCourt M, 1994, J Perinat Neonatal Nurs, V7, P52; Medlock S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023441; Mitchell P H, 1998, Image J Nurs Sch, V30, P43; Murphy J, 2011, US NEWS WORLD REPORT; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Pollack MM, 2003, CRIT CARE MED, V31, P1620, DOI 10.1097/01.CCM.0000063302.76602.86; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; *STAT CORP, 2007, STAT STAT SOFTW REL; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4	39	65	69	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1709	1716		10.1001/jama.2012.504	http://dx.doi.org/10.1001/jama.2012.504			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930OA	22535856	Green Accepted			2022-12-28	WOS:000303147500024
J	Khalil, AM; Cambier, JC; Shlomchik, MJ				Khalil, Ashraf M.; Cambier, John C.; Shlomchik, Mark J.			B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity	SCIENCE			English	Article							ANTIGEN-RECEPTOR; TYROSINE-PHOSPHATASE; GERMINAL-CENTER; SHP-1; SELECTION; SHIP; PROMOTES; MEMORY; CD22	Germinal centers (GCs) generate memory B and plasma cells, which are essential for long-lived humoral immunity. GC B cells with high-affinity B cell receptors (BCRs) are selectively expanded. To enable this selection, BCRs of such cells are thought to signal differently from those with lower affinity. We show that, surprisingly, most proliferating GC B cells did not demonstrate active BCR signaling. Rather, spontaneous and induced signaling was limited by increased phosphatase activity. Accordingly, both SH2 domain-containing phosphatase-1 (SHP-1) and SH2 domain-containing inositol 5 phosphatase were hyperphosphorylated in GC cells and remained colocalized with BCRs after ligation. Furthermore, SHP-1 was required for GC maintenance. Intriguingly, GC B cells in the cell-cycle G(2) period regained responsiveness to BCR stimulation. These data have implications for how higher-affinity B cells are selected in the GC.	[Khalil, Ashraf M.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cambier, John C.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Cambier, John C.] Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA	Yale University; Yale University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Cambier, John/0000-0002-7803-242X	NIH [AI43603, AR44077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603, R56AI043603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Haberman for critical reading of the manuscript; J. Bezbradica for assistance and advice on Western blotting, immunoprecipitation, and LiCor imaging; and G. Nolan for advice and protocols for flow cytometric detection of intracellular phosphoproteins. The data are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI43603 and AR44077 (to M. J. S.). A. M. K. performed experiments; A. M. K., J. C. C., and M. J. S. designed experiments, interpreted data, and wrote the manuscript; and J. C. C. contributed key reagents.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Okada H, 1998, J IMMUNOL, V161, P5129; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Shlomchik MJ, 1998, CURR TOP MICROBIOL, V229, P173; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200	27	172	173	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1178	1181		10.1126/science.1213368	http://dx.doi.org/10.1126/science.1213368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22555432	Green Accepted			2022-12-28	WOS:000304647900055
J	Black, DM; Bauer, DC; Schwartz, AV; Cummings, SR; Rosen, CJ				Black, Dennis M.; Bauer, Douglas C.; Schwartz, Ann V.; Cummings, Steven R.; Rosen, Clifford J.			Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRACTURE; TRIAL; ALENDRONATE; EXTENSION; FLEX		[Black, Dennis M.; Bauer, Douglas C.; Schwartz, Ann V.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, Scarborough, ME 04074 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Maine Medical Center	Black, DM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.				NIAMS NIH HHS [K24 AR051895] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; *FOOD DRUG ADM, 2009, BACKGR DOC M ADV COM; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11	4	199	213	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2051	2053		10.1056/NEJMp1202623	http://dx.doi.org/10.1056/NEJMp1202623			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22571169	Green Accepted			2022-12-28	WOS:000304613400004
J	Chant, C; Burns, KEA				Chant, Clarence; Burns, Karen E. A.			IV salbutamol increased mortality in patients with the acute respiratory distress syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTROLLED CLINICAL-TRIAL; LUNG INJURY		[Chant, Clarence; Burns, Karen E. A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Chant, C (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.							Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10							JC5-6	10.7326/0003-4819-156-10-201205150-02006	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586024				2022-12-28	WOS:000304193400005
J	De Sanctis, MC; Ammannito, E; Capria, MT; Tosi, F; Capaccioni, F; Zambon, F; Carraro, F; Fonte, S; Frigeri, A; Jaumann, R; Magni, G; Marchi, S; McCord, TB; McFadden, LA; McSween, HY; Mittlefehldt, DW; Nathues, A; Palomba, E; Pieters, CM; Raymond, CA; Russell, CT; Toplis, MJ; Turrini, D				De Sanctis, M. C.; Ammannito, E.; Capria, M. T.; Tosi, F.; Capaccioni, F.; Zambon, F.; Carraro, F.; Fonte, S.; Frigeri, A.; Jaumann, R.; Magni, G.; Marchi, S.; McCord, T. B.; McFadden, L. A.; McSween, H. Y.; Mittlefehldt, D. W.; Nathues, A.; Palomba, E.; Pieters, C. M.; Raymond, C. A.; Russell, C. T.; Toplis, M. J.; Turrini, D.			Spectroscopic Characterization of Mineralogy and Its Diversity Across Vesta	SCIENCE			English	Article							ASTEROID VESTA; EUCRITES; CONSTRAINTS; EVOLUTION; MODEL; DAWN	The mineralogy of Vesta, based on data obtained by the Dawn spacecraft's visible and infrared spectrometer, is consistent with howardite-eucrite-diogenite meteorites. There are considerable regional and local variations across the asteroid: Spectrally distinct regions include the south-polar Rheasilvia basin, which displays a higher diogenitic component, and equatorial regions, which show a higher eucritic component. The lithologic distribution indicates a deeper diogenitic crust, exposed after excavation by the impact that formed Rheasilvia, and an upper eucritic crust. Evidence for mineralogical stratigraphic layering is observed on crater walls and in ejecta. This is broadly consistent with magma-ocean models, but spectral variability highlights local variations, which suggests that the crust can be a complex assemblage of eucritic basalts and pyroxene cumulates. Overall, Vesta mineralogy indicates a complex magmatic evolution that led to a differentiated crust and mantle.	[De Sanctis, M. C.; Ammannito, E.; Capria, M. T.; Tosi, F.; Capaccioni, F.; Zambon, F.; Carraro, F.; Fonte, S.; Frigeri, A.; Magni, G.; Palomba, E.; Turrini, D.] Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, Rome, Italy; [Jaumann, R.] German Aerosp Ctr DLR, Inst Planetary Res, Berlin, Germany; [Marchi, S.] NASA, Lunar Sci Inst, Boulder, CO USA; [McCord, T. B.] Bear Fight Inst, Winthrop, WA USA; [McFadden, L. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [McSween, H. Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Nathues, A.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Pieters, C. M.] Brown Univ, Providence, RI 02912 USA; [Raymond, C. A.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA; [Toplis, M. J.] Observ Midi Pyrenees, F-31400 Toulouse, France	Istituto Nazionale Astrofisica (INAF); Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Max Planck Society; Brown University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	De Sanctis, MC (corresponding author), Ist Nazl Astrofis, Ist Astrofis & Planetol Spaziali, Rome, Italy.	mariacristina.desanctis@iaps.inaf.it	Zambon, Francesca/J-2855-2018; Nathues, Andreas/AAW-4340-2020; De Sanctis, Maria Cristina/G-5232-2013; Palomba, Ernesto/E-8287-2017; Beck, Andrew W/J-7215-2015; Frigeri, Alessandro/K-9679-2019; Tosi, Federico/F-2321-2018; Russell, Christopher T/E-7745-2012; Frigeri, Alessandro/F-2151-2010; McFadden, Lucy-Ann/I-4902-2013; Jaumann, Ralf/N-1001-2018	Zambon, Francesca/0000-0002-4190-6592; De Sanctis, Maria Cristina/0000-0002-3463-4437; Palomba, Ernesto/0000-0002-9101-6774; Beck, Andrew W/0000-0003-4455-2299; Frigeri, Alessandro/0000-0002-9140-3977; Tosi, Federico/0000-0003-4002-2434; Russell, Christopher T/0000-0003-1639-8298; Frigeri, Alessandro/0000-0002-9140-3977; McFadden, Lucy-Ann/0000-0002-0537-9975; Jaumann, Ralf/0000-0002-9759-6597; Capaccioni, Fabrizio/0000-0003-1631-4314; capria, maria teresa/0000-0002-9814-9588; Turrini, Diego/0000-0002-1923-7740	Italian Space Agency; Dawn Science, Instrument, and Operations Teams; NASA's Dawn; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Dawn Science, Instrument, and Operations Teams; NASA's Dawn; NASA(National Aeronautics & Space Administration (NASA))	VIR is funded by the Italian Space Agency and was developed under the leadership of INAF-Istituto di Astrofisica e Planetologia Spaziali, Rome, Italy. The instrument was built by Selex-Galileo, Florence, Italy. The authors acknowledge the support of the Dawn Science, Instrument, and Operations Teams. This work was supported by the Italian Space Agency, and NASA's Dawn at Vesta Participating Scientists Program. A portion of this work was performed at the Jet Propulsion Laboratory under contract with NASA.	Barrat JA, 2010, GEOCHIM COSMOCHIM AC, V74, P6218, DOI 10.1016/j.gca.2010.07.028; Beck AW, 2010, METEORIT PLANET SCI, V45, P850, DOI 10.1111/j.1945-5100.2010.01061.x; Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; Bowman LE, 1997, METEORIT PLANET SCI, V32, P869, DOI 10.1111/j.1945-5100.1997.tb01577.x; Burns R. G, 1993, MINERALOGICAL APPL C; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; Coradini A, 2011, SCIENCE, V334, P492, DOI 10.1126/science.1204062; De Sanctis MC, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117136; De Sanctis M. C., 2010, SPACE SCI REV; De Sanctis MC, 2011, MON NOT R ASTRON SOC, V412, P2318, DOI 10.1111/j.1365-2966.2010.18058.x; DELANEY JS, 1984, J GEOPHYS RES, V89, pC251, DOI 10.1029/JB089iS01p0C251; Drake M. J., 1979, ASTEROIDS, P765; FEIERBERG MA, 1980, SCIENCE, V209, P805, DOI 10.1126/science.209.4458.805; GAFFEY MJ, 1976, J GEOPHYS RES, V81, P905, DOI 10.1029/JB081i005p00905; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Li JY, 2010, ICARUS, V208, P238, DOI 10.1016/j.icarus.2010.02.008; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; MCFADDEN LA, 1977, ICARUS, V31, P439, DOI 10.1016/0019-1035(77)90147-6; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Mittlefehldt D. W., 1998, REV MINERAL, V6, P4; Moskovitz NA, 2010, ICARUS, V208, P773, DOI 10.1016/j.icarus.2010.03.002; Righter K, 1997, METEORIT PLANET SCI, V32, P929, DOI 10.1111/j.1945-5100.1997.tb01582.x; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Schenk P, 2012, SCIENCE, V336, P694, DOI 10.1126/science.1223272; TAKEDA H, 1979, ICARUS, V40, P455, DOI 10.1016/0019-1035(79)90039-3; Veverka J, 2000, SCIENCE, V289, P2088, DOI 10.1126/science.289.5487.2088; Warren PH, 2009, GEOCHIM COSMOCHIM AC, V73, P5918, DOI 10.1016/j.gca.2009.06.030; Warren PH, 1997, METEORIT PLANET SCI, V32, P945, DOI 10.1111/j.1945-5100.1997.tb01583.x; WILKENING L, 1971, EARTH PLANET SC LETT, V10, P334, DOI 10.1016/0012-821X(71)90039-2	31	208	209	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					697	700		10.1126/science.1219270	http://dx.doi.org/10.1126/science.1219270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582257				2022-12-28	WOS:000303872300043
J	Schenk, P; O'Brien, DP; Marchi, S; Gaskell, R; Preusker, F; Roatsch, T; Jaumann, R; Buczkowski, D; McCord, T; McSween, HY; Williams, D; Yingst, A; Raymond, C; Russell, C				Schenk, Paul; O'Brien, David P.; Marchi, Simone; Gaskell, Robert; Preusker, Frank; Roatsch, Thomas; Jaumann, Ralf; Buczkowski, Debra; McCord, Thomas; McSween, Harry Y.; Williams, David; Yingst, Aileen; Raymond, Carol; Russell, Chris			The Geologically Recent Giant Impact Basins at Vesta's South Pole	SCIENCE			English	Article							PARENT BODY; METEORITES; EVOLUTION; FAMILY; ORIGIN; EARTH; AGES	Dawn's global mapping of Vesta reveals that its observed south polar depression is composed of two overlapping giant impact features. These large basins provide exceptional windows into impact processes at planetary scales. The youngest, Rheasilvia, is 500 kilometers wide and 19 kilometers deep and finds its nearest morphologic analog among large basins on low-gravity icy satellites. Extensive ejecta deposits occur, but impact melt volume is low, exposing an unusual spiral fracture pattern that is likely related to faulting during uplift and convergence of the basin floor. Rheasilvia obliterated half of another 400-kilometer-wide impact basin, Veneneia. Both basins are unexpectedly young, roughly 1 to 2 billion years, and their formation substantially reset Vestan geology and excavated sufficient volumes of older compositionally heterogeneous crustal material to have created the Vestoids and howardite-eucrite-diogenite meteorites.	[Schenk, Paul] Lunar & Planetary Inst, Houston, TX 77058 USA; [O'Brien, David P.; Gaskell, Robert; Yingst, Aileen] Planetary Sci Inst, Tucson, AZ 85719 USA; [Marchi, Simone] NASA, Lunar Sci Inst, Boulder, CO USA; [Preusker, Frank; Roatsch, Thomas; Jaumann, Ralf] Deutsch Zentrum Luft & Raumfahrt, Inst Planetary Res, D-80302 Berlin, Germany; [Buczkowski, Debra] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [McCord, Thomas] Bear Fight Inst, Wintrop, WA 98862 USA; [McSween, Harry Y.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Williams, David] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Raymond, Carol] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Russell, Chris] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	National Aeronautics & Space Administration (NASA); Helmholtz Association; German Aerospace Centre (DLR); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Tennessee System; University of Tennessee Knoxville; Arizona State University; Arizona State University-Tempe; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles	Schenk, P (corresponding author), Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA.	schenk@lpi.usra.edu	Buczkowski, Debra L/I-7842-2015; Jaumann, Ralf/N-1001-2018; Russell, Christopher T/E-7745-2012	Buczkowski, Debra L/0000-0002-4729-7804; Jaumann, Ralf/0000-0002-9759-6597; Russell, Christopher T/0000-0003-1639-8298	NASA Dawn; NASA	NASA Dawn; NASA(National Aeronautics & Space Administration (NASA))	The authors thank D. Bogard, E. Asphaug, and H. J. Melosh for helpful discussions and comments and the NASA Dawn at Vesta Participating Scientist program for support. We thank the Dawn team for the development, cruise, orbital insertion, and operations of the Dawn spacecraft at Vesta. A portion of this work was performed at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Dawn data are archived with the NASA Planetary Data System.	Allemand P, 1999, J GEOPHYS RES-PLANET, V104, P16501, DOI 10.1029/1999JE900008; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Bogard DD, 2003, METEORIT PLANET SCI, V38, P669, DOI 10.1111/j.1945-5100.2003.tb00035.x; BOGARD DD, 1995, METEORITICS, V30, P244, DOI 10.1111/j.1945-5100.1995.tb01124.x; Bogard DD, 2011, CHEM ERDE-GEOCHEM, V71, P207, DOI 10.1016/j.chemer.2011.03.001; Bottke W., 1996, ICARUS, V124, P72; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; De Sanctis MC, 2012, SCIENCE, V336, P697, DOI 10.1126/science.1219270; Jaumann R, 2012, SCIENCE, V336, P687, DOI 10.1126/science.1219122; Jutzi M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045517; Keil K, 1997, METEORIT PLANET SCI, V32, P349, DOI 10.1111/j.1945-5100.1997.tb01278.x; Kenkmann T, 2002, GEOLOGY, V30, P231, DOI 10.1130/0091-7613(2002)030<0231:FWS>2.0.CO;2; Kriens BJ, 1999, J GEOPHYS RES-PLANET, V104, P18867, DOI 10.1029/1998JE000587; Marchi S, 2012, SCIENCE, V336, P690, DOI 10.1126/science.1218757; Marzari F, 1996, ASTRON ASTROPHYS, V316, P248; Marzari F, 1999, ICARUS, V142, P63, DOI 10.1006/icar.1999.6208; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; Melosh H.L, 1989, IMPACT CRATERING GEO; Nesvorny D, 2008, ICARUS, V193, P85, DOI 10.1016/j.icarus.2007.08.034; Reddy V, 2012, SCIENCE, V336, P700, DOI 10.1126/science.1219088; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; WISDOM J, 1985, NATURE, V315, P731, DOI 10.1038/315731a0	23	148	149	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					694	697		10.1126/science.1223272	http://dx.doi.org/10.1126/science.1223272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582256				2022-12-28	WOS:000303872300042
J	Oka, T; Hikoso, S; Yamaguchi, O; Taneike, M; Takeda, T; Tamai, T; Oyabu, J; Murakawa, T; Nakayama, H; Nishida, K; Akira, S; Yamamoto, A; Komuro, I; Otsu, K				Oka, Takafumi; Hikoso, Shungo; Yamaguchi, Osamu; Taneike, Manabu; Takeda, Toshihiro; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Nishida, Kazuhiko; Akira, Shizuo; Yamamoto, Akitsugu; Komuro, Issei; Otsu, Kinya			Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure	NATURE			English	Article							PATTERN; DAMPS	Heart failure is a leading cause of morbidity and mortality in industrialized countries. Although infection with microorganisms is not involved in the development of heart failure in most cases, inflammation has been implicated in the pathogenesis of heart failure(1). However, the mechanisms responsible for initiating and integrating inflammatory responses within the heart remain poorly defined. Mitochondria are evolutionary endosymbionts derived from bacteria and contain DNA similar to bacterial DNA(2-4). Mitochondria damaged by external haemodynamic stress are degraded by the autophagy/lysosome systemin cardiomyocytes(5). Here we show that mitochondrial DNA that escapes from autophagy cell-autonomously leads to Toll-like receptor (TLR) 9-mediated inflammatory responses in cardiomyocytes and is capable of inducing myocarditis and dilated cardiomyopathy. Cardiac-specific deletion of lysosomal deoxyribonuclease (DNase) II showed no cardiac phenotypes under baseline conditions, but increased mortality and caused severe myocarditis and dilated cardiomyopathy 10 days after treatment with pressure overload. Early in the pathogenesis, DNase II-deficient hearts showed infiltration of inflammatory cells and increased messenger RNA expression of inflammatory cytokines, with accumulation of mitochondrial DNA deposits in autolysosomes in the myocardium. Administration of inhibitory oligodeoxynucleotides against TLR9, which is known to be activated by bacterial DNA(6), or ablation of Tlr9 attenuated the development of cardiomyopathy in DNase II-deficient mice. Furthermore, Tlr9 ablation improved pressure overload-induced cardiac dysfunction and inflammation even in mice with wild-type Dnase2a alleles. These data provide new perspectives on the mechanism of genesis of chronic inflammation in failing hearts.	[Oka, Takafumi; Hikoso, Shungo; Yamaguchi, Osamu; Taneike, Manabu; Takeda, Toshihiro; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nishida, Kazuhiko; Komuro, Issei; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Taneike, Manabu; Nishida, Kazuhiko; Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Osaka University; University of London; King's College London; Osaka University; Osaka University; Osaka University	Otsu, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kinya.otsu@kcl.ac.uk	Akira, Shizuo/C-3134-2009; Hikoso, Shungo/R-4281-2018	Yamaguchi, Osamu/0000-0002-7461-369X; Hikoso, Shungo/0000-0003-2284-1970	Ministry of Education, Culture, Sports, Science and Technology in Japan; Mitsubishi Pharma Research Foundation; British Heart Foundation [CH/11/3/29051, RG/11/12/29052]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; British Heart Foundation(British Heart Foundation)	We thank S. Nagata and K. Kawane, Kyoto University, for discussions and a gift of Dnase2a<SUP>flox/flox</SUP> mice, and Y. Uchiyama, Juntendo University, for anti-LC3 antibody. We also thank K. Takada for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan and research grants from Mitsubishi Pharma Research Foundation and the British Heart Foundation (CH/11/3/29051, RG/11/12/29052).	Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P169, DOI 10.1538/expanim.44.169; Lentz SI, 2010, J HISTOCHEM CYTOCHEM, V58, P207, DOI 10.1369/jhc.2009.954701; Lu ZH, 2005, ARCH HISTOL CYTOL, V68, P71, DOI 10.1679/aohc.68.71; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; MEERSON FZ, 1964, EXP CELL RES, V36, P568, DOI 10.1016/0014-4827(64)90313-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MOSGOLLER W, 1993, J HISTOCHEM CYTOCHEM, V41, P1487, DOI 10.1177/41.10.7504007; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	26	759	794	6	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					251	U142		10.1038/nature10992	http://dx.doi.org/10.1038/nature10992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22535248	Green Accepted			2022-12-28	WOS:000303799800044
J	Palumbo, A; Hajek, R; Delforge, M; Kropff, M; Petrucci, MT; Catalano, J; Gisslinger, H; Wiktor-Jedrzejczak, W; Zodelava, M; Weisel, K; Cascavilla, N; Iosava, G; Cavo, M; Kloczko, J; Blade, J; Beksac, M; Spicka, I; Plesner, T; Radke, J; Langer, C; Ben Yehuda, D; Corso, A; Herbein, L; Yu, ZN; Mei, J; Jacques, C; Dimopoulos, MA				Palumbo, Antonio; Hajek, Roman; Delforge, Michel; Kropff, Martin; Petrucci, Maria Teresa; Catalano, John; Gisslinger, Heinz; Wiktor-Jedrzejczak, Wieslaw; Zodelava, Mamia; Weisel, Katja; Cascavilla, Nicola; Iosava, Genadi; Cavo, Michele; Kloczko, Janusz; Blade, Joan; Beksac, Meral; Spicka, Ivan; Plesner, Torben; Radke, Joergen; Langer, Christian; Ben Yehuda, Dina; Corso, Alessandro; Herbein, Lindsay; Yu, Zhinuan; Mei, Jay; Jacques, Christian; Dimopoulos, Meletios A.		MM-015 Investigators	Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREDNISONE PLUS THALIDOMIDE; ELDERLY-PATIENTS; INITIAL TREATMENT; MELPHALAN; DEXAMETHASONE; CHEMOTHERAPY; MALIGNANCY	Background Lenalidomide has tumoricidal and immunomodulatory activity against multiple myeloma. This double-blind, multicenter, randomized study compared melphalan-prednisone-lenalidomide induction followed by lenalidomide maintenance (MPR-R) with melphalan-prednisone-lenalidomide (MPR) or melphalan-prednisone (MP) followed by placebo in patients 65 years of age or older with newly diagnosed multiple myeloma. Methods We randomly assigned patients who were ineligible for transplantation to receive MPR-R (nine 4-week cycles of MPR followed by lenalidomide maintenance therapy until a relapse or disease progression occurred [152 patients]) or to receive MPR (153 patients) or MP (154 patients) without maintenance therapy. The primary end point was progression-free survival. Results The median follow-up period was 30 months. The median progression-free survival was significantly longer with MPR-R (31 months) than with MPR (14 months; hazard ratio, 0.49; P<0.001) or MP (13 months; hazard ratio, 0.40; P<0.001). Response rates were superior with MPR-R and MPR (77% and 68%, respectively, vs. 50% with MP; P<0.001 and P=0.002, respectively, for the comparison with MP). The progression-free survival benefit associated with MPR-R was noted in patients 65 to 75 years of age but not in those older than 75 years of age (P=0.001 for treatment-by-age interaction). After induction therapy, a landmark analysis showed a 66% reduction in the rate of progression with MPR-R (hazard ratio for the comparison with MPR, 0.34; P<0.001) that was age-independent. During induction therapy, the most frequent adverse events were hematologic; grade 4 neutropenia was reported in 35%, 32%, and 8% of the patients in the MPR-R, MPR, and MP groups, respectively. The 3-year rate of second primary tumors was 7% with MPR-R, 7% with MPR, and 3% with MP. Conclusions MPR-R significantly prolonged progression-free survival in patients with newly diagnosed multiple myeloma who were ineligible for transplantation, with the greatest benefit observed in patients 65 to 75 years of age.	[Palumbo, Antonio] Univ Turin, I-10126 Turin, Italy; [Petrucci, Maria Teresa] Sapienza Univ Rome, Dept Hematol, Rome, Italy; [Cascavilla, Nicola] Hosp Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Cavo, Michele] Univ Bologna, Sch Med, Bologna, Italy; [Corso, Alessandro] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Hajek, Roman] Masaryk Univ Brno, Univ Hosp Brno, Fac Med, Brno, Czech Republic; [Spicka, Ivan] Charles Univ Prague, Prague, Czech Republic; [Delforge, Michel] Belgian Hematol Soc, Louvain, Belgium; [Kropff, Martin] Univ Munster, Munster, Germany; [Weisel, Katja] Univ Tubingen, Tubingen, Germany; [Radke, Joergen] Univ Hosp Carl Gustav Carus, Dresden, Germany; [Langer, Christian] Univ Ulm, Ulm, Germany; [Catalano, John] Frankston Hosp, Frankston, Australia; [Catalano, John] Monash Univ, Dept Clin Haematol, Melbourne, Vic 3004, Australia; [Gisslinger, Heinz] Med Univ Vienna, Dept Hematol, Vienna, Austria; [Wiktor-Jedrzejczak, Wieslaw] Med Univ Warsaw, Warsaw, Poland; [Kloczko, Janusz] Med Univ Bialystok, Bialystok, Poland; [Zodelava, Mamia] Clin Hematol & Chemotherapy Hema, Tbilisi, Georgia; [Iosava, Genadi] Inst Hematol & Transfusiol, Tbilisi, Georgia; [Blade, Joan] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain; [Beksac, Meral] Ankara Univ, Dept Hematol, TR-06100 Ankara, Turkey; [Plesner, Torben] Vejle Hosp, Dept Hematol, Vejle, Denmark; [Ben Yehuda, Dina] Hadassah Med Ctr, IL-91120 Jerusalem, Israel; [Herbein, Lindsay; Yu, Zhinuan; Mei, Jay; Jacques, Christian] Celgene, Summit, NJ USA; [Dimopoulos, Meletios A.] Univ Athens, Alexandra Hosp, Sch Med, GR-10679 Athens, Greece	University of Turin; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; University of Bologna; IRCCS Fondazione San Matteo; Masaryk University Brno; University Hospital Brno; Charles University Prague; University of Munster; Eberhard Karls University of Tubingen; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ulm University; Frankston Hospital; Monash University; Medical University of Vienna; Medical University of Warsaw; Medical University of Bialystok; University of Barcelona; Hospital Clinic de Barcelona; Ankara University; University of Southern Denmark; Lillebaelt Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center; Bristol-Myers Squibb; Celgene Corporation; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Palumbo, A (corresponding author), Univ Turin, Myeloma Unit, Div Hematol, Azienda Osped Univ, Via Genova 3, I-10126 Turin, Italy.	appalumbo@yahoo.com	Hajek, Roman/I-6639-2017; CAVO, MICHELE/AAK-8274-2020; Greil, Richard F/C-7673-2017; Dimopoulos, Meletios Athanasios/AAD-4130-2019; ALEGRE, ADRIAN/AAE-4268-2021; Beksac, Meral/D-6411-2013; Schey, Steve A/F-9317-2013	Hajek, Roman/0000-0001-6955-6267; CAVO, MICHELE/0000-0003-4514-3227; Greil, Richard F/0000-0002-4462-3694; ALEGRE, ADRIAN/0000-0002-2423-822X; Beksac, Meral/0000-0003-1797-8657; Schey, Steve A/0000-0002-2474-9484; Cascavilla, Nicola/0000-0002-8901-2379; Dimopoulos, Meletios/0000-0001-8990-3254; Spicka, Ivan/0000-0002-5451-5283; Stenner, Frank/0000-0003-4541-8817	Celgene [MM-015]; Janssen-Cilag; Merck; Amgen; Mundipharma; AOP Orphan; Novartis; Pfizer; Bayer; Genopharm; Genzyme; Bristol-Myers Squibb; Onyx; GenMark	Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Amgen(Amgen); Mundipharma; AOP Orphan; Novartis(Novartis); Pfizer(Pfizer); Bayer(Bayer AG); Genopharm; Genzyme(Sanofi-AventisGenzyme Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Onyx; GenMark	Funded by Celgene; MM-015 ClinicalTrials.gov number, NCT00405756.; Supported by Celgene, including funding for editorial support in the preparation of the manuscript. Dr. Palumbo reports being a board member of and receiving consulting fees and payment for the development of educational presentations from Celgene and Janssen-Cilag and receiving lecture fees, including service on speakers bureaus, from Celgene, Janssen-Cilag, Merck, and Amgen; Dr. Hajek, receiving payment for the development of educational presentations from Merck, Celgene, and Janssen-Cilag; Dr. Delforge, receiving consulting fees, grant support, and lecture fees, including service on speakers bureaus, from Celgene and Janssen-Cilag; Dr. Petrucci, receiving consulting fees from Merck; Dr. Catalano, being a board member of and receiving lecture fees, including service on the speakers bureau, and funding for meeting attendance from Celgene; Dr. Gisslinger, being a board member of and receiving lecture fees, including service on speakers bureaus, from Celgene, Janssen-Cilag, Mundipharma, and AOP Orphan and receiving payment from AOP Orphan for expert testimony regarding interferon treatment in myeloproliferative neoplasms and grant support from Celgene; Dr. Wiktor-Jedrzejczak, receiving consulting fees from Janssen-Cilag, Amgen, Novartis, Pfizer, and Bayer, being an advisory board member of Bristol-Myers Squibb, receiving payment from Genopharm for a review article regarding melphalan in hematopoietic-cell transplantation in multiple myeloma, and receiving lecture fees, including service on speakers bureaus, from Celgene, Genzyme, Novartis, and Bristol-Myers Squibb; Dr. Weisel, receiving grant support from Celgene and being an advisory board member of and receiving lecture fees, including service on speakers bureaus, consulting fees, and funding for meeting attendance from Celgene and Janssen-Cilag; Dr. Cascavilla, receiving funding for meeting attendance from Celgene; Dr. Cavo, being a board member of and receiving lecture fees, including service on speakers bureaus, from Janssen-Cilag and Celgene; Dr. Kloczko, receiving funding for meeting attendance from Celgene; Dr. Blade, receiving consulting fees from Merck, Celgene, and Onyx, grant support from Janssen-Cilag, lecture fees, including service on speakers bureaus, from Janssen-Cilag, Celgene, Novartis, and Merck, and payment for the development of educational presentations from Janssen-Cilag, Celgene, and Novartis; Dr. Beksac, receiving lecture fees, including service on speakers bureaus, from Celgene, Janssen-Cilag, and Amgen and funding for meeting attendance from Novartis; Dr. Spicka, receiving payment for the development of educational presentations from Celgene and Janssen-Cilag, and receiving honoraria from Celgene and Janssen-Cilag; Dr. Plesner, receiving consulting fees from GenMark and being an advisory board member of and receiving lecture fees, including service on the speakers bureau, from Janssen-Cilag; Dr. Langer, receiving consulting fees from Celgene; Ms. Herbein, Dr. Yu, Dr. Mei, and Dr. Jacques, being employees of Celgene; and Dr. Dimopoulos, receiving consulting fees from Celgene, Merck, and Novartis and grant support from Celgene and Merck. No other potential conflict of interest relevant to this article was reported.	Attal M, 2011, HAEMATOLOGICA, V96, pS23; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Dimopoulos M, 2009, NEW ENGL J MED, V361, P544; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dimopoulos MA, 2012, BLOOD, V119, P2764, DOI 10.1182/blood-2011-08-373514; Dong C, 2001, BRIT J CANCER, V85, P997, DOI 10.1054/bjoc.2001.1998; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2006, LEUKEMIA, V20, P2220, DOI 10.1038/sj.leu.2404428; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; McCarthy P, 2011, HAEMATOLOGICA, V96, pS23; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sevilla J, 2002, ANN HEMATOL, V81, P11, DOI 10.1007/s00277-001-0400-0; Waage A, 2010, BLOOD, V116, P1405, DOI 10.1182/blood-2009-08-237974; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Zonder JA, 2010, BLOOD, V116, P5838, DOI 10.1182/blood-2010-08-303487	27	567	585	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1759	1769		10.1056/NEJMoa1112704	http://dx.doi.org/10.1056/NEJMoa1112704			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571200	Green Published			2022-12-28	WOS:000303817000005
J	Owen, J				Owen, James			Never a cross word	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e3281	10.1136/bmj.e3281	http://dx.doi.org/10.1136/bmj.e3281			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XB	22573657				2022-12-28	WOS:000304083800013
J	Relman, A				Relman, Arnold			Why the US healthcare system is failing, and what might rescue it	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Relman, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	arnoldrelman@gmail.com						ANGELL M, 2011, NY REV BOOKS    0623, P20; [Anonymous], 2011, INSIDE NATL HLTH REF; ARROW KJ, 1963, AM ECON REV, V53, P941; Davis K., 2010, MIRROR WALL PERFORMA; ENTHOVEN A, 2004, 21 CENTURY HLTH SYST; Keehan SP, 2011, HEALTH AFFAIR, V30, P1594, DOI 10.1377/hlthaff.2011.0662; Relman AS, 2010, 2 OPINION RESCUING A; Relman AS, 2010, NEW YORK REV    0930, P45; Relman AS, 2011, NEW YORK REV    1027, P14; Relman AS, 2012, AM PROSPECT, V23, P34; Squires D., 2011, US HLTH SYSTEM PERSP	11	1	1	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 9	2012	344								e3052	10.1136/bmj.e3052	http://dx.doi.org/10.1136/bmj.e3052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942XB	22573650				2022-12-28	WOS:000304083800006
J	Spence, D				Spence, Des			The psychiatric oligarchs who medicalise normality	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						American Psychiatric Association, DSM 5 DEV MAJ DEPR E; *CDCP, ATT DEF HYP DIS DAT; Centers for Disease Control and Prevention, AUT SPECTR DIS ASDS; Centers for Disease Control and Prevention, CDC MENT ILLN SURV; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Morrison AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2233	7	7	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e3135	10.1136/bmj.e3135	http://dx.doi.org/10.1136/bmj.e3135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NC	22551806				2022-12-28	WOS:000303817200006
J	Whooley, MA				Whooley, Mary A.			Diagnosis and Treatment of Depression in Adults With Comorbid Medical Conditions A 52-Year-Old Man With Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN-REUPTAKE INHIBITORS; CASE-FINDING INSTRUMENTS; BEHAVIORAL ACTIVATION TREATMENTS; PHYSICAL HEALTH-PROBLEMS; PRIMARY-CARE TREATMENT; COLLABORATIVE CARE; COST-EFFECTIVENESS; PSYCHOLOGICAL TREATMENTS; NATIONAL PATTERNS; OLDER-ADULTS	Approximately 1 in 10 primary care patients has major depressive disorder, and its presence is associated with poor health outcomes in numerous medical conditions. Using the case of Mr J, a 52-year-old man with depressive symptoms and several comorbid medical conditions, diagnosis and treatment of depression are discussed. Specific topics include evidence regarding appropriate depression screening and diagnosis, the importance of team-based care, patient self-management, exercise, structured psychotherapy, pharmacotherapy, monitoring of therapy, and indications for referral. JAMA. 2012;307(17):1848-1857 www.jama.com	[Whooley, Mary A.] Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Whooley, Mary A.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Whooley, MA (corresponding author), Dept Vet Affairs Med Ctr, 4150 Clement St 111A1, San Francisco, CA 94121 USA.	mary.whooley@ucsf.edu						Abo-Zena RA, 2000, PHARMACOTHERAPY, V20, P476, DOI 10.1592/phco.20.5.476.35061; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson B, 2007, AM J MANAG CARE, V13, pS103; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Bachman J, 2006, GEN HOSP PSYCHIAT, V28, P278, DOI 10.1016/j.genhosppsych.2006.03.006; Bachman J, 2006, ADM POLICY MENT HLTH, V33, P76, DOI 10.1007/s10488-005-4238-y; Bao YH, 2011, HEALTH SERV RES, V46, P1436, DOI 10.1111/j.1475-6773.2011.01272.x; Casacalenda N, 2002, AM J PSYCHIAT, V159, P1354, DOI 10.1176/appi.ajp.159.8.1354; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Consumer Reports Health Best Buy Drugs, 2011, ANT TREAT DEPR COMP; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Cuijpers P, 2011, AM J PSYCHIAT, V168, P581, DOI 10.1176/appi.ajp.2010.10101411; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; Cuijpers P, 2009, J CLIN PSYCHIAT, V70, P1219, DOI 10.4088/JCP.09r05021; Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075; Cuijpers P, 2009, BRIT J GEN PRACT, V59, P120, DOI 10.3399/bjgp09X395139; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2011, ANNU REV CLIN PSYCHO, V7, P1, DOI 10.1146/annurev-clinpsy-032210-104535; Dube Priyanka, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.10m00978blu; Dukakis K, 2006, SHOCK HEALING POWER; Elderon L, 2011, CIRC-CARDIOVASC QUAL, V4, P533, DOI 10.1161/CIRCOUTCOMES.110.960302; Even C, 2008, J AFFECT DISORDERS, V108, P11, DOI 10.1016/j.jad.2007.09.008; Foroushani PS, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-131; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Fullerton CA, 2011, ARCH GEN PSYCHIAT, V68, P1218, DOI 10.1001/archgenpsychiatry.2011.146; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gaynes BN, 2008, CLEV CLIN J MED, V75, P57, DOI 10.3949/ccjm.75.1.57; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696; Jacob S, 2006, ANN PHARMACOTHER, V40, P1618, DOI 10.1345/aph.1G293; Johnsen E, 2011, EVID-BASED MENT HEAL, V14, P47, DOI [10.1136/ebmh.14.2.47, 10.1136/ebmh1149]; Katon W, 2006, DIABETES CARE, V29, P265, DOI 10.2337/diacare.29.02.06.dc05-1572; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon W, 2010, GEN HOSP PSYCHIAT, V32, P456, DOI 10.1016/j.genhosppsych.2010.04.001; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2005, ARCH GEN PSYCHIAT, V62, P1313, DOI 10.1001/archpsyc.62.12.1313; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Koliscak LP, 2009, J AM PHARM ASSOC, V49, pE28, DOI 10.1331/JAPhA.2009.08083; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, JAMA-J AM MED ASSOC, V287, P1568, DOI 10.1001/jama.287.12.1568; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krogh J, 2011, J CLIN PSYCHIAT, V72, P529, DOI 10.4088/JCP.08r04913blu; Lefebvre R, 2009, SHAME ME ONE MANS JO; Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Loftis JM, 2004, J AFFECT DISORDERS, V82, P175, DOI 10.1016/j.jad.2004.04.002; MacArthur Initiative on Depression in Primary Care, DEPR SELF CAR ACT PL; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matreja PS, 2007, HUM PSYCHOPHARM CLIN, V22, P477, DOI 10.1002/hup.864; Mead GE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub4; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Moncrieff J, 2004, Cochrane Database Syst Rev, pCD003012; Mullins CD, 2005, PHARMACOTHERAPY, V25, P660, DOI 10.1592/phco.25.5.660.63590; Nader P, 2007, GEN HOSP PSYCHIAT, V29, P72, DOI 10.1016/j.genhosppsych.2006.10.006; National Institute of Health and Clinical Excellence, COMP COGN BEH THER D; Newcomer JW, 2005, CNS DRUGS, V19, P1; Nieuwstraten CE, 2001, ANN PHARMACOTHER, V35, P1608; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Nutting PA, 2008, ANN FAM MED, V6, P30, DOI 10.1370/afm.742; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Oslin DW, 2003, J CLIN PSYCHIAT, V64, P875, DOI 10.4088/JCP.v64n0804; Ostacher MJ, 2007, PSYCHIAT CLIN N AM, V30, P69, DOI 10.1016/j.psc.2006.12.009; Pacher P, 2004, CURR PHARM DESIGN, V10, P2463, DOI 10.2174/1381612043383872; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; Papakostas GI, 2008, BIOL PSYCHIAT, V63, P699, DOI 10.1016/j.biopsych.2007.08.010; PATTEN SB, 1993, J PSYCHIATR NEUROSCI, V18, P92; Rayner L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007503.pub2; Reeves William C., 2011, Morbidity and Mortality Weekly Report, V60, P1; Roose SP, 2003, BIOL PSYCHIAT, V54, P262, DOI 10.1016/S0006-3223(03)00320-2; Rudkin L, 2004, COCHRANE DB SYST REV; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Saarto T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005454, 10.1002/14651858.CD005454.pub2]; Schoenbaum M, 2002, HEALTH SERV RES, V37, P1145, DOI 10.1111/1475-6773.01086; Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65; Simon GE, 2006, J CLIN PSYCHIAT, V67, P1226, DOI 10.4088/JCP.v67n0808; Stahl SM, 2000, BIOL PSYCHIAT, V48, P894, DOI 10.1016/S0006-3223(00)00957-4; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Stimmel GL, 1997, PHARMACOTHERAPY, V17, P10; Taylor D, 2011, BRIT J PSYCHIAT, V198, P179, DOI 10.1192/bjp.bp.110.077610; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Tuunainen A, 2004, Cochrane Database Syst Rev, pCD004050, DOI 10.1002/14651858.CD004050.pub2; U.S. Food and Drug Administration, 2012, FDA DRUG SAF COMM RE; UK National Institute of Health and Clinical Excellence, TREATM MAN DEPR AD; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Unutzer J, 2008, AM J MANAG CARE, V14, P95; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; US Preventive Services Task Force, GRADE DEF; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 2002, ARCH INTERN MED, V162, P2614, DOI 10.1001/archinte.162.22.2614; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Zellweger MJ, 2004, EUR HEART J, V25, P3, DOI 10.1016/j.ehj.2003.09.009	110	15	15	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1848	1857		10.1001/jama.2012.3466	http://dx.doi.org/10.1001/jama.2012.3466			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550199				2022-12-28	WOS:000303386800024
J	Neupert, W				Neupert, Walter			SnapShot: Mitochondrial Architecture	CELL			English	Editorial Material							MEMBRANE ORGANIZATION; COMPLEX; MITOFILIN; CRISTAE; FUSION		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Neupert, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.							Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Fawcett D.W., 1981, CELL; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052	12	15	15	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					722	+		10.1016/j.cell.2012.04.010	http://dx.doi.org/10.1016/j.cell.2012.04.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541440	Bronze			2022-12-28	WOS:000303443100021
J	Warrington, B				Warrington, Bruce			Two Atomic Clocks Ticking as One	SCIENCE			English	Editorial Material							FREQUENCY; TIME; SYNCHRONIZATION		Natl Measurement Inst, Sydney, NSW 2070, Australia	National Measurement Institute Australia - NMI	Warrington, B (corresponding author), Natl Measurement Inst, Sydney, NSW 2070, Australia.	bruce.warrington@measurement.gov.au						[Anonymous], CIRC T; BAGLEY AS, 1964, HEWLETT-PACKARD J, V15, P1; Bauch A, 2006, METROLOGIA, V43, P109, DOI 10.1088/0026-1394/43/1/016; Chou CW, 2010, SCIENCE, V329, P1630, DOI 10.1126/science.1192720; ESSEN L, 1960, NATURE, V187, P452, DOI 10.1038/187452a0; Kleppner D, 2008, SCIENCE, V319, P1768, DOI 10.1126/science.1155948; Lopez O, 2010, OPT EXPRESS, V18, P16849, DOI 10.1364/OE.18.016849; MARKOWITZ W, 1958, PHYS REV LETT, V1, P105, DOI 10.1103/PhysRevLett.1.105; Predehl K, 2012, SCIENCE, V336, P441, DOI 10.1126/science.1218442; REDER FH, 1961, P IRE, V49, P1028, DOI 10.1109/JRPROC.1961.287886; STEELE JM, 1964, IEEE T INSTRUM MEAS, VIM13, P164, DOI 10.1109/TIM.1964.4313398	11	10	10	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					421	422		10.1126/science.1220826	http://dx.doi.org/10.1126/science.1220826			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539707				2022-12-28	WOS:000303233400030
J	Crabb, BS; Beeson, JG; Amino, R; Menard, R; Waters, A; Winzeler, EA; Wahlgren, M; Fidock, DA; Nwaka, S				Crabb, Brendan S.; Beeson, James G.; Amino, Rogerio; Menard, Robert; Waters, Andy; Winzeler, Elizabeth A.; Wahlgren, Mats; Fidock, David A.; Nwaka, Solomon			PERSPECTIVES The missing pieces	NATURE			English	Editorial Material									[Crabb, Brendan S.; Beeson, James G.] Burnet Inst, Melbourne, Vic, Australia; [Amino, Rogerio; Menard, Robert] Inst Pasteur, Unite Biol & Genet Paludisme, Paris, France; [Waters, Andy] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA; [Fidock, David A.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Nwaka, Solomon] WHO, African Network Drugs & Diagnost Innovat ANDI, Geneva, Switzerland; [Nwaka, Solomon] WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland	Burnet Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Glasgow; University of California System; University of California San Diego; Karolinska Institutet; Columbia University; Columbia University; World Health Organization; World Health Organization	Crabb, BS (corresponding author), Burnet Inst, Melbourne, Vic, Australia.		Winzeler, Elizabeth/AAP-6752-2020; Crabb, Brendan/F-5287-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Fidock, David/0000-0001-6753-8938	Wellcome Trust [085349, 083811] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S22	S23		10.1038/484S22a	http://dx.doi.org/10.1038/484S22a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534528	Bronze			2022-12-28	WOS:000303200400003
J	Jenkins, C; Seccombe, L; Tomlins, R				Jenkins, Christine; Seccombe, Leigh; Tomlins, Ron			RATIONAL TESTING Investigating asthma symptoms in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG-FUNCTION; LIFE		[Jenkins, Christine; Seccombe, Leigh] Concord Hosp, Dept Thorac Med, Concord, NSW 2139, Australia; [Seccombe, Leigh] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW 2109, Australia; [Tomlins, Ron] Univ Sydney, Discipline Gen Practice, Western Clin Sch, Sydney, NSW 2006, Australia	Concord Repatriation General Hospital; Macquarie University; University of Sydney	Jenkins, C (corresponding author), Concord Hosp, Dept Thorac Med, Concord, NSW 2139, Australia.	christine.jenkins@sydney.edu.au		Seccombe, Leigh/0000-0001-8037-3824				Anderson SD, 2010, CHEST, V138, p25S, DOI 10.1378/chest.10-0116; Australian Centre for Asthma Monitoring, 2011, AUSTR CTR ASTHM MON, V4; *BRIT THOR SOC, 2008, BRIT GUID MAN ASTHM; Burton D, 2011, SPIROMETER USERS BUY; Carlsen KH, 2011, EUR RESPIR J, V38, P713, DOI 10.1183/09031936.00068510; Carlsen KH, 2002, PAEDIATR RESPIR REV, V3, P152; Cockcroft DW, 2010, CHEST, V138, p18S, DOI 10.1378/chest.10-0088; Delgado L, 2005, EUR RESPIR MONOGR, P67; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; GLINDMEYER HW, 1995, AM J RESP CRIT CARE, V151, P412, DOI 10.1164/ajrccm.151.2.7842200; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Lowhagen O, 1999, RESP MED, V93, P734, DOI 10.1016/S0954-6111(99)90041-0; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; National Asthma Council Australia, SPIR TECHN VID; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Porsbjerg C, 2008, CLIN EXP ALLERGY, V38, P43, DOI 10.1111/j.1365-2222.2007.02878.x; Randolph C, 2011, CURR ALLERGY ASTHM R, V11, P482, DOI 10.1007/s11882-011-0225-4; Starren ES, 2012, PRIM CARE RESP J, V21, P180, DOI 10.4104/pcrj.2012.00013; Tilles SA, 2010, ANN ALLERG ASTHMA IM, V104, P361, DOI 10.1016/j.anai.2009.12.008; Toelle BG, 2004, EUR RESPIR J, V23, P66, DOI 10.1183/09031936.03.00046903; Yawn BF, 2007, CHEST, V132, P1162, DOI 10.1378/chest.06-2722	26	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2012	344								e2734	10.1136/bmj.e2734	http://dx.doi.org/10.1136/bmj.e2734			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HC	22535737				2022-12-28	WOS:000303433800001
J	Mills, A; Ataguba, JE; Akazili, J; Borghi, J; Garshong, B; Makawia, S; Mtei, G; Harris, B; Macha, J; Meheus, F; McIntyre, D				Mills, Anne; Ataguba, John E.; Akazili, James; Borghi, Jo; Garshong, Bertha; Makawia, Suzan; Mtei, Gemini; Harris, Bronwyn; Macha, Jane; Meheus, Filip; McIntyre, Di			Equity in financing and use of health care in Ghana, South Africa, and Tanzania: implications for paths to universal coverage	LANCET			English	Article								Background Universal coverage of health care is now receiving substantial worldwide and national attention, but debate continues on the best mix of financing mechanisms, especially to protect people outside the formal employment sector. Crucial issues are the equity implications of different financing mechanisms, and patterns of service use. We report a whole-system analysis-integrating both public and private sectors-of the equity of health-system financing and service use in Ghana, South Africa, and Tanzania. Methods We used primary and secondary data to calculate the progressivity of each health-care financing mechanism, catastrophic spending on health care, and the distribution of health-care benefits. We collected qualitative data to inform interpretation. Findings Overall health-care financing was progressive in all three countries, as were direct taxes. Indirect taxes were regressive in South Africa but progressive in Ghana and Tanzania. Out-of-pocket payments were regressive in all three countries. Health-insurance contributions by those outside the formal sector were regressive in both Ghana and Tanzania. The overall distribution of service benefits in all three countries favoured richer people, although the burden of illness was greater for lower-income groups. Access to needed, appropriate services was the biggest challenge to universal coverage in all three countries. Interpretation Analyses of the equity of financing and service use provide guidance on which financing mechanisms to expand, and especially raise questions over the appropriate financing mechanism for the health care of people outside the formal sector. Physical and financial barriers to service access must be addressed if universal coverage is to become a reality.	[McIntyre, Di] Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Mills, Anne; Borghi, Jo] Univ London London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England; [Akazili, James] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Navrongo, Ghana; [Garshong, Bertha] Ghana Hlth Serv, Accra, Ghana; [Makawia, Suzan; Mtei, Gemini; Macha, Jane] Ifakara Hlth Inst, Hlth Syst Grp, Dar Es Salaam, Tanzania; [Harris, Bronwyn] Univ Witwatersrand, Ctr Hlth Policy, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Meheus, Filip] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Meheus, Filip] Royal Trop Inst, NL-1105 AZ Amsterdam, Netherlands	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service; Navrongo Health Research Center; Ghana Health Service; Ifakara Health Institute; University of Witwatersrand; Institute of Tropical Medicine (ITM)	McIntyre, D (corresponding author), Univ Cape Town, Hlth Econ Unit, Sch Publ Hlth & Family Med, Fac Hlth Sci, Anzio Rd, ZA-7925 Cape Town, South Africa.	diane.mcIntyre@uct.ac.za	PAN, ZEQIANG/X-6341-2018	Borghi, Josephine/0000-0002-0482-5451; McIntyre, Diane/0000-0001-6319-4111; Harris, Bronwyn/0000-0003-4695-008X; Ataguba, John Ele-Ojo/0000-0002-7746-3826; Mills, Anne/0000-0001-9863-9950	European Union; International Development Research Centre; International Development and Research Centre [103457]; European Commission [32289]	European Union(European Commission); International Development Research Centre; International Development and Research Centre; European Commission(European CommissionEuropean Commission Joint Research Centre)	European Union and International Development Research Centre.; This work was supported by the International Development and Research Centre (Grant number 103457) and the European Commission (Sixth Framework Programme; Specific Targeted Research Project number 32289). We also acknowledge all the other colleagues who contributed to the SHIELD project: Mariam Ally, Ermin Erasmus, Lucy Gilson, Jane Goudge, Peter Kamuzora, Jahangir AM Khan, August Kuwawenaruwa, and Clas Rehnberg.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Ataguba JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-48; Council for Medical Schemes, 2010, ANN REP 2009 10; Drechsler D, 2005, IS THERE ROLE PRIVAT; Garshong B, 2011, THESIS U CAPE TOWN C; High Level Expert Group, 2011, REP UN HLTH CO UNPUB; KAKWANI NC, 1977, ECON J, V87, P71, DOI 10.2307/2231833; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; National Department of Health, 2011, GREEN PAP NAT HLTH I; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; Preker AS, 2003, HLTH FINANCING POOR; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Tanzania National Bureau of Statistics, 2010, TANZ DEM HLTH SURV 2; Vogel Ronald J., 1988, 82 WORLD BANK; Wagstaff A, 1999, J HEALTH ECON, V18, P263, DOI 10.1016/S0167-6296(98)00044-7; WHA, SUST HLTH FIN STRUCT; WHO, 2010, WOR HEALT REP, P1	17	190	191	1	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					126	133		10.1016/S0140-6736(12)60357-2	http://dx.doi.org/10.1016/S0140-6736(12)60357-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22591542	Green Accepted			2022-12-28	WOS:000306359100039
J	Garwood, R				Garwood, Russell			Reach out to defend evolution	NATURE			English	Editorial Material									Univ Manchester, Dept Mat, Manchester M13 9PL, Lancs, England	University of Manchester	Garwood, R (corresponding author), Univ Manchester, Dept Mat, Harwell Complex, Manchester M13 9PL, Lancs, England.	russell.garwood@manchester.ac.uk		Garwood, Russell/0000-0002-2803-9471	Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish; EPSRC [EP/I02249X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))			0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					281	281		10.1038/485281a	http://dx.doi.org/10.1038/485281a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596116	Bronze			2022-12-28	WOS:000304099100004
J	Patrick, SW; Schumacher, RE; Benneyworth, BD; Krans, EE; McAllister, JM; Davis, MM				Patrick, Stephen W.; Schumacher, Robert E.; Benneyworth, Brian D.; Krans, Elizabeth E.; McAllister, Jennifer M.; Davis, Matthew M.			Neonatal Abstinence Syndrome and Associated Health Care Expenditures United States, 2000-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHADONE-MAINTENANCE; WITHDRAWAL SYMPTOMS; PREGNANCY; TERM; EXPOSURE; PREVALENCE; MANAGEMENT; CHILDREN; INFANTS; HEROIN	Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome primarily caused by maternal opiate use. No national estimates are available for the incidence of maternal opiate use at the time of delivery or NAS. Objectives To determine the national incidence of NAS and antepartum maternal opiate use and to characterize trends in national health care expenditures associated with NAS between 2000 and 2009. Design, Setting, and Patients Aretrospective, serial, cross-sectional analysis of a nationally representative sample of newborns with NAS. The Kids' Inpatient Database (KID) was used to identify newborns with NAS by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code. The Nationwide Inpatient Sample (NIS) was used to identify mothers using diagnosis related groups for vaginal and cesarean deliveries. Clinical conditions were identified using ICD-9-CM diagnosis codes. NAS and maternal opiate use were described as an annual frequency per 1000 hospital births. Missing hospital charges (<5% of cases) were estimated using multiple imputation. Trends in health care utilization outcomes over time were evaluated using variance-weighted regression. All hospital charges were adjusted for inflation to 2009 US dollars. Main Outcome Measures Incidence of NAS and maternal opiate use, and related hospital charges. Results The separate years (2000, 2003, 2006, and 2009) of national discharge data included 2920 to 9674 unweighted discharges with NAS and 987 to 4563 unweighted discharges for mothers diagnosed with antepartum opiate use, within data sets including 784 191 to 1.1 million discharges for children (KID) and 816 554 to 879 910 discharges for all ages of delivering mothers (NIS). Between 2000 and 2009, the incidence of NAS among newborns increased from 1.20 (95% CI, 1.04-1.37) to 3.39 (95% CI, 3.12-3.67) per 1000 hospital births per year (P for trend<.001). Antepartum maternal opiate use also increased from 1.19 (95% CI, 1.01-1.35) to 5.63 (95% CI, 4.40-6.71) per 1000 hospital births per year (P for trend<.001). In 2009, newborns with NAS were more likely than all other hospital births to have low birthweight (19.1%; SE, 0.5%; vs 7.0%; SE, 0.2%), have respiratory complications (30.9%; SE, 0.7%; vs 8.9%; SE, 0.1%), and be covered by Medicaid (78.1%; SE, 0.8%; vs 45.5%; SE, 0.7%; all P<.001). Mean hospital charges for discharges with NAS increased from $39 400 (95% CI, $33 400-$45 400) in 2000 to $53 400 (95% CI, $49 000-$57 700) in 2009 (P for trend<.001). By 2009, 77.6% of charges for NAS were attributed to state Medicaid programs. Conclusion Between 2000 and 2009, a substantial increase in the incidence of NAS and maternal opiate use in the United States was observed, as well as hospital charges related to NAS. JAMA. 2012;307(18):1934-1940 Published online April 30, 2012. doi:10.1001/jama.2012.3951 www.jama.com	[Patrick, Stephen W.; Schumacher, Robert E.; Benneyworth, Brian D.; McAllister, Jennifer M.; Davis, Matthew M.] Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Patrick, Stephen W.; Davis, Matthew M.] Univ Michigan Hlth Syst, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Krans, Elizabeth E.] Univ Pittsburgh, Dept Obstet & Gynecol, Pittsburgh, PA USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Patrick, SW (corresponding author), Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, 6312 Med Sci Bldg 1,1150 Med Ctr Dr,SPC 5604, Ann Arbor, MI 48109 USA.	stepatri@med.umich.edu	Patrick, Stephen/ABD-8528-2021; Benneyworth, Brian/A-4667-2009	McAllister, Jennifer/0000-0003-3225-5561; Benneyworth, Brian/0000-0002-4692-5303	Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA038720] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the Robert Wood Johnson Foundation Clinical Scholars Program (Drs Patrick and Davis).	Agthe AG, 2009, PEDIATRICS, V123, pE849, DOI 10.1542/peds.2008-0978; Almario CV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.052; Arlettaz R, 2005, ACTA OBSTET GYN SCAN, V84, P145, DOI 10.1111/j.0001-6349.2005.00510.x; Backes CH, 2012, J PERINATOL, V32, P425, DOI 10.1038/jp.2011.114; Bauer CR, 2005, ARCH PEDIAT ADOL MED, V159, P824, DOI 10.1001/archpedi.159.9.824; Benneyworth BD, 2011, PEDIATRICS, V127, pE1533, DOI 10.1542/peds.2010-2026; Berlin CM, 1998, PEDIATRICS, V101, P1079; Brown HL, 1998, AM J OBSTET GYNECOL, V179, P459, DOI 10.1016/S0002-9378(98)70379-5; Burns L, 2007, DRUG ALCOHOL REV, V26, P487, DOI 10.1080/09595230701494416; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Coyle MG, 2002, J PEDIATR-US, V140, P561, DOI 10.1067/mpd.2002.123099; DOBERCZAK TM, 1991, J PEDIATR-US, V118, P933, DOI 10.1016/S0022-3476(05)82214-0; Dryden C, 2009, BJOG-INT J OBSTET GY, V116, P665, DOI 10.1111/j.1471-0528.2008.02073.x; HCUP databases, 2011, OV NAT INP SAMPL NIS; Healthcare Cost and Utilization Project (HCUP), 2011, INTR KID 2009 HCUP; Healthcare Cost and Utilization Project (HCUP), 2003, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2009, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2011, INTR NIS 2009 HCUP N; Healthcare Cost and Utilization Project (HCUP), 2006, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2000, OV KIDS INP DAT KID; Hulse GK, 1997, ADDICTION, V92, P1571; Jansson LM, 2004, J HUM LACT, V20, P62, DOI 10.1177/0890334403261027; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kaltenbach K, 1998, OBSTET GYN CLIN N AM, V25, P139, DOI 10.1016/S0889-8545(05)70362-4; KANDALL SR, 1976, PEDIATRICS, V58, P681; Kellogg A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.050; Levison-Castiel R, 2006, ARCH PEDIAT ADOL MED, V160, P173, DOI 10.1001/archpedi.160.2.173; Macy ML, 2010, MED CARE, V48, P827, DOI 10.1097/MLR.0b013e3181f2595e; MADDEN JD, 1977, AM J OBSTET GYNECOL, V127, P199, DOI 10.1016/S0002-9378(16)33250-1; Minozzi S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006318.pub2; Myrvik MP, 2012, PEDIATR BLOOD CANCER, V58, P239, DOI 10.1002/pbc.23117; O'Donnell M, 2009, PEDIATRICS, V123, pE614, DOI 10.1542/peds.2008-2888; Odetola FO, 2010, PEDIATR CRIT CARE ME, V11, P457, DOI 10.1097/PCC.0b013e3181c514fa; Osborn DA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002053.pub3; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; PIEROG S, 1977, J PEDIATR-US, V90, P630, DOI 10.1016/S0022-3476(77)80387-9; REMENTERIA JL, 1977, J PEDIATR-US, V90, P123, DOI 10.1016/S0022-3476(77)80785-3; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Saiki T, 2010, EUR J PEDIATR, V169, P95, DOI 10.1007/s00431-009-0994-0; Sarkar S, 2006, J PERINATOL, V26, P15, DOI 10.1038/sj.jp.7211427; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; US Bureau of Labor Statistics, 2010, 2010 CONS PRIC IND; *US GEN ACC OFF, 1990, DRUG EXP INF GEN RIS; Wachman EM, 2010, BREASTFEED MED, V5, P159, DOI 10.1089/bfm.2009.0079; Weisberg S., 2005, WILEY SERIES PROBABI; Zickafoose JS, 2012, ARCH PEDIAT ADOL MED, V166, P350, DOI 10.1001/archpediatrics.2011.1501	47	660	664	1	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1934	1940		10.1001/jama.2012.3951	http://dx.doi.org/10.1001/jama.2012.3951			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	938OD	22546608	Bronze			2022-12-28	WOS:000303741900027
J	Crawford, SM				Crawford, S. Michael			PERSONAL VIEW Competition is intrinsically wasteful	BRITISH MEDICAL JOURNAL			English	Editorial Material												Michael.Crawford@anhst.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3199	10.1136/bmj.e3199	http://dx.doi.org/10.1136/bmj.e3199			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569867				2022-12-28	WOS:000304083400014
J	Rodda, J; Carter, J				Rodda, Joanne; Carter, Janet			Cholinesterase inhibitors and memantine for symptomatic treatment of dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE ALZHEIMERS-DISEASE; DOUBLE-BLIND; VASCULAR DEMENTIA; DONEPEZIL; EFFICACY; RIVASTIGMINE; MODERATE; METAANALYSIS; GALANTAMINE; COGNITION		[Rodda, Joanne; Carter, Janet] Havering Older Peoples Serv, Romford RM3 0SH, Essex, England; [Rodda, Joanne; Carter, Janet] NE London NHS Fdn Trust, Univ Coll London, London, England	University of London; University College London	Carter, J (corresponding author), Havering Older Peoples Serv, Romford RM3 0SH, Essex, England.	j.carter@ucl.ac.uk						Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bentham P, 2004, LANCET, V363, P2105; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Black SE, 2007, NEUROLOGY, V69, P459, DOI 10.1212/01.wnl.0000266627.96040.5a; Burns A, 2009, LANCET NEUROL, V8, P39, DOI 10.1016/S1474-4422(08)70261-8; Cummings J, 2010, J ALZHEIMERS DIS, V21, P843, DOI 10.3233/JAD-2010-100078; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Emre M, 2010, LANCET NEUROL, V9, P969, DOI 10.1016/S1474-4422(10)70194-0; Erkinjuntti T, 2002, LANCET, V359, P1283, DOI 10.1016/S0140-6736(02)08267-3; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; Howard R, 2012, NEW ENGL J MED, V366, P11; Kavirajan H, 2007, LANCET NEUROL, V6, P782, DOI 10.1016/S1474-4422(07)70195-3; Kim DH, 2011, J AM GERIATR SOC, V59, P1019, DOI 10.1111/j.1532-5415.2011.03450.x; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; *NAT COLL CTR MENT, 2006, DEM NICE SCIE GUID S; Porsteinsson AP, 2008, CURR ALZHEIMER RES, V5, P83, DOI 10.2174/156720508783884576; Rockwood K, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-26; Rowland J.P., 2007, ADV PSYCHIAT TREATME, V13, P178, DOI DOI 10.1192/APT.BP.106.002725; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; The technologies, 2011, DON GAL RIV MEM TREA; Wilkinson D, 2009, DEMENT GERIATR COGN, V28, P244, DOI 10.1159/000241877; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5; Winblad B, 2007, INT J GERIATR PSYCH, V22, P456, DOI 10.1002/gps.1788	27	73	73	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2012	344								e2986	10.1136/bmj.e2986	http://dx.doi.org/10.1136/bmj.e2986			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939MZ	22550350				2022-12-28	WOS:000303816700014
J	Turcu, S; Sonnappa, S				Turcu, Simona; Sonnappa, Samatha			A teenager with a cough, fever, and poor appetite	BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG ABSCESS; CHILDREN		[Turcu, Simona; Sonnappa, Samatha] Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Turcu, S (corresponding author), Great Ormond St Hosp Sick Children, London WC1N 3JH, England.	sfturcu@googlemail.com						Brook I., 2006, KENDIGS DISORDERS RE, P478; Chan Pei-Chun, 2005, Journal of Microbiology Immunology and Infection, V38, P183; Levison J, 2004, J PAEDIATR CHILD H, V40, P474, DOI 10.1111/j.1440-1754.2004.00433.x; Patradoon-Ho P, 2007, PAEDIATR RESPIR REV, V8, P77, DOI 10.1016/j.prrv.2006.10.002; Puligandla PS, 2008, SEMIN PEDIATR SURG, V17, P42, DOI 10.1053/j.sempedsurg.2007.10.007; Tseng YL, 2001, J PEDIATR SURG, V36, P470, DOI 10.1053/jpsu.2001.21611; Wali SO, 2002, SCAND J INFECT DIS, V34, P673, DOI 10.1080/00365540210147660; Yen Chen-Chieh, 2004, Journal of Microbiology Immunology and Infection, V37, P45	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 26	2012	344								e2821	10.1136/bmj.e2821	http://dx.doi.org/10.1136/bmj.e2821			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HD	22539177				2022-12-28	WOS:000303433900008
J	Jackson, JL; Kuriyama, A; Hayashino, Y				Jackson, Jeffrey L.; Kuriyama, Akira; Hayashino, Yasuaki			Botulinum Toxin A for Prophylactic Treatment of Migraine and Tension Headaches in Adults A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED PHASE; DOUBLE-BLIND; PREVENTIVE TREATMENT; EPISODIC MIGRAINE; CLINICAL-TRIALS; OPEN-LABEL; MULTICENTER; ONABOTULINUMTOXINA; INJECTION; BOTOX	Context Botulinum toxin A is US Food and Drug Administration approved for prophylactic treatment for chronic migraines. Objective To assess botulinum toxin A for the prophylactic treatment of headaches in adults. Data Sources A search of MEDLINE, EMBASE, bibliographies of published systematic reviews, and the Cochrane trial registries between 1966 and March 15, 2012. Inclusion and exclusion criteria of each study were reviewed. Headaches were categorized as episodic (<15 headaches per month) or chronic (>= 15 headaches per month) migraine and episodic or chronic daily or tension headaches. Study Selection Randomized controlled trials comparing botulinum toxin A with placebo or other interventions for headaches among adults. Data Extraction Data were abstracted and quality assessed independently by 2 reviewers. Outcomes were pooled using a random-effects model. Data Synthesis Pooled analyses suggested that botulinum toxin A was associated with fewer headaches per month among patients with chronic daily headaches (1115 patients, -2.06 headaches per month; 95% CI, -3.56 to -0.56; 3 studies) and among patients with chronic migraine headaches (n=1508, -2.30 headaches per month; 95% CI, -3.66 to -0.94; 5 studies). There was no significant association between use of botulinum toxin A and reduction in the number of episodic migraine (n=1838, 0.05 headaches per month; 95% CI, -0.26 to 0.36; 9 studies) or chronic tension-type headaches (n=675, -1.43 headaches per month; 95% CI, -3.13 to 0.27; 7 studies). In single trials, botulinum toxin A was not associated with fewer migraine headaches per month vs valproate (standardized mean difference [SMD], -0.20; 95% CI, -0.91 to 0.31), topiramate (SMD, 0.20; 95% CI, -0.36 to 0.76), or amitriptyline (SMD, 0.29; 95% CI, -0.17 to 0.76). Botulinum toxin A was associated with fewer chronic tension-type headaches per month vs methylprednisolone injections (SMD, -2.5; 95% CI, -3.5 to -1.5). Compared with placebo, botulinum toxin A was associated with a greater frequency of blepharoptosis, skin tightness, paresthesias, neck stiffness, muscle weakness, and neck pain. Conclusion Botulinum toxin A compared with placebo was associated with a small to modest benefit for chronic daily headaches and chronic migraines but was not associated with fewer episodic migraine or chronic tension-type headaches per month. JAMA. 2012;307(16):1736-1745	[Jackson, Jeffrey L.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53295 USA; [Jackson, Jeffrey L.] Med Coll Wisconsin, Zablocki Vet Affairs Med Ctr, Dept Gen Internal Med, Milwaukee, WI 53295 USA; [Kuriyama, Akira] Rakuwakai Otowa Hosp, Dept Gen Internal Med, Kyoto, Japan; [Hayashino, Yasuaki] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan	Medical College of Wisconsin; Medical College of Wisconsin; Kyoto University	Jackson, JL (corresponding author), Med Coll Wisconsin, Dept Med, 5000 W Natl Ave, Milwaukee, WI 53295 USA.	jjackson@mcw.edu	Hayashino, Yasuaki/AAA-8637-2022; Jackson, Jeffrey/AAA-3519-2019	Hayashino, Yasuaki/0000-0002-2932-8478; Jackson, Jeffrey/0000-0002-9820-5834				Anand K S, 2006, Am J Ther, V13, P183, DOI 10.1097/01.mjt.0000212705.79248.74; Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Aurora SK, 2007, HEADACHE, V47, P486, DOI 10.1111/j.1526-4610.2006.00624.x; Behmand RA, 2003, HEADACHE, V43, P1085, DOI 10.1046/j.1526-4610.2003.03210.x; Bendtsen L, 2010, CEPHALALGIA, V30, P1, DOI 10.1111/j.1468-2982.2009.01948.x; Binder WJ, 2000, OTOLARYNG HEAD NECK, V123, P669, DOI 10.1067/mhn.2000.110960; Binder WJ, 2002, DM-DIS MON, V48, P323, DOI 10.1053/mda.2002.24423; Blumenfeld A, 2003, HEADACHE, V43, P853, DOI 10.1046/j.1526-4610.2003.03163.x; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; Blumenfeld AM, 2008, HEADACHE, V48, P210, DOI 10.1111/j.1526-4610.2007.00949.x; Burstein R, 2009, TOXICON, V54, P624, DOI 10.1016/j.toxicon.2009.01.009; Cady R, 2008, HEADACHE, V48, P900, DOI 10.1111/j.1526-4610.2007.00953.x; Cady RK, 2011, HEADACHE, V51, P21, DOI 10.1111/j.1526-4610.2010.01796.x; Calandre EP, 2006, EUR J NEUROL, V13, P244, DOI 10.1111/j.1468-1331.2006.01181.x; Chan VW, 2009, J NEUROSCI NURS, V41, P235, DOI 10.1097/JNN.0b013e3181aaa98f; Chankrachang S, 2011, HEADACHE, V51, P52, DOI 10.1111/j.1526-4610.2010.01807.x; Christie SN, 2010, CAN J NEUROL SCI, V37, P588, DOI 10.1017/S031716710001074X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Dowson AJ, 2008, DRUGS R&D, V9, P147, DOI 10.2165/00126839-200809030-00002; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elkind AH, 2006, J PAIN, V7, P688, DOI 10.1016/j.jpain.2006.03.002; Erdemoglu A Kemal, 2007, J Headache Pain, V8, P294; Eross EJ, 2005, HEADACHE, V45, P308, DOI 10.1111/j.1526-4610.2005.05067.x; Evans RW, 2003, HEADACHE, V43, P682, DOI 10.1046/j.1526-4610.2003.03115.x; Evers S, 2004, CEPHALALGIA, V24, P838, DOI 10.1111/j.1468-2982.2004.00754.x; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Freitag FG, 2008, HEADACHE, V48, P201, DOI 10.1111/i.1526-4610.2007.00963.x; Freitag FG, 2007, CLIN THER, V29, P939, DOI 10.1016/j.clinthera.2007.05.008; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gallahan WC, 2009, ALIMENT PHARM THER, V31, P102, DOI 10.1111/j.1365-2036.2009.04125.x; Goldberg LD, 2005, AM J MANAG CARE, V11, pS62; Hamdy SM, 2009, J HEADACHE PAIN, V10, P27, DOI 10.1007/s10194-008-0082-2; Harden RN, 2009, HEADACHE, V49, P732, DOI 10.1111/j.1526-4610.2008.01286.x; Harrison AR, 2008, OPHTHAL PLAST RECONS, V24, P113, DOI 10.1097/IOP.0b013e31816386e1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Jackson JL, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5222; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kapural Leonardo, 2007, Pain Pract, V7, P337, DOI 10.1111/j.1533-2500.2007.00150.x; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Lipton RB, 2003, CEPHALALGIA, V23, P429, DOI 10.1046/j.1468-2982.2003.00543.x; Liu Yi-Chung, 2007, J Chin Med Assoc, V70, P535, DOI 10.1016/S1726-4901(08)70056-X; Lu CL, 2011, J GASTROEN HEPATOL, V26, P116, DOI 10.1111/j.1440-1746.2011.06651.x; Magalhaes E, 2010, CLIN NEUROL NEUROSUR, V112, P463, DOI 10.1016/j.clineuro.2010.02.004; Mangera A, 2011, NAT REV UROL, V8, P495, DOI 10.1038/nrurol.2011.99; Mathew NT, 2008, HEADACHE, V48, P194, DOI 10.1111/j.1526-4610.2007.00914.x; Mathew NT, 2005, HEADACHE, V45, P293, DOI 10.1111/j.1526-4610.2005.05066.x; Menezes C, 2007, ARQ NEURO-PSIQUIAT, V65, P596, DOI 10.1590/S0004-282X2007000400009; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Ondo WG, 2004, CEPHALALGIA, V24, P60, DOI 10.1111/j.1468-2982.2004.00641.x; Padberg M, 2004, CEPHALALGIA, V24, P675, DOI 10.1111/j.1468-2982.2004.00738.x; Pascual J, 2004, NEUROLOGIA, V19, P260; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Petri S, 2009, EUR NEUROL, V62, P204, DOI 10.1159/000228987; Porta M, 2000, Curr Rev Pain, V4, P31; Pringsheim T, 2010, CAN MED ASSOC J, V182, pE269, DOI 10.1503/cmaj.081657; Puhl AA, 2011, PAIN RES MANAG, V16, P45, DOI 10.1155/2011/625315; Radtke A, 2009, HEADACHE, V49, P79, DOI 10.1111/j.1526-4610.2008.01263.x; Relja M, 2007, CEPHALALGIA, V27, P492, DOI 10.1111/j.1468-2982.2007.01315.x; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Rollnik JD, 2001, HEADACHE, V41, P985, DOI 10.1046/j.1526-4610.2001.01193.x; Rollnik JD, 2000, HEADACHE, V40, P300, DOI 10.1046/j.1526-4610.2000.00044.x; Sandrini G, 2011, J HEADACHE PAIN, V12, P427, DOI 10.1007/s10194-011-0339-z; Saper JR, 2007, PAIN MED, V8, P478, DOI 10.1111/j.1526-4637.2006.00168.x; Schmitt WJ, 2001, HEADACHE, V41, P658, DOI 10.1046/j.1526-4610.2001.041007658.x; Schulte-Mattler WJ, 2004, PAIN, V109, P110, DOI 10.1016/j.pain.2004.01.016; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Silberstein S, 2008, CEPHALALGIA, V28, P484, DOI 10.1111/j.1468-2982.2008.01555.x; Silberstein S, 2000, HEADACHE, V40, P445, DOI 10.1046/j.1526-4610.2000.00066.x; Silberstein SD, 2006, CEPHALALGIA, V26, P790, DOI 10.1111/j.1468-2982.2006.01114.x; Silberstein SD, 2005, MAYO CLIN PROC, V80, P1126, DOI 10.4065/80.9.1126; SILBERSTEIN SD, 1994, HEADACHE, V34, P1, DOI 10.1111/j.1526-4610.1994.hed3401001.x; Smuts JA, 2004, HEADACHE, V44, P801, DOI 10.1111/j.1526-4610.2004.04148.x; Solomon S, 2011, HEADACHE, V51, P980, DOI 10.1111/j.1526-4610.2011.01915.x; Sostak P, 2007, J HEADACHE PAIN, V8, P236, DOI 10.1007/s10194-007-0400-0; Straube A, 2008, EUR J NEUROL, V15, P205, DOI 10.1111/j.1468-1331.2007.02051.x; Suzuki K, 2007, INTERNAL MED, V46, P959, DOI 10.2169/internalmedicine.46.6416; Taylor M, 2008, HEADACHE, V48, P1476, DOI 10.1111/j.1526-4610.2008.01089.x; Tepper SJ, 2004, HEADACHE, V44, P794, DOI 10.1111/j.1526-4610.2004.04147.x; Turk U, 2005, CLIN NEUROPHARMACOL, V28, P161; Vo AH, 2007, AVIAT SPACE ENVIR MD, V78, pB113; Wang Shuu-Jiun, 2003, Curr Neurol Neurosci Rep, V3, P104, DOI 10.1007/s11910-003-0060-7	84	139	152	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1736	1745		10.1001/jama.2012.505	http://dx.doi.org/10.1001/jama.2012.505			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535858				2022-12-28	WOS:000303147500027
J	McComas, DJ; Alexashov, D; Bzowski, M; Fahr, H; Heerikhuisen, J; Izmodenov, V; Lee, MA; Mobius, E; Pogorelov, N; Schwadron, NA; Zank, GP				McComas, D. J.; Alexashov, D.; Bzowski, M.; Fahr, H.; Heerikhuisen, J.; Izmodenov, V.; Lee, M. A.; Moebius, E.; Pogorelov, N.; Schwadron, N. A.; Zank, G. P.			The Heliosphere's Interstellar Interaction: No Bow Shock	SCIENCE			English	Article							TERMINATION-SHOCK; LO OBSERVATIONS; SOLAR-WIND; PARAMETERS; HELIUM; GAS	As the Sun moves through the local interstellar medium, its supersonic, ionized solar wind carves out a cavity called the heliosphere. Recent observations from the Interstellar Boundary Explorer (IBEX) spacecraft show that the relative motion of the Sun with respect to the interstellar medium is slower and in a somewhat different direction than previously thought. Here, we provide combined consensus values for this velocity vector and show that they have important implications for the global interstellar interaction. In particular, the velocity is almost certainly slower than the fast magnetosonic speed, with no bow shock forming ahead of the heliosphere, as was widely expected in the past.	[McComas, D. J.] SW Res Inst, San Antonio, TX 78228 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Alexashov, D.; Izmodenov, V.] Russian Acad Sci, Inst Problems Mech, Moscow, Russia; [Alexashov, D.; Izmodenov, V.] Moscow MV Lomonosov State Univ, Space Res Inst IKI, Moscow, Russia; [Bzowski, M.] Polish Acad Sci, Space Res Ctr, PL-01237 Warsaw, Poland; [Fahr, H.] Univ Bonn, Bonn, Germany; [Heerikhuisen, J.; Pogorelov, N.; Zank, G. P.] Univ Alabama, Huntsville, AL 35805 USA; [Lee, M. A.; Moebius, E.; Schwadron, N. A.] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; [Moebius, E.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); Russian Academy of Sciences; Ishlinsky Institute for Problems in Mechanics RAS; Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; University of Bonn; University of Alabama System; University of Alabama Huntsville; University System Of New Hampshire; University of New Hampshire; United States Department of Energy (DOE); Los Alamos National Laboratory	McComas, DJ (corresponding author), SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78228 USA.	dmccomas@swri.edu	Izmodenov, Vladislav V/K-6073-2012; Alexashov, Dmitry/M-7512-2013; McComas, David J/H-6202-2011	Izmodenov, Vladislav V/0000-0002-1748-0982; Alexashov, Dmitry/0000-0002-5623-8136; McComas, David J/0000-0001-6160-1158; Bzowski, Maciej/0000-0003-3957-2359; Moebius, Eberhard/0000-0002-2745-6978; Heerikhuisen, Jacob/0000-0001-7867-3633	NASA [NNG05EC85C, NNX09AG63G, NNX12AB30G]; Polish Ministry of Science and Higher Education [N-N203-513-038]; Presidium Russian Academy of Sciences [10-02-01316-a]; Russian Foundation of Basic Research [11-02-92605-KO-a]	NASA(National Aeronautics & Space Administration (NASA)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Presidium Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	We thank everyone who made the IBEX mission a reality. IBEX was primarily funded by NASA's Explorers Program (contract no. NNG05EC85C); the University of Alabama, Huntsville, was also supported, in part, by NASA grants NNX09AG63G and NNX12AB30G. Polish and Russian contributions were supported by the Polish Ministry of Science and Higher Education grant N-N203-513-038 and Presidium Russian Academy of Sciences Program 22/Russian Foundation of Basic Research grants 10-02-01316-a and 11-02-92605-KO-a, respectively. IBEX data used in (16), (17), and this study have been archived with and are available from the IBEX project and NASA's National Space Science Data Center.	Baranov V. B., 1971, Soviet Physics - Doklady, V15, P791; Bochsler P, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/13; Bzowski M, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/12; Fahr HJ, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000214; FAHR HJ, 1986, ADV SPACE RES, V6, P13; Frisch PC, 2009, SPACE SCI REV, V146, P235, DOI 10.1007/s11214-009-9502-0; Fuselier SA, 2009, SPACE SCI REV, V146, P117, DOI 10.1007/s11214-009-9495-8; Gayley KG, 1997, ASTROPHYS J, V487, P259, DOI 10.1086/304600; Heerikhuisen J, 2008, ASTROPHYS J, V682, P679, DOI 10.1086/588248; Hlond M, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/9; Izmodenov V, 2005, ASTRON ASTROPHYS, V437, pL35, DOI 10.1051/0004-6361:200500132; Izmodenov VV, 2009, SPACE SCI REV, V146, P329, DOI 10.1007/s11214-009-9528-3; Lallement R, 2010, AIP CONF PROC, V1216, P555, DOI 10.1063/1.3395925; Lee MA, 2009, SPACE SCI REV, V146, P275, DOI 10.1007/s11214-009-9522-9; Lee MA, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/10; McComas DJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048763; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; McComas DJ, 2009, SPACE SCI REV, V146, P11, DOI 10.1007/s11214-009-9499-4; McComas DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025437; Mobius E, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/11; Mobius E, 2009, SCIENCE, V326, P969, DOI 10.1126/science.1180971; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; PARKER EN, 1961, ASTROPHYS J, V134, P20, DOI 10.1086/147124; Pogorelov NV, 2008, ASTROPHYS J LETT, V675, pL41, DOI 10.1086/529547; Ratkiewicz R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036117; Redfield S, 2008, ASTROPHYS J, V673, P283, DOI 10.1086/524002; Saul L, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/14; Schwadron NA, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/9; Schwadron NA, 2009, SCIENCE, V326, P966, DOI 10.1126/science.1180986; Stone EC, 2008, NATURE, V454, P71, DOI 10.1038/nature07022; Washimi H, 2007, ASTROPHYS J, V670, pL139, DOI 10.1086/524358; Witte M, 2004, ASTRON ASTROPHYS, V426, P835, DOI 10.1051/0004-6361:20035956; Zank GP, 2009, SPACE SCI REV, V146, P295, DOI 10.1007/s11214-009-9497-6; Zank GP, 1996, J GEOPHYS RES-SPACE, V101, P21639, DOI 10.1029/96JA02127	34	206	208	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1291	1293		10.1126/science.1221054	http://dx.doi.org/10.1126/science.1221054			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582011				2022-12-28	WOS:000304905300042
J	Nelson, HD; Bougatsos, C; Blazina, I				Nelson, Heidi D.; Bougatsos, Christina; Blazina, Ian			Screening Women for Intimate Partner Violence: A Systematic Review to Update the US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; HEALTH-CARE SETTINGS; DOMESTIC VIOLENCE; INTERVENTION; CONSEQUENCES; QUESTIONS; OUTCOMES; MOTHERS; ABUSE; BIRTH	Background: In 2004, the U.S. Preventive Services Task Force determined that evidence was insufficient to support screening women for intimate partner violence (IPV). Purpose: To review new evidence on the effectiveness of screening and interventions for women in health care settings in reducing IPV and related health outcomes, the diagnostic accuracy of screening instruments, and adverse effects of screening and interventions. Data Sources: MEDLINE and PsycINFO (January 2002 to January 2012), Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through fourth quarter 2011), Scopus, and reference lists. Study Selection: English-language trials of the effectiveness of screening and interventions, diagnostic accuracy studies of screening instruments, and studies of any design about adverse effects. Data Extraction: Investigators extracted data about study populations, designs, and outcomes and rated study quality by using established criteria. Data Synthesis: A large fair-quality trial of screening versus usual care indicated reduced IPV and improved health outcomes for both groups, but no statistically significant differences between groups. Fifteen fair- and good-quality studies evaluated 13 screening instruments, and six instruments were highly accurate. Four fair-and good-quality trials of counseling reported reduced IPV and improved birth outcomes for pregnant women, reduced IPV for new mothers, and reduced pregnancy coercion and unsafe relationships for women in family-planning clinics. Fourteen studies indicated minimal adverse effects with screening, but some women experienced discomfort, loss of privacy, emotional distress, and concerns about further abuse. Limitation: Trials were limited by heterogeneity, lack of true control groups, high loss to follow-up, self-reported measures, and lack of accepted reference standards. Conclusion: Screening instruments accurately identify women experiencing IPV. Screening women for IPV can provide benefits that vary by population, while potential adverse effects have minimal effect on most women.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mail Code BICC, Portland, OR 97239 USA; Providence Hlth & Serv, Portland, OR USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mail Code BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality [HHSA-290-2007-10057-IEPC3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.; By AHRQ under contract HHSA-290-2007-10057-IEPC3, Task Order 3. This work was contracted by AHRQ and used by the U.S. Preventive Services Task Force to determine its recommendation.; Dr. Nelson: Grant (money to institution): AHRQ; Support for travel to meetings for the study or other purposes (money to institution): AHRQ. Ms. Bougatsos: Support for travel to meetings for the study or other purposes (money to institution): AHRQ; Other (money to institution): AHRQ. Mr. Blazina: Grant (money to institution): AHRQ. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-2667.	Ahmad F, 2007, DISS ABSTR INT B; Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; Aktins D, 2010, AHRQ PUBLICATION; American Congress of Obstetricians and Gynecologists, 2012, SCREEN TOOLS DOM VIO; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; Bair-Merritt MH, 2006, ARCH PEDIAT ADOL MED, V160, P311, DOI 10.1001/archpedi.160.3.311; Black M.C., 2011, NATL INTIMATE PARTNE; Brock K, 2002, MEN MURDER WOMEN ANA; Brown DS, 2008, J INTERPERS VIOLENCE, V23, P1747, DOI 10.1177/0886260508314338; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 1997, PSYCHIAT CLIN N AM, V20, P353, DOI 10.1016/S0193-953X(05)70317-8; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P113; Chang Judy C, 2003, J Am Med Womens Assoc (1972), V58, P76; Chen PH, 2005, FAM PRACT, V22, P617, DOI 10.1093/fampra/cmi075; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Collins KS, 1999, HLTH CONCERNS WOMANS; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Curry MA, 2006, JOGNN-J OBST GYN NEO, V35, P181, DOI 10.1111/J.1552-6909.2006.00027.x; Dubowitz H, 2008, PEDIATRICS, V121, pE85, DOI 10.1542/peds.2007-0904; El Kady D, 2005, OBSTET GYNECOL, V105, P357, DOI 10.1097/01.AOG.0000151109.46641.03; El-Mohandes AAE, 2008, OBSTET GYNECOL, V112, P611, DOI 10.1097/AOG.0b013e3181834b10; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Ernst Amy A, 2004, Violence Vict, V19, P375, DOI 10.1891/088667004780905688; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2009, HEALTH TECHNOL ASSES, V13, pxi; Fulfer JL, 2007, J INTERPERS VIOLENCE, V22, P238, DOI 10.1177/0886260506295814; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Houry D, 2004, J INTERPERS VIOLENCE, V19, P955, DOI 10.1177/0886260504267999; Houry D, 2008, ANN EMERG MED, V51, P433, DOI 10.1016/j.annemergmed.2007.11.019; Humphreys J, 2011, WOMEN HEALTH ISS, V21, P136, DOI 10.1016/j.whi.2010.09.006; Hurley KF, 2005, EMERG MED J, V22, P97, DOI 10.1136/emj.2002.002626; Huth-Bocks Alissa C, 2002, Violence Vict, V17, P169, DOI 10.1891/vivi.17.2.169.33647; Kapur NA, 2011, J INTERPERS VIOLENCE, V26, P2335, DOI 10.1177/0886260510383034; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Koziol-McLain J, 2008, J MIDWIFERY WOM HEAL, V53, P504, DOI 10.1016/j.jmwh.2008.06.002; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lehmann P, 2000, CHILD YOUTH SERV REV, V22, P275, DOI 10.1016/S0190-7409(00)00078-5; Letourneau EJ, 1999, WOMEN HEALTH ISS, V9, P115, DOI 10.1016/S1049-3867(98)00031-0; Lewis-O'Connor A, 2008, DISS ABSTR INT B; Liebschutz J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-229; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; McFarlane JM, 2006, NURS RES, V55, P52, DOI 10.1097/00006199-200601000-00007; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; National Advisory Council on Violence and Abuse, 2008, POL COMP; National Center for Injury Prevention and Control, 2003, COSTS INT PARTN VIOL; National Institute for Health and Clinical Excellence, 2006, GUID MAN 2006; National Research Council, 2011, CLIN PREV SERV WOM C; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Nelson HD, 2012, AHRQ PUBLICATION, V12-05167-EF-1; Nelson HD, 2004, SYSTEMATIC EVIDENCE; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Paranjape A, 2003, J WOMEN HEALTH GEN-B, V12, P233, DOI 10.1089/154099903321667573; Paranjape A, 2006, J NATL MED ASSOC, V98, P1663; Peralta RL, 2003, J AM BOARD FAM PRACT, V16, P525, DOI 10.3122/jabfm.16.6.525; Reichenheim ME, 2004, J EPIDEMIOL COMMUN H, V58, P523, DOI 10.1136/jech.2003.011742; Renker PR, 2006, OBSTET GYNECOL, V107, P348, DOI 10.1097/01.AOG.0000195356.90589.c5; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Schafer SD, 2008, PUBLIC HEALTH REP, V123, P628, DOI 10.1177/003335490812300513; Sethi D, 2004, EMERG MED J, V21, P180, DOI 10.1136/emj.2003.012419; Shah PS, 2010, J WOMENS HEALTH, V19, P2017, DOI 10.1089/jwh.2010.2051; Silverman ME, 2010, ARCH WOMEN MENT HLTH, V13, P411, DOI 10.1007/s00737-010-0161-7; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Spangaro JM, 2010, WOMEN HEALTH, V50, P125, DOI 10.1080/03630241003705060; Spangaro JM, 2011, PSYCHOL VIOLENCE, V1, P150, DOI 10.1037/a0023136; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Taft AJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-159; Thackeray JD, 2010, PEDIATRICS, V125, P1094, DOI 10.1542/peds.2010-0451; Thombs BD, 2007, GEN HOSP PSYCHIAT, V29, P8, DOI 10.1016/j.genhosppsych.2006.10.013; Tjaden P., 2000, FULL REPORT PREVALEN; U.S. Preventive Services Task Force Agency for Healthcare Research and Quality, 2004, SCREEN FAM INT PARTN; Wathen CN, 2008, WOMEN HEALTH ISS, V18, P423, DOI 10.1016/j.whi.2008.08.003; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Weinsheimer RL, 2005, J TRAUMA, V58, P22, DOI 10.1097/01.TA.0000151180.77168.A6; Weiss Steve J, 2003, Violence Vict, V18, P131, DOI 10.1891/vivi.2003.18.2.131; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wingood GM, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e72; Zeitler MS, 2006, J ADOLESCENT HEALTH, V39, p119e1; Zink T, 2007, CLIN PEDIATR, V46, P127, DOI 10.1177/0009922806290029	82	218	218	1	83	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2012	156	11					796	+		10.7326/0003-4819-156-11-201206050-00447	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00447			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	954ZK	22565034				2022-12-28	WOS:000304986500005
J	Leucht, S; Tardy, M; Komossa, K; Heres, S; Kissling, W; Salanti, G; Davis, JM				Leucht, Stefan; Tardy, Magdolna; Komossa, Katja; Heres, Stephan; Kissling, Werner; Salanti, Georgia; Davis, John M.			Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis	LANCET			English	Article							DOUBLE-BLIND; CONTROLLED TRIAL; 1ST EPISODE; NEUROLEPTIC WITHDRAWAL; MAINTENANCE TREATMENT; GRADUAL WITHDRAWAL; PUBLICATION BIAS; DISCONTINUATION; SOCIOTHERAPY; PREDICTORS	Background Relapse prevention with antipsychotic drugs compared with placebo in patients with schizophrenia has not been sufficiently addressed by previous systematic reviews. We aimed to assess the association between such drugs and various outcomes in patients with schizophrenia to resolve controversial issues. Methods We searched the Cochrane Schizophrenia Group's specialised register for reports published before Nov 11, 2008; and PubMed, Embase, and ClinicalTrials.gov for those before June 8, 2011. We also contacted pharmaceutical companies and searched the reference lists of included studies and previous reviews. Randomised trials of patients with schizophrenia continued on or withdrawn from any antipsychotic drug regimen after stabilisation were eligible. Our primary outcome was relapse between 7 and 12 months. We also examined safety and various functional outcomes. We used the random effects model and verified results for the primary outcome with a fixed effects model. Heterogeneity was investigated with subgroup and meta-regression analyses. Findings We identified 116 suitable reports from 65 trials, with data for 6493 patients. Antipsychotic drugs significantly reduced relapse rates at 1 year (drugs 27% vs placebo 64%; risk ratio [RR] 0.40, 95% CI 0.33-0.49; number needed to treat to benefit [NNTB] 3, 95% CI 2-3). Fewer patients given antipsychotic drugs than placebo were readmitted (10% vs 26%; RR 0.38, 95% CI 0.27-0.55; NNTB 5, 4-9), but less than a third of relapsed patients had to be admitted. Limited evidence suggested better quality of life (standardised mean difference -0.62, 95% CI -1.15 to -0.09) and fewer aggressive acts (2% vs 12%; RR 0.27, 95% CI 0.15-0.52; NNTB 11, 6-100) with antipsychotic drugs than with placebo. Employment data were scarce and too few deaths were reported to allow significant differences to be identified. More patients given antipsychotic drugs than placebo gained weight (10% vs 6%; RR 2.07, 95% CI 2.31-3.25), had movement disorders (16% vs 9%; 1.55, 1.25-1.93), and experienced sedation (13% vs 9%; 1.50, 1.22-1.84). Substantial heterogeneity in size of effect was recorded. In subgroup analyses, number of episodes, whether patients were in remission, abrupt or gradual withdrawal of treatment, length of stability before trial entry, first-generation or second-generation drugs, and allocation concealment method did not significantly affect relapse risk. Depot preparations reduced relapse (RR 0.31, 95% CI 0.21-0.41) more than did oral drugs (0.46, 0.37-0.57; p=0.03); depot haloperidol (RR 0.14, 95% CI 0.04-0.55) and fluphenazine (0.23, 0.14-0.39) had the greatest effects. The effects of antipsychotic drugs were greater in two unblinded trials (0.26, 0.17-0.39) than in most blinded studies (0.42, 0.35-0.51; p=0.03). In a meta-regression, the difference between drug and placebo decreased with study length. Interpretation Maintenance treatment with antipsychotic drugs benefits patients with schizophrenia. The advantages of these drugs must be weighed against their side-effects. Future studies should focus on outcomes of social participation and clarify the long-term morbidity and mortality of these drugs.	[Leucht, Stefan; Tardy, Magdolna; Komossa, Katja; Heres, Stephan; Kissling, Werner] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany; [Salanti, Georgia] Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece; [Davis, John M.] Univ Illinois, Inst Psychiat, Chicago, IL USA; [Davis, John M.] Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	Technical University of Munich; University of Munich; University of Ioannina; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Leucht, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany.	stefan.leucht@lrz.tum.de	Leucht, Stefan/Y-2408-2019	Leucht, Stefan/0000-0002-4934-4352; Salanti, Georgia/0000-0002-3830-8508	Janssen; AstraZeneca; German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [01KG0816 88166528]; European Research Council [IMMA 260559]; Cochrane Schizophrenia Group	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); AstraZeneca(AstraZeneca); German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Cochrane Schizophrenia Group	SL has received honoraria as a consultant or a member of advisory boards from Alkermes, Bristol-Myers Squibb, Eli Lilly, Janssen, Johnson and Johnson, Medavante, Roche; he has received lecture honoraria from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, EssexPharma, Janssen, Johnson and Johnson, Lundbeck Institute, Pfizer, and Sanofi-Aventis; and is primary investigator of a trial for which Eli Lilly has provided medication. SH has received honoraria from Janssen-Cilag, Sanofi-Aventis, and Johnson and Johnson; and has accepted travel or hospitality payment from Janssen-Cilag, Sanofi-Aventis, Johnson and Johnson, Pfizer, Bristol-Myers Squibb, AstraZeneca, Lundbeck, Novartis, and Eli Lilly. WK has received honoraria for board memberships, consulting, and lectures from Janssen and Eli Lilly; honoraria for development of educational materials from Janssen; grant support from Janssen and AstraZeneca; and travel and accommodation expenses from AstraZeneca, Eli Lilly, and Janssen. The other authors declare that they have no conflicts of interest.; Financial support was mainly provided by a grant from the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung), number 01KG0816 88166528. GS was supported by a grant from the European Research Council (IMMA 260559). The authors thank the Cochrane Schizophrenia Group for its support for this review; Michael Borenstein for his statistical advice on publication bias; Richard Skodnek for his work on a preliminary version of this review; and Astellas, Bristol-Myers Squibb, Eli Lilly, Lundbeck, Pfizer, Johnson and Johnson, Sanofi-Aventis, Eric Chen, George Gardos, Julian Leff, and Erik Denys for additional information. This Article is a copublication with a Cochrane Review (Cochrane Database Syst Rev 2012; 5: CD008016).	Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Arato M, 2002, INT CLIN PSYCHOPHARM, V17, P207, DOI 10.1097/00004850-200209000-00001; BCC Research, 2010, ANT DRUGS TECHN GLOB; Beasley CM, 2003, J CLIN PSYCHOPHARM, V23, P582, DOI 10.1097/01.jcp.0000095348.32154.ec; Boonstra G, 2011, INT J PSYCHIAT CLIN, V15, P128, DOI 10.3109/13651501.2010.534801; CAFFEY EM, 1964, J CHRON DIS, V17, P347, DOI 10.1016/0021-9681(64)90075-X; CARPENTER WT, 1990, AM J PSYCHIAT, V147, P1138; Chen Eric Y H, 2010, BMJ, V341, pc4024, DOI 10.1136/bmj.c4024; CHEUNG HK, 1981, BRIT J PSYCHIAT, V138, P490, DOI 10.1192/bjp.138.6.490; CHOUINARD G, 1981, ACTA PSYCHIAT SCAND, V64, P353, DOI 10.1111/j.1600-0447.1981.tb00794.x; Cooper SJ, 2000, PSYCHOPHARMACOLOGY, V150, P237, DOI 10.1007/s002130000452; CROW TJ, 1986, BRIT J PSYCHIAT, V148, P120, DOI 10.1192/bjp.148.2.120; DAVIS JM, 1975, AM J PSYCHIAT, V132, P1237; DAVIS JM, 1994, DRUGS, V47, P741, DOI 10.2165/00003495-199447050-00004; DENIJS EL, 1973, PSYCHIAT NEUROL NEUR, V76, P47; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; GARDOS G, 1984, ARCH GEN PSYCHIAT, V41, P1030; GILBERT PL, 1995, ARCH GEN PSYCHIAT, V52, P173; Gleeson JFM, 2010, SCHIZOPHR RES, V119, P79, DOI 10.1016/j.schres.2010.02.1073; GREENBERG LM, 1966, AM J PSYCHIAT, V123, P221, DOI 10.1176/ajp.123.2.221; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOGARTY GE, 1973, ARCH GEN PSYCHIAT, V28, P54; HOGARTY GE, 1974, ARCH GEN PSYCHIAT, V31, P603; Hough D, 2010, SCHIZOPHR RES, V116, P107, DOI 10.1016/j.schres.2009.10.026; KANE JM, 2003, J CLIN PSYCHIAT S12, V64, P1; Kane JM, 2011, J CLIN PSYCHIAT, V72, P349, DOI 10.4088/JCP.10m06306; Komossa K, MAINTENANCE TREATMEN; Kramer M, 2007, J CLIN PSYCHOPHARM, V27, P6, DOI 10.1097/JCP.0b013e31802dda4a; LEFF JP, 1971, BRIT MED J, V3, P599, DOI 10.1136/bmj.3.5775.599; Leucht C, 2011, SCHIZOPHR RES, V127, P83, DOI 10.1016/j.schres.2010.11.020; Leucht S, 2003, AM J PSYCHIAT, V160, P1209, DOI 10.1176/appi.ajp.160.7.1209; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Levine J, 1980, Adv Biochem Psychopharmacol, V24, P483; National Collaborating Centre for Mental Health (UK), 2009, SCHIZ COR INT TREATM; NISHIKAWA T, 1982, PSYCHOPHARMACOLOGY, V77, P301, DOI 10.1007/BF00432759; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peuskens Joseph, 2007, Psychiatry (Edgmont), V4, P34; PIETZCKER A, 1993, J PSYCHIAT RES, V27, P321, DOI 10.1016/0022-3956(93)90059-B; Pigott TA, 2003, J CLIN PSYCHIAT, V64, P1048, DOI 10.4088/JCP.v64n0910; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Robinson DG, 1999, AM J PSYCHIAT, V156, P544; SAMPATH G, 1992, HUM PSYCHOPHARM CLIN, V7, P255, DOI 10.1002/hup.470070405; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SHEPHERD M, 1989, PSYCHOL MED, P1, DOI 10.1017/S026418010000059X; Tiihonen J, 2011, AM J PSYCHIAT, V168, P603, DOI 10.1176/appi.ajp.2011.10081224; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Viguera AC, 1997, ARCH GEN PSYCHIAT, V54, P49	52	529	545	3	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2063	2071		10.1016/S0140-6736(12)60239-6	http://dx.doi.org/10.1016/S0140-6736(12)60239-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951ZI	22560607				2022-12-28	WOS:000304759100031
J	Nesvorny, D; Kipping, DM; Buchhave, LA; Bakos, GA; Hartman, J; Schmitt, AR				Nesvorny, David; Kipping, David M.; Buchhave, Lars A.; Bakos, Gaspar A.; Hartman, Joel; Schmitt, Allan R.			The Detection and Characterization of a Nontransiting Planet by Transit Timing Variations	SCIENCE			English	Article							EXTRASOLAR PLANETS; MASS; SYSTEM; EFFICIENT; EXOMOON	The Kepler mission is monitoring the brightness of similar to 150,000 stars, searching for evidence of planetary transits. As part of the Hunt for Exomoons with Kepler (HEK) project, we report a planetary system with two confirmed planets and one candidate planet discovered with the publicly available data for KOI-872. Planet b transits the host star with a period P-b = 33.6 days and exhibits large transit timing variations indicative of a perturber. Dynamical modeling uniquely detects an outer nontransiting planet c near the 5: 3 resonance (P-c = 57.0 days) with a mass 0.37 times that of Jupiter. Transits of a third planetary candidate are also found: a 1.7-Earth radius super-Earth with a 6.8-day period. Our analysis indicates a system with nearly coplanar and circular orbits, reminiscent of the orderly arrangement within the solar system.	[Nesvorny, David] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Kipping, David M.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Bakos, Gaspar A.; Hartman, Joel] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Princeton University	Nesvorny, D (corresponding author), SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA.	davidn@boulder.swri.edu	Buchhave, Lars A./ABF-2000-2020	Buchhave, Lars A./0000-0003-1605-5666; Schmitt, Allan/0000-0002-5034-0949; Bakos, Gaspar/0000-0001-7204-6727; Kipping, David/0000-0002-4365-7366; Hartman, Joel/0000-0001-8732-6166	NSF [AST-1008890, AST-1108686]; NASA [NNX09AB29G]; Direct For Mathematical & Physical Scien [1108686] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1008890] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is part of the Hunt for Exomoons with Kepler (HEK) project. We thank the Kepler Science Team, especially the Data Analysis Working Group, for making the data used here available. D.N. acknowledges support from NSF AST-1008890. D. M. K. is supported by the NASA Sagan fellowship. G. A. B. acknowledges support from NASA grant NNX09AB29G. J.H. acknowledges support from NSF AST-1108686.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Ballard S, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/200; Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Carter JA, 2008, ASTROPHYS J, V689, P499, DOI 10.1086/592321; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Kipping DM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/115; Kipping DM, 2009, MON NOT R ASTRON SOC, V396, P1797, DOI 10.1111/j.1365-2966.2009.14869.x; Kipping DM, 2009, MON NOT R ASTRON SOC, V392, P181, DOI 10.1111/j.1365-2966.2008.13999.x; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Miralda-Escude J, 2002, ASTROPHYS J, V564, P1019, DOI 10.1086/324279; Montalto M, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201014486; Nesvorny D, 2008, ASTROPHYS J, V688, P636, DOI 10.1086/592230; Nesvorny D, 2010, ASTROPHYS J LETT, V709, pL44, DOI 10.1088/2041-8205/709/1/L44; Rafikov RR, 2009, ASTROPHYS J, V700, P965, DOI 10.1088/0004-637X/700/2/965; Sartoretti P, 1999, ASTRON ASTROPHYS SUP, V134, P553, DOI 10.1051/aas:1999148; Scharf CA, 2007, ASTROPHYS J, V661, P1218, DOI 10.1086/517504; Watson CA, 2010, MON NOT R ASTRON SOC, V405, P2037, DOI 10.1111/j.1365-2966.2010.16602.x	23	110	111	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1133	1136		10.1126/science.1221141	http://dx.doi.org/10.1126/science.1221141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22582018	Green Submitted			2022-12-28	WOS:000304647900042
J	Nager, CW; Brubaker, L; Litman, HJ; Zyczynski, HM; Varner, RE; Amundsen, C; Sirls, LT; Norton, PA; Arisco, AM; Chai, TC; Zimmern, P; Barber, MD; Dandreo, KJ; Menefee, SA; Kenton, K; Lowder, J; Richter, HE; Khandwala, S; Nygaard, I; Kraus, SR; Johnson, HW; Lemack, GE; Mihova, M; Albo, ME; Mueller, E; Sutkin, G; Wilson, TS; Hsu, Y; Rozanski, TA; Rickey, LM; Rahn, D; Tennstedt, S; Kusek, JW; Gormley, EA				Nager, Charles W.; Brubaker, Linda; Litman, Heather J.; Zyczynski, Halina M.; Varner, R. Edward; Amundsen, Cindy; Sirls, Larry T.; Norton, Peggy A.; Arisco, Amy M.; Chai, Toby C.; Zimmern, Philippe; Barber, Matthew D.; Dandreo, Kimberly J.; Menefee, Shawn A.; Kenton, Kimberly; Lowder, Jerry; Richter, Holly E.; Khandwala, Salil; Nygaard, Ingrid; Kraus, Stephen R.; Johnson, Harry W.; Lemack, Gary E.; Mihova, Marina; Albo, Michael E.; Mueller, Elizabeth; Sutkin, Gary; Wilson, Tracey S.; Hsu, Yvonne; Rozanski, Thomas A.; Rickey, Leslie M.; Rahn, David; Tennstedt, Sharon; Kusek, John W.; Gormley, E. Ann		Urinary Incontinence Treatment Net	A Randomized Trial of Urodynamic Testing before Stress-Incontinence Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC ORGAN PROLAPSE; URINARY-INCONTINENCE; BURCH COLPOSUSPENSION; WOMEN; HEALTH; STANDARDIZATION; TERMINOLOGY; VALIDATION; GUIDELINES; COMMITTEE	BACKGROUND Urodynamic studies are commonly performed in women before surgery for stress urinary incontinence, but there is no good evidence that they improve outcomes. METHODS We performed a multicenter, randomized, noninferiority trial involving women with uncomplicated, demonstrable stress urinary incontinence to compare outcomes after preoperative office evaluation and urodynamic tests or evaluation only. The primary outcome was treatment success at 12 months, defined as a reduction in the score on the Urogenital Distress Inventory of 70% or more and a response of "much better" or "very much better" on the Patient Global Impression of Improvement. The predetermined noninferiority margin was 11 percentage points. RESULTS A total of 630 women were randomly assigned to undergo office evaluation with urodynamic tests or evaluation only ( 315 per group); the proportion in whom treatment was successful was 76.9% in the urodynamic-testing group versus 77.2% in the evaluation-only group ( difference, -0.3 percentage points; 95% confidence interval, -7.5 to 6.9), which was consistent with noninferiority. There were no significant between-group differences in secondary measures of incontinence severity, quality of life, patient satisfaction, rates of positive provocative stress tests, voiding dysfunction, or adverse events. Women who underwent urodynamic tests were significantly less likely to receive a diagnosis of overactive bladder and more likely to receive a diagnosis of voiding-phase dysfunction, but these changes did not lead to significant between-group differences in treatment selection or outcomes. CONCLUSIONS For women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone was not inferior to evaluation with urodynamic testing for outcomes at 1 year.	[Nager, Charles W.; Albo, Michael E.] Univ Calif San Diego, La Jolla, CA 92037 USA; [Menefee, Shawn A.] Kaiser Permanente So Calif, San Diego, CA USA; [Brubaker, Linda; Kenton, Kimberly; Mueller, Elizabeth] Loyola Univ, Chicago, IL 60611 USA; [Litman, Heather J.; Dandreo, Kimberly J.; Mihova, Marina; Tennstedt, Sharon] New England Res Inst, Watertown, MA 02172 USA; [Zyczynski, Halina M.; Lowder, Jerry; Sutkin, Gary] Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Varner, R. Edward; Richter, Holly E.; Wilson, Tracey S.] Univ Alabama Birmingham, Birmingham, AL USA; [Amundsen, Cindy] Duke Univ, Durham, NC USA; [Sirls, Larry T.; Khandwala, Salil] William Beaumont Hosp, Royal Oak, MI 48072 USA; [Sirls, Larry T.; Khandwala, Salil] Oakwood Hosp, Dearborn, MI USA; [Norton, Peggy A.; Nygaard, Ingrid; Hsu, Yvonne] Univ Utah, Salt Lake City, UT USA; [Arisco, Amy M.; Kraus, Stephen R.; Rozanski, Thomas A.] Univ Texas San Antonio, San Antonio, TX USA; [Chai, Toby C.; Johnson, Harry W.; Rickey, Leslie M.] Univ Maryland, Baltimore, MD 21201 USA; [Zimmern, Philippe; Lemack, Gary E.; Rahn, David] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Barber, Matthew D.] Cleveland Clin, Cleveland, OH USA; [Kusek, John W.] NIH, Bethesda, MD 20892 USA; [Gormley, E. Ann] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	University of California System; University of California San Diego; Kaiser Permanente; Loyola University Chicago; HealthCore, Inc; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Duke University; Beaumont Health; Beaumont Health; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas at San Antonio (UTSA); University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; Dartmouth College	Nager, CW (corresponding author), Univ Calif San Diego, Perlman Suite 2A,Mail Code 0974,9350 Campus Pt Dr, La Jolla, CA 92037 USA.	cnager@ucsd.edu	Rahn, David/AAB-2551-2019; Brubaker, Linda/J-5918-2019	Rahn, David/0000-0003-4775-2368; Brubaker, Linda/0000-0002-8598-2589; Wadie, Bassem/0000-0002-6977-6849; Chai, Toby/0000-0002-1119-546X; Sutkin, Gary/0000-0002-6336-5109; Richter, Holly E/0000-0001-7741-5771	National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK58225, U01 DK58229, U01 DK58234, U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60393, U01 DK60395, U01 DK60397, U01DK60401]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054214, UG1HD041267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060395, U01DK058229, U01DK060380, U01DK058231, U01DK058225, U01DK058234, U01DK060379, U01DK060393, U01DK060397, U01DK060401] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT00803959.; Supported by cooperative agreements (U01 DK58225, U01 DK58229, U01 DK58234, U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60393, U01 DK60395, U01 DK60397, and U01DK60401) from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Agur W, 2009, BJU INT, V103, P635, DOI 10.1111/j.1464-410X.2008.08121.x; Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; [Anonymous], 2006, US MORT DAT 1960 200, V40, P1; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CRYSTLE CD, 1971, OBSTET GYNECOL, V38, P313; Digesu GA, 2009, UROLOGY, V74, P278, DOI 10.1016/j.urology.2009.01.089; Fletcher SG, 2008, THESCIENTIFICWORLDJO, V8, P1259, DOI 10.1100/tsw.2008.159; Food and Drug Administration, 2011, UR SURG MESH UPD SAF; Ghoniem G, 2008, INT UROGYNECOL J, V19, P5, DOI 10.1007/s00192-007-0495-5; Glazener CM, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003195, DOI 10.1002/14651858.CD003195]; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; Ingenix, 2011, NAT FEE AN 2011 CHAR; Lemack GE, 2008, J UROLOGY, V180, P2076, DOI 10.1016/j.juro.2008.07.027; Nager CW, 2008, J UROLOGY, V179, P1470, DOI 10.1016/j.juro.2007.11.077; Nager CW, 2011, J UROLOGY, V186, P597, DOI 10.1016/j.juro.2011.03.105; Nager CW, 2009, CONTEMP CLIN TRIALS, V30, P531, DOI 10.1016/j.cct.2009.07.001; Okorocha I, 2002, BJU INT, V89, P863, DOI 10.1046/j.1464-410X.2002.02770.x; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Schierlitz L, 2008, OBSTET GYNECOL, V112, P1253, DOI 10.1097/AOG.0b013e31818db391; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	26	292	301	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1987	1997		10.1056/NEJMoa1113595	http://dx.doi.org/10.1056/NEJMoa1113595			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22551104	Green Accepted			2022-12-28	WOS:000304353000009
J	Law, S				Law, Simon			Is minimally invasive preferable to open oesophagectomy?	LANCET			English	Editorial Material							LIMITED TRANSHIATAL RESECTION; CANCER; ESOPHAGUS; ADENOCARCINOMA		Univ Hong Kong, Queen Mary Hosp, Dept Surg, Div Esophageal & Upper Gastrointestinal Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Law, S (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Div Esophageal & Upper Gastrointestinal Surg, Hong Kong, Hong Kong, Peoples R China.	slaw@hku.hk	Law, Simon/C-4324-2009	Law, Simon/0000-0002-6518-5806				Biere SSAY, 2009, MINERVA CHIR, V64, P121; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Cuschieri A, 1992, J R Coll Surg Edinb, V37, P7; Decker G, 2009, EUR J CARDIO-THORAC, V35, P13, DOI 10.1016/j.ejcts.2008.09.024; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Law S, 2002, LANCET ONCOL, V3, P215, DOI 10.1016/S1470-2045(02)00712-X; Law S, 2006, BEST PRACT RES CL GA, V20, P925, DOI 10.1016/j.bpg.2006.03.011; Nagpal K, 2010, SURG ENDOSC, V24, P1621, DOI 10.1007/s00464-009-0822-7; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Orringer MB, 2007, ANN SURG, V246, P363, DOI 10.1097/SLA.0b013e31814697f2; Osugi Harushi, 2005, Ann Thorac Cardiovasc Surg, V11, P221; Sgourakis G, 2010, DIGEST DIS SCI, V55, P3031, DOI 10.1007/s10620-010-1153-1; Smithers BM, 2007, ANN SURG, V245, P232, DOI 10.1097/01.sla.0000225093.58071.c6	13	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 19	2012	379	9829					1856	1858		10.1016/S0140-6736(12)60601-1	http://dx.doi.org/10.1016/S0140-6736(12)60601-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IW	22552193				2022-12-28	WOS:000304194200006
J	Peron, S; Laffleur, B; Denis-Lagache, N; Cook-Moreau, J; Tinguely, A; Delpy, L; Denizot, Y; Pinaud, E; Cogne, M				Peron, Sophie; Laffleur, Brice; Denis-Lagache, Nicolas; Cook-Moreau, Jeanne; Tinguely, Aurelien; Delpy, Laurent; Denizot, Yves; Pinaud, Eric; Cogne, Michel			AID-Driven Deletion Causes Immunoglobulin Heavy Chain Locus Suicide Recombination in B Cells	SCIENCE			English	Article							CLASS-SWITCH RECOMBINATION; IGH LOCUS; HISTONE MODIFICATIONS; REGION; ELEMENTS; IDENTIFICATION; ACTIVATION; END; MU	Remodeling of immunoglobulin genes by activation-induced deaminase (AID) is required for affinity maturation and class-switch recombination in mature B lymphocytes. In the immunoglobulin heavy chain locus, these processes are predominantly controlled by the 3' cis-regulatory region. We now show that this region is transcribed and undergoes AID-mediated mutation and recombination around phylogenetically conserved switchlike DNA repeats. Such recombination, which we term locus suicide recombination, deletes the whole constant region gene cluster and thus stops expression of the immunoglobulin of the B cell surface, which is critical for B cell survival. The frequency of this event is approaching that of class switching and makes it a potential regulator of B cell homeostasis.	[Peron, Sophie; Laffleur, Brice; Denis-Lagache, Nicolas; Cook-Moreau, Jeanne; Tinguely, Aurelien; Delpy, Laurent; Denizot, Yves; Pinaud, Eric; Cogne, Michel] Univ Limoges, CNRS, F-87025 Limoges, France	Centre National de la Recherche Scientifique (CNRS); Universite de Limoges	Cogne, M (corresponding author), Univ Limoges, CNRS, 2 Rue Marcland, F-87025 Limoges, France.	cogne@unilim.fr	Denizot, Yves/H-9769-2016; PERON, SOPHIE/O-8364-2016; PINAUD, Eric/O-8443-2016; Delpy, Laurent/O-8408-2016; cogné, michel/D-7370-2015; Moreau, Jeanne/O-8522-2016	PERON, SOPHIE/0000-0002-0056-3271; PINAUD, Eric/0000-0001-7405-9273; Delpy, Laurent/0000-0002-9480-8515; cogné, michel/0000-0002-8519-4427; Moreau, Jeanne/0000-0003-3590-1602	Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer; Canceropole Grand Sud-Ouest; Institut National du Cancer; Region Limousin	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France); Region Limousin	We thank T. Honjo for providing AID<SUP>-/-</SUP> mice and F. Lechouane for sorted B cells DNA samples. We are indebted to the cell sorting facility of Limoges University for excellent technical assistance in cell sorting. This work was supported by grants from Association pour la Recherche sur le Cancer, Ligue Nationale contre le Cancer, Canceropole Grand Sud-Ouest, Institut National du Cancer, and Region Limousin. The data presented in this paper are tabulated here and in the supplementary materials.	Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.0.CO;2-V; Chauveau C, 1996, NAT GENET, V14, P15, DOI 10.1038/ng0996-15; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Duan H, 2008, ONCOGENE, V27, P6720, DOI 10.1038/onc.2008.286; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Giambra V, 2008, MOL CELL BIOL, V28, P6123, DOI 10.1128/MCB.00233-08; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Pinaud E, 1997, EUR J IMMUNOL, V27, P2981, DOI 10.1002/eji.1830271134; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Sepulveda MA, 2005, MOL IMMUNOL, V42, P605, DOI 10.1016/j.molimm.2004.09.006; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	26	57	60	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					931	934		10.1126/science.1218692	http://dx.doi.org/10.1126/science.1218692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22539552				2022-12-28	WOS:000304145600069
J	Hochberg, LR; Bacher, D; Jarosiewicz, B; Masse, NY; Simeral, JD; Vogel, J; Haddadin, S; Liu, J; Cash, SS; van der Smagt, P; Donoghue, JP				Hochberg, Leigh R.; Bacher, Daniel; Jarosiewicz, Beata; Masse, Nicolas Y.; Simeral, John D.; Vogel, Joern; Haddadin, Sami; Liu, Jie; Cash, Sydney S.; van der Smagt, Patrick; Donoghue, John P.			Reach and grasp by people with tetraplegia using a neurally controlled robotic arm	NATURE			English	Article							LOCAL-FIELD POTENTIALS; PRIMARY MOTOR; CORTICAL CONTROL; SPIKING ACTIVITY; PROSTHETIC ARM; BRAIN; RESTORATION; MOVEMENTS; SIGNALS; HUMANS	Paralysis following spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis and other disorders can disconnect the brain from the body, eliminating the ability to perform volitional movements. A neural interface system(1-5) could restore mobility and independence for people with paralysis by translating neuronal activity directly into control signals for assistive devices. We have previously shown that people with long-standing tetraplegia can use a neural interface system to move and click a computer cursor and to control physical devices(6-8). Able-bodied monkeys have used a neural interface system to control a robotic arm(9), but it is unknown whether people with profound upper extremity paralysis or limb loss could use cortical neuronal ensemble signals to direct useful arm actions. Here we demonstrate the ability of two people with long-standing tetraplegia to use neural interface system-based control of a robotic arm to perform three-dimensional reach and grasp movements. Participants controlled the arm and hand over a broad space without explicit training, using signals decoded from a small, local population of motor cortex (MI) neurons recorded from a 96-channel microelectrode array. One of the study participants, implanted with the sensor 5 years earlier, also used a robotic arm to drink coffee from a bottle. Although robotic reach and grasp actions were not as fast or accurate as those of an able-bodied person, our results demonstrate the feasibility for people with tetraplegia, years after injury to the central nervous system, to recreate useful multidimensional control of complex devices directly from a small sample of neural signals.	[Hochberg, Leigh R.; Jarosiewicz, Beata; Simeral, John D.; Liu, Jie; Donoghue, John P.] Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI 02908 USA; [Hochberg, Leigh R.; Bacher, Daniel; Simeral, John D.; Liu, Jie; Donoghue, John P.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.; Bacher, Daniel; Jarosiewicz, Beata; Masse, Nicolas Y.; Simeral, John D.; Liu, Jie; Donoghue, John P.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.; Simeral, John D.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Hochberg, Leigh R.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jarosiewicz, Beata; Masse, Nicolas Y.; Donoghue, John P.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Vogel, Joern; Haddadin, Sami; van der Smagt, Patrick] German Aerosp Ctr, Inst Robot & Mechatron DLR Oberpfaffenhofen, D-82230 Oberpfaffenhofen, Germany	Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Helmholtz Association; German Aerospace Centre (DLR)	Donoghue, JP (corresponding author), Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI 02908 USA.	leigh@brown.edu; john_donoghue@brown.edu	Simeral, John/CCI-2624-2022; Hochberg, Leigh/R-6872-2019; Jarosiewicz, Beata/AAT-8548-2021	Hochberg, Leigh/0000-0003-0261-2273; Masse, Nicolas/0000-0002-9094-1298; van der Smagt, Patrick/0000-0003-4418-4916; Vogel, Jorn/0000-0002-1987-0028	Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs [B6453R, A6779I, B6310N]; National Institutes of Health: NINDS/NICHD [RC1HD063931]; NIDCD [R01DC009899]; NICHD-NCMRR [N01HD53403, N01HD10018]; NIBIB [R01EB007401]; NINDS-Javits [NS25074]; Defense Advanced Research Projects Agency (DARPA); Department of Veterans Affairs; Doris Duke Charitable Foundation; MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; European Commission [248587]; Cyberkinetics Neurotechnology Systems (CKI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063931, R03HD053403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025074, R01NS025074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER	Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health: NINDS/NICHD; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD-NCMRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS-Javits; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Veterans Affairs(US Department of Veterans Affairs); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Cyberkinetics Neurotechnology Systems (CKI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank participants S3 and T2 for their dedication to this research. We thank M. Black for initial guidance in the BrainGate-DLR research. We thank E. Gallivan, E. Berhanu, D. Rosler, L. Barefoot, K. Centrella and B. King for their contributions to this research. We thank G. Friehs and E. Eskandar for their surgical contributions. We thank K. Knoper for assistance with illustrations. We thank D. Van Der Merwe and DEKA Research and Development for their technical support. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The research was supported by the Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs (Merit Review Awards B6453R and A6779I; Career Development Transition Award B6310N). Support was also provided by the National Institutes of Health: NINDS/NICHD (RC1HD063931), NIDCD (R01DC009899), NICHD-NCMRR (N01HD53403 and N01HD10018), NIBIB (R01EB007401), NINDS-Javits (NS25074); a Memorandum of Agreement between the Defense Advanced Research Projects Agency (DARPA) and the Department of Veterans Affairs; the Doris Duke Charitable Foundation; the MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; the European Commission's Seventh Framework Programme through the project The Hand Embodied (grant 248587). The pilot clinical trial into which participant S3 was recruited was sponsored in part by Cyberkinetics Neurotechnology Systems (CKI).	Albu-Schaffer A, 2007, IND ROBOT, V34, P376, DOI 10.1108/01439910710774386; Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979; Bansal AK, 2011, J NEUROPHYSIOL, V105, P1603, DOI 10.1152/jn.00532.2010; Burrow M., 1997, P INT C REH ROB, P83; Chadwick EK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/034003; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Haddadin S, 2009, INT J ROBOT RES, V28, P1507, DOI 10.1177/0278364909343970; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Kim SP, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P486, DOI 10.1109/CNE.2007.369715; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kruger Jurgen, 2010, Front Neuroeng, V3, P6, DOI 10.3389/fneng.2010.00006; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Liu H, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3692, DOI 10.1109/IROS.2008.4650624; Malik WQ, 2011, IEEE T NEUR SYS REH, V19, P25, DOI 10.1109/TNSRE.2010.2092443; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Pohlmeyer EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005924; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Resnik L, 2010, J REHABIL RES DEV, V47, pIX, DOI 10.1682/JRRD.2010.03.0034; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shin HC, 2010, IEEE T BIO-MED ENG, V57, P754, DOI 10.1109/TBME.2009.2020791; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	38	1466	1508	62	927	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					372	U121		10.1038/nature11076	http://dx.doi.org/10.1038/nature11076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596161	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000304099100043
J	Burns, KH; Boeke, JD				Burns, Kathleen H.; Boeke, Jef D.			Human Transposon Tectonics	CELL			English	Review							CONGENITAL MUSCULAR-DYSTROPHY; HUMAN L1 RETROTRANSPOSITION; HUMAN GENOME; REPETITIVE ELEMENTS; LINE-1 RETROTRANSPOSITION; ENDOGENOUS RETROVIRUSES; DNA METHYLATION; RETINITIS-PIGMENTOSA; PIRNA AMPLIFICATION; ANTISENSE PROMOTER	Mobile DNAs have had a central role in shaping our genome. More than half of our DNA is comprised of interspersed repeats resulting from replicative copy and paste events of retrotransposons. Although most are fixed, incapable of templating new copies, there are important exceptions to retrotransposon quiescence. De novo insertions cause genetic diseases and cancers, though reliably detecting these occurrences has been difficult. New technologies aimed at uncovering polymorphic insertions reveal that mobile DNAs provide a substantial and dynamic source of structural variation. Key questions going forward include how and how much new transposition events affect human health and disease.	[Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Burns, Kathleen H.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Burns, Kathleen H.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Burns, Kathleen H.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD 21205 USA; [Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burns, KH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	kburns@jhmi.edu; jboeke@jhmi.edu		Burns, Kathleen/0000-0003-1620-3761; Boeke, Jef/0000-0001-5322-4946	Burroughs Wellcome Foundation [P01 CA16519, RC1 HG005359, K08 CA134746]; NATIONAL CANCER INSTITUTE [P01CA016519, K08CA134746, R01CA161210] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005359] Funding Source: NIH RePORTER	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants P01 CA16519 and RC1 HG005359 (to J.D.B.) and K08 CA134746 and a Career Award for Medical Scientists from the Burroughs Wellcome Foundation (to K.H.B.).	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Aleman C, 2000, NUCLEIC ACIDS RES, V28, P4755, DOI 10.1093/nar/28.23.4755; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Boissinot S, 2006, P NATL ACAD SCI USA, V103, P9590, DOI 10.1073/pnas.0603334103; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRITTEN RJ, 1994, P NATL ACAD SCI USA, V91, P6148, DOI 10.1073/pnas.91.13.6148; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Buzdin A, 2003, HUM GENET, V112, P527, DOI 10.1007/s00439-002-0904-2; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; COHEN M, 1988, BIOESSAYS, V9, P191, DOI 10.1002/bies.950090603; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; DANTE R, 1992, ANTICANCER RES, V12, P559; Dawkins Richard, 1976, SELFISH GENE; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Ganguly A, 2003, HUM GENET, V113, P348, DOI 10.1007/s00439-003-0986-5; Garcia-Perez JL, 2010, NATURE, V466, P769, DOI 10.1038/nature09209; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Geiman TM, 2001, BBA-GEN SUBJECTS, V1526, P211, DOI 10.1016/S0304-4165(01)00129-5; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Harris Chris R, 2010, Genes Cancer, V1, P115, DOI 10.1177/1947601909360812; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Konkel MK, 2007, GENE, V390, P28, DOI 10.1016/j.gene.2006.07.040; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mager D.L., 2005, NATURE ENCY HUMAN GE, DOI 10.1038/npg.els.0005062; Martin SL, 2010, RNA BIOL, V7, P706, DOI 10.4161/rna.7.6.13766; Martinez-Garay I, 2003, CLIN GENET, V64, P491, DOI 10.1046/j.1399-0004.2003.00166.x; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MIKI Y, 1992, CANCER RES, V52, P643; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ostertag EM, 2001, GENOME RES, V11, P2059, DOI 10.1101/gr.205701; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pornthanakasem W, 2004, BIOTECHNIQUES, V37, P750, DOI 10.2144/04375BM07; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Rangwala SH, 2009, METHODS, V49, P219, DOI 10.1016/j.ymeth.2009.04.012; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Santourlidis S, 1999, PROSTATE, V39, P166; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SHEN MR, 1991, J MOL EVOL, V33, P311; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit AF., 1996, REPEATMASKER 1996 20; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Taniguchi-Ikeda M, 2011, NATURE, V478, P127, DOI 10.1038/nature10456; Tighe PJ, 2002, GENES IMMUN, V3, pS66, DOI 10.1038/sj.gene.6363864; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Weber B, 2010, ONCOGENE, V29, P5775, DOI 10.1038/onc.2010.227; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wheelan SJ, 2006, P NATL ACAD SCI USA, V103, P17632, DOI 10.1073/pnas.0605450103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zhang YH, 2000, HUM MUTAT, V15, P316, DOI 10.1002/(SICI)1098-1004(200004)15:4<316::AID-HUMU3>3.0.CO;2-9; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	127	194	197	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					740	752		10.1016/j.cell.2012.04.019	http://dx.doi.org/10.1016/j.cell.2012.04.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579280	Green Accepted, Bronze			2022-12-28	WOS:000303934700009
J	Gill, PJ; Harnden, A; Karpe, F				Gill, Peter J.; Harnden, Anthony; Karpe, Fredrik			EASILY MISSED? Familial hypercholesterolaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE REGISTRY; DIAGNOSIS; MANAGEMENT; MORTALITY; IDENTIFICATION; CHILDREN; DISEASE; COHORT		[Gill, Peter J.; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Gill, Peter J.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Karpe, Fredrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; University of Alberta; University of Oxford	Gill, PJ (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	peter.gill@phc.ox.ac.uk	Gill, Peter J./A-6021-2012	Gill, Peter J./0000-0002-6253-1312; Karpe, Fredrik/0000-0002-2751-1770				ASSOULINE L, 1995, PEDIATRICS, V96, P239; Beeharry D, 2006, ANN RHEUM DIS, V65, P312, DOI 10.1136/ard.2005.040766; Campagna F, 2008, ATHEROSCLEROSIS, V196, P356, DOI 10.1016/j.atherosclerosis.2006.11.015; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; Durrington PN, 2003, OXFORD TXB MED, P74; Goldberg AC, 2011, J CLIN LIPIDOL, V5, pS1, DOI 10.1016/j.jacl.2011.04.003; Junyent M, 2005, ARTERIOSCL THROM VAS, V25, P2203, DOI 10.1161/01.ATV.0000183888.48105.d1; Mant D, 2009, BRIT J GEN PRACT, V59, P777, DOI 10.3399/bjgp09X472683; Marks D, 2006, J MED SCREEN, V13, P156, DOI 10.1258/096914106778440617; Marks D, 2004, J PUBLIC HEALTH-UK, V26, P353, DOI 10.1093/pubmed/fdh176; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; National Institute for Health and Clinical Excellence, 2008, ID MAN FAM HYP; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Qureshi N, 2009, BRIT J GEN PRACT, V59, P773, DOI 10.3399/bjgp09X472674; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Rodenburg J, 2007, CIRCULATION, V116, P664, DOI 10.1161/CIRCULATIONAHA.106.671016; SLACK J, 1969, LANCET, V2, P1380; Starr B, 2008, CLIN CHEM LAB MED, V46, P791, DOI 10.1515/CCLM.2008.135; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; 1991, BMJ CLIN RES ED, V303, P893; 1999, ATHEROSCLEROSIS, V142, P105	24	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 11	2012	344								e3228	10.1136/bmj.e3228	http://dx.doi.org/10.1136/bmj.e3228			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XU	22581572				2022-12-28	WOS:000304085700002
J	Carpenter, D				Carpenter, Daniel			Strengthen and stabilize the FDA	NATURE			English	Editorial Material							DRUGS		[Carpenter, Daniel] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Carpenter, D (corresponding author), Univ Strasbourg, Inst Polit Studies, F-67081 Strasbourg, France.	dcarpenter@gov.harvard.edu						Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D, 2012, AM J POLIT SCI, V56, P98, DOI 10.1111/j.1540-5907.2011.00544.x; Cohen PA, 2009, NEW ENGL J MED, V361, P1523, DOI 10.1056/NEJMp0904768; Harris G., 2012, NY TIMES        0403; Miller JD, 2009, JAMA-J AM MED ASSOC, V302, P189, DOI 10.1001/jama.2009.974; Roberts SA, 2011, HEALTH AFFAIR, V30, P1375, DOI 10.1377/hlthaff.2011.0231	6	7	7	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					169	170		10.1038/485169a	http://dx.doi.org/10.1038/485169a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	939HJ	22575942				2022-12-28	WOS:000303799800016
J	Shahian, DM; Meyer, GS; Yeh, RW; Fifer, MA; Torchiana, DF				Shahian, David M.; Meyer, Gregg S.; Yeh, Robert W.; Fifer, Michael A.; Torchiana, David F.			Percutaneous Coronary Interventions without On-Site Cardiac Surgical Backup	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE-MYOCARDIAL-INFARCTION; ARTERY-BYPASS-SURGERY; IN-HOSPITAL MORTALITY; INTRAVENOUS THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; ST-SEGMENT; UNITED-STATES; COMMUNITY HOSPITALS; AMERICAN-COLLEGE; RANDOMIZED-TRIAL		[Shahian, David M.] Massachusetts Gen Hosp, Ctr Qual & Safety, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Shahian, DM (corresponding author), Massachusetts Gen Hosp, Ctr Qual & Safety, 55 Fruit St, Boston, MA 02114 USA.	dshahian@partners.org	Yeh, Robert/AAJ-3463-2020		RAND; Institute for Clinical Effectiveness and Health Policy, Buenos Aires; CRICO/RM; Kaiser Permanente Division of Research; Harvard Clinical Research Institute; Schering-Plough	RAND; Institute for Clinical Effectiveness and Health Policy, Buenos Aires; CRICO/RM; Kaiser Permanente Division of Research; Harvard Clinical Research Institute; Schering-Plough(Merck & CompanySchering Plough Corporation)	Dr. Fifer reports serving as an expert witness in malpractice and workers' compensation cases regarding diagnosis and management of cardiac disease and complications of cardiac catheterization and holding a patent (number 12/277,740) for a blood test for early diagnosis of myocardial infarction; Dr. Meyer reports holding unpaid board memberships in CRICO/RMF and the National Patient Safety Foundation, receiving consulting fees from RAND and lecture fees from the Institute for Clinical Effectiveness and Health Policy, Buenos Aires, and receiving expert-testimony fees regarding serious reportable events from CRICO/RM on behalf of his institution; Dr. Yeh reports receiving consulting fees from Kaiser Permanente Division of Research, consulting fees from Harvard Clinical Research Institute on behalf of his institution, and grant support from Schering-Plough on behalf of his former institution. No other potential conflict of interest relevant to this article was reported.	Akdemir Ramazan, 2004, J Invasive Cardiol, V16, P645; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ANTMAN EM, 2008, CIRCULATION, V117, pE162; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P3212; Aversano T, 2012, NEW ENGL J MED, V366, P1792, DOI 10.1056/NEJMoa1114540; Baduini G, 1994, G Ital Cardiol, V24, P1529; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Brown DC, 2006, CLIN CARDIOL, V29, P337, DOI 10.1002/clc.4960290804; Buckley JW, 2008, AM HEART J, V155, P668, DOI 10.1016/j.ahj.2007.10.051; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Carey JS, 2008, J THORAC CARDIOV SUR, V135, P1254, DOI 10.1016/j.jtcvs.2007.10.077; Carlsson J, 2007, HEART, V93, P335, DOI 10.1136/hrt.2006.098061; Carrillo P, 2007, REV ESP CARDIOL, V60, P801, DOI 10.1157/13108993; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Cheong YM, 1998, AUST NZ J MED, V28, P165, DOI 10.1111/j.1445-5994.1998.tb02965.x; COWLEY MJ, 1984, AM J CARDIOL, V53, pC22, DOI 10.1016/0002-9149(84)90740-9; Dawkins KD, 2005, HEART, V91, pIII1, DOI 10.1136/hrt.2005.060285; de Belder MA, 2007, HEART, V93, P281, DOI 10.1136/hrt.2006.104034; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Dehmer GJ, 2004, J AM COLL CARDIOL, V43, P343, DOI 10.1016/j.jacc.2003.11.008; Dehmer GJ, 2007, CATHETER CARDIOVASC, V69, P931; Dehmer GJ, 2007, CATHETER CARDIO INTE, V69, P471, DOI 10.1002/ccd.21097; Dehmer Gregory J, 2008, Curr Cardiol Rep, V10, P407, DOI 10.1007/s11886-008-0064-7; Dehmer GJ, 2009, CIRC-CARDIOVASC INTE, V2, P497, DOI 10.1161/CIRCINTERVENTIONS.109.921346; Djelmami-Hani M, 2007, WMJ, V106, P481; Dudek Dariusz, 2003, Kardiol Pol, V58, P356; Dudek Dariusz, 2004, Przegl Lek, V61, P1; Egger M, 2001, SYSTEMATIC REV HLTH; ELLIS SG, 1995, AM HEART J, V130, P643, DOI 10.1016/0002-8703(95)90300-3; Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551; Escarcega RO, 2010, ISR MED ASSOC J, V12, P592; Frutkin AD, 2008, AM J CARDIOL, V101, P53, DOI 10.1016/j.amjcard.2007.07.047; Gunalingam B, 2008, HEART LUNG CIRC, V17, P388, DOI 10.1016/j.hlc.2008.01.004; Hannan EL, 2009, CIRC-CARDIOVASC INTE, V2, P519, DOI 10.1161/CIRCINTERVENTIONS.109.894048; Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATIONAHA.104.528455; Hayat NJ, 1998, INT J CARDIOL, V64, P241, DOI 10.1016/S0167-5273(98)00076-X; Holmes DR, 2003, CIRCULATION, V107, P1871, DOI 10.1161/01.CIR.0000065229.72905.78; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Jacobs AK, 2008, AM HEART J, V155, P585, DOI 10.1016/j.ahj.2008.01.024; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; KLINKE WP, 1992, AM J CARDIOL, V70, P1520, DOI 10.1016/0002-9149(92)90451-4; Krone RJ, 2000, AM J CARDIOL, V85, P1179, DOI 10.1016/S0002-9149(00)00724-4; Kutcher MA, 2009, J AM COLL CARDIOL, V54, P16, DOI 10.1016/j.jacc.2009.03.038; Lemkes JS, 2007, NETH HEART J, V15, P173, DOI 10.1007/BF03085976; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Liem AL, 1998, J AM COLL CARDIOL, V32, P629, DOI 10.1016/S0735-1097(98)00280-0; Long KH, 2006, MED CARE, V44, P406, DOI 10.1097/01.mlr.0000207489.13557.cc; Lotfi M, 2004, J AM COLL CARDIOL, V43, P337, DOI 10.1016/j.jacc.2003.08.045; Loubeyre C, 1999, CATHETER CARDIO INTE, V47, P441, DOI 10.1002/(SICI)1522-726X(199908)47:4<441::AID-CCD12>3.0.CO;2-S; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; Mauri L, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.018; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Melberg T, 2006, AM HEART J, V152, P888, DOI 10.1016/j.ahj.2006.06.026; Melberg T, 2010, EUR J CARDIOV PREV R, V17, P235, DOI 10.1097/HJR.0b013e3283378880; Moyer Peter, 2004, Crit Pathw Cardiol, V3, P53, DOI 10.1097/01.hpc.0000128714.35330.6d; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2006, CIRCULATION, V113, P1189, DOI 10.1161/CIRCULATIONAHA.105.596346; O'Connor GT, 1999, J AM COLL CARDIOL, V34, P681, DOI 10.1016/S0735-1097(99)00267-3; O'Neill WW, 2009, CIRCULATION, V120, P546, DOI 10.1161/CIRCULATIONAHA.109.885269; Ong SH, 2009, ANN ACAD MED SINGAP, V38, P1085; Paraschos A, 2005, AM J CARDIOL, V95, P1091, DOI 10.1016/j.amjcard.2004.12.066; Peels HO, 2007, AM J CARDIOL, V100, P1353, DOI 10.1016/j.amjcard.2007.06.022; Peels JOJ, 2009, INT J CARDIOL, V132, P59, DOI 10.1016/j.ijcard.2007.10.037; Pereira Helder, 2008, Rev Port Cardiol, V27, P769; Peters JL, 2007, STAT MED, V26, P4544, DOI 10.1002/sim.2889; Pride Yuri B, 2011, Curr Cardiol Rep, V13, P432, DOI 10.1007/s11886-011-0197-y; Pride YB, 2009, JACC-CARDIOVASC INTE, V2, P944, DOI 10.1016/j.jcin.2009.07.008; Pride YB, 2009, CIRC-CARDIOVASC QUAL, V2, P574, DOI 10.1161/CIRCOUTCOMES.108.841296; Reinecke H, 2000, ANN THORAC SURG, V70, P1997, DOI 10.1016/S0003-4975(00)02172-X; Ribichini F, 1999, Semin Interv Cardiol, V4, P47; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; Roussanov O, 2006, AM HEART J, V152, P909, DOI 10.1016/j.ahj.2006.05.016; Ryan TJ, 2003, AM HEART J, V145, P214, DOI 10.1067/mhj.2003.62; Seshadri N, 2002, CIRCULATION, V106, P2346, DOI 10.1161/01.CIR.0000036595.92742.69; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Shiraishi J, 2007, CIRC J, V71, P1208, DOI 10.1253/circj.71.1208; Shubrooks SJ, 2001, AM HEART J, V142, P190, DOI 10.1067/mhj.2001.116077; Singh M, 2005, CATHETER CARDIO INTE, V65, P1, DOI 10.1002/ccd.20341; Singh M, 2004, MAYO CLIN PROC, V79, P738; Singh M, 2002, J AM COLL CARDIOL, V39, P1881, DOI 10.1016/S0735-1097(02)01901-0; Singh M, 2008, CIRCULATION, V117, P356, DOI 10.1161/CIRCULATIONAHA.107.711523; Singh M, 2006, AM HEART J, V152, P810, DOI 10.1016/j.ahj.2005.08.024; Singh M, 2011, JAMA-J AM MED ASSOC, V306, P2487, DOI 10.1001/jama.2011.1790; Singh M, 2009, MAYO CLIN PROC, V84, P501, DOI 10.1016/S0025-6196(11)60581-8; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Sorensen LL, 2010, DAN MED BULL, V57; Srinivas VS, 2009, J AM COLL CARDIOL, V53, P574, DOI 10.1016/j.jacc.2008.09.056; Stone GW, 2000, AM J CARDIOL, V85, P1292, DOI 10.1016/S0002-9149(00)00758-X; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tebbe U, 2009, CLIN RES CARDIOL, V98, P701, DOI 10.1007/s00392-009-0045-x; Ting HH, 2006, J AM COLL CARDIOL, V47, P1713, DOI 10.1016/j.jacc.2006.02.039; Ting HH, 2003, AM HEART J, V145, P278, DOI 10.1067/mhj.2003.61; Turgeman Y, 2003, ISR MED ASSOC J, V5, P89; Varbella Ferdinando, 2004, Ital Heart J Suppl, V5, P847; Voith Laszlo, 2005, Orvosi Hetilap, V146, P1615; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; Weaver WD, 2004, JAMA-J AM MED ASSOC, V292, P2014, DOI 10.1001/jama.292.16.2014; Weaver WD, 1998, JAMA-J AM MED ASSOC, V279, P1876; Weaver WD, 1995, J INVASIVE CARDIOL, V7, pF34; WEAVER WD, 1993, CIRCULATION, V88, P2067, DOI 10.1161/01.CIR.88.5.2067; Wennberg DE, 2004, JAMA-J AM MED ASSOC, V292, P1961, DOI 10.1001/jama.292.16.1961; Wharton TP, 2004, J AM COLL CARDIOL, V43, P1943, DOI 10.1016/j.jacc.2004.03.013; Wharton TP, 1999, J AM COLL CARDIOL, V33, P1257, DOI 10.1016/S0735-1097(99)00009-1; Wu CT, 2006, J AM COLL CARDIOL, V47, P654, DOI 10.1016/j.jacc.2005.09.071; Yang EH, 2005, J AM COLL CARDIOL, V46, P2004, DOI 10.1016/j.jacc.2005.06.083; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zahn R, 1999, J INVASIVE CARDIOL, V11, P213; Zavala-Alarcon E, 2004, AM HEART J, V148, P676, DOI 10.1016/j.ahj.2004.03.040; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	110	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1814	1823		10.1056/NEJMra1109616	http://dx.doi.org/10.1056/NEJMra1109616			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22571203				2022-12-28	WOS:000303817000010
J	Balents, L				Balents, Leon			The Impact of Ionic Frustration on Electronic Order	SCIENCE			English	Editorial Material									Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Balents, L (corresponding author), Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA.	balents@kitp.ucsb.edu						Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; BHATT RN, 1982, PHYS REV LETT, V48, P344, DOI 10.1103/PhysRevLett.48.344; Cheng JG, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.197204; Feiner LF, 1997, PHYS REV LETT, V78, P2799, DOI 10.1103/PhysRevLett.78.2799; Goodenough JB, 1998, ANNU REV MATER SCI, V28, P1, DOI 10.1146/annurev.matsci.28.1.1; Nakatsuji S, 2012, SCIENCE, V336, P559, DOI 10.1126/science.1212154; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Zhou HD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147204	8	5	5	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					547	548		10.1126/science.1221364	http://dx.doi.org/10.1126/science.1221364			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	935DJ	22556239				2022-12-28	WOS:000303498800031
J	Duncan, JL; Harrild, KA; Iversen, L; Lee, AJ; Godden, DJ				Duncan, John L.; Harrild, Kirsten A.; Iversen, Lisa; Lee, Amanda J.; Godden, David J.			Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FOLLOW-UP; MORTALITY; RISK; SURVEILLANCE; DIAMETER	Objective To determine whether there is a relation between aortic diameter and morbidity and mortality in men screened for abdominal aortic aneurysm. Design Prospective cohort study. Setting Highland and Western Isles (a large, sparsely populated area of Scotland). Participants 8146 men aged 65-74. Main outcome measures Morbidity and mortality in relation to presence of abdominal aortic aneurysm and three categories of aortic diameter (<= 24 mm, 25-29 mm, and >= 30 mm). Results When screened, 414 men (5.1%) had an aneurysm (diameter >= 30 mm), 669 (8.2%) an aortic diameter of 25-29 mm, and 7063 (86.7%) an aortic diameter of <= 24 mm. The cohort was followed up for a median of 7.4 (interquartile range 6.9-8.2) years. Mortality was significantly associated with aortic diameter: 512 (7.2%) men in the <= 24 mm group died compared with 69 (10.3%) in the 25-29 mm group and 73 (17.6%) in the >= 30 mm group. The mortality risk in men with an aneurysm or with an aorta measuring 25-29 mm was significantly higher than in men with an aorta of <= 24 mm. The increased mortality risk in the 25-29 mm group was reduced when taking confounders such as smoking and known heart disease into account. After adjustment, compared with men with an aortic diameter of <= 24 mm, the risk of hospital admission for cardiovascular disease and chronic obstructive pulmonary disease was significantly higher in men with aneurysm and those with aortas measuring 25-29 mm. Men with an aneurysm also had an increased risk of hospital admission for cerebrovascular disease, atherosclerosis, peripheral arterial disease, and respiratory disease. In men with aortas measuring 25-29 mm, the risk of hospital admission with abdominal aortic aneurysm was significantly higher than in men with an aorta of <= 24 mm (adjusted hazard ratio 6.7, 99% confidence interval 3.4 to 13.2) and this increased risk became apparent two years after screening. Conclusions Men with abdominal aortic aneurysm and those with aortic diameters measuring 25-29 mm have an increased risk of mortality and subsequent hospital admissions compared with men with an aorta diameter of <= 24 mm. Consideration should be given to control of risk factors and to rescreening men with aortas measuring 25-29 mm at index scanning.	[Duncan, John L.] Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland; [Harrild, Kirsten A.; Lee, Amanda J.] Univ Aberdeen, Div Appl Hlth Sci, Med Stat Team, Aberdeen, Scotland; [Godden, David J.] Univ Aberdeen, Ctr Hlth Sci, Ctr Rural Hlth, Inverness, Scotland	University of Aberdeen; UHI Millennium Institute; University of Aberdeen	Duncan, JL (corresponding author), Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland.	john.duncan3@nhs.net		Iversen, Lisa/0000-0002-2524-5229	Chief Scientist Office, Scotland [CZG/2/485]; Chief Scientist Office [CZG/2/485] Funding Source: researchfish	Chief Scientist Office, Scotland; Chief Scientist Office	The project was funded by a grant from the Chief Scientist Office, Scotland (CZG/2/485). The funder had no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit the article for publication.	[Anonymous], 2012, NHS ABD AORT AN SCRE; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Duncan JL, 2005, BRIT J SURG, V92, P984, DOI 10.1002/bjs.5120; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Freiberg MS, 2008, CIRCULATION, V117, P1010, DOI 10.1161/CIRCULATIONAHA.107.720219; Lindholt JS, 2007, EUR J VASC ENDOVASC, V33, P94, DOI 10.1016/j.ejvs.2006.06.007; Lindholt JS, 2011, BRIT J SURG, V98, P619, DOI 10.1002/bjs.7464; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; Lindsay SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-80; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; REED D, 1992, CIRCULATION, V85, P205, DOI 10.1161/01.CIR.85.1.205; Scott RAP, 2001, EUR J VASC ENDOVASC, V21, P535, DOI 10.1053/ejvs.2001.1368; Scottish Government, 2008, SCOTT GOV URB RUR CL; Scottish Government, 2004, SCOTT IND MULT DEPR; Takagi H, 2010, J VASC SURG, V52, P1103, DOI 10.1016/j.jvs.2010.02.283; The Scottish Government, 2010, SCOTT ABD AORT AN SC; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307	22	46	46	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2012	344								e2958	10.1136/bmj.e2958	http://dx.doi.org/10.1136/bmj.e2958			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NN	22563092	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000303818500001
J	Kahn, JS				Kahn, James S.			Next: Text	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kahn, James S.] Vet Adm Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA USA; [Kahn, James S.] Stanford Univ, Dept Med, Gen Med Disciplines, Palo Alto, CA 94304 USA	Stanford University	Kahn, JS (corresponding author), Vet Adm Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA USA.	james.kahn@va.gov						Stockwell MS, 2012, JAMA-J AM MED ASSOC, V307, P1702, DOI 10.1001/jama.2012.502; Wellbery C, 2012, JAMA-J AM MED ASSOC, V307, P1263, DOI 10.1001/jama.2012.343	2	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1807	1808		10.1001/jama.2012.3462	http://dx.doi.org/10.1001/jama.2012.3462			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550195				2022-12-28	WOS:000303386800019
J	Cutler, DM; Gruber, J				Cutler, David M.; Gruber, Jonathan			The Affordable Care Act Is Constitutional	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Cutler, David M.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Cutler, DM (corresponding author), Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917				[Anonymous], 2010, EFF EL IND MAND OBT; [Anonymous], 2011, MED EXP PAN SURV SUM; [Anonymous], 2010, COMMUNICATION; Gruber J., 2011, HLTH CARE REFORM IND; Gruber J, 2011, AVOIDING MED CARE SY; Gruber Jonathan, 2011, 17168 NBER; Kaiser Family Foundation, 2009, TRENDS HLTH CAR COST; Rask KN, 2000, J HEALTH ECON, V19, P1, DOI 10.1016/S0167-6296(98)00050-2; Romney M., 2006, WALL STREET J   0411, pA16; Rosenbaum S, 2010, NEW ENGL J MED, V363, P401, DOI 10.1056/NEJMp1005897; Walzer M, 1983, SPHERES JUSTICE DEFE	11	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					660	662		10.7326/0003-4819-156-12-201206190-00430	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00430			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547476				2022-12-28	WOS:000303403700008
J	Torjesen, I				Torjesen, Ingrid			Why using Avastin for eye disease is so difficult	BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2012, MOORFIELDS PHARM REC; [Anonymous], 2011, INPHARM         1007; European Alliance for Access to Safe Medicines, MEMB FUND; Macular Disease Society, GOV MUST ACT AV; North Yorkshire and York PCT, MIN BOARD M 24 JAN 2; North Yorkshire and York PCT, 2012, RAN LUC BEV AV OPHTH; Royal College of Ophthalmologists, 2011, RCOPHTH REV CONCL AV	7	9	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 1	2012	344								e3012	10.1136/bmj.e3012	http://dx.doi.org/10.1136/bmj.e3012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MZ	22549057				2022-12-28	WOS:000303816700016
J	Lasserson, D; Fox, R; Farmer, A				Lasserson, Daniel; Fox, Robin; Farmer, Andrew			Late onset type 1 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							YOUNG-ADULTS; MORTALITY; DIAGNOSIS; CHILDREN		[Lasserson, Daniel; Farmer, Andrew] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Fox, Robin] Ctr Hlth, Bicester, Oxon, England	University of Oxford	Lasserson, D (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	daniel.lasserson@phc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017	Lasserson, Daniel/0000-0001-8274-5580				Bruno G, 2005, DIABETES CARE, V28, P2613, DOI 10.2337/diacare.28.11.2613; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Imkampe AK, 2011, DIABETIC MED, V28, P811, DOI 10.1111/j.1464-5491.2011.03288.x; Royal College of General Practitioners NHS Diabetes, 2011, NHS DIAB COD CLASS D; Sabbah E, 2000, DIABETES CARE, V23, P1326, DOI 10.2337/diacare.23.9.1326; The National Collaborating Centre for Chronic Conditions, 2004, FEN MICR EV TYP 1 DI; Tuomi T, 2005, DIABETES, V54, pS40, DOI 10.2337/diabetes.54.suppl_2.S40; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, pd4092, DOI DOI 10.1136/BMJ.D4092; Zimmet P, 1999, DIABETES CARE, V22, pB59	11	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 30	2012	344								e2827	10.1136/bmj.e2827	http://dx.doi.org/10.1136/bmj.e2827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MY	22547644				2022-12-28	WOS:000303816600005
J	Pelkmans, L				Pelkmans, Lucas			Using Cell-to-Cell Variability-A New Era in Molecular Biology	SCIENCE			English	Editorial Material							HETEROGENEITY; CONSEQUENCES; INFORMATION; INFECTION; ORIGINS; GROWTH; IMAGES		Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch		Pelkmans, Lucas/0000-0002-6754-9730				Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Boland MV, 1999, TRENDS CELL BIOL, V9, P201, DOI 10.1016/S0962-8924(99)01550-0; BROOKS RF, 1988, J CELL SCI, V90, P601; Carpenter Anne E., 2009, V486, P193, DOI 10.1007/978-1-60327-545-3_14; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Li DL, 2011, P NATL ACAD SCI USA, V108, P21063, DOI 10.1073/pnas.1109773109; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047	23	118	118	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					425	426		10.1126/science.1222161	http://dx.doi.org/10.1126/science.1222161			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539709				2022-12-28	WOS:000303233400033
J	Boulay, RM				Boulay, Richard M.			Keep That	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Lehigh Valley Hlth Network, Dept Obstet & Gynecol, Allentown, PA USA	Lehigh Valley Health Network	Boulay, RM (corresponding author), Lehigh Valley Hlth Network, Dept Obstet & Gynecol, Allentown, PA USA.	Dr_Rick@Catherineboulayfoundation.org							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1701	1701		10.1001/jama.2012.501	http://dx.doi.org/10.1001/jama.2012.501			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535854				2022-12-28	WOS:000303147500022
J	Powell, K				Powell, Kendall			MOLECULAR ONCOLOGY The positive in the negative	NATURE			English	Editorial Material																		Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Shah S.P, 2012, NATURE          0404, DOI [10.1038/nature10933, DOI 10.1038/NATURE10933]; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242	6	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S52	S53		10.1038/nj7395-553a	http://dx.doi.org/10.1038/nj7395-553a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22548214	Bronze			2022-12-28	WOS:000304608000002
J	Ray, WA; Murray, KT; Hall, K; Arbogast, PG; Stein, CM				Ray, Wayne A.; Murray, Katherine T.; Hall, Kathi; Arbogast, Patrick G.; Stein, C. Michael			Azithromycin and the Risk of Cardiovascular Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QT-INTERVAL PROLONGATION; TORSADES-DE-POINTES; EVENT REPORTING SYSTEM; SUDDEN CARDIAC DEATH; ORAL ERYTHROMYCIN; PROPENSITY SCORES; DRUGS; PHARMACOEPIDEMIOLOGY; ADJUSTMENT; MACROLIDE	BACKGROUND Although several macrolide antibiotics are proarrhythmic and associated with an increased risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity. However, published reports of arrhythmias suggest that azithromycin may increase the risk of cardiovascular death. METHODS We studied a Tennessee Medicaid cohort designed to detect an increased risk of death related to short-term cardiac effects of medication, excluding patients with serious noncardiovascular illness and person-time during and shortly after hospitalization. The cohort included patients who took azithromycin (347,795 prescriptions), propensity-score-matched persons who took no antibiotics (1,391,180 control periods), and patients who took amoxicillin (1,348,672 prescriptions), ciprofloxacin (264,626 prescriptions), or levofloxacin (193,906 prescriptions). RESULTS During 5 days of therapy, patients taking azithromycin, as compared with those who took no antibiotics, had an increased risk of cardiovascular death (hazard ratio, 2.88; 95% confidence interval [CI], 1.79 to 4.63; P<0.001) and death from any cause (hazard ratio, 1.85; 95% CI, 1.25 to 2.75; P=0.002). Patients who took amoxicillin had no increase in the risk of death during this period. Relative to amoxicillin, azithromycin was associated with an increased risk of cardiovascular death (hazard ratio, 2.49; 95% CI, 1.38 to 4.50; P=0.002) and death from any cause (hazard ratio, 2.02; 95% CI, 1.24 to 3.30; P=0.005), with an estimated 47 additional cardiovascular deaths per 1 million courses; patients in the highest decile of risk for cardiovascular disease had an estimated 245 additional cardiovascular deaths per 1 million courses. The risk of cardiovascular death was significantly greater with azithromycin than with ciprofloxacin but did not differ significantly from that with levofloxacin. CONCLUSIONS During 5 days of azithromycin therapy, there was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease.	[Ray, Wayne A.; Hall, Kathi] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiol, Nashville, TN 37212 USA; [Murray, Katherine T.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Cardiol, Nashville, TN 37212 USA; [Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Arbogast, Patrick G.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Ray, Wayne A.] Nashville Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Suite 2600,1501 21st Ave S, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu			National Heart, Lung, and Blood Institute [HL081707]; Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics [HS1-0384]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096844, R01HL081707] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics.Supported by a grant from the National Heart, Lung, and Blood Institute (HL081707) and a cooperative agreement from the Agency for Healthcare Quality and Research Centers for Education and Research on Therapeutics (HS1-0384).	Arbogast PG, 2008, EPIDEMIOLOGY, V19, P30, DOI 10.1097/EDE.0b013e31815be000; Arellano-Rodrigo E, 2001, MED CLIN-BARCELONA, V117, P118, DOI 10.1016/S0025-7753(01)72036-2; Brenner H, 2004, EUR J CANCER, V40, P2317, DOI 10.1016/j.ejca.2004.07.007; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; Drici MD, 1998, JAMA-J AM MED ASSOC, V280, P1774, DOI 10.1001/jama.280.20.1774; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kezerashvili A, 2007, J INTERV CARD ELECTR, V18, P243, DOI 10.1007/s10840-007-9124-y; Kim MH, 2005, PACE, V28, P1221, DOI 10.1111/j.1540-8159.2005.50146.x; Koh TW, 2001, PACE, V24, P1575, DOI 10.1046/j.1460-9592.2001.01575.x; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; Matsunaga Naohisa, 2003, N Z Med J, V116, pU666; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Poluzzi E, 2009, PHARMACOEPIDEM DR S, V18, P512, DOI 10.1002/pds.1746; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Rothman K., 1998, MODERN EPIDEMIOLOGY; Russo Vincenzo, 2006, Acta Biomed, V77, P30; Samarendra P, 2001, PACE, V24, P1572, DOI 10.1046/j.1460-9592.2001.01572.x; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Simko J, 2008, INFECTION, V36, P194, DOI 10.1007/s15010-007-7211-8; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Tschida SJ, 1996, PHARMACOTHERAPY, V16, P663; Vogt AW, 1997, ANESTH ANALG, V85, P1011, DOI 10.1097/00000539-199711000-00010; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Zambon A, 2009, DRUG SAFETY, V32, P159, DOI 10.2165/00002018-200932020-00008	32	632	670	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1881	1890		10.1056/NEJMoa1003833	http://dx.doi.org/10.1056/NEJMoa1003833			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591294	Green Accepted, Bronze			2022-12-28	WOS:000304083000007
J	Knirsch, CA; Chandra, R				Knirsch, Charles A.; Chandra, Richa			Azithromycin and the Risk of Cardiovascular Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							SECONDARY PREVENTION		[Knirsch, Charles A.] Pfizer, New York, NY USA; [Chandra, Richa] Pfizer Inc, Groton, CT 06340 USA	Pfizer; Pfizer	Knirsch, CA (corresponding author), Pfizer, New York, NY USA.	charles.knirsch@pfizer.com			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096844, R01HL081707] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], ZITHR; Fossa AA, 2007, AM J TROP MED HYG, V77, P929, DOI 10.4269/ajtmh.2007.77.929; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; O'Connor CM, 2003, JAMA-J AM MED ASSOC, V290, P1459, DOI 10.1001/jama.290.11.1459; Thomsen MB, 2006, BRIT J PHARMACOL, V149, P1039, DOI 10.1038/sj.bjp.0706900	6	632	670	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					772	773		10.1056/NEJMoa1003833	http://dx.doi.org/10.1056/NEJMoa1003833			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22591294				2022-12-28	WOS:000307754200019
